Psyllid ID: psy6357
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | 2.2.26 [Sep-21-2011] | |||||||
| Q9Y2K2 | 1263 | Serine/threonine-protein | yes | N/A | 0.362 | 0.182 | 0.691 | 6e-96 | |
| Q6P4S6 | 1311 | Serine/threonine-protein | yes | N/A | 0.362 | 0.175 | 0.691 | 6e-96 | |
| Q8CFH6 | 931 | Serine/threonine-protein | no | N/A | 0.379 | 0.258 | 0.626 | 2e-91 | |
| Q9H0K1 | 926 | Serine/threonine-protein | no | N/A | 0.379 | 0.260 | 0.622 | 2e-91 | |
| Q6NSM8 | 1187 | Serine/threonine-protein | yes | N/A | 0.4 | 0.213 | 0.599 | 3e-91 | |
| Q60670 | 779 | Serine/threonine-protein | no | N/A | 0.371 | 0.302 | 0.616 | 1e-89 | |
| Q9IA88 | 798 | Serine/threonine-protein | no | N/A | 0.359 | 0.285 | 0.635 | 2e-89 | |
| Q5REX1 | 925 | Serine/threonine-protein | no | N/A | 0.379 | 0.260 | 0.614 | 3e-89 | |
| Q9R1U5 | 776 | Serine/threonine-protein | no | N/A | 0.371 | 0.304 | 0.612 | 3e-89 | |
| P57059 | 783 | Serine/threonine-protein | no | N/A | 0.407 | 0.330 | 0.571 | 1e-88 |
| >sp|Q9Y2K2|SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 352 bits (903), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 159/230 (69%), Positives = 187/230 (81%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM +
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKL 261
|
Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus GN=Sik3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 159/230 (69%), Positives = 187/230 (81%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 AKVAIKIIDKSQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM +
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICRHKWMKL 261
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8CFH6|SIK2_MOUSE Serine/threonine-protein kinase SIK2 OS=Mus musculus GN=Sik2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (864), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 151/241 (62%), Positives = 188/241 (78%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK +LD NL K++REV IM LDHPHIIKL+QVMET + LYLVTEYA+ GE
Sbjct: 44 TEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTEYAKNGE 103
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF +L G++ E EA R F QILSAV YCH VVHRD+KAENLL D N +IK+ADFGF
Sbjct: 104 IFDYLANHGRLNESEARRKFWQILSAVDYCHGRKVVHRDLKAENLLLDNNMNIKIADFGF 163
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N+F G +L TWCGSPPYAAPE+F G++Y+G + D+WS+GVVLYV+V LPFDGP L
Sbjct: 164 GNFFKTGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLP 223
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
+L+QR+L G+FRIP++MS +CE+LIR MLVLDP+KRL++ QI HKWM + P I+
Sbjct: 224 ILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLSIAQIKEHKWMLIEVPVQRPILY 283
Query: 505 P 505
P
Sbjct: 284 P 284
|
Phosphorylates 'Ser-789' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 150/241 (62%), Positives = 188/241 (78%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK +LD NL K++REV IM LDHPHIIKL+QVMET + LYLVTEYA+ GE
Sbjct: 44 TEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTEYAKNGE 103
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF +L G++ E EA R F QILSAV YCH +VHRD+KAENLL D N +IK+ADFGF
Sbjct: 104 IFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMNIKIADFGF 163
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N+F G +L TWCGSPPYAAPE+F G++Y+G + D+WS+GVVLYV+V LPFDGP L
Sbjct: 164 GNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLP 223
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
+L+QR+L G+FRIP++MS +CE+LIR MLVLDP+KRLT+ QI HKWM + P ++
Sbjct: 224 ILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEVPVQRPVLY 283
Query: 505 P 505
P
Sbjct: 284 P 284
|
Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NSM8|SIK3_DANRE Serine/threonine-protein kinase SIK3 homolog OS=Danio rerio GN=zgc:66101 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 157/262 (59%), Positives = 199/262 (75%), Gaps = 8/262 (3%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YE+++ K A +L + +KVAIKI+DK +LD+ NL+K+FREV IM L HP
Sbjct: 57 GYYEMERTIGKGNFAVVKLATHMITKAKVAIKIVDKTQLDDENLKKIFREVQIMKMLRHP 116
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+MAEK+A R F+QI++AV +CH +
Sbjct: 117 HIIRLYQVMETERMIYLVTEYASGGEIFDHLVAHGRMAEKDARRKFKQIVAAVYFCHCRS 176
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
+VHRD+KAENLL D N +IK+ADFGFSN F+ G +L TWCGSPPYAAPELF G+EYDG K
Sbjct: 177 IVHRDLKAENLLLDHNLNIKIADFGFSNLFSRGQLLKTWCGSPPYAAPELFEGKEYDGPK 236
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
D+WSLGVVLYV+V LPFDG L L+ R+L GKFRIPF+MS +CE LIR ML+L+P+
Sbjct: 237 VDIWSLGVVLYVLVCGALPFDGSTLQNLRARVLSGKFRIPFFMSTDCEYLIRHMLILEPS 296
Query: 479 KRLTLTQISNHKWMSVHCPGDP 500
+RL++ QI +KWM GDP
Sbjct: 297 RRLSMEQICKNKWMRQ---GDP 315
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60670|SIK1_MOUSE Serine/threonine-protein kinase SIK1 OS=Mus musculus GN=Sik1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 148/240 (61%), Positives = 189/240 (78%), Gaps = 4/240 (1%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK RLD NL K++REV +M L+HP+IIKL+QVMET + LY+VTE+A+ GE
Sbjct: 51 TQVAIKIIDKTRLDSSNLEKIYREVQLMKLLNHPNIIKLYQVMETKDMLYIVTEFAKNGE 110
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+F +L + G ++E EA + F QILSAV YCH +++VHRD+K ENLL D N DIKLADFGF
Sbjct: 111 MFDYLTSNGHLSENEARQKFWQILSAVEYCHNHHIVHRDLKTENLLLDSNMDIKLADFGF 170
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N++ PG L+TWCGSPPYAAPE+F G+EY+G + DVWSLGVVLYV+V LPFDGPNL
Sbjct: 171 GNFYKPGEPLSTWCGSPPYAAPEVFEGKEYEGPQLDVWSLGVVLYVLVCGSLPFDGPNLP 230
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
L+QR+L G+FRIPF+MS +CE LIR MLV+DPAKR+T+ QI H+WM DP ++
Sbjct: 231 TLRQRVLEGRFRIPFFMSQDCETLIRRMLVVDPAKRITIAQIRQHRWMQ----ADPTLLQ 286
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9IA88|SIK2_CHICK Serine/threonine-protein kinase SIK2 OS=Gallus gallus GN=SIK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (847), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 145/228 (63%), Positives = 184/228 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK RLD NL K++REV IM L+HPHIIKL+QVMET + LY+VTE+A+ GE
Sbjct: 50 TQVAIKIIDKTRLDPSNLEKIYREVQIMKLLNHPHIIKLYQVMETKDMLYIVTEFAKNGE 109
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+F HL + G ++E EA + F QILSAV YCH++++VHRD+K ENLL D N +IKLADFGF
Sbjct: 110 MFDHLTSNGHLSESEARKKFWQILSAVEYCHSHHIVHRDLKTENLLLDANMNIKLADFGF 169
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N++ G L+TWCGSPPYAAPE+F G+EY+G D+WSLGVVLYV+V LPFDGPNL
Sbjct: 170 GNFYKSGEPLSTWCGSPPYAAPEVFEGKEYEGPHLDIWSLGVVLYVLVCGSLPFDGPNLP 229
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
L+QR+L G+FRIP++MS +CE LIR MLV+DP KR+T++QI HKWM
Sbjct: 230 TLRQRVLEGRFRIPYFMSEDCETLIRRMLVVDPTKRITISQIKQHKWM 277
|
Phosphorylates IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing the CREB-specific coactivators, CRTC1-3. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5REX1|SIK2_PONAB Serine/threonine-protein kinase SIK2 OS=Pongo abelii GN=SIK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 148/241 (61%), Positives = 186/241 (77%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK +LD NL K++REV IM LDHPHIIKL+QVMET + LYLVTEYA+ GE
Sbjct: 44 TEVAIKIIDKSQLDAVNLEKIYREVQIMKMLDHPHIIKLYQVMETKSMLYLVTEYAKNGE 103
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF +L G++ E EA R F QILSAV YCH +VHRD+KAENLL D N +IK+ADF F
Sbjct: 104 IFDYLANHGRLNESEARRKFWQILSAVDYCHGRKIVHRDLKAENLLLDNNMNIKIADFSF 163
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N+F G +L TW GSPPYAAPE+F G++Y+G + D+WS+GVVLYV+V LPFDGP L
Sbjct: 164 GNFFKSGELLATWRGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLP 223
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
+L+QR+L G+FRIP++MS +CE+LIR MLVLDP+KRLT+ QI HKWM + P ++
Sbjct: 224 ILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPSKRLTIAQIKEHKWMLIEVPVQRPVLY 283
Query: 505 P 505
P
Sbjct: 284 P 284
|
Phosphorylates 'Ser-794' of IRS1 in insulin-stimulated adipocytes, potentially modulating the efficiency of insulin signal transduction. Inhibits CREB activity by phosphorylating and repressing TORCs, the CREB-specific coactivators. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1U5|SIK1_RAT Serine/threonine-protein kinase SIK1 OS=Rattus norvegicus GN=Sik1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 147/240 (61%), Positives = 189/240 (78%), Gaps = 4/240 (1%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK RLD NL K++REV +M L+HP+IIKL+QVMET + LY+VTE+A+ GE
Sbjct: 51 TQVAIKIIDKTRLDSSNLEKIYREVQLMKLLNHPNIIKLYQVMETKDMLYIVTEFAKNGE 110
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+F +L + G ++E EA + F QILSAV YCH +++VHRD+K ENLL D N DIKLADFGF
Sbjct: 111 MFDYLTSNGHLSENEARKKFWQILSAVEYCHNHHIVHRDLKTENLLLDGNMDIKLADFGF 170
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N++ PG L+TWCGSPPYAAPE+F G+EY+G + D+WSLGVVLYV+V LPFDGPNL
Sbjct: 171 GNFYKPGEPLSTWCGSPPYAAPEVFEGKEYEGPQLDIWSLGVVLYVLVCGSLPFDGPNLP 230
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
L+QR+L G+FRIPF+MS +CE LIR MLV+DPAKR+T+ QI H+WM DP ++
Sbjct: 231 TLRQRVLEGRFRIPFFMSQDCETLIRRMLVVDPAKRITIAQIRQHRWMQ----ADPTLLQ 286
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P57059|SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 151/264 (57%), Positives = 199/264 (75%), Gaps = 5/264 (1%)
Query: 234 GEGEDLSQWEGMYELKKK--KEEAAAAQLIEE---LSKVAIKIIDKKRLDERNLRKLFRE 288
G+G+ G Y++++ K A +L ++VAIKIIDK RLD NL K++RE
Sbjct: 15 GQGQQKPLRVGFYDIERTLGKGNFAVVKLARHRVTKTQVAIKIIDKTRLDSSNLEKIYRE 74
Query: 289 VDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQIL 348
V +M L+HPHIIKL+QVMET + LY+VTE+A+ GE+F +L + G ++E EA + F QIL
Sbjct: 75 VQLMKLLNHPHIIKLYQVMETKDMLYIVTEFAKNGEMFDYLTSNGHLSENEARKKFWQIL 134
Query: 349 SAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPEL 408
SAV YCH +++VHRD+K ENLL D N DIKLADFGF N++ G L+TWCGSPPYAAPE+
Sbjct: 135 SAVEYCHDHHIVHRDLKTENLLLDGNMDIKLADFGFGNFYKSGEPLSTWCGSPPYAAPEV 194
Query: 409 FGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468
F G+EY+G + D+WSLGVVLYV+V LPFDGPNL L+QR+L G+FRIPF+MS +CE+L
Sbjct: 195 FEGKEYEGPQLDIWSLGVVLYVLVCGSLPFDGPNLPTLRQRVLEGRFRIPFFMSQDCESL 254
Query: 469 IRSMLVLDPAKRLTLTQISNHKWM 492
IR MLV+DPA+R+T+ QI H+WM
Sbjct: 255 IRRMLVVDPARRITIAQIRQHRWM 278
|
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, gluconeogenesis and lipogenesis regulation, muscle growth and differentiation and tumor suppression. Phosphorylates HDAC4, HDAC5, PPME1, SREBF1, TORC1/CRTC1 and TORC2/CRTC2. Acts as a tumor suppressor and plays a key role in p53/TP53-dependent anoikis, a type of apoptosis triggered by cell detachment: required for phosphorylation of p53/TP53 in response to loss of adhesion and is able to suppress metastasis. Part of a sodium-sensing signaling network, probably by mediating phosphorylation of PPME1: following increases in intracellular sodium, SIK1 is activated by CaMK1 and phosphorylates PPME1 subunit of protein phosphatase 2A (PP2A), leading to dephosphorylation of sodium/potassium-transporting ATPase ATP1A1 and subsequent increase activity of ATP1A1. Acts as a regulator of muscle cells by phosphorylating and inhibiting class II histone deacetylases HDAC4 and HDAC5, leading to promote expression of MEF2 target genes in myocytes. Also required during cardiomyogenesis by regulating the exit of cardiomyoblasts from the cell cycle via down-regulation of CDKN1C/p57Kip2. Acts as a regulator of hepatic gluconeogenesis by phosphorylating and repressing the CREB-specific coactivators TORC1/CRTC1 and TORC2/CRTC2, leading to inhibit CREB activity. Also regulates hepatic lipogenesis by phosphorylating and inhibiting SREBF1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | ||||||
| 380029523 | 925 | PREDICTED: serine/threonine-protein kina | 0.596 | 0.409 | 0.484 | 1e-107 | |
| 350403617 | 925 | PREDICTED: serine/threonine-protein kina | 0.596 | 0.409 | 0.485 | 1e-106 | |
| 383865174 | 925 | PREDICTED: serine/threonine-protein kina | 0.595 | 0.408 | 0.484 | 1e-105 | |
| 340722853 | 925 | PREDICTED: serine/threonine-protein kina | 0.596 | 0.409 | 0.483 | 1e-105 | |
| 345479200 | 933 | PREDICTED: serine/threonine-protein kina | 0.592 | 0.403 | 0.476 | 1e-103 | |
| 345479204 | 940 | PREDICTED: serine/threonine-protein kina | 0.592 | 0.4 | 0.476 | 1e-103 | |
| 345479202 | 884 | PREDICTED: serine/threonine-protein kina | 0.592 | 0.425 | 0.476 | 1e-103 | |
| 307195299 | 925 | Serine/threonine-protein kinase QSK [Har | 0.596 | 0.409 | 0.485 | 1e-103 | |
| 224083117 | 1291 | PREDICTED: serine/threonine-protein kina | 0.395 | 0.194 | 0.648 | 4e-95 | |
| 417413621 | 1198 | Putative serine/threonine-protein kinase | 0.362 | 0.191 | 0.691 | 1e-94 |
| >gi|380029523|ref|XP_003698419.1| PREDICTED: serine/threonine-protein kinase SIK3-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1012), Expect = e-107, Method: Compositional matrix adjust.
Identities = 222/458 (48%), Positives = 273/458 (59%), Gaps = 79/458 (17%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 24 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 83
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 84 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMPEPEARRIFRQIVLAVRYLHQQR 143
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN +TPG L TWCGSPPYAAPE+F G+ YDG +
Sbjct: 144 VVHRDLKAENLLLDADNNIKLADFGFSNEYTPGVPLNTWCGSPPYAAPEIFEGKHYDGPR 203
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + +L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 204 ADVWSLGVVLYVLVCGALPFDGPTMQLLRSVVISGKFRIPFFMSAECEKLIRHMLVVEPE 263
Query: 479 KRLTLTQISNHKWMSVHCPGDPVI------VNPVPSEPKLPNSFVIDQMLQLPALTRNRI 532
+RL+++QI H WM GD V NP P++ N VI+ ML+LP L+ +
Sbjct: 264 RRLSISQILAHSWMG----GDGVTEPEPGGCNPENVPPQI-NQVVIENMLRLPGLSAETL 318
Query: 533 L------------------------------------------------EFDDNLMETE- 543
L +F D ETE
Sbjct: 319 LKAVQGNAFDHVSAIYNLLVDRLEPTMPSLPSIQSIPGDYAPDGAHQLEKFGDTEAETEE 378
Query: 544 -ICVSPTPQTSVTATRRHTVGPGDESHSQVLDAHSLQHYT-------------NHLNIPQ 589
+ TP T TRRHTVGPGD +H +S H + N+ +
Sbjct: 379 RSGMQLTPGTPYHTTRRHTVGPGDTAHQPPSYPYSYNHTSGDPALRLLPILQCNNTDPQV 438
Query: 590 LPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGAC 627
LP+ NL NLPLVQ+Q PQNF I DQ+LLKPPPVMGA
Sbjct: 439 LPHTNLPLNLPLVQHQPPQNFQIKDQHLLKPPPVMGAT 476
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350403617|ref|XP_003486855.1| PREDICTED: serine/threonine-protein kinase SIK3-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1007), Expect = e-106, Method: Compositional matrix adjust.
Identities = 223/459 (48%), Positives = 274/459 (59%), Gaps = 80/459 (17%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 24 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 83
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 84 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMPEPEARRIFRQIVLAVRYLHQQR 143
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN +TPG L+TWCGSPPYAAPE+F G+ YDG +
Sbjct: 144 VVHRDLKAENLLLDADNNIKLADFGFSNEYTPGVPLSTWCGSPPYAAPEIFEGKHYDGPR 203
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + +L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 204 ADVWSLGVVLYVLVCGALPFDGPTMQLLRSVVISGKFRIPFFMSAECEKLIRHMLVVEPE 263
Query: 479 KRLTLTQISNHKWMSVHCPGD------PVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRI 532
+RL+++QI H WM GD P NP P+L N VI+ ML+LP L+ +
Sbjct: 264 RRLSISQILAHSWMG----GDGTTEPEPGGCNPENVPPQL-NQVVIENMLRLPGLSPETL 318
Query: 533 L------------------------------------------------EFDDNLMETE- 543
L +F D ETE
Sbjct: 319 LKAVQGNAFDHVSAIYNLLVDRLEPTMPSLPSIQSIPGDYAPDGAHQLEKFGDTEAETEE 378
Query: 544 -ICVSPTPQTSVTATRRHTVGPGDESHSQVLD-AHSLQHYT-------------NHLNIP 588
+ TP T TRRHTVGPGD +H ++ H T N+ +
Sbjct: 379 RSGLQLTPGTPYHTTRRHTVGPGDTAHQPPTSYPYNYNHTTGDPALRLLPILQYNNTDPQ 438
Query: 589 QLPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGAC 627
LP+ NL NLPLVQ+Q PQNF I DQ+LLKPPPVMGA
Sbjct: 439 VLPHTNLPLNLPLVQHQPPQNFQIKDQHLLKPPPVMGAT 477
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383865174|ref|XP_003708050.1| PREDICTED: serine/threonine-protein kinase SIK3-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1001), Expect = e-105, Method: Compositional matrix adjust.
Identities = 222/458 (48%), Positives = 272/458 (59%), Gaps = 80/458 (17%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E L K+FREV IM L HP
Sbjct: 24 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEETLAKIFREVHIMKRLRHP 83
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 84 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMPEPEARRIFRQIVLAVRYLHQQR 143
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN +TPG L+TWCGSPPYAAPE+F G+ YDG +
Sbjct: 144 VVHRDLKAENLLLDADNNIKLADFGFSNEYTPGVPLSTWCGSPPYAAPEIFEGKHYDGPR 203
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + VL+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 204 ADVWSLGVVLYVLVCGALPFDGPTMQVLRSVVISGKFRIPFFMSAECEKLIRHMLVVEPE 263
Query: 479 KRLTLTQISNHKWMSVHCPGD------PVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRI 532
+RL++ QI H WM GD P +P P+L N VID ML+LP LT +
Sbjct: 264 RRLSILQILAHSWMG----GDGTTEPEPGGCSPENVPPQL-NQIVIDNMLKLPGLTAETL 318
Query: 533 L------------------------------------------------EFDDNLMETE- 543
L +F D ETE
Sbjct: 319 LSAVQGNAFDHVSAIYNLLVDRLESTMSSLPSIQSITGDYAHDGAHQLEKFGDTEAETEE 378
Query: 544 -ICVSPTPQTSVTATRRHTVGPGDESHSQVLD-AHSLQHYT-------------NHLNIP 588
+ +P T TRRHTVGPGD +H ++ H + N+ +
Sbjct: 379 RSGMQLSPGTPYHTTRRHTVGPGDTAHQPSTQYPYNYNHTSGDPALRLLPILQCNNTDPQ 438
Query: 589 QLPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGA 626
LP+ NL NLPLVQ+Q PQNF I DQ+LLKPPPVMGA
Sbjct: 439 VLPHTNLPLNLPLVQHQPPQNFQIKDQHLLKPPPVMGA 476
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340722853|ref|XP_003399815.1| PREDICTED: serine/threonine-protein kinase SIK3-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 389 bits (998), Expect = e-105, Method: Compositional matrix adjust.
Identities = 222/459 (48%), Positives = 273/459 (59%), Gaps = 80/459 (17%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 24 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 83
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 84 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMPEPEARRIFRQIVLAVRYLHQQR 143
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN +TPG L+TWCGSPPYAAPE+F G+ YDG +
Sbjct: 144 VVHRDLKAENLLLDADNNIKLADFGFSNEYTPGVPLSTWCGSPPYAAPEIFEGKHYDGPR 203
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + +L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 204 ADVWSLGVVLYVLVCGALPFDGPTMQLLRSVVISGKFRIPFFMSAECEKLIRHMLVVEPE 263
Query: 479 KRLTLTQISNHKWMSVHCPGD------PVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRI 532
+RL+++QI H WM GD P N P+L N VI+ ML+LP L+ +
Sbjct: 264 RRLSISQILAHSWMG----GDGTTEPEPGGCNSENVPPQL-NQVVIENMLRLPGLSPETL 318
Query: 533 L------------------------------------------------EFDDNLMETE- 543
L +F D ETE
Sbjct: 319 LKAVQGNAFDHVSAIYNLLVDRLEPTMPSLPSIQSIPGDYAPDGAHQLEKFGDTEAETEE 378
Query: 544 -ICVSPTPQTSVTATRRHTVGPGDESHSQVLD-AHSLQHYT-------------NHLNIP 588
+ TP T TRRHTVGPGD +H ++ H T N+ +
Sbjct: 379 RSGLQLTPGTPYHTTRRHTVGPGDTAHQPPTSYPYNYNHTTGDPALRLLPILQYNNTDPQ 438
Query: 589 QLPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGAC 627
LP+ NL NLPLVQ+Q PQNF I DQ+LLKPPPVMGA
Sbjct: 439 VLPHTNLPLNLPLVQHQPPQNFQIKDQHLLKPPPVMGAT 477
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345479200|ref|XP_003423900.1| PREDICTED: serine/threonine-protein kinase SIK3-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-103, Method: Compositional matrix adjust.
Identities = 221/464 (47%), Positives = 277/464 (59%), Gaps = 88/464 (18%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 25 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 84
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 85 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMVEPEARRIFRQIVQAVRYLHQQR 144
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN F PG L+TWCGSPPYAAPE+F GR+YDG +
Sbjct: 145 VVHRDLKAENLLLDADNNIKLADFGFSNEFKPGVPLSTWCGSPPYAAPEIFEGRQYDGPR 204
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 205 ADVWSLGVVLYVLVCGVLPFDGPTMQSLRSVVISGKFRIPFFMSAECEWLIRHMLVVEPE 264
Query: 479 KRLTLTQISNHKWM-------------SVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLP 525
+RL+++QI +H+WM S+ GD ++ P+ N VI+ ML+LP
Sbjct: 265 RRLSISQILSHQWMFGEGSQPTEAESESISLNGDSLV-------PQQLNQLVIESMLKLP 317
Query: 526 ALTRNRILE------FDD-----NL----METEICVSPTPQ------------------- 551
L + +L+ F+ NL +E + P+ Q
Sbjct: 318 GLDIDTLLQAVQGNAFNHVSAIYNLLCDQLENAVTSVPSIQNVPGGYVPDDAHQLEKFGE 377
Query: 552 -----------------TSVTATRRHTVGPGDESHSQVLDA--------HSLQHYTNHLN 586
T ATRRHTVGPGD +H A ++ H +L
Sbjct: 378 TEGVEMEERSGLQLPIGTPYHATRRHTVGPGDTAHQPANAAYPCGYPMGYAPLHLLPNLQ 437
Query: 587 I---PQ-LPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGA 626
+ PQ LP+ NL NLPLVQ Q PQNF I DQ+LLKPP MGA
Sbjct: 438 LNADPQLLPHTNLALNLPLVQNQPPQNFQIKDQHLLKPPSAMGA 481
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345479204|ref|XP_003423901.1| PREDICTED: serine/threonine-protein kinase SIK3-like isoform 3 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-103, Method: Compositional matrix adjust.
Identities = 221/464 (47%), Positives = 277/464 (59%), Gaps = 88/464 (18%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 25 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 84
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 85 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMVEPEARRIFRQIVQAVRYLHQQR 144
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN F PG L+TWCGSPPYAAPE+F GR+YDG +
Sbjct: 145 VVHRDLKAENLLLDADNNIKLADFGFSNEFKPGVPLSTWCGSPPYAAPEIFEGRQYDGPR 204
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 205 ADVWSLGVVLYVLVCGVLPFDGPTMQSLRSVVISGKFRIPFFMSAECEWLIRHMLVVEPE 264
Query: 479 KRLTLTQISNHKWM-------------SVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLP 525
+RL+++QI +H+WM S+ GD ++ P+ N VI+ ML+LP
Sbjct: 265 RRLSISQILSHQWMFGEGSQPTEAESESISLNGDSLV-------PQQLNQLVIESMLKLP 317
Query: 526 ALTRNRILE------FDD-----NL----METEICVSPTPQ------------------- 551
L + +L+ F+ NL +E + P+ Q
Sbjct: 318 GLDIDTLLQAVQGNAFNHVSAIYNLLCDQLENAVTSVPSIQNVPGGYVPDDAHQLEKFGE 377
Query: 552 -----------------TSVTATRRHTVGPGDESHSQVLDA--------HSLQHYTNHLN 586
T ATRRHTVGPGD +H A ++ H +L
Sbjct: 378 TEGVEMEERSGLQLPIGTPYHATRRHTVGPGDTAHQPANAAYPCGYPMGYAPLHLLPNLQ 437
Query: 587 I---PQ-LPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGA 626
+ PQ LP+ NL NLPLVQ Q PQNF I DQ+LLKPP MGA
Sbjct: 438 LNADPQLLPHTNLALNLPLVQNQPPQNFQIKDQHLLKPPSAMGA 481
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345479202|ref|XP_001603970.2| PREDICTED: serine/threonine-protein kinase SIK3-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 384 bits (985), Expect = e-103, Method: Compositional matrix adjust.
Identities = 221/464 (47%), Positives = 277/464 (59%), Gaps = 88/464 (18%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 25 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 84
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 85 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMVEPEARRIFRQIVQAVRYLHQQR 144
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN F PG L+TWCGSPPYAAPE+F GR+YDG +
Sbjct: 145 VVHRDLKAENLLLDADNNIKLADFGFSNEFKPGVPLSTWCGSPPYAAPEIFEGRQYDGPR 204
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDGP + L+ ++ GKFRIPF+MSAECE LIR MLV++P
Sbjct: 205 ADVWSLGVVLYVLVCGVLPFDGPTMQSLRSVVISGKFRIPFFMSAECEWLIRHMLVVEPE 264
Query: 479 KRLTLTQISNHKWM-------------SVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLP 525
+RL+++QI +H+WM S+ GD ++ P+ N VI+ ML+LP
Sbjct: 265 RRLSISQILSHQWMFGEGSQPTEAESESISLNGDSLV-------PQQLNQLVIESMLKLP 317
Query: 526 ALTRNRILE------FDD-----NL----METEICVSPTPQ------------------- 551
L + +L+ F+ NL +E + P+ Q
Sbjct: 318 GLDIDTLLQAVQGNAFNHVSAIYNLLCDQLENAVTSVPSIQNVPGGYVPDDAHQLEKFGE 377
Query: 552 -----------------TSVTATRRHTVGPGDESHSQVLDA--------HSLQHYTNHLN 586
T ATRRHTVGPGD +H A ++ H +L
Sbjct: 378 TEGVEMEERSGLQLPIGTPYHATRRHTVGPGDTAHQPANAAYPCGYPMGYAPLHLLPNLQ 437
Query: 587 I---PQ-LPNANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGA 626
+ PQ LP+ NL NLPLVQ Q PQNF I DQ+LLKPP MGA
Sbjct: 438 LNADPQLLPHTNLALNLPLVQNQPPQNFQIKDQHLLKPPSAMGA 481
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307195299|gb|EFN77247.1| Serine/threonine-protein kinase QSK [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 382 bits (982), Expect = e-103, Method: Compositional matrix adjust.
Identities = 221/455 (48%), Positives = 279/455 (61%), Gaps = 76/455 (16%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YEL+K K A ++ + SKVAIKIIDK +L+E NL K+FREV IM L HP
Sbjct: 24 GYYELEKTIGKGNFAVVKMATHVVTKSKVAIKIIDKTKLNEENLAKIFREVHIMKRLRHP 83
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+M E EA R+FRQI+ AV Y H
Sbjct: 84 HIIRLYQVMETEKMIYLVTEYAPGGEIFDHLVRNGRMPEPEARRIFRQIVLAVRYLHQQR 143
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
VVHRD+KAENLL D + +IKLADFGFSN +TPG L+TWCGSPPYAAPE+F G+ YDG +
Sbjct: 144 VVHRDLKAENLLLDADNNIKLADFGFSNEYTPGVPLSTWCGSPPYAAPEIFEGKHYDGPR 203
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
+DVWSLGVVLYV+V LPFDG + +L+ ++ GKFRIP++MSA+CE LIR MLV++P
Sbjct: 204 ADVWSLGVVLYVLVCGALPFDGATMQLLRSVVISGKFRIPYFMSADCEKLIRHMLVVEPE 263
Query: 479 KRLTLTQISNHKWMSVHC-----PGDPVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRIL 533
+RL+++QI +H WMS PG + VP P+L N VI+ ML+LP L+ + +L
Sbjct: 264 RRLSISQILDHTWMSEDGVVELEPGGCNLDVSVP--PQL-NQLVIENMLRLPGLSADTLL 320
Query: 534 E------FDD-----NL----METEICVSPTPQ--------------------------- 551
+ FD NL +E + P+ Q
Sbjct: 321 QAINGNAFDHVSAIYNLLVDRLEPTMPNLPSIQSIPGDYLPDGAHQLEKFGETEAETEER 380
Query: 552 --------TSVTATRRHTVGPGDESHSQVLDAHSLQHYTNH-----LNIPQ-------LP 591
T TRRHTVGPGD +H Q ++ H + + L IP LP
Sbjct: 381 SSLYLPSGTPYHTTRRHTVGPGDAAH-QPPTSYPYNHMSGYQTLRPLPIPHCNMDPQVLP 439
Query: 592 NANLLFNLPLVQYQHPQNFIIHDQYLLKPPPVMGA 626
+ NL NLPLVQ+Q PQNF I DQ+LLKPPPVMG
Sbjct: 440 HTNLPLNLPLVQHQPPQNFQIKDQHLLKPPPVMGV 474
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|224083117|ref|XP_002189030.1| PREDICTED: serine/threonine-protein kinase SIK3-like [Taeniopygia guttata] | Back alignment and taxonomy information |
|---|
Score = 355 bits (911), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 166/256 (64%), Positives = 199/256 (77%), Gaps = 5/256 (1%)
Query: 244 GMYELKKK--KEEAAAAQLIEEL---SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298
G YE+++ K A +L L +KVAIKIIDK +LDE NL+K+FREV IM L HP
Sbjct: 40 GYYEIERTIGKGNFAVVKLATHLVTRAKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHP 99
Query: 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN 358
HII+L+QVMET +YLVTEYA GGEIF HL+ G+MAEKEA R F+QI++AV +CH N
Sbjct: 100 HIIRLYQVMETERMIYLVTEYASGGEIFDHLVAHGRMAEKEARRKFKQIVAAVNFCHCRN 159
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
+VHRD+KAENLL D N +IK+ADFGFSN FTPG +L TWCGSPPYAAPELF G+EYDG K
Sbjct: 160 IVHRDLKAENLLLDANLNIKIADFGFSNIFTPGQLLKTWCGSPPYAAPELFEGKEYDGPK 219
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPA 478
D+WSLGVVLYV+V LPFDG L L+ R+L GKFRIPF+MS ECE+LIR MLVLDP+
Sbjct: 220 VDIWSLGVVLYVLVCGALPFDGSTLQNLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPS 279
Query: 479 KRLTLTQISNHKWMSV 494
KRL++ QI HKWM +
Sbjct: 280 KRLSMEQICKHKWMKL 295
|
Source: Taeniopygia guttata Species: Taeniopygia guttata Genus: Taeniopygia Family: Estrildidae Order: Passeriformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
| >gi|417413621|gb|JAA53129.1| Putative serine/threonine-protein kinase qsk, partial [Desmodus rotundus] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 159/230 (69%), Positives = 189/230 (82%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 56 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 115
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 116 IFDHLVAHGRMAEKEARRKFKQIVAAVFFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 175
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN+FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 176 SNHFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 235
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP+KRL++ QI HKWM +
Sbjct: 236 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPSKRLSMEQICKHKWMKL 285
|
Source: Desmodus rotundus Species: Desmodus rotundus Genus: Desmodus Family: Phyllostomidae Order: Chiroptera Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 635 | ||||||
| UNIPROTKB|F1MKW8 | 906 | SIK2 "Uncharacterized protein" | 0.409 | 0.286 | 0.603 | 2e-89 | |
| UNIPROTKB|A1A5A8 | 1203 | KIAA0999 "KIAA0999 protein" [H | 0.370 | 0.195 | 0.682 | 2.3e-89 | |
| UNIPROTKB|H0Y494 | 1261 | SIK3 "Serine/threonine-protein | 0.370 | 0.186 | 0.682 | 1.3e-88 | |
| UNIPROTKB|Q9Y2K2 | 1263 | SIK3 "Serine/threonine-protein | 0.370 | 0.186 | 0.682 | 1.4e-88 | |
| UNIPROTKB|J3KPC8 | 1321 | SIK3 "Serine/threonine-protein | 0.370 | 0.177 | 0.682 | 3.3e-88 | |
| UNIPROTKB|H0Y4E8 | 1363 | SIK3 "Serine/threonine-protein | 0.370 | 0.172 | 0.682 | 5.3e-88 | |
| MGI|MGI:2446296 | 1311 | Sik3 "SIK family kinase 3" [Mu | 0.370 | 0.179 | 0.682 | 6e-88 | |
| UNIPROTKB|F1PG01 | 1276 | SIK3 "Uncharacterized protein" | 0.362 | 0.180 | 0.691 | 1.1e-87 | |
| UNIPROTKB|F1MXE2 | 1304 | Bt.105020 "Uncharacterized pro | 0.370 | 0.180 | 0.682 | 1.1e-87 | |
| UNIPROTKB|F1N8N8 | 1284 | LOC100859778 "Uncharacterized | 0.359 | 0.177 | 0.688 | 1.3e-87 |
| UNIPROTKB|F1MKW8 SIK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 2.0e-89, Sum P(3) = 2.0e-89
Identities = 157/260 (60%), Positives = 197/260 (75%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIKIIDK +LDE NL K++REV IM LDHPHIIKL+QVMET + LYLVTEYA+ GE
Sbjct: 44 TEVAIKIIDKSQLDEVNLEKIYREVKIMKLLDHPHIIKLYQVMETKSMLYLVTEYAKNGE 103
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF +L G++ E EA R F QILSAV YCH +VHRD+KAENLL D N +IK+ADFGF
Sbjct: 104 IFDYLANHGRLNESEARRKFWQILSAVDYCHGRQIVHRDLKAENLLLDNNMNIKIADFGF 163
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
N+F G +L TWCGSPPYAAPE+F G++Y+G + D+WS+GVVLYV+V LPFDGP L
Sbjct: 164 GNFFKSGELLATWCGSPPYAAPEVFEGQQYEGPQLDIWSMGVVLYVLVCGALPFDGPTLP 223
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
+L+QR+L G+FRIP++MS +CE+LIR MLVLDPAKRLT+ QI HKWM V P ++
Sbjct: 224 ILRQRVLEGRFRIPYFMSEDCEHLIRRMLVLDPAKRLTIAQIKEHKWMLVEVPVQRPVLY 283
Query: 505 PVPSEPKLPNSFVIDQMLQL 524
P E + +Q+L+L
Sbjct: 284 PQEQENEPSIGEFNEQVLRL 303
|
|
| UNIPROTKB|A1A5A8 KIAA0999 "KIAA0999 protein" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 2.3e-89, Sum P(2) = 2.3e-89
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 266
|
|
| UNIPROTKB|H0Y494 SIK3 "Serine/threonine-protein kinase SIK3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.3e-88, Sum P(2) = 1.3e-88
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 90 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 149
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 150 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 209
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 210 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 269
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 270 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 324
|
|
| UNIPROTKB|Q9Y2K2 SIK3 "Serine/threonine-protein kinase SIK3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-88, Sum P(2) = 1.4e-88
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 266
|
|
| UNIPROTKB|J3KPC8 SIK3 "Serine/threonine-protein kinase SIK3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 3.3e-88, Sum P(2) = 3.3e-88
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 90 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 149
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 150 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 209
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 210 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 269
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 270 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 324
|
|
| UNIPROTKB|H0Y4E8 SIK3 "Serine/threonine-protein kinase SIK3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 5.3e-88, Sum P(2) = 5.3e-88
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 84 AKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 143
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 144 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 203
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 204 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 263
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 264 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 318
|
|
| MGI|MGI:2446296 Sik3 "SIK family kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 6.0e-88, Sum P(2) = 6.0e-88
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 AKVAIKIIDKSQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVTAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICRHKWMKLG-DADP 266
|
|
| UNIPROTKB|F1PG01 SIK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 850 (304.3 bits), Expect = 1.1e-87, Sum P(2) = 1.1e-87
Identities = 159/230 (69%), Positives = 186/230 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
S+VAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 1 SQVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 60
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 61 IFDHLVAHGRMAEKEARRKFKQIVAAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 120
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 121 SNLFTPGQPLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 180
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM +
Sbjct: 181 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKL 230
|
|
| UNIPROTKB|F1MXE2 Bt.105020 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.1e-87, Sum P(2) = 1.1e-87
Identities = 161/236 (68%), Positives = 189/236 (80%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIKIIDK +LDE NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGE
Sbjct: 32 TKVAIKIIDKTQLDEENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
IF HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGF
Sbjct: 92 IFDHLVAHGRMAEKEARRKFKQIVAAVYFCHCRNIVHRDLKAENLLLDANLNIKIADFGF 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
SN FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L
Sbjct: 152 SNLFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQ 211
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
L+ R+L GKFRIPF+MS ECE+LIR MLVLDP KRL++ QI HKWM + DP
Sbjct: 212 NLRARVLSGKFRIPFFMSTECEHLIRHMLVLDPNKRLSMEQICKHKWMKLG-DADP 266
|
|
| UNIPROTKB|F1N8N8 LOC100859778 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 1.3e-87, Sum P(2) = 1.3e-87
Identities = 157/228 (68%), Positives = 186/228 (81%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIKIIDK +LD+ NL+K+FREV IM L HPHII+L+QVMET +YLVTEYA GGEIF
Sbjct: 1 VAIKIIDKTQLDDENLKKIFREVQIMKMLCHPHIIRLYQVMETERMIYLVTEYASGGEIF 60
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
HL+ G+MAEKEA R F+QI++AV +CH N+VHRD+KAENLL D N +IK+ADFGFSN
Sbjct: 61 DHLVAHGRMAEKEARRKFKQIVAAVNFCHCRNIVHRDLKAENLLLDANLNIKIADFGFSN 120
Query: 387 YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446
FTPG +L TWCGSPPYAAPELF G+EYDG K D+WSLGVVLYV+V LPFDG L L
Sbjct: 121 IFTPGQLLKTWCGSPPYAAPELFEGKEYDGPKVDIWSLGVVLYVLVCGALPFDGSTLQNL 180
Query: 447 KQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
+ R+L GKFRIPF+MS ECE+LIR MLVLDP+KRL++ QI HKWM +
Sbjct: 181 RARVLSGKFRIPFFMSTECEHLIRHMLVLDPSKRLSMDQICKHKWMKL 228
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 635 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-94 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-85 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-68 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-57 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-51 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-50 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-49 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-43 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-41 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-40 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-39 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-39 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-38 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-36 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-35 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-34 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-33 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-32 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-32 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-32 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-32 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-31 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-31 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-31 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-30 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-30 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-30 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-30 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-29 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-29 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-29 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-25 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-25 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-25 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-24 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-24 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-20 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-18 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-15 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| pfam04774 | 106 | pfam04774, HABP4_PAI-RBP1, Hyaluronan / mRNA bindi | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-06 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 4e-04 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 6e-04 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 289 bits (742), Expect = 6e-94
Identities = 100/231 (43%), Positives = 143/231 (61%), Gaps = 6/231 (2%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK+I KK++ + + ++ RE+ I+ L HP+I++L+ V E + LYLV EY GG++
Sbjct: 26 LVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
F L G+++E EA RQILSA+ Y H+ +VHRD+K EN+L DE+G +KLADFG +
Sbjct: 85 FDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLA 144
Query: 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-NLA 444
PG LTT+ G+P Y APE+ G+ Y D+WSLGV+LY ++T + PF G L
Sbjct: 145 RQLDPGEKLTTFVGTPEYMAPEVLLGKGYG-KAVDIWSLGVILYELLTGKPPFPGDDQLL 203
Query: 445 VLKQRILFGKFRIPFYM---SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
L ++I K P S E ++LIR +LV DP KRLT + H +
Sbjct: 204 ELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 267 bits (686), Expect = 1e-85
Identities = 94/243 (38%), Positives = 136/243 (55%), Gaps = 8/243 (3%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVT 317
A+ VA+KI+ K+ + + RE+ I+ L HP+I++L E ++LYLV
Sbjct: 18 AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVM 77
Query: 318 EYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
EY GG++F +L G ++E EA ++ QIL + Y H+N ++HRD+K EN+L DENG +
Sbjct: 78 EYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV 137
Query: 378 KLADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
K+ADFG + LTT+ G+P Y APE+ G G K DVWSLGV+LY ++T +
Sbjct: 138 KIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
Query: 437 PFDGPNLAVLKQ---RILFGKFRIPFY----MSAECENLIRSMLVLDPAKRLTLTQISNH 489
PF G N+ Q RIL S E ++LI+ L DP+KR T +I H
Sbjct: 198 PFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
Query: 490 KWM 492
W
Sbjct: 258 PWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-68
Identities = 85/238 (35%), Positives = 128/238 (53%), Gaps = 10/238 (4%)
Query: 258 AQLIEELS---KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLY 314
L+ S +K ID + E+ EV I+ L+HP+IIK ++ E L
Sbjct: 16 VYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLC 75
Query: 315 LVTEYARGGEIFSHL---LTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370
+V EYA GG++ + G+ E++ F Q+ A+ Y H+ ++HRDIK +N+
Sbjct: 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135
Query: 371 FDENGDIKLADFGFSN-YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429
NG +KL DFG S + + T G+P Y +PEL + Y+ KSD+WSLG VLY
Sbjct: 136 LTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLY 194
Query: 430 VMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ T + PF+G NL L +IL G++ IP S+E NL+ S+L DP +R ++ QI
Sbjct: 195 ELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (559), Expect = 7e-67
Identities = 89/230 (38%), Positives = 135/230 (58%), Gaps = 6/230 (2%)
Query: 268 AIKIIDKKRLDERNLRK-LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ KK++ +R + E +I+S ++HP I+KL +T LYLV EYA GGE+F
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
SHL G+ +E+ A +I+ A+ Y H+ +++RD+K EN+L D +G IKL DFG +
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAK 141
Query: 387 YFTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
+ T T+CG+P Y APE+ G+ Y G D WSLGV+LY M+T + PF +
Sbjct: 142 ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
Query: 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLT---LTQISNHKWM 492
+ ++IL R P ++S E +LI +L DP KRL +I H +
Sbjct: 201 IYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-66
Identities = 90/227 (39%), Positives = 122/227 (53%), Gaps = 35/227 (15%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVAIKII K+ L +L RE++I+ L+HP+I+KL+ V E N+LYLV EY GG +
Sbjct: 20 KVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78
Query: 326 FSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN-LLFDENGDIKLADFG 383
L G+++E E R+ QIL + Y H+N ++HRD+K EN LL +NG +KLADFG
Sbjct: 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFG 138
Query: 384 FSNYFTPGHMLTTW-CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
S T L G+P Y APE+ G+ Y KSD+WSLGV+LY +
Sbjct: 139 LSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------- 187
Query: 443 LAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
E ++LIR ML DP KR + +I H
Sbjct: 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 5e-59
Identities = 81/261 (31%), Positives = 135/261 (51%), Gaps = 28/261 (10%)
Query: 258 AQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLD-HPHIIKLFQVMETTNNLYL 315
A+ E + AIKI+DK++L E+ ++ + E ++++ L+ HP IIKL+ + NLY
Sbjct: 20 AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79
Query: 316 VTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375
V EYA GE+ ++ G + EK +IL A+ Y H+ ++HRD+K EN+L D++
Sbjct: 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM 139
Query: 376 DIKLADFGFSNYFTPGHM---------------------LTTWCGSPPYAAPELFGGREY 414
IK+ DFG + P ++ G+ Y +PEL +
Sbjct: 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199
Query: 415 DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLV 474
G SD+W+LG ++Y M+T + PF G N + Q+IL ++ P + ++LI +LV
Sbjct: 200 -GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLV 258
Query: 475 LDPAKRLTL----TQISNHKW 491
LDP RL + ++ H +
Sbjct: 259 LDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 9e-57
Identities = 82/235 (34%), Positives = 125/235 (53%), Gaps = 11/235 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF--QVMETTNNLYLVTEYARGGE 324
+A+K ++ E L L RE+ I+S L HP+I++ + + E N L + EY GG
Sbjct: 28 MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGS 87
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ S L G++ E + RQIL +AY H+N +VHRDIK N+L D +G +KLADFG
Sbjct: 88 LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147
Query: 385 SNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD-- 439
+ G + G+P + APE+ G EY G +D+WSLG + M T + P+
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 440 GPNLAVLKQRILFGKF--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
G +A L +I IP ++S E ++ +R L DP KR T ++ H ++
Sbjct: 207 GNPMAALY-KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 1e-51
Identities = 84/242 (34%), Positives = 123/242 (50%), Gaps = 16/242 (6%)
Query: 267 VAIKIIDKKRLDERNLRK-LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
AIK+I K + +N + E DI+S P+++KL+ + NLYLV EY GG++
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
S L +G + E A +I+ A+ Y H+N ++HRD+K +N+L D NG +KL DFG S
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS 140
Query: 386 NYFTPGHMLTTW---------CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
+ G+P Y APE+ G+ + D WSLG +LY +
Sbjct: 141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIP 199
Query: 437 PFDGPNLAVLKQRILFGKFRIP--FYMSAECENLIRSMLVLDPAKRL---TLTQISNHKW 491
PF G + Q IL GK P +S E +LI +LV DP KRL ++ +I NH +
Sbjct: 200 PFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259
Query: 492 MS 493
Sbjct: 260 FK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 69/232 (29%), Positives = 118/232 (50%), Gaps = 9/232 (3%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K ++K++ E+ +R + E I+ L+HP ++ L+ + N+YLV + GG++
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 327 SHLLTIGQMAEKEASRLFR-QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
HL + +E E + + +I+ A+ Y H+ ++HRDIK +N+L DE G + + DF +
Sbjct: 89 YHLSQKVKFSE-EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
Query: 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
TP + T+ G+P Y APE+ + Y D WSLGV Y + + P+ G + +
Sbjct: 148 TKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206
Query: 446 LKQRILFGKFRIPFYMSA---ECENLIRSMLVLDPAKRL--TLTQISNHKWM 492
Q + Y + E + I +L DP KRL L + NH +
Sbjct: 207 RDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 77/234 (32%), Positives = 127/234 (54%), Gaps = 11/234 (4%)
Query: 268 AIKIIDKKRLDERNLRK-LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K + K+ + E ++ +F E +I+ +HP I+KL++ + +Y++ EY GGE++
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L G E A ++ A Y H +++RD+K ENLL D NG +KL DFGF+
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
Query: 387 YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446
G T+CG+P Y APE+ + YD D WSLG++LY ++T + PF + +
Sbjct: 142 KLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
Query: 447 K--QRILFGKFRI--PFYMSAECENLIRSMLVLDPAKRLTLTQ-----ISNHKW 491
+ IL G ++ P Y+ ++LI+ +L +P +RL + I HKW
Sbjct: 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 4e-50
Identities = 68/231 (29%), Positives = 119/231 (51%), Gaps = 11/231 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG--- 323
VAIK+I + +++ K+ E+ I+ HP+I+K + + L++V E+ GG
Sbjct: 28 VAIKVIKLESKEKK--EKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ T + E + + + +++L + Y H+N ++HRDIKA N+L +G++KL DFG
Sbjct: 86 DLLKS--TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF--DGP 441
S + T G+P + APE+ G+ YD K+D+WSLG+ + + P+ P
Sbjct: 144 LSAQLSDTKARNTMVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPP 202
Query: 442 NLAVLK-QRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
A+ K R P S E ++ ++ L +P KR T Q+ H +
Sbjct: 203 MKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 86/233 (36%), Positives = 131/233 (56%), Gaps = 13/233 (5%)
Query: 267 VAIKIIDK-KRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+KI+ K K + + + + E I+ + HP ++ L+ + +NLYLV EY GGE+
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
FSHL G+ E A Q++ A+ Y H+ ++V+RD+K ENLL D +G IK+ DFGF+
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148
Query: 386 NYFTPGHMLTTW--CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
T+ CG+P Y APE+ + Y G D W+LG+++Y M+ PF N
Sbjct: 149 KRVKGR----TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNP 203
Query: 444 AVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-TLTQ----ISNHKW 491
+ ++IL GK R P + S + ++LIR++L +D KRL L I NH W
Sbjct: 204 IQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 175 bits (443), Expect = 5e-49
Identities = 86/278 (30%), Positives = 140/278 (50%), Gaps = 30/278 (10%)
Query: 246 YELKKKKEEAAAAQ--LIEELSKVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHP-HII 301
Y + +K E + + L + VA+K++ KK + + F RE+ I++ L+HP +I+
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANN 358
KL+ + +LYLV EY GG + L IG+ ++E EA + QILSA+ Y H+
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 359 VVHRDIKAENLLFDENGD-IKLADFGFSNYFTPG-------HMLTTWCGSPPYAAPELFG 410
++HRDIK EN+L D +G +KL DFG + + +T G+P Y APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 411 G--REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL-------FGKFRIPFY- 460
G Y + SD+WSLG+ LY ++T PF+G + + L P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 461 -----MSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493
+S +L++ +L DP RL+ + +H ++
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 78/238 (32%), Positives = 123/238 (51%), Gaps = 16/238 (6%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ--VMETTNNLYLVTEYARGGE 324
+ K ID + E+ ++L EV+I+ L HP+I++ + + + LY+V EY GG+
Sbjct: 28 LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD 87
Query: 325 IFSHLL-----TIGQMAEKEASRLFRQILSAVAYCH-----ANNVVHRDIKAENLLFDEN 374
+ + L+ + E+ R+ Q+L A+ CH N V+HRD+K N+ D N
Sbjct: 88 L-AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146
Query: 375 GDIKLADFGFSNYFTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
++KL DFG + T+ G+P Y +PE YD KSD+WSLG ++Y +
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCA 205
Query: 434 AQLPFDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490
PF N L +I GKF RIP+ S+E +I+SML +DP KR + ++
Sbjct: 206 LSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 74/239 (30%), Positives = 123/239 (51%), Gaps = 13/239 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG-- 323
+VAIK + RL ++N + E+ IM HP+I+ + + L++V EY GG
Sbjct: 46 EVAIKKM---RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102
Query: 324 -EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+I + +M E + + + R++L + Y H+ NV+HRDIK++N+L ++G +KLADF
Sbjct: 103 TDIITQ--NFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
Query: 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDG 440
GF+ T + G+P + APE+ ++Y K D+WSLG++ M + P
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLRE 219
Query: 441 PNLAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
P L L G + P S E ++ + LV DP KR + ++ H ++ CP
Sbjct: 220 PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-44
Identities = 75/236 (31%), Positives = 120/236 (50%), Gaps = 19/236 (8%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK I +++ E L+ + +E+D++ +L HP+I+K +ET+++LY++ EYA G +
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ G E + Q+L +AY H V+HRDIKA N+L ++G +KLADFG +
Sbjct: 88 QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT 147
Query: 387 YFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPNLA 444
+ G+P + APE+ T SD+WSLG + ++T P +D +A
Sbjct: 148 KLNDVSKDDASVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMA 206
Query: 445 VLKQRILFGKFRI--------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
L FRI P +S E ++ + DP R T Q+ H W+
Sbjct: 207 AL--------FRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 9e-43
Identities = 75/220 (34%), Positives = 117/220 (53%), Gaps = 15/220 (6%)
Query: 273 DKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI 332
K+R D N E+ I++ ++HP+II + N L +V EYA G++ S ++
Sbjct: 40 QKEREDAVN------EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDL-SKAISK 92
Query: 333 GQMA-----EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387
+ E+E R+F Q+L + H ++HRD+K+ N+L N +K+ D G S
Sbjct: 93 RKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152
Query: 388 FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447
+M T G+P Y APE++ GR Y KSD+WSLG +LY M T PF+ ++ L+
Sbjct: 153 LK-KNMAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210
Query: 448 QRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
++ GK+ IP S + +N IRSML + P R +I
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 5e-42
Identities = 84/229 (36%), Positives = 125/229 (54%), Gaps = 5/229 (2%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYAR 321
E+ S V K ++ RL E+ R E+ I+S L HP+II + N L + EYA
Sbjct: 23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82
Query: 322 GGEIFSHLL-TIGQMAEKE-ASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
GG ++ ++ GQ+ E+E QI+SAV+Y H ++HRDIK N+ + G IKL
Sbjct: 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKL 142
Query: 380 ADFGFSNYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
DFG S + M T G+P Y +PEL G +Y+ KSD+W+LG VLY ++T + F
Sbjct: 143 GDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTF 201
Query: 439 DGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
D N L +I+ G + + S+E +L+ S+L DP KR T ++
Sbjct: 202 DATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 59/272 (21%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGGE 324
VA+K I + E RE+ ++ L HP+I++L +++ + ++Y+V EY
Sbjct: 27 VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY----- 81
Query: 325 IFSHLLT------IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
H LT + E + +Q+L + Y H+N ++HRDIK N+L + +G +K
Sbjct: 82 -MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLK 140
Query: 379 LADFGFSNYFTPGH-------MLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYV 430
LADFG + +T + ++T W Y PE L G Y G + D+WS+G +L
Sbjct: 141 LADFGLARPYTKRNSADYTNRVITLW-----YRPPELLLGATRY-GPEVDMWSVGCILAE 194
Query: 431 MVTAQLPFDG----------------PNLAV---LKQRILFGKFRIP------------F 459
+ + F G P + + F +
Sbjct: 195 LFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254
Query: 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
+ +L+ +L LDP KR++ Q H++
Sbjct: 255 LIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 71/211 (33%), Positives = 114/211 (54%), Gaps = 12/211 (5%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQI 347
E ++ + HP II+LF LY++ EY GGE+FS+L G+ + +I
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 348 LSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTW--CGSPPYAA 405
+ A+ Y H+ +V+RD+K EN+L D+ G IKL DFGF+ TW CG+P Y A
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----RTWTLCGTPEYLA 166
Query: 406 PELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAEC 465
PE+ + + D W+LG+++Y M+ PF N + ++IL GK P ++
Sbjct: 167 PEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYA 225
Query: 466 ENLIRSMLVLDPAKRLTLTQ-----ISNHKW 491
++LI+ +LV+D +RL + + NH+W
Sbjct: 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-40
Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 10/244 (4%)
Query: 246 YELKKKKEEAAAAQLIEELSKV-----AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300
+E+ K + + + + + K A+K ID +++ R + E +++ LD +I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 301 IKLFQVMETTNNLYLVTEYARGGEIFSHL-LTIGQ-MAEKEASRLFRQILSAVAYCHANN 358
I+ ++ L +V EYA G++ L + G+ + E + R F QIL +A+ H+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT-TWCGSPPYAAPELFGGREYDGT 417
++HRDIK+ NL D ++K+ D G + + T G+P Y +PEL + Y+
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN-E 180
Query: 418 KSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLD 476
KSDVW+LGVVLY T + PFD N L +I+ G F + S + LI L D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 477 PAKR 480
+R
Sbjct: 241 YRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 76/271 (28%), Positives = 119/271 (43%), Gaps = 34/271 (12%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
+K GEG ++G + K +E +VA+K + K+ E+ + + RE
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEV----------EVAVKTL-KEDASEQQIEEFLREA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-------LTIGQ---MAEKE 339
IM LDHP+I+KL V L +V EY GG++ +L L++ A
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA--- 109
Query: 340 ASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCG 399
QI + Y + N +HRD+ A N L EN +K++DFG S G
Sbjct: 110 -----LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164
Query: 400 SPPYA--APELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFR 456
P APE ++ +KSDVWS GV+L+ + T + P+ G + A + + + G
Sbjct: 165 KLPIRWMAPESLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL 223
Query: 457 -IPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
P E L+ DP R T +++
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 64/273 (23%)
Query: 266 KVAIKIIDKKRLDERN-------LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTE 318
VA+K I RLD LR E+ ++ L HP+I+KL V+ T LYLV E
Sbjct: 26 IVALKKI---RLDNEEEGIPSTALR----EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 319 YARGGEI-FSHLL--TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375
Y ++ L G ++ + Q+L +AYCH++ ++HRD+K +N+L + +G
Sbjct: 79 YC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135
Query: 376 DIKLADFGFSNYFT-PGHMLTT-----WCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVL 428
+KLADFG + F P T W Y APE L G + Y T D+WS+G +
Sbjct: 136 VLKLADFGLARAFGIPLRTYTHEVVTLW-----YRAPEILLGSKHY-STAVDIWSVGCIF 189
Query: 429 YVMVTAQLPFDG----------------------PNLAVLKQ-RILFGKFR-------IP 458
M+T + F G P + L + F KF +P
Sbjct: 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLP 249
Query: 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
+ E +L+ ML +PAKR++ + H +
Sbjct: 250 -RLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 17/262 (6%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
+K GEG ++G + K K++ +VA+K + K+ E+ + + RE
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKV----------EVAVKTL-KEDASEQQIEEFLREA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLL-TIGQMAEKEASRLFRQIL 348
IM LDHP+++KL V LY+V EY GG++ S+L +++ + QI
Sbjct: 53 RIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIA 112
Query: 349 SAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYA--AP 406
+ Y + N +HRD+ A N L EN +K++DFG S G P AP
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 407 ELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFR-IPFYMSAE 464
E ++ +KSDVWS GV+L+ + T + P+ G + + + + G P E
Sbjct: 173 ESLKEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE 231
Query: 465 CENLIRSMLVLDPAKRLTLTQI 486
+L+ DP R T +++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 15/236 (6%)
Query: 267 VAIKIIDKKRLDERNLRK-LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K I + RK L RE+ + + P+++K + + +V EY GG +
Sbjct: 29 YALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFGF 384
L +G++ E + + RQIL + Y H +++HRDIK NLL + G++K+ADFG
Sbjct: 87 ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI 146
Query: 385 SNYFTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF---DG 440
S T+ G+ Y +PE G E +D+WSLG+ L + PF
Sbjct: 147 SKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQ 205
Query: 441 PNLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
P+ L Q I G P S E + I + L DP KR + ++ H ++
Sbjct: 206 PSFFELMQAICDGP--PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-39
Identities = 70/233 (30%), Positives = 119/233 (51%), Gaps = 9/233 (3%)
Query: 267 VAIKIIDKKR-LDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
AIK + K+ L + ++ + +E I+ L HP I+ + + N +Y + E+ GGE+
Sbjct: 46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
F+HL G+ A +++ A Y H+ ++++RD+K ENLL D G +K+ DFGF+
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
T CG+P Y APE+ + + G D W++GV+LY + PF
Sbjct: 166 KKVP--DRTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222
Query: 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-TLTQ----ISNHKWMS 493
+ ++IL G+ + P + +L++ +L D KRL TL + NH +
Sbjct: 223 IYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 7e-39
Identities = 72/237 (30%), Positives = 123/237 (51%), Gaps = 15/237 (6%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS 327
A+K I + D + ++++ E+ ++ L HP+++K + V +Y+ EY GG +
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 328 HLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
LL G++ ++ R++ Q+L +AY H++ +VHRDIK N+ D NG IKL DFG +
Sbjct: 89 -LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147
Query: 387 YF-----TPGHMLTTWCGSPPYAAPELFGGREYDGT--KSDVWSLGVVLYVMVTAQLPFD 439
T G + + G+P Y APE+ G + G +D+WSLG V+ M T + P+
Sbjct: 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
Query: 440 G--PNLAVLKQRILFG-KFRIP--FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
++ + G K IP +S E ++ + L DP KR T +++ H +
Sbjct: 208 ELDNEFQIM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 77/216 (35%), Positives = 121/216 (56%), Gaps = 3/216 (1%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K+ + ++ + E ++ + HP + L +T + L V EYA GGE+F
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
HL +E A +I+SA+ Y H+ +VV+RD+K ENL+ D++G IK+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 387 Y-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
+ G + T+CG+P Y APE+ +Y G D W LGVV+Y M+ +LPF +
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
Query: 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L + IL + R P +S E ++L+ +L DP +RL
Sbjct: 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 76/228 (33%), Positives = 118/228 (51%), Gaps = 5/228 (2%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
V IK I +++ + E ++ L HP+II+ ++ L +V EYA GG +
Sbjct: 27 LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 326 FSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI-KLADF 382
++ + E F QIL A+ + H ++HRD+K +N+L D++ + K+ DF
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDF 146
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G S + T G+P Y +PEL G+ Y+ KSD+W+LG VLY + + + F+ N
Sbjct: 147 GISKILSSKSKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAAN 205
Query: 443 LAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
L L +I+ G F I S + LI SML LDP+KR L+QI
Sbjct: 206 LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 75/259 (28%), Positives = 114/259 (44%), Gaps = 37/259 (14%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK I + E + RE+ ++ L+HP+IIKL V +LYLV E+
Sbjct: 27 VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD--TDL 84
Query: 327 SHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
L+ Q + E Q+L +A+CH++ ++HRD+K ENLL + G +KLADFG
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGL 144
Query: 385 SNYF-TPGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
+ F +P T + + Y APE L G + Y T D+WS+G + +++ + F G +
Sbjct: 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY-STPVDIWSVGCIFAELLSRRPLFPGKS 203
Query: 443 -------------------LAVLKQRILFGKFRIPFY-----------MSAECENLIRSM 472
KF P S + +L+ M
Sbjct: 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263
Query: 473 LVLDPAKRLTLTQISNHKW 491
L DP KR+T Q H +
Sbjct: 264 LHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 40/255 (15%)
Query: 267 VAIKIIDKKRLDERN--LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VAIK+ID L+E + + +E+ +S P+I K + + L+++ EY GG
Sbjct: 29 VAIKVID---LEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
LL G++ E + + R++L + Y H +HRDIKA N+L E GD+KLADFG
Sbjct: 86 C-LDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGV 144
Query: 385 SNYFTPGHM------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
S G + T+ G+P + APE+ YD K+D+WSLG+ + +
Sbjct: 145 S-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGE--- 195
Query: 439 DGPNLAVLK-QRILFGKFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQI 486
P L+ L R+L F IP F S ++ + L DP +R + ++
Sbjct: 196 --PPLSDLHPMRVL---FLIPKNNPPSLEGNKF--SKPFKDFVSLCLNKDPKERPSAKEL 248
Query: 487 SNHKWMSVHCPGDPV 501
HK++ +
Sbjct: 249 LKHKFIKKAKKTSYL 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 66/186 (35%), Positives = 105/186 (56%), Gaps = 2/186 (1%)
Query: 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA 356
HP + +L +T + L+ V EY GG++ H+ G+ E A +I+ + + H
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYD 415
+++RD+K +N+L D G IK+ADFG G +T+CG+P Y APE+ + Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY- 173
Query: 416 GTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL 475
G D W+LGV+LY M+ Q PF+G + L Q IL + R P ++S E +++++S L
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK 233
Query: 476 DPAKRL 481
+P KRL
Sbjct: 234 NPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 79/260 (30%), Positives = 118/260 (45%), Gaps = 38/260 (14%)
Query: 268 AIKIIDKKRLDERNLRKLFR-EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K + +RN R E DI++ D P I+KL+ + +LYLV EY GG++
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS- 385
+ L+ E+ A +++ A+ H +HRDIK +N+L D +G IKLADFG
Sbjct: 90 NLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149
Query: 386 ------------------NYFTPGHMLTTWC-----------GSPPYAAPELFGGREYDG 416
+ + G+P Y APE+ G Y G
Sbjct: 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-G 208
Query: 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--FRIPFY--MSAECENLIRSM 472
+ D WSLGV+LY M+ PF L +I+ K R P +S E +LI
Sbjct: 209 LECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR- 267
Query: 473 LVLDPAKRLT-LTQISNHKW 491
L+ DP RL +I +H +
Sbjct: 268 LLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 75/236 (31%), Positives = 113/236 (47%), Gaps = 15/236 (6%)
Query: 268 AIKIIDKKRLDERNLRK--LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
AIK++ K + +N +M + P++ KL+ ++ + LYLV EY GG+
Sbjct: 25 AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
S + T+G + E A + +++ V H ++HRDIK ENLL D+ G +KL DFG S
Sbjct: 85 ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144
Query: 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTK-SDVWSLGVVLYVMVTAQLPFDGPNLA 444
G + G+P Y APE G K SD WSLG V++ + PF
Sbjct: 145 RN---GLENKKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
Query: 445 VLKQRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRL---TLTQISNHKWMS 493
+ IL + P + S E +LI +L +DPAKRL +I +H +
Sbjct: 200 AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 71/227 (31%), Positives = 111/227 (48%), Gaps = 10/227 (4%)
Query: 269 IKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSH 328
+ + D + + +++L +E+ ++S L HP+I++ +NLY+ E GG +
Sbjct: 33 VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKL 92
Query: 329 LLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388
L G E RQIL + Y H N VHRDIK N+L D NG +KLADFG +
Sbjct: 93 LKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152
Query: 389 TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG--PNLAVL 446
++ GSP + APE+ + G +D+WSLG + M T + P+ AV
Sbjct: 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212
Query: 447 KQRILFGKFR----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
K G+ + IP ++S E ++ I L DP+ R T ++ H
Sbjct: 213 K----IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 78/216 (36%), Positives = 121/216 (56%), Gaps = 3/216 (1%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K+ + ++ + E ++ + HP + L +T + L V EYA GGE+F
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
HL E+ A +I+SA+ Y H+ +VV+RDIK ENL+ D++G IK+ DFG
Sbjct: 84 FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143
Query: 387 Y-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
+ G + T+CG+P Y APE+ +Y G D W LGVV+Y M+ +LPF +
Sbjct: 144 EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
Query: 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L + IL + R P +S E ++L+ +L DP +RL
Sbjct: 203 LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 64/243 (26%), Positives = 99/243 (40%), Gaps = 28/243 (11%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K + K+ E + +E +M L HP++++L V LYLV EY GG++
Sbjct: 26 VAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLL 84
Query: 327 SHLLTIGQMAEKEASRLF---------RQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+L + QI + Y + VHRD+ A N L E+ +
Sbjct: 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVV 144
Query: 378 KLADFGFSNYFTPGHMLTT---------WCGSPPYAAPELFGGREYDGTKSDVWSLGVVL 428
K++DFG S W APE + +KSDVWS GV+L
Sbjct: 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWM------APESLKDGIFT-SKSDVWSFGVLL 197
Query: 429 YVMVT-AQLPFDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ + T P+ G + + + + G P Y E L+ S LDP R T +++
Sbjct: 198 WEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
Query: 487 SNH 489
Sbjct: 258 VER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 72/236 (30%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVA+K + K+ E + E IM L HP+I++L V LY+VTEY GG++
Sbjct: 30 KVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL 88
Query: 326 FSHL------LTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
L LT+ MA QI + Y + N VHRD+ A N L EN
Sbjct: 89 LDFLRKHGEKLTLKDLLQMA--------LQIAKGMEYLESKNFVHRDLAARNCLVTENLV 140
Query: 377 IKLADFGFSN--YFTPGHMLTTWCGSP-PYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+K++DFG S Y + P + APE ++ +KSDVWS GV+L+ + T
Sbjct: 141 VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT-SKSDVWSFGVLLWEIFT 199
Query: 434 -AQLPFDGPNLAVLKQRILFGKFR--IPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ P+ G + + + + G R P E L+ DP R T +++
Sbjct: 200 LGEQPYPGMSNEEVLELLEDGY-RLPRPENCPDELYELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 78/240 (32%), Positives = 128/240 (53%), Gaps = 18/240 (7%)
Query: 267 VAIKIIDKKRLD--ERNLRKLFREVDIMSHLDH---PHIIKLFQVMETTNNLYLVTEYAR 321
VA+KII+ LD + ++ + REV ++S L P+I K + L+++ EYA
Sbjct: 29 VALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85
Query: 322 GGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
GG + + L+ G +AEK S + R++L A+ Y H V+HRDIKA N+L G++KL D
Sbjct: 86 GGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCD 144
Query: 382 FGFSNYFTPGHM-LTTWCGSPPYAAPELF-GGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439
FG + +T+ G+P + APE+ G+ YD TK+D+WSLG+ +Y M T P+
Sbjct: 145 FGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD-TKADIWSLGITIYEMATGNPPY- 202
Query: 440 GPNLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
++ + +L K + P S + + L +P +RL+ ++ KW+ H
Sbjct: 203 -SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 70/195 (35%), Positives = 103/195 (52%), Gaps = 2/195 (1%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQI 347
E +I+ + HP I+ L +T LYL+ EY GGE+F HL G E A +I
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 348 LSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-SNYFTPGHMLTTWCGSPPYAAP 406
A+ + H +++RD+K EN+L D G +KL DFG G + T+CG+ Y AP
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 407 ELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECE 466
E+ R G D WSLG ++Y M+T PF N +IL GK +P Y++ E
Sbjct: 170 EIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228
Query: 467 NLIRSMLVLDPAKRL 481
+L++ +L +P+ RL
Sbjct: 229 DLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 74/240 (30%), Positives = 116/240 (48%), Gaps = 26/240 (10%)
Query: 264 LSKVAI-KIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
L KV I +++D K +E+D++ LDHP++IK N L +V E A
Sbjct: 32 LKKVQIFEMMDAKARQ-----DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86
Query: 323 GEIFSHLLTIGQ-----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
G++ S ++ + + E+ + F Q+ SA+ + H+ ++HRDIK N+ G +
Sbjct: 87 GDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145
Query: 378 KLADFGFSNYF----TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
KL D G +F T H L G+P Y +PE Y+ KSD+WSLG +LY M
Sbjct: 146 KLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAA 201
Query: 434 AQLPF--DGPNLAVLKQRILFGKFRIPF---YMSAECENLIRSMLVLDPAKRLTLTQISN 488
Q PF D NL L ++I + P + S E +L+ + DP KR ++ +
Sbjct: 202 LQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 78/239 (32%), Positives = 136/239 (56%), Gaps = 14/239 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VA+K +D ++ R L LF EV IM HP+I++++ + L++V E+ GG +
Sbjct: 46 QVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T +M E++ + + +L A+++ HA V+HRDIK++++L +G +KL+DFGF
Sbjct: 104 -TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 386 NYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGP 441
+ P + G+P + APE+ R GT+ D+WSLG+++ MV + P F+ P
Sbjct: 163 AQVSKEVPRR--KSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219
Query: 442 NLAVLKQRI---LFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
L +K RI L K + +S + + MLV DPA+R T ++ NH +++ P
Sbjct: 220 PLQAMK-RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 10/206 (4%)
Query: 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN 357
P ++ L +T L+L+ +Y GGE+F+HL E E +I+ A+ + H
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 358 NVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT--WCGSPPYAAPELFGGREYD 415
+++RDIK EN+L D G + L DFG S F +CG+ Y APE+ G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184
Query: 416 GTKS-DVWSLGVVLYVMVTAQLPF--DGP--NLAVLKQRILFGKFRIPFYMSAECENLIR 470
K+ D WSLGV+ + ++T PF DG + + + +RIL K P MSAE + I+
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244
Query: 471 SMLVLDPAKRL---TLTQISNHKWMS 493
+L DP KRL +I NH +
Sbjct: 245 KLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 86/310 (27%), Positives = 125/310 (40%), Gaps = 100/310 (32%)
Query: 266 KVAIKIIDKKRLDERNLRK------LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEY 319
VAIK K +L ER K RE+ ++ L HP+II L V +N+ LV E+
Sbjct: 27 IVAIK---KIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83
Query: 320 ARG---------------GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364
+I S++L L + Y H+N ++HRD+
Sbjct: 84 METDLEKVIKDKSIVLTPADIKSYML---------------MTLRGLEYLHSNWILHRDL 128
Query: 365 KAENLLFDENGDIKLADFGFSNYF-TPGHMLTT-----WCGSPPYAAPEL-FGGREYDGT 417
K NLL +G +KLADFG + F +P +T W Y APEL FG R Y G
Sbjct: 129 KPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELLFGARHY-GV 182
Query: 418 KSDVWSLGVVLYVMVTAQL----PF-----------------------DGPNLAVLKQRI 450
D+WS+G + A+L PF + P + L +
Sbjct: 183 GVDMWSVGCIF-----AELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 451 LFGKFR-IPFYM-----SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
F F P S + +L++ +L L+P KR+T Q H + S +
Sbjct: 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS---------ND 288
Query: 505 PVPSEP-KLP 513
P P+ P +LP
Sbjct: 289 PAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 71/215 (33%), Positives = 120/215 (55%), Gaps = 2/215 (0%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS 327
A+K++ K L R+ + E DI++ ++HP I+KL +T LYL+ ++ RGG++F+
Sbjct: 28 AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 87
Query: 328 HLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387
L E++ ++ A+ + H+ +++RD+K EN+L DE G IKL DFG S
Sbjct: 88 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147
Query: 388 FTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446
++CG+ Y APE+ R + +D WS GV+++ M+T LPF G +
Sbjct: 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKET 206
Query: 447 KQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
IL K +P ++S E ++L+R++ +PA RL
Sbjct: 207 MTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 75/250 (30%), Positives = 119/250 (47%), Gaps = 37/250 (14%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG-- 323
KVAIK ID ++ ++ +L +EV MS +HP+++K + + L+LV Y GG
Sbjct: 28 KVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86
Query: 324 -EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+I G + E + + +++L + Y H+N +HRDIKA N+L E+G +K+ADF
Sbjct: 87 LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADF 146
Query: 383 GFS-NYFTPG----HMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
G S + G + T+ G+P + APE + YD K+D+WS G+ + T
Sbjct: 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD-FKADIWSFGITAIELATGAA 205
Query: 437 PF---------------DGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKR 480
P+ D P+L + K FR +I L DP+KR
Sbjct: 206 PYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR----------KMISLCLQKDPSKR 255
Query: 481 LTLTQISNHK 490
T ++ HK
Sbjct: 256 PTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 77/234 (32%), Positives = 118/234 (50%), Gaps = 10/234 (4%)
Query: 268 AIKIIDKKRLDERNLRKLF---REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
A+K++ KK + ++ +K R V ++ ++ HP ++ L +T + LY V +Y GGE
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE 82
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+F HL E A +I SA+ Y H+ N+++RD+K EN+L D G + L DFG
Sbjct: 83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142
Query: 385 SNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
+T+CG+P Y APE+ + YD T D W LG VLY M+ PF +
Sbjct: 143 CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDT 201
Query: 444 AVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL----TLTQISNHKWMS 493
A + IL R+ +S +L+ +L D KRL +I NH + S
Sbjct: 202 AEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 66/195 (33%), Positives = 107/195 (54%), Gaps = 3/195 (1%)
Query: 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA 356
HP + LF +T +L+ V EY GG++ H+ + G+ E A +I+ + + H
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYD 415
+++RD+K +N+L D++G IK+ADFG G +T+CG+P Y APE+ G++Y+
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 416 GTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL 475
+ D WS GV+LY M+ Q PF G + L IL + P ++S E ++ + +
Sbjct: 175 ES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFER 233
Query: 476 DPAKRLTLT-QISNH 489
DP KRL + I H
Sbjct: 234 DPTKRLGVDGDIRQH 248
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 6e-33
Identities = 74/216 (34%), Positives = 118/216 (54%), Gaps = 3/216 (1%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K+ + ++ + E ++ + HP + L +T + L V EY GGE+F
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
HL +E +I+SA+ Y H+ +V+RD+K ENL+ D++G IK+ DFG
Sbjct: 84 FHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143
Query: 387 Y-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
T + T+CG+P Y APE+ +Y G D W LGVV+Y M+ +LPF +
Sbjct: 144 EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
Query: 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L + IL + P +SA+ ++L+ +L+ DP KRL
Sbjct: 203 LFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 78/217 (35%), Positives = 120/217 (55%), Gaps = 4/217 (1%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K+ + ++ + E ++ + HP + L +T + L V EYA GGE+F
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFGFS 385
HL +E A +I+SA+ Y H+ NVV+RD+K ENL+ D++G IK+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 143
Query: 386 NY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
G + T+CG+P Y APE+ +Y G D W LGVV+Y M+ +LPF +
Sbjct: 144 KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L + IL + R P +S E ++L+ +L DP +RL
Sbjct: 203 KLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 77/244 (31%), Positives = 122/244 (50%), Gaps = 18/244 (7%)
Query: 245 MYELKKKKEEAAAAQLIEELSKVAIKIIDKKR-----LDERNLRKLFREVDIMSHLDHPH 299
+Y+++KK + I + ++ K I K+ + ERN+ L R + P
Sbjct: 9 VYQVRKKD-----TRRIYAMKVLSKKEIVAKKEVAHTIGERNI--LVRT----LLDESPF 57
Query: 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNV 359
I+ L +T ++LYLVT+Y GGE+F HL G+ +E A +++ A+ + H ++
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 360 VHRDIKAENLLFDENGDIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTK 418
V+RD+K EN+L D G I L DFG S T T+CG+ Y APE+ +
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 419 SDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF-YMSAECENLIRSMLVLDP 477
D WSLGV+++ M PF + + + I FGK R P +S E ++ +L +P
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 478 AKRL 481
RL
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 10/233 (4%)
Query: 266 KVAIKIIDKKRLD---ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
++A+K + ++ + L E+ ++ +L H I++ + + L + EY G
Sbjct: 29 ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
G + L G + E + RQIL V Y H+N +VHRDIK N+L D G++KL DF
Sbjct: 89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDF 148
Query: 383 GFSNYFTPGHMLTTWC----GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
G S T G+P + +PE+ G Y G K+DVWS+G + M+T + P+
Sbjct: 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPW 207
Query: 439 DG--PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
A+ K ++P ++S + N +R V + KR + ++ H
Sbjct: 208 AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 80/253 (31%), Positives = 129/253 (50%), Gaps = 25/253 (9%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVT 317
AQ E A KII + E L E+DI+S HP+I+ L++ N L+++
Sbjct: 24 AQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81
Query: 318 EYARGGEIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
E+ GG + S +L + + + E + + RQ+L A+ + H++ V+HRD+KA N+L +GD
Sbjct: 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD 141
Query: 377 IKLADFGFSNYFTPGHML---TTWCGSPPYAAPEL-----FGGREYDGTKSDVWSLGVVL 428
+KLADFG S L T+ G+P + APE+ F YD K+D+WSLG+ L
Sbjct: 142 VKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITL 198
Query: 429 YVMVTAQLPFDGPNLAVLKQRILFG-------KFRIPFYMSAECENLIRSMLVLDPAKRL 481
+ AQ+ + P+ + R+L P S+ + ++S LV DP R
Sbjct: 199 IEL--AQM--EPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254
Query: 482 TLTQISNHKWMSV 494
T ++ H ++S
Sbjct: 255 TAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 77/233 (33%), Positives = 118/233 (50%), Gaps = 8/233 (3%)
Query: 268 AIKIIDKKR-LDERNLRKLFREVDIM-SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K++ KK L ++ + + E +++ ++ HP ++ L +T + LY V +Y GGE+
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF- 384
F HL E A +I SA+ Y H+ N+V+RD+K EN+L D G I L DFG
Sbjct: 84 FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 143
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
+T+CG+P Y APE+ + YD T D W LG VLY M+ PF N A
Sbjct: 144 KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTA 202
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL----TLTQISNHKWMS 493
+ IL ++ ++ +L+ +L D KRL +I NH + S
Sbjct: 203 EMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 71/260 (27%), Positives = 115/260 (44%), Gaps = 38/260 (14%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K + +RL+ + RE+ + HP+++KL V + LV EY
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM--PSDL 85
Query: 327 SHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
S +L + + E + R +L VAY HAN ++HRD+K NLL +G +K+ADFG
Sbjct: 86 SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGL 145
Query: 385 SNYFTPG--HMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG- 440
+ F+ + + + Y APE L+G R+YD D+W++G + ++ F G
Sbjct: 146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG-VDLWAVGCIFAELLNGSPLFPGE 204
Query: 441 ---------------PNLAV---LKQRILFGKFRIPFY-----------MSAECENLIRS 471
PN L + K P S E +L++
Sbjct: 205 NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG 264
Query: 472 MLVLDPAKRLTLTQISNHKW 491
+LV DP+KRL+ + H +
Sbjct: 265 LLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 81/275 (29%), Positives = 126/275 (45%), Gaps = 44/275 (16%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLV 316
+L A+K++DKK + +RN ++++ E +I++ LDHP + L+ +T L LV
Sbjct: 20 VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79
Query: 317 TEYARGGEIFSHLLTI-GQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDEN 374
+Y GGE+F L G+ +E +R + ++L A+ Y H +V+RD+K EN+L E+
Sbjct: 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 375 GDIKLADFGFSNYFTPGHMLTTWCGSPP------------------------------YA 404
G I L+DF S + Y
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 405 APELFGGREYDGTKSDV--WSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY-- 460
APE+ G DG S V W+LG++LY M+ PF G N IL + P
Sbjct: 200 APEVISG---DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPP 256
Query: 461 MSAECENLIRSMLVLDPAKRL----TLTQISNHKW 491
+S+ +LIR +LV DP+KRL +I H +
Sbjct: 257 VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 89/321 (27%), Positives = 137/321 (42%), Gaps = 70/321 (21%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM-----ETTNNLYLVTEYA 320
KVAIK I D + +++ RE+ ++ HL H +II L ++ E N++Y+VTE
Sbjct: 27 KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM 86
Query: 321 RGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
+ L + + + QIL + Y H+ NV+HRD+K N+L + N D
Sbjct: 87 E-----TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD 141
Query: 377 IKLADFGFS-----NYFTPGHM----LTTWCGSPPYAAPEL-FGGREYDGTKS-DVWSLG 425
+K+ DFG + + G + +T W Y APEL Y TK+ D+WS+G
Sbjct: 142 LKICDFGLARGVDPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRY--TKAIDIWSVG 194
Query: 426 VVLYVMVTAQLPFDG----------------PNLAVLKQ----------RILFGKFRIPF 459
+ ++T + F G P+ LK + L K + P
Sbjct: 195 CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPL 254
Query: 460 -----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM-SVHCPGDPVIVNPVPSEPKLP 513
S E +L+ MLV DP KR+T + H ++ +H P D PV +P
Sbjct: 255 SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED----EPVA-KPPFD 309
Query: 514 NSFVIDQMLQLPALTRNRILE 534
F D L L + I E
Sbjct: 310 FDFFDDDELTEEEL-KELIYE 329
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 78/234 (33%), Positives = 118/234 (50%), Gaps = 8/234 (3%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K I K + R+ + E +++ ++ P I+ L ++ LYLV + GGE+F
Sbjct: 22 ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF 81
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
HL G+ A ++L A+ H NV++RD+K EN+L D G I L DFG
Sbjct: 82 HHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK 141
Query: 387 Y-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKS-DVWSLGVVLYVMVTAQLPFDGPNLA 444
T+CG+P Y APEL G Y TK+ D W+LGV+LY M+T PF N+
Sbjct: 142 LNMKDDDKTNTFCGTPEYLAPELLLGHGY--TKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLT---QISNHKWMSVH 495
+ ++IL R P + ++L+ +L DP +RL +I NH + S
Sbjct: 200 EMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 63/187 (33%), Positives = 104/187 (55%), Gaps = 2/187 (1%)
Query: 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355
+HP + L+ +T NL+ V EY GG++ H+ + + A+ +I+ + + H
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 356 ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT-TWCGSPPYAAPELFGGREY 414
+ +V+RD+K +N+L D +G IK+ADFG G T T+CG+P Y APE+ G++Y
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 415 DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLV 474
T D WS GV+LY M+ Q PF G + L Q I P +++ E ++++ + V
Sbjct: 174 -NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 475 LDPAKRL 481
+P +RL
Sbjct: 233 REPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-31
Identities = 86/268 (32%), Positives = 139/268 (51%), Gaps = 13/268 (4%)
Query: 237 EDLSQWEGMYELKK--KKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIM 292
E + E MY L + AA + S K++ K + DER E+ +
Sbjct: 60 ESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCL 119
Query: 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGG----EIFSHLLTIGQMAEKEASRLFRQIL 348
+ DH I+K F ++ + L L+ EY GG +I L E E LF QI+
Sbjct: 120 AACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV 179
Query: 349 SAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHML---TTWCGSPPYAA 405
A+ H+ ++HRD+K+ N+ G IKL DFGFS ++ L +++CG+P Y A
Sbjct: 180 LALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 406 PELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAE 464
PEL+ + Y K+D+WSLGV+LY ++T PF GP+ + Q++L+GK+ P +S+
Sbjct: 240 PELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298
Query: 465 CENLIRSMLVLDPAKRLTLTQISNHKWM 492
+ L+ +L +PA R T Q+ + +++
Sbjct: 299 MKALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 61/186 (32%), Positives = 98/186 (52%), Gaps = 2/186 (1%)
Query: 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA 356
HP + L +T + L+ V EY GG++ + + E + ++ A+ + H
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYD 415
+ V++RD+K +N+L D G KLADFG G TT+CG+P Y APE+ EY
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY- 173
Query: 416 GTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL 475
G D W+LGV++Y M+ Q PF+ N L + IL P ++S E +++++ +
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
Query: 476 DPAKRL 481
+P KRL
Sbjct: 234 NPNKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 74/233 (31%), Positives = 117/233 (50%), Gaps = 8/233 (3%)
Query: 268 AIKIIDKKR-LDERNLRKLFREVDIM-SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K++ KK L ++ + E +++ +L HP ++ L +T LY V +Y GGE+
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
F HL E A ++ SA+ Y H+ N+++RD+K EN+L D G + L DFG
Sbjct: 84 FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC 143
Query: 386 NY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
P +T+CG+P Y APE+ YD T D W LG VLY M+ PF +++
Sbjct: 144 KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVS 202
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL----TLTQISNHKWMS 493
+ IL ++P + +L+ +L D +RL +I NH + S
Sbjct: 203 QMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 24/235 (10%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK++ ++E +L+++ +E+ I+ D P+I+K + +L++V EY G +
Sbjct: 31 VAIKVV---PVEE-DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV- 85
Query: 327 SHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
S ++ I + E+E + + Q L + Y H+N +HRDIKA N+L +E G KLADFG
Sbjct: 86 SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV 145
Query: 385 SNYFTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG--P 441
S T T G+P + APE+ Y+ K+D+WSLG+ M +G P
Sbjct: 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEM------AEGKPP 198
Query: 442 NLAVLKQRILFG-------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ R +F P S E + ++ LV DP +R + Q+ H
Sbjct: 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 77/229 (33%), Positives = 127/229 (55%), Gaps = 17/229 (7%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ--VMETTNN------LYLVTEY 319
A+K++D + + E + + EV + + D I+K + + N + LV +Y
Sbjct: 61 AVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDY 120
Query: 320 ARGG----EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375
A G EI S T E EA LF Q+L AV + H+ +++HRDIK+ N+L NG
Sbjct: 121 ANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180
Query: 376 DIKLADFGFSNYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432
+KL DFGFS + + T+CG+P Y APE++ + Y K+D++SLGV+LY ++
Sbjct: 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELL 239
Query: 433 TAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKR 480
T + PFDG N+ + + L G++ +P +S E + ++ ++L DP +R
Sbjct: 240 TLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 81/236 (34%), Positives = 116/236 (49%), Gaps = 20/236 (8%)
Query: 267 VAIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+K + K L + N +R + E DI++ ++KL + LYL EY GG+
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ L +G ++E A ++ AV H +HRD+K EN L D +G IKL DFG S
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
Query: 386 -NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL- 443
T + + GSP Y APE+ G+ YD T D WSLG +LY + PF G
Sbjct: 149 KGIVTYANSVV---GSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPN 204
Query: 444 ---AVLK------QRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-TLTQISNH 489
LK QR ++ R F +S E +LI ++ DP++R +L I NH
Sbjct: 205 ETWENLKYWKETLQRPVYDDPR--FNLSDEAWDLITKLIN-DPSRRFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 68/222 (30%), Positives = 119/222 (53%), Gaps = 5/222 (2%)
Query: 269 IKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSH 328
IK I+ ++ + + +EV ++S++ HP+I++ + E NLY+V +Y GG+++
Sbjct: 30 IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89
Query: 329 LLTIGQMAEKEASRL--FRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ + E L F QI A+ + H ++HRDIK++N+ ++G IKL DFG +
Sbjct: 90 INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 387 YFTPGHMLTTWC-GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
L C G+P Y +PE+ R Y+ KSD+W+LG VLY M T + F+ N+
Sbjct: 150 VLNSTVELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
Query: 446 LKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
L +I+ G + + + S + NL+ + +P R ++ I
Sbjct: 209 LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 66/193 (34%), Positives = 109/193 (56%), Gaps = 9/193 (4%)
Query: 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA 356
+P ++ L +TT+ L+LV EY GG++ H+ ++ E+ A +I A+ + H
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYD 415
+++RD+K +N+L D +G IKL D+G PG +T+CG+P Y APE+ G EY
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY- 173
Query: 416 GTKSDVWSLGVVLYVMVTAQLPF----DGPNLAV---LKQRILFGKFRIPFYMSAECENL 468
G D W+LGV+++ M+ + PF D P++ L Q IL RIP ++S + ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 469 IRSMLVLDPAKRL 481
++ L DP +RL
Sbjct: 234 LKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 30/296 (10%)
Query: 268 AIKIIDKKR-LDERNLRKLFREVDIM-SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K++ KK L+ + + + E +++ ++ HP ++ L +TT LY V ++ GGE+
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
F HL E A +I SA+ Y H+ N+V+RD+K EN+L D G + L DFG
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC 143
Query: 386 NY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
TT+CG+P Y APE+ + YD T D W LG VLY M+ PF ++A
Sbjct: 144 KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVA 202
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL----TLTQISNHKWM-------- 492
+ IL + S +++ +L D +RL +I H +
Sbjct: 203 EMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262
Query: 493 -----------SVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRILEFDD 537
+V P D + V +E +P S ++ +LE DD
Sbjct: 263 EQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSD---YSIVNASVLEADD 315
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 79/237 (33%), Positives = 126/237 (53%), Gaps = 13/237 (5%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS 327
A K+ID K +E L E+DI++ DHP+I+KL NNL+++ E+ GG + +
Sbjct: 34 AAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91
Query: 328 HLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+L + + + E + + +Q L A+ Y H N ++HRD+KA N+LF +GDIKLADFG S
Sbjct: 92 VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151
Query: 387 YFTPG-HMLTTWCGSPPYAAPELF-----GGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
T ++ G+P + APE+ R YD K+DVWSLG+ L M + P
Sbjct: 152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHE 210
Query: 441 PNLAVLKQRILFGK---FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
N + +I + P S+E ++ ++ L + R T TQ+ H +++V
Sbjct: 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 69/241 (28%), Positives = 122/241 (50%), Gaps = 4/241 (1%)
Query: 258 AQLIEELSKVAIKIIDKKR-LDERNLRKLFREVDIMS-HLDHPHIIKLFQVMETTNNLYL 315
A+L E A+K++ K L + ++ E I+S +HP + +L+ +T + L+
Sbjct: 14 ARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF 73
Query: 316 VTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375
V E+ GG++ H+ + E A +I SA+ + H +++RD+K +N+L D G
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG 133
Query: 376 DIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA 434
KLADFG G +T+CG+P Y APE+ Y G D W++GV+LY M+
Sbjct: 134 HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCG 192
Query: 435 QLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
PF+ N L + IL + P ++S + +++++ + +P RL + + +
Sbjct: 193 HAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252
Query: 495 H 495
H
Sbjct: 253 H 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 71/221 (32%), Positives = 113/221 (51%), Gaps = 8/221 (3%)
Query: 268 AIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A K +DKKRL +R ++ E I+ + I+ L ET ++L LV GG++
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 327 SHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
H+ +G+ EA +F QI+ + + H +V+RD+K EN+L D++G+++++D G
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL 141
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
+ G + G+P Y APE+ G YD D ++LG LY M+ + PF
Sbjct: 142 AVELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEK 200
Query: 445 V----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
V LK+R L P S E ++L ++L DP KRL
Sbjct: 201 VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 16/265 (6%)
Query: 262 EELSKVAIKIIDK-KRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
E+ VAIK +K K + ++ + +F E I+++++HP + L+ + + LYLV E+
Sbjct: 54 EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113
Query: 321 RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
GGE F+ L + QI+ Y + N+V+RD+K ENLL D++G IK+
Sbjct: 114 IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173
Query: 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
DFGF+ T CG+P Y APE+ + G +D W+LG+ +Y ++ PF
Sbjct: 174 DFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYA 230
Query: 441 PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMS-- 493
++ Q+IL G P ++ C++L++ +L D KR + H W
Sbjct: 231 NEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290
Query: 494 --VHCPGDPVIVNPVPSEPKLPNSF 516
V V VP +PK N F
Sbjct: 291 DWVSLLHKNV---EVPYKPKYKNVF 312
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 6/218 (2%)
Query: 268 AIKIIDKKR-LDERNLRKLFREVDIMSHLDHPH-IIKLFQVMETTNNLYLVTEYARGGEI 325
AIKI+ K + + ++ E +++ P + +L +T + LY V EY GG++
Sbjct: 29 AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF- 384
H+ +G+ E A +I + + H+ +++RD+K +N++ D G IK+ADFG
Sbjct: 89 MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148
Query: 385 -SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
N F G T+CG+P Y APE+ + Y G D W+ GV+LY M+ Q PFDG +
Sbjct: 149 KENIF-GGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDE 206
Query: 444 AVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L Q I+ P +S E ++ + +L PAKRL
Sbjct: 207 DELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 68/217 (31%), Positives = 114/217 (52%), Gaps = 4/217 (1%)
Query: 268 AIKIIDKKR-LDERNLRKLFREVDIMSHLDHP-HIIKLFQVMETTNNLYLVTEYARGGEI 325
AIKI+ K + + ++ E +++ D P + +L +T + LY V EY GG++
Sbjct: 29 AIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF- 384
H+ +G+ E +A +I + + H +++RD+K +N++ D G IK+ADFG
Sbjct: 89 MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
+ G T+CG+P Y APE+ + Y G D W+ GV+LY M+ Q PFDG +
Sbjct: 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
L Q I+ P +S E ++ + ++ P+KRL
Sbjct: 208 ELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 91/302 (30%), Positives = 132/302 (43%), Gaps = 81/302 (26%)
Query: 243 EGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHLDHPH 299
EG Y + K ++ VA+K K RLD E RE+ ++ L+HP+
Sbjct: 10 EGTYGVVYKARNKLTGEV------VALK---KIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 300 IIKLFQVMETTNNLYLVTEY-----------ARGGEIFSHLLTIGQMAEKEASRLFRQIL 348
I+KL V+ T N LYLV E+ + I L+ S LF Q+L
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK---------SYLF-QLL 110
Query: 349 SAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF-----TPGH-MLTTWCGSPP 402
+A+CH++ V+HRD+K +NLL + G IKLADFG + F T H ++T W
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW----- 165
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR------ 456
Y APE+ G +Y T D+WSLG + MVT + F P + + Q LF FR
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQ--LFRIFRTLGTPD 221
Query: 457 ---------IPFY------------------MSAECENLIRSMLVLDPAKRLTLTQISNH 489
+P Y + + +L+ ML DP KR++ H
Sbjct: 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281
Query: 490 KW 491
+
Sbjct: 282 PF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-30
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 5/204 (2%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-LTIGQM-AEKEASRLF 344
+E +++ + HP+I+ + E +LY+V EY GG++ + L G++ E + F
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106
Query: 345 RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT-PGHMLTTWCGSPPY 403
Q+ V + H V+HRDIK++N+ +NG +KL DFG + T PG T+ G+P Y
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166
Query: 404 AAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMS 462
PE++ Y+ KSD+WSLG +LY + T + PF + L ++ G ++ +P + S
Sbjct: 167 VPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYS 225
Query: 463 AECENLIRSMLVLDPAKRLTLTQI 486
E +LI+ M +P R + T I
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 81/240 (33%), Positives = 116/240 (48%), Gaps = 16/240 (6%)
Query: 268 AIKIIDKKRLDERNLRKLFREV-DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K L + F E DI+S + P I +L + +NLYLV EY GG++
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 327 SHLLT--IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
S LL Q E A +++ A+ H VHRDIK EN+L D G IKLADFG
Sbjct: 90 S-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGS 148
Query: 385 SNYFTPGHML--TTWCGSPPYAAPELF-----GGREYDGTKSDVWSLGVVLYVMVTAQLP 437
+ T M+ G+P Y APE+ G+ G + D WSLGV+ Y M+ + P
Sbjct: 149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
Query: 438 FDGPNLAVLKQRIL----FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493
F A I+ F KF +S++ +LI+S L+ +RL + H + S
Sbjct: 209 FHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQS-LLCGQKERLGYEGLCCHPFFS 267
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-29
Identities = 71/226 (31%), Positives = 122/226 (53%), Gaps = 13/226 (5%)
Query: 268 AIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K++ K+ + D+ ++ + E + +HP ++ L +T + L+ V EY GG++
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
H+ ++ E+ A +I A+ Y H +++RD+K +N+L D G IKL D+G
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 143
Query: 386 NY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF------ 438
PG +T+CG+P Y APE+ G +Y G D W+LGV+++ M+ + PF
Sbjct: 144 KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSS 202
Query: 439 DGPNLAV---LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
D P+ L Q IL + RIP +S + ++++S L DP +RL
Sbjct: 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 40/260 (15%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK + DE + REV ++ L H +I+ L + LYLV EY
Sbjct: 29 VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTL 86
Query: 327 SHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
LL G + Q+L A+AYCH++N++HRDIK EN+L E+G +KL DFGF
Sbjct: 87 LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146
Query: 385 SNYFT--PGHMLTTWCGSPPYAAPELF-GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
+ P LT + + Y APEL G Y G DVW++G ++ ++ + F G
Sbjct: 147 ARALRARPASPLTDYVATRWYRAPELLVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGD 205
Query: 442 N-------------------LAVLKQRILFGKFRIP-------------FYMSAECENLI 469
+ + F P +S+ + +
Sbjct: 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFL 265
Query: 470 RSMLVLDPAKRLTLTQISNH 489
++ L +DP +RLT ++ H
Sbjct: 266 KACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 11/196 (5%)
Query: 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355
+HP ++ L +T + L+ V E+ GG++ H+ ++ E+ A +I A+ + H
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113
Query: 356 ANNVVHRDIKAENLLFDENGDIKLADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREY 414
+++RD+K +N+L D G IKL D+G PG +T+CG+P Y APE+ G +Y
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 415 DGTKSDVWSLGVVLYVMVTAQLPFD------GPNLAV---LKQRILFGKFRIPFYMSAEC 465
G D W+LGV+++ M+ + PFD P+ L Q IL + RIP +S +
Sbjct: 174 -GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 466 ENLIRSMLVLDPAKRL 481
++++ L DP +RL
Sbjct: 233 SSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 3e-29
Identities = 74/238 (31%), Positives = 119/238 (50%), Gaps = 13/238 (5%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VAIKIID + E + + +E+ ++S D P++ K + L+++ EY GG
Sbjct: 30 QVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
LL G E + + + ++IL + Y H+ +HRDIKA N+L E GD+KLADFG
Sbjct: 89 ALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGV 147
Query: 385 SNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
+ T + T+ G+P + APE+ YD +K+D+WSLG+ + + PN
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGE----PPNS 202
Query: 444 AVLKQRILF--GKFRIPFYM---SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496
+ R+LF K P S + I + L DP+ R T ++ HK++ +
Sbjct: 203 DMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 270 KIIDKKR----LDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KI+ K ++E +++ RE+DI+ + P+I+ + ++ + EY GG +
Sbjct: 27 KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86
Query: 326 FSHL-LTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFG 383
L G++ E+ ++ +L + Y H ++HRD+K N+L + G IKL DFG
Sbjct: 87 DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG 146
Query: 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN- 442
S + T+ G+ Y APE G +Y KSD+WSLG+ L + T + P+ N
Sbjct: 147 VSGQLV-NSLAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPEND 204
Query: 443 -----LAVLKQ-------RILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490
+L+ R+ GKF S + ++ + L+ DP +R + ++ H
Sbjct: 205 PPDGIFELLQYIVNEPPPRLPSGKF------SPDFQDFVNLCLIKDPRERPSYKELLEHP 258
Query: 491 W 491
+
Sbjct: 259 F 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 77/266 (28%), Positives = 117/266 (43%), Gaps = 43/266 (16%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
RK G G WEG+++ +VAIKI+ K D + +EV
Sbjct: 11 ERKLGSGYFGEVWEGLWK---------------NRVRVAIKIL--KSDDLLKQQDFQKEV 53
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF--RQI 347
+ L H H+I LF V +Y++TE G + + L + AS + Q+
Sbjct: 54 QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113
Query: 348 LSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN------YFTPGHMLTTWCGSP 401
+AY N +HRD+ A N+L E+ K+ADFG + Y + +
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI------- 166
Query: 402 PY--AAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRIP 458
PY APE + TKSDVWS G++LY M T Q+P+ G N + +I G +R+P
Sbjct: 167 PYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMP 224
Query: 459 FYMSAECENLIRSMLV----LDPAKR 480
A+C I +++ +P R
Sbjct: 225 --CPAKCPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 69/220 (31%), Positives = 116/220 (52%), Gaps = 9/220 (4%)
Query: 268 AIKIIDKKRLDERN----LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG 323
AIK + K + R+ L R + + HP ++ LF +T +++ V EYA GG
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ H+ T +E A ++ + Y H N +V+RD+K +NLL D G +K+ADFG
Sbjct: 88 DLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146
Query: 384 FSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKS-DVWSLGVVLYVMVTAQLPFDGP 441
G +T+CG+P + APE+ Y T++ D W LGV++Y M+ + PF G
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY--TRAVDWWGLGVLIYEMLVGESPFPGD 204
Query: 442 NLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
+ + I+ + R P ++S E +++R +L +P +RL
Sbjct: 205 DEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 68/202 (33%), Positives = 112/202 (55%), Gaps = 8/202 (3%)
Query: 288 EVDIMSHLDH-PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQ 346
E ++ H+ P ++ L +T L+L+ +Y GGE+F+HL + E+E +
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTW--CGSPPYA 404
I+ A+ + H +++RDIK EN+L D NG + L DFG S F + + CG+ Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 405 APELFGGREYDGTKS-DVWSLGVVLYVMVTAQLPF--DGP--NLAVLKQRILFGKFRIPF 459
AP++ G + K+ D WS+GV++Y ++T PF DG + A + +RIL + P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233
Query: 460 YMSAECENLIRSMLVLDPAKRL 481
MSA +++I+ +L+ DP KRL
Sbjct: 234 EMSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 77/243 (31%), Positives = 122/243 (50%), Gaps = 27/243 (11%)
Query: 262 EELSKVAIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
E + A+K I+K+ L RN ++++F E DI++ ++P ++ +F ET +L +V EY
Sbjct: 24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83
Query: 321 RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
GG+ + L IG + A F + + A+ Y H +VHRD+K +NLL G IKL
Sbjct: 84 EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLT 143
Query: 381 DFGFSNYFTPGHM-LTT------------------WCGSPPYAAPELFGGREYDGTKSDV 421
DFG S G M LTT CG+P Y APE+ + Y G D
Sbjct: 144 DFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDW 199
Query: 422 WSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF---YMSAECENLIRSMLVLDPA 478
W++G++LY + +PF G L +++ P + A+ ++LI +L +P
Sbjct: 200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPL 259
Query: 479 KRL 481
+RL
Sbjct: 260 ERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 11/251 (4%)
Query: 246 YELKKKKEEAA-----AAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300
YE+ KK E + A+ + IK ID ++ + +EV +++ + HP+I
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 301 IKLFQVMETTNNLYLVTEYARGGEIFSHL-LTIGQM-AEKEASRLFRQILSAVAYCHANN 358
+ F + L++V EY GG++ + G + +E + F QI + + H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 359 VVHRDIKAENLLFDENGDI-KLADFGFSNYFTPGHMLTTWC-GSPPYAAPELFGGREYDG 416
++HRDIK++N+ +NG + KL DFG + L C G+P Y +PE+ R Y+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN- 180
Query: 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVL 475
K+D+WSLG VLY + T + PF+G NL L +I G F I S + +LI + +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240
Query: 476 DPAKRLTLTQI 486
P R ++T I
Sbjct: 241 SPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/226 (32%), Positives = 108/226 (47%), Gaps = 15/226 (6%)
Query: 279 ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEK 338
E+ KL EVD++ L H +I++ N + + E+ GG I S L G + E
Sbjct: 43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP 102
Query: 339 EASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF-------TPG 391
+ +QIL VAY H N VVHRDIK N++ NG IKL DFG + T
Sbjct: 103 VFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 392 HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451
+ML + G+P + APE+ Y G KSD+WS+G ++ M T + P ++ L
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFY 219
Query: 452 FGKFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
G R +P SA + + S L D +R + Q+ H ++
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 60/185 (32%), Positives = 95/185 (51%), Gaps = 2/185 (1%)
Query: 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN 357
P + +L +T + LY V EY GG++ + +G+ E A +I + + H+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 358 NVVHRDIKAENLLFDENGDIKLADFGF-SNYFTPGHMLTTWCGSPPYAAPELFGGREYDG 416
+++RD+K +N++ D G IK+ADFG G T+CG+P Y APE+ + Y G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-G 179
Query: 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLD 476
D W+ GV+LY M+ Q PF+G + L Q I+ P MS E + + ++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239
Query: 477 PAKRL 481
P KRL
Sbjct: 240 PGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 83/270 (30%), Positives = 123/270 (45%), Gaps = 59/270 (21%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K I + DE RE+ ++ L+HP+I++L V+ + N LYLV E+ ++
Sbjct: 27 VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLK 85
Query: 327 SHLLTIGQMAEKEA---SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ + S L+ Q+L +AYCH++ V+HRD+K +NLL D G +KLADFG
Sbjct: 86 KYMDSSPLTGLDPPLIKSYLY-QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG 144
Query: 384 FSNYF-----TPGH-MLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
+ F T H ++T W Y APE L G R+Y T D+WS+G + MV +
Sbjct: 145 LARAFGVPVRTYTHEVVTLW-----YRAPEILLGSRQY-STPVDIWSIGCIFAEMVNRRP 198
Query: 437 PFDGPNLAVLKQRI--LFGKFRI---------------PFYMSA---------------- 463
F G I LF FR P Y
Sbjct: 199 LFPG------DSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL 252
Query: 464 --ECENLIRSMLVLDPAKRLTLTQISNHKW 491
+ +L+ MLV DPAKR++ H +
Sbjct: 253 DEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 257 AAQLIEELSKVAIKIIDKKRLD----ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN 312
A+ ++ + +A+K + R E + L +E+ +M+ L+HPHII++ ++
Sbjct: 18 QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372
L E+ GG + L G E Q+L ++Y H N ++HRD+K NLL D
Sbjct: 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID 137
Query: 373 ENG-DIKLADFGFSNYFTP---------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVW 422
G +++ADFG + G +L G+ + APE+ G +Y G DVW
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLL----GTIAFMAPEVLRGEQY-GRSCDVW 192
Query: 423 SLGVVLYVMVTAQLPFDGPNLA 444
S+G V+ M TA+ P++ +
Sbjct: 193 SVGCVIIEMATAKPPWNAEKHS 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 71/236 (30%), Positives = 124/236 (52%), Gaps = 8/236 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK ++ ++ ++ L + E+ +M HP+I+ + L++V EY GG +
Sbjct: 46 EVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T M E + + + R+ L A+ + H+N V+HRDIK++N+L +G +KL DFGF
Sbjct: 104 -TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-L 443
TP +T G+P + APE+ + Y G K D+WSLG++ MV + P+ N L
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 444 AVLKQRILFGK--FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
L G + P +SA + + L +D KR + ++ H ++ + P
Sbjct: 222 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 54/287 (18%)
Query: 243 EGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302
EG Y + K Q+ VA+K I + +E RE+ ++ L HP+I+
Sbjct: 10 EGTYGVVYKGRNKKTGQI------VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKE--ASRLFRQILSAVAYCHANN 358
L V+ + LYL+ E+ ++ +L ++ GQ + E S L+ QIL + +CH+
Sbjct: 64 LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLY-QILQGILFCHSRR 121
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFSNYF-TP-----GHMLTTWCGSPPYAAPE-LFGG 411
V+HRD+K +NLL D G IKLADFG + F P ++T W Y APE L G
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-----YRAPEVLLGS 176
Query: 412 REYDGTKSDVWSLGVVLYVMVTAQLPFDG----------------------PNLAVLKQ- 448
Y T D+WS+G + M T + F G P + L
Sbjct: 177 PRY-STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 449 RILFGKFRIPFY------MSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ F K++ + + +L+ ML+ DPAKR++ + NH
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 279 ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEK 338
ERN+ + R+ P ++ L +T L+L+ +Y GGE+F+HL +E
Sbjct: 54 ERNVLEHVRQS--------PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED 105
Query: 339 EASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTW- 397
E +I+ A+ + H +V+RDIK EN+L D G + L DFG S F T+
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 398 -CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF----DGPNLAVLKQRILF 452
CG+ Y APE+ G+ G D WSLG++++ ++T PF + + + +RIL
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK 225
Query: 453 GKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNH 489
P ++ E ++L+ +L DP KRL ++I H
Sbjct: 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 76/247 (30%), Positives = 123/247 (49%), Gaps = 27/247 (10%)
Query: 261 IEELSK--VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTE 318
I+ +K VAIKIID + E + + +E+ ++S D P+I + + L+++ E
Sbjct: 24 IDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82
Query: 319 YARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
Y GG LL G + E + + R+IL + Y H+ +HRDIKA N+L E GD+K
Sbjct: 83 YLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVK 141
Query: 379 LADFGFSNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437
LADFG + T + T+ G+P + APE+ YD K+D+WSLG+ + +
Sbjct: 142 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGE-- 198
Query: 438 FDGPNLAVLKQRILF-----------GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
PN + R+LF G++ PF + + + L DP R T ++
Sbjct: 199 --PPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF------KEFVEACLNKDPRFRPTAKEL 250
Query: 487 SNHKWMS 493
HK+++
Sbjct: 251 LKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/190 (29%), Positives = 104/190 (54%), Gaps = 2/190 (1%)
Query: 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355
++P + L+ +T +L+ V E+ GG++ H+ G+ A+ +I+ + + H
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 356 ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREY 414
+ +++RD+K +N++ D +G IK+ADFG G + +T+CG+P Y APE+ G +Y
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 415 DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLV 474
+ D WS GV+LY M+ Q PF G + L + I P +++ E ++++ +
Sbjct: 174 TFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFE 232
Query: 475 LDPAKRLTLT 484
DP +RL +
Sbjct: 233 RDPTRRLGVV 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-27
Identities = 70/223 (31%), Positives = 114/223 (51%), Gaps = 6/223 (2%)
Query: 269 IKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN-LYLVTEYARGGEIFS 327
IK ++ + R + +E ++S L HP+I+ + E + LY+V + GG+++
Sbjct: 30 IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89
Query: 328 HLL-TIGQM-AEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
L G++ E + F QI A+ Y H +++HRD+K +N+ IK+ D G +
Sbjct: 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149
Query: 386 NYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
M +T G+P Y +PELF + Y+ KSDVW+LG +Y M T + F+ ++
Sbjct: 150 RVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMN 208
Query: 445 VLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
L RI+ GK +P S E LI +ML P KR ++ I
Sbjct: 209 SLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 8/205 (3%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ----MAEKEASRL 343
E ++S LDHP I+K + ++TEY G ++ L + ++E +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 344 FRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGSPP 402
F Q+L V Y H ++HRD+KA+N +F +N +K+ DFG S + TT+ G+P
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKN-IFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPY 170
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFYM 461
Y +PE + YD +KSD+WSLG +LY M F+G N + RI+ G +P
Sbjct: 171 YMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY 229
Query: 462 SAECENLIRSMLVLDPAKRLTLTQI 486
S + ++++SML DP+ R + +I
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 73/244 (29%), Positives = 133/244 (54%), Gaps = 10/244 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K +D ++ R L LF EV IM H ++++++ + L++V E+ GG +
Sbjct: 48 VAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL- 104
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ ++T +M E++ + + +L A++ HA V+HRDIK++++L +G +KL+DFGF
Sbjct: 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 164
Query: 387 YFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPNLA 444
+ + G+P + APEL Y G + D+WSLG+++ MV + P F+ P L
Sbjct: 165 QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223
Query: 445 VLK--QRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVI 502
+K + L K + +S + + +LV DPA+R T ++ H +++ G P
Sbjct: 224 AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK--AGPPSC 281
Query: 503 VNPV 506
+ P+
Sbjct: 282 IVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 78/245 (31%), Positives = 118/245 (48%), Gaps = 35/245 (14%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG--- 323
VAIK+I K + + +E+ ++ HP+I+ F + L++V EY GG
Sbjct: 31 VAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+I+ +T G ++E + + + R+ L +AY H +HRDIK N+L E+GD+KLADFG
Sbjct: 89 DIYQ--VTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFG 146
Query: 384 FSNYFTPGHML---TTWCGSPPYAAPE-----LFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
S T + ++ G+P + APE GG YDG K D+W+LG+ + Q
Sbjct: 147 VSAQLT--ATIAKRKSFIGTPYWMAPEVAAVERKGG--YDG-KCDIWALGITAIELAELQ 201
Query: 436 LP-FDGPNLAVLKQRILF--GKFRIPFYM-------SAECENLIRSMLVLDPAKRLTLTQ 485
P FD + R LF K P S + I+ L DP KR T T+
Sbjct: 202 PPMFD-----LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
Query: 486 ISNHK 490
+ H
Sbjct: 257 LLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 44/261 (16%)
Query: 267 VAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG-- 323
VAIK + D++ ++K+ RE+ ++ L H +++ L +V LYLV E+
Sbjct: 29 VAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL 87
Query: 324 ---EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
E + + L E + QIL + +CH++N++HRDIK EN+L ++G +KL
Sbjct: 88 DDLEKYPNGLD-----ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLC 142
Query: 381 DFGFSNYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439
DFGF+ PG + T + + Y APEL G G D+W++G ++ M+T + F
Sbjct: 143 DFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202
Query: 440 GP--------------NLAVLKQRI-----LFGKFRIPFY------------MSAECENL 468
G NL Q I LF R+P +S +L
Sbjct: 203 GDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDL 262
Query: 469 IRSMLVLDPAKRLTLTQISNH 489
+ L +DP R + +Q+ +H
Sbjct: 263 AKQCLRIDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 71/238 (29%), Positives = 125/238 (52%), Gaps = 12/238 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK I+ ++ ++ L + E+ +M L +P+I+ + L++V EY GG +
Sbjct: 46 EVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T M E + + + R+ L A+ + HAN V+HRDIK++N+L +G +KL DFGF
Sbjct: 104 -TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162
Query: 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
TP +T G+P + APE+ + Y G K D+WSLG++ MV + P+ N
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNEN-- 219
Query: 445 VLKQRILFG-----KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
L+ L + + P +S + + L +D KR + ++ H ++ + P
Sbjct: 220 PLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 73/248 (29%), Positives = 136/248 (54%), Gaps = 16/248 (6%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VA+K +D ++ R L LF EV IM H +++ ++ + L++V E+ GG +
Sbjct: 49 QVAVKKMDLRKQQRREL--LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T +M E++ + + +L A++Y H V+HRDIK++++L +G IKL+DFGF
Sbjct: 107 -TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 386 NYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGP 441
+ P + G+P + APE+ Y GT+ D+WSLG+++ M+ + P F+ P
Sbjct: 166 AQVSKEVPKR--KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEP 222
Query: 442 NLAVLKQRI---LFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPG 498
L ++ RI L + + +S+ + MLV +P++R T ++ H ++ + G
Sbjct: 223 PLQAMR-RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL--AG 279
Query: 499 DPVIVNPV 506
P + P+
Sbjct: 280 PPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 71/230 (30%), Positives = 118/230 (51%), Gaps = 9/230 (3%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIKIID + E + + +E+ ++S D P++ K + L+++ EY GG
Sbjct: 32 VAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
LL G + E + + + R+IL + Y H+ +HRDIKA N+L E+G++KLADFG +
Sbjct: 91 D-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149
Query: 387 YFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445
T + T+ G+P + APE+ YD +K+D+WSLG+ + + P L
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHS--ELHP 206
Query: 446 LKQRILFGKFRIPFY---MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
+K L K P S + + + L +P+ R T ++ HK++
Sbjct: 207 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 71/236 (30%), Positives = 122/236 (51%), Gaps = 13/236 (5%)
Query: 268 AIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K + +R+ F E DIM+H + I++L + LY+V EY GG++
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L++ + EK A +++ A+ H+ +HRD+K +N+L D++G +KLADFG
Sbjct: 132 N-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 387 YFTPGHML--TTWCGSPPYAAPELF---GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
M+ T G+P Y +PE+ GG Y G + D WS+GV LY M+ PF
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 442 NLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAK--RLTLTQISNHKW 491
+L +I+ K + F +S + ++LI + L + R + +I +H +
Sbjct: 251 SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 16/240 (6%)
Query: 263 ELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
EL V+ D+KR L L RE+ ++ L H +I++ ++L + EY G
Sbjct: 34 ELPSVSASSKDRKR---SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPG 90
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
G + + L G E RQIL + Y H ++HRDIK N+L D G IK++DF
Sbjct: 91 GSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF 150
Query: 383 GFSNYFTPGHMLTTWCGSPP-------YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
G S + T G+ P + APE+ Y K+D+WSLG ++ M+T +
Sbjct: 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGK 209
Query: 436 LPFDGPNLAVLKQRILFGKF---RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
PF P+ L+ G+ IP +S+E + + +D KR T ++ H ++
Sbjct: 210 HPF--PDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 11/238 (4%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNN 312
E +A Q+ A K ++KKRL +R E I++ + I+ L +T +
Sbjct: 8 EVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD 67
Query: 313 LYLVTEYARGGEIFSHLLTIGQ----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368
L LV GG++ H+ + + E A QI+S + + H +++RD+K EN
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127
Query: 369 LLFDENGDIKLADFGFSNYFTPGHMLTT-WCGSPPYAAPELFGGREYDGTKSDVWSLGVV 427
+L D +G+++++D G + G T + G+P + APEL G EYD D ++LGV
Sbjct: 128 VLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVT 186
Query: 428 LYVMVTAQLPFDGPNLAV----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
LY M+ A+ PF V LKQRIL P S ++ ++L DP KRL
Sbjct: 187 LYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/233 (27%), Positives = 130/233 (55%), Gaps = 12/233 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VA+K++D ++ R L LF EV IM H +++++++ L+++ E+ +GG +
Sbjct: 48 QVAVKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ +++ ++ E++ + + +L A+ Y H+ V+HRDIK++++L +G +KL+DFGF
Sbjct: 106 -TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164
Query: 386 NYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF--DG 440
+ P + G+P + APE+ Y GT+ D+WSLG+++ MV + P+ D
Sbjct: 165 AQISKDVPKR--KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDS 221
Query: 441 PNLAVLKQR-ILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
P A+ + R K + +S + + ML +P +R T ++ +H ++
Sbjct: 222 PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 80/293 (27%), Positives = 119/293 (40%), Gaps = 85/293 (29%)
Query: 258 AQLIEELSKVAIKIIDKK--------RLDE-RNLRKLFREVDIMSHLDHPHIIKLFQVME 308
A+ E VAIK + KK L E ++LRKL HP+I+KL +V
Sbjct: 18 ARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE---------HPNIVKLKEVFR 68
Query: 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF---------RQILSAVAYCHANNV 359
+ LY V EY G + Q+ + + F QIL +A+ H +
Sbjct: 69 ENDELYFVFEYMEG--------NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 360 VHRDIKAENLLFDENGDIKLADFG----------FSNYFTPGHMLTTWCGSPPYAAPELF 409
HRD+K ENLL +K+ADFG +++Y + T W Y APE+
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-----TRW-----YRAPEIL 170
Query: 410 GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--------LAVL---KQRI------LF 452
+ D+W+LG ++ + T + F G + +VL ++ L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 453 GK--FRIPFYM-----------SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
K FR P + S E +LI+ ML DP KR T +Q H +
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 53/267 (19%)
Query: 267 VAIKIIDKKRLD--ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K I LD E RE+ +M L H +I++L V+ T N L LV EY +
Sbjct: 28 VALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83
Query: 325 IFSHLLTIGQMAEKEAS--RLFR-QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
+ ++ T G + + + F Q+L +A+CH N V+HRD+K +NLL ++ G++KLAD
Sbjct: 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLAD 143
Query: 382 FGFS-------NYFTPGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVT 433
FG + N F+ ++T W Y AP+ L G R Y T D+WS+G ++ M+T
Sbjct: 144 FGLARAFGIPVNTFS-NEVVTLW-----YRAPDVLLGSRTYS-TSIDIWSVGCIMAEMIT 196
Query: 434 AQLPFDG----------------PNLAVLKQRILFGKFR--IPFYMSAECENLI------ 469
+ F G P + +++ P Y + + L
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256
Query: 470 -----RSMLVLDPAKRLTLTQISNHKW 491
+L L+P R++ H W
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 73/259 (28%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 267 VAIKIIDKKRLDERNLRKLFR-EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K + K + E+ R E DI++ D+P ++KL+ + N LYL+ EY GG++
Sbjct: 29 YAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDM 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ L+ E+E + + A+ H +HRDIK +NLL D G IKL+DFG
Sbjct: 89 MTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148
Query: 386 NYFTPGH----------------------------MLTTW-----------CGSPPYAAP 406
H TW G+P Y AP
Sbjct: 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP 208
Query: 407 ELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM----S 462
E+F Y + D WSLGV++Y M+ PF N ++I+ K + F S
Sbjct: 209 EVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLS 267
Query: 463 AECENLIRSMLVLDPAKRL 481
E ++LI+ L + +RL
Sbjct: 268 PEAKDLIKR-LCCEAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 21/240 (8%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS 327
A K+I+ K +E L E++I++ +HP+I+KL L+++ E+ GG + +
Sbjct: 41 AAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98
Query: 328 HLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+L + + + E + + RQ+L A+ Y H+ ++HRD+KA N+L +GDIKLADFG S
Sbjct: 99 IMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158
Query: 387 YFTPG-HMLTTWCGSPPYAAPEL-----FGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
++ G+P + APE+ YD K+D+WSLG+ L M + P
Sbjct: 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHE 217
Query: 441 PNLAVLKQRILFG-------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493
N R+L P S E + +++ L P R + Q+ H ++S
Sbjct: 218 LN----PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/245 (27%), Positives = 112/245 (45%), Gaps = 22/245 (8%)
Query: 263 ELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
EL D ++ D ++ L E++ + LDH +I++ T L + EY G
Sbjct: 35 ELPATIAGRHDSRQKD--MVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPG 92
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
G I S L T G+ E+ Q+L +AY H+ ++HRD+KA+NLL D +G K++DF
Sbjct: 93 GSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF 152
Query: 383 GFSN-----YFTPGHMLTTWCGSPPYAAPELFG--GREYDGTKSDVWSLGVVLYVMVTAQ 435
G S Y +M + GS + APE+ + Y K D+WSLG V+ M +
Sbjct: 153 GISKKSDDIYDNDQNM--SMQGSVFWMAPEVIHSYSQGYSA-KVDIWSLGCVVLEMFAGR 209
Query: 436 LPFDGPNLAVLKQRILFGKFR----IP----FYMSAECENLIRSMLVLDPAKRLTLTQIS 487
P+ + + G R IP +S + + + ++P R T ++
Sbjct: 210 RPWS--DEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 488 NHKWM 492
H ++
Sbjct: 268 QHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 76/277 (27%), Positives = 116/277 (41%), Gaps = 56/277 (20%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K + K + RN + E DI++ D+ ++KL+ + +NLY V +Y GG++
Sbjct: 30 AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-- 384
S L+ +G E A ++ A+ H +HRDIK +N+L D +G IKL DFG
Sbjct: 90 SLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149
Query: 385 -------SNYFTPG-HM------------------LTT----------------WCGSPP 402
S Y+ G H L G+P
Sbjct: 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209
Query: 403 YAAPELFGGREYDGTKS-DVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--FRIPF 459
Y APE+ Y T+ D WS+GV+LY M+ Q PF A + +++ + IP
Sbjct: 210 YIAPEVLLRTGY--TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS 267
Query: 460 Y--MSAECENLIRSMLVLDPAKRL---TLTQISNHKW 491
+S E +LI L RL +I H +
Sbjct: 268 QAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPF 303
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 265 SKVAIKII---DKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM-----ETTNNLYLV 316
KVAIK I + + +R LR E+ I+ H +II + ++ E+ N++Y+V
Sbjct: 31 VKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86
Query: 317 TEYARGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENG 375
E E + L Q + + F QIL + Y H+ NV+HRD+K NLL + N
Sbjct: 87 QELM---ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC 143
Query: 376 DIKLADFGFSNYFTPGH----MLTTWCGSPPYAAPE-LFGGREYDGTKS-DVWSLGVVLY 429
D+K+ DFG + P H LT + + Y APE + + Y TK+ D+WS+G +L
Sbjct: 144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY--TKAIDIWSVGCILA 201
Query: 430 VMVTAQLPFDGPN--------LAVLK-------QRILFGKFR-----IPFY--------- 460
M++ + F G + L VL I+ + R +PF
Sbjct: 202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLF 261
Query: 461 --MSAECENLIRSMLVLDPAKRLTLTQISNHKWMS-VHCPGD-PVIVNPVPSEPKLPNSF 516
+ +L+ ML +P KR+T+ + H ++ H P D PV P P + +L +
Sbjct: 262 PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDL 321
Query: 517 VIDQMLQL 524
+++ +L
Sbjct: 322 PKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 68/253 (26%), Positives = 106/253 (41%), Gaps = 61/253 (24%)
Query: 287 REVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGGEIFSH----LLTI--GQMAEK 338
RE++I+ L HP+I+ + +V+ + +Y+V EY H L+ +
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY------VEHDLKSLMETMKQPFLQS 106
Query: 339 EASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF--TPGHM--- 393
E L Q+LS VA+ H N ++HRD+K NLL + G +K+ DFG + +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166
Query: 394 -LTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG----------- 440
+T W Y APE L G +EY T D+WS+G + ++T + F G
Sbjct: 167 VVTLW-----YRAPELLLGAKEY-STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 441 -----PN-----------LAVLKQRI------LFGKFRIPFYMSAECENLIRSMLVLDPA 478
P A K L KF +S +L+ +L DPA
Sbjct: 221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALS-LSDNGFDLLNRLLTYDPA 279
Query: 479 KRLTLTQISNHKW 491
KR++ H +
Sbjct: 280 KRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 82/265 (30%), Positives = 121/265 (45%), Gaps = 27/265 (10%)
Query: 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVD 290
R GEG+ ++G+Y + E A VA+K K K +E
Sbjct: 12 RCIGEGQFGDVYQGVY--MSPENEKIA---------VAVKTC-KNCTSPSVREKFLQEAY 59
Query: 291 IMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-RQILS 349
IM DHPHI+KL V+ N +++V E A GE+ S+L + + L+ Q+ +
Sbjct: 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 350 AVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP--YAAPE 407
A+AY + VHRDI A N+L +KL DFG S Y G P + APE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 408 LFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFDG-PNLAVLKQRILFGKFRIPFYMSAEC 465
R + + SDVW GV ++ +++ PF G N V+ RI G+ R+P M C
Sbjct: 179 SINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGE-RLP--MPPNC 233
Query: 466 E----NLIRSMLVLDPAKRLTLTQI 486
+L+ DP+KR T++
Sbjct: 234 PPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 10/223 (4%)
Query: 273 DKKRLDERNLRKLFREVDIM-SHLDHPHIIKLFQVMETTNNLYLVTEYARG---GEIFSH 328
DK+ D+ ++ + EV I+ L HP+I++ ++ + LY+V + G GE F+
Sbjct: 44 DKRERDK-SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 329 LLTIGQ-MAEKEASRLFRQILSAVAYCHANN-VVHRDIKAENLLFDENGDIKLADFGFSN 386
L Q E+ +F Q++ A+ Y H +VHRD+ N++ E+ + + DFG +
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
Query: 387 YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446
P LT+ G+ Y+ PE+ Y G K+DVW+ G +LY M T Q PF N+ L
Sbjct: 163 QKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221
Query: 447 KQRILFGKFR-IPFYM-SAECENLIRSMLVLDPAKRLTLTQIS 487
+I+ + +P M S + ++I S L D R + Q+S
Sbjct: 222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 67/235 (28%), Positives = 118/235 (50%), Gaps = 27/235 (11%)
Query: 274 KKRLDERNLRKLFREVDIMSHL---DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLL 330
+K + +N F ++ M H D+P+ IKL+ + T L+ +Y + G++F L
Sbjct: 46 QKIIKAKN----FNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101
Query: 331 TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD-IKLADFGFSNYFT 389
G+++E E ++ RQ++ A+ H +N++H DIK EN+L+D D I L D+G
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--- 158
Query: 390 PGHMLTTWC--GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-----N 442
+ T C G+ Y +PE G YD D W++GV+ Y ++T + PF +
Sbjct: 159 --IIGTPSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 443 LAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDPAKRL-TLTQISNHKWMSV 494
L L +R + ++PF +S + ++SML + RL +I H ++ +
Sbjct: 216 LESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVD 290
+K G G+ + L +K Q+ E +D + + +E+D
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFE-------------MMDAKARQDCVKEID 54
Query: 291 IMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ----MAEKEASRLFRQ 346
++ L+HP++IK N L +V E A G++ + + + E+ + F Q
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF----TPGHMLTTWCGSPP 402
+ SAV + H+ V+HRDIK N+ G +KL D G +F T H L G+P
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPY 171
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF--DGPNLAVLKQRI 450
Y +PE Y+ KSD+WSLG +LY M Q PF D NL L Q+I
Sbjct: 172 YMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 50/267 (18%)
Query: 267 VAIK-IIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VAIK ++ + D+ ++K+ RE+ ++ L HP+++ L +V L+LV EY
Sbjct: 29 VAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD--- 83
Query: 325 IFSHLLTIGQ----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
+ L + + + E ++ Q L AV +CH +N +HRD+K EN+L + G IKL
Sbjct: 84 -HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLC 142
Query: 381 DFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ---- 435
DFGF+ T PG T + + Y APEL G G DVW++G V ++T Q
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 436 ------------------LP-----------FDGPNLAVLKQRI-LFGKFRIPFYMSAEC 465
+P F G ++ + R L KF +S+
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFP---NISSPA 259
Query: 466 ENLIRSMLVLDPAKRLTLTQISNHKWM 492
+ ++ L +DP +RL+ ++ H +
Sbjct: 260 LSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/231 (31%), Positives = 117/231 (50%), Gaps = 13/231 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
++AIK I ++ D R ++ L E+ + S+L H +I++ + E GG +
Sbjct: 35 RIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92
Query: 326 FSHLLT-IGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLAD 381
+ L + G + + E + +F +QIL + Y H N +VHRDIK +N+L + +G +K++D
Sbjct: 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISD 152
Query: 382 FGFSNYFTPGHMLT-TWCGSPPYAAPELF--GGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
FG S + T T+ G+ Y APE+ G R Y G +D+WSLG + M T + PF
Sbjct: 153 FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPF 211
Query: 439 ---DGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
P A+ K + IP +SAE +N I DP KR + +
Sbjct: 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 283 RKLFREVDIMSHLDHPHIIKLFQ--VMETTNNLYLVTEYARGGEIFSHLLTI----GQMA 336
+++ RE++I P+I+K + + E+++++ + EY GG + S + G++
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103
Query: 337 EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT 396
EK ++ +L ++Y H+ ++HRDIK N+L G +KL DFG S + T
Sbjct: 104 EKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-NSLAGT 162
Query: 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF--DGPNLAVLKQRILFGK 454
+ G+ Y APE G+ Y T SDVWSLG+ L + + PF +G + + +
Sbjct: 163 FTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
Query: 455 FRIPFYMSAECENLI---RSM-------LVLDPAKRLTLTQISNHKWM 492
+ E N I L DP +R T + H W+
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 68/216 (31%), Positives = 115/216 (53%), Gaps = 11/216 (5%)
Query: 268 AIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K + +R+ F E DIM+ + P +++LF + LY+V EY GG++
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV 131
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L++ + EK A +++ A+ H+ ++HRD+K +N+L D++G +KLADFG
Sbjct: 132 N-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190
Query: 387 YFTPGHML--TTWCGSPPYAAPELF---GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
M+ T G+P Y +PE+ GG Y G + D WS+GV L+ M+ PF
Sbjct: 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
Query: 442 NLAVLKQRILFGKFRIPF----YMSAECENLIRSML 473
+L +I+ K + F +S +NLI + L
Sbjct: 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 72/286 (25%)
Query: 286 FREVDIMSHL-DHPHIIKLFQVMETTNN--LYLVTEYARGGE------IFSHLLTIGQMA 336
FRE+ + L DHP+I+KL V++ N+ +YLV EY E I +++L
Sbjct: 54 FREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM---ETDLHAVIRANIL------ 104
Query: 337 EKEASR--LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH-- 392
++ + + Q+L A+ Y H+ NV+HRD+K N+L + + +KLADFG + +
Sbjct: 105 -EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 393 ----MLTTWCGSPPYAAPE-LFGGREYDGTKS-DVWSLGVVLYVMVTAQLPFDGPNLAVL 446
+LT + + Y APE L G Y TK D+WS+G +L M+ + F G + L
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGKPLFPGTS--TL 219
Query: 447 KQ--RIL-----------------FG-----------KFRIPFYM---SAECENLIRSML 473
Q +I+ F + + + S + +L++ +L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 474 VLDPAKRLTLTQISNHKWMS-VHCPGD-PV----IVNPVPSEPKLP 513
V +P KRLT + H +++ H P D PV I P+ KL
Sbjct: 280 VFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLS 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 73/277 (26%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEY------- 319
VA+K + DE RE+ ++ L H +I++L+ V+ + L LV EY
Sbjct: 28 VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKK 87
Query: 320 ---ARGGEIFSHLLTIGQMAEKEASRLFR-QILSAVAYCHANNVVHRDIKAENLLFDENG 375
+ G+I + E + F Q+L +A+CH++NV+HRD+K +NLL ++NG
Sbjct: 88 YFDSCNGDI-----------DPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG 136
Query: 376 DIKLADFGFS-NYFTP-----GHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVL 428
++KLADFG + + P ++T W Y P+ LFG + Y T D+WS G +
Sbjct: 137 ELKLADFGLARAFGIPVRCYSAEVVTLW-----YRPPDVLFGAKLYS-TSIDMWSAGCIF 190
Query: 429 YVMVTAQLP-FDGPNLAVLKQRILFGKFRI------------------PFY--------- 460
+ A P F G ++ +RI FR+ Y
Sbjct: 191 AELANAGRPLFPGNDVDDQLKRI----FRLLGTPTEESWPGVSKLPDYKPYPMYPATTSL 246
Query: 461 ------MSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
+++ +L++++LV +P +R++ + H +
Sbjct: 247 VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 288 EVDIMSHLDHPHIIKLFQVME--TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR 345
E+ ++ +L H I++ + + L + EY GG I L G + E R R
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS----NYFTPGHMLTTWCGSP 401
QIL V+Y H+N +VHRDIK N+L D G++KL DFG S G + + G+P
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 402 PYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD--GPNLAVLKQRILFGKFRIPF 459
+ +PE+ G Y G K+DVWS+ + M+T + P+ A+ K K +P
Sbjct: 174 YWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 460 YMSAECENLIRSMLV 474
+S C + ++ + V
Sbjct: 233 GVSDACRDFLKQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 75/255 (29%), Positives = 126/255 (49%), Gaps = 21/255 (8%)
Query: 268 AIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K + +R+ F E DIM+ + P +++LF + LY+V EY GG++
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 131
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L++ + EK A +++ A+ H+ +HRD+K +N+L D++G +KLADFG
Sbjct: 132 N-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 387 YFTPGHML--TTWCGSPPYAAPELF---GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
M+ T G+P Y +PE+ GG Y G + D WS+GV LY M+ PF
Sbjct: 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 442 NLAVLKQRILFGKFRIPFY----MSAECENLIRSMLV----------LDPAKRLTLTQIS 487
+L +I+ K + F +S E +NLI + L ++ KR +
Sbjct: 251 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
Query: 488 NHKWMSVHCPGDPVI 502
W ++ PV+
Sbjct: 311 QWAWETLRDTVAPVV 325
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 68/238 (28%), Positives = 125/238 (52%), Gaps = 12/238 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK ++ ++ ++ L + E+ +M +P+I+ + L++V EY GG +
Sbjct: 46 EVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T M E + + + R+ L A+ + H+N V+HRDIK++N+L +G +KL DFGF
Sbjct: 104 -TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
TP +T G+P + APE+ + Y G K D+WSLG++ MV + P+ N
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNEN-- 219
Query: 445 VLKQRILFG-----KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
L+ L + + P +SA + + L +D +R + ++ H ++ + P
Sbjct: 220 PLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 72/230 (31%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 269 IKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSH 328
++I D +D + +E+D++ L+HP++IK + N L +V E A G++
Sbjct: 35 VQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 92
Query: 329 LLTIGQ----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ + + EK + F Q+ SA+ + H+ V+HRDIK N+ G +KL D G
Sbjct: 93 IKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
Query: 385 SNYF----TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF-- 438
+F T H L G+P Y +PE Y+ KSD+WSLG +LY M Q PF
Sbjct: 153 GRFFSSKTTAAHSLV---GTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYG 208
Query: 439 DGPNLAVLKQRILFGKF-RIPF-YMSAECENLIRSMLVLDPAKRLTLTQI 486
D NL L ++I + +P + S E L+ + DP KR +T +
Sbjct: 209 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 80/281 (28%), Positives = 119/281 (42%), Gaps = 68/281 (24%)
Query: 267 VAIKIIDKKRLDERNLRKLF-----REVDIMSHLDHPHIIKLFQVM----------ETTN 311
VA+K K RLD N ++ F RE+ I+ L+H +I+ L +++ +
Sbjct: 35 VALK---KVRLD--NEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89
Query: 312 NLYLVTEYARG---GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368
YLV EY G + S L+ +E +Q+L + YCH N +HRDIK N
Sbjct: 90 AFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSN 146
Query: 369 LLFDENGDIKLADFGFSNYFTPG-------HMLTTWCGSPPYAAPELFGGREYDGTKSDV 421
+L + G IKLADFG + + ++T W Y PEL G E G DV
Sbjct: 147 ILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW-----YRPPELLLGEERYGPAIDV 201
Query: 422 WSLGVVLYVMVTAQLPFDG----------------PNLAV------------LKQRILFG 453
WS G +L + T + F P AV +K + +
Sbjct: 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYR 261
Query: 454 -KFRIPF-YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
+ R F ++ +L+ ML LDP+KR T + N W+
Sbjct: 262 RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 55/277 (19%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNL----YLVTEYAR 321
KVAIK I ++ RE+ I+ H H +II + ++ Y+V +
Sbjct: 32 KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME 91
Query: 322 GGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
H++ Q +E R F Q+L + Y H+ NV+HRD+K NLL +E+ ++++
Sbjct: 92 SD--LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149
Query: 381 DFGFS----------NYFTPGHMLTTWCGSPPYAAPEL-FGGREYDGTKSDVWSLGVVLY 429
DFG + YF ++ T W Y APEL EY T D+WS+G +
Sbjct: 150 DFGMARGLSSSPTEHKYFMTEYVATRW-----YRAPELLLSLPEYT-TAIDMWSVGCIFA 203
Query: 430 VMVTAQLPFDG----------------PNLAVLKQ------RILFGKF----RIPF---Y 460
M+ + F G P+ VL + R +P+ +
Sbjct: 204 EMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF 263
Query: 461 MSAECE--NLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
A E +L+ ML DP +R+T+ Q H +++ +
Sbjct: 264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV-METTNNLYLVTEYARGGEI 325
VAIK I K ++ +RE+ ++ HL H +II L + + ++Y VTE G
Sbjct: 38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTD 95
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
LLT + ++ QIL + Y H+ VVHRD+K N+L +EN D+K+ DFG +
Sbjct: 96 LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
Query: 386 NYFTPGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG---- 440
P M T + + Y APE + ++YD + D+WS G + M+ + F G
Sbjct: 156 RIQDP-QM-TGYVSTRYYRAPEIMLTWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHV 212
Query: 441 ------------PNLAVLKQ----------RILFGKFRIPFY-----MSAECENLIRSML 473
P V+ + L + +PF +L+ ML
Sbjct: 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272
Query: 474 VLDPAKRLTLTQISNHKWMS-VHCPGDPVIVNPVPSE 509
V DP KR++ + H +++ H P D PV E
Sbjct: 273 VFDPQKRISAAEALAHPYLAPYHDPTD----EPVAEE 305
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 67/238 (28%), Positives = 126/238 (52%), Gaps = 12/238 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAI+ ++ ++ ++ L + E+ +M +P+I+ + L++V EY GG +
Sbjct: 47 EVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ ++T M E + + + R+ L A+ + H+N V+HRDIK++N+L +G +KL DFGF
Sbjct: 105 -TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
TP +T G+P + APE+ + Y G K D+WSLG++ M+ + P+ N
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNEN-- 220
Query: 445 VLKQRILFG-----KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
L+ L + + P +SA + + L +D KR + ++ H+++ + P
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 87/276 (31%), Positives = 127/276 (46%), Gaps = 47/276 (17%)
Query: 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKII-----DKKRLDERNLRKLFRE 288
G GE G +L KKE VAIK + DK+RLD E
Sbjct: 13 GGGEFGEVCRGRLKLPGKKEI-----------DVAIKTLKAGSSDKQRLD------FLTE 55
Query: 289 VDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL------LTIGQMAEKEASR 342
IM DHP+II+L V+ + + ++TEY G + L T+GQ+
Sbjct: 56 ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV-----G 110
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF-TPGHMLTTWCGSP 401
+ R I S + Y N VHRD+ A N+L + N K++DFG S TT G
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 402 P--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPF-DGPNLAVLKQRILFGKFRI 457
P + APE R++ + SDVWS G+V++ VM + P+ D N V+K + G +R+
Sbjct: 171 PIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDG-YRL 227
Query: 458 PFYMSAECENLI-RSML---VLDPAKRLTLTQISNH 489
P M +C + + + ML D +R T +QI +
Sbjct: 228 PPPM--DCPSALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 7e-23
Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 7/157 (4%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETT--NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR 345
E+ ++ +L H I++ + + L + E+ GG I L + G + E + R
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT----PGHMLTTWCGSP 401
QIL V+Y H+N +VHRDIK N+L D G++KL DFG S G + + G+P
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 402 PYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
+ +PE+ G Y G K+D+WS+G + M+T + P+
Sbjct: 174 YWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS 293
G G S +G+Y +K KE +VA+K + ++ + ++ RE +M+
Sbjct: 4 GHGNFGSVVKGVYLMKSGKE-----------VEVAVKTLKQEHIAA-GKKEFLREASVMA 51
Query: 294 HLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAY 353
LDHP I++L V + L LV E A G + +L ++ + L Q+ +AY
Sbjct: 52 QLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 354 CHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG--HMLTTWCGSPP--YAAPELF 409
+ + VHRD+ A N+L K++DFG S G + T G P + APE
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 410 GGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440
++ +KSDVWS GV L+ + P+
Sbjct: 171 NYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 74/241 (30%), Positives = 118/241 (48%), Gaps = 14/241 (5%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV-DIMSHLDHPHIIKLFQVMETTNN 312
E A ++ A+KI++K + +R FRE D++ + D I L + NN
Sbjct: 16 EVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLF 371
LYLV +Y GG++ + L ++ +R + +++ A+ H VHRDIK +N+L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 372 DENGDIKLADFGFSNYFTPGHMLTT--WCGSPPYAAPELF----GGREYDGTKSDVWSLG 425
D+NG I+LADFG + + G+P Y +PE+ G+ G + D WSLG
Sbjct: 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG 195
Query: 426 VVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF-----YMSAECENLIRSMLVLDPAKR 480
V +Y M+ + PF +L +I+ K F +S E ++LIR L+ P R
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETR 254
Query: 481 L 481
L
Sbjct: 255 L 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 11/237 (4%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNN 312
E A Q+ A K +DKKRL +++ K+ E +I+ ++ P I+ L E+ +
Sbjct: 8 EVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH 67
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR---QILSAVAYCHANNVVHRDIKAENL 369
L LV GG++ H+ +G+ E R+ QI + + H+ ++V+RD+K EN+
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126
Query: 370 LFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429
L D+ G+ +L+D G + G +T G+ Y APE+ Y D +++G +Y
Sbjct: 127 LLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVDWFAMGCSIY 185
Query: 430 VMVTAQLPFDGPNLAV----LKQRILFGKFRIPFY-MSAECENLIRSMLVLDPAKRL 481
MV + PF V LK+R L + + + E +++ R L P RL
Sbjct: 186 EMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 75/254 (29%), Positives = 117/254 (46%), Gaps = 38/254 (14%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNN-------LYLV 316
VAIKI+D +E +++ E +I+ +HP+I F N L+LV
Sbjct: 32 QLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIAT-FYGAFIKKNPPGNDDQLWLV 87
Query: 317 TEYARGG---EIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372
E GG ++ L G+ + E+ + + R+ L +AY H N V+HRDIK +N+L
Sbjct: 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT 147
Query: 373 ENGDIKLADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGRE-----YDGTKSDVWSLGV 426
+N ++KL DFG S T+ G+P + APE+ E YD +SDVWSLG
Sbjct: 148 KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYD-ARSDVWSLG- 205
Query: 427 VLYVMVTAQLPFDG-PNLAVLK-QRILF-------GKFRIPFYMSAECENLIRSMLVLDP 477
+TA DG P L + R LF + P S + + I L+ +
Sbjct: 206 -----ITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNY 260
Query: 478 AKRLTLTQISNHKW 491
+R + ++ H +
Sbjct: 261 EQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 63/282 (22%)
Query: 259 QLIEELSKVAIKIIDKKR----------------LDERNLRKLFREVDI-MSHLDHPHII 301
++IEEL + A ++DK R ++ + ++L ++DI M +D P+ +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 302 K----LFQ---------VMETT-NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQI 347
LF+ VM+T+ + Y +++ LTI E ++ I
Sbjct: 64 TFYGALFREGDVWICMEVMDTSLDKFY--------KKVYDKGLTIP---EDILGKIAVSI 112
Query: 348 LSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAP 406
+ A+ Y H+ +V+HRD+K N+L + NG +KL DFG S Y T G PY AP
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172
Query: 407 ELFGG----REYDGTKSDVWSLGVVLYVMVTAQLPFD--GPNLAVLKQ-------RILFG 453
E + YD KSDVWSLG+ + + T + P+D LKQ ++
Sbjct: 173 ERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231
Query: 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
KF S E ++ + L + +R ++ H + +H
Sbjct: 232 KF------SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 71/233 (30%), Positives = 117/233 (50%), Gaps = 13/233 (5%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV-DIMSHLDHPHIIKLFQVMETTNN 312
E A +L A+KI++K + +R FRE D++ + D+ I L + NN
Sbjct: 16 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLF 371
LYLV +Y GG++ + L ++ +R + +++ A+ H + VHRDIK +N+L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 372 DENGDIKLADFGFSNYFTPGHML--TTWCGSPPYAAPELF----GGREYDGTKSDVWSLG 425
D NG I+LADFG + + G+P Y +PE+ G+ G + D WSLG
Sbjct: 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG 195
Query: 426 VVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY-----MSAECENLIRSML 473
V +Y M+ + PF +L +I+ K R F +S + ++LIR ++
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 84/270 (31%), Positives = 126/270 (46%), Gaps = 58/270 (21%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
+A+K I ++ DE RE+ ++ + H +I++L V+ + LYLV EY ++
Sbjct: 30 IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLK 88
Query: 327 SHLLTIGQMAEKEASRLFR----QILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLAD 381
H+ + A+ RL + QIL +AYCH++ V+HRD+K +NLL D +KLAD
Sbjct: 89 KHMDSSPDFAKNP--RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146
Query: 382 FGFSNYF-----TPGH-MLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTA 434
FG + F T H ++T W Y APE L G R Y T D+WS+G + MV
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLW-----YRAPEILLGSRHYS-TPVDIWSVGCIFAEMVNQ 200
Query: 435 QLPFDGPNLAVLKQRILFGKFRI---------------PFYMSA---------------- 463
+ F P + + + LF FRI P Y SA
Sbjct: 201 KPLF--PGDSEIDE--LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTL 256
Query: 464 --ECENLIRSMLVLDPAKRLTLTQISNHKW 491
+L+ ML LDP+KR+T H++
Sbjct: 257 EPAGVDLLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 288 EVDIMSHLDHPHIIKLFQVME--TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR 345
E+ ++ +L H I++ + + L + EY GG + L G + E + R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF----TPGHMLTTWCGSP 401
QIL ++Y H+N +VHRDIK N+L D G++KL DFG S G + + G+P
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 402 PYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
+ +PE+ G Y G K+DVWSLG + M+T + P+
Sbjct: 174 YWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 74/292 (25%), Positives = 135/292 (46%), Gaps = 54/292 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEY 319
KVAIK + + + ++ +RE+ ++ H+DH ++I L V +E ++YLVT
Sbjct: 42 KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL 101
Query: 320 ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G ++++ ++++ L QIL + Y H+ ++HRD+K N+ +E+ ++K+
Sbjct: 102 M--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKI 159
Query: 380 ADFGFS---NYFTPGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
DFG + + G++ T W Y APE + Y+ T D+WS+G ++ ++T +
Sbjct: 160 LDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGK 213
Query: 436 LPFDGPN-LAVLKQRI-LFGK----------------------------FRIPF-YMSAE 464
F G + + LK+ + L G F+ F +
Sbjct: 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPL 273
Query: 465 CENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPNSF 516
+L+ MLVLDP KR+T + H +++ + DP P P SF
Sbjct: 274 AIDLLEKMLVLDPDKRITAAEALAHPYLAEY--HDP---EDEPVAPPYDQSF 320
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK+I + + E + E +M L HP++++L+ V +++VTEY G +
Sbjct: 30 DVAIKMIREGAMSEDDF---IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86
Query: 326 FSHLLTIGQMAEKEASRLF----RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
++L + K + + A+ Y +N +HRD+ A N L E+ +K++D
Sbjct: 87 LNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSD 143
Query: 382 FGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPF 438
FG + Y ++ P +A PE+F + +KSDVWS GV+++ V ++P+
Sbjct: 144 FGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPY 202
Query: 439 DG-PNLAVLKQRILFGKFRIP 458
+ N V+ + + G +R+
Sbjct: 203 ERFSNSEVV-ESVSAG-YRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 8/235 (3%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNN 312
E A Q+ A K ++KKR+ +R + E I+ ++ ++ L ET +
Sbjct: 15 EVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLL 370
L LV GG++ H+ +G +E LF +IL + H N V+RD+K EN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYV 430
D+ G I+++D G + G + G+ Y APE+ + Y D W LG ++Y
Sbjct: 135 LDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYE 193
Query: 431 MVTAQLPFDGPNLAV----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
M+ Q PF G V + +R+L + S E +++ + +L DP +RL
Sbjct: 194 MIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 80/297 (26%), Positives = 122/297 (41%), Gaps = 66/297 (22%)
Query: 243 EGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDH-P 298
EG Y K + +L VA+K K RL +E RE+ ++ L
Sbjct: 11 EGTYGKVYKARDKNTGKL------VALK---KTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 299 HIIKLFQVMETTNN-----LYLVTEYARGGEIFSHLLTIGQ-----MAEKEASRLFRQIL 348
+I++L V LYLV EY ++ + + G+ + K Q+L
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 349 SAVAYCHANNVVHRDIKAENLLFD-ENGDIKLADFGFSNYFT------PGHMLTTWCGSP 401
VA+CH + V+HRD+K +NLL D + G +K+AD G F+ ++T W
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW---- 176
Query: 402 PYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG-------------------- 440
Y APE L G Y T D+WS+G + M Q F G
Sbjct: 177 -YRAPEVLLGSTHYS-TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234
Query: 441 --PNLAVLKQRILFGKF------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
P ++ L+ F ++ R +S E +L++ ML DPAKR++ H
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 90/325 (27%), Positives = 143/325 (44%), Gaps = 68/325 (20%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM-----ETTNNLYLVTEYA 320
KVAIK I + + ++ RE+ ++ HLDH ++I + +M E N++Y+V E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91
Query: 321 RGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
++ Q + + F Q+L + Y H+ NV+HRD+K NLL + N D+K+
Sbjct: 92 DTD--LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 149
Query: 380 ADFGF------SNYFTPGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMV 432
DFG F +++T W Y APE L EY T DVWS+G + ++
Sbjct: 150 CDFGLARTTSEKGDFMTEYVVTRW-----YRAPELLLNCSEY-TTAIDVWSVGCIFAELL 203
Query: 433 TAQLPFDGPN-LAVLKQRI-LFG----------------KF--------RIPF-----YM 461
+ F G + + LK L G ++ R F +
Sbjct: 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA 263
Query: 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWM-SVHCPGDPVIVNPVPSEPKLPNSFVIDQ 520
+ +L+ MLV DP+KR+T+ + H ++ S+H P D PV P SF ++
Sbjct: 264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD----EPVCQ---TPFSFDFEE 316
Query: 521 MLQLPALTRNRILEFDDNLMETEIC 545
ALT I E L+ E+
Sbjct: 317 ----DALTEEDIKE----LIYNEML 333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 72/272 (26%), Positives = 103/272 (37%), Gaps = 82/272 (30%)
Query: 286 FREVDIMSHLDHPHIIKLF--------QVMETTNNLYLVTEYARGGEIFSHLLTIG---- 333
RE+ I+ L HP+++ L + ++Y+VT Y H L+ G
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPY------MDHDLS-GLLEN 107
Query: 334 ---QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS-NYFT 389
++ E + Q+L + Y H N+++HRDIKA N+L D G +K+ADFG + Y
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 390 PGHML----------------TTWCGSPPYAAPEL-FGGREYDGTKSDVWSLGVVLYVMV 432
P T W Y PEL G R Y T D+W +G V M
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRW-----YRPPELLLGERRY-TTAVDIWGIGCVFAEMF 221
Query: 433 T-------------AQLPFD--G-------PNLAVL-----------KQRILFGKFRIPF 459
T L F G P L R L +F
Sbjct: 222 TRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG--- 278
Query: 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
+ E +L+ +L LDP KRLT + H +
Sbjct: 279 KLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 78/277 (28%)
Query: 267 VAIKIIDK--KRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVM--ETTNNLYLVTE--- 318
AIK + K K L++ N RE+ + L HP+I++L +V+ T L LV E
Sbjct: 27 YAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83
Query: 319 -----YARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
+G + L EK Q+L ++ + H N + HRDIK EN+L +
Sbjct: 84 MNLYELIKGRK---RPL-----PEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135
Query: 374 NGDIKLADFG----------FSNYFTPGHMLTTWCGSPPYAAPE--LFGGREYDGTKSDV 421
+ +KLADFG ++ Y + T W Y APE L G Y G K D+
Sbjct: 136 D-ILKLADFGSCRGIYSKPPYTEYIS-----TRW-----YRAPECLLTDG--YYGPKMDI 182
Query: 422 WSLGVVLYVMVTAQLPFDG----------------PNLAVL-KQRILFGK-FRIPF---- 459
W++G V + +++ F G P+ VL K R + P
Sbjct: 183 WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242
Query: 460 -------YMSAECENLIRSMLVLDPAKRLTLTQISNH 489
SAE +L++ +L DP +R+T Q H
Sbjct: 243 GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 28/200 (14%)
Query: 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS 293
G+GE G Y +K VA+K + + D + E +M+
Sbjct: 15 GKGEFGDVMLGDYRGQK----------------VAVKCL---KDDSTAAQAFLAEASVMT 55
Query: 294 HLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMA-EKEASRLF-RQILSAV 351
L HP++++L V+ N LY+VTEY G + +L + G+ F + +
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115
Query: 352 AYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP--YAAPELF 409
Y N VHRD+ A N+L E+ K++DFG + + G G P + APE
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS----GKLPVKWTAPEAL 171
Query: 410 GGREYDGTKSDVWSLGVVLY 429
+++ TKSDVWS G++L+
Sbjct: 172 REKKFS-TKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 49/247 (19%)
Query: 287 REVDIMSHLD---HPHIIKLFQV-----METTNNLYLVTEYARG--GEIFSHLLTIGQMA 336
RE+ ++ L+ HP+I++L V + L LV E+ S G +
Sbjct: 47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LP 105
Query: 337 EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT 396
+ L RQ+L V + H++ +VHRD+K +N+L +G +K+ADFG + ++ LT+
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 397 -----WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451
W Y APE+ Y T D+WS+G + + + F G + A +I
Sbjct: 166 VVVTLW-----YRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219
Query: 452 ---------------------FG-KFRIPF-----YMSAECENLIRSMLVLDPAKRLTLT 484
F F + E +L++ ML +P KR++
Sbjct: 220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 485 QISNHKW 491
+ H +
Sbjct: 280 EALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 34/244 (13%)
Query: 279 ERNLRK-LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAE 337
+ ++RK + RE+ IM P+I+ + NN+ + E+ G + G +
Sbjct: 43 KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV 102
Query: 338 KEASRLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT- 395
+ ++ ++ + Y + + ++HRDIK N+L + G IKL DFG S G ++
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINS 157
Query: 396 ---TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452
T+ G+ Y +PE G +Y KSDVWSLG+ + + + PF N+ Q
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216
Query: 453 GKF------------RIPF-YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGD 499
G R+P + + + + L+ DP +R T Q+ C
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL---------CAMP 267
Query: 500 PVIV 503
P I
Sbjct: 268 PFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
LRK G G+ WEG++ + VA+K + +D ++ E
Sbjct: 11 LRKLGAGQFGEVWEGLWN---------------NTTPVAVKTLKPGTMDPKDF---LAEA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-------LTIGQMAEKEASR 342
IM L HP +I+L+ V +Y+VTE + G + +L L + Q+ + A
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-- 110
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402
Q+ S +AY A N +HRD+ A N+L EN K+ADFG + P
Sbjct: 111 ---QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167
Query: 403 --YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG-PNLAVLKQ 448
+ APE + KSDVWS G++L +VT ++P+ G N VL+Q
Sbjct: 168 IKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 70/265 (26%), Positives = 108/265 (40%), Gaps = 75/265 (28%)
Query: 287 REVDIMSHLDHPHIIKLFQVMET----TNN----LYLVTEYARGGEIFSHLL------TI 332
RE+ I+ L H +++ L ++ T N YLV E+ H L
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKN 113
Query: 333 GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT--- 389
+ E ++ + +L+ + Y H N ++HRD+KA N+L ++G +KLADFG + F+
Sbjct: 114 VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 390 -------PGHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVT-------- 433
++T W Y PE L G R+Y G D+W G ++ M T
Sbjct: 174 NSKPNRYTNRVVTLW-----YRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGN 227
Query: 434 ---AQL-----------PFDGPNLAVLKQRILFGKFRIP-------------FYMSAECE 466
QL P P + L+ LF K +P +
Sbjct: 228 TEQHQLTLISQLCGSITPEVWPGVDKLE---LFKKMELPQGQKRKVKERLKPYVKDPHAL 284
Query: 467 NLIRSMLVLDPAKRLTLTQISNHKW 491
+LI +LVLDPAKR+ NH +
Sbjct: 285 DLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 66/295 (22%)
Query: 267 VAIKIIDKKRLD-ERNLRKL--FREVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYAR 321
VA+K K R+D ER+ + RE+ ++ +L HP+I++L +V+ + ++++LV EY
Sbjct: 35 VALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91
Query: 322 GGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
+ + LL +E + L Q+L + Y H N ++HRD+K NLL + G +K+
Sbjct: 92 --QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKI 149
Query: 380 ADFGFSNYFT--PGHM----LTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMV 432
ADFG + + M +T W Y APE L G Y T D+W++G +L ++
Sbjct: 150 ADFGLARTYGLPAKPMTPKVVTLW-----YRAPELLLGCTTYT-TAIDMWAVGCILAELL 203
Query: 433 TAQLPFDG----------------------PNLAVL---------KQRILFGKFRIPFYM 461
+ G P + L KQ K + P+ +
Sbjct: 204 AHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW-L 262
Query: 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPNSF 516
S L+ +L+ DP KR T + + P+P EP++ +F
Sbjct: 263 SEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK---------PLPCEPEMMPTF 308
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 69/298 (23%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT--------------N 311
+VA+K I D ++++ RE+ I+ LDH +I+K+++V+ + N
Sbjct: 32 RVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371
++Y+V EY +++L G ++E+ A Q+L + Y H+ NV+HRD+K N+
Sbjct: 90 SVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 372 D-ENGDIKLADFGFSNYFTP-----GH----MLTTWCGSPPYAAPE-LFGGREYDGTKS- 419
+ E+ +K+ DFG + P G+ ++T W Y +P L Y TK+
Sbjct: 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-----YRSPRLLLSPNNY--TKAI 200
Query: 420 DVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL-------------------------FGK 454
D+W+ G + M+T + F G + Q IL G+
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 455 FRIPFY-----MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH-CPGD-PVIVNP 505
R P ++ E + + +L +P RLT + H +MS + CP D PV ++P
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHP 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 6/156 (3%)
Query: 283 RKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASR 342
+++ E++I+ D P+II + N + + TE+ GG L ++ E R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGR 99
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402
+ ++ + Y + ++HRD+K N+L + G +KL DFG S + T+ G+
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-NSIAKTYVGTNA 158
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
Y APE G +Y G SDVWSLG+ + + P+
Sbjct: 159 YMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 8/235 (3%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNN 312
E A Q+ A K ++KKR+ +R + E I+ ++ ++ L ET +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 74
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLL 370
L LV GG++ H+ +G E +F +I + H +V+RD+K EN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYV 430
D+ G I+++D G + G + G+ Y APE+ Y D W LG ++Y
Sbjct: 135 LDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYE 193
Query: 431 MVTAQLPFDGPNLAV----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
M+ + PF V +++R+ + S ++ R +L DP RL
Sbjct: 194 MIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 52/178 (29%), Positives = 94/178 (52%), Gaps = 8/178 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVAIK I++ + E + E +M L HP +++L+ V LY+VTE+ G +
Sbjct: 30 KVAIKAINEGAMSEEDF---IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86
Query: 326 FSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
++L G++++ + + + + Y N+ +HRD+ A N L G +K++DFG
Sbjct: 87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGM 146
Query: 385 SNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFD 439
+ Y ++ P ++ PE+F +Y +KSDVWS GV+++ V ++PF+
Sbjct: 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 31/250 (12%)
Query: 278 DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAE 337
++ R++ RE++I+ ++HP+++K + + + ++ E+ GG + I E
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIAD--E 167
Query: 338 KEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT----PGHM 393
+ + + RQILS +AY H ++VHRDIK NLL + ++K+ADFG S P
Sbjct: 168 QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--- 224
Query: 394 LTTWCGSPPYAAPE-----LFGGREYDGTKSDVWSLGVVLYVMVTAQLPF---DGPNLAV 445
+ G+ Y +PE L G YDG D+WSLGV + + PF + A
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGA-YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283
Query: 446 LKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVN 504
L I + P S E + I L +PAKR + Q+ H P I+
Sbjct: 284 LMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH----------PFILR 333
Query: 505 PVPSEPKLPN 514
P + +
Sbjct: 334 AQPGQGQGGP 343
|
Length = 353 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 43/253 (16%)
Query: 262 EELSKVAIKII-DKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
E ++VAIK + + + ER + E +M + H+++L V+ T +V E
Sbjct: 34 EPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM 91
Query: 321 RGGEIFSHLLTIGQMAEKE---------ASRLFR---QILSAVAYCHANNVVHRDIKAEN 368
G++ S+L + E E + + +I +AY A VHRD+ A N
Sbjct: 92 AKGDLKSYLR--SRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 369 LLFDENGDIKLADFGF------SNYFTP---GHMLTTWCGSPPYAAPELFGGREYDGTKS 419
+ E+ +K+ DFG ++Y+ G + W APE + TKS
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW------MAPESLKDGVFT-TKS 202
Query: 420 DVWSLGVVLYVMVT-AQLPFDG-PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL-- 475
DVWS GVVL+ M T A+ P+ G N VLK I G +P C + + ++ +
Sbjct: 203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP----ENCPDKLLELMRMCW 258
Query: 476 --DPAKRLTLTQI 486
+P R T +I
Sbjct: 259 QYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 14/185 (7%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIM--SHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+A+K + + E N R L ++D++ SH D P+I+K + T +++++ E
Sbjct: 43 MAVKQMRRTGNKEENKRIL-MDLDVVLKSH-DCPYIVKCYGYFITDSDVFICMELM--ST 98
Query: 325 IFSHLLT-IGQ-MAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLAD 381
LL I + E ++ I+ A+ Y V+HRD+K N+L D +G++KL D
Sbjct: 99 CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158
Query: 382 FGFSNYFTPGHMLTTWCGSPPYAAPELF----GGREYDGTKSDVWSLGVVLYVMVTAQLP 437
FG S T G Y APE +YD ++DVWSLG+ L + T Q P
Sbjct: 159 FGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFP 217
Query: 438 FDGPN 442
+
Sbjct: 218 YKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 74/276 (26%), Positives = 116/276 (42%), Gaps = 59/276 (21%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
RK G G+ W G + +KVA+K + + +E
Sbjct: 11 ERKLGAGQFGEVWMGTWN---------------GTTKVAVKTLKPGTMS---PEAFLQEA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-------LTIGQMAEKEASR 342
IM L H +++L+ V +Y+VTEY G + L L + Q+ + A
Sbjct: 53 QIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-- 110
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS-----NYFTPGH---ML 394
QI +AY + N +HRD+ A N+L EN K+ADFG + + +T
Sbjct: 111 ---QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167
Query: 395 TTWCGSPPYAAPE--LFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG-PNLAVLKQRI 450
W APE +G KSDVWS G++L +VT ++P+ G N VL+Q
Sbjct: 168 IKW------TAPEAANYGRFT---IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ-- 216
Query: 451 LFGKFRIPFYMSAECENLIRSMLVL----DPAKRLT 482
+ +R+P C + +++ DP +R T
Sbjct: 217 VERGYRMP--RPPNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K + +L + + +E IM LDH ++I+L+ V+ T+ L +VTE A G +
Sbjct: 26 VAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRLYGVV-LTHPLMMVTELAPLGSLL 83
Query: 327 SHLLTIGQMAEKEASRLFR---QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
L + S L QI + + Y + +HRD+ A N+L + +K+ DFG
Sbjct: 84 DRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG 142
Query: 384 FS--------NYFTPGHMLT--TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+Y H+ WC APE R + SDVW GV L+ M T
Sbjct: 143 LMRALPQNEDHYVMEEHLKVPFAWC------APESLRTRTFS-HASDVWMFGVTLWEMFT 195
Query: 434 -AQLPFDGPNLAVLKQRILFGKFRI--PFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ P+ G + + + ++I R+ P + N++ +PA R T +
Sbjct: 196 YGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 74/259 (28%), Positives = 112/259 (43%), Gaps = 39/259 (15%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG--E 324
VAIK +E RE+ ++ L +I++L + LYLV EY E
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ + G EK S ++ Q++ A+ +CH N++VHRDIK ENLL N +KL DFGF
Sbjct: 89 LLEEMPN-GVPPEKVRSYIY-QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
Query: 385 SNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP- 441
+ + G T + + Y +PEL G Y G D+WS+G +L + Q F G
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGES 205
Query: 442 --NLAVLKQRIL----------------FGKFRIPFY-------------MSAECENLIR 470
+ Q++L F R P +S +L++
Sbjct: 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMK 265
Query: 471 SMLVLDPAKRLTLTQISNH 489
++L L+P R Q NH
Sbjct: 266 NLLKLNPTDRYLTEQCLNH 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR- 345
REV ++ +L H +I+ L ++ T L LV EY ++ +L G + ++F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT------PGHMLTTWCG 399
Q+L ++YCH ++HRD+K +NLL +E G++KLADFG + + ++T W
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW-- 168
Query: 400 SPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
Y P+ L G EY T D+W +G +LY M T + F G
Sbjct: 169 ---YRPPDVLLGSTEYS-TPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 7e-20
Identities = 53/179 (29%), Positives = 96/179 (53%), Gaps = 10/179 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVAIK I + + E + + E +M L HP +++L+ V + + LV E+ G +
Sbjct: 30 KVAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86
Query: 326 FSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+L G+ +++ + + +AY ++NV+HRD+ A N L EN +K++DFG
Sbjct: 87 SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM 146
Query: 385 SNYFTPGHMLTTWCGSP---PYAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFD 439
+ F T+ G+ +++PE+F +Y +KSDVWS GV+++ V + P++
Sbjct: 147 TR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 48/177 (27%), Positives = 92/177 (51%), Gaps = 8/177 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK+I + + E + E +M L H +++L+ V +Y+VTEY G +
Sbjct: 31 VAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87
Query: 327 SHLLTIGQMAE-KEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
++L G+ + + + + + +AY + +HRD+ A N L D+ G +K++DFG S
Sbjct: 88 NYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
Query: 386 NYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFD 439
Y ++ P ++ PE+ ++ +KSDVW+ GV+++ V ++P++
Sbjct: 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 62/272 (22%), Positives = 104/272 (38%), Gaps = 74/272 (27%)
Query: 287 REVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYAR---GGEIFSHLLTIG-QMAEKEA 340
RE+ ++ L H +++ L +V ++YL+ +YA I H +
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 341 SRLFRQILSAVAYCHANNVVHRDIKAENLL----FDENGDIKLADFGFSNYFTP------ 390
L QIL+ V Y H+N V+HRD+K N+L E G +K+ D G + F
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 391 ---GHMLTTWCGSPPYAAPEL-FGGREYDGTKS-DVWSLGVVLYVMVTAQLPFDG----- 440
++T W Y APEL G R Y TK+ D+W++G + ++T + F G
Sbjct: 171 DLDPVVVTIW-----YRAPELLLGARHY--TKAIDIWAIGCIFAELLTLEPIFKGREAKI 223
Query: 441 -----------------------------------PNLAVLKQRILFGKFRIPFYM---- 461
L + + + +M
Sbjct: 224 KKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHK 283
Query: 462 --SAECENLIRSMLVLDPAKRLTLTQISNHKW 491
++ +L+R +L DP KR+T + H +
Sbjct: 284 KPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 54/246 (21%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQI 347
E D+++ D P ++ L+ + LYL+ E+ GG++ + L+ +E +
Sbjct: 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 348 LSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH--------------- 392
+ A+ H +HRDIK +N+L D G IKL+DFG S F H
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 393 ----------------------MLTTW-----------CGSPPYAAPELFGGREYDGTKS 419
+ TW G+P Y APE+F + Y G +
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQEC 229
Query: 420 DVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVL 475
D WSLG +++ + PF N ++I+ + + F ++S E E+LIR L+
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LIT 288
Query: 476 DPAKRL 481
+ RL
Sbjct: 289 NAENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 62/235 (26%), Positives = 113/235 (48%), Gaps = 8/235 (3%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNN 312
E A Q+ A K ++KKR+ +R + E I+ ++ ++ L ET +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLL 370
L LV GG++ H+ +G+ +E +F +I + H +V+RD+K EN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYV 430
D++G I+++D G + + G + G+ Y APE+ Y + D W+LG +LY
Sbjct: 135 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYE 193
Query: 431 MVTAQLPFDGPNLAVLKQRI--LFGKFRIPFY--MSAECENLIRSMLVLDPAKRL 481
M+ Q PF + ++ + L + + + S + +L + +L DP +RL
Sbjct: 194 MIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 78/254 (30%), Positives = 118/254 (46%), Gaps = 37/254 (14%)
Query: 265 SKVAIKIIDK-KRLDERNLRKLFREVDIMSHL-DHPHIIKLFQV-----METTNNLYLVT 317
SK A+KI+D +DE ++ E +I+ L DHP+++K + + ++ + L+LV
Sbjct: 44 SKAAVKILDPIHDIDE----EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99
Query: 318 EYARGG---EIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
E GG ++ L G+ M E + + + L + + H N +HRD+K N+L
Sbjct: 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT 159
Query: 374 NGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGRE-----YDGTKSDVWSLGVV 427
G +KL DFG S T T G+P + APE+ + YD + DVWSLG
Sbjct: 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLG-- 216
Query: 428 LYVMVTAQLPFDG-PNLAVLK-QRILFG-------KFRIPFYMSAECENLIRSMLVLDPA 478
+TA DG P LA L R LF P S E + IR L D
Sbjct: 217 ----ITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYE 272
Query: 479 KRLTLTQISNHKWM 492
KR T++ + H ++
Sbjct: 273 KRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 80/288 (27%), Positives = 135/288 (46%), Gaps = 25/288 (8%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV-DIMSHLDHPHIIKLFQVMETTNN 312
E A ++ A+KI++K + +R FRE +++ + D I L + N
Sbjct: 16 EVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLF 371
LYLV +Y GG++ + L ++ +R + +++ A+ H + VHRDIK +N+L
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 372 DENGDIKLADFGFSNYFTPGHML--TTWCGSPPYAAPELFGGREYD----GTKSDVWSLG 425
D NG I+LADFG + + G+P Y +PE+ E G + D WSLG
Sbjct: 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 426 VVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIPFYM---SAECENLIRSMLVLDPAKR 480
V +Y M+ + PF +L +I+ +F+ P ++ S E ++LI+ L+ +R
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERR 254
Query: 481 LTLTQISNHK---------WMSVHCPGDPVIVNPVPSEPKLPNSFVID 519
L I + K W ++ P I P S P ++F +D
Sbjct: 255 LGQNGIEDFKKHAFFEGIDWENIRNLEAPYI--PDVSSPSDTSNFDVD 300
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR- 345
REV ++ L H +I+ L ++ T +L LV EY ++ +L G +LF
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT------PGHMLTTWCG 399
Q+L + YCH V+HRD+K +NLL +E G++KLADFG + + ++T W
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW-- 169
Query: 400 SPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
Y P+ L G +Y T+ D+W +G + Y M T + F G
Sbjct: 170 ---YRPPDILLGSTDYS-TQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 46/192 (23%)
Query: 278 DERNLRKLFREVD-IMSHLDHPHIIKLF-------------QVMETT-NNLYLVTEYARG 322
DE+ ++L ++D +M D P+I+K + ++M+ + + Y
Sbjct: 42 DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYK------- 94
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN---------NVVHRDIKAENLLFDE 373
+ + E S + +IL +A ++HRD+K N+L D
Sbjct: 95 ---YVY--------EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR 143
Query: 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPEL---FGGREYDGTKSDVWSLGVVLYV 430
NG+IKL DFG S T G PY APE YD +SDVWSLG+ LY
Sbjct: 144 NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYE 202
Query: 431 MVTAQLPFDGPN 442
+ T + P+ N
Sbjct: 203 VATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 38/208 (18%)
Query: 268 AIKIIDKKRLDERNLRKLFR-EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K + E+ R E DI+ D ++K+F + NLYL+ E+ GG++
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L+ ++E+ + + A+ H +HRDIK +NLL D G +KL+DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149
Query: 387 YFTPGHM------LT-------------------TW-----------CGSPPYAAPELFG 410
H LT TW G+P Y APE+F
Sbjct: 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209
Query: 411 GREYDGTKSDVWSLGVVLYVMVTAQLPF 438
Y+ D WSLGV++Y M+ PF
Sbjct: 210 QTGYNKL-CDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 53/162 (32%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-R 345
REV ++ L H +I+ L ++ T +L LV EY ++ ++ G + ++F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLY 111
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT------PGHMLTTWCG 399
QIL +AYCH V+HRD+K +NLL +E G++KLADFG + + ++T W
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW-- 169
Query: 400 SPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
Y P+ L G EY T+ D+W +G + + M + + F G
Sbjct: 170 ---YRPPDVLLGSSEYS-TQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 64/188 (34%), Positives = 92/188 (48%), Gaps = 9/188 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK + K E+ R E IM DHP+II L V+ + + +VTEY G +
Sbjct: 35 VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 327 SHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ L GQ + + R I S + Y VHRD+ A N+L + N K++DFG S
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 386 NYFT--PGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPF-D 439
P TT G P + APE R++ + SDVWS G+V++ VM + P+ +
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWE 212
Query: 440 GPNLAVLK 447
N V+K
Sbjct: 213 MSNQDVIK 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 58/180 (32%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK + K E+ R E IM DHP+II L V+ + + ++TE+ G +
Sbjct: 35 VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 327 SHL-LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
S L GQ + + R I + + Y N VHRD+ A N+L + N K++DFG S
Sbjct: 94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 386 NYFTPGHMLTTWCGS-----P-PYAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPF 438
+ T+ S P + APE R++ + SDVWS G+V++ VM + P+
Sbjct: 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 54/149 (36%), Positives = 83/149 (55%), Gaps = 15/149 (10%)
Query: 285 LFREVDIMSHLDHPHII--KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEA 340
+ +EV + L HP+ I K + E T +LV EY G S +L + + + E E
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHT--AWLVMEYCLGSA--SDILEVHKKPLQEVEI 117
Query: 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGS 400
+ + L +AY H++ +HRDIKA N+L E G +KLADFG ++ +P + ++ G+
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGT 174
Query: 401 PPYAAPELFGGR---EYDGTKSDVWSLGV 426
P + APE+ +YDG K DVWSLG+
Sbjct: 175 PYWMAPEVILAMDEGQYDG-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-18
Identities = 79/315 (25%), Positives = 133/315 (42%), Gaps = 56/315 (17%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTE 318
+KVAIK + + E ++ +RE+ ++ H+ H ++I L V ++ ++ YLV
Sbjct: 41 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100
Query: 319 YARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
+ G L+ +++E L Q+L + Y HA ++HRD+K NL +E+ ++K
Sbjct: 101 FM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELK 158
Query: 379 LADFGFSNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
+ DFG + G+++T W Y APE+ + D+WS+G ++ M+T +
Sbjct: 159 ILDFGLARQTDSEMTGYVVTRW-----YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
Query: 436 LPFDGPN-LAVLKQ-----------------------------RILFGKFRIPF-YMSAE 464
F G + L L + R FR +
Sbjct: 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPL 273
Query: 465 CENLIRSMLVLDPAKRLTLTQISNHKWMS-VHCPGDPVIVNPVPSEPKLPNSF-VIDQML 522
N++ MLVLD R+T + H + H P D P +SF +DQ L
Sbjct: 274 AVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE------TEAPPYDDSFDEVDQSL 327
Query: 523 -QLPALTRNRILEFD 536
+ LT IL F
Sbjct: 328 EEWKRLTFTEILSFQ 342
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 50/234 (21%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNN 312
E A+ ++ + A+K + KK + RN + + E DI++ D+ +++L+ + +N
Sbjct: 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372
LY V +Y GG++ S L+ +G E A ++ AV H +HRDIK +N+L D
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135
Query: 373 ENGDIKLADFGF---------SNYFTPGHML--------TTW------------------ 397
+G IKL DFG S Y+ G + W
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR 195
Query: 398 -------------CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
G+P Y APE+ Y D WS+GV+LY M+ Q PF
Sbjct: 196 AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/235 (27%), Positives = 114/235 (48%), Gaps = 16/235 (6%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS 327
A+KII + D+ +L + +E+ ++ H +I+ F + L++ EY GG +
Sbjct: 38 AVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD 95
Query: 328 HLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387
G ++E + + + R+ L +AY H+ +HRDIK N+L +NGD+KLADFG +
Sbjct: 96 IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAK 155
Query: 388 FTPG-HMLTTWCGSPPYAAPELFGGREYDGTKS--DVWSLGVVLYVMVTAQLP-FDGPNL 443
T ++ G+P + APE+ + G D+W++G+ + Q P FD L
Sbjct: 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD---L 212
Query: 444 AVLKQRILFGK--FRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
++ L K F+ P S+ N ++ L +P KR T ++ H +
Sbjct: 213 HPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 268 AIKIIDKKRLDERNLRKLFR-EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+KI+ K + E+ R E DI+ D ++K+F + NLYL+ E+ GG++
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
+ L+ + E+E + + A+ H +HRDIK +NLL D G +KL+DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149
Query: 387 YFTPGHMLT-------------------------TW-----------CGSPPYAAPELFG 410
H TW G+P Y APE+F
Sbjct: 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209
Query: 411 GREYDGTKSDVWSLGVVLYVMVTAQLPF 438
Y+ D WSLGV++Y M+ PF
Sbjct: 210 QTGYNKL-CDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 68/281 (24%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEY 319
+VA+K + + + ++ +RE+ ++ H+ H ++I L V +E N++YLVT
Sbjct: 44 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 103
Query: 320 ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G ++++ ++ + L QIL + Y H+ +++HRD+K NL +E+ ++K+
Sbjct: 104 M--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161
Query: 380 ADFGFSNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
DFG + + G++ T W Y APE+ + D+WS+G ++ ++T +
Sbjct: 162 LDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
Query: 437 PFDGPNL---------------AVLKQRILFGKFR-----IPFYMSAECEN--------- 467
F G + A L ++I R + N
Sbjct: 217 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 276
Query: 468 --LIRSMLVLDPAKRLTLTQISNHKWMS-VHCPGDPVIVNP 505
L+ MLVLD KR+T Q H + + H P D + +P
Sbjct: 277 VDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 317
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT--NNLYLVTEYARGGE 324
VA+K + +E++ RE++I+ LDH +I+K V E +L L+ EY G
Sbjct: 36 VAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 325 IFSHLLTIGQMAEKEASRLFR---QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
L + RL QI + Y + +HRD+ A N+L + +K++D
Sbjct: 95 -LRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISD 152
Query: 382 FGFS-------NYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431
FG + +Y+ PG W Y APE ++ + SDVWS GV LY +
Sbjct: 153 FGLAKVLPEDKDYYYVKEPGESPIFW-----Y-APECLRTSKFS-SASDVWSFGVTLYEL 205
Query: 432 VTAQLPFDGP 441
T P P
Sbjct: 206 FTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-18
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 53/263 (20%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+VA+K I + + L+K F RE I + L HP I+ ++ + + +Y Y G
Sbjct: 29 RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 325 IFSHLLTIGQ-------MAEKEAS----RLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
+ S L ++ Q +AEK + +F +I + + Y H+ V+HRD+K +N+L
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL 148
Query: 374 NGDIKLADFG-----------------------FSNYFTPGHMLTTWCGSPPYAAPELFG 410
G++ + D+G +S+ PG ++ G+P Y APE
Sbjct: 149 FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIV----GTPDYMAPERLL 204
Query: 411 GREYDGTKSDVWSLGVVLYVMVTAQLPF---DGPNLAVLKQRILF----GKFR-IPFYMS 462
G +D+++LGV+LY M+T P+ G + + IL +R IP ++S
Sbjct: 205 GVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI-SYRDVILSPIEVAPYREIPPFLS 262
Query: 463 AECENLIRSMLVLDPAKRLTLTQ 485
+ L +DPA+R + Q
Sbjct: 263 Q----IAMKALAVDPAERYSSVQ 281
|
Length = 932 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 58/167 (34%), Positives = 94/167 (56%), Gaps = 14/167 (8%)
Query: 267 VAIKIID--KKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K + K+ +E+ + + +EV + L HP+ I+ + +LV EY G
Sbjct: 49 VAVKKMSYSGKQTNEK-WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSA 107
Query: 325 IFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
S LL + + + E E + + L +AY H++N++HRDIKA N+L E G +KLADF
Sbjct: 108 --SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGV 426
G ++ +P + ++ G+P + APE+ +YDG K DVWSLG+
Sbjct: 166 GSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 9/213 (4%)
Query: 283 RKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEAS 341
RK +E +I+ DHP+I+KL V +Y+V E GG + + L ++ K+
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL 96
Query: 342 RLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGS 400
++ + + Y + N +HRD+ A N L EN +K++DFG S G + ++
Sbjct: 97 QMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156
Query: 401 PP--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRI 457
P + APE Y ++SDVWS G++L+ + P+ G + ++RI G +R+
Sbjct: 157 IPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRM 214
Query: 458 PF--YMSAECENLIRSMLVLDPAKRLTLTQISN 488
P E L+ DP R + ++I N
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 11/184 (5%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K + + D + + +E +M + HP++++L V Y++TE+ G +
Sbjct: 34 VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90
Query: 327 SHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+L + L+ QI SA+ Y N +HRD+ A N L EN +K+ADFG
Sbjct: 91 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150
Query: 385 SNYFTPGHMLTTWCGSP---PYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL-PFDG 440
S T G T G+ + APE ++ KSDVW+ GV+L+ + T + P+ G
Sbjct: 151 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPG 208
Query: 441 PNLA 444
+L+
Sbjct: 209 IDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-18
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 16/230 (6%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNN-LYLVTEYARGG 323
+VAIK++ +E + R F RE + + L HP+I+ L E L+ V EY G
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD---IKLA 380
+ L G + E RL Q+L A+A H +VHRD+K +N++ + G K+
Sbjct: 65 TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 381 DFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432
DFG T G+P Y APE G E SD+++ G++ +
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECL 183
Query: 433 TAQLPFDGPNLA-VLKQRILFGKFRIPFYMSAE-CENLIRSMLVLDPAKR 480
T Q G ++A +L Q++ +P +++ ++R L DP +R
Sbjct: 184 TGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 71/248 (28%), Positives = 116/248 (46%), Gaps = 24/248 (9%)
Query: 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS 293
G GE + G+ ++ +KE VAIK + K E+ + E IM
Sbjct: 14 GAGEFGEVFRGILKMPGRKE-----------VAVAIKTL-KPGYTEKQRQDFLSEASIMG 61
Query: 294 HLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLL-TIGQMAEKEASRLFRQILSAVA 352
H +II+L V+ ++TEY G + +L G+ + + + R I + +
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 353 YCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT--PGHMLTTWCGSPP--YAAPEL 408
Y N VHRD+ A N+L + N + K++DFG S P TT G P + APE
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 409 FGGREYDGTKSDVWSLGVVLY-VMVTAQLPF-DGPNLAVLKQRILFGKFRIPFYMSAECE 466
R++ + SDVWS G+V++ VM + P+ D N V+K + FR+P M +C
Sbjct: 182 IAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA--INDGFRLPAPM--DCP 236
Query: 467 NLIRSMLV 474
+ + +++
Sbjct: 237 SAVYQLML 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 50/223 (22%)
Query: 268 AIKIIDKKRLDERN-LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K + KK + RN + + E DI++ D+ ++KL+ + +NLY V +Y GG++
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-- 384
S L+ + E A ++ A+ H +HRDIK +N+L D +G IKL DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149
Query: 385 -------SNYFTPGH---------------------------------------MLTTWC 398
S Y+ G + +
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209
Query: 399 GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
G+P Y APE+ + Y D WS+GV+L+ M+ Q PF P
Sbjct: 210 GTPNYIAPEVLLRKGYTQL-CDWWSVGVILFEMLVGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 7e-18
Identities = 53/161 (32%), Positives = 87/161 (54%), Gaps = 11/161 (6%)
Query: 283 RKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEA 340
+ + +EV + + HP+ I+ + +LV EY G S LL + + + E E
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 127
Query: 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGS 400
+ + L +AY H++N++HRDIKA N+L E G +KLADFG ++ +P + ++ G+
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGT 184
Query: 401 PPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPF 438
P + APE+ +YDG K DVWSLG+ + + P
Sbjct: 185 PYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 73/257 (28%), Positives = 114/257 (44%), Gaps = 41/257 (15%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+ VA+K++ K+ LR L E +++ ++HPH+IKL+ L L+ EYA+ G
Sbjct: 31 TTVAVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGS 89
Query: 325 IFSHLLT--------IGQMAEKEASRLFR----------------QILSAVAYCHANNVV 360
+ S L +G + +S L QI + Y +V
Sbjct: 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV 149
Query: 361 HRDIKAENLLFDENGDIKLADFGFS-NYFTPGHMLTTWCGSPP--YAAPELFGGREYDGT 417
HRD+ A N+L E +K++DFG S + + + G P + A E Y T
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-T 208
Query: 418 KSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRIPFYM------SAECENLIR 470
+SDVWS GV+L+ +VT P+ G + +R LF + + M S E NL+
Sbjct: 209 QSDVWSFGVLLWEIVTLGGNPYPG----IAPER-LFNLLKTGYRMERPENCSEEMYNLML 263
Query: 471 SMLVLDPAKRLTLTQIS 487
+ +P KR T IS
Sbjct: 264 TCWKQEPDKRPTFADIS 280
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 57/167 (34%), Positives = 82/167 (49%), Gaps = 25/167 (14%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFR- 345
RE ++ L H +I+ L ++ T L LV EY ++ ++ G RLF
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG-----------FSNYFTPGHML 394
Q+L +AYCH V+HRD+K +NLL E G++KLADFG +SN ++
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN-----EVV 165
Query: 395 TTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
T W Y P+ L G EY T D+W +G + Y M T + F G
Sbjct: 166 TLW-----YRPPDVLLGSTEYS-TSLDMWGVGCIFYEMATGRPLFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 77/328 (23%)
Query: 262 EELSKVAIK----IIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETT-----N 311
E VAIK + KK L +R LR E+ ++ H H +I L+ M+ N
Sbjct: 25 SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKNITCLYD-MDIVFPGNFN 79
Query: 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLL 370
LYL E ++ GQ + F QIL + Y H+ NV+HRD+K NLL
Sbjct: 80 ELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137
Query: 371 FDENGDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPE-LFGGREYDGTKS-DVWS 423
+ + ++K+ DFG + F+ +T + + Y APE + + Y TK+ DVWS
Sbjct: 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY--TKAIDVWS 195
Query: 424 LGVVLYVMVTAQLPFDG----------------PNLAVLKQ----------RILFGKFRI 457
+G +L ++ + F G P+ L + R L +
Sbjct: 196 VGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKK 255
Query: 458 PF-----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV-HCPGDPVIVNPVPSEPK 511
PF + +L+ +L DP KR+++ + H ++++ H P D EP
Sbjct: 256 PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD---------EPV 306
Query: 512 LPNSF-----VIDQMLQLPALTRNRILE 534
F D M +L R+ I+E
Sbjct: 307 CQKPFDFSFESEDSMEEL----RDMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 20/242 (8%)
Query: 267 VAIKIID--KKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VAIK + K+ +E+ + + +EV + L HP+ I+ + +LV EY G
Sbjct: 43 VAIKKMSYSGKQSNEK-WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 325 IFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
S LL + + + E E + + L +AY H++N++HRD+KA N+L E G +KL DF
Sbjct: 102 --SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFD 439
G ++ P + + G+P + APE+ +YDG K DVWSLG+ + + P
Sbjct: 160 GSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLF 215
Query: 440 GPNLAVLKQRILFGKFRIPFYMSAEC----ENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
N+ + + P S N + S L P R T + H+++
Sbjct: 216 --NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
Query: 496 CP 497
P
Sbjct: 274 RP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 58/293 (19%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEYA 320
VAIK + + ++ + ++ +RE+ +M ++H +II L V +E ++YLV E
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL- 103
Query: 321 RGGEIFSHLLTIGQMA--EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
+ ++L + QM + S L Q+L + + H+ ++HRD+K N++ + +K
Sbjct: 104 ----MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159
Query: 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
+ DFG + M+T + + Y APE+ G Y D+WS+G ++ MV ++ F
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILF 218
Query: 439 DG------------------------------------PNLAVLKQRILFGKFRIPF--- 459
G P A L LF P
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 460 ---YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSE 509
+++ +L+ MLV+DPAKR+++ + H +++V DP V P +
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY--DPAEVEAPPPQ 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 52/268 (19%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT------NNLYLVTEY 319
KVAIK + + E ++ +RE+ ++ H+ H ++I L V + + YLV Y
Sbjct: 42 KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY 101
Query: 320 ARG--GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ +I H ++E + L Q+L + Y H+ ++HRD+K NL +E+ ++
Sbjct: 102 MQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCEL 156
Query: 378 KLADFGFSNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA 434
K+ DFG + + G+++T W Y APE+ + D+WS+G ++ M+T
Sbjct: 157 KILDFGLARHADAEMTGYVVTRW-----YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
Query: 435 QLPFDGPN-LAVLKQ-----------------------------RILFGKFRIPF-YMSA 463
+ F G + L L Q + F F S
Sbjct: 212 KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP 271
Query: 464 ECENLIRSMLVLDPAKRLTLTQISNHKW 491
+ +L+ ML LD KRLT T+ H +
Sbjct: 272 QAVDLLEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHL----DHPHIIKLFQVMETTNNLYLVTEYARGG 323
A+K +DKKR+ + L IM L D P I+ + T + L + + GG
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG 82
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ HL G +EKE +I+ + + H VV+RD+K N+L DE+G ++++D G
Sbjct: 83 DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 384 FSNYFTPGHMLTTWCGSPPYAAPELF-GGREYDGTKSDVWSLGVVLYVMVTAQLPF---D 439
+ F+ + G+ Y APE+ G YD + +D +SLG +L+ ++ PF
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYD-SSADWFSLGCMLFKLLRGHSPFRQHK 200
Query: 440 GPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
+ + + L +P S E ++L+ +L D +KRL
Sbjct: 201 TKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 243 EGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302
+GMY++KK ++ VA+KI+ D +L RE ++M LD+P+I++
Sbjct: 13 KGMYKMKKSEK------------TVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHR 362
+ + E + LV E A G + L + EK + L Q+ + Y N VHR
Sbjct: 61 MIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 363 DIKAENLLFDENGDIKLADFGFS-------NYF---TPGHMLTTWCGSPPYAAPELFGGR 412
D+ A N+L K++DFG S NY+ T G W APE
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW------YAPECMNYY 173
Query: 413 EYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440
++ +KSDVWS GV+++ + Q P+ G
Sbjct: 174 KFS-SKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 41/254 (16%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
+ VA+K + K + RK F RE +++++ H +I+K + V + +V EY
Sbjct: 33 NDKELVAVKTL--KETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM 90
Query: 321 RGGEIFSHLL--------------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366
G++ L +G++ + ++ QI S + Y + + VHRD+
Sbjct: 91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLAT 150
Query: 367 ENLLFDENGDIKLADFGFSN-------YFTPGH-MLTT-WCGSPPYAAPELFGGREYDGT 417
N L + +K+ DFG S Y GH ML W PE R++ T
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW------MPPESIMYRKFT-T 203
Query: 418 KSDVWSLGVVLYVMVT-AQLPFDGPN----LAVLKQRILFGKFRIPFYMSAECENLIRSM 472
+SDVWS GVVL+ + T + P+ G + + + Q L + P +E +++
Sbjct: 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGC 260
Query: 473 LVLDPAKRLTLTQI 486
DP +R+ + I
Sbjct: 261 WKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 8/238 (3%)
Query: 254 EAAAAQLIEELSKVAIKIIDKKRLDERNLRKL-FREVDIMSHLDHPHIIKLFQVMETTNN 312
E A Q+ A K ++KKR+ +R + E I+ ++ ++ L ET +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74
Query: 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLF--RQILSAVAYCHANNVVHRDIKAENLL 370
L LV GG++ H+ +G E +F ++ + +V+RD+K EN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYV 430
D+ G I+++D G + G + G+ Y APE+ +Y + D W LG ++Y
Sbjct: 135 LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYE 193
Query: 431 MVTAQLPFDGPNLAV----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLT 484
M+ Q PF V + +R+ + S + +++ R +L +P +RL
Sbjct: 194 MIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCR 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 37/257 (14%)
Query: 254 EAAAAQLIEELS--KVAIKIIDKK-RLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMET 309
EA A L + + KVA+K++ ER L E+ IMSHL +H +I+ L
Sbjct: 53 EATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHENIVNLLGACTI 110
Query: 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILS-------AVAYCHANNVVHR 362
+ ++TEY G++ + L ++E+ +LS +A+ + N +HR
Sbjct: 111 GGPILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHR 165
Query: 363 DIKAENLLFDENGDIKLADFGF-------SNYFTPGH--MLTTWCGSPPYAAPELFGGRE 413
D+ A N+L +K+ DFG SNY G+ + W APE
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW------MAPESIFNCV 219
Query: 414 YDGTKSDVWSLGVVLYVMVTAQL-PFDGPNLAVLKQRILFGKFRI--PFYMSAECENLIR 470
Y +SDVWS G++L+ + + P+ G + +++ +R+ P + AE ++++
Sbjct: 220 YT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278
Query: 471 SMLVLDPAKRLTLTQIS 487
+ DP KR T QI
Sbjct: 279 TCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 44/204 (21%)
Query: 243 EGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLR-KLFREVDIMSHLDHPHII 301
+G+Y+++KK+ + VAIK++ K +E+++R ++ RE +IM LD+P+I+
Sbjct: 13 KGVYKMRKKQID------------VAIKVL--KNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 302 KLFQVMETTNNLYLVTEYARGGEIFSHL------LTIGQMAEKEASRLFRQILSAVAYCH 355
++ V E L LV E A GG + L +T+ + E L Q+ + Y
Sbjct: 59 RMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVE-----LMHQVSMGMKYLE 112
Query: 356 ANNVVHRDIKAENLLFDENGDIKLADFGFS-------NYF---TPGHMLTTWCGSPPYAA 405
N VHRD+ A N+L K++DFG S +Y+ + G W A
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW------YA 166
Query: 406 PELFGGREYDGTKSDVWSLGVVLY 429
PE R++ ++SDVWS G+ ++
Sbjct: 167 PECINFRKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 16/230 (6%)
Query: 277 LDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMA 336
LDE ++ E+DI+ P+I+ + +Y+ EY G + L G
Sbjct: 38 LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVAT 96
Query: 337 EKEASRLFRQILSAVAYC-----HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391
E + R+I AV +N++HRD+K N+L + NG +KL DFG S
Sbjct: 97 EGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-A 155
Query: 392 HMLTTWCGSPPYAAPELF--GGREYDGT---KSDVWSLGVVLYVMVTAQLPF---DGPNL 443
+ T G Y APE GG + T +SDVWSLG+ + M + P+ N+
Sbjct: 156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 444 AVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
I+ G +P S + ++ + L P +R T Q+ H W+
Sbjct: 216 FAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 60/278 (21%), Positives = 124/278 (44%), Gaps = 56/278 (20%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEYA 320
VA+K + + ++ + ++ +RE+ ++ ++H +II L V +E ++YLV E
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL- 107
Query: 321 RGGEIFSHLLTIGQMA--EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
+ ++L + M + S L Q+L + + H+ ++HRD+K N++ + +K
Sbjct: 108 ----MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 163
Query: 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
+ DFG + M+T + + Y APE+ G Y D+WS+G ++ +V + F
Sbjct: 164 ILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222
Query: 439 DGPN-------------------LAVLKQRI-----------------LFGKFRIPF--- 459
G + + L+ + LF + P
Sbjct: 223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESE 282
Query: 460 ---YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
+++ +L+ MLV+DP KR+++ + H +++V
Sbjct: 283 RDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 8/211 (3%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQ 346
+E+ +M H +I+ F + L++ E+ GG + G ++E + + + R+
Sbjct: 55 QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE 114
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAA 405
L + Y H+ +HRDIK N+L +NG +KLADFG S T ++ G+P + A
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174
Query: 406 PELFGGREYDGTKS--DVWSLGVVLYVMVTAQLP-FDGPNLAVL----KQRILFGKFRIP 458
PE+ G D+W++G+ + Q P FD + L K K +
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234
Query: 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
S + ++ L +P KR T ++ H
Sbjct: 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 10/222 (4%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHL----DHPHIIKLFQVMETTNNLYLVTEYARGG 323
A+K +DKKR+ + L IM L D P I+ + T + L + + GG
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 82
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ HL G +E E +I+ + + H VV+RD+K N+L DE+G ++++D G
Sbjct: 83 DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 384 FSNYFTPGHMLTTWCGSPPYAAPELFG-GREYDGTKSDVWSLGVVLYVMVTAQLPFDG-- 440
+ F+ + G+ Y APE+ G YD + +D +SLG +L+ ++ PF
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHK 200
Query: 441 -PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL 481
+ + + L +P S E +L+ +L D +RL
Sbjct: 201 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
++K G G+ W G Y +KVA+K + + +++ E
Sbjct: 11 VKKLGAGQFGEVWMGYYN---------------NSTKVAVKTLKPGTM---SVQAFLEEA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLF----- 344
++M L H +++L+ V+ +Y++TEY G + L E ++
Sbjct: 53 NLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL------KSDEGGKVLLPKLI 106
Query: 345 ---RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSP 401
QI +AY N +HRD++A N+L E+ K+ADFG +
Sbjct: 107 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 402 P--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440
P + APE + KSDVWS G++LY +VT ++P+ G
Sbjct: 167 PIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQ 346
RE+DI+ + H II L + + +V + ++F+++ G + ++A + R+
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT----WCGSPP 402
+L A+AY H ++HRD+K EN+ DE + L DFG + H T W G+
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYGWSGTLE 252
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
+PEL Y K+D+WS G+VL+ M + G
Sbjct: 253 TNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVAIK + + + E ++M L HP +++L+ V+ T +Y++TEY G +
Sbjct: 32 KVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87
Query: 326 FSHL-------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
L LTI ++ + A QI +A+ N +HRD++A N+L E K
Sbjct: 88 VDFLKTPEGIKLTINKLIDMAA-----QIAEGMAFIERKNYIHRDLRAANILVSETLCCK 142
Query: 379 LADFGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQ 435
+ADFG + P + APE + KSDVWS G++L +VT +
Sbjct: 143 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGR 201
Query: 436 LPFDG 440
+P+ G
Sbjct: 202 IPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 18/229 (7%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM-ETTNNLYLVTEYARGGE 324
KVA+K I ++ + E +M+ L H ++++L V+ E LY+VTEY G
Sbjct: 31 KVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 325 IFSHLLTIGQMAEKEASRLFR---QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
+ +L + G+ L + + A+ Y ANN VHRD+ A N+L E+ K++D
Sbjct: 87 LVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSD 145
Query: 382 FGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
FG + + T G P + APE +++ TKSDVWS G++L+ + + ++P+
Sbjct: 146 FGLTKEASS----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 200
Query: 439 DGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
L + R+ G K P ++++ LD A R + Q+
Sbjct: 201 PRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 20/178 (11%)
Query: 265 SKVAIKIIDKKR-LDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNN-----LYLVT 317
S A+KI+D +DE ++ E +I+ L +HP+++K + + + L+LV
Sbjct: 48 SLAAVKILDPISDVDE----EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103
Query: 318 EYARGG---EIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
E GG E+ LL GQ + E S + L + + H N ++HRD+K N+L
Sbjct: 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT 163
Query: 374 NGDIKLADFGFSNYFTPGHM-LTTWCGSPPYAAPELFG-GREYDGT---KSDVWSLGV 426
G +KL DFG S T + T G+P + APE+ ++YD + + DVWSLG+
Sbjct: 164 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 68/298 (22%), Positives = 129/298 (43%), Gaps = 60/298 (20%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEYA 320
VAIK + + ++ + ++ +RE+ +M ++H +II L V +E ++Y+V E
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL- 110
Query: 321 RGGEIFSHLLTIGQMA--EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
+ ++L + QM + S L Q+L + + H+ ++HRD+K N++ + +K
Sbjct: 111 ----MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
+ DFG + M+T + + Y APE+ G Y D+WS+G ++ M+ + F
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225
Query: 439 DG------------------------------------PNLAVLKQRILFGKFRIPF--- 459
G P A LF P
Sbjct: 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE 285
Query: 460 ---YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPN 514
+++ +L+ MLV+D +KR+++ + H +++V DP P PK+P+
Sbjct: 286 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY--DPSEAEAPP--PKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 52/172 (30%), Positives = 85/172 (49%), Gaps = 5/172 (2%)
Query: 261 IEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
+++ + VA+K K+ L + K E I+ DHP+I+KL V +Y+V E
Sbjct: 16 LKDKTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV 74
Query: 321 RGGEIFSHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
GG+ S L ++ K+ + + +AY + N +HRD+ A N L EN +K+
Sbjct: 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKI 134
Query: 380 ADFGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY 429
+DFG S G ++ P + APE Y ++SDVWS G++L+
Sbjct: 135 SDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 50/271 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN-----NLYLVTEYA 320
+VA+K + + + +++FRE+ ++ H +++ +++ + +Y+VTE
Sbjct: 27 RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86
Query: 321 RGGEIFSHLLTI---GQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
+ S L I Q + ++F QIL + Y H+ ++HRDIK NLL + N
Sbjct: 87 Q-----SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV 141
Query: 377 IKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+K+ DFG + P HM T + Y APE+ G + + D+WS+G + ++
Sbjct: 142 LKICDFGLARVEEPDESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG 200
Query: 434 AQLPFDG----------------PNLAVL-------KQRILFGKFRIP-----FYMSA-- 463
++ F P+L + + IL G + P + +S+
Sbjct: 201 RRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQA 260
Query: 464 --ECENLIRSMLVLDPAKRLTLTQISNHKWM 492
E +L+ MLV DP KR++ H ++
Sbjct: 261 THEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFRE 288
NL K GEG + ++G+ + QL VA+K+I K +E RE
Sbjct: 9 NLEKLGEGSYATVYKGISRIN--------GQL------VALKVISMKT-EEGVPFTAIRE 53
Query: 289 VDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEAS------R 342
++ L H +I+ L ++ T L V EY H M + R
Sbjct: 54 ASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-------HTDLAQYMIQHPGGLHPYNVR 106
Query: 343 LFR-QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT------PGHMLT 395
LF Q+L +AY H +++HRD+K +NLL G++KLADFG + + ++T
Sbjct: 107 LFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 396 TWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
W Y P+ L G +Y + D+W G + M+ Q F G
Sbjct: 167 LW-----YRPPDVLLGATDYS-SALDIWGAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 5/171 (2%)
Query: 284 KLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRL 343
++ RE+ ++ + P+I+ + + + + E+ GG + L G++ E+ ++
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 344 FRQILSAVAYC-HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402
++ + Y + ++HRD+K N+L + G+IKL DFG S M ++ G+
Sbjct: 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRS 167
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453
Y +PE G Y +SD+WS+G+ L M + P P+ L+ +FG
Sbjct: 168 YMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL--MFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 67/278 (24%), Positives = 126/278 (45%), Gaps = 54/278 (19%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEY 319
KVA+K + + + R+ +RE+ ++ H+ H ++I L V +E N +YLVT
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101
Query: 320 ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G ++++ +++++ L Q+L + Y H+ ++HRD+K N+ +E+ ++++
Sbjct: 102 M--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 380 ADFGFSNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
DFG + G++ T W Y APE+ + D+WS+G ++ ++ +
Sbjct: 160 LDFGLARQADDEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
Query: 437 PFDG----------------PNLAVLK------------------QRILFGKFRIPFYMS 462
F G P+ VLK Q+ L FR ++
Sbjct: 215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLA 274
Query: 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMS-VHCPGD 499
+ L+ MLVLD KR++ ++ H + S H P D
Sbjct: 275 ID---LLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 25/199 (12%)
Query: 255 AAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLY 314
A L E K+ + + K + + RE +++++L H HI+K + V + L
Sbjct: 24 AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83
Query: 315 LVTEYARGGEIFSHLLTIG-------------QMAEKEASRLFRQILSAVAYCHANNVVH 361
+V EY + G++ L G ++ + + + +QI + + Y + + VH
Sbjct: 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVH 143
Query: 362 RDIKAENLLFDENGDIKLADFGFSN-------YFTPGHMLTTWCGSPPYAAPELFGGREY 414
RD+ N L EN +K+ DFG S Y GH + P PE R++
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP----PESIMYRKF 199
Query: 415 DGTKSDVWSLGVVLYVMVT 433
T+SDVWSLGVVL+ + T
Sbjct: 200 T-TESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 70/245 (28%), Positives = 113/245 (46%), Gaps = 27/245 (11%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN------NLYLVTEYAR 321
AIK++D +E +++ + SH H +I + N L+LV E+
Sbjct: 35 AIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 92
Query: 322 GGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G + + + E+ + + R+IL +++ H + V+HRDIK +N+L EN ++KL
Sbjct: 93 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 152
Query: 380 ADFGFSNYF--TPGHMLTTWCGSPPYAAPELFGGREY-DGT---KSDVWSLGVVLYVMVT 433
DFG S T G T+ G+P + APE+ E D T KSD+WSLG+ M
Sbjct: 153 VDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211
Query: 434 AQLPFDGPNLAVLKQRILFGKFRIPF------YMSAECENLIRSMLVLDPAKRLTLTQIS 487
P + R LF R P S + ++ I S LV + ++R T Q+
Sbjct: 212 GAPPL----CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267
Query: 488 NHKWM 492
H ++
Sbjct: 268 KHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM------ETTNNLYLVTEYAR 321
AIK++D +E ++ + SH H +I + + L+LV E+
Sbjct: 45 AIKVMDVTEDEEEEIKLEINMLKKYSH--HRNIATYYGAFIKKSPPGHDDQLWLVMEFCG 102
Query: 322 GGEIFSHLLTIGQMAEKE--ASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G + + A KE + + R+IL +A+ HA+ V+HRDIK +N+L EN ++KL
Sbjct: 103 AGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162
Query: 380 ADFGFSNYF--TPGHMLTTWCGSPPYAAPELFGGRE-----YDGTKSDVWSLGVVLYVMV 432
DFG S T G T+ G+P + APE+ E YD +SD+WSLG+ M
Sbjct: 163 VDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMA 220
Query: 433 TAQLPF 438
P
Sbjct: 221 EGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 246 YELKKKKEEAAAAQLIEELSKVAIKIIDKK--RLDERNLRKL--FREVDIMSHLDHPHII 301
YE +K E + A + + SKV K++ K RL E RE ++ L H +I+
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVH 361
L ++ T L LV EY G + + Q+L ++Y H ++H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126
Query: 362 RDIKAENLLFDENGDIKLADFGFSNYFT-PGHMLTTWCGSPPYAAPE-LFGGREYDGTKS 419
RD+K +NLL + G++KLADFG + + P H + + Y P+ L G EY T
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS-TCL 185
Query: 420 DVWSLGVVLYVMVTAQLPFDG 440
D+W +G + M+ F G
Sbjct: 186 DMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 11/232 (4%)
Query: 284 KLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRL 343
++ RE+ ++ + P+I+ + + + + E+ GG + L ++ E+ ++
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108
Query: 344 FRQILSAVAYC-HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402
+L +AY + ++HRD+K N+L + G+IKL DFG S M ++ G+
Sbjct: 109 SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRS 167
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462
Y +PE G Y +SD+WS+G+ L + + P P+ L+ +FG+ P
Sbjct: 168 YMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEA--IFGR---PVVDG 221
Query: 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPN 514
E E S P + ++ + + M++ D IVN P PKLPN
Sbjct: 222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLD-YIVNEPP--PKLPN 270
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 3/157 (1%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQ 346
RE+ ++ + P+I+ + + + + E+ GG + L G++ E ++
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 347 ILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAA 405
+L + Y ++HRD+K N+L + G+IKL DFG S M ++ G+ Y +
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMS 166
Query: 406 PELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
PE G Y +SD+WSLG+ L M + P P+
Sbjct: 167 PERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPD 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK++ ++ + +++ E +M+ +DHPH+++L + ++ + L+T+ G +
Sbjct: 39 VAIKVL-REETSPKANKEILDEAYVMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLL 96
Query: 327 SHLLTIGQMAEKEASRLF----RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
++ + S+ QI ++Y +VHRD+ A N+L +K+ DF
Sbjct: 97 DYV---RNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF 153
Query: 383 GFSNYFTP---------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
G + G + W A E R Y KSDVWS GV ++ ++T
Sbjct: 154 GLAKLLDVDEKEYHAEGGKVPIKW------MALESILHRIYT-HKSDVWSYGVTVWELMT 206
Query: 434 -AQLPFDGPNLAVLKQRILFGKFRIP 458
P++G + + G+ R+P
Sbjct: 207 FGAKPYEGIPAVEIPDLLEKGE-RLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 41/279 (14%)
Query: 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS 293
GEGE S EG + ++ + KVA+K + + + E M
Sbjct: 8 GEGEFGSVMEG-----QLSQDDGSQL------KVAVKTMKLDIHTYSEIEEFLSEAACMK 56
Query: 294 HLDHPHIIKLFQV---METTNNL---YLVTEYARGGEIFSHLLT--IGQMAEKEASRLFR 345
DHP+++KL V + + ++ + + G++ S LL +G + EK +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 346 QILSAVA----YCHANNVVHRDIKAENLLFDENGDIKLADFGFS------NYFTPGH--- 392
+ + +A Y N +HRD+ A N + E+ + +ADFG S +Y+ G
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 393 MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFDGPNLAVLKQRIL 451
M W A E R Y +KSDVW+ GV ++ + Q P+ G + +
Sbjct: 177 MPVKW------IAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229
Query: 452 FG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
G + + P E +L+ S DP R T T++
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 69/258 (26%), Positives = 112/258 (43%), Gaps = 46/258 (17%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYA 320
E S VA+K++ K E++L L E+++M + H +II L V LY+V EYA
Sbjct: 40 NETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA 98
Query: 321 RGGEIFSHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364
G + L + +K+ Q+ + + + +HRD+
Sbjct: 99 AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158
Query: 365 KAENLLFDENGDIKLADFGFS------NYF---TPGHMLTTWCGSPPYAAPELFGGREYD 415
A N+L E+ +K+ADFG + +Y+ T G + W APE R Y
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKW------MAPEALFDRVYT 212
Query: 416 GTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFR------IPFYMSAECENL 468
+SDVWS GV+L+ + T P+ P + V + LF + P + E +L
Sbjct: 213 -HQSDVWSFGVLLWEIFTLGGSPY--PGIPVEE---LFKLLKEGYRMEKPQNCTQELYHL 266
Query: 469 IRSMLVLDPAKRLTLTQI 486
+R P++R T Q+
Sbjct: 267 MRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 4/150 (2%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQI 347
E I+ ++HP II+L L+ + +++ +L +A + + R +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 348 LSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP--GHMLTTWCGSPPYAA 405
L A+ Y H N ++HRDIKAEN+ + GD+ L DFG + + + W G+ A
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNA 251
Query: 406 PELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
PEL Y G D+WS G+VL+ M T
Sbjct: 252 PELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 15/188 (7%)
Query: 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN 357
P+++ L + + + ++++LV ++A GG+++SH+ + E+ R +++ A+ H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 358 NVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP----YAAPELFGGRE 413
+V RD+ N+L D+ G I+L YF+ + C Y APE+ GG
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQL------TYFSRWSEVEDSCDGEAVENMYCAPEV-GGIS 157
Query: 414 YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSML 473
+ D WSLG +L+ ++T + + + L IP ++S E +L++ +L
Sbjct: 158 EETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTL----NIPEWVSEEARSLLQQLL 213
Query: 474 VLDPAKRL 481
+P +RL
Sbjct: 214 QFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 40/119 (33%), Positives = 69/119 (57%), Gaps = 1/119 (0%)
Query: 268 AIKIIDKKRLDERNL-RKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
A+K++ K + +N+ ++ E D ++ P I+ L+ +++ NN+YLV EY GG++
Sbjct: 33 AVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92
Query: 327 SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
S L G E+ A + ++ A+ Y H + ++HRD+K +N+L G IKL DFG S
Sbjct: 93 SLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 258 AQLIEE---LSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV---METTN 311
AQL E KVA+K++ ++ + RE M DHP++IKL V
Sbjct: 18 AQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77
Query: 312 NL---YLVTEYARGGEIFSHLLT--IGQ----MAEKEASRLFRQILSAVAYCHANNVVHR 362
L ++ + + G++ + LL IG+ + + R I S + Y + N +HR
Sbjct: 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR 137
Query: 363 DIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSP---PYAAPELFGGREYDGTKS 419
D+ A N + +EN + +ADFG S G C S + A E Y T S
Sbjct: 138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THS 196
Query: 420 DVWSLGVVLY-VMVTAQLPFDG 440
DVW+ GV ++ +M Q P+ G
Sbjct: 197 DVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 70/285 (24%)
Query: 285 LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG--GEIFSHLLTIGQMAEKEASR 342
RE+ IM+ + H +I+ L V + + LV + ++ + ++ E +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKC 123
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF-------------- 388
+ QIL+ + H +HRD+ N+ + G K+ADFG + +
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 389 -------TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
T ++T W Y APEL G E D+WS+G + ++T + F G
Sbjct: 184 MQRREEMTS-KVVTLW-----YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 442 NLAVLKQRI--LFGK---------FRIPFYM-----------------SAECENLIRSML 473
N RI L G ++P Y S + +L++S+L
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 474 VLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPK-LPNSFV 517
L+P +R++ + H++ +P+P +P LP +F+
Sbjct: 298 KLNPLERISAKEALKHEYFK---------SDPLPCDPSQLPFNFL 333
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 287 REVDIM---SHLDHPHIIKLFQVMETTNN-----LYLVTEYARGGEIFSHLLTI---GQM 335
REV ++ DHP+I++L V T+ + LV E+ ++ ++L + G
Sbjct: 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLP 106
Query: 336 AEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT 395
AE L RQ L + + HAN +VHRD+K EN+L G +KLADFG + ++ LT
Sbjct: 107 AET-IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT 165
Query: 396 TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431
+ Y APE+ Y T D+WS+G + M
Sbjct: 166 PVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 68/262 (25%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYAR 321
+VA+K + K D+ ++ +E +MS+ +HP+I+KL V Y++ E
Sbjct: 24 SGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELME 82
Query: 322 GGEIFSHL------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369
GG++ S+L LT+ KE + + Y + +HRD+ A N
Sbjct: 83 GGDLLSYLRDARVERFGPPLLTL-----KELLDICLDVAKGCVYLEQMHFIHRDLAARNC 137
Query: 370 LFDENGD-----IKLADFGF------SNYFT---PGHMLTTWCGSPPYAAPELFGGREYD 415
L E G +K+ DFG S+Y+ G + W APE D
Sbjct: 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW------MAPESL----LD 187
Query: 416 G---TKSDVWSLGVVLY-VMVTAQLPFDG-PNLAVLKQRILFGKFRIPFYMSAECENLIR 470
G T+SDVWS GV+++ ++ Q P+ N VL+ G+ + P C + I
Sbjct: 188 GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP----ENCPDKIY 243
Query: 471 SMLVL----DPAKRLTLTQISN 488
++ DP++R T +I
Sbjct: 244 QLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 71/234 (30%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 226 PQYNLR---KAGEGE----DLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD 278
P+ LR K GEG+ L + EG+ E A + + VA+K++ R D
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFL----GEGAPEFDGQPVLVAVKML---RAD 55
Query: 279 -ERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI----------- 325
+ R F +E+ IMS L +P+II+L V + + L ++TEY G++
Sbjct: 56 VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES 115
Query: 326 -FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
F+H I ++ + QI S + Y + N VHRD+ N L + IK+ADFG
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
Query: 385 S-NYFTPGHMLTTWCGSPP--YAAPE--LFGGREYDGTKSDVWSLGVVLYVMVT 433
S N ++ + P + A E L G T SDVW+ GV L+ M T
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT---TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 56/191 (29%), Positives = 84/191 (43%), Gaps = 36/191 (18%)
Query: 267 VAIKIIDKKRLDE-RNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K++ R D N R+ F +EV I+S L P+I +L V L ++ EY G+
Sbjct: 49 VAVKVL---RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 325 IFSHLLTIGQMAEKEASRLFR------------QILSAVAYCHANNVVHRDIKAENLLFD 372
+ + L + + QI S + Y + N VHRD+ N L
Sbjct: 106 L-NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
Query: 373 ENGDIKLADFGFSN------YFTPGHMLTTWCGSPP----YAAPELFGGREYDGTKSDVW 422
+N IK+ADFG S Y+ G P + A E ++ TKSDVW
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQ-------GRAPLPIRWMAWESVLLGKFT-TKSDVW 216
Query: 423 SLGVVLYVMVT 433
+ GV L+ ++T
Sbjct: 217 AFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 64/280 (22%), Positives = 119/280 (42%), Gaps = 57/280 (20%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEY 319
VAIK + + + + ++ +RE+ +M ++H +II L V +E ++YLV E
Sbjct: 43 NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL 102
Query: 320 ARGGEIFSHLLTIGQMA--EKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ ++L + QM + S L Q+L + + H+ ++HRD+K N++ + +
Sbjct: 103 -----MDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 157
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437
K+ DFG + M+T + + Y APE+ G Y D+WS+G ++ M+ +
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVL 216
Query: 438 FDG------------------------------------PNLAVLKQRILFGKFRIP--- 458
F G P A LF P
Sbjct: 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS 276
Query: 459 ----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
+++ +L+ MLV+DP KR+++ H +++V
Sbjct: 277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV-METTNNL-----YL 315
+ + KVA+K + + E M DHP++++L V ++T + +
Sbjct: 24 DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83
Query: 316 VTEYARGGEIFSHLL--TIGQ----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369
+ + + G++ S LL +G + + + I S + Y + + +HRD+ A N
Sbjct: 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143
Query: 370 LFDENGDIKLADFGFS------NYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSD 420
+ +EN ++ +ADFG S +Y+ G M W A E R Y TKSD
Sbjct: 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI------AIESLADRVYT-TKSD 196
Query: 421 VWSLGVVLYVMVT-AQLPFDG 440
VWS GV ++ + T Q P+ G
Sbjct: 197 VWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-14
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 33/205 (16%)
Query: 270 KIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ--VMETTNNLYLVTEYARGGEIFS 327
K I + L ER +L EV++M L H +I++ + + LY++ E+ G++
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 328 HLLT----IGQMAEKEASRLFRQILSAVAYCH-------ANNVVHRDIKAENLLFDEN-- 374
++ G++ E + RQ+L A+AYCH V+HRD+K +N+
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 375 --GDI-------------KLADFGFSNYFTPGHMLTTWCGSPPYAAPELF--GGREYDGT 417
G I K+ DFG S M + G+P Y +PEL + YD
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD-D 222
Query: 418 KSDVWSLGVVLYVMVTAQLPFDGPN 442
KSD+W+LG ++Y + + + PF N
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 284 KLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASR 342
K +E I+ HP+I++L V +Y+V E +GG+ + L T G ++ KE +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ 98
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN------YFTPGHMLTT 396
+ + + Y + + +HRD+ A N L E +K++DFG S Y + G M
Sbjct: 99 MVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429
+ APE Y ++SDVWS G++L+
Sbjct: 159 ---PVKWTAPEALNYGRYS-SESDVWSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 25/197 (12%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
++VAIK + + +E +M L H +++L+ V+ + +Y+VTEY G
Sbjct: 31 TRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 86
Query: 325 I-------FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ L + Q+ + A QI S +AY N VHRD++A N+L EN
Sbjct: 87 LLDFLKGEMGKYLRLPQLVDMAA-----QIASGMAYVERMNYVHRDLRAANILVGENLVC 141
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPP--YAAPE--LFGGREYDGTKSDVWSLGVVLYVMVT 433
K+ADFG + P + APE L+G KSDVWS G++L + T
Sbjct: 142 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT---IKSDVWSFGILLTELTT 198
Query: 434 -AQLPFDG-PNLAVLKQ 448
++P+ G N VL Q
Sbjct: 199 KGRVPYPGMVNREVLDQ 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 34/146 (23%), Positives = 76/146 (52%), Gaps = 3/146 (2%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-LTIGQMAEKEASRLFRQ 346
E ++ +++HP +I++ + + +V + +++++L + +A + +Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAP 406
IL + Y HA ++HRD+K EN+ ++ + + D G + + G+ AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 407 ELFGGREYDGTKSDVWSLGVVLYVMV 432
E+ +Y+ +K+D+WS G+VL+ M+
Sbjct: 226 EVLARDKYN-SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289
++K G G+ W G + +KVA+K + + + E
Sbjct: 11 IKKLGNGQFGEVWMGTWNGN---------------TKVAVKTLKPGTMSPESF---LEEA 52
Query: 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHL-------LTIGQMAEKEASR 342
IM L H +++L+ V+ + +Y+VTEY G + L L + + + A
Sbjct: 53 QIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-- 109
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402
Q+ + +AY N +HRD+++ N+L + K+ADFG + P
Sbjct: 110 ---QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 403 --YAAPE--LFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG-PNLAVLKQ 448
+ APE L+G KSDVWS G++L +VT ++P+ G N VL+Q
Sbjct: 167 IKWTAPEAALYGRFT---IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-13
Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 32/265 (12%)
Query: 183 NESNPEKAESVPGADQPTTEADE-AAKEITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQ 241
+E+ P+ A VP A DE A +D+ A K+ LR + E + +
Sbjct: 123 DEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFI--CALRASTEEAEARR 180
Query: 242 WEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301
K K E A+ ++ S+ AI+ L E+ + L+H +I+
Sbjct: 181 GVNSTNQGKPKCERLIAKRVKAGSRAAIQ--------------LENEILALGRLNHENIL 226
Query: 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEK------EASRLFRQILSAVAYCH 355
K+ +++ + N Y++T+ +++S + K + + +Q+L AV Y H
Sbjct: 227 KIEEILRSEANTYMITQKYDF-DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284
Query: 356 ANNVVHRDIKAENLLFDENGDIKLADFG----FSNYFTPGHMLTTWCGSPPYAAPELFGG 411
++HRDIK EN+ + +G I L DFG F W G+ +PE+ G
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY--GWVGTVATNSPEILAG 342
Query: 412 REYDGTKSDVWSLGVVLYVMVTAQL 436
Y +D+WS G++L M++
Sbjct: 343 DGY-CEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 232 KAGEGE----DLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLF 286
K GEG+ L + EGM + K + L VA+K++ R D +N R F
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVL--VAVKML---REDANKNARNDF 66
Query: 287 -REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI---FSHLLTIGQMAEKEASR 342
+E+ IMS L P+II+L V T++ L ++TEY G++ S + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 343 --------LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH-- 392
+ QI S + Y + N VHRD+ N L +N IK+ADFG S G
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 393 -------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+ W L G T SDVW+ GV L+ ++T
Sbjct: 187 RIQGRAVLPIRWMSWESI----LLGKFT---TASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN--LYLVTEYARGGE 324
VA+K + K+ ++N +E++I+ L H +I+K L L+ EY G
Sbjct: 36 VAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 325 IFSHL----LTIGQMAEKEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
+ +L L + Q+ LF +QI +AY H+ + +HRD+ A N+L D + +K+
Sbjct: 95 LRDYLPKHKLNLAQLL------LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKI 148
Query: 380 ADFGFSNYFTPGHML--TTWCGSPP--YAAPELFGGREYDGT-KSDVWSLGVVLYVMVTA 434
DFG + GH G P + A E +E + SDVWS GV LY ++T
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTH 206
Query: 435 QLPFDGP 441
P
Sbjct: 207 CDSKQSP 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 32/199 (16%)
Query: 267 VAIKIIDKKRLD-ERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+KI+ R D +N R F +EV I+S L P+II+L V + L ++TEY G+
Sbjct: 49 VAVKIL---RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 325 IFSHLLTIGQMAEKEAS--------------------RLFRQILSAVAYCHANNVVHRDI 364
+ + L+ + +KE + + QI S + Y + N VHRD+
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 365 KAENLLFDENGDIKLADFGFS-NYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDV 421
N L EN IK+ADFG S N + + P + A E ++ T SDV
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDV 223
Query: 422 WSLGVVLY--VMVTAQLPF 438
W+ GV L+ +M+ + P+
Sbjct: 224 WAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 53/184 (28%), Positives = 94/184 (51%), Gaps = 12/184 (6%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPHIIKLFQVMETT-----NNLYLVTE 318
VA+K + + +E REV ++ HL+ HP++++LF V + L LV E
Sbjct: 30 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 89
Query: 319 YARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
+ ++ ++L + + + + + Q+L + + H++ VVHRD+K +N+L +G
Sbjct: 90 HV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 148
Query: 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
IKLADFG + ++ LT+ + Y APE+ Y T D+WS+G + M +
Sbjct: 149 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKP 207
Query: 437 PFDG 440
F G
Sbjct: 208 LFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVAIK + + +E IM L H ++ L+ V+ + +Y+VTE+ G
Sbjct: 31 TKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGS 86
Query: 325 IFSHL-------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ L L + Q+ + A QI +AY N +HRD++A N+L +N
Sbjct: 87 LLDFLKEGDGKYLKLPQLVDMAA-----QIADGMAYIERMNYIHRDLRAANILVGDNLVC 141
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPP--YAAPE--LFGGREYDGTKSDVWSLGVVLYVMVT 433
K+ADFG + P + APE L+G KSDVWS G++L +VT
Sbjct: 142 KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT---IKSDVWSFGILLTELVT 198
Query: 434 -AQLPFDG-PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488
++P+ G N VL+Q + P L++ DP +R T I +
Sbjct: 199 KGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 12/219 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVA+K I + + E +M+ L H ++++L V+ N LY+V E G +
Sbjct: 31 KVAVKNIKC----DVTAQAFLEETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNL 85
Query: 326 FSHLLTIGQMAEKEAS--RLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+ L T G+ + + + Y + +VHRD+ A N+L E+G K++DFG
Sbjct: 86 VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFG 145
Query: 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFDGPN 442
+ + G + + APE +++ +KSDVWS GV+L+ V + P+ +
Sbjct: 146 LARVGSMG--VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMS 202
Query: 443 LAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKR 480
L +K+ + G + P A+ L+ S +P KR
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 255 AAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLY 314
A L+ E K+ + + K E + RE ++++ L H HI++ + V L
Sbjct: 24 AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83
Query: 315 LVTEYARGGEIF---------SHLLTIGQMAE------KEASRLFRQILSAVAYCHANNV 359
+V EY R G++ + +L G+ + + QI S + Y + +
Sbjct: 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF 143
Query: 360 VHRDIKAENLLFDENGDIKLADFGFS------NYFTPG--HMLTTWCGSPPYAAPELFGG 411
VHRD+ N L + +K+ DFG S +Y+ G ML + PE
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI-----RWMPPESILY 198
Query: 412 REYDGTKSDVWSLGVVLYVMVT 433
R++ T+SD+WS GVVL+ + T
Sbjct: 199 RKFT-TESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VA+K + L R + RE +++++L H HI+K + V + L +V EY + G++
Sbjct: 38 VAVKALKDPTLAAR--KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 327 SHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370
L G++ + + QI S + Y + + VHRD+ N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 371 FDENGDIKLADFGFSN-------YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWS 423
N +K+ DFG S Y GH + P PE R++ T+SDVWS
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP----PESIMYRKFT-TESDVWS 210
Query: 424 LGVVLYVMVT 433
GV+L+ + T
Sbjct: 211 FGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM-----ETTNNLYLVTEYA 320
KVAIK I+ + ++ RE+ ++ L HP I+++ +M ++Y+V E
Sbjct: 27 KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM 86
Query: 321 RGGEIFSHLLTIGQMAE---KEASRLF-RQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
S L + + + E + F Q+L A+ Y H NV HRD+K +N+L + +
Sbjct: 87 E-----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK 141
Query: 377 IKLADFGFSNYF---TPGHML-TTWCGSPPYAAPELFGGREYDGTKS-DVWSLGVVLYVM 431
+K+ DFG + TP + T + + Y APEL G T + D+WS+G + +
Sbjct: 142 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201
Query: 432 VTAQLPFDGPNL 443
+T + F G N+
Sbjct: 202 LTGKPLFPGKNV 213
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 263 ELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYAR 321
++KVA+K++ K E++L L E+++M + H +II L LY++ EYA
Sbjct: 49 RVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 107
Query: 322 GGEIFSHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365
G + +L + Q++ K+ Q+ + Y + +HRD+
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167
Query: 366 AENLLFDENGDIKLADFGFS------NYF---TPGHMLTTWCGSPPYAAPELFGGREYDG 416
A N+L E+ +K+ADFG + +Y+ T G + W APE R Y
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW------MAPEALFDRIYT- 220
Query: 417 TKSDVWSLGVVLYVMVT 433
+SDVWS GV+L+ + T
Sbjct: 221 HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 25/234 (10%)
Query: 267 VAIKII-----DKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYAR 321
VAI + DK+R R E + DH +I++L V+ N + +VTEY
Sbjct: 36 VAIHTLRAGCSDKQR------RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89
Query: 322 GGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
G + S L GQ+ + + + S + Y VH+ + A +L + + K++
Sbjct: 90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKIS 149
Query: 381 DFGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLP 437
F + TT G P +AAPE + + SDVWS G+V++ VM + P
Sbjct: 150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERP 208
Query: 438 F-DGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLV----LDPAKRLTLTQI 486
+ D V+K + FR+P C NL+ +++ + +R +QI
Sbjct: 209 YWDMSGQDVIKA--VEDGFRLP--APRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 43/188 (22%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE-- 324
VA+K I+ + +L+ L +E+ L HP+I+ + LY+V+ G
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 325 --IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ +H G + E + + + +L+A+ Y H+ +HR +KA ++L +G + L+
Sbjct: 88 DLLKTH-FPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS-- 143
Query: 383 GFSN---YFTPGHMLTTWCGSP-------PYAAPELFGG--REYDGTKSDVWSLGVVLYV 430
G G P P+ +PE+ + Y+ KSD++S+G+
Sbjct: 144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACE 202
Query: 431 MVTAQLPF 438
+ +PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYA 320
+E VA+K++ K E++L L E+++M + H +II L LY++ EYA
Sbjct: 45 KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 321 RGGEIFSHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364
G + +L + QM K+ Q+ + Y + +HRD+
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163
Query: 365 KAENLLFDENGDIKLADFGFS------NYF---TPGHMLTTWCGSPPYAAPELFGGREYD 415
A N+L EN +K+ADFG + +Y+ T G + W APE R Y
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW------MAPEALFDRVYT 217
Query: 416 GTKSDVWSLGVVLYVMVT 433
+SDVWS GV+++ + T
Sbjct: 218 -HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
AIK++ K+ E + R E++++ L HP+II L E LY+ EYA G +
Sbjct: 33 AIKML-KEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLL 91
Query: 327 SHLL----------------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370
L T + ++ + + + + Y +HRD+ A N+L
Sbjct: 92 DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151
Query: 371 FDENGDIKLADFGFSN----YF--TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSL 424
EN K+ADFG S Y T G + W A E Y TKSDVWS
Sbjct: 152 VGENLASKIADFGLSRGEEVYVKKTMGRLPVRW------MAIESLNYSVYT-TKSDVWSF 204
Query: 425 GVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRI--PFYMSAECENLIRSMLVLDPAKRL 481
GV+L+ +V+ P+ G A L +++ G +R+ P E L+R P +R
Sbjct: 205 GVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERP 263
Query: 482 TLTQIS 487
QIS
Sbjct: 264 PFAQIS 269
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 67/245 (27%), Positives = 101/245 (41%), Gaps = 33/245 (13%)
Query: 268 AIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
AIK + K+ + + R E++++ L HP+II L E LYL EYA G +
Sbjct: 26 AIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84
Query: 327 SHLL----------------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370
L T ++ ++ + + Y +HRD+ A N+L
Sbjct: 85 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 144
Query: 371 FDENGDIKLADFGFSN----YF--TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSL 424
EN K+ADFG S Y T G + W A E Y T SDVWS
Sbjct: 145 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW------MAIESLNYSVYT-TNSDVWSY 197
Query: 425 GVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLT 482
GV+L+ +V+ P+ G A L +++ G + P E +L+R P +R +
Sbjct: 198 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS 257
Query: 483 LTQIS 487
QI
Sbjct: 258 FAQIL 262
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 32/177 (18%)
Query: 287 REVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGGEIFSHLLTIG----------Q 334
RE+ ++ L HP++I L +V + ++L+ +YA H++ Q
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIKFHRASKANKKPMQ 104
Query: 335 MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----DENGDIKLADFGFSNYFTP 390
+ L QIL + Y HAN V+HRD+K N+L E G +K+AD GF+ F
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 391 GH---------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
++T W Y APEL G + D+W++G + ++T++ F
Sbjct: 165 PLKPLADLDPVVVTFW-----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 34/198 (17%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMETTNNLYLVTEYA 320
++ VA+K++ K +++L L E+++M + H +II L V LY++ EYA
Sbjct: 42 DQTVTVAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 321 RGGEIFSHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364
G + L + Q++ K+ Q+ + Y + +HRD+
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160
Query: 365 KAENLLFDENGDIKLADFGFS------NYF---TPGHMLTTWCGSPPYAAPELFGGREYD 415
A N+L E+ +K+ADFG + +Y+ + G + W APE R Y
Sbjct: 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW------MAPEALFDRVYT 214
Query: 416 GTKSDVWSLGVVLYVMVT 433
+SDVWS G++++ + T
Sbjct: 215 -HQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 32/177 (18%)
Query: 287 REVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGGEIFSHLLTIG----------Q 334
RE+ ++ L HP++I L +V ++L+ +YA H++ Q
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIKFHRASKANKKPVQ 104
Query: 335 MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----DENGDIKLADFGFSNYFTP 390
+ L QIL + Y HAN V+HRD+K N+L E G +K+AD GF+ F
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 391 GH---------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438
++T W Y APEL G + D+W++G + ++T++ F
Sbjct: 165 PLKPLADLDPVVVTFW-----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYAR 321
E ++VAIK +++ R + E +M + H+++L V+ ++ E
Sbjct: 34 EPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 92
Query: 322 GGEIFSHLLTIGQMAE----------KEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371
G++ S+L ++ E K+ ++ +I +AY +AN VHRD+ A N +
Sbjct: 93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 152
Query: 372 DENGDIKLADFGF------SNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWS 423
E+ +K+ DFG ++Y+ G +L SP +F T SDVWS
Sbjct: 153 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF------TTYSDVWS 206
Query: 424 LGVVLYVMVT-AQLPFDG 440
GVVL+ + T A+ P+ G
Sbjct: 207 FGVVLWEIATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 29/194 (14%)
Query: 262 EELSKVAIKII-DKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
E + VA+K++ ++ D + RE +M+ DHP+I+KL V + L+ EY
Sbjct: 33 EPFTMVAVKMLKEEASADMQA--DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM 90
Query: 321 RGGEIFSHLLTIGQMAEKEASR----------------------LFRQILSAVAYCHANN 358
G++ L A+ S + +Q+ + +AY
Sbjct: 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK 150
Query: 359 VVHRDIKAENLLFDENGDIKLADFGFS-NYFTPGHMLTTWCGSPP--YAAPELFGGREYD 415
VHRD+ N L EN +K+ADFG S N ++ + + + P + PE Y
Sbjct: 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210
Query: 416 GTKSDVWSLGVVLY 429
T+SDVW+ GVVL+
Sbjct: 211 -TESDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 47/256 (18%)
Query: 267 VAIKIIDKKRLDERNLRKLFR-EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK + + E +++ FR E ++MS L HP+I+ L V ++ EY G++
Sbjct: 38 VAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 326 FSHLLTIGQMAEKEASRLFR----------------QILSAVAYCHANNVVHRDIKAENL 369
L+ ++ A QI + + Y +++ VHRD+ A N
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155
Query: 370 LFDENGDIKLADFGFSN-------YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVW 422
L E +K++DFG S Y L PP A L+G T+SD+W
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFT---TESDIW 210
Query: 423 SLGVVLYVMVTAQL-PFDGPN----LAVLKQRILFG-KFRIPFYMSA---ECENLIRSML 473
S GVVL+ + + L P+ G + + +++ R L P + A EC N I
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEI---- 266
Query: 474 VLDPAKRLTLTQISNH 489
PA+R I
Sbjct: 267 ---PARRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 71/230 (30%), Positives = 98/230 (42%), Gaps = 34/230 (14%)
Query: 283 RKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEIF-----SHLLTIG--- 333
R E++++ L HP+II L E LYL EYA G + S +L
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 334 QMAEKEASRLFRQILSAVA--------YCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+A AS L Q L A Y +HRD+ A N+L EN K+ADFG S
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 386 N----YF--TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
Y T G + W A E Y T SDVWS GV+L+ +V+ P+
Sbjct: 172 RGQEVYVKKTMGRLPVRW------MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPY 224
Query: 439 DGPNLAVLKQRILFGKFRI--PFYMSAECENLIRSMLVLDPAKRLTLTQI 486
G A L +++ G +R+ P E +L+R P +R + QI
Sbjct: 225 CGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 50/170 (29%), Positives = 73/170 (42%), Gaps = 24/170 (14%)
Query: 279 ERNLRKLFREVDIMSHLDHPHIIKLFQVMETT--NNLYLVTEYARGGEIFSHLLTIGQMA 336
+LR RE++I+ L H +I+K V + NL LV EY G + +L
Sbjct: 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRE 103
Query: 337 EKEASRLFR---QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS-------N 386
+ +L QI + Y + VHRD+ N+L + +K+ DFG +
Sbjct: 104 RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
Query: 387 YFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
Y+ PG W APE ++ SDVWS GVVLY + T
Sbjct: 164 YYKVREPGESPIFW------YAPESLTESKFS-VASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVA+K + + ++ E ++M L H ++KL V+ T +Y++TE+ G
Sbjct: 31 TKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGS 86
Query: 325 IFSHLLTIGQMAEKEASRLF---RQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
+ L + + +++ +L QI +A+ N +HRD++A N+L + K+AD
Sbjct: 87 LLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 145
Query: 382 FGFSNYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
FG + P + APE + KSDVWS G++L +VT ++P+
Sbjct: 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPY 204
Query: 439 DG 440
G
Sbjct: 205 PG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 261 IEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA 320
I+ KVAIK K L + + RE+ IM +L+H +II L Y TE
Sbjct: 88 IDTSEKVAIK----KVLQDPQYKN--RELLIMKNLNHINIIFLKD--------YYYTECF 133
Query: 321 RGGE--IFSHLLT--IGQMAEKEASRLFR---------------QILSAVAYCHANNVVH 361
+ E IF +++ I Q K R Q+ A+AY H+ + H
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICH 193
Query: 362 RDIKAENLLFDENG-DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSD 420
RD+K +NLL D N +KL DFG + G ++ S Y APEL G T D
Sbjct: 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHID 253
Query: 421 VWSLGVVLYVMVTAQLPFDG 440
+WSLG ++ M+ F G
Sbjct: 254 LWSLGCIIAEMILGYPIFSG 273
|
Length = 440 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 35/248 (14%)
Query: 265 SKVAIKIIDKK-RLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG 323
++VA+K +++ L ER + E +M H+++L V+ +V E G
Sbjct: 37 TRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 324 EIFSHLLTIGQMAE----------KEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
++ S+L ++ AE +E ++ +I +AY +A VHRD+ A N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154
Query: 374 NGDIKLADFGF------SNYFTPGHMLTTWCGSPP--YAAPELFGGREYDG---TKSDVW 422
+ +K+ DFG ++Y+ G G P + APE DG T SD+W
Sbjct: 155 DFTVKIGDFGMTRDIYETDYYRKGGK-----GLLPVRWMAPESLK----DGVFTTSSDMW 205
Query: 423 SLGVVLYVMVT-AQLPFDG-PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKR 480
S GVVL+ + + A+ P+ G N VLK + G P +L+R +P R
Sbjct: 206 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 265
Query: 481 LTLTQISN 488
T +I N
Sbjct: 266 PTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGG 323
+ V ++I D + E +L+ L EV ++SH HP+I+ + V T + L++++ + G
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEV-VLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 324 EIFSHLLTIGQMAEKEASRLFRQIL----SAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
+ LL E + L IL + Y H N +HR+IKA ++L +G + L
Sbjct: 85 SA-NSLLK-TYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSL 142
Query: 380 ADFGFSNYFT---PGHMLTTWCGSP-------PYAAPELFGGREYD-GTKSDVWSLGVVL 428
+ G S+ ++ G P P+ +PEL Y KSD++S+G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200
Query: 429 YVMVTAQLPF-DGPNLAVLKQRILFGKFRIPFYMSA 463
+ T ++PF D +L Q+ L G P ++
Sbjct: 201 CELATGRVPFQDMLRTQMLLQK-LKGPPYSPLDITT 235
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 34/193 (17%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+K++ D ++L L E+++M + H +II L LY++ EYA G +
Sbjct: 47 VAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 326 FSHL----------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369
+L L Q+ K+ Q+ + Y + +HRD+ A N+
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165
Query: 370 LFDENGDIKLADFGFS------NYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSD 420
L E+ +K+ADFG + +Y+ T G + W APE R Y +SD
Sbjct: 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW------MAPEALFDRVYT-HQSD 218
Query: 421 VWSLGVVLYVMVT 433
VWS GV+L+ + T
Sbjct: 219 VWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 34/245 (13%)
Query: 267 VAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
V +K + K + NL+ F RE+D+ L H ++++L + Y++ EY G++
Sbjct: 38 VLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 326 FSHLLTIGQMAEKEASR---------LFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376
L EK L QI + + VHRD+ A N L +
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155
Query: 377 IKLADFGFSN------YFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVL 428
+K++ S Y+ + P + APE ++ TKSDVWS GV++
Sbjct: 156 VKVSLLSLSKDVYNSEYY---KLRNALI---PLRWLAPEAVQEDDFS-TKSDVWSFGVLM 208
Query: 429 Y-VMVTAQLPFDG-PNLAVLKQRILFGKFRIPFYMSAECENLIRSML---VLDPAKRLTL 483
+ V +LPF G + VL R+ GK +P L + M ++P R +
Sbjct: 209 WEVFTQGELPFYGLSDEEVL-NRLQAGKLELPVP-EGCPSRLYKLMTRCWAVNPKDRPSF 266
Query: 484 TQISN 488
+++ +
Sbjct: 267 SELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQ 346
E ++ L HP ++ L V LV R +++++L + + + + + RQ
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQ 268
Query: 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYA-- 404
+LSA+ Y H ++HRDIK EN+L + DI L DFG + F G +W Y
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARG----SWSTPFHYGIA 323
Query: 405 ------APELFGGREYDGTKSDVWSLGVVLY 429
APE+ G Y D+WS G+V++
Sbjct: 324 GTVDTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG--HMLTTWCGSP-P 402
QI ++Y H V+H+DI A N + DE +K+ D S P H L P
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
+ A E +EY + SDVWS GV+L+ ++T Q P+
Sbjct: 185 WMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIKI+++ + N+ + E IM+ +DHPH+++L V + + LVT+ G +
Sbjct: 39 VAIKILNETTGPKANV-EFMDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLL 96
Query: 327 SHLLTIGQMAEKEASRLFR----QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ + + + S+L QI + Y +VHRD+ A N+L +K+ DF
Sbjct: 97 DY---VHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 383 GFSNYFT---------PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
G + G M W A E R++ +SDVWS GV ++ ++T
Sbjct: 154 GLARLLEGDEKEYNADGGKMPIKW------MALECIHYRKFT-HQSDVWSYGVTIWELMT 206
Query: 434 -AQLPFDG 440
P+DG
Sbjct: 207 FGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGGE 324
VA+K + K ++ L +E++I+ +L H +I+K + + N + L+ E+ G
Sbjct: 36 VAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 325 IFSHL-LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+ +L ++ K+ + QI + Y + VHRD+ A N+L + +K+ DFG
Sbjct: 95 LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154
Query: 384 FSN-------YFTPGHMLTTWCGSPPY-AAPE-LFGGREYDGTKSDVWSLGVVLYVMVT 433
+ Y+T L SP + APE L + Y SDVWS GV LY ++T
Sbjct: 155 LTKAIETDKEYYTVKDDLD----SPVFWYAPECLIQSKFY--IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 52/190 (27%), Positives = 95/190 (50%), Gaps = 20/190 (10%)
Query: 287 REVDIMSHLDHPHIIKLF-QVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEA- 340
+EV L+HP++++ Q +E+ L LV E+ G++ ++L + + QMA+K+
Sbjct: 44 QEVQPYRELNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL 102
Query: 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG--FSNYFTPGHMLTTWC 398
R+ ++ S + + H + +H D+ N + +K+ D+G Y + +T C
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-PEDYYITKDC 161
Query: 399 GSPP--YAAPELFGGREYD------GTKSDVWSLGVVLYVMVT-AQLPF-DGPNLAVLKQ 448
+ P + APEL R D KS++WSLGV ++ + T A P+ D + VLKQ
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221
Query: 449 RILFGKFRIP 458
+ ++P
Sbjct: 222 VVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVD----IMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
VAIK I +R+ R+ F+E+ M LDH +I++L + + L LVT+ +
Sbjct: 39 VAIKTIQ-----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPL 92
Query: 323 GEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381
G + H+ + + QI + Y + +VHR++ A N+L + +++AD
Sbjct: 93 GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 382 FGFSNYFTPG--HMLTTWCGSP-PYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
FG ++ P + +P + A E Y +SDVWS GV ++ M++
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
V +K++ D R+ F +MS L H H++KL+ V N+ +V EY + G +
Sbjct: 32 SVVLKVLGS---DHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87
Query: 326 --FSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG------- 375
F H + K + +Q+ SA+ Y +VH ++ +N+L G
Sbjct: 88 DVFLHREKNNVSLHWK--LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVP 145
Query: 376 DIKLADFGFSNYFTPGHMLTTWCGSP-PYAAPELF-GGREYDGTKSDVWSLGVVLY-VMV 432
IKL+D G + P+ APE G+ +D WS G L +
Sbjct: 146 FIKLSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
Query: 433 TAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ P + + ++ R+P AE NLI DP KR + I
Sbjct: 202 NGEEPLSTLSSSEKERFYQDQH-RLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 32/182 (17%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFS-------HLLTIGQMAEKEA 340
E IMS +H +I++L V +++ E GG++ S + K+
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD---IKLADFGF------SNYFTPG 391
R + Y N+ +HRDI A N L G K+ADFG ++Y+ G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 392 --HMLTTWCGSPPYAAPELFGGREYDG---TKSDVWSLGVVLY-VMVTAQLPFDG-PNLA 444
ML + PE F DG +K+DVWS GV+L+ + +P+ G N
Sbjct: 179 GRAMLPI-----KWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
Query: 445 VL 446
V+
Sbjct: 230 VM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 28/232 (12%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFRE-VDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGG 323
++V +K++DK RN + F E +MS L H H++ + V + +V EY + G
Sbjct: 28 TEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFG 84
Query: 324 EIFSHLL----TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD--- 376
+ ++L I + E + +Q+ A+ + + H ++ A+N+L D
Sbjct: 85 SLDTYLKKNKNLINISWKLEVA---KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKT 141
Query: 377 -----IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431
IKL+D G S P +L P+ PE + +D WS G L+ +
Sbjct: 142 GNPPFIKLSDPGISITVLPKEILLE---RIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198
Query: 432 VTAQLPFDGPNLAVLKQRILF---GKFRIPFYMSAECENLIRSMLVLDPAKR 480
+ D P A+ Q+ L + ++P E NLI + +P R
Sbjct: 199 FSGG---DKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVT-EYARGGE 324
A+K +++ D + + +E IM HP+++ L + + LV Y + G+
Sbjct: 25 HCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGD 83
Query: 325 IF------SHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378
+ +H T+ K+ Q+ + Y + VHRD+ A N + DE+ +K
Sbjct: 84 LRNFIRSETHNPTV-----KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK 138
Query: 379 LADFGFS------NYFTP-----GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVV 427
+ADFG + Y++ + W A E +++ TKSDVWS GV+
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKW------MALESLQTQKFT-TKSDVWSFGVL 191
Query: 428 LYVMVTAQLP 437
L+ ++T P
Sbjct: 192 LWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 26/188 (13%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK + + + N +++ E +M+ +D+PH+ +L + T+ + L+T+ G +
Sbjct: 39 VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLL 96
Query: 327 SHLLTIGQMAEKEASRLFR----QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ + + + S+ QI + Y +VHRD+ A N+L +K+ DF
Sbjct: 97 DY---VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDF 153
Query: 383 GFSNYFTP---------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
G + G + W A E R Y +SDVWS GV ++ ++T
Sbjct: 154 GLAKLLGADEKEYHAEGGKVPIKW------MALESILHRIYT-HQSDVWSYGVTVWELMT 206
Query: 434 AQL-PFDG 440
P+DG
Sbjct: 207 FGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN--YFTPGHMLTTWCGSP-P 402
Q+ + + + +HRD+ A N+L EN +K+ DFG + Y P ++ P
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFDGPNL-AVLKQRILFG-KFRIPF 459
+ APE R Y +SDVWS GV+L+ + P+ G + +R+ G + R P
Sbjct: 247 WMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 305
Query: 460 YMSAECENLIRSMLVLDPAKRLTLTQISNH 489
Y + E + +P++R T +++ H
Sbjct: 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 21/116 (18%)
Query: 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEA---SRLFRQILSAVAYCHANNV 359
L +M++ Y V Y + + + + E+E + RQIL A+ H+ +
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 360 VHRDIKAENLLFDE-NGDIKLADFGFS-------NYFTPGHMLTTWCGSPPYAAPE 407
VHRD+K +N++F E +G K+ D G + NY +L P YAAPE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL-----DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 27/190 (14%)
Query: 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIM-SHLDHPHIIKLFQVMETTNNLYLVTEYA 320
E+ VAIK + K E LR+ F+ +M S L HP+I+ L V+ L ++ Y
Sbjct: 33 EQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90
Query: 321 RGGEIFSHLLT------IGQMAEKEASR----------LFRQILSAVAYCHANNVVHRDI 364
++ L+ +G + + + + QI + + + +++VVH+D+
Sbjct: 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150
Query: 365 KAENLLFDENGDIKLADFG-FSNYFTPGHMLTTWCGSPP--YAAPE--LFGGREYDGTKS 419
N+L + ++K++D G F + + P + +PE ++G D S
Sbjct: 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID---S 207
Query: 420 DVWSLGVVLY 429
D+WS GVVL+
Sbjct: 208 DIWSYGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 7/147 (4%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN--YFTPGHMLTTWCGSP-P 402
Q+ + + + +HRD+ A N+L EN +K+ DFG + Y P ++ P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 403 YAAPELFGGREYDGTKSDVWSLGVVLY-VMVTAQLPFDGPNL-AVLKQRILFG-KFRIPF 459
+ APE + Y T+SDVWS GV+L+ + P+ G + QR+ G + R P
Sbjct: 242 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE 300
Query: 460 YMSAECENLIRSMLVLDPAKRLTLTQI 486
+ E ++ + DP +R T + +
Sbjct: 301 NATPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 34/181 (18%)
Query: 287 REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT------IGQMAEKEA 340
+E +M+ L HP+I+ L V+ + ++ EY G++ L+ +G ++++
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 341 S-----------RLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS---- 385
+ + QI + + Y ++ VH+D+ A N+L E +K++D G S
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 386 --NYF--TPGHMLTT-WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL-PFD 439
+Y+ P +L W PP A ++G D SD+WS GVVL+ + + L P+
Sbjct: 176 SADYYRVQPKSLLPIRWM--PPEAI--MYGKFSSD---SDIWSFGVVLWEIFSFGLQPYY 228
Query: 440 G 440
G
Sbjct: 229 G 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 23/156 (14%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-------SNYFTPGH--MLTT 396
Q+ + + + N +HRD+ A N+L + K+ DFG SNY G+ +
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAV---LKQRILF 452
W APE Y +SDVWS G++L+ + + + P+ P + V + +
Sbjct: 280 W------MAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPY--PGILVNSKFYKMVKR 330
Query: 453 G-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487
G + P + E ++++ L+P +R T +QIS
Sbjct: 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 27/254 (10%)
Query: 248 LKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM 307
L K ++ E+ KV +K++D D F +M + H HI+ L+ V
Sbjct: 16 LNYKDDDEDDGYSYEKEIKVILKVLDPSHRDIS--LAFFETASMMRQVSHKHIVLLYGVC 73
Query: 308 ETTNNLYLVTEYARGG--EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365
+V E+ G ++F H + + ++ +Q+ SA++Y ++VH ++
Sbjct: 74 VRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVC 132
Query: 366 AENLLFDENGD-------IKLADFGFSNYFTPGHMLTTWCGSP-----PYAAPELFGGRE 413
+N+L G IKL+D PG +T P+ APE +
Sbjct: 133 TKNILLAREGIDGECGPFIKLSD--------PGIPITVLSRQECVERIPWIAPECVEDSK 184
Query: 414 YDGTKSDVWSLGVVLY-VMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSM 472
+D WS G L+ + ++P LA K+R G+ + E +L+
Sbjct: 185 NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCMLVTPSCKELADLMTHC 243
Query: 473 LVLDPAKRLTLTQI 486
+ DP +R I
Sbjct: 244 MNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|218258 pfam04774, HABP4_PAI-RBP1, Hyaluronan / mRNA binding family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 28/104 (26%), Positives = 43/104 (41%), Gaps = 21/104 (20%)
Query: 151 DRRPNVSGGNPANDI------SGDWG---DQNAKLSDSVTNNESNPEKAESVPGADQPTT 201
DR SG + G+WG D+ A+L++ E E E ++
Sbjct: 6 DRH---SGSGRGGEDKREGAGRGNWGSVKDEIAELTEEQGEEEEKNEVEEKQAVEEEANK 62
Query: 202 E--------ADEAAKEITLDEW-KASRGTKLLKPQYNLRKAGEG 236
E +E KE+TL+E+ KA + + P +RKA EG
Sbjct: 63 EGVVEEEEVEEEEDKEMTLEEYEKALQEKRKALPALKVRKAKEG 106
|
This family includes the HABP4 family of hyaluronan-binding proteins, and the PAI-1 mRNA-binding protein, PAI-RBP1. HABP4 has been observed to bind hyaluronan (a glucosaminoglycan), but it is not known whether this is its primary role in vivo. It has also been observed to bind RNA, but with a lower affinity than that for hyaluronan. PAI-1 mRNA-binding protein specifically binds the mRNA of type-1 plasminogen activator inhibitor (PAI-1), and is thought to be involved in regulation of mRNA stability. However, in both cases, the sequence motifs predicted to be important for ligand binding are not conserved throughout the family, so it is not known whether members of this family share a common function. Length = 106 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK++ + + N +++ E +M+ + P++ +L + T+ + LVT+ G +
Sbjct: 39 VAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVCRLLGIC-LTSTVQLVTQLMPYGCLL 96
Query: 327 SHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
++ ++ ++ QI ++Y +VHRD+ A N+L +K+ DFG +
Sbjct: 97 DYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
Query: 386 --------NYFTPGHMLTTWCGSPP--YAAPELFGGREYDGTKSDVWSLGVVLYVMVT-A 434
Y G G P + A E R + +SDVWS GV ++ ++T
Sbjct: 157 RLLDIDETEYHADG-------GKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFG 208
Query: 435 QLPFDG 440
P+DG
Sbjct: 209 AKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 3e-06
Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 5/125 (4%)
Query: 22 GGGGGGRGDYRGGKREFDRQSGSDRTSTRKDTHHSDSGDAKERRYNGEARSYQGNRDREP 81
RGD + E +R R +D D D ++RR G+ R +G RD
Sbjct: 169 RDERRRRGDREDRQAEAERGERGRREERGRD---GDDRDRRDRREQGDRREERGRRDGGD 225
Query: 82 REYREPREFREPREFREPREYREPREPRGEDGDRYRGGLGGSRPPRGRGGRGGRGGYCGG 141
R R R R+ R+ R + + G+DG+ G G R R GR G G
Sbjct: 226 R--RGRRRRRDRRDARGDDNREDRGDRDGDDGEGRGGRRGRRFRDRDRRGRRGGDGGNER 283
Query: 142 KARIR 146
+ +R
Sbjct: 284 EPELR 288
|
Length = 672 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 360 VHRDIKAENLLFDENGDIKLADFGFSN--YFTPGHMLTTWCGSP-PYAAPELFGGREYDG 416
+HRD+ A N+L EN +K+ DFG + Y P ++ P + APE + Y
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYT- 253
Query: 417 TKSDVWSLGVVLYVMVT-AQLPFDGPNL-AVLKQRILFG-KFRIPFYMSAECENLIRSML 473
T+SDVWS GV+L+ + + P+ G + +R+ G + R P Y + E +++
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313
Query: 474 VLDPAKRLTLTQISNH 489
+P R T +++
Sbjct: 314 HNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-------SNYFTPGHMLTTWC 398
Q+ + + + + N VHRD+ A N+L E +K+ DFG SNY + G
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL- 305
Query: 399 GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+ APE Y T SDVWS G++L+ + T
Sbjct: 306 ---KWMAPESIFNNLYT-TLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 38/123 (30%), Positives = 56/123 (45%), Gaps = 16/123 (13%)
Query: 399 GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458
G+P Y APEL G+ + G D W+LGV L+ +T PF+ + Q IL IP
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL--NRDIP 598
Query: 459 F-----YMSAECENLIRSMLVLDPAKRLTLTQISNHK------WMSVHCPGDPVIVNPVP 507
+ +S +N I +L +DP KR L ++ H W ++ P I P P
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFI--PQP 656
Query: 508 SEP 510
+
Sbjct: 657 DDE 659
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 29/158 (18%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-------SNYFTPGH--MLTT 396
Q+ +++ + N +HRD+ A N+L K+ DFG SNY G+ +
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT------AQLPFDGPNLAVLKQRI 450
W APE Y +SDVWS G++L+ + + +P D ++K+
Sbjct: 282 W------MAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-- 332
Query: 451 LFGKFRI--PFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+R+ P +E ++++S DP KR T QI
Sbjct: 333 ---GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 283 RKLFREVDIMSHLDHPHIIK-LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEA- 340
K E L H ++++ L Q E T L LV E+ G++ +L + + AE
Sbjct: 40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSC-RKAELMTP 97
Query: 341 -----SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN-------YF 388
R+ +I + + H NN +H D+ N L + +K+ D+G S+ Y
Sbjct: 98 DPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
Query: 389 TPGHMLTTWCGSPP--YAAPELFGGRE-----YDGTK-SDVWSLGVVLY 429
TP + W P + APEL D TK S+VWSLGV ++
Sbjct: 158 TPDQL---WV---PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIW 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 295 LDHPHIIK-LFQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILS 349
L HP+I++ L Q +E L LV EY G++ S+L R+ +I +
Sbjct: 52 LQHPNILQCLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 350 AVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT---WCGSPPYAAP 406
V + H +N +H D+ N + +K+ D+G + T C + AP
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 407 ELFGGRE-----YDGTK-SDVWSLGVVLY 429
EL G + TK S+VW+LGV L+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLW 199
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE----IFSHLLTIGQMAEKEASRL 343
E+ + +HP+I+ N L++VT + G I +H + M+E + +
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMSELAIAYI 106
Query: 344 FRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT---PGHMLTTWCGS 400
+ +L A+ Y H VHR +KA ++L +G + L+ G + + G L
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDF 164
Query: 401 P-------PYAAPELFGG--REYDGTKSDVWSLGVVLYVMVTAQLPF-DGPNLAVLKQRI 450
P P+ +PE+ + YD KSD++S+G+ + +PF D P +L +++
Sbjct: 165 PKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 46/244 (18%), Positives = 92/244 (37%), Gaps = 39/244 (15%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLF----QVMETTNNLYLVTEYA 320
+V I+ K + L + E+ + +D +I+K++ +++ L L+ EY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 321 RGGEIFSHLLTIGQMAEKE---ASRLFRQILSAV----AYCHANNVVHRDIKAENLLFDE 373
G + L EK+ ++L + N ++++ + + L E
Sbjct: 105 TRGYLREVL-----DKEKDLSFKTKL-DMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158
Query: 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYD---------GTKSDVWSL 424
N +K+ H L SPP+ Y K D++SL
Sbjct: 159 NYKLKII----------CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 425 GVVLYVMVTAQLPFDGPNLAVLKQRILF--GKFRIPFYMSAECENLIRSMLVLDPAKRLT 482
GVVL+ + T ++PF+ + I+ ++P E + ++ + D KR
Sbjct: 209 GVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
Query: 483 LTQI 486
+ +I
Sbjct: 269 IKEI 272
|
Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 12/91 (13%)
Query: 346 QILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF-------SNYFTPGHMLTTWC 398
Q+ + + + N VHRD+ A N+L + +K+ DFG SNY + G
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--- 301
Query: 399 GSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429
+ APE Y T SDVWS G++L+
Sbjct: 302 -PVKWMAPESIFDNLYT-TLSDVWSYGILLW 330
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 7e-05
Identities = 32/149 (21%), Positives = 42/149 (28%), Gaps = 15/149 (10%)
Query: 20 QGGGGGGGRGDYRGGKREFDRQSGSDRTSTRKDTHHSDSGDAKERRYNGEARSYQGNRDR 79
+ R +R R++G + DA ER E + DR
Sbjct: 123 EAAQARERRERGEAARRGAARKAGEGGEQPATE----ARADAAERTEEEERDERRRRGDR 178
Query: 80 EPREYREPREFREPREFREPREYREPREPRGEDGDRYRGGLGGSRPPRGRGGRGGRGGYC 139
E R+ R R RE R R R E GDR R GR G
Sbjct: 179 EDRQAEAERGERGRREERGRDGDDRDRRDRREQGDR-----------REERGRRDGGDRR 227
Query: 140 GGKARIRTASLDRRPNVSGGNPANDISGD 168
G + R N + G+
Sbjct: 228 GRRRRRDRRDARGDDNREDRGDRDGDDGE 256
|
Length = 672 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 25/67 (37%), Positives = 35/67 (52%), Gaps = 2/67 (2%)
Query: 343 LFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCG--S 400
+ RQ+L+ + H +VHRDIK ENLL +G +K+ DFG + G G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD 373
Query: 401 PPYAAPE 407
P Y+ PE
Sbjct: 374 PRYSPPE 380
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 23/159 (14%)
Query: 254 EAAAAQLIEELS--KVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMETT 310
EA A L S KVA+K++ K + L E+ IMSHL H +I+ L
Sbjct: 55 EATAHGLSHSQSTMKVAVKML-KSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113
Query: 311 NNLYLVTEYARGGEIFSHL--------LTIGQMAEKEASRLF------RQILSAVAYCHA 356
+Y++TEY R G++ +L + S + Q S V+
Sbjct: 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173
Query: 357 NNVVHRDI-KAENLLF----DENGDIKLADFGFSNYFTP 390
++ + D+ K E+ + D G +K AD SNY +P
Sbjct: 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESP 212
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 39/146 (26%), Positives = 48/146 (32%), Gaps = 10/146 (6%)
Query: 21 GGGGGGGRGDYRGGKREFDRQSGSDRTSTRKD-THHSDSGDAKERRYNGEARSYQGNRDR 79
G GG + R E + D R D + ER E +RDR
Sbjct: 146 GEGGEQPATEARADAAERTEEEERDERRRRGDREDRQAEAERGERGRREERGRDGDDRDR 205
Query: 80 E-PREYREPREFREPREFREPREYREPREPRGEDGDRYRGGLGGSRPPRGRGGRGGRGGY 138
RE + RE R R+ + R R R+ R GD R G G G G R
Sbjct: 206 RDRREQGDRREERGRRDGGDRRGRRRRRDRRDARGDDNREDRGDRDGDDGEGRGGRR--- 262
Query: 139 CGGKARIRTASLDRRPNVSGGNPAND 164
G + R R DRR G
Sbjct: 263 -GRRFRDR----DRRGRRGGDGGNER 283
|
Length = 672 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 27/136 (19%), Positives = 43/136 (31%), Gaps = 5/136 (3%)
Query: 18 SGQGGGGGGGRGDYRGGKREFDRQSGSDRTSTRKDTHHSDSGDAKERRYNGEARSYQGNR 77
+ G RG R ++ + R + T + + + R + ++
Sbjct: 129 ERRERGEAARRGAARKAGEGGEQPATEARADAAERTEEEERDERRRRGDREDRQAEAERG 188
Query: 78 DREPREYREPREFREPREFREPREYREPREPRGEDGDRYRGGLGGSRPPRGRGGRGGRGG 137
+R RE R + R+ R+ RE + R E G R G G R R R G
Sbjct: 189 ERGRREER-----GRDGDDRDRRDRREQGDRREERGRRDGGDRRGRRRRRDRRDARGDDN 243
Query: 138 YCGGKARIRTASLDRR 153
R R
Sbjct: 244 REDRGDRDGDDGEGRG 259
|
Length = 672 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 8e-04
Identities = 30/135 (22%), Positives = 41/135 (30%)
Query: 39 DRQSGSDRTSTRKDTHHSDSGDAKERRYNGEARSYQGNRDREPREYREPREFREPREFRE 98
+ S + R+ ++ R GE R R E R+ R R
Sbjct: 117 EAASAPEAAQARERRERGEAARRGAARKAGEGGEQPATEARADAAERTEEEERDERRRRG 176
Query: 99 PREYREPREPRGEDGDRYRGGLGGSRPPRGRGGRGGRGGYCGGKARIRTASLDRRPNVSG 158
RE R+ RGE G R G G R G G+ RR
Sbjct: 177 DREDRQAEAERGERGRREERGRDGDDRDRRDRREQGDRREERGRRDGGDRRGRRRRRDRR 236
Query: 159 GNPANDISGDWGDQN 173
+D D GD++
Sbjct: 237 DARGDDNREDRGDRD 251
|
Length = 672 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 59/242 (24%), Positives = 93/242 (38%), Gaps = 39/242 (16%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+V +K++D D F +MS + H H+ + V + +V E+ G +
Sbjct: 46 RVVLKVLDPSHRDIA--LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 326 FSHLLTIGQMAEKEASRL--------FRQILSAVAYCHANNVVHRDIKAENLLFDENG-- 375
L KE R+ +Q+ SA++Y N+VH ++ A+N+L G
Sbjct: 104 DVCL-------RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156
Query: 376 -----DIKLADFGFSNYFTPGHMLTTWCGSP-----PYAAPELFGGREYDGTKSDVWSLG 425
IKL+D PG T P+ APE G T +D WS G
Sbjct: 157 EGTSPFIKLSD--------PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFG 208
Query: 426 VVLY-VMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLT 484
L + ++P + K+R K R+P E LI L +P +R +
Sbjct: 209 TTLLEICFDGEVPLKERTPSE-KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFR 267
Query: 485 QI 486
I
Sbjct: 268 TI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 29/124 (23%), Positives = 46/124 (37%), Gaps = 4/124 (3%)
Query: 18 SGQGGGGGGGRGDYRGGKREFDRQSGSDRTST---RKDTHHSDSGDAKERRYNGEARSYQ 74
G G G+ R + RQ R S+ R+ + S+ + ++ + + Q
Sbjct: 445 RPVSRGRGRGQRGPRSQPQNQRRQQNRGRQSSQPPRQQQNRSNQNNQRQSQGPNQGPRGQ 504
Query: 75 GNRDREPREYREPREFREPREFREPREYREPREPRGEDGDRYRGGLG-GSRPPRGRGGRG 133
G + PR Y+ R P YR+ + R + G SR P G+G
Sbjct: 505 GGYNLRPRTYQPQRYGGGQGRRWNPNPYRQSGQGRSQQQQPQPEARGNQSRTPGPGRGQG 564
Query: 134 GRGG 137
GRG
Sbjct: 565 GRGN 568
|
Length = 582 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 29/108 (26%), Positives = 47/108 (43%), Gaps = 13/108 (12%)
Query: 335 MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHML 394
+ E+E + Q L A+ H K+ N+L D L G + TP
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQA------KSGNILL--TWDGLLKLDGSVAFKTP---- 61
Query: 395 TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
P + APE+ G+ Y K+D++SLG+ LY + +LP++
Sbjct: 62 EQSRPDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0983|consensus | 391 | 100.0 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG3653|consensus | 534 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| KOG1167|consensus | 418 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984|consensus | 282 | 99.96 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024|consensus | 563 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1345|consensus | 378 | 99.93 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1164|consensus | 322 | 99.92 | ||
| KOG0603|consensus | 612 | 99.92 | ||
| KOG1165|consensus | 449 | 99.91 | ||
| KOG1163|consensus | 341 | 99.91 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0606|consensus | 1205 | 99.84 | ||
| KOG1240|consensus | 1431 | 99.84 | ||
| KOG0195|consensus | 448 | 99.84 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG4158|consensus | 598 | 99.83 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG0590|consensus | 601 | 99.78 | ||
| KOG1033|consensus | 516 | 99.77 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG1166|consensus | 974 | 99.74 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG1023|consensus | 484 | 99.7 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0601|consensus | 524 | 99.54 | ||
| KOG0606|consensus | 1205 | 99.48 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG0601|consensus | 524 | 99.38 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG1243|consensus | 690 | 99.35 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG1266|consensus | 458 | 99.32 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| KOG3087|consensus | 229 | 98.98 | ||
| KOG3741|consensus | 655 | 98.95 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| KOG2137|consensus | 700 | 98.87 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| KOG0576|consensus | 829 | 98.48 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| KOG1035|consensus | 1351 | 98.37 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.06 | |
| KOG2945|consensus | 365 | 97.94 | ||
| KOG1235|consensus | 538 | 97.91 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| KOG1826|consensus | 2724 | 97.83 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.73 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| KOG2268|consensus | 465 | 97.49 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.1 | |
| KOG1093|consensus | 725 | 97.0 | ||
| KOG2270|consensus | 520 | 96.8 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.79 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.5 | |
| PLN02236 | 344 | choline kinase | 96.15 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.08 | |
| PF04774 | 106 | HABP4_PAI-RBP1: Hyaluronan / mRNA binding family; | 96.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.87 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.5 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.25 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.16 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.97 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.43 | |
| KOG3973|consensus | 465 | 94.36 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.77 | |
| KOG1236|consensus | 565 | 92.91 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.18 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.5 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=464.82 Aligned_cols=256 Identities=30% Similarity=0.572 Sum_probs=242.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+|..-+.||+|+|+.||++.+ +..++.||+|++.+..+ .....+++.+||+|.+.|+|||||+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~--------------~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f 83 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARD--------------LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQF 83 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEE--------------cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEee
Confidence 6788889999999999999987 46778999999988665 45677899999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|++.+++|||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+.+|||||||..||||+++.+|||+|||
T Consensus 84 ~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 84 YHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 384 FSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 384 la~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
||..+.. ++...+.||||.|.|||++....+. ..+||||+|||||.||.|++||+..+..+.+.+|....+.+|..+|
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLS 242 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccC
Confidence 9999874 4778899999999999999988775 9999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++++||.+||+.||.+|||+++||.|+||...
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 999999999999999999999999999999544
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=453.53 Aligned_cols=258 Identities=33% Similarity=0.588 Sum_probs=231.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-----HHHHHHHHHHHHHhhCCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-----RNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-----~~~~~~~~Ei~iL~~L~H 297 (635)
..+.|.+.+.||+|+||.|-+|..+ .++..||||++++..... .....+.+|++||++|+|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~--------------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H 235 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK--------------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH 235 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc--------------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC
Confidence 4566777899999999999999873 467899999998765432 123446799999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC---
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN--- 374 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~--- 374 (635)
||||+++++|+..+..|+||||++||+|++.+...+.+.+...+.+++||+.||.|||+.||+||||||+||||..+
T Consensus 236 P~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 236 PNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred CCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCC--cCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGRE--YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV-LKQRIL 451 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~--~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~-l~~~i~ 451 (635)
..+||+|||+|........+.+.||||.|.|||++.+.. ++..++||||||||||.+|+|.+||....... +.+.|.
T Consensus 316 ~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred eEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 789999999999998889999999999999999997543 44468999999999999999999998766555 899999
Q ss_pred hCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 FGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+.+.+-. .+|+++.+||.+||..||++|||++|+|+||||+.
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99887642 48999999999999999999999999999999974
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-52 Score=448.91 Aligned_cols=259 Identities=43% Similarity=0.745 Sum_probs=244.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccc-ccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKK-RLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+|.+-+.||.|+.|.|-+|. ..++|+.+|||++.+. ...+.....+.+||.||+.|.||||++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlak--------------h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~ 76 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAK--------------HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLR 76 (786)
T ss_pred ccceeccccccCCCCceehhhh--------------cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeee
Confidence 4556666889999999998554 4678899999999887 445556678899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
||++|+...++|||.||+++|.|+++|..+++|++.++.+++.||+.||.|+|..+|+||||||+|+||+..++|||+||
T Consensus 77 LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 77 LYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
|+|..-.++..+.+.||+|.|.|||++.|.+|++.++||||.|||||.||+|.+||++.+...++.++..+.|.+|..+|
T Consensus 157 GMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is 236 (786)
T KOG0588|consen 157 GMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNIS 236 (786)
T ss_pred ceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCC
Confidence 99999889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.++++||.+||..||++|+|.+||++|||+....
T Consensus 237 ~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 237 SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999999999998643
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=423.42 Aligned_cols=259 Identities=33% Similarity=0.619 Sum_probs=240.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.+.++||.|+|++||+|..+ +++..||||.+.+..+.....+.+..|+.+|+.|+|||||.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~--------------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~ 73 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHK--------------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVR 73 (429)
T ss_pred ccccceehhhccCcceEEEEEeEec--------------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceee
Confidence 4567888899999999999999884 34578999999999888888899999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC------CC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN------GD 376 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~------~~ 376 (635)
|++++++.+.+|||||||.||+|.+||.+.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.
T Consensus 74 l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 74 LLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred EEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCce
Confidence 999999999999999999999999999999999999999999999999999999999999999999999865 46
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
+||+|||+|+.+.+.....+.||++.|||||++....|+ .|+|+||+|+|||+|++|+.||+..+..+++..+..+...
T Consensus 154 LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~ 232 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI 232 (429)
T ss_pred EEecccchhhhCCchhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence 999999999999999999999999999999999999997 9999999999999999999999999999999988877654
Q ss_pred C---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 457 I---PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 457 ~---p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. +..++..+.+|+...|..+|.+|.++.+-+.|+++....
T Consensus 233 ~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 3 345788888999999999999999999999999997554
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=422.63 Aligned_cols=258 Identities=35% Similarity=0.604 Sum_probs=237.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.....|.+++.||+|+||.||.+..+ ++++.+|+|++++..+.+ ...+....|..||..++||.|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~--------------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFi 87 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKK--------------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFI 87 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEc--------------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcE
Confidence 34556777999999999999988774 356789999999887644 467889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
|+|+..|++.+.+|||+||+.||+|+.+|++.+.|+|..+.-++..|+.||.|||++|||||||||+||||+.+|+|+|+
T Consensus 88 v~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 88 VKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred eeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-cCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 381 DFGFSNYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 381 DFGla~~~-~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
|||||... ..+....++|||+.|||||++.+..|+ .++|.||||+++|||++|.+||.+.+...+.++|..++ ...|
T Consensus 168 DFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p 246 (357)
T KOG0598|consen 168 DFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP 246 (357)
T ss_pred ccccchhcccCCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC
Confidence 99999854 445667788999999999999999997 99999999999999999999999999999999999998 5556
Q ss_pred CCCCHHHHHHHHHhcccCCCCCC----CHHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRL----TLTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rp----s~~eiL~Hpw~~~ 494 (635)
..++.++++||+++|+.||.+|. ++.+|-+||||..
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 66999999999999999999996 7999999999974
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=420.50 Aligned_cols=254 Identities=26% Similarity=0.490 Sum_probs=230.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
....++.||+|..|+||++.++ .++..+|+|++.. ..++...+++.+|++||+.++||+||.+|+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk--------------~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~yg 144 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHK--------------PTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYG 144 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEc--------------CCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence 3344789999999999999884 3456899999943 446777889999999999999999999999
Q ss_pred EEecCC-eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTN-NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
.|..+. .++|+||||++|+|.+++...++++|..+..|+.+|++||.|||+ .+||||||||+||||+..|.|||||||
T Consensus 145 aF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 145 AFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 999998 599999999999999999999999999999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC-ccCC
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-----NLAVLKQRILFG-KFRI 457 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-----~~~~l~~~i~~~-~~~~ 457 (635)
.+..+... ...+++||..|||||.+.+..|. .++||||||++|+||.+|+.||... +..+++..|..+ ...+
T Consensus 225 VS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l 302 (364)
T KOG0581|consen 225 VSGILVNS-IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL 302 (364)
T ss_pred ccHHhhhh-hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC
Confidence 99988766 67889999999999999999987 9999999999999999999999774 677888888885 4567
Q ss_pred CCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 458 PFY-MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 458 p~~-~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
|.. +|+++.+||..||++||.+|||+.|+|+|||+....
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 775 999999999999999999999999999999998654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-51 Score=432.92 Aligned_cols=258 Identities=31% Similarity=0.557 Sum_probs=236.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
.....|...+.||+|+|++|++|..+ +.+..|||||+.+..+ .+...+.+.+|-.+|.+| .||.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~--------------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPg 135 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREK--------------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPG 135 (604)
T ss_pred CChhhcchhheeccccceeEEEeeec--------------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCC
Confidence 34455666789999999999999873 4667899999988766 344556778899999999 7999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|++||..|.++..+|+|+||+++|+|+++|.+.+.|++..++.++.+|+.||+|||++|||||||||+||||+.++++||
T Consensus 136 ivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 136 IVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred eEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCc--------------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 380 ADFGFSNYFTPGHM--------------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 380 ~DFGla~~~~~~~~--------------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
+|||.|..+.+... ..+++||..|++||++...... ..+|||+||||||.|+.|.+||.+.+...
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 99999988753211 1568999999999999988775 99999999999999999999999999999
Q ss_pred HHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 446 LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 446 l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
++++|+.-.+.+|..+++.+.+||+++|..||.+|+|+.||.+||||..
T Consensus 295 iFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 295 IFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999999999999999999974
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=436.41 Aligned_cols=260 Identities=43% Similarity=0.770 Sum_probs=241.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---HHHHHHHHHHHHHHhhCC-C
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHLD-H 297 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---~~~~~~~~~Ei~iL~~L~-H 297 (635)
...+.|.+.+.||+|+||.|+.+... .++..||||++++.... ....+.+.+|+.+|+.+. |
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~--------------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~H 79 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHR--------------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSH 79 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeec--------------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccC
Confidence 45678999999999999999999873 34578999998875322 123456778999999999 9
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-CC
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-GD 376 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-~~ 376 (635)
|||+++++++.....+|+|||||.||+|++++...+++.|.++..+++||+.||+|||+.||+||||||+||||+.+ ++
T Consensus 80 pnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 80 PNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred CCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999 99
Q ss_pred eeeecccccccc-cCCCccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 377 IKLADFGFSNYF-TPGHMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 377 ikL~DFGla~~~-~~~~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
+||+|||++... .......+.|||+.|+|||++.+.. |.+.++||||+|||||.|++|..||+..+...++.+|..+.
T Consensus 160 ~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 160 LKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred EEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 999999999988 5677889999999999999999988 99999999999999999999999999999999999999999
Q ss_pred cCCCCCC-CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 FRIPFYM-SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ~~~p~~~-s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+.+|.++ |.++++||.+||..||.+|+|+.+|+.||||+..
T Consensus 240 ~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 240 FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999 9999999999999999999999999999999863
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=399.82 Aligned_cols=268 Identities=31% Similarity=0.581 Sum_probs=244.8
Q ss_pred cchhhhhhccCC-cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHH
Q psy6357 210 ITLDEWKASRGT-KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFR 287 (635)
Q Consensus 210 ~tl~e~~~~~~~-~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~ 287 (635)
.....|...... .....|.+++.||.|+||.|-++..+ .++..+|+|++++... .-...+...+
T Consensus 28 ~~~~~~~~~~~~~~~l~dfe~~~tlGtGSFGrV~LVr~k--------------~~g~yYAmKvL~k~~vVklKQveH~~n 93 (355)
T KOG0616|consen 28 DFPKKWANTPQNPYSLQDFERLKTLGTGSFGRVHLVREK--------------HSGNYYAMKVLDKQKVVKLKQVEHTHN 93 (355)
T ss_pred hhhhhhcCCCCCCcchhhhhheeeeccCccceEEEEEEc--------------cCCceeehhhcCHHHHHHHHHHHHHhh
Confidence 334445544333 56778889999999999999988774 4567899999988765 4466778889
Q ss_pred HHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 288 Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
|..+|+.+.||.+++|++.|.+...+|+||||++||.|+.+|.+.++|++..++.++.||+.||+|||+++|++|||||+
T Consensus 94 Ek~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPE 173 (355)
T KOG0616|consen 94 EKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPE 173 (355)
T ss_pred HHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
||||+.+|.+||+|||+|...... ..+.||||.|+|||++....|. .++|.|||||++|||+.|.+||...+...++
T Consensus 174 NiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 174 NLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred HeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 999999999999999999987643 7789999999999999999987 9999999999999999999999999999999
Q ss_pred HHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 448 QRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 448 ~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
++|..+++.+|.+++.++++||+++|+.|-.+|. ...+|..||||..
T Consensus 251 ~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 251 EKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999999999999999999999999993 5689999999973
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=426.27 Aligned_cols=260 Identities=29% Similarity=0.416 Sum_probs=230.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI 300 (635)
.+..+|.++++||.|+||.||+|.. .+.+..||||.+++.....++... +||++.|++|+ ||||
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~--------------~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpni 71 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKS--------------KETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNI 71 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeee--------------cCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcc
Confidence 4567899999999999999998876 456778999999988776555433 59999999998 9999
Q ss_pred eeEEEEEecCC-eEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 301 IKLFQVMETTN-NLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 301 v~l~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
|+|.+++.+.+ .+|+|||||+ ..|+++++.+. .|++..+..|+.||++||+|+|.+|++||||||+|||+.....||
T Consensus 72 ikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 72 IKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred hhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeE
Confidence 99999998877 9999999994 78999997764 599999999999999999999999999999999999999899999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF------ 452 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~------ 452 (635)
|+|||+|+.+......+.++.|.||+|||++....+++.++|||++|||++|+.+-++.|++.+..+...+|+.
T Consensus 151 iaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 151 IADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred ecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 99999999999888899999999999999999888888999999999999999999999999887776666652
Q ss_pred -------------CccCCCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 453 -------------GKFRIPF-----------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 453 -------------~~~~~p~-----------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
-.+.+|. .++.++.+||.+||.|||.+||||.|+|+||||+....
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1233332 37899999999999999999999999999999986543
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=401.38 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=222.9
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|..+.++|+|+||+||++.. .++|+-||||++.....++...+-.++||++|++|+|+|+|.|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrn--------------k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLi 67 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRN--------------KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLI 67 (396)
T ss_pred cHHhhhhccccCcceEEEEecc--------------CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHH
Confidence 4688899999999999999877 35678999999987766677777788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++|.....++||+|||+.. +.+.|... ..+++..+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||
T Consensus 68 EVFrrkrklhLVFE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 68 EVFRRKRKLHLVFEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred HHHHhcceeEEEeeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccch
Confidence 9999999999999999754 44445544 459999999999999999999999999999999999999999999999999
Q ss_pred cccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6357 384 FSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 384 la~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--------- 453 (635)
+|+.+. ++...+.++.|.||+|||.+.+...++..+||||+||++.||++|.+.|++.+..+....|...
T Consensus 147 FAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 147 FARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred hhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 999987 7888899999999999999999777789999999999999999999999998876665555421
Q ss_pred ----------ccCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 ----------KFRIPF------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ----------~~~~p~------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
...+|. .++.-+.+|+++||..||.+|++.+|+|.|+||.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 112221 2567899999999999999999999999999994
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=403.86 Aligned_cols=260 Identities=29% Similarity=0.466 Sum_probs=227.5
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
......|..+++||+|+||.||++.+ +.++..||+|.+......+....-..+||.||++|+||||
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~--------------~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNI 178 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARD--------------LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNI 178 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeee--------------cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcc
Confidence 34566788899999999999999987 4667789999999888777777788899999999999999
Q ss_pred eeEEEEEecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 301 IKLFQVMETT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 301 v~l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++|.++.... ..+|||+|||+ -+|.-++... -+|++.+++.|++||+.||+|||++||+|||||.+||||+.+|.+
T Consensus 179 ikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~L 257 (560)
T KOG0600|consen 179 IKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVL 257 (560)
T ss_pred cceeeEEEecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCE
Confidence 9999998766 68999999996 4666666553 379999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 378 KLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 378 kL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
||+|||||+++.... .++..+.|+||+|||++.|..-++.++|+||+||||.||+.|++.|.+.+..+...+|...
T Consensus 258 KiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG 337 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG 337 (560)
T ss_pred EeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence 999999999876543 5778889999999999999988889999999999999999999999999988777777531
Q ss_pred --------ccCCCC-------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 --------KFRIPF-------------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 --------~~~~p~-------------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+|. .++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 112331 267889999999999999999999999999999543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=402.99 Aligned_cols=264 Identities=33% Similarity=0.573 Sum_probs=230.5
Q ss_pred ccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH------------HHHHH
Q psy6357 218 SRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER------------NLRKL 285 (635)
Q Consensus 218 ~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~------------~~~~~ 285 (635)
..+.+.++.|.+++.||+|.||.|-+|++... +..||||++.+..+... .++++
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~--------------~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv 155 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVD--------------GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKV 155 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCC--------------CcEEEEEeechhhhhhhcccccccccccCcHHHH
Confidence 34456788999999999999999999988544 46899999987543221 24688
Q ss_pred HHHHHHHhhCCCCceeeEEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeec
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRD 363 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrD 363 (635)
.+||.||++|.|||||+|+++..+ .+.+|||+|||..|.+...-.....|++.+++.|+++++.||+|||.+||||||
T Consensus 156 ~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD 235 (576)
T KOG0585|consen 156 RREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD 235 (576)
T ss_pred HHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 999999999999999999999865 467999999999988755333333399999999999999999999999999999
Q ss_pred ccCcceeecCCCCeeeecccccccccC------CCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhC
Q psy6357 364 IKAENLLFDENGDIKLADFGFSNYFTP------GHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTA 434 (635)
Q Consensus 364 LKp~NILl~~~~~ikL~DFGla~~~~~------~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG 434 (635)
|||+|+||+.+|++||+|||.+..+.. ...+...+|||.|+|||+..+ ..+.+.+.|||||||+||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 999999999999999999999987622 233455789999999999987 56778999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCccCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 435 QLPFDGPNLAVLKQRILFGKFRIPFY--MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 435 ~~PF~~~~~~~l~~~i~~~~~~~p~~--~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
++||-+....+++.+|....+.+|.. +.+++++||.+||.+||++|+++.+|..|||+...
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 99999999999999999999888875 79999999999999999999999999999999765
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=405.57 Aligned_cols=298 Identities=39% Similarity=0.649 Sum_probs=263.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.+..=|.+-+.||.|-|..|- +++..-+|++||||++++..++.-....+++|+..|+.++|||||
T Consensus 15 kIAGLYDLekTlG~GHFAVVK--------------LArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiV 80 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVK--------------LARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIV 80 (864)
T ss_pred ceeeeehhhhhhcCCceehhh--------------hhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCee
Confidence 344556667789999999887 445567889999999999999888888999999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec-CCCCeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD-ENGDIKL 379 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~-~~~~ikL 379 (635)
+||++......+|||+|+-++|+|++||.+.. .+.|+.+.+++.||+.|+.|+|+..+|||||||+||++- +-|.+||
T Consensus 81 RLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 81 RLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred eeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEe
Confidence 99999999999999999999999999998764 599999999999999999999999999999999998875 5689999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
.|||++..+.++..+.+.||++.|.|||++.+..|+..++||||||||||.|++|++||...+..+....|+..+|.+|.
T Consensus 161 TDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred eeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCCCCCcccCCCCCCCCCC---ChHHHHHHhcCccchhhhhhh
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLP---NSFVIDQMLQLPALTRNRILE 534 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~ 534 (635)
.+|.++++||..||..||++|.+.++|..|+|++...+.+... -|......++ ..+++++|+.-.-...+.|++
T Consensus 241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~-iPLvsr~~L~ee~Ha~IIq~Mv~G~IAs~e~Il~ 317 (864)
T KOG4717|consen 241 HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA-IPLVSRHHLPEEAHATIIQQMVAGAIASEEDILR 317 (864)
T ss_pred hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc-CceeehhhCChHHHHHHHHHHhcccccCHHHHHH
Confidence 9999999999999999999999999999999998765444332 2333333333 456788887644445555654
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=410.00 Aligned_cols=255 Identities=35% Similarity=0.606 Sum_probs=239.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|.+.+.||+|+||.||+|.-+ .+...||||.+.+....+.+++.+.+|++|++.|+|||||.++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK--------------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~ 67 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK--------------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEML 67 (808)
T ss_pred cchhHHHHhcCCccceeeecccc--------------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHH
Confidence 46888999999999999999763 3456899999999888888999999999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++|+...++|+|+|||.| +|+.+|...+.++|+.+..|+.+++.||.|||+.+|+|||+||.||||...+.+||||||+
T Consensus 68 esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 68 ESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred HhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhh
Confidence 999999999999999976 9999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCH
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSA 463 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~ 463 (635)
|+..... .......|||.|||||++.+.+|+ ..+|+||||||+|||+.|++||...+...+...|.......|...|.
T Consensus 147 Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~ 225 (808)
T KOG0597|consen 147 ARAMSTNTSVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASS 225 (808)
T ss_pred hhhcccCceeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccH
Confidence 9987654 456667899999999999999997 99999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.||+.+|.+||.+|.|+.+++.|||++..
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999999999999753
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=391.84 Aligned_cols=247 Identities=30% Similarity=0.513 Sum_probs=223.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.....|+++++||.|+||+||++... .++..||.|.+....++......+..|+.+|++|+|||||
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~--------------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIV 81 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCL--------------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIV 81 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeec--------------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHH
Confidence 33456788999999999999999873 4556799999998888888889999999999999999999
Q ss_pred eEEE-EEecCCe-EEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhcc--Cc--eeeecccCcceee
Q psy6357 302 KLFQ-VMETTNN-LYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHA--NN--VVHRDIKAENLLF 371 (635)
Q Consensus 302 ~l~~-~~~~~~~-~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs--~g--IiHrDLKp~NILl 371 (635)
++++ .|..+.. ++||||||.+|+|...++.. +.++|..+|+++.||+.||.++|+ .. |+||||||.||+|
T Consensus 82 qYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl 161 (375)
T KOG0591|consen 82 QYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL 161 (375)
T ss_pred HHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE
Confidence 9998 4544444 89999999999999988654 459999999999999999999999 44 9999999999999
Q ss_pred cCCCCeeeecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
+.+|.+||+||||++.+.... ...+++|||.||+||++....|+ .++||||+||++|||+.-.+||.+.+...+..+|
T Consensus 162 ~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 162 TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 999999999999999887543 45678999999999999999997 9999999999999999999999999999999999
Q ss_pred HhCccC-CC-CCCCHHHHHHHHHhcccCCCCCCCH
Q psy6357 451 LFGKFR-IP-FYMSAECENLIRSMLVLDPAKRLTL 483 (635)
Q Consensus 451 ~~~~~~-~p-~~~s~~l~~LI~~~L~~dP~~Rps~ 483 (635)
..+.++ +| ..+|.++..||..|+..||..||+.
T Consensus 241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999885 77 6899999999999999999999985
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=408.95 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=232.7
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
-....+.|.++..||+|+||.||++..+ .+|..+|+|++++..+ ....++.+..|-.||...+++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk--------------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~ 201 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKK--------------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSP 201 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEc--------------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCC
Confidence 3445788999999999999999988763 4678999999998765 456778889999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
+||+||..|++.+++||||||++||++..+|.+.+.|++.++..++.+++.|++.||..|||||||||+|+||+..|++|
T Consensus 202 ~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 202 WVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred cEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccccccccC----------------------CC--------------------------ccccccCCCCCCCccccC
Q psy6357 379 LADFGFSNYFTP----------------------GH--------------------------MLTTWCGSPPYAAPELFG 410 (635)
Q Consensus 379 L~DFGla~~~~~----------------------~~--------------------------~~~~~~gt~~Y~APEvl~ 410 (635)
|+|||||.-+.. .. .....+|||.||||||+.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 999999853311 00 012368999999999999
Q ss_pred CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--cCCCC--CCCHHHHHHHHHhcccCCCCCCC---H
Q psy6357 411 GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--FRIPF--YMSAECENLIRSMLVLDPAKRLT---L 483 (635)
Q Consensus 411 ~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--~~~p~--~~s~~l~~LI~~~L~~dP~~Rps---~ 483 (635)
+..|. ..+|+|||||||||||.|.+||...+..+.+.+|...+ +.+|. .++.+++|||.+||. ||++|.. +
T Consensus 362 ~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 362 GKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred cCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 99986 99999999999999999999999999999999998775 55664 588999999999999 9999985 9
Q ss_pred HHHHcCcccccC
Q psy6357 484 TQISNHKWMSVH 495 (635)
Q Consensus 484 ~eiL~Hpw~~~~ 495 (635)
+||.+||||..-
T Consensus 440 ~EIK~HPfF~~v 451 (550)
T KOG0605|consen 440 EEIKKHPFFKGV 451 (550)
T ss_pred HHHhcCCccccC
Confidence 999999999853
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=382.41 Aligned_cols=259 Identities=33% Similarity=0.578 Sum_probs=238.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.+...|.+-+.||+|.|+.||.... ..++..+|+|+++...+.....+.+.+|+.|-+.|+|||||
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~--------------~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~Iv 73 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVH--------------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 73 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHh--------------ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEe
Confidence 3446677788999999999997765 34667899999998888877889999999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---CCCee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---NGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~~~ik 378 (635)
+|.+.+......|||+|+|.|++|..-|....-++|..+..+++||+++|.|+|.++|||||+||+|+||.. ..-+|
T Consensus 74 rL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 74 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred ehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCcee
Confidence 999999999999999999999999888877778999999999999999999999999999999999999964 34699
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
|+|||+|..+..+......+|||.|||||++...+|. ..+|||+.|||||.||.|.+||.+.+...+++.|..+.+.+|
T Consensus 154 L~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 154 LADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP 232 (355)
T ss_pred ecccceEEEeCCccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence 9999999998888888899999999999999999986 999999999999999999999999999999999999999887
Q ss_pred C----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 F----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. .+++++++||++||..||.+|+|+.|+|+|||+...
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 5 489999999999999999999999999999999643
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=397.97 Aligned_cols=258 Identities=42% Similarity=0.753 Sum_probs=243.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
....+|.+.++||+|+||.|-++.. ...++.||||.+++..+ ++.++-.+.+||+||..|+||||
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e--------------~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI 115 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYE--------------HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI 115 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhh--------------ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce
Confidence 3456899999999999999997765 34567899999998876 56778889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++|++|+..+.+.|||||..+|+|++|+...+.|++.++..|++||+.|+.|+|.++++|||||.+||||+.++++||+
T Consensus 116 I~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 116 IQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred eehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
||||+..+.....+.++||++.|.+||++.+.+|.+..+|-|||||+||.|+.|..||++.+...+...|..+.+.-|.
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~- 274 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE- 274 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999988776
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
-+.++.-||++||-.+|++|.|+.+|..|=|++-
T Consensus 275 ~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 275 TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 4667899999999999999999999999999863
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=377.48 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=223.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|..+++||+|.||.||+|.+ .++++.||||.++.....+..-..+.+||++|+.++|+||+.|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d--------------~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~Li 67 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARD--------------TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELI 67 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEe--------------cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhh
Confidence 4688899999999999999987 35678899999988776555556788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++|.+.+.+.||+|||+ .+|+..++... .|+..+++.++.++++||+|||++.|+||||||.|+||+.+|.+||+|||
T Consensus 68 D~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 68 DVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred hhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeeccc
Confidence 99999999999999995 67888776553 59999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--------
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-------- 454 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-------- 454 (635)
+|+.+.... .....+.|.||+|||++.|...++..+||||.|||+.||+.+.+-|.+.+.-+....|....
T Consensus 147 LAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 147 LARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred chhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 999886543 34445889999999999998888899999999999999999999999988776666665210
Q ss_pred ---cCCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 455 ---FRIP-----------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 455 ---~~~p-----------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
..+| ...+.++.+||.+||.+||.+|+|+.|+|+|+||.....
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 0111 125788999999999999999999999999999986433
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=393.63 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=221.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|..++.||.|+||.|+.+.+. .+++.||||.+.....+....++..+|+++|++++|+||+.++
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~--------------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~ 87 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDK--------------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLL 87 (359)
T ss_pred ceecccccccCcceeeEEEEEEc--------------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEE
Confidence 44455799999999999999884 4557899999987666778889999999999999999999999
Q ss_pred EEEec-----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 305 QVMET-----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 305 ~~~~~-----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++.. -..+|+|+|+| ..+|...|.....|++..+..+++||+.||+|+|+.+|+||||||.|||++.++.+||
T Consensus 88 di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 88 DIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred eecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence 99854 35699999999 5788888887777999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC---CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Q psy6357 380 ADFGFSNYFTP---GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF---- 452 (635)
Q Consensus 380 ~DFGla~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~---- 452 (635)
||||+|+.... ...++.++.|.||+|||++....-++.++||||+||||.|||+|++.|.+.+.....+.|..
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 99999998863 55678889999999999987665556999999999999999999999999875544444431
Q ss_pred -------------------CccCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 453 -------------------GKFRIP--------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 453 -------------------~~~~~p--------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.....| ...++.+.+|+.+||..||.+|+|++|+|+||||....
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 011111 14789999999999999999999999999999998744
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=412.96 Aligned_cols=258 Identities=28% Similarity=0.519 Sum_probs=238.4
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCC-CC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLD-HP 298 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~-Hp 298 (635)
......|..++.||+|.||.|+++.++ .+++.+|||++++..+ ..++++.++.|..|+.... ||
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k--------------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HP 429 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELK--------------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHP 429 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEc--------------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCC
Confidence 456677888999999999999999884 3456899999998775 5677889999999999885 99
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
.++.|+..|++.+++|+||||+.||+ ..+++..+.|++..+..++..|+.||+|||++||||||||.+|||||.+|++|
T Consensus 430 FL~~L~~~fQT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 430 FLVNLFSCFQTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred eEeecccccccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEE
Confidence 99999999999999999999999999 44556668899999999999999999999999999999999999999999999
Q ss_pred eeccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 379 LADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 379 L~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
|+|||+++..- .+....++||||.|||||++.+..|+ .++|.|||||+|||||.|+.||.+.+.++++..|......+
T Consensus 509 iADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y 587 (694)
T KOG0694|consen 509 IADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY 587 (694)
T ss_pred ecccccccccCCCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 99999998754 66788999999999999999999997 99999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
|..+|.++.++|+++|.++|++|.. +++|..||||..
T Consensus 588 P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 588 PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999999999999999985 589999999974
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=409.72 Aligned_cols=256 Identities=27% Similarity=0.504 Sum_probs=228.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|....+||+|+.|.||.+... ..+..||||.++....... +-+++|+.+|+.++|+|||.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~--------------~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnf 335 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKI--------------STKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNF 335 (550)
T ss_pred hhhhcchhhhccccccceeeeeec--------------cCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHH
Confidence 356777899999999999988763 4456799999988765433 568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.|...+.+|+|||||+||+|.+.+.. ..++|.++..|++.++.||+|||..||+|||||.+|||++.+|.+||+|||
T Consensus 336 l~Sylv~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFG 414 (550)
T KOG0578|consen 336 LDSYLVGDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFG 414 (550)
T ss_pred HHHhcccceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeee
Confidence 9999988999999999999999887766 459999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIPF 459 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p~ 459 (635)
+|..+.... ...+.+|||+|||||++....|. .++||||||++++||+.|++||-..+.......|... .+..|.
T Consensus 415 Fcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~ 493 (550)
T KOG0578|consen 415 FCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPE 493 (550)
T ss_pred eeeccccccCccccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcc
Confidence 999887654 67889999999999999999986 9999999999999999999999887766666666544 455677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+|.++++||.+||+.|+.+|+++.|||+||||...++
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 89999999999999999999999999999999976554
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.99 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=216.9
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
+...+.||+|+||+||++.+. +++...|||.+...... ..+.+.+|+.+|.+|+|||||++++.
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~--------------~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~ 82 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNK--------------KTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGS 82 (313)
T ss_pred hhhhccccCccceEEEEEEec--------------CCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCc
Confidence 344678999999999999883 33678999999876322 26778999999999999999999997
Q ss_pred EecCC--eEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeeecc
Q psy6357 307 METTN--NLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLADF 382 (635)
Q Consensus 307 ~~~~~--~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~DF 382 (635)
..... .++|+|||+++|+|.+++.+.+ .|++..+..+++||++||.|||++|||||||||+||||+. ++.+||+||
T Consensus 83 ~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 83 SSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred cccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccC
Confidence 54444 6899999999999999999887 7999999999999999999999999999999999999999 799999999
Q ss_pred cccccccC----CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCc--c
Q psy6357 383 GFSNYFTP----GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG-PNLAVLKQRILFGK--F 455 (635)
Q Consensus 383 Gla~~~~~----~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~-~~~~~l~~~i~~~~--~ 455 (635)
|++..... ........||+.|||||++........++|||||||++.||+||..||.. .......-.+.... .
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 99987663 23345688999999999998633333599999999999999999999987 34444444444443 5
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+|..+|.++++||.+||.+||++||||.++|+|||+.....
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 678899999999999999999999999999999999976543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=394.93 Aligned_cols=255 Identities=27% Similarity=0.519 Sum_probs=230.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....|.+++.||.|+||.||++.+. .++..||||++.+... .......+.+|+.+|++++||||+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 81 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHK--------------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCC
Confidence 3567888999999999999999873 3456899999976533 234456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++...+.+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred cEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+..+.+.+|..+
T Consensus 162 fg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~ 238 (329)
T PTZ00263 162 FGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238 (329)
T ss_pred ccCceEcCCC--cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCC
Confidence 9999876432 2356899999999999888875 899999999999999999999999888888888988888899999
Q ss_pred CHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+..+.+||.+||+.||.+|++ +++|++||||..
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999999999999997 799999999974
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=392.96 Aligned_cols=249 Identities=32% Similarity=0.546 Sum_probs=224.6
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+.||+|+||.||++... .++..||||++.+... .......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 66 (323)
T cd05571 1 KLLGKGTFGKVILVREK--------------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT 66 (323)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc
Confidence 36899999999998763 3457899999976543 34455678899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+.+||||||+.+++|.+++.....+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||+|||++....
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 67 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987542
Q ss_pred -CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHH
Q psy6357 390 -PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468 (635)
Q Consensus 390 -~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~L 468 (635)
........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+|
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l 225 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 23344567899999999999888876 8999999999999999999999999888888888888888999999999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 469 IRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 469 I~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
|.+||..||++|| ++.+|++||||..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.33 Aligned_cols=242 Identities=28% Similarity=0.515 Sum_probs=216.3
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCce-EEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSK-VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~-VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 308 (635)
...||.|+||+||+|.|. ++. ||||++.....+....+.+.+|+.+|.+|+|||||+|++++.
T Consensus 46 ~~~iG~G~~g~V~~~~~~----------------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR----------------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred hhhcccCCceeEEEEEeC----------------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 345999999999999993 345 999999887766665789999999999999999999999998
Q ss_pred cCC-eEEEEEeccccchhhhhhhh--cccCCHHHHHHHHHHHHHhhhhhccCc-eeeecccCcceeecCCC-Ceeeeccc
Q psy6357 309 TTN-NLYLVTEYARGGEIFSHLLT--IGQMAEKEASRLFRQILSAVAYCHANN-VVHRDIKAENLLFDENG-DIKLADFG 383 (635)
Q Consensus 309 ~~~-~~~LV~E~~~ggsL~~~l~~--~~~l~e~~~~~i~~qIl~gL~~LHs~g-IiHrDLKp~NILl~~~~-~ikL~DFG 383 (635)
... .++|||||+++|+|.+++.. ...++...++.|+.||+.||.|||+.+ ||||||||+||||+.++ ++||||||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 887 79999999999999999988 578999999999999999999999999 99999999999999998 99999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccC--CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFG--GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIP 458 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~--~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p 458 (635)
+++..... .......||+.|||||++. ...|+ .++||||||++||||++|..||.+.....+...+... ...+|
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 99877654 3445578999999999999 55776 9999999999999999999999998876666666544 34567
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..+++.+..||..||..||.+||++.+|+.
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 779999999999999999999999999975
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=387.67 Aligned_cols=252 Identities=29% Similarity=0.533 Sum_probs=227.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||.|+||.||++.+. .++..||||++..... .......+.+|+.+|++++||||++++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 67 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDR--------------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEc--------------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhH
Confidence 5788999999999999999873 2456899999976433 233456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+|+||||+.+++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred hhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHH
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAE 464 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~ 464 (635)
+...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+.+.+......+|..++..
T Consensus 148 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (291)
T cd05612 148 AKKLRDR--TWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY 224 (291)
T ss_pred chhccCC--cccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHH
Confidence 9876432 2346799999999999888775 899999999999999999999999998888999998888899889999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 465 CENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+++||.+||+.||.+|++ ++++++||||..
T Consensus 225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999999999995 999999999963
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=401.65 Aligned_cols=263 Identities=54% Similarity=0.909 Sum_probs=251.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..+..|.++++||+|.|+.|.++...+ ++..||||++++...+...+..+.+|+++|+.|+|||||
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~--------------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIv 118 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHIL--------------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIV 118 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecC--------------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCccee
Confidence 456678889999999999999998744 456899999999999888888899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+|+.+.+....+|+||||+.+|.+++++.+.+++.+..+..++.|++.|++|||+++|||||||++||||+.+.++||+|
T Consensus 119 kl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 119 KLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred eeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
||++.++.......++||++.|.|||++.+..|++..+|+||+|++||.|++|.+||++.+...+....+.+++.+|.++
T Consensus 199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM 278 (596)
T ss_pred cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCCC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPG 498 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~~ 498 (635)
+.++++||+++|..+|.+|+++++|+.|.|+......
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999999999999865443
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=368.54 Aligned_cols=260 Identities=31% Similarity=0.513 Sum_probs=231.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc------CHHHHHHHHHHHHHHhhC-
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL------DERNLRKLFREVDIMSHL- 295 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~------~~~~~~~~~~Ei~iL~~L- 295 (635)
....|+--+.||.|..++|-.+..+ +.+..+|+|++..... ..+.++...+|+.||+++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k--------------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~ 80 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHK--------------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM 80 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhc--------------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc
Confidence 3456666788999999999866552 4567899999975432 123456667899999998
Q ss_pred CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 296 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
.||+|++|.++|+.+..+++|+|+|+.|.|+++|...-.++|....+|++||++|+.|||..+||||||||+|||++++.
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM 160 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc
Confidence 59999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
+|||+|||+|+.+.++..+...||||.|+|||.+. +.+-++..+|+|++|||||-||.|.+||.......+...|
T Consensus 161 ~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 99999999999999999999999999999999874 2333358999999999999999999999999888999999
Q ss_pred HhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 451 LFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 451 ~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+.+++.+-. .+|...++||.+||+.||.+|+|++|+|+||||.+..
T Consensus 241 meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 241 MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 999887753 4899999999999999999999999999999997543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=390.89 Aligned_cols=257 Identities=28% Similarity=0.531 Sum_probs=229.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
...+.|.++++||.|+||.||+|.+... ....||||++.+... .......+.+|+.+|+.++||||
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I 93 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNE-------------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECC-------------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCC
Confidence 3456788899999999999999986322 224799999976433 33455678899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.....+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 94 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999999988899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
|||++..... .....+||+.|+|||++.+..++ .++||||||||+|+|++|..||...+...+.+.+......+|..
T Consensus 174 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 250 (340)
T PTZ00426 174 DFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF 250 (340)
T ss_pred cCCCCeecCC--CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 9999986643 23456899999999999887775 89999999999999999999999998888888898888888999
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
++..+.+||++||+.||.+|+ ++++|++||||..
T Consensus 251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999995 8999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=384.06 Aligned_cols=247 Identities=31% Similarity=0.535 Sum_probs=222.4
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||+|+||.||++.+. .++..||||++.+... .......+.+|+.+|++++||||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~--------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 66 (312)
T cd05585 1 IGKGSFGKVMQVRKR--------------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE 66 (312)
T ss_pred CCcCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC
Confidence 799999999999873 3456899999976432 3445667889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC-
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP- 390 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~- 390 (635)
.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.....
T Consensus 67 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 67 KLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred eEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999999976432
Q ss_pred CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHH
Q psy6357 391 GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIR 470 (635)
Q Consensus 391 ~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~ 470 (635)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+||.
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 225 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLI 225 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2334456799999999999988876 899999999999999999999999988888888888888899999999999999
Q ss_pred HhcccCCCCCC---CHHHHHcCccccc
Q psy6357 471 SMLVLDPAKRL---TLTQISNHKWMSV 494 (635)
Q Consensus 471 ~~L~~dP~~Rp---s~~eiL~Hpw~~~ 494 (635)
+||..||.+|| ++.++|.||||..
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 99999999997 5899999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.85 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=222.5
Q ss_pred cCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC
Q psy6357 219 RGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 219 ~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
.+...+..|+.+.+|++|+||.||+|.++ .+++.||+|.++.+...+..--..++||.+|.+++||
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk--------------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~ 135 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDK--------------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHP 135 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccC--------------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCC
Confidence 34566778889999999999999999874 4557899999987653333334567999999999999
Q ss_pred ceeeEEEEEe--cCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 299 HIIKLFQVME--TTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 299 nIv~l~~~~~--~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|||.+-++.. .-+.+|||||||+ -+|..+|...+ +|...+++.++.|++.||+|||.+.|+|||||++|+|++..|
T Consensus 136 NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G 214 (419)
T KOG0663|consen 136 NIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG 214 (419)
T ss_pred CeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC
Confidence 9999999875 3457999999996 57888887765 799999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy6357 376 DIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG- 453 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~- 453 (635)
.+||+|||+|+.+... ..++..+.|.||+|||++.+..-+++++||||+|||+.||+++++.|.+....+...+|...
T Consensus 215 ~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 215 ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 9999999999988654 45677889999999999999877779999999999999999999999998877766666521
Q ss_pred ------------------ccCCC------------CC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ------------------KFRIP------------FY-MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ------------------~~~~p------------~~-~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+.++ .. +++...+|+..+|.+||.+|.||+|.|+|.||..
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 11111 11 5688999999999999999999999999999975
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=361.74 Aligned_cols=253 Identities=33% Similarity=0.594 Sum_probs=233.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+.+-+.||.|.||.||.|..+ +++--||+|++.+..+.. ....++.+|++|-..|+||||+++|+
T Consensus 24 feigr~LgkgkFG~vYlarek--------------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~ 89 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREK--------------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG 89 (281)
T ss_pred ccccccccCCccccEeEeeec--------------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence 344578999999999999874 345679999998876533 33457789999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhh--hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLL--TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~--~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+|.+...+||++||...|+|+..|. ...++++..++.++.|++.||.|+|.++||||||||+|+|++..+.+||+|||
T Consensus 90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 9999999999999999999999998 66789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCH
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSA 463 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~ 463 (635)
-+.... .....+.|||..|.+||+..+..++ ..+|+|++|++.||++.|.+||...+..+.+++|...++.+|..++.
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~ 247 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISG 247 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccCh
Confidence 997665 5677889999999999999999997 99999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
++.|||.+||.++|.+|.+..|++.|||+...
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 99999999999999999999999999999643
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=376.89 Aligned_cols=260 Identities=30% Similarity=0.470 Sum_probs=231.7
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~Hp 298 (635)
+.+.+..+.++++||.|.-|+||++.... ....+|+|++.+..+. ...+.+++.|-+||+.++||
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~--------------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHP 137 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG--------------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHP 137 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecC--------------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCC
Confidence 45566778889999999999999998742 3368999999988764 56677888999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
.++.||..|+.+...|||||||+||+|..++++. +.|++..++.++..++.||+|||-.|||+|||||+||||.++|+
T Consensus 138 FlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH 217 (459)
T KOG0610|consen 138 FLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH 217 (459)
T ss_pred ccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc
Confidence 9999999999999999999999999999988776 45999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccC-----------------------------------C----------------------CccccccC
Q psy6357 377 IKLADFGFSNYFTP-----------------------------------G----------------------HMLTTWCG 399 (635)
Q Consensus 377 ikL~DFGla~~~~~-----------------------------------~----------------------~~~~~~~g 399 (635)
|.|+||.|+..... . .....++|
T Consensus 218 IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVG 297 (459)
T KOG0610|consen 218 IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVG 297 (459)
T ss_pred EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccc
Confidence 99999998643210 0 01224679
Q ss_pred CCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC--CCCHHHHHHHHHhcccCC
Q psy6357 400 SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDP 477 (635)
Q Consensus 400 t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~--~~s~~l~~LI~~~L~~dP 477 (635)
|-.|+|||++.+.... .++|+|+|||+|||||.|..||.+.+..+.+..|......+|. .++..++|||+++|.+||
T Consensus 298 ThEYlAPEvI~G~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 298 THEYLAPEVIRGEGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred ccccccceeeecCCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999886 9999999999999999999999999999999999998888886 478999999999999999
Q ss_pred CCCCC----HHHHHcCccccc
Q psy6357 478 AKRLT----LTQISNHKWMSV 494 (635)
Q Consensus 478 ~~Rps----~~eiL~Hpw~~~ 494 (635)
.+|.. +.||.+||||..
T Consensus 377 ~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred hhhhccccchHHhhcCccccC
Confidence 99998 999999999974
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=390.97 Aligned_cols=257 Identities=37% Similarity=0.651 Sum_probs=234.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCC-CCce
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLD-HPHI 300 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~-HpnI 300 (635)
....|.+.+.||.|.||.||++..+ .++..+|+|++.+.... ......+.+|+.||++|. ||||
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~--------------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpni 98 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK--------------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNI 98 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec--------------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCE
Confidence 3456777789999999999999873 34678999999887663 335678899999999998 9999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC----CC
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN----GD 376 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~----~~ 376 (635)
|+++++|++...++||||+|.||+|++.+... .+++..+..++.||+.++.|||+.||+||||||+|||+... +.
T Consensus 99 v~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 99 VQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCc
Confidence 99999999999999999999999999999887 59999999999999999999999999999999999999643 47
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
+|++|||++............+||+.|+|||++....|. ..+||||+||++|.|++|.+||.+.+.......|..+.+.
T Consensus 178 ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD 256 (382)
T ss_pred EEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence 999999999999887788999999999999999988886 9999999999999999999999999999999999999887
Q ss_pred CCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 IPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
++. .+|..+++||..||..||.+|+|+.++|+|||+...
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 653 479999999999999999999999999999999754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=382.62 Aligned_cols=249 Identities=32% Similarity=0.542 Sum_probs=223.3
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+.||+|+||.||++... .++..||+|++..... .......+.+|+.+|+.++||||++++++|..
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~ 66 (323)
T cd05595 1 KLLGKGTFGKVILVREK--------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 66 (323)
T ss_pred CeeeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 36899999999998863 3457899999976543 33455677899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
...+||||||+++++|..++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++....
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 67 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987642
Q ss_pred -CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHH
Q psy6357 390 -PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468 (635)
Q Consensus 390 -~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~L 468 (635)
........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..+++++.+|
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l 225 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 225 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 22334456799999999999888876 8999999999999999999999998888888888888888899999999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 469 IRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 469 I~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
|.+||..||.+|+ ++.++++|+||..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999998 8999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=386.02 Aligned_cols=249 Identities=31% Similarity=0.535 Sum_probs=223.3
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+.||+|+||.||++... .++..||||++.+... .......+.+|+.+|+.+.||||+++++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 66 (328)
T cd05593 1 KLLGKGTFGKVILVREK--------------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT 66 (328)
T ss_pred CeeeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence 36899999999998873 3457899999976543 34456778899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+.+||||||+++++|..++.....+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++....
T Consensus 67 ~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 67 KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987643
Q ss_pred C-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHH
Q psy6357 390 P-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468 (635)
Q Consensus 390 ~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~L 468 (635)
. .......+||+.|+|||++.+..++ .++|||||||+||+|++|..||...+...+...+......+|..++.++.+|
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l 225 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSL 225 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHH
Confidence 2 2334456899999999999888775 8999999999999999999999998888888888888888899999999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 469 IRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 469 I~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
|.+||..||.+|+ ++.+|++||||..
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999997 8999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.98 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=217.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|.+++.||+|+||.||++.+. .++..||||++.+.... ......+.+|+.+|.+++|+||+.+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~ 67 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR--------------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe--------------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 677899999999999999873 34568999999765432 223346778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++...+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 68 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999999998877543 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCccCCCC
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLKQRILFGKFRIPF 459 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~~~i~~~~~~~p~ 459 (635)
++.............||..|+|||++.+..++ .++|||||||++|+|++|..||..... ..+...+......++.
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 148 LAVQIPEGETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226 (285)
T ss_pred CcEEcCCCCeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc
Confidence 99876554445566899999999999988876 899999999999999999999987543 2333344444556677
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
.++.++.+||.+||+.||.+||+ ++++++||||..
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 78999999999999999999997 899999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=379.36 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=223.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+.|.+...||.|..++||+|++ +..++.||||+++.+..+.. ++.+.+|+..|+.++||||++
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c--------------~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~ 88 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARC--------------IPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVT 88 (516)
T ss_pred CccceeEEEEEeccceeEeeeeee--------------cccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcce
Confidence 467788899999999999999987 34557999999999887655 789999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++..|..+..+|+||.||.+|++++++...- .|.|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+
T Consensus 89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEc
Confidence 9999999999999999999999999997753 49999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CC----ccccccCCCCCCCcccc-CCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 381 DFGFSNYFTP-GH----MLTTWCGSPPYAAPELF-GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 381 DFGla~~~~~-~~----~~~~~~gt~~Y~APEvl-~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|||.+..+.. +. ...+++||++|||||++ ....-++.|+||||||++..||.+|..||.......+.-.-+.+.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 9998765532 21 12677999999999994 333333499999999999999999999998877655554444444
Q ss_pred cCCCC----------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 455 FRIPF----------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 455 ~~~p~----------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
++.+. .++..++++|..||++||.+|||++++|+|+||+....
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 43221 26778999999999999999999999999999986543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.53 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=211.9
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+++.++|+||++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK--------------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC--------------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchh
Confidence 36888999999999999999873 2456899999987654445557788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++...+.+|+||||+.++.|..+......+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred hhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 99999999999999999877765555556799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6357 385 SNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 385 a~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--------- 453 (635)
+....... ......||+.|+|||++.+..++ .++|||||||++|+|++|++||...+.......+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccccccccccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 98764322 23346789999999999888875 8999999999999999999999876644332222110
Q ss_pred ----------ccCCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ----------KFRIP-------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ----------~~~~p-------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
....| ..+|.++.+||.+||++||++|||++|+|+||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00111 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=386.81 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=218.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||+||++... .++..||||++.+... .......+.+|+.+|.+++|+||++++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~ 67 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKK--------------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788999999999999999763 3456899999976543 234456788899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+|||||||++++|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------------------------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHH
Q psy6357 385 SNYFTPGH------------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVL 428 (635)
Q Consensus 385 a~~~~~~~------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvil 428 (635)
+..+.... .....+||+.|+|||++.+..++ .++|||||||+|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil 226 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIM 226 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHH
Confidence 87543210 11345899999999999888876 899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhC--ccCCCC--CCCHHHHHHHHHhcccCCC---CCCCHHHHHcCccccc
Q psy6357 429 YVMVTAQLPFDGPNLAVLKQRILFG--KFRIPF--YMSAECENLIRSMLVLDPA---KRLTLTQISNHKWMSV 494 (635)
Q Consensus 429 yeLltG~~PF~~~~~~~l~~~i~~~--~~~~p~--~~s~~l~~LI~~~L~~dP~---~Rps~~eiL~Hpw~~~ 494 (635)
|+|++|..||.+.+.......+... ...+|. .++.++++||.+|+. +|. .||+++||++||||..
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 9999999999998888888877753 334443 478999999999875 454 4589999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=380.84 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=224.1
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIMSHLDHPHIIKLFQVM 307 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 307 (635)
+++||+|+||.||++...... ..+..||||++.+... .......+..|+.+|+.++||||++++++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~ 69 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA-----------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF 69 (323)
T ss_pred CceeeecCCeEEEEEEEcccC-----------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE
Confidence 468999999999998763321 3567899999976432 223345677899999999999999999999
Q ss_pred ecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..++.+|+||||+.+++|.+++...+.+.+..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++..
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 70 QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred ecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999875
Q ss_pred ccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHH
Q psy6357 388 FTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECE 466 (635)
Q Consensus 388 ~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~ 466 (635)
... .......+||+.|+|||++.+..++ .++|||||||+||+|++|..||...+.......+..+...+|..++.++.
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 432 2334456799999999999887775 89999999999999999999999988888888888888888999999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 467 NLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 467 ~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+||.+||..||++|| ++.++++||||..
T Consensus 229 ~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999999 8999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=382.89 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=222.9
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+.||+|+||.||++... .++..||||++.+... .......+..|+.+++.+.||||+++++++..
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~ 66 (325)
T cd05594 1 KLLGKGTFGKVILVKEK--------------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 66 (325)
T ss_pred CeeeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc
Confidence 36899999999998763 3457899999976543 33445677889999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
...+||||||+.+++|..++.....+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 67 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99999999999999999999888889999999999999999999997 79999999999999999999999999998754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||+||+|++|..||...+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 225 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 225 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 3 23334456799999999999888776 899999999999999999999999988888888888888889999999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
||.+||..||++|+ ++.+|++||||..
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 99999999999997 9999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=387.19 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=216.3
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||+||++.+. .++..||||++.+... .......+.+|+.+|++++|+||++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~--------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~ 67 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV--------------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeE
Confidence 4778999999999999999863 3457899999976543 344567788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+.+.+|||||||++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC------------------------------------------------CccccccCCCCCCCccccCCCCcCC
Q psy6357 385 SNYFTPG------------------------------------------------HMLTTWCGSPPYAAPELFGGREYDG 416 (635)
Q Consensus 385 a~~~~~~------------------------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~ 416 (635)
+..+... ......+||+.|+|||++.+..++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~- 226 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT- 226 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-
Confidence 7543100 011245799999999999888876
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCCC--CCCHHHHHHHHHhccc--CCCCCCCHHHHHcCc
Q psy6357 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIPF--YMSAECENLIRSMLVL--DPAKRLTLTQISNHK 490 (635)
Q Consensus 417 ~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p~--~~s~~l~~LI~~~L~~--dP~~Rps~~eiL~Hp 490 (635)
.++||||||||+|||++|..||...+.......+... ...+|. .++.++.+||.+||.. ++..|+++.+|++||
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 8999999999999999999999887766665555532 334443 5899999999996654 555599999999999
Q ss_pred cccc
Q psy6357 491 WMSV 494 (635)
Q Consensus 491 w~~~ 494 (635)
||..
T Consensus 307 ~f~~ 310 (381)
T cd05626 307 FFSE 310 (381)
T ss_pred ccCC
Confidence 9974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=380.67 Aligned_cols=249 Identities=28% Similarity=0.519 Sum_probs=222.1
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||+||++.++ .++..||||++.+... .......+..|+.++..+ +||||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 66 (320)
T cd05590 1 RVLGKGSFGKVMLARLK--------------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ 66 (320)
T ss_pred CeeeeCCCeEEEEEEEc--------------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE
Confidence 36899999999999873 3456899999976533 234456777899998876 6999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+||||||+++++|.+++.+...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 67 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (320)
T cd05590 147 IFNGKTTSTFCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVD 225 (320)
T ss_pred CcCCCcccccccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2 23344556799999999999887775 899999999999999999999999998889999988888888889999999
Q ss_pred HHHHhcccCCCCCCCH------HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL------TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~------~eiL~Hpw~~~ 494 (635)
||.+||+.||.+|+++ +++++||||..
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999998 99999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=382.59 Aligned_cols=253 Identities=30% Similarity=0.535 Sum_probs=225.7
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
++.||+|+||.||++.....+ ..+..||||++.+..........+.+|+.+|++++||||+++++++..
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGP-----------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69 (318)
T ss_pred CceeeeCCCEEEEEEEEeccC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 467999999999988764332 256789999998765444455667889999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
...+|+||||+.+++|.+++.+...+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++....
T Consensus 70 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 70 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997654
Q ss_pred CC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHH
Q psy6357 390 PG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468 (635)
Q Consensus 390 ~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~L 468 (635)
.. ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+......+|..++.++.+|
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 228 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228 (318)
T ss_pred CCCCceecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 33 334456799999999999887775 8999999999999999999999998888888888888888898999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 469 IRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 469 I~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
|.+||+.||.+||+ +.+++.||||..
T Consensus 229 i~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 229 LRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 99999999999999 788999999963
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=381.25 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=222.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.++++||.|+||.||++.+. .++..||||++.+.... ......+.+|+.+|..++|+||+++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~ 66 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK--------------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccE
Confidence 36888999999999999999873 34568999999765432 2345678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.....+||||||+++++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCc
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--cCCCC--
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--FRIPF-- 459 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--~~~p~-- 459 (635)
++..... .....+||+.|+|||++.+..++ .++||||||||||+|++|..||...+.......+.... +..|.
T Consensus 147 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 147 LSKGIVT--YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred CCccccc--ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 9986543 34556899999999999888776 89999999999999999999999988777766665432 22222
Q ss_pred ----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 460 ----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 460 ----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++.++.+||.+||..+|.+||++.+|++||||..
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 35899999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=388.12 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=220.8
Q ss_pred hhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHH
Q psy6357 212 LDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDI 291 (635)
Q Consensus 212 l~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~i 291 (635)
.+.|.+.+....+ +++||+|.||.||+|.|+ ...+||||.++...+.. +.+.+|++|
T Consensus 198 ~d~wei~r~~l~l-----~~~LG~G~FG~V~~g~~~---------------~~~~vavk~ik~~~m~~---~~f~~Ea~i 254 (468)
T KOG0197|consen 198 RDPWEIPREELKL-----IRELGSGQFGEVWLGKWN---------------GSTKVAVKTIKEGSMSP---EAFLREAQI 254 (468)
T ss_pred cCCeeecHHHHHH-----HHHhcCCccceEEEEEEc---------------CCCcccceEEeccccCh---hHHHHHHHH
Confidence 4555555444433 799999999999999994 23479999998766554 467799999
Q ss_pred HhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhh--cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 292 MSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT--IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~--~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
|++|+|++||+|+++|..+..+|||||||..|+|.++|.. ...+...+.+.++.||++||+||+++++|||||-+.||
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi 334 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI 334 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence 9999999999999999998899999999999999999987 45699999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCCcccccc--CCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGHMLTTWC--GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~~~~~~~--gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
||+++..+||+|||||+...++....... -...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..++
T Consensus 335 LV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 335 LVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred eeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 99999999999999999655544322222 24569999999999997 99999999999999999 9999999999999
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
.+.+..+ .++-|..||+++.+||..||..+|++||||+.+.
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999877 5677889999999999999999999999999765
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=385.05 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=223.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++|.++++||+|+||+||++.+. .++..||||++.+..... .....+..|+.+|..+.|+||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~ 66 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK--------------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC--------------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccch
Confidence 36888999999999999999873 245789999997654322 445678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.+...+|+||||+.+++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred hhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCC
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC------------------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh
Q psy6357 384 FSNYFTPGH------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433 (635)
Q Consensus 384 la~~~~~~~------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt 433 (635)
++....... ......||+.|+|||++.+..++ .++||||||||||+|++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~ 225 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLY 225 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhcc
Confidence 998664432 23456799999999999988776 99999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHh--CccCCCCC--CCHHHHHHHHHhcccCCCCCCC-HHHHHcCccccc
Q psy6357 434 AQLPFDGPNLAVLKQRILF--GKFRIPFY--MSAECENLIRSMLVLDPAKRLT-LTQISNHKWMSV 494 (635)
Q Consensus 434 G~~PF~~~~~~~l~~~i~~--~~~~~p~~--~s~~l~~LI~~~L~~dP~~Rps-~~eiL~Hpw~~~ 494 (635)
|..||...+.......+.. ....+|.. ++.++.+||.+||. ||.+|++ +.+||+||||..
T Consensus 226 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 226 GFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9999999887777777766 44455543 59999999999997 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=385.44 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=219.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.+++.||.|+||+||++... .++..||||++..... .......+.+|+.+|..++|+||++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~ 67 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKK--------------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67 (364)
T ss_pred CceEEEEEEecCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceE
Confidence 6888999999999999999873 3456899999976533 234456678999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+|||||||.+++|.+++...+.+++..+..++.||+.||+|||+.+|+||||||+||||+.++.++|+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred EEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccc
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---------------------------------------ccccccCCCCCCCccccCCCCcCCCccchhhHH
Q psy6357 385 SNYFTPGH---------------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLG 425 (635)
Q Consensus 385 a~~~~~~~---------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlG 425 (635)
+..+.... .....+||+.|+|||++....++ .++||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG 226 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLG 226 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-Ceeeeecch
Confidence 86543211 11235799999999999888876 899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCc--cCCCC--CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccc
Q psy6357 426 VVLYVMVTAQLPFDGPNLAVLKQRILFGK--FRIPF--YMSAECENLIRSMLVLDPAKRLT---LTQISNHKWMSV 494 (635)
Q Consensus 426 vilyeLltG~~PF~~~~~~~l~~~i~~~~--~~~p~--~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~Hpw~~~ 494 (635)
||+|+|++|..||...+.......+.... +.+|. .+++++.+||.+||. +|.+|++ +.++|+||||..
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 99999999999999888777776665433 33333 478999999999997 9999998 999999999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=377.62 Aligned_cols=254 Identities=29% Similarity=0.499 Sum_probs=225.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCC-ceeeE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHP-HIIKL 303 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIv~l 303 (635)
.|.+++.||.|+||.||+|.+. .++..||||++.+... .......+..|+.++..+.|+ +|+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~ 66 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK--------------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeee
Confidence 3778999999999999999873 2446899999976543 334556788999999999765 68899
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++...+.+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 67 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred cccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 384 FSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 384 la~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
++.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|..++
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (324)
T cd05587 147 MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLS 225 (324)
T ss_pred cceecCCCCCceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 987532 22334456799999999999988876 8999999999999999999999999988888989888888888999
Q ss_pred HHHHHHHHHhcccCCCCCCCH-----HHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRLTL-----TQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~-----~eiL~Hpw~~~ 494 (635)
.++.+||.+||..||.+|+++ .++++||||..
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999999999986 89999999963
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=378.41 Aligned_cols=249 Identities=28% Similarity=0.508 Sum_probs=222.4
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||.|+||.||+|.+. ..+..||||++.+... .......+..|+.++..+ +||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~ 66 (321)
T cd05591 1 KVLGKGSFGKVMLAELK--------------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ 66 (321)
T ss_pred CccccCCCeEEEEEEEC--------------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 36999999999999873 3456899999976543 334456677899999876 7999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+||||||+++++|..++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 67 TKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998764
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 225 (321)
T cd05591 147 ILNGVTTTTFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVS 225 (321)
T ss_pred ccCCccccccccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 3 22334556799999999999888876 899999999999999999999999999999999988888888889999999
Q ss_pred HHHHhcccCCCCCC-------CHHHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRL-------TLTQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rp-------s~~eiL~Hpw~~~ 494 (635)
||.+||..||.+|+ ++.++++||||..
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999 9999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=370.50 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=209.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|+||.||++... .++..||||++...... .....+.+|+.+|++++|+||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 68 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK--------------LTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTL 68 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC--------------CCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeE
Confidence 467899999999999999999773 24568999999754322 223467799999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Df 147 (288)
T cd07871 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADF 147 (288)
T ss_pred EEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcC
Confidence 9999999999999999974 8888886654 4799999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q psy6357 383 GFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-------- 453 (635)
Q Consensus 383 Gla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-------- 453 (635)
|++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 148 G~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 148 GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred cceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 999765322 23345678999999999876443348999999999999999999999887765544433211
Q ss_pred -----------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 -----------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 -----------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+.+| ..++.++.+||.+||++||.+|||++|+|+||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 2367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=377.13 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=221.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHH---hhCCCCceee
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIM---SHLDHPHIIK 302 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIv~ 302 (635)
|.+++.||+|+||.||++.+. .++..||||++.+... .....+.+.+|+.++ +.++||||++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~ 66 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK--------------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhc
Confidence 567899999999999999873 3456899999976542 233456677777665 5668999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.....+|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+||
T Consensus 67 ~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred eeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcc
Confidence 99999999999999999999999887754 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 383 GFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 383 Gla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
|++..... .......+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|..+
T Consensus 146 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~ 224 (324)
T cd05589 146 GLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL 224 (324)
T ss_pred cCCccCCCCCCcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 99875432 2334567899999999999888775 899999999999999999999999988888888888888888899
Q ss_pred CHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 462 SAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+.++.+||.+||..||.+|| ++.+|++||||..
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999999999999999 7999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=379.16 Aligned_cols=258 Identities=28% Similarity=0.482 Sum_probs=220.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.|.++++||+|+||.||++..... ...+..||||++.+... .....+.+..|+.+|.++ .|+||++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~-----------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~ 69 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG-----------HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVT 69 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc-----------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCccc
Confidence 377899999999999998876322 13567899999976432 223456678899999999 5999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.....+|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+||
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred EEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeC
Confidence 99999999999999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCccC
Q psy6357 383 GFSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP----NLAVLKQRILFGKFR 456 (635)
Q Consensus 383 Gla~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~----~~~~l~~~i~~~~~~ 456 (635)
|++...... ......+||+.|+|||++.+....+.++||||||||||+|++|..||... ....+...+......
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 999865332 22345679999999999987654458999999999999999999999643 344555566666677
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+|..++..+.+||.+||..||++|| +++++++||||..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 7888999999999999999999999 8899999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=368.76 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=219.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-eee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-IIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~ 302 (635)
...|..+++||+|+||+||+|..+. ++..||+|.+......+..-....+|+.+|+.|+|+| ||.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~--------------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~ 75 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR--------------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVR 75 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec--------------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEE
Confidence 3446678999999999999998853 4568999999877654334456789999999999999 999
Q ss_pred EEEEEecCC------eEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 303 LFQVMETTN------NLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 303 l~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
|++++...+ .+++||||++ -+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+
T Consensus 76 L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~ 154 (323)
T KOG0594|consen 76 LHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS 154 (323)
T ss_pred EEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC
Confidence 999998877 8999999994 78888887765 478889999999999999999999999999999999999
Q ss_pred CCCCeeeeccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6357 373 ENGDIKLADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~ 451 (635)
.+|.+||+|||+|+.+. +....+..++|.+|+|||++.+..+++..+||||+|||++||+++++.|.+.+..+....|.
T Consensus 155 ~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 155 SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 99999999999999776 45567888999999999999999777799999999999999999999999988777666665
Q ss_pred hC------------------ccCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 452 FG------------------KFRIPF------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 452 ~~------------------~~~~p~------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.- +..++. ..+.+..+|+.+||+++|.+|.|++.+|.||||...
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 21 111111 123589999999999999999999999999999754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=386.85 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=217.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||.|+||.||++... .++..||||++.+... .......+.+|+.+|++++|||||+++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~ 67 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKK--------------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67 (377)
T ss_pred CceEeEEEeecCCEEEEEEEEC--------------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788999999999999998763 3557899999876433 344567788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++|.+...+||||||+++++|.+++.....+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred EEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------------------------------------------------ccccccCCCCCCCccccCCCCcCC
Q psy6357 385 SNYFTPGH------------------------------------------------MLTTWCGSPPYAAPELFGGREYDG 416 (635)
Q Consensus 385 a~~~~~~~------------------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~ 416 (635)
+..+.... .....+||+.|+|||++.+..++
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~- 226 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG- 226 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-
Confidence 86331100 00125799999999999888876
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCCC--CCCHHHHHHHHHhcccCCCCC---CCHHHHHcC
Q psy6357 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIPF--YMSAECENLIRSMLVLDPAKR---LTLTQISNH 489 (635)
Q Consensus 417 ~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p~--~~s~~l~~LI~~~L~~dP~~R---ps~~eiL~H 489 (635)
.++||||||||||||++|.+||...+.......+... .+.+|. .++.++.+||.+||. +|.+| +|+.+++.|
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 8999999999999999999999988877776666542 344454 478999999999998 77765 599999999
Q ss_pred ccccc
Q psy6357 490 KWMSV 494 (635)
Q Consensus 490 pw~~~ 494 (635)
|||..
T Consensus 306 p~~~~ 310 (377)
T cd05629 306 PFFRG 310 (377)
T ss_pred CCcCC
Confidence 99963
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=377.10 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=207.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+.++||.|+||.||++.+. .++..||||++............+.+|+.+|++++||||+++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 66 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT--------------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC--------------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecc
Confidence 5788999999999999999873 34578999998754434444567889999999999999999999
Q ss_pred EEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 306 VMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 306 ~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++... ..+|+|||||. ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 67 IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred eEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEc
Confidence 88543 35899999995 7899998888889999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC----CccccccCCCCCCCccccCC--CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Q psy6357 381 DFGFSNYFTPG----HMLTTWCGSPPYAAPELFGG--REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF-- 452 (635)
Q Consensus 381 DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~--~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~-- 452 (635)
|||++...... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++|++||.+.+.......+..
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 99999764322 12245679999999999865 4454 899999999999999999999987654332211110
Q ss_pred ------------------------CccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 453 ------------------------GKFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 ------------------------~~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.....+ ..++.++.+||.+||..||++|||+++||+||||...
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 000010 1357889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=365.79 Aligned_cols=254 Identities=33% Similarity=0.566 Sum_probs=223.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 309 (635)
+.||+|+|+.|--+.. +.++..+||||+.+. ......++++|++++.+++ |+||++|+++|++
T Consensus 84 e~LGeGAyasVqtcv~--------------i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVS--------------IQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHhcCccceeeeeeee--------------eccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 5689999999987665 456678999999887 4556689999999999995 9999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---Ceeeecccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---DIKLADFGFSN 386 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---~ikL~DFGla~ 386 (635)
+..+|||||.|.||.|+.+|++...|+|.++.+++++|+.||+|||.+||.||||||+|||..... -||||||.|..
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999999999999999999999999999999999999999999999999999997654 58999999976
Q ss_pred cccC--------CCccccccCCCCCCCccccC----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCC------------
Q psy6357 387 YFTP--------GHMLTTWCGSPPYAAPELFG----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN------------ 442 (635)
Q Consensus 387 ~~~~--------~~~~~~~~gt~~Y~APEvl~----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~------------ 442 (635)
-+.. ...+.+.+|+..|||||++. ...+++.++|+||||||||.||+|.+||.+.-
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 5431 12356778999999999863 33455699999999999999999999997632
Q ss_pred ---HHHHHHHHHhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCCCCC
Q psy6357 443 ---LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500 (635)
Q Consensus 443 ---~~~l~~~i~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~~~~ 500 (635)
...+++.|..++++||. .+|.++++||..+|..|+.+|.++.++++|||+....+...
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 56789999999999996 48999999999999999999999999999999987665543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=385.08 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=216.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||+||++... .++..||||++.+... .......+.+|+.+|++++|+|||+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~--------------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~ 67 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV--------------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC--------------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEE
Confidence 5788999999999999999873 3456899999976433 334556788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++|.+...+|||||||++++|.+++.+.+.+++..+..++.||+.||+|||+.+|+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC------------------------------------------------CccccccCCCCCCCccccCCCCcCC
Q psy6357 385 SNYFTPG------------------------------------------------HMLTTWCGSPPYAAPELFGGREYDG 416 (635)
Q Consensus 385 a~~~~~~------------------------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~ 416 (635)
+..+... ......+||+.|+|||++.+..++
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~- 226 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT- 226 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-
Confidence 7532100 011235799999999999988886
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHcC
Q psy6357 417 TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIP--FYMSAECENLIRSMLVLDPAKRLT---LTQISNH 489 (635)
Q Consensus 417 ~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~H 489 (635)
.++||||||||||||++|.+||...+.......+... ...+| ..+++++.+||.+|+ .+|.+|++ +++|++|
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 8999999999999999999999988776666665542 23333 357999999999987 59999997 9999999
Q ss_pred ccccc
Q psy6357 490 KWMSV 494 (635)
Q Consensus 490 pw~~~ 494 (635)
|||..
T Consensus 306 p~f~~ 310 (382)
T cd05625 306 PFFKT 310 (382)
T ss_pred CCcCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=377.69 Aligned_cols=248 Identities=29% Similarity=0.549 Sum_probs=216.9
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++.+. .++..||||++.+.... ......+..|+.++..+ +||||++++++|.
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~ 66 (329)
T cd05588 1 RVIGRGSYAKVLLVELK--------------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ 66 (329)
T ss_pred CeEeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE
Confidence 36899999999999873 34568999999875442 34456788999999998 6999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+|||||||++++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 67 TESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998753
Q ss_pred -cCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhCccCCC
Q psy6357 389 -TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---------NLAVLKQRILFGKFRIP 458 (635)
Q Consensus 389 -~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---------~~~~l~~~i~~~~~~~p 458 (635)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|..||... ....+.+.+......+|
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 225 (329)
T cd05588 147 IRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225 (329)
T ss_pred ccCCCccccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC
Confidence 233444567899999999999988876 8999999999999999999999632 12335566777777888
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCcccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLT------LTQISNHKWMS 493 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps------~~eiL~Hpw~~ 493 (635)
..++.++.+||.+||+.||.+|++ +.++++||||.
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 899999999999999999999997 78999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.24 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=224.9
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLF 304 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 304 (635)
|.+++.||+|+||.||++.+. .++..||||++.+... .......+..|+.++..+ .|++|++++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERK--------------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEE
Confidence 677899999999999999873 2456899999986543 233445677888888887 589999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++...+.+||||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred ccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCH
Q psy6357 385 SNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSA 463 (635)
Q Consensus 385 a~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~ 463 (635)
+.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 226 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 226 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCH
Confidence 97543 22334456799999999999988876 99999999999999999999999999888999998888888989999
Q ss_pred HHHHHHHHhcccCCCCCCCH-----HHHHcCccccc
Q psy6357 464 ECENLIRSMLVLDPAKRLTL-----TQISNHKWMSV 494 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~-----~eiL~Hpw~~~ 494 (635)
++.+||.+||+.||.+|+++ .+|++||||..
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 227 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999999999984 89999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=379.46 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=224.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|..+..||+|+||.||+|.+.. .++.||||+++... .+..++.+.+|+.+|.+++++||.++|+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~--------------t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yyg 78 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNK--------------TKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYG 78 (467)
T ss_pred ccccchhccccccceeeeeeecc--------------ccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhh
Confidence 45567899999999999999843 44679999998876 4456788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
.|..+..+|++||||.||++.+.|.....+.+..+..++++++.||.|||..+.+|||||+.||||..+|.+||+|||++
T Consensus 79 syl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 79 SYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred heeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEeccee
Confidence 99999999999999999999999988777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC-CCCCCCH
Q psy6357 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSA 463 (635)
Q Consensus 386 ~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-~p~~~s~ 463 (635)
....... ...+++||+.||||||+....|+ .++||||||+++|||++|.+||...........|....++ +...+|+
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~ 237 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSP 237 (467)
T ss_pred eeeechhhccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCH
Confidence 8776543 34889999999999999988887 9999999999999999999999887765444444333222 2236899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+++||..||++||+.||+|.++|+|+|++..+
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999999999999998644
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=370.34 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=206.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|+||.||++... .++..||||++...... .....+.+|+.+|+.++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 68 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK--------------VNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLL 68 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC--------------CCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeE
Confidence 457889999999999999999873 24568999999754322 222456789999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.+....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df 147 (303)
T cd07869 69 HDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADF 147 (303)
T ss_pred EEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCC
Confidence 999999999999999995 6777777554 56999999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhC--c----
Q psy6357 383 GFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFG--K---- 454 (635)
Q Consensus 383 Gla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~--~---- 454 (635)
|++..... ........+|+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+... .
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 148 GLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred CcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 99875432 22334567899999999987655445899999999999999999999987532 2222222110 0
Q ss_pred ---------------cC--CC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 ---------------FR--IP---------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ---------------~~--~p---------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+. .+ ..++.++.+||.+||++||.+|||+.|+|+||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00 00 024578999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.07 Aligned_cols=249 Identities=25% Similarity=0.512 Sum_probs=219.4
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++.+. .++..||||++.+... .......+..|+.++..+ +|+||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 66 (316)
T cd05620 1 KVLGKGSFGKVLLAELK--------------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ 66 (316)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE
Confidence 46999999999999873 3456899999976532 223445677888888765 8999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+||||||+.+++|..++.....+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 67 TKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998753
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (316)
T cd05620 147 VFGDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225 (316)
T ss_pred ccCCCceeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2 22334567899999999999988876 899999999999999999999999888888888887777888889999999
Q ss_pred HHHHhcccCCCCCCCH-HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL-TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~-~eiL~Hpw~~~ 494 (635)
||.+||..||.+|+++ +++++||||..
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 9999999999999997 58999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=382.66 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=238.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.+++.+|.|+||.+|+...+. +...|++|.+......+.......+|+.+++++.|||||.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~--------------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y 68 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS--------------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEY 68 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc--------------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeee
Confidence 3578889999999999999776543 44589999999998888888899999999999999999999
Q ss_pred EEEEecCCe-EEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 304 FQVMETTNN-LYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 304 ~~~~~~~~~-~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++.|+.++. +||||+||+||+|.+.|.+.+ .|+++.+..|+.||+.||.|||++.|+|||||+.|||++.++.|+|.
T Consensus 69 ~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLg 148 (426)
T KOG0589|consen 69 KDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLG 148 (426)
T ss_pred ccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeec
Confidence 999999888 999999999999999997765 49999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 381 DFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 381 DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
|||+|+...+.. ...+.+||+.||.||++.+.+|. .|+|||||||++|||++-+++|...+...+..+|.... .++|
T Consensus 149 DfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 149 DFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP 227 (426)
T ss_pred chhhhhhcCCchhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC
Confidence 999999998776 78889999999999999999997 99999999999999999999999999999999999887 6788
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..++.+++.||+.||..+|..||++.++|.+|.+.
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 89999999999999999999999999999999886
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.33 Aligned_cols=249 Identities=29% Similarity=0.552 Sum_probs=218.6
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++.+. .++..||||++..... .......+..|..++..+ .||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~ 66 (316)
T cd05592 1 KVLGKGSFGKVMLAELK--------------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ 66 (316)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 36999999999999873 3456899999976543 233445666777777754 8999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+|+||||+++++|..++.....+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 67 TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 TP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
.. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (316)
T cd05592 147 MNGEGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKD 225 (316)
T ss_pred CCCCCccccccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 32 2334556899999999999888876 899999999999999999999999988888888887777788889999999
Q ss_pred HHHHhcccCCCCCCCH-HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL-TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~-~eiL~Hpw~~~ 494 (635)
||.+||..||.+||++ .++++||||..
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 9999999999999986 58889999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.12 Aligned_cols=249 Identities=29% Similarity=0.553 Sum_probs=222.1
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||.|+||+||++.+. .++..||||++.+... .......+.+|+.++..+ .||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~ 66 (318)
T cd05570 1 KVLGKGSFGKVLLAELK--------------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ 66 (318)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence 36999999999999873 2456899999986543 334456778899999888 6999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+|+||||+.+++|..++.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 67 TKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998753
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (318)
T cd05570 147 ILGGVTTSTFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKS 225 (318)
T ss_pred CcCCCcccceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 2 22334456799999999999988886 899999999999999999999999888888888888888888889999999
Q ss_pred HHHHhcccCCCCCCCH-----HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL-----TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~-----~eiL~Hpw~~~ 494 (635)
||.+||..||.+||++ .+++.||||..
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999 99999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=374.89 Aligned_cols=249 Identities=31% Similarity=0.536 Sum_probs=218.3
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHH-HHhhCCCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVD-IMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~ 308 (635)
+.||+|+||+||++.+. .++..||||++.+... .......+..|.. +++.++||||+++++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~ 66 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK--------------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ 66 (323)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE
Confidence 36899999999999873 3457899999976533 2233345556655 467899999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+|+||||+.+++|..++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 67 TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred eCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......++..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARH 225 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 3 22334456799999999999888876 899999999999999999999999988888888888877888889999999
Q ss_pred HHHHhcccCCCCCCCH----HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL----TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~----~eiL~Hpw~~~ 494 (635)
||.+||+.||.+||++ .++++||||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.63 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=216.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||.||++... .++..||||++.+... .......+.+|+.+|+.++|+||++++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~ 67 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKV--------------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEEC--------------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 5888999999999999999863 3456899999975432 223456678999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+.+.+|||||||++++|.+++.+.+.+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--------------------------------------------CccccccCCCCCCCccccCCCCcCCCccc
Q psy6357 385 SNYFTPG--------------------------------------------HMLTTWCGSPPYAAPELFGGREYDGTKSD 420 (635)
Q Consensus 385 a~~~~~~--------------------------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksD 420 (635)
|..+... ......+||+.|||||++.+..++ .++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~D 226 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCD 226 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-ccee
Confidence 7532100 001235799999999999888876 8999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCC--CCCCHHHHHHHHHhcccCCCCCC---CHHHHHcCcccc
Q psy6357 421 VWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIP--FYMSAECENLIRSMLVLDPAKRL---TLTQISNHKWMS 493 (635)
Q Consensus 421 IwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p--~~~s~~l~~LI~~~L~~dP~~Rp---s~~eiL~Hpw~~ 493 (635)
|||||||||+|++|..||...+.......+... .+.+| ..++.++.+||.+|+ .+|.+|+ ++.++++||||.
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 999999999999999999988876666655543 22333 257899999999987 5999999 999999999996
Q ss_pred c
Q psy6357 494 V 494 (635)
Q Consensus 494 ~ 494 (635)
.
T Consensus 306 ~ 306 (376)
T cd05598 306 G 306 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=370.54 Aligned_cols=256 Identities=21% Similarity=0.396 Sum_probs=217.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||.|+||.||++.+. .++..||+|++.... .......+.+|+++|++++|+||++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 67 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHK--------------PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVG 67 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEEC--------------CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCe
Confidence 4567889999999999999999873 345689999997643 3445577899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++...+.+++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred EEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEcc
Confidence 9999999999999999999999999998888899999999999999999999986 699999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF--------- 452 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~--------- 452 (635)
||++...... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..++...+..
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence 9999766432 33456799999999999888776 899999999999999999999977655443322110
Q ss_pred -------------------------------------Cc-cCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 453 -------------------------------------GK-FRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 453 -------------------------------------~~-~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. ...+ ..++.++.+||.+||.+||++|||+.+||+||||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 00 0111 13678999999999999999999999999999997
Q ss_pred cC
Q psy6357 494 VH 495 (635)
Q Consensus 494 ~~ 495 (635)
..
T Consensus 306 ~~ 307 (331)
T cd06649 306 RS 307 (331)
T ss_pred hc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.56 Aligned_cols=262 Identities=28% Similarity=0.365 Sum_probs=222.4
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
.+|.....+.+..+|.|++.||+|+||.|-++++ .++++.|||||++.. .....+...|+.||
T Consensus 174 ~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d--------------~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL 236 (586)
T KOG0667|consen 174 GDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYD--------------HKTGEIVAIKIIKNK---KRFLRQAQIEIRIL 236 (586)
T ss_pred CceeEEecceeEEEEEEEEEecccccceeEEEEe--------------cCCCcEEEEEeeccC---hHHHHHHHHHHHHH
Confidence 3455666667777999999999999999999988 356789999999764 34556778899999
Q ss_pred hhCC-C-----CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 293 SHLD-H-----PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 293 ~~L~-H-----pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
..|+ | -|||+++++|...+++|||+|++ ..+|+++|+.+. .|+...++.|+.||+.||.+||+.+|||+||
T Consensus 237 ~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDL 315 (586)
T KOG0667|consen 237 ELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDL 315 (586)
T ss_pred HHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9996 4 38999999999999999999999 689999998764 5999999999999999999999999999999
Q ss_pred cCcceeecCC--CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy6357 365 KAENLLFDEN--GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442 (635)
Q Consensus 365 Kp~NILl~~~--~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~ 442 (635)
||+||||... ..|||+|||+|+.... ...+++.+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+
T Consensus 316 KPENILL~~~~r~~vKVIDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 316 KPENILLKDPKRSRIKVIDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ChhheeeccCCcCceeEEecccccccCC--cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCC
Confidence 9999999754 4799999999987654 34488999999999999999997 99999999999999999999999988
Q ss_pred HHHHHHHHHhC----------------------------------------------------ccCCC-C----------
Q psy6357 443 LAVLKQRILFG----------------------------------------------------KFRIP-F---------- 459 (635)
Q Consensus 443 ~~~l~~~i~~~----------------------------------------------------~~~~p-~---------- 459 (635)
..+.+..|..- ....| .
T Consensus 393 e~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~ 472 (586)
T KOG0667|consen 393 EYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPK 472 (586)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccc
Confidence 77666655410 00011 0
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.-...+.+||.+||.+||.+|+|+.|+|+||||...
T Consensus 473 ~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 473 ADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred ccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 012458999999999999999999999999999843
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=373.84 Aligned_cols=249 Identities=30% Similarity=0.558 Sum_probs=216.3
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++.+. .++..||||++.+... .......+..|+.++.++ +||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~ 66 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK--------------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 66 (329)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE
Confidence 36899999999999873 3456899999987543 334556778899998877 7999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+||||||+++++|..++.....+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 67 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhCccCCC
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG---------PNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~---------~~~~~l~~~i~~~~~~~p 458 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.. .....+.+.+......+|
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 225 (329)
T cd05618 147 LRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 225 (329)
T ss_pred cCCCCccccccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC
Confidence 2 23334557899999999999988876 899999999999999999999952 122345566667777889
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC------HHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLT------LTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps------~~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||..||.+|++ +.+|++||||..
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 899999999999999999999998 589999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=364.19 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=208.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC---CCCcee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPHII 301 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv 301 (635)
.+|.++++||+|+||.||++.+... .+..||||++............+.+|+.+++.+ .||||+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv 67 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN-------------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC-------------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcc
Confidence 3688899999999999999976321 246799999976544333334566787777766 699999
Q ss_pred eEEEEEe-----cCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 302 KLFQVME-----TTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 302 ~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
++++++. ....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~ 146 (290)
T cd07862 68 RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 146 (290)
T ss_pred eEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC
Confidence 9999985 3456899999996 6888888654 358999999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
+.+||+|||++.............||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 147 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred CCEEEccccceEeccCCcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 99999999999876655555567799999999999887776 89999999999999999999999877666555554210
Q ss_pred c-C--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 F-R--------------------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 ~-~--------------------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. + +...++..+.+||.+||+.||++|||+.++|+||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0 0 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=369.15 Aligned_cols=249 Identities=29% Similarity=0.536 Sum_probs=218.7
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++.+. ..+..||||++..... ..........|..++..+ +||||+++++++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~ 66 (316)
T cd05619 1 KMLGKGSFGKVFLAELK--------------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ 66 (316)
T ss_pred CeeeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE
Confidence 36999999999999873 3456899999976532 223345667788888764 8999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
+.+.+||||||+++++|.+++.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 67 TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 99999999999999999999988788999999999999999999999999999999999999999999999999998754
Q ss_pred cC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 TP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
.. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+.+.+......+|..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (316)
T cd05619 147 MLGDAKTCTFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225 (316)
T ss_pred CCCCCceeeecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 22 2334456799999999999888776 899999999999999999999999888888888877777778889999999
Q ss_pred HHHHhcccCCCCCCCHH-HHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTLT-QISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~~-eiL~Hpw~~~ 494 (635)
||.+||..||.+||++. +|++||||..
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 99999999999999996 9999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=360.69 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=238.9
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.+....|..++.||+|.||.|-++.-+ .++..+||||+++..+ ...++...+.|-.+|+..+||.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEK--------------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPF 229 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREK--------------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPF 229 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeec--------------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcH
Confidence 344556667899999999999977652 3567899999998865 5566777889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+..|...|+..+.+|+||||..||.|+-+|.+..-|+++.+..+...|+.||.|||+.+||+||||.+|+||+++|+|||
T Consensus 230 Lt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 230 LTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred HHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccccccc-ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~-~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+||||+.. +..+....++||||.|+|||++....|. .++|.|.+||+||||++|++||...+...++..|+...+.+|
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP 388 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC
Confidence 99999975 4556778899999999999999999986 999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
..++++++.|+..+|.+||.+|. .+.||.+|+||..
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999999999999999997 5899999999974
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=378.21 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=218.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.+++.||+|+||.||++... .++..||||++..... .......+.+|+.+|..++|++|++++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~ 67 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKK--------------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 5778999999999999999873 3456899999975432 334556788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+|||||||++++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||||+.++.++|+|||+
T Consensus 68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred EEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC------------------------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHH
Q psy6357 385 SNYFTPGH------------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVL 428 (635)
Q Consensus 385 a~~~~~~~------------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvil 428 (635)
+..+.... .....+||+.|+|||++.+..++ .++|||||||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil 226 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIM 226 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-Ccceecccccee
Confidence 87542210 11245799999999999988886 899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhC--ccCCCC--CCCHHHHHHHHHhcccCCCCCC---CHHHHHcCccccc
Q psy6357 429 YVMVTAQLPFDGPNLAVLKQRILFG--KFRIPF--YMSAECENLIRSMLVLDPAKRL---TLTQISNHKWMSV 494 (635)
Q Consensus 429 yeLltG~~PF~~~~~~~l~~~i~~~--~~~~p~--~~s~~l~~LI~~~L~~dP~~Rp---s~~eiL~Hpw~~~ 494 (635)
|+|++|..||...+.......+... .+.+|. .++.++++||.+|+. ||.+|+ ++.+|++||||..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9999999999998888777777653 233443 478999999999874 999998 4899999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=362.33 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=217.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||+||++... .++..||||++....... .....+.+|+.+|+.++|+||++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR--------------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc--------------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeee
Confidence 3778999999999999998763 345689999997654322 2334567899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++...+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+||
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Df 146 (285)
T cd05605 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred eeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999999999998887653 45999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCccCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV----LKQRILFGKFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~----l~~~i~~~~~~~p 458 (635)
|++............+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+..... +...+......++
T Consensus 147 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05605 147 GLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS 225 (285)
T ss_pred CCceecCCCCccccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC
Confidence 999876544444556889999999999887776 89999999999999999999998765433 2333334444566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
..++..+.+||.+||..||.+|| ++++|++||||..
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 67899999999999999999999 9999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=377.78 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=221.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.....|.++++||+|+||.||++... .++..||||++.+... .......+.+|+.+|+.++||||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i 105 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHK--------------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc
Confidence 45678899999999999999998873 3456899999976433 22334557789999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.+...+|||||||++++|.+++.. ..+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred ceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEE
Confidence 9999999999999999999999999988765 468999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCC---cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGRE---YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~---~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~- 454 (635)
|||++....... .....+||+.|+|||++.+.. ..+.++|||||||+||+|++|.+||...+....+..+....
T Consensus 185 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05596 185 DFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred eccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 999998764332 234567999999999986542 23489999999999999999999999988888888876543
Q ss_pred -cCCCC--CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 -FRIPF--YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 -~~~p~--~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+.+|. .+|.++++||.+||+.+|.+ |+|+++|++||||..
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 44454 57999999999999999988 999999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=373.42 Aligned_cols=254 Identities=31% Similarity=0.440 Sum_probs=218.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.++++||+|+||+||++... .++..||||++..... .......+.+|+.+++.++|+||+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~ 66 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK--------------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcce
Confidence 36888999999999999999873 3456899999986543 33455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.....+||||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+||
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred eeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccC
Confidence 99999999999999999999999999876 67999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc--cccccCCCCCCCccccC------CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 383 GFSNYFTPGHM--LTTWCGSPPYAAPELFG------GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 383 Gla~~~~~~~~--~~~~~gt~~Y~APEvl~------~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|++..+..... .....||+.|+|||++. ...+ +.++||||||||+|+|++|..||...+.......+....
T Consensus 147 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 147 GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred CCCeECCCCCceeeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 99987654322 23357899999999986 3344 489999999999999999999999887777777665432
Q ss_pred --cCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 --FRIPF--YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 --~~~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+|. .++.++.+||..||. +|.+|||+.++++||||..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 226 RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 23333 579999999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=370.13 Aligned_cols=249 Identities=30% Similarity=0.534 Sum_probs=217.6
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHH-HHhhCCCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVD-IMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~ 308 (635)
+.||.|+||.||++.+. .++..||||++.+... .......+..|+. +++.++|+||+++++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~ 66 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK--------------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ 66 (321)
T ss_pred CeeeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 36899999999999873 3456899999976543 2233445556654 678899999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
+.+.+|||||||++++|..++.....+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 67 TAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998753
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|...+.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACD 225 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2 22334556799999999999888776 899999999999999999999999988888888888888888889999999
Q ss_pred HHHHhcccCCCCCCCH----HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL----TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~----~eiL~Hpw~~~ 494 (635)
||.+||+.||.+|+++ .++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9999999999999875 59999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.71 Aligned_cols=256 Identities=23% Similarity=0.434 Sum_probs=211.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||.|+||.||++.+. ..+..||||++............+.+|+.+++.++||||++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT--------------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc--------------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEee
Confidence 4678999999999999999999873 34568999999776555556677889999999999999999
Q ss_pred EEEEEecCC------eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTN------NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++.... .+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 85 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred eeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC
Confidence 999986443 57999999965 5655553 35889999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF---- 452 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~---- 452 (635)
+||+|||++.............+|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..
T Consensus 162 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EEEecCCCccccccCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999876555555567889999999999988876 899999999999999999999987654332221110
Q ss_pred ------------------CccC--------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 453 ------------------GKFR--------------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 453 ------------------~~~~--------------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.... .....+.++.+||.+||..||++|||+.|||+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 01124678999999999999999999999999999976
Q ss_pred CC
Q psy6357 495 HC 496 (635)
Q Consensus 495 ~~ 496 (635)
+.
T Consensus 321 ~~ 322 (359)
T cd07876 321 WY 322 (359)
T ss_pred hc
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=369.38 Aligned_cols=249 Identities=30% Similarity=0.564 Sum_probs=217.1
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++... .++..||||++.+... .......+.+|+.++.++ .|++|+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 66 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK--------------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ 66 (327)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE
Confidence 36999999999999873 3456899999987543 334566788999999888 6999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+||||||+++++|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 67 TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998753
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCccCCCCC
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-------NLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-------~~~~l~~~i~~~~~~~p~~ 460 (635)
. ........+||+.|+|||++.+..++ .++|||||||+||+|++|..||... ....+.+.+......+|..
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 225 (327)
T cd05617 147 LGPGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF 225 (327)
T ss_pred cCCCCceecccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC
Confidence 2 33344567899999999999888876 8999999999999999999999532 2344556666667788888
Q ss_pred CCHHHHHHHHHhcccCCCCCCC------HHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLT------LTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps------~~eiL~Hpw~~~ 494 (635)
++..+.+||.+||..||.+|++ +.+|++||||..
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999999999999999998 579999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.53 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=217.7
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHH-HHhhCCCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVD-IMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~ 308 (635)
+.||+|+||.||++... .++..||||++.+... .......+..|.. +++.++||||+++++++.
T Consensus 1 ~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~ 66 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK--------------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ 66 (325)
T ss_pred CceeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 36899999999999873 3567899999976532 2333455566655 467789999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+||||||+.+++|..++.+...+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 67 TTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......++..++..+.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS 225 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHH
Confidence 3 22334566799999999999988876 899999999999999999999999888888888888777777779999999
Q ss_pred HHHHhcccCCCCCCCH----HHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTL----TQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~----~eiL~Hpw~~~ 494 (635)
||.+||..+|.+||++ .+|++||||..
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 9999999999999976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.16 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=223.5
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCC-CCceeeEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLD-HPHIIKLF 304 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 304 (635)
|..++.||+|+||.||++... .++..||||++.+... .......+..|+.++..+. |++|++++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~ 67 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK--------------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhhee
Confidence 566889999999999999873 3457899999976533 2344566778999998886 57788999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++...+.+||||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred eEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCH
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSA 463 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~ 463 (635)
+...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+.+.+......+|..++.
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 226 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSK 226 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 8764322 233456799999999999888776 89999999999999999999999998888888888888888889999
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 464 ECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
++.+||.+||..+|.+|++ ..++++||||..
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 227 EAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 9999999999999999997 579999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=370.53 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=207.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|..+++||.|+||.||++.+. .++..||||++.... .......+.+|+.+|+.++|+||++++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~ 138 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHR--------------PTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCH 138 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEEC--------------CCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 34455789999999999999873 345689999996543 344456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++...+.+|+||||+++++|... ..+.+..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+
T Consensus 139 ~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 139 DMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred eEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999999999988653 3456788899999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCC----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hCcc
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGG----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL---AVLKQRIL-FGKF 455 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~---~~l~~~i~-~~~~ 455 (635)
+..+... ......+||..|+|||++.. ..+.+.++|||||||+||+|++|+.||..... ..+...+. ....
T Consensus 215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 294 (353)
T PLN00034 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294 (353)
T ss_pred ceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC
Confidence 9876432 22345679999999998843 23445689999999999999999999974332 22222222 2233
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+..++.++.+||.+||..||++|||+.|||+||||...
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 4566789999999999999999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=372.91 Aligned_cols=248 Identities=29% Similarity=0.527 Sum_probs=216.0
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC---CCCceeeEEEEEe
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL---DHPHIIKLFQVME 308 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~ 308 (635)
||+|+||+||++.+. .++..||||++.+... .......+..|..++..+ .||||+.+++++.
T Consensus 1 lG~G~~g~Vy~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~ 66 (330)
T cd05586 1 IGKGTFGQVYQVRKK--------------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ 66 (330)
T ss_pred CCCCCceEEEEEEEC--------------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe
Confidence 799999999999873 3456899999975433 233445566777777765 6999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....+|+||||+.+++|.+++.+...+++..++.++.||+.||+|||+.+|+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998764
Q ss_pred cC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC-CCCHHHH
Q psy6357 389 TP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF-YMSAECE 466 (635)
Q Consensus 389 ~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~-~~s~~l~ 466 (635)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+...+...+..+...+|. .++.++.
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 226 (330)
T cd05586 147 LTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGR 226 (330)
T ss_pred CCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 32 333456789999999999976553358999999999999999999999999888888888888777775 4799999
Q ss_pred HHHHHhcccCCCCCC----CHHHHHcCccccc
Q psy6357 467 NLIRSMLVLDPAKRL----TLTQISNHKWMSV 494 (635)
Q Consensus 467 ~LI~~~L~~dP~~Rp----s~~eiL~Hpw~~~ 494 (635)
+||.+||..||.+|| ++.++++||||..
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 999999999999998 7999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=376.12 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=219.9
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
......|.++++||+|+||.||++.+. .++..||+|++.+... .......+.+|+.+++.++|||
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~ 104 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHK--------------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCC
Confidence 445678999999999999999999873 3456899999975432 2334456778999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+|+|||||++++|.+++.. ..+++..+..++.||+.||+|||+.+|+||||||+||||+.++.+||
T Consensus 105 iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred EeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999998865 46899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC--ccccccCCCCCCCccccCCCC---cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 380 ADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGRE---YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 380 ~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~---~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
+|||+|....... .....+||+.|+|||++.+.. +.+.++|||||||+||+|++|..||...+.......+....
T Consensus 184 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 184 ADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred EecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 9999998764322 234667999999999997543 23489999999999999999999999988877777776543
Q ss_pred --cCCCC--CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 --FRIPF--YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 --~~~p~--~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+.+|. .++..+++||..||..++.+ |+++.|+++||||..
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 44454 47999999999999865543 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=368.83 Aligned_cols=249 Identities=31% Similarity=0.523 Sum_probs=215.8
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHH-HHhhCCCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVD-IMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~ 308 (635)
+.||+|+||+||++.+. .++..||+|++.+.... ......+..|.. +++.++|+||+++++++.
T Consensus 1 ~~lg~G~fg~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~ 66 (325)
T cd05602 1 KVIGKGSFGKVLLARHK--------------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 66 (325)
T ss_pred CeeeeCCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE
Confidence 36999999999999873 34468999999764332 222334445544 567889999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 67 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred cCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999754
Q ss_pred c-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHH
Q psy6357 389 T-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECEN 467 (635)
Q Consensus 389 ~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~ 467 (635)
. ........+||+.|+|||++.+..++ .++|||||||++|+|++|.+||...+...+...+......++..++.++.+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 225 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 225 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHH
Confidence 3 22334567899999999999988876 899999999999999999999999888888888887777777789999999
Q ss_pred HHHHhcccCCCCCCCHH----HHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLTLT----QISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~~----eiL~Hpw~~~ 494 (635)
||.+||+.||.+|+++. ++++|+||..
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999865 8999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.16 Aligned_cols=250 Identities=34% Similarity=0.593 Sum_probs=219.2
Q ss_pred CCccc-eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 225 KPQYN-LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 225 ~~y~i-l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
..|.+ -.+||-|-.|.|-.+..+ .+++++|+|++... .+..+|+++.-.. .|+|||.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k--------------~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~ 119 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHK--------------RTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVS 119 (400)
T ss_pred hhheehhhhhccccCCceEEEEec--------------cchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEE
Confidence 34444 357899999999988763 35578999998654 5677898886655 6999999
Q ss_pred EEEEEec----CCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---
Q psy6357 303 LFQVMET----TNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--- 373 (635)
Q Consensus 303 l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--- 373 (635)
++++|+. ...+.+|||+|+||+|+..++..+. |+|.++..|++||..||.|||+.+|.||||||+|+|++.
T Consensus 120 IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 120 IIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP 199 (400)
T ss_pred eehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC
Confidence 9999864 4578899999999999999998876 999999999999999999999999999999999999975
Q ss_pred CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQR 449 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~ 449 (635)
+..+||+|||+|........+.+.|.||+|.|||++....|+ ..+|+||+|||+|.||+|.+||.... ...+..+
T Consensus 200 na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r 278 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR 278 (400)
T ss_pred CcceEecccccccccCCCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH
Confidence 457999999999988877788899999999999999988887 99999999999999999999997644 3467788
Q ss_pred HHhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 450 ILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 450 i~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
|..+.+.||. .+|++++++|+.+|..+|.+|.|+.++++|||+....
T Consensus 279 I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 279 IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 9999999986 4899999999999999999999999999999998643
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.47 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=213.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.-.|...+.+|.|+||.||.|... ++.+.||||.+-.+.- ---+|+++|+.++|||||+|
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~--------------e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L 82 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLR--------------ETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRL 82 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEc--------------CCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeE
Confidence 345667899999999999999873 4457899999865431 12379999999999999999
Q ss_pred EEEEecC---C--eEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 304 FQVMETT---N--NLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 304 ~~~~~~~---~--~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+.+|... + ...||||||+ .+|..++.. ..+++...++-++.||++||.|||+.||+||||||+|||+|.+
T Consensus 83 ~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 83 LYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD 161 (364)
T ss_pred EEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC
Confidence 9888532 2 3569999995 788888774 4679999999999999999999999999999999999999976
Q ss_pred -CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Q psy6357 375 -GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF- 452 (635)
Q Consensus 375 -~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~- 452 (635)
|.+||||||.|+.+..+....++..|..|+|||.+.+...++.++||||.|||+.||+.|++.|.+.+..+....|..
T Consensus 162 tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 162 TGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred CCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 999999999999998888888999999999999999988778999999999999999999999999876555444431
Q ss_pred ----------------CccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 453 ----------------GKFRIP------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 453 ----------------~~~~~p------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..+.+| ..+++++.+|+.++|.++|.+|.++.|+|.||||..-.
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 011222 23689999999999999999999999999999997543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.94 Aligned_cols=253 Identities=23% Similarity=0.406 Sum_probs=212.5
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||+|+||.||++.+. .++..||||++............+.+|+.+|+.++|+||++++++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 67 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDP--------------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67 (372)
T ss_pred CcccceeeeCCCEEEEEEEEC--------------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence 567899999999999999863 345789999997654444556788899999999999999999999
Q ss_pred EecCC-----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 307 METTN-----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 307 ~~~~~-----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+.... .+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 68 LQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred ecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecc
Confidence 98776 7999999996 67888887778899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC--CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Q psy6357 382 FGFSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF------- 452 (635)
Q Consensus 382 FGla~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~------- 452 (635)
||++...... .......+|+.|+|||++.+....+.++||||||||+|+|++|..||.+.+.......+..
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9999865432 2234456899999999998765445899999999999999999999988765544443321
Q ss_pred ----------------Ccc---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 453 ----------------GKF---------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 453 ----------------~~~---------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
... .+....+.++.+||.+||..||.+|||+.|+|+||||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 111 122346889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=384.13 Aligned_cols=251 Identities=27% Similarity=0.308 Sum_probs=205.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||+|+||.||+|.+. ..+..||||++.... ....+|+.+|+.++|+|||+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------------~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~ 123 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI--------------DTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIF 123 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC--------------CCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcc
Confidence 4567999999999999999999873 345689999886432 23347999999999999999
Q ss_pred EEEEEecC--------CeEEEEEeccccchhhhhhh----hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 303 LFQVMETT--------NNLYLVTEYARGGEIFSHLL----TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 303 l~~~~~~~--------~~~~LV~E~~~ggsL~~~l~----~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
+++++... ..+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+.+|+||||||+|||
T Consensus 124 l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NIL 202 (440)
T PTZ00036 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202 (440)
T ss_pred eeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEE
Confidence 99887432 247799999974 6666554 3456999999999999999999999999999999999999
Q ss_pred ecCCC-CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 371 FDENG-DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 371 l~~~~-~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
|+.++ .+||+|||+|..+.........+||+.|+|||++.+...++.++||||||||||+|++|.+||.+.+.......
T Consensus 203 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 282 (440)
T PTZ00036 203 IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282 (440)
T ss_pred EcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 98665 79999999998776555555678899999999987754345899999999999999999999988765444333
Q ss_pred HHhC-----------------cc------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 450 ILFG-----------------KF------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 450 i~~~-----------------~~------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+... .+ .+|...+.++.+||.+||++||.+|||+.|+|+||||..
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 3210 01 123457889999999999999999999999999999974
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.67 Aligned_cols=247 Identities=29% Similarity=0.454 Sum_probs=210.5
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||+|+||+||++.+. .++..||||++...... ......+..|+.+|+.++|+||+++++++....
T Consensus 1 lg~G~~g~Vy~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 66 (280)
T cd05608 1 LGKGGFGEVSACQMR--------------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT 66 (280)
T ss_pred CCCCCceeEEEEEEc--------------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC
Confidence 799999999998773 34568999999765432 234466788999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 312 NLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
.+|+||||+++++|..++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..
T Consensus 67 ~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 67 DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 99999999999999877743 34699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCccCCCCCCC
Q psy6357 388 FTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 388 ~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~~~i~~~~~~~p~~~s 462 (635)
+.... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||..... ..+...+......+|..++
T Consensus 147 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (280)
T cd05608 147 LKDGQSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFS 225 (280)
T ss_pred cCCCCccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCC
Confidence 64432 23446789999999999988876 899999999999999999999976542 3334444444556667789
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
.++.+||.+||+.||++|| +++++++||||+.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=398.97 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=218.0
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
+...+..|.++++||.|+||+||++.+. ..+..||+|++............+..|+.+|++|+|||
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk--------------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPN 73 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHK--------------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEEC--------------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCC
Confidence 4566789999999999999999999873 34568999999877666677788999999999999999
Q ss_pred eeeEEEEEec--CCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccC-------ceeeecccC
Q psy6357 300 IIKLFQVMET--TNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHAN-------NVVHRDIKA 366 (635)
Q Consensus 300 Iv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~-------gIiHrDLKp 366 (635)
||+++++|.. ...+|||||||.+++|.++|... ..+++..++.|+.||+.||.|||+. +||||||||
T Consensus 74 IVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKP 153 (1021)
T PTZ00266 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153 (1021)
T ss_pred cCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcH
Confidence 9999998854 45799999999999999988653 5699999999999999999999984 499999999
Q ss_pred cceeecC-----------------CCCeeeecccccccccCCCccccccCCCCCCCccccCCC--CcCCCccchhhHHHH
Q psy6357 367 ENLLFDE-----------------NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR--EYDGTKSDVWSLGVV 427 (635)
Q Consensus 367 ~NILl~~-----------------~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~~~ksDIwSlGvi 427 (635)
+||||+. ...+||+|||++..+.........+||+.|+|||++.+. .+ +.++||||||||
T Consensus 154 eNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~-s~KSDVWSLG~I 232 (1021)
T PTZ00266 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSY-DDKSDMWALGCI 232 (1021)
T ss_pred HHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCC-CchhHHHHHHHH
Confidence 9999964 235899999999877555455567899999999998643 34 489999999999
Q ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHhCccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 428 LYVMVTAQLPFDGPNLA-VLKQRILFGKFRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 428 lyeLltG~~PF~~~~~~-~l~~~i~~~~~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
||+|++|..||...... .+...+.. ...+| ..++.++.+||..||..+|.+||++.|+|.|+||....
T Consensus 233 LYELLTGk~PF~~~~~~~qli~~lk~-~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 233 IYELCSGKTPFHKANNFSQLISELKR-GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHHHCCCCCCcCCcHHHHHHHHhc-CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 99999999999765533 33333332 23333 34789999999999999999999999999999997543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=370.05 Aligned_cols=255 Identities=23% Similarity=0.445 Sum_probs=212.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+.. .+..||||++............+.+|+.+++.++|+||++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~ 87 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI--------------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 87 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC--------------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccc
Confidence 46789999999999999999998732 3467999999876555556677889999999999999999
Q ss_pred EEEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++... ..+|+||||+.+ +|..++.. .+++..+..++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 88 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred cceeecccccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc
Confidence 99987543 357999999964 66666643 5889999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||++.............+|+.|+|||++.+..++ .++|||||||+||+|++|..||.+.+.......+...
T Consensus 165 ~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 165 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999876655555667899999999999988876 8999999999999999999999887755544443211
Q ss_pred -------------------ccC--------------C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 -------------------KFR--------------I------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 -------------------~~~--------------~------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
... + ....+.++.+||.+||..||.+|||+.++|+||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 0 0113567899999999999999999999999999975
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 324 ~ 324 (364)
T cd07875 324 W 324 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=376.03 Aligned_cols=251 Identities=28% Similarity=0.482 Sum_probs=220.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
+.|++.||.|+||.||++..+-. +-..|.|+|... +++.++.++-||.||..++||+||+|++.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket--------------~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~a 97 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKET--------------KLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSA 97 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccc--------------hhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHH
Confidence 45578999999999999877422 234677777544 66778999999999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
|..++.+||+.|||.||-+...+...+ .|++.++..+++|++.||.|||+.+|||||||..|||++-+|.|+|+|||.+
T Consensus 98 yy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 98 YYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred HhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccc
Confidence 999999999999999999988887765 5999999999999999999999999999999999999999999999999997
Q ss_pred cccc-CCCccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC---
Q psy6357 386 NYFT-PGHMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR--- 456 (635)
Q Consensus 386 ~~~~-~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~--- 456 (635)
.... .-....+++|||+|||||++. ..+|+ +++||||||++|.||..+.+|....+...++-+|.....+
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 5543 334567899999999999874 45676 9999999999999999999999998888888777766543
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.|..++..+.|||.+||.+||..||++.+||+||||+.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 46679999999999999999999999999999999973
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.05 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=205.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC---CCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~ 302 (635)
+|.++++||.|+||+||++.+. .++..||||++............+.+|+.+++.+ +|+||++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~ 66 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP--------------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC--------------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeee
Confidence 4788999999999999999873 3557899999976433322223455677777665 7999999
Q ss_pred EEEEEec-----CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 303 LFQVMET-----TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 303 l~~~~~~-----~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
+++++.. ...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++
T Consensus 67 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~ 145 (288)
T cd07863 67 LMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 145 (288)
T ss_pred eeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9998854 345899999997 5788887654 3489999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~- 454 (635)
.+||+|||++.............+|..|+|||++.+..++ .++|||||||++|+|++|.+||..........++....
T Consensus 146 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 146 QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred CEEECccCccccccCcccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 9999999999877654444556789999999999887775 89999999999999999999998776555444443210
Q ss_pred ----------cC----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 ----------FR----------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 ----------~~----------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.. +...++.++.+||.+||++||.+|||+.++|.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.43 Aligned_cols=251 Identities=37% Similarity=0.652 Sum_probs=213.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||+|+||+||++... .++..||+|++..............+|+.++++++|+||++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~--------------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~ 66 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK--------------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDV 66 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET--------------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC--------------CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccc
Confidence 678899999999999999873 345689999998876555555555679999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+.+...+++||||+.+++|.+++.....+++..++.++.||+.||.+||+.+|+|+||||+|||++.++.++|+|||++.
T Consensus 67 ~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 67 FQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999997
Q ss_pred cc-cCCCccccccCCCCCCCccccC-CCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCccCCCC--
Q psy6357 387 YF-TPGHMLTTWCGSPPYAAPELFG-GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAVLKQRILFGKFRIPF-- 459 (635)
Q Consensus 387 ~~-~~~~~~~~~~gt~~Y~APEvl~-~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~l~~~i~~~~~~~p~-- 459 (635)
.. ..........++..|+|||++. +..+. .++||||||+++|+|++|..||.... .................
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYT-RKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBS-THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccchhhhhhhhhcccccccccccc
Confidence 63 3334455677899999999998 55554 99999999999999999999999873 23333333322222111
Q ss_pred --CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 460 --YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 460 --~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..+..+.+||.+||+.||++|||+.++++||||
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 234899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=380.30 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=201.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC-----
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH----- 297 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H----- 297 (635)
...+|.++++||+|+||+||++.+. ..+..||||++.... .....+..|+.+++.+.|
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~--------------~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~ 189 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR--------------KRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPAD 189 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc--------------CCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCccc
Confidence 3578999999999999999999873 244689999996432 122345567777777644
Q ss_pred -CceeeEEEEEecC-CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCC
Q psy6357 298 -PHIIKLFQVMETT-NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 298 -pnIv~l~~~~~~~-~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~ 374 (635)
.+|+.++++|... .++|||||++ +++|.+++.+.+.+++..+..|+.||+.||.|||+ .|||||||||+||||+.+
T Consensus 190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS 268 (467)
T ss_pred CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecC
Confidence 4689999988754 5789999998 78899999888889999999999999999999997 599999999999999876
Q ss_pred C----------------CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 375 G----------------DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 375 ~----------------~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
+ .+||+|||++.... ......+||+.|+|||++.+..|. .++||||||||||||++|++||
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCC
Confidence 5 49999999886432 234467899999999999988886 8999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCccCCC------------------------------------------CCCCHHHHHHHHHhcccC
Q psy6357 439 DGPNLAVLKQRILFGKFRIP------------------------------------------FYMSAECENLIRSMLVLD 476 (635)
Q Consensus 439 ~~~~~~~l~~~i~~~~~~~p------------------------------------------~~~s~~l~~LI~~~L~~d 476 (635)
.+.+..+....+....-.+| ...+..+.+||.+||++|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 88765443333221100000 012356789999999999
Q ss_pred CCCCCCHHHHHcCcccccC
Q psy6357 477 PAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 477 P~~Rps~~eiL~Hpw~~~~ 495 (635)
|.+|||++|||+||||...
T Consensus 426 P~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhhCCCHHHHhcCcccccc
Confidence 9999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=374.42 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=205.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.++++||+|+||.||++.+. ..+..||||+... ..+.+|+.+|++|+|||||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~--------------~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv 146 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDN--------------KTCEHVVIKAGQR--------GGTATEAHILRAINHPSII 146 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEEC--------------CCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCC
Confidence 45568999999999999999999873 3456899997532 3467899999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++|......|+|||++. ++|..++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 147 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 147 QLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred CEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999994 78888888878899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH-
Q psy6357 382 FGFSNYFTP--GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-------LAVLKQRIL- 451 (635)
Q Consensus 382 FGla~~~~~--~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-------~~~l~~~i~- 451 (635)
||+|..... .......+||+.|+|||++.+..++ .++||||||||||+|++|..||.... .......+.
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 999975432 1234456899999999999888875 89999999999999999998764321 111111110
Q ss_pred -------------------------hCccCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 -------------------------FGKFRIP---------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 -------------------------~~~~~~p---------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
......| ..++.++.+||.+||++||.+|||+.|+|+||||..
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0000001 124668999999999999999999999999999974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=368.21 Aligned_cols=255 Identities=25% Similarity=0.451 Sum_probs=211.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. ..+..||||++............+.+|+.+++.++|+||++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 80 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA--------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec--------------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhc
Confidence 4678999999999999999998763 23467999999876555566678889999999999999999
Q ss_pred EEEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++... ...|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~ 157 (355)
T cd07874 81 LLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred eeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC
Confidence 99998543 357999999965 56666543 5889999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||++.............+|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+...
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999876655555667899999999999888876 8999999999999999999999876643332222110
Q ss_pred ------------------------ccC---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ------------------------KFR---------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ------------------------~~~---------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
... .+...+.++.+||.+||..||.+|||+.|||+||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 000 11124567899999999999999999999999999975
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 317 ~ 317 (355)
T cd07874 317 W 317 (355)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.91 Aligned_cols=256 Identities=22% Similarity=0.423 Sum_probs=214.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||.|+||.||++.+. ..+..||+|++.... .......+.+|+++|++++|+||++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~--------------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 67 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHK--------------PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVG 67 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEEC--------------CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccc
Confidence 4567889999999999999999773 245689999987653 3445567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++|...+.+||||||+.+++|.+++...+.+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~D 147 (333)
T cd06650 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 147 (333)
T ss_pred eeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEee
Confidence 9999999999999999999999999998888899999999999999999999975 799999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI----------- 450 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i----------- 450 (635)
||++..+... ......++..|+|||++.+..++ .++|||||||++|+|++|..||.......+...+
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 9999765332 23445789999999999887765 8999999999999999999999765543332111
Q ss_pred ---------------------------------HhCc-cCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 451 ---------------------------------LFGK-FRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 451 ---------------------------------~~~~-~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.... ..++ ..++.++.+||.+||++||++|||+.||+.||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 0111 1357889999999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.73 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=207.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||.|+||.||++..... ..+..||||.+... ..+.+|+.+|++|+|+|||
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~------------~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv 149 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGD------------EQRKKVIVKAVTGG-------KTPGREIDILKTISHRAII 149 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCC------------ccceeEEEEecccc-------ccHHHHHHHHHhcCCCCcc
Confidence 3456799999999999999999875321 23467999998654 2346899999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.....+|+|||++. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++.++|+|
T Consensus 150 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~D 228 (392)
T PHA03207 150 NLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGD 228 (392)
T ss_pred ceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999995 68888887778899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---
Q psy6357 382 FGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA---VLKQRILF--- 452 (635)
Q Consensus 382 FGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~---~l~~~i~~--- 452 (635)
||++....... ......||+.|+|||++.+..++ .++|||||||+||+|++|..||.+.... .....+..
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~ 307 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence 99997654322 22356799999999999988886 8999999999999999999999764321 11111110
Q ss_pred -C-------------------------ccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 453 -G-------------------------KFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 -~-------------------------~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. .+..| ..++.++.+||.+||..||++|||+.+||.||||...
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 01111 1246789999999999999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=362.85 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=214.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.+++.||+|+||.||++... .++..||||++.+... .......+.+|+.++..++|+||+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~ 66 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK--------------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC--------------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCce
Confidence 36888999999999999998773 3456899999975332 33345668889999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.....+|+||||+.+++|.+++.+ ...+++..+..++.||+.||+|||+.+|+||||||+||||+.++.+||+||
T Consensus 67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred EEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999999999976 357999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc--cccccCCCCCCCccccCC----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 383 GFSNYFTPGHM--LTTWCGSPPYAAPELFGG----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 383 Gla~~~~~~~~--~~~~~gt~~Y~APEvl~~----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
|++..+..... ....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+..+....+....
T Consensus 147 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (331)
T cd05597 147 GSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH 226 (331)
T ss_pred CceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 99876543322 223568999999999863 2223489999999999999999999999888777777765432
Q ss_pred cCCCC---CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 FRIPF---YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~p~---~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+.+|. .++.++++||.+||..++.. |+++.++++||||..
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 33332 47999999999999764444 789999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.90 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=217.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---HHHHHHHHHHHHHHhhCCCCcee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+.|.+.+.||.|++|.||.+... .++..||||.+...... ......+.+|+.++++++||||+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~--------------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 67 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV--------------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67 (263)
T ss_pred CcccccceecCCCceEEEEEEEc--------------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCee
Confidence 35777899999999999999762 34568999998765432 23456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.....+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|
T Consensus 68 ~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred eeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEee
Confidence 99999999999999999999999999998888899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--cc
Q psy6357 382 FGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KF 455 (635)
Q Consensus 382 FGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~ 455 (635)
||++........ .....++..|+|||++.+..++ .++||||||+++|+|++|+.||...+.......+... ..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 226 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC
Confidence 999876543211 1335678899999999887765 9999999999999999999999876655544444333 34
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+|..++..+.+||.+||..+|.+|||+.+||+|+||
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 5667789999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=369.22 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=219.5
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
.....+.|.+++.||+|+||.||++.+. .++..||+|++.+... .......+.+|+.+++.++||
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~--------------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp 103 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK--------------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEEC--------------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCC
Confidence 3455688999999999999999999873 3456899999975432 233445677899999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
||+++++++.....+|+|||||++++|.+++.. ..+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+|
T Consensus 104 ~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred CCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999999998865 4689999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC--ccccccCCCCCCCccccCCCC---cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 379 LADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGRE---YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 379 L~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~---~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
|+|||++....... .....+||+.|+|||++.... ..+.++|||||||+||+|++|..||...+.......+...
T Consensus 183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999998764322 234567999999999987543 2348999999999999999999999998888788887754
Q ss_pred c--cCCCC--CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 454 K--FRIPF--YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ~--~~~p~--~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
. +.+|. .++.++++||..||..++.+ |+++.+|++|+||..
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 3 33443 58999999999999844433 789999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.39 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=210.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||.|+||.||++.+.. .+..||||++...... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------------~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~ 68 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKL--------------TENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVT 68 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecC--------------CCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcce
Confidence 34678999999999999999998732 3467999999755322 22245678999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++...+..|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECc
Confidence 99999999999999999974 7877776543 489999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG------- 453 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~------- 453 (635)
||++...... .......+|+.|+|||++.+....+.++|||||||++|+|++|.+||...+..+....+...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07872 148 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227 (309)
T ss_pred cccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999765322 22344567899999999876543358999999999999999999999887655444333210
Q ss_pred ------------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 ------------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ------------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...++ ..++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 1368899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=374.90 Aligned_cols=246 Identities=22% Similarity=0.384 Sum_probs=216.5
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
+.|++..+.+.- ++-||.|+.|.||+|.+ .++.||||.++.. -..+|+-|
T Consensus 117 e~WeiPFe~IsE-----LeWlGSGaQGAVF~Grl----------------~netVAVKKV~el---------kETdIKHL 166 (904)
T KOG4721|consen 117 ELWEIPFEEISE-----LEWLGSGAQGAVFLGRL----------------HNETVAVKKVREL---------KETDIKHL 166 (904)
T ss_pred hhccCCHHHhhh-----hhhhccCcccceeeeec----------------cCceehhHHHhhh---------hhhhHHHH
Confidence 446665433333 67799999999999987 3467999987422 12578889
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++|+|+||+.|.++|.....+|||||||..|.|...|+....++......|..+|+.||.|||.+.|||||||.-||||+
T Consensus 167 RkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs 246 (904)
T KOG4721|consen 167 RKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS 246 (904)
T ss_pred HhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
.+..|||+|||-++..........++||..|||||+|...+.. .|+|||||||||||||||..||...+...++--+-.
T Consensus 247 ~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs 325 (904)
T KOG4721|consen 247 YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS 325 (904)
T ss_pred ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccC
Confidence 9999999999999888776677789999999999999999987 999999999999999999999988765544333332
Q ss_pred C--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 G--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
. .+++|..+++.++-||+.||+-.|..||+|.+||.|
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 2 456778899999999999999999999999999999
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=364.82 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=208.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||.|+||.||++.+. .++..||||++............+.+|+.+|++++|+||+++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT--------------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC--------------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhh
Confidence 468999999999999999999863 345689999997654444455678899999999999999999
Q ss_pred EEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++... ..+|++|+++ +++|.+++. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred hhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCE
Confidence 9987543 4579999998 778877664 4679999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--- 454 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--- 454 (635)
||+|||++..... .....++|+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 158 kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 158 RILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred EEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999987543 23456789999999999875444589999999999999999999998766544333332100
Q ss_pred --------------------cCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 --------------------FRIP--------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 --------------------~~~p--------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+ ..+++.+.+||.+||..||.+|||+.|||+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 1246678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=381.97 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=225.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.+.+.||+|+||+||++.+. .++..||||++............+.+|+.+|..++|+||++
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~--------------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~ 95 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV--------------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc--------------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEE
Confidence 4568999999999999999999763 35678999999887777777788899999999999999999
Q ss_pred EEEEEecCC--------eEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 303 LFQVMETTN--------NLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 303 l~~~~~~~~--------~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
+++.+.... .+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 96 ~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NIL 175 (496)
T PTZ00283 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175 (496)
T ss_pred eecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 988775332 378999999999999988643 46899999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
|+.++.+||+|||+++.+... ......+||+.|+|||++.+..++ .++|||||||+||+|++|..||...+...+.
T Consensus 176 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~ 254 (496)
T PTZ00283 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVM 254 (496)
T ss_pred EeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999999765432 233457899999999999988876 8999999999999999999999998888887
Q ss_pred HHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 448 QRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 448 ~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+..+.+ .+|..++.++.+||.+||..||.+||++.++|+|||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 255 HKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 77776544 4677899999999999999999999999999999998743
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=379.39 Aligned_cols=255 Identities=30% Similarity=0.530 Sum_probs=221.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.+.||.|+||.||++..... .+..||+|.+... .......+.+|+.+|+.++|||||++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~-------------~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~ 130 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSD-------------PKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKH 130 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCC-------------CCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 34588899999999999999976322 1457999987544 33444567789999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++|...+.+||||||+++++|.++|.. ...+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||
T Consensus 131 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL 210 (478)
T PTZ00267 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210 (478)
T ss_pred EEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEE
Confidence 9999999999999999999999887753 346899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-
Q psy6357 380 ADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF- 455 (635)
Q Consensus 380 ~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~- 455 (635)
+|||++..+.... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+..+..
T Consensus 211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 289 (478)
T PTZ00267 211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289 (478)
T ss_pred EeCcCceecCCccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999998765332 24456799999999999888776 899999999999999999999999888888887776654
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
++|..++.++.+||.+||..||++||++.++|.|+|+..
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 456678999999999999999999999999999999863
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=351.97 Aligned_cols=252 Identities=34% Similarity=0.597 Sum_probs=226.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.+++.||.|+||.||++.+. .++..||||++..... .......+.+|+++|++++||||++++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHK--------------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEc--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence 5788999999999999999873 2457899999976543 234557788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.....+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred eEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHH
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAE 464 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~ 464 (635)
+...... ....++++.|+|||.+.+..++ .++||||||+++|+|++|..||...+.....+.+..+...+|..++..
T Consensus 148 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (290)
T cd05580 148 AKRVKGR--TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPD 224 (290)
T ss_pred ccccCCC--CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHH
Confidence 9876544 3455789999999999877765 899999999999999999999998887777788887788888889999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 465 CENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+.+||.+||..||.+|+ +++++++||||..
T Consensus 225 l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 99999999999999999 9999999999963
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.19 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=213.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|.+.+.||+|+||+||++.+. .++..||||.+...... ......+.+|+.+|+.++|++|+.+++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR--------------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc--------------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeE
Confidence 567889999999999999874 34568999998765433 233456778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
.+...+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred EEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999999888644 359999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH-HhCccCCCC
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA---VLKQRI-LFGKFRIPF 459 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~---~l~~~i-~~~~~~~p~ 459 (635)
++.............|+..|+|||++.+..++ .++|||||||++|+|++|..||...... .....+ ......++.
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05630 148 LAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226 (285)
T ss_pred ceeecCCCccccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc
Confidence 99776544444456789999999999888876 8999999999999999999999864321 111111 112233556
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
.++.++.+||.+||+.||.+||| ++|+++||||..
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 78999999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.10 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=213.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.++++||+|+||.||++.+. ..+..||||++.+... .......+.+|+.++..++|++|++++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLK--------------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEEC--------------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEE
Confidence 5788999999999999999873 2346799999975332 233345577899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.+...+||||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 68 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999999999773 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--ccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 384 FSNYFTPGH--MLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 384 la~~~~~~~--~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
++..+.... .....+||+.|+|||++.. ..+ +.++|||||||+||+|++|..||...+.......+....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 226 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCC-CCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence 987653322 2234579999999999862 234 489999999999999999999999988888877776543
Q ss_pred cCCCC---CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 FRIPF---YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~p~---~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+.+|. .++.++++||.+||..++.. |+++.++++||||..
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 23333 57999999999999765544 689999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.03 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=206.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
..+|.++++||.|+||.||+|.+...... ..+..||||++.... .......+.+|+.+|.++ +||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKK---------SSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCc---------ccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceee
Confidence 35688899999999999999976322111 234579999997543 344456789999999999 8999999
Q ss_pred EEEEEecC-CeEEEEEeccccchhhhhhhhc-------------------------------------------------
Q psy6357 303 LFQVMETT-NNLYLVTEYARGGEIFSHLLTI------------------------------------------------- 332 (635)
Q Consensus 303 l~~~~~~~-~~~~LV~E~~~ggsL~~~l~~~------------------------------------------------- 332 (635)
+++++... ..+|+||||+++|+|.+++...
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99988654 4689999999999999888642
Q ss_pred -------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCC---cccc
Q psy6357 333 -------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTT 396 (635)
Q Consensus 333 -------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~ 396 (635)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 237788899999999999999999999999999999999999999999999998654321 1123
Q ss_pred ccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhC-ccCCCCCCCHHHHHHHHHhc
Q psy6357 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA-VLKQRILFG-KFRIPFYMSAECENLIRSML 473 (635)
Q Consensus 397 ~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~-~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L 473 (635)
..+++.|+|||++.+..++ .++|||||||+||||++ |..||.+.... .+...+..+ ....|..++.++.+||.+||
T Consensus 236 ~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CCCCccccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 3456789999999888776 89999999999999997 99999876543 333333333 34456678999999999999
Q ss_pred ccCCCCCCCHHHHHc
Q psy6357 474 VLDPAKRLTLTQISN 488 (635)
Q Consensus 474 ~~dP~~Rps~~eiL~ 488 (635)
..||.+|||+.+|++
T Consensus 315 ~~dp~~RPs~~el~~ 329 (338)
T cd05102 315 QGDPKERPTFSALVE 329 (338)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.64 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=215.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.++++||+|+||.||++... .++..||||++.+... .......+.+|+.++..+.|++|+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l 66 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK--------------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 36888999999999999999773 3456899999976332 33344567889999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++...+.+||||||+.+++|.+++.+ ...+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+||
T Consensus 67 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999999999987 467999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc--cccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-
Q psy6357 383 GFSNYFTPGHM--LTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 383 Gla~~~~~~~~--~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~- 454 (635)
|++........ ....+||+.|+|||++.+ ..+ +.++|||||||+||+|++|..||...+.......+....
T Consensus 147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~ 225 (331)
T cd05624 147 GSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE 225 (331)
T ss_pred cceeeccCCCceeeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC
Confidence 99976643322 233579999999999875 334 489999999999999999999999888777777776543
Q ss_pred -cCCCC---CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 -FRIPF---YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 -~~~p~---~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+++|. .++.++.+||.+||..++.+ |++++++++|+||..
T Consensus 226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 33443 36899999999999976654 569999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=339.33 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=218.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|++|.||.+... .++..||||.+............+.+|+.++++++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR--------------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc--------------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 4788999999999999998873 23467999999776555566677889999999999999999999
Q ss_pred EEec-CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 306 VMET-TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 306 ~~~~-~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
.+.. ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+||
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred eecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecc
Confidence 8864 44689999999999999988763 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCC
Q psy6357 383 GFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFY 460 (635)
Q Consensus 383 Gla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~ 460 (635)
|++...... .......+++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. ..+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08223 147 GIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD 225 (257)
T ss_pred cceEEecccCCccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 999766432 233455788999999999888776 899999999999999999999998877666666655544 45567
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++.++.+||.+||..||.+|||+.+|++||||
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.91 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=215.5
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|.+.+.||.|+||+||++.+. .++..||||++....... .....+.+|+.+|+.++|+||+.+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~ 67 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR--------------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC--------------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEE
Confidence 567889999999999998873 345689999997654332 23455778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++...+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||
T Consensus 68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg 147 (285)
T cd05632 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred EEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCC
Confidence 999999999999999999998887654 359999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCccCCCC
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK----QRILFGKFRIPF 459 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~----~~i~~~~~~~p~ 459 (635)
++.............|+..|+|||++.+..++ .++|||||||++|+|++|..||......... ..+......++.
T Consensus 148 ~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05632 148 LAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226 (285)
T ss_pred cceecCCCCcccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc
Confidence 99766544444556789999999999887776 8999999999999999999999876544332 333333445566
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
.++.++.+||..||+.||++||+ +.+++.|+||..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 78899999999999999999999 899999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=348.67 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=206.8
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||.|+||.||++... .++..||+|++....... .....+..|+++|++++||||++++++++...
T Consensus 1 lg~G~~g~Vy~~~~~--------------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~ 66 (277)
T cd05607 1 LGKGGFGEVCAVQVK--------------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT 66 (277)
T ss_pred CCCCCceEEEEEEEc--------------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC
Confidence 799999999998873 345689999997544322 22344567999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 67 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK 146 (277)
T ss_pred eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence 9999999999999988876543 48899999999999999999999999999999999999999999999999998776
Q ss_pred CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCccCCC-CCCCHH
Q psy6357 390 PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLKQRILFGKFRIP-FYMSAE 464 (635)
Q Consensus 390 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~~~i~~~~~~~p-~~~s~~ 464 (635)
.........++..|+|||++.+..++ .++|||||||++|+|++|..||..... ..+...+......++ ..++.+
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd05607 147 DGKTITQRAGTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEE 225 (277)
T ss_pred CCceeeccCCCCCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHH
Confidence 54444556789999999999888875 899999999999999999999976432 233333333333332 357999
Q ss_pred HHHHHHHhcccCCCCCCCH----HHHHcCccccc
Q psy6357 465 CENLIRSMLVLDPAKRLTL----TQISNHKWMSV 494 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~----~eiL~Hpw~~~ 494 (635)
+.+||.+||+.||++||++ ++++.|+||..
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 9999999999999999999 77889999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=338.43 Aligned_cols=251 Identities=30% Similarity=0.481 Sum_probs=221.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+.+.||+|++|.||++.+. .++..||+|.+............+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRK--------------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEc--------------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheee
Confidence 667889999999999999873 345689999998766666677889999999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+......|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred eccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccc
Confidence 99999999999999999999998764 5689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCCCC
Q psy6357 385 SNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFYMS 462 (635)
Q Consensus 385 a~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~~s 462 (635)
+....... ......+++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+....+ .++..++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08529 148 AKLLSDNTNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYS 226 (256)
T ss_pred ceeccCccchhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 88765432 23345788999999999888776 899999999999999999999998887777777665543 3444688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.++.++|.+||+.+|++||++.+|+.|||+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.09 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=192.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
..+||+|+||+||+|..... ..+..||||++...... ..+.+|+.+|++++||||+++++++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~------------~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG------------KDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLS 69 (317)
T ss_pred ccccccCCCeEEEEEEEccC------------CCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEec
Confidence 46899999999999986322 23468999999765432 346789999999999999999999854
Q ss_pred --CCeEEEEEeccccchhhhhhhhc---------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee----cCC
Q psy6357 310 --TNNLYLVTEYARGGEIFSHLLTI---------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----DEN 374 (635)
Q Consensus 310 --~~~~~LV~E~~~ggsL~~~l~~~---------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl----~~~ 374 (635)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +..
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 70 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred CCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc
Confidence 457899999995 5777766432 258999999999999999999999999999999999999 456
Q ss_pred CCeeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH------
Q psy6357 375 GDIKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA------ 444 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~------ 444 (635)
+.+||+|||++...... ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||......
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~ 228 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccc
Confidence 78999999999876432 22345678999999999987654458999999999999999999999653311
Q ss_pred ---HHHHHHHhC-c----------cCC---------------------------CCCCCHHHHHHHHHhcccCCCCCCCH
Q psy6357 445 ---VLKQRILFG-K----------FRI---------------------------PFYMSAECENLIRSMLVLDPAKRLTL 483 (635)
Q Consensus 445 ---~l~~~i~~~-~----------~~~---------------------------p~~~s~~l~~LI~~~L~~dP~~Rps~ 483 (635)
.....+... . ..+ ....+.++.+||.+||++||.+|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~ 308 (317)
T cd07868 229 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 308 (317)
T ss_pred ccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH
Confidence 111111100 0 000 01135678999999999999999999
Q ss_pred HHHHcCccc
Q psy6357 484 TQISNHKWM 492 (635)
Q Consensus 484 ~eiL~Hpw~ 492 (635)
+|+|+||||
T Consensus 309 ~e~l~hp~f 317 (317)
T cd07868 309 EQAMQDPYF 317 (317)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=344.84 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=210.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++.+||.|+||.||++.+. .++..||+|++..........+.+.+|+.++++++|+||++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~ 66 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR--------------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC--------------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeee
Confidence 36888999999999999999873 2456899999875543333335678999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.....+++||||++++.|..++.....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||+
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred eEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999999999999988888777767899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6357 385 SNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---------- 453 (635)
Q Consensus 385 a~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---------- 453 (635)
+....... ......++..|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 147 ARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred ceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 98765433 2334567889999999876443348999999999999999999999876644333222110
Q ss_pred ---------ccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------KFRIP------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~~~~p------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
....| ..++..+.+||.+||..+|++|||+.|++.||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00011 1357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=344.92 Aligned_cols=252 Identities=30% Similarity=0.440 Sum_probs=206.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.++++||.|++|.||+|... .++..||||++............+.+|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK--------------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66 (285)
T ss_pred CceEeeEecccCceEEEEEEEC--------------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3678899999999999999873 34568999999765444444467789999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++.....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+||
T Consensus 67 ~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 67 VLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred EEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcc
Confidence 9999999999999997 5787777543 46899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Q psy6357 383 GFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-------- 453 (635)
Q Consensus 383 Gla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-------- 453 (635)
|++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 146 GLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred cceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 998765322 22234467889999999876554348999999999999999999999876543322221100
Q ss_pred ---------------c------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------------K------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------------~------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. ......++.++.+||.+||..||.+|||+.+|+.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00112478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.56 Aligned_cols=255 Identities=31% Similarity=0.504 Sum_probs=221.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++|.++++||.|+||+||++... .++..||||.+....... .....+..|+++|+.++|+||+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 66 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK--------------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc--------------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 36788999999999999999773 245689999998765443 456778899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++......|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||||+.++.++|+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~d 146 (316)
T cd05574 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSD 146 (316)
T ss_pred eeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEee
Confidence 99999999999999999999999988754 4699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC------------------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHH
Q psy6357 382 FGFSNYFTPGH------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431 (635)
Q Consensus 382 FGla~~~~~~~------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeL 431 (635)
||++....... ......||..|+|||++.+..++ .++|||||||++|+|
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l 225 (316)
T cd05574 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEM 225 (316)
T ss_pred cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHH
Confidence 99987543211 11234688899999999887775 899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCccCCCCC--CCHHHHHHHHHhcccCCCCCCC----HHHHHcCccccc
Q psy6357 432 VTAQLPFDGPNLAVLKQRILFGKFRIPFY--MSAECENLIRSMLVLDPAKRLT----LTQISNHKWMSV 494 (635)
Q Consensus 432 ltG~~PF~~~~~~~l~~~i~~~~~~~p~~--~s~~l~~LI~~~L~~dP~~Rps----~~eiL~Hpw~~~ 494 (635)
++|..||...+.......+......++.. ++.++.+||.+||..||++||| +++||.||||+.
T Consensus 226 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 226 LYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 99999999888777777776665555544 6899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=348.69 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=210.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||.|+||.||++.+. .++..||||.+...... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~ 68 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSK--------------LTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVT 68 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEc--------------CCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcce
Confidence 4678999999999999999999873 24468999998754322 22345678999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 69 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 69 LHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECc
Confidence 9999999999999999996 5888877654 4689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG------- 453 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~------- 453 (635)
||++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 227 (301)
T cd07873 148 FGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227 (301)
T ss_pred CcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 9999765322 22334567889999999876554458999999999999999999999887765444332210
Q ss_pred ------------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ------------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ------------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+.+| ..++.++++||.+||+.||.+|||++|||+||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 236889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.92 Aligned_cols=251 Identities=30% Similarity=0.448 Sum_probs=213.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc----CHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL----DERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+|.+.+.||.|+||.||+|.. .++..||||++..... .......+.+|+.+|++++|+||+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~---------------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 65 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT---------------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65 (265)
T ss_pred CccccceEeccCCeEEEEEEE---------------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 366778999999999999865 2456899999875432 233456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.....+|+||||+++++|.+++.+...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|
T Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred eEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEecc
Confidence 99999999999999999999999999998878899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-------CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy6357 382 FGFSNYFTP-------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG- 453 (635)
Q Consensus 382 FGla~~~~~-------~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~- 453 (635)
||++..... ........++..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+...
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 224 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR 224 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc
Confidence 999875421 1223345688999999999887775 8999999999999999999999876544433333322
Q ss_pred --ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 --KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 --~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...++..++.++.+||.+||..+|.+||++.++|+||||
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 234566789999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=342.32 Aligned_cols=252 Identities=28% Similarity=0.489 Sum_probs=221.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.+++.||.|+||.||++.+. .++..||+|++.+.... ....+.+.+|++++++++||||++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 66 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR--------------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc--------------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHH
Confidence 4788999999999999999763 34578999999865443 35567889999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++......|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred HhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999999999999998877899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCccCCCCCC
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~l~~~i~~~~~~~p~~~ 461 (635)
+.............++..|+|||++....+. .++|+||||+++|+|++|..||...+ ...+.+........+|..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccC
Confidence 9876654444556788899999999887765 89999999999999999999998766 3444444443556677788
Q ss_pred CHHHHHHHHHhcccCCCCCCCH--HHHHcCccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTL--TQISNHKWM 492 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~--~eiL~Hpw~ 492 (635)
+.++.++|.+||..||.+||++ .++++||||
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.17 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=212.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.++++||.|+||.||++.+. .++..||+|++.... .......+.+|+++|++++||||+++++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~--------------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHR--------------PSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYG 66 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEc--------------CCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5788999999999999999763 344679999986543 3445567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++...+.+|+||||+++++|.+++.+...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||+
T Consensus 67 ~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 67 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 999999999999999999999999888889999999999999999999997 6999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG----------- 453 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~----------- 453 (635)
+...... .....+++..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+...
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 8765432 23456789999999999877765 8999999999999999999999765533332222110
Q ss_pred --------------------------ccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 --------------------------KFRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 --------------------------~~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
....| ..++.++.+||.+||..+|++|||+.+|++||||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 01111 1367889999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.60 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=221.3
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+++.||.|+||.||++... .++..||||.+............+.+|+.+|+.++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK--------------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66 (256)
T ss_pred CceEEEEecccCceEEEEEEEc--------------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheee
Confidence 4788999999999999998873 24568999999877666666788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeeecc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLADF 382 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~DF 382 (635)
++......++||||+++++|.+++... ..+++..+..++.||+.+|.|||+++|+|+||||+||+++.++ .++|+||
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~ 146 (256)
T cd08220 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDF 146 (256)
T ss_pred eEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccC
Confidence 999999999999999999999999764 3489999999999999999999999999999999999998654 6899999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPFYM 461 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~~~ 461 (635)
|++.............++..|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.... ..++..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08220 147 GISKILSSKSKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225 (256)
T ss_pred CCceecCCCccccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence 999877655444556789999999999887765 89999999999999999999999887777666665543 3456678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
+.++.+||.+||..+|.+|||+.|||+||||
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.49 Aligned_cols=252 Identities=32% Similarity=0.561 Sum_probs=221.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|+||.||++... .++..||+|++............+..|+.+|+.++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK--------------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec--------------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeee
Confidence 4778899999999999998763 34568999999877666777788999999999999999999999
Q ss_pred EEe--cCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhc-----cCceeeecccCcceeecCC
Q psy6357 306 VME--TTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCH-----ANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 306 ~~~--~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LH-----s~gIiHrDLKp~NILl~~~ 374 (635)
++. ....+|+||||+.+++|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.+
T Consensus 67 ~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~ 146 (265)
T cd08217 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146 (265)
T ss_pred eeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC
Confidence 875 345689999999999999988653 57999999999999999999999 8999999999999999999
Q ss_pred CCeeeecccccccccCCCc-cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 375 GDIKLADFGFSNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
+.+||+|||++........ .....+++.|+|||++....++ .++||||||+++|+|++|..||...+...+.+.+...
T Consensus 147 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 225 (265)
T cd08217 147 NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG 225 (265)
T ss_pred CCEEEecccccccccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence 9999999999987754432 4456789999999999887765 8999999999999999999999988877777777665
Q ss_pred cc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 KF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+ .++..++.++.+||.+||..+|.+||++.+||+|||+
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 44 4566789999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.22 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=199.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||+|+||.||++.+.. .+..||+|+.... ....|+.+|++++|+||+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------------~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~ 122 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG--------------QPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRM 122 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC--------------CCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcCh
Confidence 4579999999999999999998732 3457999986443 23569999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+|||++. ++|.+++.. ...+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 123 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 123 KDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred hheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecC
Confidence 999999999999999995 678777765 456999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCH----------HHHHHHHH
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGPNL----------AVLKQRIL 451 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~~PF~~~~~----------~~l~~~i~ 451 (635)
|++.............||+.|+|||++.+..++ .++|||||||++|||+++ ..+|..... ..+...+.
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 999865444444567799999999999888876 899999999999999984 444443211 11111111
Q ss_pred hC---ccCCC------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 452 FG---KFRIP------------------------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 452 ~~---~~~~p------------------------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. ...++ ..++.++.+||.+||+.||.+|||+.|||+||||.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 00 00011 13466788899999999999999999999999996
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.05 Aligned_cols=253 Identities=32% Similarity=0.512 Sum_probs=213.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||.|+||.||++.+. ..+..||+|.+... .......+.+|+.+++.++|+||++++++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~--------------~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~ 70 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK--------------ETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 70 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC--------------CCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEE
Confidence 556789999999999999873 23457899998654 34456778899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+......|+||||+.+++|..++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred EeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccc
Confidence 9999999999999999999887764 456999999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-CccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cC
Q psy6357 386 NYFTPG-HMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FR 456 (635)
Q Consensus 386 ~~~~~~-~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~ 456 (635)
...... .......++..|+|||++. +..++ .++|||||||++|+|++|.+||...+.......+.... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd06643 151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA 229 (282)
T ss_pred ccccccccccccccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC
Confidence 765332 2234457899999999984 33344 78999999999999999999998877655555554332 23
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.|..++.++.+||.+||..||.+||++.+|++||||....
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 4556889999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=333.97 Aligned_cols=252 Identities=33% Similarity=0.512 Sum_probs=222.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+++.||.|+||.||.+... .++..||+|.+.....+......+.+|+.+|++++|+||+++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 66 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT--------------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66 (256)
T ss_pred CceEeeEecccCCceEEEEEEc--------------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEe
Confidence 4788999999999999987753 35578999999877666666778899999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.....+++||||+++++|.+++... ..+++..+..++.||+.+|.|||+.+++|+||+|+||+++.++.+||+|||
T Consensus 67 ~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~ 146 (256)
T cd08221 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFG 146 (256)
T ss_pred EEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCc
Confidence 999999999999999999999998765 458999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC-CCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYM 461 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-~p~~~ 461 (635)
++....... ......+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.+. .+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08221 147 ISKILGSEYSMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY 225 (256)
T ss_pred ceEEcccccccccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 998664432 33456789999999999887765 8999999999999999999999988877777777665443 34557
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
+.++.+||.+||..+|.+||++.++|+|+|+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.06 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=204.0
Q ss_pred ceeecccc--CCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 229 NLRKAGEG--EDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 229 il~kLG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
++.+||+| +|++||++... .++..||||++............+.+|+.+++.++||||++++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~ 67 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK--------------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRAT 67 (327)
T ss_pred hhhhccccccceEEEEEEeec--------------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 46789999 78899988773 456789999998766555556678889999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
|..++..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.++|+||+.
T Consensus 68 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~ 147 (327)
T cd08227 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 147 (327)
T ss_pred EEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccch
Confidence 99999999999999999999998653 4589999999999999999999999999999999999999999999999987
Q ss_pred cccccCC--------CccccccCCCCCCCccccCCC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 385 SNYFTPG--------HMLTTWCGSPPYAAPELFGGR--EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 385 a~~~~~~--------~~~~~~~gt~~Y~APEvl~~~--~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
+...... .......++..|+|||++.+. .++ .++|||||||++|+|++|..||................
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 226 (327)
T cd08227 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 226 (327)
T ss_pred hhccccccccccccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC
Confidence 5433211 011223567789999999763 454 89999999999999999999998654433322222111
Q ss_pred cC----------------------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 455 FR----------------------------------------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 455 ~~----------------------------------------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+ ....++.++.+||.+||++||++|||++|||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 11125678999999999999999999999999
Q ss_pred Cccccc
Q psy6357 489 HKWMSV 494 (635)
Q Consensus 489 Hpw~~~ 494 (635)
||||..
T Consensus 307 ~p~f~~ 312 (327)
T cd08227 307 HSFFKQ 312 (327)
T ss_pred Chhhhh
Confidence 999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.39 Aligned_cols=252 Identities=26% Similarity=0.463 Sum_probs=205.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|+||.||++.+. .++..||+|++............+.+|+.++++++|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~--------------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 66 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR--------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC--------------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHH
Confidence 4788999999999999999873 34568999999765433333456778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++.+...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||+
T Consensus 67 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 67 VLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred HhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccch
Confidence 9999999999999996 577777754 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC---------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF-DGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF-~~~~~~~l~~~i~~~--------- 453 (635)
+...... .......+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+.......+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred hhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 9865432 22334567889999999877654458999999999999999988875 444433333322110
Q ss_pred -------cc-------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 -------KF-------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 -------~~-------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+ .....++.++.+||.+||..||.+|||+++||.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.53 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=214.2
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-------HHHHHHHHHHHHHHhhCCCCc
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-------ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-------~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
|.+...||.|+||.||+|.+. ..+..||+|.+...... ....+.+.+|+.++++++|+|
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 67 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA--------------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67 (267)
T ss_pred ccccceeecCCCeEEEEEEec--------------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 556788999999999999863 23468999998765432 123466889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++......++||||+++++|.+++...+.+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred eeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEe
Confidence 99999999999999999999999999999988888999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC-------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 380 ADFGFSNYFTPGH-------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 380 ~DFGla~~~~~~~-------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 9999988765211 12234678899999999887775 899999999999999999999987665444444333
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 453 G-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 453 ~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. ...+|..++..+.+||.+||+.||.+||++.+|++||||
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3 335666789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.46 Aligned_cols=252 Identities=28% Similarity=0.527 Sum_probs=220.4
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|+||.||.+... .++..||||.+............+.+|+.++++++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK--------------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc--------------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEe
Confidence 4788999999999999988763 34568999999766555556678899999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||+|+|||++.++.++|+|||
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~ 146 (256)
T cd08218 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFG 146 (256)
T ss_pred eecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999999999887643 58999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFYM 461 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~~ 461 (635)
++....... ......+++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. ..+..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08218 147 IARVLNSTVELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY 225 (256)
T ss_pred ceeecCcchhhhhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccC
Confidence 997664322 22334678899999999887765 899999999999999999999988877777776665544 456678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
+.++.+||.+||+.+|.+||++.+||+||||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.91 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=212.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+++.||.|+||.||++.+. .++..||||++............+.+|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR--------------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC--------------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceee
Confidence 4788999999999999999873 34568999999876654555678889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++.....+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||+
T Consensus 67 ~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred EEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 999999999999999 99999988653 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6357 385 SNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 385 a~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--------- 453 (635)
+....... ......++..|+|||++.+....+.++|||||||++|+|++|.++|.+.........+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred cccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence 98765432 2445678999999999876554458999999999999999999999776654443333211
Q ss_pred ----------ccCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 ----------KFRI-----------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ----------~~~~-----------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
...+ ...++.++.+||.+||..+|.+|||++++|.||||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 123578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=359.07 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=213.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI 300 (635)
++...|.++++||.||.+.||++.. .+..-||+|.+.....+...+.-+.+|+.+|.+|+ |.+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~---------------s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~I 422 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN---------------SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKI 422 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec---------------CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceE
Confidence 4567899999999999999999876 23346788887777778888999999999999995 9999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhccc-CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+||+|-..++.+|+||||- ..+|..+|.+... ++...++.+..||+.|+.++|.+||||.||||.|+|+ -.|.+||
T Consensus 423 IqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKL 500 (677)
T KOG0596|consen 423 IQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKL 500 (677)
T ss_pred EEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEe
Confidence 99999999999999999987 4789888887665 3435888999999999999999999999999999999 4679999
Q ss_pred ecccccccccCC---CccccccCCCCCCCccccCCCCcC----------CCccchhhHHHHHHHHHhCCCCCCCCC-HHH
Q psy6357 380 ADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYD----------GTKSDVWSLGVVLYVMVTAQLPFDGPN-LAV 445 (635)
Q Consensus 380 ~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~----------~~ksDIwSlGvilyeLltG~~PF~~~~-~~~ 445 (635)
+|||+|..+..+ -...+.+||+.||+||.+....+. +.++||||||||||+|+.|++||.... ...
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a 580 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA 580 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence 999999887654 345678999999999998643332 478999999999999999999996543 333
Q ss_pred HHHHHHhCc--cCCCCCCCH-HHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 446 LKQRILFGK--FRIPFYMSA-ECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 446 l~~~i~~~~--~~~p~~~s~-~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
-+..|.... +++|..-+. ++.++|+.||.+||.+|||+.++|+|||++.
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 344454443 355554333 4999999999999999999999999999975
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.43 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=217.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|.++++||.|+||.||++.+. .++..||+|++... .......+.+|+.++++++|+||++++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK--------------ETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLY 68 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc--------------CCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 46888999999999999999873 24568999998654 445557788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g 148 (280)
T cd06611 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG 148 (280)
T ss_pred EEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCc
Confidence 9999999999999999999999988764 469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--- 454 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--- 454 (635)
++...... .......+++.|+|||++.. ..++ .++|||||||++|+|++|.+||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd06611 149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227 (280)
T ss_pred cchhhcccccccceeecchhhcCHHHHhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC
Confidence 98765332 22344578999999999852 3343 78999999999999999999998877666666665443
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+..|..++.++.+||.+||..+|.+||++.+||+||||...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 23455688999999999999999999999999999999744
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.40 Aligned_cols=239 Identities=18% Similarity=0.271 Sum_probs=207.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
..||+|+++.||+|.+ ++..||||++...... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 26 ~~i~~g~~~~v~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 26 VLIKENDQNSIYKGIF----------------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred eEEeeCCceEEEEEEE----------------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 4689999999999987 3568999999765443 2335678899999999999999999999866
Q ss_pred ----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeecccc
Q psy6357 310 ----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 310 ----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
...+++||||+.+|+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 45789999999999999999888889999999999999999999998 5999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccCC--CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCCCC
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFGG--REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIPFY 460 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p~~ 460 (635)
+...... .....++..|+|||++.+ ..++ .++|||||||++|||++|..||...+...+...+... .+.+|..
T Consensus 170 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (283)
T PHA02988 170 EKILSSP--PFKNVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLD 246 (283)
T ss_pred Hhhhccc--cccccCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCc
Confidence 9865432 234568899999999976 4554 8999999999999999999999998887777777544 3455556
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
++.++.+||.+||+.||++|||+.+|++
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 8999999999999999999999999985
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.90 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=208.9
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.++++||.|+||.||++... .++..||||++.... ......+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~ 72 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV--------------NTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYF 72 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc--------------CCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 46777899999999999999763 345689999987553 23345678999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++...+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccee
Confidence 99999999999999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC--
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP-- 458 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p-- 458 (635)
+...... .......|+..|+|||++. ...++ .++|||||||++|+|++|..||...........+....+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL 231 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc
Confidence 8765432 2234457899999999974 33444 899999999999999999999866543333222222222211
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
..++..+.+||.+||..+|++|||+++|++|||
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 246789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=340.39 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=214.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+.|.++++||.|+||.||++... .++..||+|++... +......+.+|+.+++.++|+||++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~--------------~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~ 73 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNK--------------ETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVK 73 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEEC--------------CCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEee
Confidence 3467889999999999999999773 34568999998754 4455677889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++..+..+|+||||+++++|..++.+ ...+++..++.++.||+.+|.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred eEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEcc
Confidence 99999999999999999999999887754 35689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~- 454 (635)
||++...... .......+++.|+|||++.+ ..++ .++|||||||++|+|++|..||...+.......+....
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 232 (292)
T cd06644 154 FGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 232 (292)
T ss_pred CccceeccccccccceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC
Confidence 9998754322 22344568889999999853 3343 78999999999999999999998776555444444332
Q ss_pred --cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 --FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 --~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...+..++.++.+||.+||..+|.+||++.+|++||||..
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 2234567899999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.92 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=209.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||.|+||.||+|.+. .++..||||++..... .....+.+|+.++++++|+||+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~ 71 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL--------------HTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAY 71 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC--------------CCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeee
Confidence 456888999999999999999863 3456899999975432 233567789999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.....+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred eEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCc
Confidence 99999999999999999999999999887889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC--
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI-- 457 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~-- 457 (635)
++....... ......++..|+|||++.. ..++ .++|||||||++|+|++|..||...........+....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK 230 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC
Confidence 998664322 2334568899999999852 3343 78999999999999999999997654333322222222221
Q ss_pred ---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 458 ---PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 458 ---p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
+..++..+.+||.+||..+|++|||+++||+|+|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 2346889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.73 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=215.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.+++.||.|+||+||++... .++..||||++....... ....+.+|+.+|+.++|+||++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~ 65 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL--------------PNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYY 65 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc--------------CCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEE
Confidence 35788999999999999999863 245689999997665444 567889999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+.+......|+|||++++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 9999999999999999999999998764 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 382 FGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 382 FGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
||++..+.... ......++..|+|||++......+.++|+|||||++|+|++|..||...+.......+......
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC
Confidence 99987665432 2244568899999999877633348999999999999999999999887665555554443221
Q ss_pred -CC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 457 -IP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 457 -~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++ ..++.++.+||.+||..||.+|||+.+|++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 11 2467899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=360.25 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=217.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|.-++.||.|+||.||.+.+ ..+.+.||||.+..... +.+.+..++.|+.+|++|.|||+|.+.+
T Consensus 28 f~dLrEIGHGSFGAVYfArd--------------~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkg 93 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARD--------------VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKG 93 (948)
T ss_pred HHHHHHhcCCccceeEEeec--------------cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccc
Confidence 55689999999999998876 34557899999976543 4566788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhh-hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~-~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+|..+...|||||||- |+-.++|. ..++|-+.++..|+.+.+.||.|||+.+.||||||..||||++.|.|||+|||.
T Consensus 94 CyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 94 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred eeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccc
Confidence 9999999999999995 55556554 335799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC-CC-C
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IP-F 459 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-~p-~ 459 (635)
|....+. .+++|||+|||||||. ...|+ -++||||||++..||...++|+.+.+.......|.....+ ++ .
T Consensus 173 Asi~~PA---nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~ 248 (948)
T KOG0577|consen 173 ASIMAPA---NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN 248 (948)
T ss_pred hhhcCch---hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc
Confidence 9877654 5789999999999985 34565 7999999999999999999999888877777777766543 22 2
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+|..+..||..||++-|.+|||.+++|.|+|+.-.-|
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 58999999999999999999999999999999975433
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.18 Aligned_cols=247 Identities=32% Similarity=0.613 Sum_probs=217.6
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||.|+||.||++.+. ..+..||||++.+... .....+.+.+|+.+++.++|+||+++++++.+..
T Consensus 1 lg~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (262)
T cd05572 1 LGVGGFGRVELVKVK--------------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK 66 (262)
T ss_pred CCCCCceEEEEEEEC--------------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC
Confidence 799999999999873 2456899999976543 2344577889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
.+|+||||+++++|.+++.+...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 67 YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred ccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999877654
Q ss_pred CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCccCCCCCCCHHHHH
Q psy6357 392 HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--LAVLKQRIL--FGKFRIPFYMSAECEN 467 (635)
Q Consensus 392 ~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~--~~~l~~~i~--~~~~~~p~~~s~~l~~ 467 (635)
.......++..|+|||++.+..++ .++|+||||+++|+|++|..||.... .......+. .....+|..++.++.+
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKD 225 (262)
T ss_pred cccccccCCcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 334456788999999999877775 89999999999999999999998776 556666666 3456677778999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 468 LIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 468 LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
||.+||..+|.+||+ +.|+++||||..
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=348.15 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=219.2
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+++|||+|+||.||+++. .+.|..||||.+... .++..+..|+.||++++.++||++|+.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH--------------~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGS 96 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIH--------------RESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGS 96 (502)
T ss_pred HHHHHHhcCCcchHHHHHHH--------------hccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhh
Confidence 34589999999999997765 467889999998654 356788999999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
|.....+|||||||-.|++.+.+.. ++.|++.++..+++..++||+|||...-||||||..||||+.+|.+||+|||.|
T Consensus 97 YFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 97 YFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred hccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhcccc
Confidence 9999999999999999999998864 467999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCCCCC
Q psy6357 386 NYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIPFYM 461 (635)
Q Consensus 386 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p~~~ 461 (635)
..+... ....+.+|||.|||||++....|+ .++||||||++..||..|++||...........|-.. -+.-|..+
T Consensus 177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEW 255 (502)
T ss_pred chhhhhHHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhh
Confidence 877543 345678999999999999988887 8999999999999999999999876654443333322 23445678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
|.++.+||+.||.+.|++|-|+.++++|||++..
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999999999999999754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.29 Aligned_cols=264 Identities=23% Similarity=0.245 Sum_probs=208.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHH--HHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAA--AQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~--~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
...+|.+.++||+|+||.||++.+........... ......+..||||++.... .......+.+|+.+|.+++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 34578888999999999999998643321110000 0111234579999987543 34455678899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc-------------------cCCHHHHHHHHHHHHHhhhhhccCceee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-------------------QMAEKEASRLFRQILSAVAYCHANNVVH 361 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiH 361 (635)
+++++++......||||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999885431 3677889999999999999999999999
Q ss_pred ecccCcceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh--CCC
Q psy6357 362 RDIKAENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT--AQL 436 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt--G~~ 436 (635)
|||||+||||+.++.+||+|||++........ .....++..|+|||++....++ .++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999986543321 2234457889999999887775 89999999999999986 678
Q ss_pred CCCCCCHHHHHHHHHh--------CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 437 PFDGPNLAVLKQRILF--------GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 437 PF~~~~~~~l~~~i~~--------~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
||...+.......+.. .....|..++..+.+||.+||..||.+|||+.+|.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8887665554443321 112234568899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=337.39 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=213.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.+.||+|+||.||+|.+..... .+..||+|++.... .......+.+|+.+|.+++||||+++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~-----------~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~ 71 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSK-----------RELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRL 71 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCC-----------ceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeE
Confidence 4567788999999999999998754332 34689999997653 33445678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+||||+.+++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred EEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCC
Confidence 99999999999999999999999998764 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccc--cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 383 GFSNYFTPGHMLT--TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~~~~--~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|++.......... ...++..|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...+..+ ..+.|
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred cccccccccchhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 9876543222111 22345789999999888776 89999999999999875 99999988877777776654 33556
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..++..+.+||.+||..+|.+||++.+|++
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=370.10 Aligned_cols=248 Identities=29% Similarity=0.447 Sum_probs=208.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l 303 (635)
.++.|.+.|.+|||+.||++.+. ..+.+||+|.+-.. ++..++.+.+||.+|++|. |+|||.+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~--------------~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDV--------------KGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEec--------------CCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 34556788999999999999873 23368999998665 7888899999999999996 9999999
Q ss_pred EEEEe-c------CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeec
Q psy6357 304 FQVME-T------TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFD 372 (635)
Q Consensus 304 ~~~~~-~------~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~ 372 (635)
++... . .-.++|+||||.||.|.++|.++ ..|++.++++|+.|+++||.+||... |||||||-+||||.
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 99431 1 13588999999999999999854 45999999999999999999999998 99999999999999
Q ss_pred CCCCeeeecccccccccCCCc----------cccccCCCCCCCcccc---CCCCcCCCccchhhHHHHHHHHHhCCCCCC
Q psy6357 373 ENGDIKLADFGFSNYFTPGHM----------LTTWCGSPPYAAPELF---GGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~----------~~~~~gt~~Y~APEvl---~~~~~~~~ksDIwSlGvilyeLltG~~PF~ 439 (635)
.++++||||||.|........ .-...-|+.|+|||++ .+...+ +|+|||+|||+||-|+....||+
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcC
Confidence 999999999999976432210 0112358999999987 455665 99999999999999999999998
Q ss_pred CCCHHHHHHHHHhCccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 440 GPNLAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 440 ~~~~~~l~~~i~~~~~~~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
... .-.|+.++|.+|. .++..+++||+.||+.||.+||++.|++.+-+..
T Consensus 260 ~sg----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 260 ESG----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred cCc----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 764 2357778888886 5999999999999999999999999999875543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=338.14 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=207.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|+||.||++.+. .++..||||++.... .......+.+|+.+|++++||||+++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHL--------------LTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYG 66 (279)
T ss_pred cchheeeeccCCCeEEEEEEEc--------------CCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4677899999999999999763 345689999997653 3344567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++......++||||+++++|..+ ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 67 AFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 99999999999999999988643 35789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCc-cCC
Q psy6357 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-------AVLKQRILFGK-FRI 457 (635)
Q Consensus 386 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-------~~l~~~i~~~~-~~~ 457 (635)
...... .....++|..|+|||++.+..++ .++|||||||++|+|++|..||..... ......+.... ..+
T Consensus 143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 143 TQLVNS-IAKTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred eecccc-cccCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 765432 33456789999999999888775 899999999999999999999965321 12222222221 122
Q ss_pred C-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 P-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+ ..++.++.+||.+||..+|.+||++++++.||||...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 2 3478899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=337.45 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=219.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.+++.||.|+||.||++.+. .++..||||++.... .......+.+|+.+++.++|+||++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK--------------RTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYY 65 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC--------------CCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeee
Confidence 36788999999999999999873 345789999997654 234456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.....+|+|+||+.+++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred EEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999999999988764 899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCC-C
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFY-M 461 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~-~ 461 (635)
+...... .......+++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..... .++.. +
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (274)
T cd06609 145 SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF 223 (274)
T ss_pred ceeecccccccccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCccccc
Confidence 9876543 233456788899999999887765 999999999999999999999987765555555544422 33334 7
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+.++.+||.+||..+|.+|||++++++||||....
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 89999999999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=333.62 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=213.7
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||.|+||.||++... .++..+|+|++..... .....+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~ 66 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI--------------ATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYF 66 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec--------------CCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceE
Confidence 46778999999999999999873 2346799999976532 2457888999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||
T Consensus 67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g 146 (262)
T cd06613 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFG 146 (262)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccc
Confidence 9999999999999999999999988776 789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC---
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR--- 456 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~---~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~--- 456 (635)
++....... ......++..|+|||++... .++ .++|||||||++|+|++|.+||...+.......+....+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd06613 147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225 (262)
T ss_pred cchhhhhhhhccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc
Confidence 997664322 23445788899999999766 665 8999999999999999999999887655544444433222
Q ss_pred --CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 457 --IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 457 --~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
.+..++.++.+||.+||..+|.+|||+.+|+.|+|
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 22346788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.39 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=216.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||.|+||.||++... .++..||||.+...... ....+.+|+.+++.+.|+||++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~ 81 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDV--------------ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVN 81 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEEC--------------CCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEee
Confidence 3468999999999999999999762 34568999999765433 2366889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++......|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred EEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999999999998854 56899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCC
Q psy6357 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p 458 (635)
|++....... ......+++.|+|||.+.+..++ .++|||||||++|+|++|..||...+.......+... ....+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06654 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239 (296)
T ss_pred ccchhccccccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCc
Confidence 9987654322 22345788999999999887775 8999999999999999999999877654333323222 12335
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++..+.+||.+||..+|++|||+.+|++||||...
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 5688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.70 Aligned_cols=252 Identities=24% Similarity=0.421 Sum_probs=211.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.|.+.+.||+|+||.||++... ..+..||+|++..... .......+.+|+.+++.++|+||++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 68 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDV--------------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68 (266)
T ss_pred CccccceecCCCCEEEEEEEEc--------------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeee
Confidence 5777899999999999999763 3456899999875433 2344567889999999999999999
Q ss_pred EEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.. ...+++||||+++++|.+++.....+++..++.++.||+.||+|||+.+|+|+||||+||+++.++.++|+
T Consensus 69 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 9999865 35789999999999999999887889999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--c
Q psy6357 381 DFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--K 454 (635)
Q Consensus 381 DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~ 454 (635)
|||++...... .......++..|+|||++.+..++ .++|||||||++|+|++|..||...........+... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC
Confidence 99998765321 122335678899999999887775 8999999999999999999999876544433333322 3
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..+|..++..+.+|| .||..+|++||+++||++||||+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 445667889999999 67778999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.40 Aligned_cols=249 Identities=28% Similarity=0.392 Sum_probs=204.7
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 305 (635)
|.++++||.|+||.||++... .++..||||++.....+... ....+|+.++.++. |+||+++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~ 65 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR--------------KTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIE 65 (282)
T ss_pred CceEeeccccccceEEEEEEc--------------CCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEE
Confidence 567899999999999999873 24568999998765433322 34457999999885 999999999
Q ss_pred EEecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 306 VMETT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 306 ~~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++.+. +.+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++. +.+||+||
T Consensus 66 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 66 VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEec
Confidence 99887 88999999996 5777777653 56899999999999999999999999999999999999999 99999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--------- 453 (635)
|++.............++..|+|||++....+.+.++|||||||++|+|++|.+||...+..+....+...
T Consensus 144 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 144 GSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred ccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99987655444445678899999998765554458999999999999999999999887655443333210
Q ss_pred ---------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+.+| ..++.++.+||.+||..+|++||++.+||+||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11111 2467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=330.87 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=216.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+|...+.||.|+||.||+|... .++..||||++..... .......+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~ 66 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL--------------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66 (258)
T ss_pred CccccceeeecCCceEEEEEEc--------------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchh
Confidence 3566788999999999999873 2456899999865432 2445678899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.....+|+||||+++++|.+++.+...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+||
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CccCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF--GKFRIPF 459 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~--~~~~~p~ 459 (635)
|++.............++..|+|||.+.... ++ .++|+|||||++|+|++|..||...........+.. ....++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD 225 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCC
Confidence 9998765444445567889999999987665 54 899999999999999999999977664444333332 2234566
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.++.++.+||.+||..+|.+||++.++|.||||
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 789999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=345.37 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=191.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME- 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~- 308 (635)
-.+||+|+||.||++..... ..+..||+|.+...... ..+.+|+.+|++++||||+++++++.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~------------~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG------------KDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLS 69 (317)
T ss_pred ceEeccCCCeeEEEEEecCC------------CccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 35899999999999986322 13467999998765432 35678999999999999999999984
Q ss_pred -cCCeEEEEEeccccchhhhhhhhc---------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee----cCC
Q psy6357 309 -TTNNLYLVTEYARGGEIFSHLLTI---------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----DEN 374 (635)
Q Consensus 309 -~~~~~~LV~E~~~ggsL~~~l~~~---------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl----~~~ 374 (635)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||+ +.+
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 70 HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC
Confidence 4567899999996 5676666421 248899999999999999999999999999999999999 456
Q ss_pred CCeeeecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-----
Q psy6357 375 GDIKLADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV----- 445 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~----- 445 (635)
+.+||+|||++....... ......+|+.|+|||++.+....+.++|||||||++|+|++|.+||.......
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~ 228 (317)
T cd07867 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 228 (317)
T ss_pred CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccc
Confidence 789999999998764321 23446789999999999875544589999999999999999999997533110
Q ss_pred ----HHHHHHh----------------------------Ccc----------CCCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy6357 446 ----LKQRILF----------------------------GKF----------RIPFYMSAECENLIRSMLVLDPAKRLTL 483 (635)
Q Consensus 446 ----l~~~i~~----------------------------~~~----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~ 483 (635)
....+.. ..+ ......+..+.+||.+||+.||.+|||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 308 (317)
T cd07867 229 FHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS 308 (317)
T ss_pred ccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH
Confidence 0000000 000 0011235678899999999999999999
Q ss_pred HHHHcCccc
Q psy6357 484 TQISNHKWM 492 (635)
Q Consensus 484 ~eiL~Hpw~ 492 (635)
.|+|+||||
T Consensus 309 ~e~l~hp~f 317 (317)
T cd07867 309 EQALQDPYF 317 (317)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.13 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=216.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||+|+||.||+|.+...... .....||+|.+.... .......+.+|+.+|..++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~---------~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 73 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNER---------LSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCL 73 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCC---------cceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceE
Confidence 34677789999999999999987543211 233579999987543 34455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++......|++|||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+
T Consensus 74 ~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05048 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAAR 153 (283)
T ss_pred EEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccc
Confidence 99999999999999999999999998764 45788999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
|||++.++.++|+|||++....... ......+++.|+|||++.+..++ .++|||||||++|||++ |..||.+...
T Consensus 154 Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 154 NCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred eEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999997653322 22344567889999999887776 89999999999999998 9999998888
Q ss_pred HHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 444 AVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 444 ~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.++...+.... ...|..++.++.+||.+||+.||.+||++.+|+++
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 233 QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877776543 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=350.66 Aligned_cols=257 Identities=24% Similarity=0.428 Sum_probs=212.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||.|+||.||++.+. .++..||||++.+..........+.+|+.+++.++|+||++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 79 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT--------------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC--------------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcc
Confidence 4578999999999999999999873 34568999999765545555677889999999999999999
Q ss_pred EEEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++++|... ...|+||||+. ++|.+.+... +++..+..++.||+.||+|||+.||+|+||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 80 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred eeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC
Confidence 99998643 35799999995 5787777653 899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||++.............++..|+|||++.+..+. .++|||||||++|+|++|..||...+.......+...
T Consensus 157 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 157 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred EEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999876554444556788999999999888876 8999999999999999999999876643333322110
Q ss_pred -------------------cc--------------CC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 -------------------KF--------------RI-------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 -------------------~~--------------~~-------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. .+ +...+.++.+||.+||..||.+|||+.|||.||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00 00 112456789999999999999999999999999998
Q ss_pred cCCC
Q psy6357 494 VHCP 497 (635)
Q Consensus 494 ~~~~ 497 (635)
.+-.
T Consensus 316 ~~~~ 319 (353)
T cd07850 316 VWYD 319 (353)
T ss_pred hccC
Confidence 6544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.51 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=217.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||.|+||.||++.+. .++..||||.+...... ....+.+|+.+++.++|+||++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~ 80 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDV--------------ATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVN 80 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEc--------------CCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceee
Confidence 3467999999999999999998762 35578999999765332 3467789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.....+|+||||+.+++|..++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred eeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999999999988765 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCC
Q psy6357 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p 458 (635)
|++....... ......++..|+|||.+.+..++ .++|||||||++|+|++|..||...+.......+... ....+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06655 160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238 (296)
T ss_pred ccchhcccccccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCc
Confidence 9987654432 23345788999999999887775 8999999999999999999999887765444444332 22345
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++..+.+||.+||..||.+|||+.+|+.||||...
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 5688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.82 Aligned_cols=254 Identities=28% Similarity=0.502 Sum_probs=218.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.|.+++.||.|+||.||++... ..+..||||.+..... .......+.+|+.+++.++|+||++++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~ 67 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHK--------------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67 (305)
T ss_pred CceEeeEeecCCCeeEEEEEEC--------------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence 5778999999999999998873 3446899999876543 233456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.....+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+.+|+|+||||.|||++.++.++|+|||+
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCC
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC----------------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 385 SNYFTPG----------------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 385 a~~~~~~----------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
+...... .......++..|+|||.+....++ .++|||||||++|+|++|..||.+.+...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 8642110 011234578899999999877775 89999999999999999999999888888777
Q ss_pred HHHhCccCCCC---CCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccc
Q psy6357 449 RILFGKFRIPF---YMSAECENLIRSMLVLDPAKRLT---LTQISNHKWMSV 494 (635)
Q Consensus 449 ~i~~~~~~~p~---~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~Hpw~~~ 494 (635)
.+.......|. .++.++.+||.+||..||++||+ +.++|+||||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 77766544443 57899999999999999999998 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=342.53 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=210.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.+++.||.|+||.||++.+. .++..||||++............+.+|+.+|++++|+||++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 70 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT--------------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVE 70 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC--------------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcc
Confidence 4567889999999999999999873 34578999999755433322335668999999999999999
Q ss_pred EEEEEecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 303 LFQVMETT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 303 l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++... +.+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 71 LKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred eEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 99998654 56899999996 4777777653 56999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----
Q psy6357 380 ADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG----- 453 (635)
Q Consensus 380 ~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~----- 453 (635)
+|||++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07845 150 ADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229 (309)
T ss_pred CccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999876533 22333456788999999876544458999999999999999999999887766655544321
Q ss_pred --------------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 --------------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 --------------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+.++ ..++.++.+||.+||..||++|||+.+||.||||...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11111 1258889999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=340.87 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=211.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||.|+||.||++.+. ..+..||+|++..........+.+.+|+++|+.++|+||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 66 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK--------------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC--------------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHH
Confidence 35788999999999999999873 2356899999876544444456778999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++......|+||||+.++.|..+......+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+
T Consensus 67 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred HhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999999999988888776666799999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---------- 453 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---------- 453 (635)
+...... .......++..|+|||++.+....+.++|||||||++|+|++|.+||......+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 147 ARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 8865432 22344568889999999876554458899999999999999999999766543332222210
Q ss_pred ---------ccCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------KFRI------------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~~~~------------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.... ...++..+.+||.+||..+|.+||++.+|++||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0001 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=334.76 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=206.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
..|.++++||.|+||.||+|.+. ..+..||||++...... ...+.+|+.++..+ +|+||+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~ 68 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHV--------------KTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATY 68 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEc--------------CCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeE
Confidence 45777889999999999999773 34568999999755322 24678899999998 69999999
Q ss_pred EEEEecC------CeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 304 FQVMETT------NNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 304 ~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
++++... ..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++
T Consensus 69 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~ 148 (272)
T cd06637 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 148 (272)
T ss_pred eeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC
Confidence 9998642 4689999999999999988764 3589999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCC-CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
.++|+|||++...... .......|+..|+|||++.. ..++ .++|||||||++|+|++|..||...........
T Consensus 149 ~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 149 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227 (272)
T ss_pred CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 9999999999765432 23345678999999999863 3344 789999999999999999999977655444443
Q ss_pred HHhCcc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 450 ILFGKF--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 450 i~~~~~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
+..... ..+..++.++.+||.+||..||.+|||+.+|+.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 228 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 333221 1223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=338.16 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=212.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|+||.||++.+. .++..||||++............+.+|+++|++++|+||+++++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~--------------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 67 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK--------------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC--------------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhh
Confidence 6888999999999999999873 24568999999765545555678899999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++...+..++||||+.++.|..++.+...+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++
T Consensus 68 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred eEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999999998777666666667999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6357 386 NYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---------- 453 (635)
Q Consensus 386 ~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---------- 453 (635)
....... ......++..|+|||++.+....+.++||||||+++|+|++|.+||...........+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 8765443 3345678899999999988733348999999999999999999999876544332222110
Q ss_pred ---------c-------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------K-------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~-------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. ..++..++.++.+||.+||..+|.+|||+++|++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.38 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=214.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+.++||.|+||.||++.+. .++..||||++............+..|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~ 66 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL--------------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC--------------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheee
Confidence 5788999999999999999763 24568999999877655567788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++.....+++|+||+++++|.+++.....+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred eEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999999999999988777999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCc-----cccccCCCCCCCccccCCCC---cCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC-cc
Q psy6357 386 NYFTPGHM-----LTTWCGSPPYAAPELFGGRE---YDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVLKQRILFG-KF 455 (635)
Q Consensus 386 ~~~~~~~~-----~~~~~gt~~Y~APEvl~~~~---~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l~~~i~~~-~~ 455 (635)
........ .....++..|+|||++.+.. +. .++||||||+++|+|++|..||.... .......+... ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence 87643322 22356788999999997655 44 89999999999999999999997653 22222222222 23
Q ss_pred CCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 456 RIPFY--MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 456 ~~p~~--~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+|.. ++..+.+||.+||+.+|.+|||+.+|+.|||+
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 44444 48999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=334.48 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=211.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC----HHHHHHHHHHHHHHhhCCCCceee
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD----ERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
|...+.||+|+||.||++... .++..||||++...... ......+.+|+++|+.++|+||++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 67 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDV--------------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67 (268)
T ss_pred ccccceecCcCceEEEEEEEc--------------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceeh
Confidence 666788999999999988762 35578999999754321 234578889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~D 381 (635)
+++++.+.+.+++||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++ .++|+|
T Consensus 68 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred hhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999999999999999999998888899999999999999999999999999999999999998776 599999
Q ss_pred ccccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H--
Q psy6357 382 FGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI---L-- 451 (635)
Q Consensus 382 FGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i---~-- 451 (635)
||++....... ......++..|+|||++.+..++ .++|||||||++|+|++|..||...........+ .
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc
Confidence 99987664321 12234678899999999887775 8999999999999999999999754432222222 1
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.....+|..++.++.++|.+||..+|.+||++.++++||||.
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 123345667889999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=337.74 Aligned_cols=247 Identities=29% Similarity=0.466 Sum_probs=211.0
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||+|+||+||++.+. .++..||+|++...... ......+..|+.+|+.++||||+++++++...+
T Consensus 1 lg~g~~g~vy~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 66 (277)
T cd05577 1 LGKGGFGEVCACQVK--------------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD 66 (277)
T ss_pred CCCCCceeEEEEEEc--------------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC
Confidence 699999999998763 34568999999765432 223456678999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++....
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred eEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 9999999999999999987765 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCccCCCCCCCHHH
Q psy6357 390 PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLKQRILFGKFRIPFYMSAEC 465 (635)
Q Consensus 390 ~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~~~i~~~~~~~p~~~s~~l 465 (635)
.........++..|+|||++.+..++ .++|||||||++|+|++|..||..... ..+...+......++..++..+
T Consensus 147 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd05577 147 GGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225 (277)
T ss_pred cCCccccccCCCCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHH
Confidence 44444456678899999999887765 899999999999999999999977543 3333444444455666789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 466 ENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 466 ~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
.+||.+||+.||.+|| ++.++++||||..
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 9999999999999999 8999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.89 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=217.1
Q ss_pred cchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHH
Q psy6357 210 ITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289 (635)
Q Consensus 210 ~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei 289 (635)
.+..+|++..+++.+ ..+||.|.||+||+|.|. -.||||+++......+.++.|.+|+
T Consensus 382 ~s~~~WeIp~~ev~l-----~~rIGsGsFGtV~Rg~wh-----------------GdVAVK~Lnv~~pt~~qlqaFKnEV 439 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLL-----GERIGSGSFGTVYRGRWH-----------------GDVAVKLLNVDDPTPEQLQAFKNEV 439 (678)
T ss_pred ccccccccCHHHhhc-----cceeccccccceeecccc-----------------cceEEEEEecCCCCHHHHHHHHHHH
Confidence 344778777555555 789999999999999983 2599999999988888999999999
Q ss_pred HHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcc
Q psy6357 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368 (635)
Q Consensus 290 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~N 368 (635)
.+|++-+|.||+-+.++|..... .||+.+|+|-+|+.+|.-. .+|.....+.|++||++||.|||.++|||||||..|
T Consensus 440 a~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnN 518 (678)
T KOG0193|consen 440 AVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNN 518 (678)
T ss_pred HHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccc
Confidence 99999999999999999988777 9999999999999998543 468999999999999999999999999999999999
Q ss_pred eeecCCCCeeeeccccccccc---CCCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy6357 369 LLFDENGDIKLADFGFSNYFT---PGHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442 (635)
Q Consensus 369 ILl~~~~~ikL~DFGla~~~~---~~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~~~ 442 (635)
|||.+++.|||+||||+.... .........|...|||||++.. .+|+ ..+||||||+|+|||++|.+||....
T Consensus 519 IFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS-~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 519 IFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS-FQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred eEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC-cccchhhhhHHHHHHHhCcCCcCCCC
Confidence 999999999999999986542 2344555678889999999863 4554 89999999999999999999999766
Q ss_pred HHHHHHHHHhCccC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 443 LAVLKQRILFGKFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 443 ~~~l~~~i~~~~~~-----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+.++-.+-.+... .-..++.++++|+..||.+++++||.+.+||.
T Consensus 598 ~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 598 RDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 66655555444221 12357789999999999999999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=339.64 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=211.4
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---HHHHHHHHHHHHHHhhCCCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+|.+++.||.|+||.||+|.+. .++..||||.+...... ......+..|+.+++.++|+||++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~--------------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~ 66 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK--------------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC--------------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChh
Confidence 4777899999999999999873 23568999999766543 333456778999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.+....++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 67 LLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred hhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEcc
Confidence 999999999999999999 899999997766 799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc------
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK------ 454 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~------ 454 (635)
||++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.++|...+.......+....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 146 FGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred ceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 9999876543 223344567889999998654444589999999999999999988888766544444432110
Q ss_pred ----------c------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 ----------F------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ----------~------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. ......+.++.+||.+||.+||.+|||+.+||.|+||...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0 0012357889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=330.92 Aligned_cols=249 Identities=30% Similarity=0.477 Sum_probs=212.7
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||.|+||.||++... .++..||+|.+.... ....+.+|+.++++++|+||++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~ 64 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK--------------ETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYY 64 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc--------------CCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeee
Confidence 45778899999999999999873 234689999986542 157888999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||
T Consensus 65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg 144 (256)
T cd06612 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144 (256)
T ss_pred eeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccc
Confidence 999999999999999999999999865 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIPF 459 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p~ 459 (635)
++....... ......++..|+|||++.+..++ .++||||||+|+|+|++|..||...........+... .+..+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd06612 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE 223 (256)
T ss_pred cchhcccCccccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchh
Confidence 998765433 23345578899999999888775 8999999999999999999999876654433333221 223344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.++.++.+||.+||+.||.+|||+.+||.||||
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.29 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=213.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|+||.||++.+. ..+..||+|.+... ........+.+|+.+|++++|+||+++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~--------------~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHR--------------PTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYG 66 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEc--------------CCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhh
Confidence 5778999999999999999873 24568999998654 24445578889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeec
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++.....+|+||||+++++|..++... ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred heecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999998887663 379999999999999999999996 6999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCc-----CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREY-----DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR---ILFG 453 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~-----~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~---i~~~ 453 (635)
||++..+... ......+++.|+|||++.+... .+.++|||||||++|+|++|..||........... +...
T Consensus 147 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 225 (286)
T cd06622 147 FGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG 225 (286)
T ss_pred cCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc
Confidence 9999765432 2344568889999999854432 24789999999999999999999976554443332 2222
Q ss_pred -ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 454 -KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 454 -~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
...+|..++.++.+||.+||..+|.+||++.++++||||....
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 2345666899999999999999999999999999999997553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=339.23 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=209.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.+++.||.|+||.||+|.+. .++..||||.+............+.+|+.+|+++.||||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~ 69 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDK--------------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEEC--------------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEE
Confidence 356888999999999999999873 235689999997655443334466789999999999999999
Q ss_pred EEEEecC--CeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 304 FQVMETT--NNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 304 ~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++... ...||||||+. ++|.+++.... .+++..++.++.||+.||+|||+.+|+|+||||+|||++.++.++|+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 70 KEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEe
Confidence 9998777 88999999997 58888876644 59999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Q psy6357 381 DFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG------ 453 (635)
Q Consensus 381 DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~------ 453 (635)
|||++...... .......+++.|+|||++.+....+.++||||||+++|+|++|.+||...+......++...
T Consensus 149 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (293)
T cd07843 149 DFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228 (293)
T ss_pred ecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 99999876543 23344567889999999876554458999999999999999999999877655444433211
Q ss_pred -------------------------ccCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 -------------------------KFRIPFY-MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 -------------------------~~~~p~~-~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...++.. ++..+.+||.+||+.+|++|||+.|+|.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0012222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=337.29 Aligned_cols=251 Identities=30% Similarity=0.449 Sum_probs=206.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+++.||.|++|.||++.+. .++..||||++............+.+|++++++++|+||++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 67 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNK--------------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67 (284)
T ss_pred ceeeeeecCCCceEEEEEEEC--------------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhh
Confidence 778999999999999999873 345689999987654444444578899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+......++||||+. ++|..++... ..+++..++.++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||+
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 68 IHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred cccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999995 6788877553 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-c--------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-K-------- 454 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-~-------- 454 (635)
+...... .......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 147 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 8765432 22334457889999999877654458899999999999999999999876644333222110 0
Q ss_pred ---------c-----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 ---------F-----------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 ---------~-----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. .....++.++.+||.+||+.||.+|||+.++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=354.11 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=207.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
...|.+++.||+|+||.||++.+..... ..+...||||++.... .......+.+|+.+|+.+ +|+|||+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~ 106 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGK---------EDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVN 106 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCc---------ccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceee
Confidence 3467778999999999999998643221 1234579999997654 334456788999999999 8999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc--------------------------------------------------
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-------------------------------------------------- 332 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-------------------------------------------------- 332 (635)
++++|.....+|+|||||.+|+|.+++...
T Consensus 107 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 107 LLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred EeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 999999999999999999999999988542
Q ss_pred --------------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCC
Q psy6357 333 --------------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH 392 (635)
Q Consensus 333 --------------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~ 392 (635)
.++++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 237888999999999999999999999999999999999999999999999997654322
Q ss_pred c---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--ccCCCCCCCHHHH
Q psy6357 393 M---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG--KFRIPFYMSAECE 466 (635)
Q Consensus 393 ~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~--~~~~p~~~s~~l~ 466 (635)
. .....++..|||||++.+..++ .++|||||||++|+|++ |..||...........+... ....|..++.++.
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 345 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIY 345 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHH
Confidence 1 1122345679999999887776 89999999999999997 99999876544433333333 3345566899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHc
Q psy6357 467 NLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 467 ~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+||.+||+.||.+|||+.+|++
T Consensus 346 ~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 346 SIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=330.04 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=211.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---CHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..|.+.+.||.|+||.||.+... .++..||||++..... .......+.+|+.+++++.|+||+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~--------------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 67 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA--------------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc--------------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCee
Confidence 35777899999999999999763 3456899999864322 234567888999999999999999
Q ss_pred eEEEEEecC--CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 302 KLFQVMETT--NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 302 ~l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++++.+. ..+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|
T Consensus 68 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred eEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEE
Confidence 999998663 568899999999999999988778999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 380 ADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 380 ~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
+|||++...... .......++..|+|||++.+..++ .++|||||||++|+|++|..||...........+...
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC
Confidence 999998765421 122345688899999999887765 8999999999999999999999876544444443322
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
....|..++..+.++|.+||. +|++||++++|++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 233556688899999999995 999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.79 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=205.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHH-HhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDI-MSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~ 304 (635)
.|.+++.||+|+||.||++.+. .++..||||++......... ..+..|+.+ ++.++|+||++++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~ 66 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHV--------------PTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFY 66 (283)
T ss_pred CceEEEEecccCCeEEEEEEEc--------------CCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeee
Confidence 5788999999999999999873 34678999999766443333 455566665 6667899999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeee
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++.....+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+|||++.++.+||
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999996 677666643 24689999999999999999999997 9999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCC----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--LAVLKQRILFG 453 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~--~~~l~~~i~~~ 453 (635)
+|||++..+..........++..|+|||++.+ ..+ +.++|||||||++|+|++|..||.... ...+...+...
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 224 (283)
T cd06617 146 CDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224 (283)
T ss_pred eecccccccccccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC
Confidence 99999987654333344578899999998864 233 488999999999999999999997532 23333333322
Q ss_pred ccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 KFRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ~~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+| ..++.++.+||.+||..+|.+||++.+|++||||...
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 33343 3478999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=361.77 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=200.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|+||.||++.+. ..+..||||.... ..+.+|+.+|++|+|+|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~--------------~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l 225 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP--------------DYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLAL 225 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC--------------CCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcE
Confidence 457889999999999999999873 2346899996432 245689999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++...+..|||||++. ++|..++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+||
T Consensus 226 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DF 304 (461)
T PHA03211 226 LDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304 (461)
T ss_pred EEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEccc
Confidence 999999999999999995 6888877654 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH
Q psy6357 383 GFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP--------NLAVLKQRIL 451 (635)
Q Consensus 383 Gla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~--------~~~~l~~~i~ 451 (635)
|++....... .....+||+.|+|||++.+..++ .++||||||||||||++|..++... ....+...+.
T Consensus 305 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 305 GAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred CCceecccccccccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 9997654321 22346799999999999988876 8999999999999999987654221 1222332222
Q ss_pred hCcc---CCC-------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 FGKF---RIP-------------------------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~---~~p-------------------------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.... .++ ..++.++.+||.+||++||.+|||+.|||+||||+.
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 2111 010 024568999999999999999999999999999963
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.10 Aligned_cols=243 Identities=28% Similarity=0.412 Sum_probs=208.3
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
+||+|+||.||+|.+...+ ++..||||++.....+....+.+.+|+.+|+.+.|+||+++++++. ..
T Consensus 2 ~lg~G~~g~v~~~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK------------SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AE 68 (257)
T ss_pred cCCCcCCcceEEeEEecCC------------CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CC
Confidence 6999999999999764332 3468999999766555566678899999999999999999999885 45
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
..++||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+|+||||.|||++.++.+||+|||++......
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 67999999999999999988788999999999999999999999999999999999999999999999999999866433
Q ss_pred Cc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCCCHHH
Q psy6357 392 HM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYMSAEC 465 (635)
Q Consensus 392 ~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~l 465 (635)
.. .....++..|+|||++....++ .++|||||||++|||++ |..||.......+...+..+. ...|..++.++
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 227 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEM 227 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 21 1222345789999999777665 89999999999999998 999999887777777776543 45677799999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHc
Q psy6357 466 ENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 466 ~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+||.+||+.||++||++.+|..
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.94 Aligned_cols=252 Identities=33% Similarity=0.562 Sum_probs=222.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+++.||.|+||.||++.+. .++..||+|++............+.+|+++++.++|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 66 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK--------------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc--------------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEE
Confidence 4778899999999999999873 24568999999877666667778999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
.+......++||||+++++|.+++... ..+++..+..++.+|+.||.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECC
Confidence 999999999999999999999988764 6799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCC
Q psy6357 382 FGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPF 459 (635)
Q Consensus 382 FGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~ 459 (635)
||++....... ......+++.|+|||.+....+. .++||||||+++|+|++|..||...+...+...+.... ..+|.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 147 FGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS 225 (258)
T ss_pred ccceeecccCcceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCC
Confidence 99998765433 33445788899999999887775 89999999999999999999998887777766665543 34566
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.++.++.++|.+||..+|.+|||+.++|+||||
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.74 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=215.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||+|+||+||++.+. ..+..||+|++.... .......+.+|+++++.++|+||++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~--------------~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~ 67 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI--------------PTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVS 67 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc--------------CCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcce
Confidence 3456788999999999999998773 345689999987543 3344577889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.....+|+||||+++++|.+++.+.+.+++..+..++.+|+.+|.|||+ .+|+|+||||+||+++.++.++|+|
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEcc
Confidence 999999999999999999999999998887889999999999999999999997 6899999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-----------HHHHHH
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-----------VLKQRI 450 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-----------~l~~~i 450 (635)
||++...... ......++..|+|||++.+..++ .++|||||||++|+|++|..||...... .....+
T Consensus 148 ~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 148 FGVSGELINS-IADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred CCcccchhhh-ccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 9998754322 22345789999999999877765 8999999999999999999999864431 222333
Q ss_pred HhCc-cCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 451 LFGK-FRIPF-YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 451 ~~~~-~~~p~-~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.... ..++. .++.++.+||.+||..||.+|||+.||++|+||...+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3221 22333 2778999999999999999999999999999997554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.45 Aligned_cols=256 Identities=26% Similarity=0.449 Sum_probs=216.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||.|+||.||++... .++..||||.+...... ..+.+.+|+.+++.++|+||++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~--------------~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~ 80 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDI--------------ATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVN 80 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEEC--------------CCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEee
Confidence 3478999999999999999999762 35578999999765433 2356789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++......|+||||+++++|.+++.+ ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred EEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcC
Confidence 99999999999999999999999998864 56899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCC
Q psy6357 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p 458 (635)
|++....... ......+++.|+|||.+.+..++ .++|||||||++|+|++|..||...+.......+... ....|
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd06656 160 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238 (297)
T ss_pred ccceEccCCccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCc
Confidence 9987654332 23345788999999999887775 8999999999999999999999776543322222221 12244
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..++..+.+||.+||..+|.+||++.+|++||||....
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 56789999999999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.79 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=214.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.++++||.|+||.||++.+. .++..||+|++..... ......+.+|+++++.+.|+||+++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR--------------PTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYG 66 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc--------------CCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhhe
Confidence 4677889999999999999873 2456899999976543 345577889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.....+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g 146 (265)
T cd06605 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG 146 (265)
T ss_pred eeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999999999876 789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhC-ccCC
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-----NLAVLKQRILFG-KFRI 457 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-----~~~~l~~~i~~~-~~~~ 457 (635)
++........ ....++..|+|||++.+..++ .++|||||||++|+|++|..||... ......+.+... ...+
T Consensus 147 ~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (265)
T cd06605 147 VSGQLVNSLA-KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL 224 (265)
T ss_pred cchhhHHHHh-hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC
Confidence 9876543222 226788899999999888776 8999999999999999999999654 233333333333 2233
Q ss_pred CCC-CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 PFY-MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p~~-~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+.. ++.++.+||.+||..||.+|||+.+|+.||||+..
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 433 78999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.31 Aligned_cols=253 Identities=32% Similarity=0.587 Sum_probs=224.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
+.|.+.+.||.|+||.||++... .++..||||++.+... .......+.+|+.+++++. |+||++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~ 66 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK--------------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc--------------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchh
Confidence 36888999999999999999873 3567899999976443 3344567889999999998 999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++...+..++||||+.+++|.+++.+...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred HHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCC
Confidence 99999999999999999999999999998888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC---------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy6357 383 GFSNYFTPGH---------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441 (635)
Q Consensus 383 Gla~~~~~~~---------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~ 441 (635)
|++....... ......++..|+|||++....+. .++||||||+++|+|++|..||...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9987654321 12334578899999998877665 8999999999999999999999988
Q ss_pred CHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCccc
Q psy6357 442 NLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTL----TQISNHKWM 492 (635)
Q Consensus 442 ~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~----~eiL~Hpw~ 492 (635)
+.....+.+......+|..++..+.+||.+||+.+|.+|||+ .+||+||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 877777777777778888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.74 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=205.9
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHH-HHHHHHHH---HHHhhCCCCceeeEEEEE
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERN-LRKLFREV---DIMSHLDHPHIIKLFQVM 307 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~-~~~~~~Ei---~iL~~L~HpnIv~l~~~~ 307 (635)
.||+|+||.||++.+. .++..||||++.+....... ......|. .+++...|++|+.+++++
T Consensus 1 ~ig~g~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 66 (278)
T cd05606 1 IIGRGGFGEVYGCRKA--------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 66 (278)
T ss_pred CcccCCCeEEEEEEEe--------------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence 3799999999998763 34568999999765433211 12233343 445556899999999999
Q ss_pred ecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
...+.+|+||||+.+++|..++.....+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..
T Consensus 67 ~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 67 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCccCCCCCCCHH
Q psy6357 388 FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---NLAVLKQRILFGKFRIPFYMSAE 464 (635)
Q Consensus 388 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---~~~~l~~~i~~~~~~~p~~~s~~ 464 (635)
+... .....+|+..|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..++.+
T Consensus 147 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 225 (278)
T cd05606 147 FSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225 (278)
T ss_pred cCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHH
Confidence 5432 2234578999999999975432348999999999999999999999876 33444444444556677778999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCcccccC
Q psy6357 465 CENLIRSMLVLDPAKRL-----TLTQISNHKWMSVH 495 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~~ 495 (635)
+.+||.+||..+|.+|| ++.++++||||...
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999999999 99999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.62 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=215.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|..+++||.|+||.||+|.+. ..+..||||++.... .......+.+|+.+++++.|+||+++++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN--------------RTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYG 69 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc--------------cCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4667899999999999999873 234689999987553 3345578889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++.+....|+||||+.+++|.+++.. ..+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999999999999999999998864 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-ccCCCCCCCH
Q psy6357 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-KFRIPFYMSA 463 (635)
Q Consensus 386 ~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~ 463 (635)
....... ......++..|+|||++.+..++ .++|+|||||++|+|++|..||...........+... ...++..++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK 227 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhH
Confidence 7664432 22334678899999999887775 8999999999999999999999877665555444333 2234445788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+.+||.+||..+|++||++.+++.|+||...
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 99999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.64 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=206.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
.+|.+.++||.|+||.||++.+..... ...+..||||++.... .......+.+|+.+|..+ +|||||++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~---------~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFK---------SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred HHeehhheecCCccceEEEEEEecccc---------CccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 457778999999999999997532111 1245689999996543 233456788999999999 89999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--------------------------------------------------
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-------------------------------------------------- 333 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------------------------------------------------- 333 (635)
+++|......++|||||++|+|.+++....
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 999999999999999999999998886421
Q ss_pred -------------------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 334 -------------------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 334 -------------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
.+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 3678889999999999999999999999999999999999999999999999865
Q ss_pred cCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhC-ccCCCCCCC
Q psy6357 389 TPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA-VLKQRILFG-KFRIPFYMS 462 (635)
Q Consensus 389 ~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~-~l~~~i~~~-~~~~p~~~s 462 (635)
..... .....++..|+|||++.+..++ .++|||||||++|+|++ |..||...... ...+.+..+ ....|...+
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence 43221 1123345679999999888876 89999999999999998 99999876543 333333332 233455678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.++.+||.+||+.||++|||+.+|++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.58 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=202.2
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH-HHHHHHHHHHHHh---hCCCCceeeEEEEE
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER-NLRKLFREVDIMS---HLDHPHIIKLFQVM 307 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~-~~~~~~~Ei~iL~---~L~HpnIv~l~~~~ 307 (635)
.||+|+||.||++... .++..||||++.+...... ....+.+|..+++ ...|+||+.+++++
T Consensus 1 ~lg~G~~g~Vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 66 (279)
T cd05633 1 IIGRGGFGEVYGCRKA--------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF 66 (279)
T ss_pred CcccCCCeEEEEEEEC--------------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE
Confidence 3899999999998873 3457899999976543221 1223344544433 34799999999999
Q ss_pred ecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
...+..|+||||+.+++|.+++...+.+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++..
T Consensus 67 ~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 67 HTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCccCCCCCCCHH
Q psy6357 388 FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAVLKQRILFGKFRIPFYMSAE 464 (635)
Q Consensus 388 ~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~l~~~i~~~~~~~p~~~s~~ 464 (635)
.... ......|+..|+|||++......+.++|||||||++|+|++|..||.... ...+..........+|..++.+
T Consensus 147 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd05633 147 FSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE 225 (279)
T ss_pred cccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHH
Confidence 5432 22345789999999998643333489999999999999999999997543 2233333333345567778999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 465 CENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+.+||.+||..||.+|+ |+.++++||||..
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999999999999 6999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.81 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=203.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||.|+||.||++... .++..||||++............+.+|+.++++++||||++
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 75 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHK--------------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 75 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEEC--------------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccc
Confidence 4567999999999999999999763 24568999998655433333345678999999999999999
Q ss_pred EEEEEecCC--------eEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 303 LFQVMETTN--------NLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 303 l~~~~~~~~--------~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
+++++.... ..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~ 154 (310)
T cd07865 76 LIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK 154 (310)
T ss_pred eEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC
Confidence 999986543 4599999996 57777776543 6899999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
++.+||+|||++....... ......++..|+|||++.+....+.++||||||+++|+|++|..||...+......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~ 234 (310)
T cd07865 155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234 (310)
T ss_pred CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999997654321 22345678899999998765433489999999999999999999998766443322
Q ss_pred HHHhC-------------------ccCCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 449 RILFG-------------------KFRIP-------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 449 ~i~~~-------------------~~~~p-------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+... ...+| ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 22210 00111 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=352.91 Aligned_cols=249 Identities=31% Similarity=0.519 Sum_probs=220.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
-+.||+|.||+||.|.. .++|+.||||++++..+....-..+.+|+.||+++.||.||.|...|+.
T Consensus 569 devLGSGQFG~VYgg~h--------------RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET 634 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKH--------------RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET 634 (888)
T ss_pred HhhccCCcceeeeccee--------------cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC
Confidence 36899999999998876 4678899999999988866666889999999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhh-hhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---Ceeeeccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHL-LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---DIKLADFGFS 385 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l-~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---~ikL~DFGla 385 (635)
.+.+++|||.+.|.-|.-.| ...++|++...+.++.||+.||.|||-++|+|+||||+||||.... ++||||||+|
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence 99999999999654444444 3457899999999999999999999999999999999999997653 7999999999
Q ss_pred ccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC----CC
Q psy6357 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF----YM 461 (635)
Q Consensus 386 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~----~~ 461 (635)
+.+.+.....+.+|||.|+|||++..+.|. ..-|+||+|||+|.-|+|..||... +++...|....+-+|. .+
T Consensus 715 RiIgEksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 715 RIIGEKSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred eecchhhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhc
Confidence 999988888999999999999999999997 8999999999999999999999654 4556666666665553 48
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+.++.+||..+|+..-.+|.|.++.|.|||++..
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999999743
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=331.72 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=214.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||.|+||.||+|....... ......||||++.... .......+.+|+++|+.+.|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~ 73 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEP---------ENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKF 73 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccC---------cCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchhe
Confidence 3457778999999999999997632211 0234679999987553 33345788999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
++++......|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+||
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 74 YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred eeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 99999999999999999999999998654 2478999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAV 445 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~ 445 (635)
|++.++.++|+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+...
T Consensus 154 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999997653321 12233457789999999888876 89999999999999998 999998888888
Q ss_pred HHHHHHhCccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 LKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 l~~~i~~~~~~-~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
....+..+... .+..++..+.+||.+||..||.+||++.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 77777766543 35568999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.84 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||.|+||+||++... .++..||||.+............+.+|+.+|+.++|+||+++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~ 69 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS--------------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec--------------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccch
Confidence 357899999999999999998863 345789999987654444445677899999999999999999
Q ss_pred EEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 304 FQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 304 ~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++... ..+||||||+. ++|.+++.....+++..++.++.||+.||.|||+.+++|+||||+|||++.++.+|
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 70 KDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred HHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 9988643 35899999995 78988888888899999999999999999999999999999999999999999999
Q ss_pred eecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----
Q psy6357 379 LADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---- 453 (635)
Q Consensus 379 L~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---- 453 (635)
|+|||++...... .......++..|+|||++......+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999999876433 33345578899999998875333348999999999999999999999876543222211100
Q ss_pred ------------------------cc---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 ------------------------KF---RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ------------------------~~---~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.. .....++.++.+||.+||+.+|++|||+.+||+||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0112478899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=326.68 Aligned_cols=245 Identities=25% Similarity=0.440 Sum_probs=209.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||.|+||.||++.+. .+..||+|.+....... ..+.+|+.+|+.++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~---------------~~~~~a~K~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR---------------AQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLY 65 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec---------------cCceEEEEecccCCccH---HHHHHHHHHHHHCCCCCceeEE
Confidence 45677899999999999998763 23479999987554332 4678899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||
T Consensus 66 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCC
Confidence 9999999999999999999999988653 568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCC
Q psy6357 384 FSNYFTPGHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPF 459 (635)
Q Consensus 384 la~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~ 459 (635)
++......... ....++..|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..+. ...|.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 224 (256)
T cd05114 146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224 (256)
T ss_pred CccccCCCceeccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 99865432221 122345679999999877776 89999999999999999 999999888777777776553 33466
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..+.++.+||.+||..+|.+||++.+|++
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 68899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.44 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=205.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
...|.++++||.|+||.||++.+. ..+..||+|++.... .....+..|+.+++++ +|+||++
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~ 77 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHV--------------KTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIAT 77 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEc--------------CCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEE
Confidence 356778899999999999999873 345689999986542 3345678899999998 6999999
Q ss_pred EEEEEe------cCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 303 LFQVME------TTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 303 l~~~~~------~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+++++. ....+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 999984 346789999999999999988653 358899999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCC-CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
+.++|+|||++...... .......+++.|+|||++.. ..++ .++|||||||++|+|++|..||..........
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 99999999998765421 22345678999999999862 3444 78999999999999999999997665433333
Q ss_pred HHHhCcc-C-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 449 RILFGKF-R-IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 449 ~i~~~~~-~-~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+..... . .+..++.++.+||.+||..||.+|||+.|||+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 3322211 1 123578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.23 Aligned_cols=252 Identities=29% Similarity=0.526 Sum_probs=215.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+++.||.|+||.||++.+. .++..||+|.+..........+.+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~ 66 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK--------------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc--------------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhh
Confidence 4778899999999999999873 34567999999776544455567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeeecc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLADF 382 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~DF 382 (635)
++......|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++ .++|+||
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~ 146 (257)
T cd08225 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDF 146 (257)
T ss_pred eeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEeccc
Confidence 9999999999999999999999887643 479999999999999999999999999999999999999886 4699999
Q ss_pred cccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCC
Q psy6357 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFY 460 (635)
Q Consensus 383 Gla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~ 460 (635)
|++....... ......|++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..... ..+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08225 147 GIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN 225 (257)
T ss_pred ccchhccCCcccccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCC
Confidence 9997765332 22344688899999999877765 899999999999999999999988776666555554432 34456
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++.++.++|.+||..+|++|||+.+|++||||
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 78999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=322.29 Aligned_cols=252 Identities=31% Similarity=0.483 Sum_probs=219.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+.+.||.|++|.||+|... .++..|+||++............+.+|+.++++++|+||+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK--------------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC--------------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 3667889999999999999873 24568999999877655566788999999999999999999999
Q ss_pred EEecC--CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETT--NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~--~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++... ..+++||||+.+++|.+++.....+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~ 146 (260)
T cd06606 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFG 146 (260)
T ss_pred EEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccc
Confidence 99888 8999999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh--CccCC
Q psy6357 384 FSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVLKQRILF--GKFRI 457 (635)
Q Consensus 384 la~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l~~~i~~--~~~~~ 457 (635)
.+........ .....++..|+|||.+....++ .++||||||+++|+|++|..||.... .......+.. ....+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI 225 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCC
Confidence 9987765442 4456788999999999877765 89999999999999999999998765 2333333332 33456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
|..++..+.+||.+||..+|.+||++.+++.||||
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 67789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.25 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=209.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.+++.||.|+||.||++... .++..||||++............+.+|+.+|++++|+||+++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR--------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC--------------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccce
Confidence 467889999999999999998762 345789999997654444455678899999999999999999
Q ss_pred EEEEecCC------eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETTN------NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++.... .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred eeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE
Confidence 99987553 468999999 7788777654 679999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc--
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-- 455 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-- 455 (635)
+|+|||++...... .....+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+.....
T Consensus 158 kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 158 KILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred EEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999999865432 23456788999999987643335899999999999999999999987664433333221100
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 456 -----------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 456 -----------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+...++.++.+||.+||..||.+|||+.+++.||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01134678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=328.79 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=207.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.++|.+++.||.|+||.||++... .++..||+|++..... ....+.+|+.+++++ .|+||++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~ 67 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHK--------------KTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIAT 67 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEEC--------------CCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChhe
Confidence 467889999999999999999873 2346899999876532 335788999999999 6999999
Q ss_pred EEEEEecCC------eEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 303 LFQVMETTN------NLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 303 l~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
+++++.... .+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~ 147 (275)
T cd06608 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT 147 (275)
T ss_pred EEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc
Confidence 999996544 589999999999999888653 4799999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCC-CccccccCCCCCCCccccCCCC----cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 373 ENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGRE----YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~----~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
.++.++|+|||++...... .......++..|+|||++.... ..+.++|||||||+||+|++|..||.........
T Consensus 148 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 227 (275)
T cd06608 148 KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227 (275)
T ss_pred cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH
Confidence 9999999999998765432 2234456889999999885422 2247899999999999999999999876554444
Q ss_pred HHHHhCcc---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 448 QRILFGKF---RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 448 ~~i~~~~~---~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..+..... ..+..++.++.+||.+||..||++|||+.+|++|||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 44443322 2223477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=325.36 Aligned_cols=253 Identities=27% Similarity=0.469 Sum_probs=218.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|++|.||++... .++..||||++...... .....+.+|+.++..++|+||+++++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHK--------------PTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYG 66 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEc--------------CCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 4677899999999999999873 24568999999766432 44577889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++......++||||+++++|.+++.....+++..++.++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999999999999888889999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCcc-ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC-ccCCCC
Q psy6357 385 SNYFTPGHML-TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---NLAVLKQRILFG-KFRIPF 459 (635)
Q Consensus 385 a~~~~~~~~~-~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---~~~~l~~~i~~~-~~~~p~ 459 (635)
+......... ....++..|+|||.+....++ .++||||||+++|+|++|..||... ........+... ...++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA 225 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCc
Confidence 9876543322 255688899999999887665 8999999999999999999999776 444555555433 233445
Q ss_pred C-CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 460 Y-MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 460 ~-~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. ++..+.+||.+||..+|++|||+.+|++||||+.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 5 7899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=355.39 Aligned_cols=266 Identities=26% Similarity=0.439 Sum_probs=230.6
Q ss_pred hhccchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccc-ccCHHHHHHH
Q psy6357 207 AKEITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKK-RLDERNLRKL 285 (635)
Q Consensus 207 ~~e~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~-~~~~~~~~~~ 285 (635)
...+....|.+...++.. .++||+|+||.||+|.++..... ....||||..... ......+..+
T Consensus 144 ~~PI~r~~Wel~H~~v~l-----~kkLGeGaFGeV~~G~l~~~~~~----------~~~~VAvK~~k~~~~~~~~~~~e~ 208 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIEL-----GKKLGEGAFGEVFKGKLKLKNGF----------KVVPVAVKTTKGSSELTKEQIKEF 208 (474)
T ss_pred cccccccccEEeccCccc-----cceeecccccEEEEEEEEecCCc----------eeeeeEEEeecccccccHHHHHHH
Confidence 445566778888877776 48999999999999999766431 0123999999863 3577888999
Q ss_pred HHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhccc-CCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
++|+++|++|+|||||+|||+......++||||+|.||+|.++|++.+. ++..+...++.+.+.||+|||++++|||||
T Consensus 209 m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI 288 (474)
T KOG0194|consen 209 MKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDI 288 (474)
T ss_pred HHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence 9999999999999999999999999999999999999999999999874 999999999999999999999999999999
Q ss_pred cCcceeecCCCCeeeecccccccccCCCccc-cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTPGHMLT-TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~~~~~~-~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
-..|+|++.++.+||+||||++....-.... ...-...|+|||.+....|+ .++|||||||++||+++ |..||.+..
T Consensus 289 AARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 289 AARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred hHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCC
Confidence 9999999999999999999998764222222 12245689999999988876 99999999999999999 899999999
Q ss_pred HHHHHHHHHhCcc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 443 LAVLKQRILFGKF--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 443 ~~~l~~~i~~~~~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..++..+|....+ ++|...+.++..++.+||..+|++|||+.++.+
T Consensus 368 ~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 368 NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 9999999966655 455678899999999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=326.09 Aligned_cols=248 Identities=29% Similarity=0.492 Sum_probs=214.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|+||.||++.+. .++..||+|.+.... .....+.+.+|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~--------------~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 65 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV--------------NSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKE 65 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc--------------CCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4778899999999999998763 345689999987543 2345577889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 66 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred EEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccC
Confidence 999999999999999999999888643 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFYM 461 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~~ 461 (635)
++...... .......+++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+..+.. .+|..+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (255)
T cd08219 146 SARLLTSPGAYACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY 224 (255)
T ss_pred cceeecccccccccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 99766432 223346788999999999887765 899999999999999999999998887777776665544 356678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+..+.+||.+||..||.+|||+.+|+.-
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.25 Aligned_cols=246 Identities=34% Similarity=0.554 Sum_probs=217.2
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||.|+||.||++.+. .++..||||++..... .......+.+|+.++++++|+||+++++.+....
T Consensus 1 lg~g~~~~vy~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 66 (265)
T cd05579 1 ISKGAYGRVFLAKKK--------------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66 (265)
T ss_pred CCCCCceEEEEEEEC--------------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc
Confidence 689999999999873 2457899999976543 2345678889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
..|+||||+.+++|.+++.+...+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++......
T Consensus 67 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 67 NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998765432
Q ss_pred C---------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC-
Q psy6357 392 H---------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM- 461 (635)
Q Consensus 392 ~---------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~- 461 (635)
. ......++..|+|||++....++ .++||||||+++|+|++|..||...........+.......|..+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE 225 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcccc
Confidence 1 22345678899999999877765 899999999999999999999998888888888877667666655
Q ss_pred -CHHHHHHHHHhcccCCCCCCCH---HHHHcCcccc
Q psy6357 462 -SAECENLIRSMLVLDPAKRLTL---TQISNHKWMS 493 (635)
Q Consensus 462 -s~~l~~LI~~~L~~dP~~Rps~---~eiL~Hpw~~ 493 (635)
+..+.+||.+||+.+|.+|||+ .++|+||||.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 9999999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.76 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=213.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||+|+||.||+|.+.... ...+..||+|.+.... .......+.+|+.+|+.++|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----------~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 72 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPG----------MDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCL 72 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCC----------CCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeE
Confidence 356777899999999999999864322 1245689999997543 34455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
++++......|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 152 (283)
T cd05090 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152 (283)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhcccc
Confidence 99999999999999999999999988532 2378899999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+..
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred ceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999997654322 22334456789999999877775 89999999999999998 999998877
Q ss_pred HHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+.+.+.... ...+..++..+.+||.+||+.||++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 766666665443 44566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=332.00 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=208.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+++.||.|+||.||++... .++..||+|++..... ....+.+|+.+++++ +|+||+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~--------------~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~ 82 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNK--------------KDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVV 82 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEEC--------------CCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeE
Confidence 3577899999999999999998763 3456899999865422 224567899999999 799999
Q ss_pred eEEEEEecC-----CeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 302 KLFQVMETT-----NNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 302 ~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++++++... ...|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~ 162 (291)
T cd06639 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 999998643 368999999999999988753 35689999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCC-ccccccCCCCCCCccccCCCCc----CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 373 ENGDIKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREY----DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~----~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
.++.+||+|||++....... ......++..|+|||++..... .+.++|||||||++|+|++|.+||.........
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 99999999999988654322 2234568889999999864321 248999999999999999999999877654444
Q ss_pred HHHHhCc---cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 448 QRILFGK---FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 448 ~~i~~~~---~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..+.... ...+..++..+.+||.+||+.+|++||++.+|++||||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 243 FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4443332 223445778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=330.93 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=211.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.+.++||.|+||.||++.+..... ...+..||||++.... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~---------~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVK---------DEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCC---------CCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 4568889999999999999998642211 1234679999986543 33344678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc----------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG----------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
++++......++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+++|+||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence 999999999999999999999999886532 3577889999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
++.++|+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999876543221 1123456789999999887775 89999999999999999 7999998887777666
Q ss_pred HHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 450 ILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 450 i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+.... ..++..++..+.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 65543 35667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.90 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=204.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 304 (635)
+|.+++.||.|+||.||++.+. .++..||||++............+.+|+.+++.+. |+||++++
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~ 67 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDK--------------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67 (295)
T ss_pred CceEeeEecccCCeEEEEEEEC--------------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCcccee
Confidence 5788999999999999999873 34568999998765433333457788999999995 69999999
Q ss_pred EEEecCCe-----EEEEEeccccchhhhhhhhc-----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-
Q psy6357 305 QVMETTNN-----LYLVTEYARGGEIFSHLLTI-----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE- 373 (635)
Q Consensus 305 ~~~~~~~~-----~~LV~E~~~ggsL~~~l~~~-----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~- 373 (635)
+++..... .|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~ 146 (295)
T cd07837 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ 146 (295)
T ss_pred eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC
Confidence 99877665 8999999975 788877543 35899999999999999999999999999999999999998
Q ss_pred CCCeeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 374 NGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
++.+||+|||++..+... .......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 147 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 147 KGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred CCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 889999999998765322 2223345688999999987644334899999999999999999999987665443333321
Q ss_pred Cc-----------------cCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 453 GK-----------------FRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 453 ~~-----------------~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. ..++ ..++.++.+||.+||..||.+||++.+||.||||.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 10 0000 23788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.73 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=208.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC--------HHHHHHHHHHHHHHhhCCC
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD--------ERNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~--------~~~~~~~~~Ei~iL~~L~H 297 (635)
+|.+.+.||.|+||.||+|... .++..||||.+...... ....+.+..|+.+++.++|
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~--------------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 67 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV--------------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67 (272)
T ss_pred ceeecceecccCceEEEEEeec--------------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC
Confidence 4667789999999999999763 34568999988643211 1234567889999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
+||+++++++.....+++||||+.+++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+
T Consensus 68 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred CCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeE
Confidence 99999999999999999999999999999999888889999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC---CccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 378 KLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 378 kL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
+|+|||++...... .......++..|+|||++.... ..+.++|+||||+++|+|++|..||...........+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999999765421 1223456788999999987654 2248999999999999999999999765544333332222
Q ss_pred --ccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 --KFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 --~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...++. .++.++.+||.+||..+|.+|||+++||+||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 122222 368899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=326.72 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=211.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+.+.||+|+||.||.|....... ....||||++............+.+|+.+|+.++|+||++++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~-----------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 69 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG-----------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC-----------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEee
Confidence 4567899999999999998743321 23579999998766566667789999999999999999999998
Q ss_pred EecCCe------EEEEEeccccchhhhhhhhc------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 307 METTNN------LYLVTEYARGGEIFSHLLTI------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 307 ~~~~~~------~~LV~E~~~ggsL~~~l~~~------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+..... .++||||+.+++|..++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++++
T Consensus 70 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~ 149 (273)
T cd05035 70 CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED 149 (273)
T ss_pred eccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC
Confidence 865443 79999999999998887443 358999999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i 450 (635)
+.+||+|||++........ .....++..|+|||++.+..++ .++|||||||++|||++ |.+||.......+...+
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543321 1122346689999999877775 89999999999999999 99999888777777766
Q ss_pred HhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 451 LFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 451 ~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+ ....|..++.++.+||.+||..||.+|||+.+|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 229 RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 654 345677889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.17 Aligned_cols=251 Identities=30% Similarity=0.463 Sum_probs=207.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||.|++|.||++.+. .++..||||++............+.+|+.+++.++|+||++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~ 66 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK--------------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66 (283)
T ss_pred CchheEecCCCCeEEEEEEEc--------------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhe
Confidence 567899999999999999873 345789999997665444344567889999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+.+....|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+++|+||+|+|||++.++.++|+|||+
T Consensus 67 ~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~ 145 (283)
T cd07835 67 VHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145 (283)
T ss_pred eccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccc
Confidence 999999999999995 68998887765 699999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---------- 453 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---------- 453 (635)
+...... .......++..|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 146 ARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 9765322 22233456889999998876543348999999999999999999999876654333222110
Q ss_pred -------------cc------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 -------------KF------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 -------------~~------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.. .....++.++.+||.+||+.||.+|||+.+|+.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.87 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=214.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+++.||.|+||.||+|.+. ..+..||||++..... ......+.+|+.+++.++|+||+++++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~--------------~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN--------------RTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYG 69 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc--------------CCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhc
Confidence 4667889999999999999773 2346899999875542 345567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++......|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 70 SYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999999999988754 57899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCCCCCH
Q psy6357 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPFYMSA 463 (635)
Q Consensus 386 ~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~ 463 (635)
....... ......++..|+|||++.+..++ .++|||||||++|+|++|..||...........+.... ..++..++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCH
Confidence 7665332 22334678899999999888775 89999999999999999999997665555444443322 234445788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
++.+||.+||..+|.+||++.+|++||||...
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999999999999999643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=307.84 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=218.4
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|..++|||+|.||+||++.. .++.+.||+|.+.....++..-...++||-+|+.|+|.|||+|++
T Consensus 3 ~ydkmekigegtygtvfkarn--------------~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~d 68 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARN--------------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_pred chHHHHhhcCCcceeeEeccc--------------CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhh
Confidence 355688999999999999876 356678999999887766666677889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+...+..+.||+|||. .+|..+... ++.+..+.+..++.|++.||.|+|+++++||||||+|+||+.+|.+||+|||+
T Consensus 69 vlhsdkkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 69 VLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred hhccCceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccch
Confidence 9999999999999995 567666654 36799999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc--------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-------- 454 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-------- 454 (635)
++.+.-. ...+..+.|.||++|.++.+...++...|+||.|||+.||.. |.+.|++.+..+...+|....
T Consensus 148 arafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 9877543 245566789999999999998888899999999999999998 899999999888777775310
Q ss_pred ---cCCCC------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 ---FRIPF------------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 ---~~~p~------------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..+|. .++..-++|++++|..+|.+|++++++|+||||...+
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 01111 1334568999999999999999999999999997543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=331.29 Aligned_cols=251 Identities=28% Similarity=0.443 Sum_probs=206.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|++|.||+|.+. .++..||||++...... .....+.+|+.++++++|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 65 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR--------------TTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHD 65 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC--------------CCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeee
Confidence 4788999999999999999873 34568999999765422 22356778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++...+..+|||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+||
T Consensus 66 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 66 VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred eEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeec
Confidence 99999999999999974 788877654 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-------
Q psy6357 383 GFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK------- 454 (635)
Q Consensus 383 Gla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~------- 454 (635)
|++...... .......++..|++||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 145 GLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224 (284)
T ss_pred chhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 999765432 222345678899999998765544589999999999999999999998876554444332110
Q ss_pred -----------cCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 -----------FRI-----------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 -----------~~~-----------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..+ ...++..+.++|.+||+.||.+||++.+|++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=336.70 Aligned_cols=250 Identities=26% Similarity=0.477 Sum_probs=210.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
..+||.|+||.||++... ..+..||||.+.... ....+.+.+|+.+++.++|+||+++++.+..
T Consensus 27 ~~~lg~g~~g~v~~~~~~--------------~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 90 (292)
T cd06658 27 FIKIGEGSTGIVCIATEK--------------HTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV 90 (292)
T ss_pred hhcccCCCCeEEEEEEEC--------------CCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence 567999999999998763 245689999986542 3345678899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++....
T Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 91 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999999999999999887754 579999999999999999999999999999999999999999999999999987653
Q ss_pred CC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cCCCCCCCHHH
Q psy6357 390 PG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FRIPFYMSAEC 465 (635)
Q Consensus 390 ~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~~p~~~s~~l 465 (635)
.. .......++..|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.... ......++..+
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVL 248 (292)
T ss_pred cccccCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHH
Confidence 22 223445789999999999887776 89999999999999999999998877655544443321 12223578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 466 ENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 466 ~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+||.+||..||.+|||+.+|++||||....+
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=341.97 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=232.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCC-CCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLD-HPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~-Hpn 299 (635)
+....|..+..||+|+||.|.++.-+. +.+.+|||++++..+ ...+++-.+.|-.+|.... -|.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkg--------------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppF 411 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKG--------------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 411 (683)
T ss_pred eeecccceEEEeccCccceeeeecccC--------------cchhhhhhhhccceeeecCcccceehhhhheecCCCCch
Confidence 445566679999999999999886532 335799999988765 3445566678888888774 678
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++|+..|+.-+.+|+||||+.||+|--+|+..++|.|..+..++..|+.||-|||++|||+||||.+||||+.+|+|||
T Consensus 412 L~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 412 LVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccccccc-ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~-~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||++.. +..+....++||||.|+|||++.-.+|. .++|.||+||+|||||.|++||++.+..++++.|..-...+|
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP 570 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc
Confidence 99999975 3455667889999999999999999986 999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTL-----TQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~-----~eiL~Hpw~~~ 494 (635)
..+|.++.++.+.+|.+.|.+|..+ .+|-.||||.-
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999999999999999854 68999999973
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.32 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=200.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||.||++... .++..||||++...... .....+.+|+.+|+.++|+||+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~ 68 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR--------------INGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLL 68 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc--------------CCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEE
Confidence 357888999999999999999873 23568999999654322 222356789999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+||
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 69 HDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred EEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecc
Confidence 999999999999999996 666666654 356889999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh--C-----
Q psy6357 383 GFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQRILF--G----- 453 (635)
Q Consensus 383 Gla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~i~~--~----- 453 (635)
|++..... ........+++.|+|||++.+....+.++|||||||++|+|++|..||...... +....+.. +
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 148 GLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 99876432 222344567899999999876543347899999999999999999999765421 11111110 0
Q ss_pred ---------c-----c--CCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------K-----F--RIP---------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~-----~--~~p---------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. . ..+ ...+.++.+||.+||..||.+|||+.|+|.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 000 0135689999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=330.96 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=205.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+++.||.|+||.||++... ..+..||||++..... ....+.+|+.+++.+ +|+||+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~--------------~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~ 78 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNK--------------KNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVV 78 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEEC--------------CCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCee
Confidence 3567888999999999999998873 3456899999864322 124577899999999 699999
Q ss_pred eEEEEEe-----cCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 302 KLFQVME-----TTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 302 ~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++++++. ....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+||+++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 158 (286)
T cd06638 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT 158 (286)
T ss_pred eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC
Confidence 9999873 44679999999999999887642 34689999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCC-ccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q psy6357 373 ENGDIKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l 446 (635)
.++.++|+|||++....... ......|++.|+|||++.. ..++ .++|||||||++|+|++|..||........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999999999997664322 2344578999999999853 3343 899999999999999999999987654433
Q ss_pred HHHHHhC---ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 447 KQRILFG---KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 447 ~~~i~~~---~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...+... ....|..++.++.+||.+||+.||++|||+.+||+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 238 LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 3333222 122345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.63 Aligned_cols=253 Identities=28% Similarity=0.481 Sum_probs=214.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|...++||.|++|.||++... ..+..||||++.... ....+.+.+|+.+++.+.|+||++++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~--------------~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~ 84 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDK--------------STGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSS 84 (285)
T ss_pred hhcceEeccCCCeEEEEEEEC--------------CCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEE
Confidence 444679999999999998763 234689999986442 2334668899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+...+..|+|+||+.+++|.+++.. .++++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 85 YLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 9999999999999999999998877 679999999999999999999999999999999999999999999999999887
Q ss_pred cccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC---CCCCCC
Q psy6357 387 YFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR---IPFYMS 462 (635)
Q Consensus 387 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~---~p~~~s 462 (635)
..... .......+++.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+...... .+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCC
Confidence 55432 122345689999999999887775 8999999999999999999999887766666655544222 223378
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
..+.+||.+||..+|.+|||+.+|++||||....+
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.78 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=214.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
+.||.|+||.||++.+.... ..+..||||++....... ....+.+|+.++..++|+||+++++++...
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-----------~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 68 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-----------GKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68 (262)
T ss_pred CccccCCceEEEEEEEecCC-----------CCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence 46999999999999884331 124689999997665433 567889999999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhc---------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTI---------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~---------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
..+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+|||++.++.++|+|
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc
Confidence 9999999999999999999875 6799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 382 FGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 382 FGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
||++...... .......++..|+|||++....++ .++|||||||++|+|++ |..||.......+.+.+... ...
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 149 FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred cccccccccccccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999876543 223345678899999999877665 89999999999999999 69999998888777777654 345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.|..++.++.++|.+||..+|.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 677789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=361.25 Aligned_cols=273 Identities=22% Similarity=0.334 Sum_probs=198.3
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHH-HhhcCceEEEEEeccc-ccCHHHHHHHHHHHHHHhhCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQ-LIEELSKVAIKIIDKK-RLDERNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~-~~~~~~~VAIKii~~~-~~~~~~~~~~~~Ei~iL~~L~H 297 (635)
+......|.++++||+|+||+||++.++..........+. ....+...+.|++.+. .........+.+|+.+|++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 3445678999999999999999998764332211100000 0000111111111111 1123345678899999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
+|||++++++...+..|+|||++. ++|.+++... .......++.|+.||+.||.|||++|||||||||+||||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999994 5677666432 2345677889999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC-CCCCC---HHHH
Q psy6357 373 ENGDIKLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPN---LAVL 446 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P-F~~~~---~~~l 446 (635)
.++.+||+|||++..+.... .....+||+.|+|||++.+..++ .++||||||||||||++|..+ |.... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999998765432 23356899999999999988876 899999999999999998754 43221 1122
Q ss_pred HHHHHhC---ccCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 447 KQRILFG---KFRIP----------------------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 447 ~~~i~~~---~~~~p----------------------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+.+... ...+| ..++.++.++|.+||++||.+|||+.|+|.||||..
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 2111100 00000 125667889999999999999999999999999964
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.16 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=204.0
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
...||+|+||.||++.+. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 13 ~~~lg~g~~g~v~~~~~~--------------~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 13 RVVLGKGTYGIVYAARDL--------------STQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred eEEEecCCceEEEEeEec--------------CCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 457999999999999763 345689999987553 3445678899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhc-ccC--CHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeeeccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI-GQM--AEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLADFGFS 385 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~-~~l--~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~DFGla 385 (635)
...+++||||+.+++|.+++... ..+ ++..+..++.||+.||.|||+.+|+|+||||+||+++. ++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999999998764 445 88889999999999999999999999999999999976 679999999998
Q ss_pred ccccCC-CccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhCccCCCCC
Q psy6357 386 NYFTPG-HMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV--LKQR-ILFGKFRIPFY 460 (635)
Q Consensus 386 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~--l~~~-i~~~~~~~p~~ 460 (635)
...... .......+++.|+|||++.... ..+.++||||||+++|+|++|..||....... .... .......+|..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 765432 2233456789999999986543 12489999999999999999999997643221 1111 11223446677
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++.++.+||.+||..+|.+|||+.+|+.||||
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 89999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=337.34 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=210.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.+++.||+|+||.||+|.+...... ....||||++.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~----------~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 73 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEK----------VKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCR 73 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCc----------cceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 345688899999999999999987433211 12359999986432 3445567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++... ..++|+||+.+|+|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|
T Consensus 74 ~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred EEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcc
Confidence 99998764 578999999999999998764 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 382 FGFSNYFTPGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 382 FGla~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
||++......... ....++..|+|||++.+..++ .++|||||||++|||++ |..||.+.....+...+... ..+
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 9999876543221 122346679999999888876 89999999999999997 99999987776665544433 234
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+..++.++.+||.+||..+|.+||++.+|+.+
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 456788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.46 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=228.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH-HHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER-NLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~-~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..+.+.+-+.||+|+||.||-+... .+|..+|.|.+.+..+... .....++|-.||.+++.+.||
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvr--------------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiV 248 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVR--------------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIV 248 (591)
T ss_pred cccceeeeEEEecccccceeEEEEe--------------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEE
Confidence 3445566789999999999976653 3556789998887665432 234567899999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
.|-..|++.+.+||||..|.||+|.-+|.+.+ .|++..+..++.+|+.||++||+.+||+|||||+|||||+.|++.|
T Consensus 249 slaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 249 SLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred EEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEe
Confidence 99999999999999999999999999998877 6999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCcc
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQRILFGKF 455 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~i~~~~~ 455 (635)
+|+|||..+..+......+||.+|||||++....|+ ...|.|||||+||||+.|..||.... .+++.+.+.....
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE 407 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh
Confidence 999999999999888888999999999999999976 99999999999999999999996533 4566777777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
.+|..+|+++++|.+.+|.+||.+|. .+.++.+||||+.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 88899999999999999999999998 4679999999974
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.99 Aligned_cols=246 Identities=31% Similarity=0.500 Sum_probs=207.9
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHH-hhCCCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIM-SHLDHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~ 308 (635)
+.||.|+||.||++... ..+..||||++.+.... ......+..|..++ ..++|+||+++++++.
T Consensus 2 ~~l~~g~~~~v~~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 67 (260)
T cd05611 2 KPISKGAFGSVYLAKKR--------------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ 67 (260)
T ss_pred ccCCcCCCeeEEEEEec--------------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE
Confidence 57999999999999873 24568999999765432 22333455565554 4458999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+.+|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++...
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 68 SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred cCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC----CCCCHH
Q psy6357 389 TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP----FYMSAE 464 (635)
Q Consensus 389 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p----~~~s~~ 464 (635)
.. .....++..|+|||.+.+..++ .++||||||+++|+|++|..||...+...+...+.......+ ..++.+
T Consensus 148 ~~---~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 148 LE---NKKFVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred cc---cccCCCCcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHH
Confidence 33 2345688899999999887754 899999999999999999999998887777776665543322 357899
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHHcCccccc
Q psy6357 465 CENLIRSMLVLDPAKRL---TLTQISNHKWMSV 494 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rp---s~~eiL~Hpw~~~ 494 (635)
+.+||.+||..+|.+|| ++.|+|.||||..
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 99999999999999999 5589999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=329.04 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=212.4
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC---CCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~ 302 (635)
-|.++++||.|+||.||+|.+. .++..||||++.... .......+.+|+.+++.+. |+||++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~--------------~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~ 66 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV--------------PTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc--------------CCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeee
Confidence 3677899999999999999873 345689999987543 3344567889999999986 999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++......|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+||
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred EeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccC
Confidence 99999999999999999999999998865 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCC-
Q psy6357 383 GFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPF- 459 (635)
Q Consensus 383 Gla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~- 459 (635)
|++....... ......|+..|+|||.+.+....+.++|||||||++|+|++|..||...........+.... ..++.
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06917 146 GVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN 225 (277)
T ss_pred CceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcc
Confidence 9998765432 23445788999999998765443589999999999999999999998776554443332221 12222
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.++.+||.+||..||.+||++.+++.|+||...
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 278899999999999999999999999999999653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.88 Aligned_cols=252 Identities=30% Similarity=0.479 Sum_probs=220.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+.++||.|++|.||++... ..+..||||.+............+.+|++++.++.|+||+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL--------------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc--------------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEE
Confidence 4778899999999999998763 24468999999887665567788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++......++||||+.+++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccc
Confidence 99999999999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCc-cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCccCCCCCCCH
Q psy6357 386 NYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL-FGKFRIPFYMSA 463 (635)
Q Consensus 386 ~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~-~~~~~~p~~~s~ 463 (635)
........ .....++..|+|||.+.+..+. .++||||||+++|+|++|..||...+.......+. .....++..++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISP 225 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCH
Confidence 87654332 2345678899999998877654 89999999999999999999998766444443333 334456677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+.++|.+||..+|++|||+.+++.||||
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.85 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=213.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|+||.||+|.+..... ...+..||||++.... .......+.+|+.++..++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~ 73 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAP---------GEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCL 73 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCC---------CCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeE
Confidence 4457778999999999999998743211 1234579999997543 33445678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++......++++||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+
T Consensus 74 ~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~ 153 (283)
T cd05091 74 LGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153 (283)
T ss_pred EEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999887532 34788899999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
|||++.++.+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|||++ |..||.+...
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred heEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999876543221 2234457789999999877775 89999999999999998 8999998888
Q ss_pred HHHHHHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 444 AVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 444 ~~l~~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+...+..... ..+..++..+.+||.+||+.+|.+||++.+|+..
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888887776543 4567799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=331.60 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=202.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||.|++|.||++... .++..||||.+....... ....+.+|+.+++.++|+||+++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~--------------~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~ 68 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK--------------LTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTL 68 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc--------------CCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeE
Confidence 467889999999999999999863 245689999987543221 12346689999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 147 (291)
T cd07844 69 HDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADF 147 (291)
T ss_pred EEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcc
Confidence 999999999999999997 4888888654 46899999999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhC-------
Q psy6357 383 GFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVLKQRILFG------- 453 (635)
Q Consensus 383 Gla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l~~~i~~~------- 453 (635)
|++...... .......++..|+|||++.+....+.++|||||||++|+|++|..||.... .......+...
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 148 GLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 998754321 122234568889999998764433489999999999999999999997655 22222111100
Q ss_pred ------------ccCCC-----------CCCC--HHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ------------KFRIP-----------FYMS--AECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ------------~~~~p-----------~~~s--~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
....+ ..++ .++.+||.+||..+|.+|||+.++|+||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 1233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.88 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=215.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||.|+||.||++.+. .++..||||++..... ......+.+|+.++..++|+||++++++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~--------------~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 70 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDN--------------RTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGS 70 (277)
T ss_pred hhhheeEeecCCeEEEEEEEC--------------CCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 556889999999999999763 2456899999865432 3445678899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+......|+||||+.+++|.+++.. ..+++..+..++.||+.+|.|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 71 YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 9999999999999999999988764 578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCCCCCHH
Q psy6357 387 YFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPFYMSAE 464 (635)
Q Consensus 387 ~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~ 464 (635)
.+.... ......++..|+|||.+....++ .++|||||||++|+|++|..||...........+.... ..++..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 228 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHH
Confidence 654322 22345678899999999877765 89999999999999999999998776655555554332 2345568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+.++|.+||..+|.+||++.++++||||....
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=336.07 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=209.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
..+.|.+.+.||.|+||.||+|.+...+. ...+|+|.+... ........+.+|+.+|.++ +|+||+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~------------~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv 71 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGL------------RMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNII 71 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCc------------eeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcc
Confidence 35577888999999999999998743211 124688776543 2344556788999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
++++++...+.+|+||||+++++|.+++.... .+++..++.++.||+.||+|||+.||+|||||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlk 151 (303)
T cd05088 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 151 (303)
T ss_pred eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 99999999999999999999999999986542 47899999999999999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA 444 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~ 444 (635)
|+|||++.++.+||+|||++..............+..|+|||++.+..++ .++|||||||++|+|++ |..||...+..
T Consensus 152 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 152 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred hheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999999999998643221111122345679999999877765 89999999999999998 99999888777
Q ss_pred HHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 445 VLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 445 ~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.....+... ....+..++.++.+||.+||+.+|.+||+++++|.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 231 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777666544 234556688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=341.55 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=210.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.+.||.|+||.||++... .++..||||++............+.+|+.+|++++|+||++++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~--------------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 70 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT--------------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc--------------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHH
Confidence 56778899999999999999763 3457899999976544444556788999999999999999999
Q ss_pred EEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 305 QVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 305 ~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++.. ...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 71 DILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred HhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEec
Confidence 98753 356899999995 6899988877789999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 381 DFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 381 DFGla~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
|||++...... .......++..|+|||++......+.++|||||||++|+|++|..||...+.......+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99999765432 12234578999999999866443458999999999999999999999876543322221110
Q ss_pred --------------------cc----CC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 454 --------------------KF----RI-----PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 454 --------------------~~----~~-----p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+ .. ...++.++.+||.+||+.+|.+|||+.+++.||||....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00 01 123688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=323.30 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=220.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.++++||.|+||.||++... .++..||||.+............+.+|+.+++.++|+||+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL--------------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC--------------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhh
Confidence 4778999999999999998763 34568999999876656666678889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++......|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|.||+++.++.+||+|
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred hhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEee
Confidence 99999999999999999999998866 35689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPFY 460 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~~ 460 (635)
||++...... ......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+...+...+....+ .++..
T Consensus 147 ~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08530 147 LGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224 (256)
T ss_pred ccchhhhccC-CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchh
Confidence 9999876554 33445688899999999887775 899999999999999999999998887777776665543 35556
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++.++.++|.+||..+|.+|||+.++++||++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 88999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=339.45 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=214.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|.+.+.||.|+||.||++... ..+..||||++..........+.+.+|+.+++.++|+||+++++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK--------------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD 66 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC--------------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhh
Confidence 5788999999999999999863 23568999999765433455578889999999999999999999
Q ss_pred EEecCC-----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 306 VMETTN-----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 306 ~~~~~~-----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++.... .+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 67 ILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred hhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 987765 7899999996 5898888877789999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 381 DFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 381 DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
|||++....... ......++..|+|||++.+....+.++|||||||++|+|++|.+||...+.......+....-.
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence 999998765442 2445678899999999988733348999999999999999999999887765555444321100
Q ss_pred -------------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 -------------------------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 -------------------------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
....++.++.+||.+||+++|.+|||+.++|.||||...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 112367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.37 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=211.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.++||.|+||.||++.+. ..+..||+|++.... .....+.+|+.+|+.++|+||++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~--------------~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWK--------------KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLL 68 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEe--------------cCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheE
Confidence 34666889999999999999874 234679999987542 2346788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++.....+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCC
Confidence 9999999999999999999999998654 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 383 GFSNYFTPGHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|++......... ....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+... ....|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (263)
T cd05052 149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP 227 (263)
T ss_pred ccccccccceeeccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence 999876543221 112235679999999887776 89999999999999998 99999988887777776654 44566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..++.++.+||.+||..||++|||+.++++.
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 7789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.38 Aligned_cols=242 Identities=24% Similarity=0.429 Sum_probs=203.5
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||.|+||.||++.+. .++..||+|++.... .......+.+|+++|+.++|+||+++++++...
T Consensus 1 ~~lg~g~~g~vy~~~~~--------------~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 65 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR--------------ADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 65 (252)
T ss_pred CccCcccCccEEEEEEe--------------cCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 36999999999999873 245689999886443 444557788999999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
...|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++....
T Consensus 66 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 66 QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccc
Confidence 99999999999999999987644 58999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccc---cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHH
Q psy6357 390 PGHMLT---TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAE 464 (635)
Q Consensus 390 ~~~~~~---~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~ 464 (635)
...... ....+..|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+... ....+..++..
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA 224 (252)
T ss_pred cccccccCCCCCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHH
Confidence 321111 11224569999999887775 89999999999999998 99999877766555555443 34556678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+||.+||..+|++|||+.+|++
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.85 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=208.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||+|+||.||.+.+. ....||||.+....... ..+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~---------------~~~~~aik~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR---------------GQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec---------------CCCcEEEEEcCCCcccH---HHHHHHHHHHhcCCCCCeeeEE
Confidence 45677899999999999998762 22359999987554332 5678999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||.|||++.++.+||+|||
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g 145 (256)
T cd05113 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG 145 (256)
T ss_pred EEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCc
Confidence 9999889999999999999999998764 368999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCcc-CCCC
Q psy6357 384 FSNYFTPGHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKF-RIPF 459 (635)
Q Consensus 384 la~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~~-~~p~ 459 (635)
++......... ....++..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..... ..+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05113 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224 (256)
T ss_pred cceecCCCceeecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC
Confidence 98765433221 122345679999999877775 89999999999999998 9999988877777776665532 3455
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+..+.+||.+||..+|.+||++.+|+.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.05 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=201.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+|.++++||.|+||.||+|.+... ..+..||||++..... .......+.+|+.+++.++||||++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~------------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG------------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC------------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceE
Confidence 478899999999999999987431 1457899999987431 122235677899999999999999999
Q ss_pred EEEecC--CeEEEEEeccccchhhhhhhhc-----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC----
Q psy6357 305 QVMETT--NNLYLVTEYARGGEIFSHLLTI-----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---- 373 (635)
Q Consensus 305 ~~~~~~--~~~~LV~E~~~ggsL~~~l~~~-----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---- 373 (635)
+++... ..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 69 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~ 147 (316)
T cd07842 69 EVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPE 147 (316)
T ss_pred EEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCc
Confidence 999887 889999999964 566655422 26899999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH----
Q psy6357 374 NGDIKLADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV---- 445 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~---- 445 (635)
++.+||+|||++....... .....+++..|+|||++.+....+.++|||||||+||+|++|.+||.+.....
T Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 148 RGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred cceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 8999999999998654321 12345678899999998765433489999999999999999999997654321
Q ss_pred -----HHHHHH--------------------------hCccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCH
Q psy6357 446 -----LKQRIL--------------------------FGKFRIP-----------FYMSAECENLIRSMLVLDPAKRLTL 483 (635)
Q Consensus 446 -----l~~~i~--------------------------~~~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~ 483 (635)
....+. .....++ ...+.++.+||.+||..||++|||+
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 000000 0000111 1466789999999999999999999
Q ss_pred HHHHcCccc
Q psy6357 484 TQISNHKWM 492 (635)
Q Consensus 484 ~eiL~Hpw~ 492 (635)
.||++||||
T Consensus 308 ~eil~~~~f 316 (316)
T cd07842 308 EEALEHPYF 316 (316)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.12 Aligned_cols=246 Identities=24% Similarity=0.434 Sum_probs=208.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~---------------~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN---------------NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRL 66 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec---------------CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeE
Confidence 456788999999999999999762 235799999865432 34678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++......++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECC
Confidence 99999999999999999999999998653 4588999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++........ .....++..|+|||++....++ .++|||||||++|+|++ |..||...........+... ..+.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999987643221 1223456689999999877775 89999999999999998 99999888777766666544 2333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++.++.+||.+||..+|++||++++|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 4568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.64 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=214.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||.|+||.||+|..+.... -..+..||||++.... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIK---------GEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCC---------CCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 5678889999999999999987642111 0123579999986543 23334567889999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc----------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG----------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
++++......|+||||+.+++|.+++.... .++...+..++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~ 154 (288)
T cd05061 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154 (288)
T ss_pred EEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence 999999999999999999999999997532 2466788999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
++.++|+|||+++....... .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+.......
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999876543221 1223446789999999887775 89999999999999998 8999998887777776
Q ss_pred HHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc------Ccccc
Q psy6357 450 ILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN------HKWMS 493 (635)
Q Consensus 450 i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~------Hpw~~ 493 (635)
+... ....+..++..+.+||.+||+.||.+|||+.++++ ||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 6544 34556678899999999999999999999999987 88885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=374.61 Aligned_cols=258 Identities=29% Similarity=0.409 Sum_probs=227.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....|.+++.||.|+||.|..+..+. ++..||+|++++-.+- .....-|..|-.||...+.+.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~--------------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS--------------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec--------------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 45678889999999999999887743 3457999999874332 23345677889999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+|+..|.++.++|+|||||+||+|..+|.+..++++++++.++..|+.||+-||+.|+|||||||+||||+..|+|||+|
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-C-ccccccCCCCCCCccccC----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 382 FGFSNYFTPG-H-MLTTWCGSPPYAAPELFG----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 382 FGla~~~~~~-~-~~~~~~gt~~Y~APEvl~----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
||.|-.+..+ . .....+|||.|.+||++. +...++..+|.|||||++|||+.|..||+..+..+.+.+|+.-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE 298 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence 9999777633 2 345678999999999985 3244579999999999999999999999999999999999865
Q ss_pred ccCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccccC
Q psy6357 454 KFRIP--FYMSAECENLIRSMLVLDPAKRLT---LTQISNHKWMSVH 495 (635)
Q Consensus 454 ~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~Hpw~~~~ 495 (635)
.+.|| ..+|.++++||.++|. +|..|.. +++|..||||...
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 57777 5699999999999997 8999998 9999999999854
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.00 Aligned_cols=246 Identities=28% Similarity=0.430 Sum_probs=208.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|++|.||++.+. .+..||||.+...... ...+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~---------------~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN---------------NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQL 66 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec---------------CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccce
Confidence 345777899999999999998762 2347999998765432 3567889999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++......|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECC
Confidence 999999999999999999999999987654 699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++......... .....+..|+|||++.+..++ .++||||||+++|+|++ |..||.+.+...+...+... ....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999876532211 111224579999999887775 89999999999999999 99999988877777666544 2345
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++..+.+||.+||+.+|.+||++.+|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 5678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.75 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=210.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||.|+||.||++.+...... .....||+|.+.... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~---------~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGD---------AVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRL 74 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCC---------CCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 35678899999999999999988532110 134579999886443 33344668899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG- 375 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~- 375 (635)
++++......++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+|||++.++
T Consensus 75 ~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred EEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC
Confidence 999999899999999999999999987653 489999999999999999999999999999999999998755
Q ss_pred --CeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 376 --DIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 376 --~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
.+||+|||++........ ......+..|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~ 233 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 599999999987633221 1122335679999999887776 99999999999999997 9999998877776665
Q ss_pred HHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 450 ILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 450 i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+... ....|..++..+.+||.+||+.+|++|||+.+||+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 234 VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5443 445667789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.31 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=213.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.+.||+|+||.||+|.+..... ....||||++.... .......+.+|+.+|+.++|+||++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----------~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK-----------KEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLE 71 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC-----------CcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEe
Confidence 356778999999999999998854321 23579999987554 344456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++......|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred EEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccc
Confidence 9999999999999999999999998764 469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-Cc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 384 FSNYFTPG-HM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 384 la~~~~~~-~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
++...... .. .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||.......+...+... ..+.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP 230 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99876421 11 1122345789999999887776 89999999999999998 99999887777777776654 33556
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..++..+.+||.+||+.+|++||++.+|+++
T Consensus 231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.87 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=204.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||.||++.+. .++..||||++.... .......+.+|+.+|++++|+||+++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 68 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK--------------PTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGI 68 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc--------------CCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCch
Confidence 367889999999999999999873 345789999986432 22344667889999999999999999
Q ss_pred EEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 304 FQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 304 ~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++... ..+|+||||+. ++|.+++. ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 69 LDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred hheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEE
Confidence 9887543 35899999996 57776664 35799999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Q psy6357 379 LADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF-- 452 (635)
Q Consensus 379 L~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~-- 452 (635)
|+|||++....... ......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~ 226 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999987654321 223457899999999876543334899999999999999999999987654332221110
Q ss_pred -------------C-----------ccC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 453 -------------G-----------KFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 453 -------------~-----------~~~-----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. ... ....++.++.+||.+||+.||++|||+.++++||||....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 0123578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.30 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=206.9
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++++||.|++|+||++.+. .+++.||||++............+.+|+++++.++|+||++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 67 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR--------------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec--------------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEE
Confidence 46888999999999999999873 3456899999876544444446778999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeeec
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLAD 381 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~D 381 (635)
+++......|+||||+. ++|.+++..... +++..++.++.||+.||.|||+.+|+|+||+|+|||++. ++.+||+|
T Consensus 68 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~d 146 (294)
T PLN00009 68 DVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146 (294)
T ss_pred EEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcc
Confidence 99999999999999995 578777765443 578899999999999999999999999999999999985 55799999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG------- 453 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~------- 453 (635)
||++...... .......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999765322 22334567889999999876543348999999999999999999999876654443332210
Q ss_pred ----------------ccC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ----------------KFR------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ----------------~~~------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+. ....++.++.+||.+||+.+|++||++.++|+||||..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000 11246888999999999999999999999999999963
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.59 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=208.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
+.|.+.+.||.|+||.||++.+..... ...+|+|.+.... .......+.+|+.++.++ .||||+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------------~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 68 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL------------KMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINL 68 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC------------cceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhhe
Confidence 467788999999999999998743221 1247888876432 334456788999999999 79999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++.....+|+||||+++++|.+++.... .+++..++.++.||+.||+|||+.||+|+||||+
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~ 148 (297)
T cd05089 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAAR 148 (297)
T ss_pred EEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcc
Confidence 999999999999999999999999986532 4889999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
|||++.++.+||+|||++..............+..|+|||++....++ .++|||||||++|+|++ |..||.......+
T Consensus 149 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~ 227 (297)
T cd05089 149 NVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227 (297)
T ss_pred eEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999998653321111122234579999999887776 89999999999999997 9999998888777
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+... ....|..++.++.+||.+||..+|.+|||+++|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776654 234566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.22 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=206.9
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 308 (635)
+.++||+|+||.||+|.+..... ...||||.+............+.+|+.+|+.++|+||+++++++.
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~------------~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDS------------ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCL 70 (272)
T ss_pred cccccCcccCceEEEeEEccCCC------------eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 46789999999999998743221 136999999876556667788999999999999999999999874
Q ss_pred cC------CeEEEEEeccccchhhhhhhh------cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 309 TT------NNLYLVTEYARGGEIFSHLLT------IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 309 ~~------~~~~LV~E~~~ggsL~~~l~~------~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
.. ...++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 71 QTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN 150 (272)
T ss_pred cCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC
Confidence 32 257899999999999887742 134899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy6357 377 IKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~ 452 (635)
+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.......+...+..
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 229 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987643321 1223456789999999887775 89999999999999999 8999988877777776665
Q ss_pred Cc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 GK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+. ...+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 43 35566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.98 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=211.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.+.||.|+||.||++....... ...+..||+|.+... .......+.+|+.+|++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~---------~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCP---------EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCC---------CCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456778899999999999987522110 123356999988654 344556789999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcc-------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIG-------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
+++.....+|+||||+.+++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||+
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili 153 (288)
T cd05093 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 153 (288)
T ss_pred EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999999986543 48999999999999999999999999999999999999
Q ss_pred cCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLK 447 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~ 447 (635)
+.++.++|+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |.+||.........
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~ 232 (288)
T cd05093 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232 (288)
T ss_pred ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986543221 2233456789999999887775 89999999999999998 99999988877777
Q ss_pred HHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 448 QRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 448 ~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..+..+. ...+..++.++.+||.+||+.||.+|||+.+|+.
T Consensus 233 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7777665 3455678999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.15 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=218.1
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 308 (635)
.+++||+|+||.||+|........ +..+-||||.++... +......|.+|+.+|..|+|||||+|+++|.
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~---------~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPG---------QDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCC---------ccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 378999999999999876433211 345689999997654 4556789999999999999999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhcc--------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIG--------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~--------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
.++.+|+|+|||..|+|.++|.... +|+..+.+.|+.||+.||.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999996542 28899999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCccc---cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPGHMLT---TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~---~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i 450 (635)
..|||+||||++.+...+... ...-...|||||.|....|+ .++|||||||+|||+++ |..||.+.+.++..+.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999998765443322 22335689999999999997 99999999999999999 99999999999999999
Q ss_pred HhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 451 LFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 451 ~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
..+. ++.|..++.++.+||..||+.+|++||+|.||-
T Consensus 719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9875 567889999999999999999999999999984
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.50 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=213.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
...|.+++.||+|+||.||++.+..... ......||+|++.... .......+.+|+.+++++ +|+||++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDN---------PNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCC---------CCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3457778999999999999998743321 1233579999987653 344556788999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++.....+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 160 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA 160 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence 999999999999999999999999998542 4589999999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999999987643221 1222345679999999887776 89999999999999997 999999888
Q ss_pred HHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+...+.... ...+..++.++.+||.+||..||++|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 240 VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 777777666543 35566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=334.56 Aligned_cols=251 Identities=25% Similarity=0.471 Sum_probs=211.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|....+||.|+||.||++.+. .++..||||++..... .....+.+|+.++..+.||||++++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~--------------~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~ 86 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK--------------HSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKS 86 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc--------------CCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhh
Confidence 344568999999999998763 2456899999865432 234568899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+......|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 87 YLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred eeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999999999999886644 579999999999999999999999999999999999999999999999999987
Q ss_pred cccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cCCCCCCC
Q psy6357 387 YFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FRIPFYMS 462 (635)
Q Consensus 387 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~~p~~~s 462 (635)
.+... .......++..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... ...+..++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 166 QISKDVPKRKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244 (297)
T ss_pred hcccccccccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCC
Confidence 55432 223446789999999999887775 89999999999999999999998777655555544332 22234578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+.+||.+||+.+|.+||++.+|++||||...
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 899999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.06 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=210.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.+.|.++++||.|+||+||++... .++..||||++..... .......+.+|+.+++.++||||++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~--------------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~ 79 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV--------------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc--------------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 456888999999999999999873 2456899999865432 3445567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||+|.||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~d 158 (307)
T cd06607 80 YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLAD 158 (307)
T ss_pred EEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEee
Confidence 9999999999999999997 566666543 45699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRI 457 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~ 457 (635)
||++...... ....++..|+|||++. ...++ .++||||||+++|+|++|..||...+.......+.... ..+
T Consensus 159 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (307)
T cd06607 159 FGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 234 (307)
T ss_pred cCcceecCCC---CCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 9998765432 3456788999999884 23444 89999999999999999999998877655544444332 222
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 -PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 -p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+..++.++.+||.+||..+|.+||++.+|+.||||...
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 23478899999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.67 Aligned_cols=245 Identities=36% Similarity=0.634 Sum_probs=219.3
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
||.|+||.||.+... .++..||+|++...... ......+..|+.++++++|+||++++++++...
T Consensus 1 lg~G~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (250)
T cd05123 1 LGKGSFGKVLLVRKK--------------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE 66 (250)
T ss_pred CCCCCceEEEEEEEC--------------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC
Confidence 699999999998873 24568999999776442 335668889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
..|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 67 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 67 KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred eeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999876543
Q ss_pred -CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHH
Q psy6357 392 -HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIR 470 (635)
Q Consensus 392 -~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~ 470 (635)
.......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+...+...+....+.+|..++..+.+||.
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 225 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLIS 225 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 234456788899999999877765 899999999999999999999988887777777777778888889999999999
Q ss_pred HhcccCCCCCCCH---HHHHcCccc
Q psy6357 471 SMLVLDPAKRLTL---TQISNHKWM 492 (635)
Q Consensus 471 ~~L~~dP~~Rps~---~eiL~Hpw~ 492 (635)
+||..||.+||++ +++++||||
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.32 Aligned_cols=259 Identities=29% Similarity=0.525 Sum_probs=239.0
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
++.+....++..||-|+||.|-++.+...+ ..+|+|++++..+ +....+.+..|-.||..+..+.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~--------------~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~f 481 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQK--------------ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDF 481 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccc--------------hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchH
Confidence 355666777899999999999988764332 1378999987665 5566788899999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
||+||-.|.++..+|++||-|-||.|...|.+.+.|.+..+..++..+++|++|||++|||+|||||+|+||+.+|-+||
T Consensus 482 IvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 482 IVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred HHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRI 457 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~ 457 (635)
.|||+|..+..+....++||||.|.|||++.....+ .++|.||||+++||||+|.+||.+.+....++.|+.+ .+.+
T Consensus 562 VDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 562 VDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF 640 (732)
T ss_pred eehhhHHHhccCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc
Confidence 999999999999999999999999999999998887 9999999999999999999999999999999999987 5788
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
|..++..+.+||+++...+|.+|.. +.+|-.|.||..
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999999999999999986 799999999974
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.24 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=207.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||.|+||.||++.+. .++..||||++............+.+|+.+++.+.|+||++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~--------------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 66 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK--------------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC--------------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheee
Confidence 567899999999999999873 235689999998764333444667899999999999999999999
Q ss_pred EecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 307 METT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 307 ~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+... ...++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+++|+||||+|||++.++.++|+|||
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 67 VTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred EecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 9887 89999999997 4888887665 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc------
Q psy6357 384 FSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF------ 455 (635)
Q Consensus 384 la~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~------ 455 (635)
++....... ......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 146 LARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225 (287)
T ss_pred ceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence 998765432 233446688899999887644335899999999999999999999988775544443332100
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 456 -------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 456 -------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011138899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.43 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=210.3
Q ss_pred ccCCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH------------HHHHHHHHH
Q psy6357 223 LLKPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER------------NLRKLFREV 289 (635)
Q Consensus 223 ~~~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~------------~~~~~~~Ei 289 (635)
..++|..+ +.||.|+||+||++.+. ..+..||||++........ ....+.+|+
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 71 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDT--------------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEEC--------------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHH
Confidence 34567665 55999999999999863 2456899999875433210 012467899
Q ss_pred HHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 290 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
.+|+.++|+||+++++++......|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||
T Consensus 72 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ni 150 (335)
T PTZ00024 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANI 150 (335)
T ss_pred HHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHe
Confidence 99999999999999999999999999999996 68999988878899999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccC---------------CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC
Q psy6357 370 LFDENGDIKLADFGFSNYFTP---------------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA 434 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~---------------~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG 434 (635)
|++.++.++|+|||++..... ........+++.|+|||++.+....+.++|||||||++|+|++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999876541 11122345688899999997755445899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCc-------c----C-----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6357 435 QLPFDGPNLAVLKQRILFGK-------F----R-----------------IPFYMSAECENLIRSMLVLDPAKRLTLTQI 486 (635)
Q Consensus 435 ~~PF~~~~~~~l~~~i~~~~-------~----~-----------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~ei 486 (635)
.+||...+.......+.... + . ....++.++.+||.+||+.+|++|||++++
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 99998877655544433210 0 0 012357889999999999999999999999
Q ss_pred HcCcccccC
Q psy6357 487 SNHKWMSVH 495 (635)
Q Consensus 487 L~Hpw~~~~ 495 (635)
|.||||...
T Consensus 311 l~~~~~~~~ 319 (335)
T PTZ00024 311 LKHEYFKSD 319 (335)
T ss_pred hcCcccCCC
Confidence 999999854
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.70 Aligned_cols=263 Identities=24% Similarity=0.275 Sum_probs=213.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHH--HHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEE--AAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~--~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..+|.++++||+|+||.||++.+........ ............||+|++.... .......+.+|+++|++++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578889999999999999988754321100 0011222345679999987653 335567888999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-----------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-----------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-----------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
++++++..+...++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987765 6899999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT--AQLPFDGPNLAV 445 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt--G~~PF~~~~~~~ 445 (635)
++.++.++|+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ +..||...+...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999997654322 12234567789999999877765 89999999999999998 788998776655
Q ss_pred HHHHHHhC--------ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 LKQRILFG--------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 l~~~i~~~--------~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+...+... ....+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 55544322 12334567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.23 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=213.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.+++.||.|+||.||++.+...... .....||||++.... .......+.+|+.+|+.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKG---------EPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCC---------CcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 45677789999999999999987533210 234689999986543 33344678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
++++......|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~ 154 (277)
T cd05032 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence 99999999999999999999999988643 23678899999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
++.+||+|||++....... ......++..|+|||++....++ .++|||||||++|+|++ |..||...+.......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 233 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence 9999999999987654332 12334567889999999877765 89999999999999998 9999988887777776
Q ss_pred HHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 450 ILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 450 i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+... ...+|..++.++.+||.+||+.+|.+|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6644 34567778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.37 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=206.9
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
......|.+.++||+|+||.||+|... .++..||||++............+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~--------------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i 68 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDK--------------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEEC--------------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCe
Confidence 345677888999999999999999873 245689999997654333333567789999999999999
Q ss_pred eeEEEEEecCC----------eEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 301 IKLFQVMETTN----------NLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 301 v~l~~~~~~~~----------~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
+++++++.... .+|+||||+.+ +|..++... ..+++..+..++.||+.||.|||+.+|+|+||||+||
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ni 147 (302)
T cd07864 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNI 147 (302)
T ss_pred eeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 99999987654 79999999976 666666543 4699999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
+++.++.+||+|||++....... ......++..|+|||++.+....+.++|||||||++|+|++|.+||...+.....
T Consensus 148 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 148 LLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred EECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999998764332 2223356778999998876543358999999999999999999999876654433
Q ss_pred HHHHhCcc------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 448 QRILFGKF------------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 448 ~~i~~~~~------------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..+..... .....++..+.+||.+||..||.+|||+.+|+.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 33322100 0012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.62 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=207.4
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+.+.||.|+||.||++.+. ....+|||++....... ..+.+|+.+++.++|+||+++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~---------------~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR---------------GKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYG 66 (256)
T ss_pred HcchhhhhccCCCceEEEeEec---------------CCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEE
Confidence 4566889999999999999763 22469999987654433 45778999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++......|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCccc
Confidence 999999999999999999999998754 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccc--cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCC
Q psy6357 385 SNYFTPGHMLT--TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFY 460 (635)
Q Consensus 385 a~~~~~~~~~~--~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~ 460 (635)
+.......... ...++..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ....|..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 97654322111 12234579999999887776 89999999999999999 89999887777766666544 3455667
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
++.++.+||.+||..+|++|||+.+|++.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 89999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=315.39 Aligned_cols=248 Identities=27% Similarity=0.487 Sum_probs=212.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+.+.||.|++|.||++... .++..|++|++..... .....+.+|+.+++++.|+||++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~ 65 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHK--------------RTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGS 65 (253)
T ss_pred ceeeeeeccCCceEEEEEEEC--------------CCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 667899999999999999873 2456899999976543 345788899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+......++|+||+.+++|.+++... ..+++..+..++.||+.||.+||..+++|+||+|+||+++.++.++|+|||++
T Consensus 66 ~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred EecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccc
Confidence 99999999999999999999998776 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-ccCCC--CCCC
Q psy6357 386 NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-KFRIP--FYMS 462 (635)
Q Consensus 386 ~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-~~~~p--~~~s 462 (635)
.............++..|+|||++.+..++ .++||||||+++|+|++|..||...+.......+... ...++ ..++
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (253)
T cd05122 146 AQLSDTKARNTMVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWS 224 (253)
T ss_pred ccccccccccceecCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccC
Confidence 877654334556788999999999877765 8999999999999999999999877544433333322 22222 2348
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
..+.+||.+||+.||++|||+.+||+|||
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=328.48 Aligned_cols=248 Identities=29% Similarity=0.505 Sum_probs=206.4
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 308 (635)
+.+.||.|.||.||+|.+..... ..+..|+||++.. .......+.+.+|+++|++++||||+++++++.
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~----------~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~ 71 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDN----------DKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI 71 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTT----------SSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccC----------CCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccc
Confidence 46789999999999999974221 2456899999954 335556788999999999999999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
....+++|||||.+++|.++|... ..+++..++.|+.||+.||.|||+.+|+|+||++.||||+.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 72 ENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp SSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 888899999999999999999886 679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCC
Q psy6357 387 YFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYM 461 (635)
Q Consensus 387 ~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~ 461 (635)
...... ..........|+|||++....++ .++||||||+++|||++ |..||...+...+...+.... ...+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNC 230 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTS
T ss_pred cccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccch
Confidence 763221 12334456789999999887775 99999999999999999 789999988888888775553 3456678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..+.+||..||..||.+|||+.+|++
T Consensus 231 ~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 231 PKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.54 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=213.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
..+|.+.++||+|+||.||++.+....+.. ......||+|++.... .......+.+|+.+++.+ +|+||++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~-------~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEK-------PNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcc-------cCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 456788899999999999998764322110 1233579999997643 344556788999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++.....+|+||||+.+++|.+++.... .+++..++.++.||+.||+|||+.||+|+||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999999999999997542 488899999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999999976543211 1122345689999999887775 89999999999999998 999998888
Q ss_pred HHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+...+.... ...|..++.++.+||.+||..+|.+|||+.+|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777666553 35667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.77 Aligned_cols=254 Identities=21% Similarity=0.344 Sum_probs=206.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
.+|.+++.||.|+||.||+|.+..... ..++..||||++.... .......+.+|+.++.++ +|+||+++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~---------~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEK---------SASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred HHhhhhcccccCcCceEEecccccccc---------ccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhhe
Confidence 468889999999999999987532211 1245689999997543 334456788999999999 79999999
Q ss_pred EEEEec-CCeEEEEEeccccchhhhhhhhc--------------------------------------------------
Q psy6357 304 FQVMET-TNNLYLVTEYARGGEIFSHLLTI-------------------------------------------------- 332 (635)
Q Consensus 304 ~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~-------------------------------------------------- 332 (635)
++++.. ...+++||||+.+++|.+++...
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998854 46789999999999999887532
Q ss_pred -----------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCC---cccccc
Q psy6357 333 -----------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWC 398 (635)
Q Consensus 333 -----------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~ 398 (635)
..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+.... ......
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 257899999999999999999999999999999999999999999999999998764321 122344
Q ss_pred CCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-ccCCCCCCCHHHHHHHHHhccc
Q psy6357 399 GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAV-LKQRILFG-KFRIPFYMSAECENLIRSMLVL 475 (635)
Q Consensus 399 gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~-l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~ 475 (635)
++..|+|||++.+..++ .++|||||||+||+|++ |..||.+....+ +...+... ....|..++.++.+|+.+||+.
T Consensus 237 ~~~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence 56789999999888886 89999999999999998 999998754433 33333222 2344566889999999999999
Q ss_pred CCCCCCCHHHHHcC
Q psy6357 476 DPAKRLTLTQISNH 489 (635)
Q Consensus 476 dP~~Rps~~eiL~H 489 (635)
+|++||++.||++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.14 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=212.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc---cCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR---LDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.|.+.+.||+|+||.||++.+. .++..||+|++.... ........+.+|+.++++++|+||++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 68 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDA--------------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEc--------------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcce
Confidence 5778899999999999999863 345789999985432 13445678889999999999999999
Q ss_pred EEEEEecC--CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETT--NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.+. ..+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+
T Consensus 69 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEC
Confidence 99998664 4688999999999999999887789999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--c
Q psy6357 381 DFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--K 454 (635)
Q Consensus 381 DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~ 454 (635)
|||++...... .......++..|+|||++.+..++ .++|||||||++|+|++|..||...........+... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC
Confidence 99999765321 122345688999999999887765 8999999999999999999999876655444444432 2
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..+|..++.++.++|.+||. +|..||++.+++.|||+
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 34677899999999999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.38 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=207.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
..+|.+.++||.|+||.||+|.+..... ......||||++.... .....+.+.+|+.+|+++. |||||+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~---------~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSR---------SQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCC---------CCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 4577778999999999999998742221 1233579999996543 3444567899999999996 999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc--------------------------------------------------
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-------------------------------------------------- 332 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-------------------------------------------------- 332 (635)
+++++.....+|||||||++|+|.++|...
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999887542
Q ss_pred ----------------------------------------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 333 ----------------------------------------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 333 ----------------------------------------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
..+++..++.++.||+.||+|||+.+|+|+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 1377888899999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999999986543221 2234467789999999887776 89999999999999997 999998754
Q ss_pred HHH-HHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 443 LAV-LKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 443 ~~~-l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
... +...+..+ ....+..++.++.+||.+||..||++|||+.+|.+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 433 33333333 23455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.43 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=212.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||.|++|.||++.+. .++..||||++............+.+|+.+++++.|+||++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 78 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT--------------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC--------------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHH
Confidence 3567889999999999999999873 24568999998765444455567889999999999999999
Q ss_pred EEEEEecCCe------EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTNN------LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~~------~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++..... +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 79 LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred HHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC
Confidence 9988866554 89999999 6788887765 57999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF- 455 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~- 455 (635)
++|+|||++...... .....++..|+|||++.+....+.++|||||||++|+|++|..||...+.......+....-
T Consensus 157 ~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 157 LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred EEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 999999999876432 34557888999999986643345899999999999999999999987665544443322100
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 456 ------------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 456 ------------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.....++.++.+||.+||..||++|||+.+|++||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 011235889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.54 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=203.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...++|.++++||.|+||.||++.+. .++..||||++............+.+|+++|+.++|+||+
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 70 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQI--------------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEEC--------------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCcc
Confidence 34678999999999999999999873 3456899999876543332234567899999999999999
Q ss_pred eEEEEEec--------CCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 302 KLFQVMET--------TNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 302 ~l~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++++++.. ...+|+||||+.+ +|...+.. ...+++..++.++.||++||.|||+.||+|+||||+|||++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~ 149 (311)
T cd07866 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID 149 (311)
T ss_pred chhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99988743 3357999999964 56665554 35799999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCCc------------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 373 ENGDIKLADFGFSNYFTPGHM------------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~------------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
.++.++|+|||++........ .....+++.|+|||++.+....+.++|||||||++|+|++|.+||.+
T Consensus 150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999976543211 12345688899999987654345899999999999999999999988
Q ss_pred CCHHHHHHHHHhCcc-----------------------CCC-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 441 PNLAVLKQRILFGKF-----------------------RIP-------FYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 441 ~~~~~l~~~i~~~~~-----------------------~~p-------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
.+.......+..... ..+ ..++.++.+||.+||..||.+|||+.+++.||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred CCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 776554444332100 000 12457889999999999999999999999999
Q ss_pred cc
Q psy6357 491 WM 492 (635)
Q Consensus 491 w~ 492 (635)
||
T Consensus 310 ~f 311 (311)
T cd07866 310 YF 311 (311)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.48 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=216.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC--HHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD--ERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
|.+.++||.|+||.||.+..... ..++..||+|++...... ....+.+.+|+.+|.++ +|+||+.+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~-----------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSG-----------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 70 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccC-----------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhce
Confidence 67789999999999999876322 135678999999754321 22345678899999999 59999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++++.+..+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+|||++.++.+||+|||
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 71 HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred eeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--ccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCccC
Q psy6357 384 FSNYFTPGH--MLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGP----NLAVLKQRILFGKFR 456 (635)
Q Consensus 384 la~~~~~~~--~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~----~~~~l~~~i~~~~~~ 456 (635)
++....... ......++..|+|||++.... ..+.++||||||+++|+|++|..||... ....+...+.....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 998764432 223456899999999987532 2247899999999999999999999643 234445555555566
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCcccccC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~~ 495 (635)
+|..++..+.+||.+||..||.+|| ++.+++.||||...
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 7777899999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=320.91 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=203.5
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
.||+|+||.||+|.+...+ .+..||||++.... .....+.+.+|+.+|++++|+||++++++++. .
T Consensus 2 ~ig~G~~g~v~~~~~~~~~------------~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~ 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK------------KQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E 67 (257)
T ss_pred ccCCCCcccEEEEEEecCC------------CceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C
Confidence 4899999999999874332 23469999987553 34445678899999999999999999998864 5
Q ss_pred eEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 312 NLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++.....
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 78999999999999998874 45699999999999999999999999999999999999999999999999999976543
Q ss_pred CCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHH
Q psy6357 391 GHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAE 464 (635)
Q Consensus 391 ~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~ 464 (635)
... .....++..|+|||++....++ .++|||||||++|+|++ |..||.......+...+..+ ....|..++.+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 221 1112235689999999877765 89999999999999996 99999888777766666554 34566778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+.+||.+||..+|++||++.+|++.
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.27 Aligned_cols=243 Identities=28% Similarity=0.433 Sum_probs=210.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.+.+.||.|+||.||++.. .+..||||.+..... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~----------------~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~ 65 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY----------------RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQL 65 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe----------------cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeee
Confidence 34667789999999999999876 246799999976532 45778899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 66 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcc
Confidence 999999999999999999999999997765 699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPF 459 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~ 459 (635)
||++........ ....+..|+|||++....+. .++||||||+++|+|++ |..||.......+...+... ....+.
T Consensus 146 ~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05039 146 FGLAKEASQGQD--SGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPE 222 (256)
T ss_pred cccccccccccc--cCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCcc
Confidence 999987643222 33445679999999877765 89999999999999997 99999888877776666544 334566
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.++.++.+||.+||..+|++|||+.+|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 78999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.54 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=209.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+.+.||.|+||.||+|.+. .++..||||.+............+.+|+.+++++ +|+||+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~ 70 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR--------------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIV 70 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc--------------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCcc
Confidence 4567888999999999999999873 2456899999865444444556778999999999 999999
Q ss_pred eEEEEEecC--CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 302 KLFQVMETT--NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 302 ~l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++++... ..+|+||||+. ++|..++... .+.+..++.++.||+.||.|||+.||+|+||||+|||++.++.+||
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 71 KLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred ceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEE
Confidence 999998643 46899999996 5888888765 7899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 380 ADFGFSNYFTPGH------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 380 ~DFGla~~~~~~~------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
+|||++....... ......++..|+|||++.+....+.++|||||||++|+|++|..||...........+...
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999998654321 2334578999999998876544458999999999999999999999876544333322111
Q ss_pred c---------------------------c----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 K---------------------------F----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ~---------------------------~----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. . .....++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0 0111268899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=326.58 Aligned_cols=251 Identities=28% Similarity=0.383 Sum_probs=210.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|++.+.||+|+||.||+|....... ......||+|++.... .......+.+|+.+|+.+.||||+++++.
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~---------~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 71 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKG---------RAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGA 71 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCC---------CCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 6678899999999999998743221 1233579999886554 34455788899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc------------------------ccCCHHHHHHHHHHHHHhhhhhccCceeee
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI------------------------GQMAEKEASRLFRQILSAVAYCHANNVVHR 362 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~------------------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHr 362 (635)
+...+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 72 CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred EecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 99999999999999999999887542 247889999999999999999999999999
Q ss_pred cccCcceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCC
Q psy6357 363 DIKAENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438 (635)
Q Consensus 363 DLKp~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF 438 (635)
||||+|||++.++.+||+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||
T Consensus 152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999976533211 1223456789999999877776 89999999999999998 99999
Q ss_pred CCCCHHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 439 DGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 439 ~~~~~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+.....+.+.+... ....|..++.++.+||.+||+.+|.+||++.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 231 PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 988877777666543 34456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=321.36 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=208.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc-cCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR-LDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+|.+.++||.|+||.||++... .++..||||.+.... ........+.+|+.+|+.++||||+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL--------------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe--------------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeee
Confidence 46788999999999999999873 245689999886533 244555678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred eeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999887753 244899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCcc-
Q psy6357 380 ADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--LAVLKQRILFGKF- 455 (635)
Q Consensus 380 ~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~--~~~l~~~i~~~~~- 455 (635)
+|||++....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||.... ...+...+....+
T Consensus 148 ~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08228 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP 226 (267)
T ss_pred CccccceeccchhHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC
Confidence 9999988764322 22345688899999999887775 89999999999999999999996543 3344444443322
Q ss_pred CC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 456 RI-PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 456 ~~-p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+. +..++..+.+||.+||..+|.+||++.+|++.
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 22 23577899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.21 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=210.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.++++||.|+||.||+|.+.. +..||+|++.... ......+..|+.+|+.++|+||++++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~---------------~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~ 68 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN---------------RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLF 68 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC---------------CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhhee
Confidence 347778999999999999998732 4579999987653 23346788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++.....+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||||+.++.+||+||
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred eeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccc
Confidence 9999999999999999999999999763 45899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc-cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCC
Q psy6357 383 GFSNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPF 459 (635)
Q Consensus 383 Gla~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~ 459 (635)
|++........ .....++..|+|||++....+. .++||||||+++|+|++ |..||...+.......+... ....+.
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCC
Confidence 99977643221 2233456679999999887775 89999999999999998 89999888777776666644 345566
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.++..+.++|.+||+.||.+|||+.+|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 78999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.54 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=202.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 305 (635)
|..+++||.|+||.||++.+. .++..||||.+...... .....+.+|+.++.++. |+||+++++
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~--------------~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~ 70 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHK--------------PSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYG 70 (288)
T ss_pred hHHHHHhCCCCceEEEEEEEC--------------CCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 445678999999999998773 34578999999765433 44567889999999996 999999999
Q ss_pred EEecCCeEEEEEeccccchhhhh---hh--hcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeee
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSH---LL--TIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~---l~--~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++......+++|||+. .+|.++ +. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||
T Consensus 71 ~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 71 ALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred EEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEE
Confidence 9999999999999985 344332 22 23569999999999999999999997 59999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCc-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFGK- 454 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~~- 454 (635)
+|||++.............++..|+|||++.+. .+ +.++|||||||++|+|++|.+||..... ......+....
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP 228 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCC-cchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC
Confidence 999999766544444455788999999999776 44 4899999999999999999999976542 11112222211
Q ss_pred cCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 FRI----PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~----p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+ +..++.++.+||.+||..||.+|||+++|+.||||..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 112 2247899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=325.00 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=206.9
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC---CCCceeeE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPHIIKL 303 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l 303 (635)
|.+++.||.|+||.||++.+.. ++..||||++............+.+|+.+++++ +|+||+++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~--------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~ 66 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN--------------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66 (287)
T ss_pred CeEEEEecccCceEEEEEEECC--------------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceE
Confidence 5678999999999999998742 356899999976544333345566788887766 59999999
Q ss_pred EEEEecCCe-----EEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 304 FQVMETTNN-----LYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 304 ~~~~~~~~~-----~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++++..... +++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~ 145 (287)
T cd07838 67 LDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ 145 (287)
T ss_pred EEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC
Confidence 999987776 999999996 47888876643 4899999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
++|+|||++.............++..|+|||++.+..+. .++|||||||++|+|++|.+||...+..+...++....
T Consensus 146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 146 VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EEEeccCcceeccCCcccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 999999999877555444555678899999999887775 89999999999999999999998877666555443210
Q ss_pred ---cC-----------CC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 455 ---FR-----------IP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 455 ---~~-----------~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.. ++ ..++..+.+||.+||..||.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00 1245788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=336.37 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=213.7
Q ss_pred hhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhh
Q psy6357 215 WKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSH 294 (635)
Q Consensus 215 ~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~ 294 (635)
|....++.+..+|+++..||+|+||.|-++++.. .+..|||||++.- ....+..+-|+++|++
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~--------------~~~~vAlKIik~V---~kYreAa~iEi~vLqk 141 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE--------------TKEHVALKIIKNV---DKYREAALIEIEVLQK 141 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecC--------------CCceehHHHHHHH---HHHhhHHHHHHHHHHH
Confidence 4444567778999999999999999999998843 3468999999642 3445677789999999
Q ss_pred CCC--C----ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 295 LDH--P----HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 295 L~H--p----nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+.+ | -+|++.++|+..+++|||+|.+ |.+++++|..+. +++...+..|..||+.+++|||+.+++|.||||
T Consensus 142 i~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 142 INESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred HHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 942 2 3789999999999999999999 779999998764 589999999999999999999999999999999
Q ss_pred cceeecC--------------------CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHH
Q psy6357 367 ENLLFDE--------------------NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGV 426 (635)
Q Consensus 367 ~NILl~~--------------------~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGv 426 (635)
+|||+.. +..|+|+|||.|++....+ .+.+.|..|+|||++.+-.|+ ..+||||+||
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGC 297 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWS-QPCDVWSIGC 297 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcC-CccCceeeee
Confidence 9999941 3469999999998766544 677889999999999999997 9999999999
Q ss_pred HHHHHHhCCCCCCCCCHHH---HHHHHHhC------------------ccCCCCC-------------------------
Q psy6357 427 VLYVMVTAQLPFDGPNLAV---LKQRILFG------------------KFRIPFY------------------------- 460 (635)
Q Consensus 427 ilyeLltG~~PF~~~~~~~---l~~~i~~~------------------~~~~p~~------------------------- 460 (635)
||+||.+|...|++.+..+ +.+.|+.. .+..|..
T Consensus 298 IL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 298 ILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence 9999999999998766443 33333310 1111110
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.-.+|.|||++||.+||.+|+|+.|+|.||||...
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 12458899999999999999999999999999743
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.21 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=214.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
+...++..||.|+.|.||++.++ ..+..+|||.+.+.. +.++.++++..+.++.+. +.|+||+.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r--------------s~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR--------------STGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc--------------ccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeee
Confidence 34455788999999999999984 345679999998765 556678888998887766 48999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++|..+..++|.||.|. .-+..++.. .++++|..+-++...++.||.||-+ ++|+|||+||+||||++.|+|||||
T Consensus 157 ~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCD 235 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCD 235 (391)
T ss_pred eeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeec
Confidence 999999999999999994 334444433 3579999999999999999999986 5899999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCccC-
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVLKQRILFGKFR- 456 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l~~~i~~~~~~- 456 (635)
||++..+.+....+...|-+.|||||-+.- ..|+ .++||||||++|+||.||+.||.+-+ .-+...+|+....+
T Consensus 236 FGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~ 314 (391)
T KOG0983|consen 236 FGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL 314 (391)
T ss_pred ccccceeecccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC
Confidence 999999888777778889999999999853 3454 89999999999999999999998843 34555666655433
Q ss_pred CCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 457 IPF--YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 457 ~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
+|. .+|+++.+|+..||++|+.+||.+.++|+|||+..+.+
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 222 38999999999999999999999999999999986643
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.31 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=200.2
Q ss_pred ecccc--CCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 232 KAGEG--EDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 232 kLG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+||.| +|++||.+.+. ..++.||||++..........+.+.+|+.+++.++||||++++++|..
T Consensus 5 ~ig~g~~~~~~v~~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 70 (328)
T cd08226 5 EIGRGFCNLTSVYLARHT--------------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70 (328)
T ss_pred HhCCcccCceeEEEEEEc--------------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec
Confidence 45555 99999998763 355789999998766566667888999999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
...+|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+||+.+..
T Consensus 71 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 99999999999999999988764 3489999999999999999999999999999999999999999999999986543
Q ss_pred ccCC----Cc----cccccCCCCCCCccccCCCCc-CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---
Q psy6357 388 FTPG----HM----LTTWCGSPPYAAPELFGGREY-DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF--- 455 (635)
Q Consensus 388 ~~~~----~~----~~~~~gt~~Y~APEvl~~~~~-~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~--- 455 (635)
.... .. .....++..|+|||++.+... .+.++|||||||++|+|++|.+||...........+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 2211 00 111234567999999976421 24899999999999999999999987654333322221110
Q ss_pred --------------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 456 --------------------------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 456 --------------------------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
..+..++..+.+||.+||+.||++|||+.++|+|||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 011235678999999999999999999999999999
Q ss_pred ccc
Q psy6357 492 MSV 494 (635)
Q Consensus 492 ~~~ 494 (635)
|..
T Consensus 311 ~~~ 313 (328)
T cd08226 311 FKQ 313 (328)
T ss_pred HHH
Confidence 964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=318.95 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=206.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||+|+||.||+|.+..... ....||+|++...... .....+.+|+.+|+.+.|+||+++++++. .
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~-----------~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 67 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG-----------KEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-G 67 (257)
T ss_pred CccCccCceeEEEeEeeccCC-----------CcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-C
Confidence 479999999999998754431 2357999999766543 44567889999999999999999999876 4
Q ss_pred CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
...++||||+.+++|.+++.....+++..+..++.||+.||.|||..+|+|+||||+|||++.++.+||+|||++.....
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 68 EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 56899999999999999998888899999999999999999999999999999999999999999999999999987643
Q ss_pred CCcc----ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCCCHH
Q psy6357 391 GHML----TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYMSAE 464 (635)
Q Consensus 391 ~~~~----~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~ 464 (635)
.... ....++..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+...+...+.... ...|..++..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQE 226 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 3221 111234579999999887775 89999999999999998 999998887776666665443 3556678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+||.+||..+|.+||++.+|++
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.67 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=211.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+++.+.++||.|+||.||++....... ...+..||+|.+... .......+.+|+++++.++|+||++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~ 71 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLP---------EQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVR 71 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCC---------CCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCce
Confidence 34567778999999999999886532110 123457999988654 3455578899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc---------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG---------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
+++++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9999999999999999999999999887543 4889999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
|||++.++.+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |.+||.....
T Consensus 152 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred hEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 99999999999999999876543221 1223456789999999888776 89999999999999998 9999988776
Q ss_pred HHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 444 AVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 444 ~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
......+... ....+..++..+.+||.+||+.||.+||++.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6666666554 34556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.08 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=213.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||.|+||.||++... .++..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~--------------~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~ 81 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV--------------ATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNY 81 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc--------------CCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeeh
Confidence 468889999999999999999762 2446799999865432 234678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++......|+||||+++++|.+++.+ ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred hheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence 9999999999999999999999998865 468899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-c--cCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-K--FRIPF 459 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-~--~~~p~ 459 (635)
++....... ......+++.|+|||++....++ .++|||||||++|+|++|..||...+.......+... . +..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred ceecccccccccccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 987654332 23345688899999999887775 8999999999999999999999876543332222211 1 22234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.++..+.+||.+||..+|.+||++.+|+.|+||....
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 5678999999999999999999999999999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.60 Aligned_cols=246 Identities=26% Similarity=0.443 Sum_probs=207.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||.|+||.||++... ++..||+|.+....... ..+.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~---------------~~~~~a~K~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~ 65 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN---------------GHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVR 65 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC---------------CCceEEEEEecCCCCcH---HHHHHHHHHHHhcCCcCeee
Confidence 3456888999999999999999752 34689999997655432 56789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++. ....|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+
T Consensus 66 ~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05067 66 LYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIA 144 (260)
T ss_pred EEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEc
Confidence 999874 45789999999999999988653 358999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 381 DFGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 381 DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|||++........ .....++..|+|||++....++ .++||||||+++|+|++ |.+||.+.+...+...+... ..+
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05067 145 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223 (260)
T ss_pred cCcceeecCCCCcccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence 9999977653221 1233456789999999877775 89999999999999999 99999888776666665443 334
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..++.++.+||.+||..+|++|||+++|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=324.25 Aligned_cols=242 Identities=27% Similarity=0.438 Sum_probs=199.3
Q ss_pred Cccceeec--cccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 226 PQYNLRKA--GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 226 ~y~il~kL--G~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.|.+++++ |.|+||.||++... .++..+|+|++........ |+.++..+ +|+||++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~ 73 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHK--------------PTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIK 73 (267)
T ss_pred hhccccceeecCCCceEEEEEEEc--------------CCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEE
Confidence 44455555 99999999988763 3456899999876533221 22222222 6999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~D 381 (635)
++++|...+.+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++ .++|+|
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999999999998877899999999999999999999999999999999999999998 999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCccC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV-----LKQRILFGKFR 456 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~-----l~~~i~~~~~~ 456 (635)
||++...... ....++..|+|||++.+..++ .++|||||||++|+|++|..||....... +.... .....
T Consensus 154 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 228 (267)
T PHA03390 154 YGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLP 228 (267)
T ss_pred CccceecCCC---ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCC
Confidence 9998765432 234688999999999888876 89999999999999999999997554322 22222 33344
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCcccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLT-LTQISNHKWMS 493 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps-~~eiL~Hpw~~ 493 (635)
.+..++..+.+||.+||+.+|.+|++ +++||+||||.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 55568999999999999999999996 69999999995
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.97 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=211.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.+.||.|+||.||.+.+..... ..+...||+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~---------~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSP---------TKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKF 72 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCC---------CCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceE
Confidence 4456778899999999999987533211 1234568999886542 3444678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 99999999999999999999999998653 23889999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
|||++.++.++|+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 153 Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred eEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999997654322 12334567889999999887776 89999999999999998 9999988877
Q ss_pred HHHHHHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 444 AVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 444 ~~l~~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
....+.+..+.. ..+..++..+.+||.+||..||.+|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 777776665543 345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=319.97 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=207.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||.|+||.||++.+. .+..||+|++....... ..+.+|+.+|++++|+||+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~---------------~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~ 66 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN---------------GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQL 66 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec---------------CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEE
Confidence 456788999999999999999762 33579999997654433 467899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++. ....|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCC
Confidence 99885 45689999999999999988753 3589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++........ .....++..|+|||++.+..++ .++||||||+++|+|++ |.+||...+.......+... ..+.
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05070 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224 (260)
T ss_pred ceeeeeccCcccccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999976543221 1223345679999999877775 89999999999999999 99999888777777766543 3455
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++..+.+||.+||..+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 6678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=323.18 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=206.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.++++||+|+||.||++.-...... -...+|||.++.+......-....+|+.+++.|+|+||+.|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k----------r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv 93 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK----------RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLV 93 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcc----------cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHH
Confidence 3577789999999999999954332211 023689999976643222335677999999999999999999
Q ss_pred EEEec-CCeEEEEEeccccchhhhhhhhc-----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC----
Q psy6357 305 QVMET-TNNLYLVTEYARGGEIFSHLLTI-----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---- 374 (635)
Q Consensus 305 ~~~~~-~~~~~LV~E~~~ggsL~~~l~~~-----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---- 374 (635)
.+|.. +..++|++||.+ -+|...|.-. ..++...++.|+.||+.|+.|||++-|+||||||.||||..+
T Consensus 94 ~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 94 KVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred HHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCcc
Confidence 99876 788999999996 5677776432 459999999999999999999999999999999999999887
Q ss_pred CCeeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-------
Q psy6357 375 GDIKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL------- 443 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~------- 443 (635)
|.|||+|||+++.+... ......+.|.||+|||++.+...++.++|||++|||+.|||+-++.|.+...
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 89999999999987543 2345567899999999999988888999999999999999999999976431
Q ss_pred --HHHHHHHHhC-----------ccCCCCC--------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q psy6357 444 --AVLKQRILFG-----------KFRIPFY--------------------------MSAECENLIRSMLVLDPAKRLTLT 484 (635)
Q Consensus 444 --~~l~~~i~~~-----------~~~~p~~--------------------------~s~~l~~LI~~~L~~dP~~Rps~~ 484 (635)
.+...+|..- .-.+|.+ -++.+.+|+.+||++||.+|+|++
T Consensus 253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~ 332 (438)
T KOG0666|consen 253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE 332 (438)
T ss_pred chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence 1222222210 0011211 245589999999999999999999
Q ss_pred HHHcCcccccC
Q psy6357 485 QISNHKWMSVH 495 (635)
Q Consensus 485 eiL~Hpw~~~~ 495 (635)
++|+|+||...
T Consensus 333 qAleh~yF~~d 343 (438)
T KOG0666|consen 333 QALEHPYFTED 343 (438)
T ss_pred HHhcccccccC
Confidence 99999999754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=321.07 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=205.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+.++||+|+||.||+|.+. ....||||++....... +.+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~---------------~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~ 66 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN---------------GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQL 66 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec---------------CCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceE
Confidence 456888999999999999999762 22369999997644332 467899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.. ...|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 67 YAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEecc
Confidence 998754 5689999999999999999763 3589999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++..+..... .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.......+...+... ....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05071 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224 (262)
T ss_pred CCceeeccccccccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC
Confidence 999976643322 1233456789999999877775 89999999999999999 89999888777666666543 2344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++..+.+||.+||..||.+||++.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.29 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=211.9
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
.||+|+||+||.|.+ +.+...+|||-+... +.+...-+..||.+.++|+|.|||++++.+..++
T Consensus 582 VLGKGTYG~VYA~RD--------------~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG 645 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARD--------------MDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG 645 (1226)
T ss_pred EeecCceeEEEeecc--------------ccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence 589999999998876 445568999988654 4455678899999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhh-cccC--CHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeeeccccccc
Q psy6357 312 NLYLVTEYARGGEIFSHLLT-IGQM--AEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLADFGFSNY 387 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~-~~~l--~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~DFGla~~ 387 (635)
++-|.||-++||+|.++|.. .+++ .|..+..+.+||++||.|||+..|||||||-+||||+. .|.+||+|||-++.
T Consensus 646 f~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 646 FFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred eEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchh
Confidence 99999999999999999864 5777 88999999999999999999999999999999999974 78999999999887
Q ss_pred ccC-CCccccccCCCCCCCccccCCC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH-hCccCCCCCCC
Q psy6357 388 FTP-GHMLTTWCGSPPYAAPELFGGR-EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL--AVLKQRIL-FGKFRIPFYMS 462 (635)
Q Consensus 388 ~~~-~~~~~~~~gt~~Y~APEvl~~~-~~~~~ksDIwSlGvilyeLltG~~PF~~~~~--~~l~~~i~-~~~~~~p~~~s 462 (635)
+.. .....++.||+.|||||++... .-++.++|||||||++.||.||++||..... ..+++.-+ ....++|..+|
T Consensus 726 LAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 726 LAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELS 805 (1226)
T ss_pred hccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence 643 3456788999999999999643 3346999999999999999999999975432 22222222 23457888999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+++.||.+|+..||.+||++.++|.+||++..
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999999754
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=324.13 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=207.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+|..+++||.|++|.||++.+. ..+..||+|++..... ......+.+|+++|+.++|+||+++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~ 66 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLK--------------NTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYG 66 (287)
T ss_pred ceEEEEEeccCCceEEEEEEEC--------------CCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 5777899999999999999874 2456899999975532 344577899999999999999999999
Q ss_pred EEec--CCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 306 VMET--TNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 306 ~~~~--~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+|.. ...+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l 146 (287)
T cd06621 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKL 146 (287)
T ss_pred EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEE
Confidence 8854 3478999999999999887653 345899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-----LAVLKQRILFG- 453 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-----~~~l~~~i~~~- 453 (635)
+|||++....... .....++..|+|||.+.+..++ .++|||||||++|+|++|..||.... ..++...+...
T Consensus 147 ~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 147 CDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred eeccccccccccc-cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 9999987654322 2245678899999999888776 89999999999999999999997652 23333333321
Q ss_pred ccCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 KFRIP------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ~~~~p------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...++ ..++..+.+||.+||..+|.+|||+.||+.||||..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 11111 134678999999999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=329.47 Aligned_cols=266 Identities=20% Similarity=0.366 Sum_probs=211.7
Q ss_pred hccchhhhhhcc------CCccc-CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH
Q psy6357 208 KEITLDEWKASR------GTKLL-KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER 280 (635)
Q Consensus 208 ~e~tl~e~~~~~------~~~~~-~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~ 280 (635)
+++...+|.... |+.+. .+|.+++|||+|-|++||++++. ...+.||+||.+.. +.
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt--------------q~~r~VAlKVvKSA---qh 116 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT--------------QNKRYVALKVVKSA---QH 116 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeec--------------cCCeEEEEEEEehh---hH
Confidence 456667775443 56655 99999999999999999999984 44568999998643 44
Q ss_pred HHHHHHHHHHHHhhCC-----C---CceeeEEEEEec----CCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHH
Q psy6357 281 NLRKLFREVDIMSHLD-----H---PHIIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQ 346 (635)
Q Consensus 281 ~~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~q 346 (635)
..+..+.||++|+++. | .+||+|++.|.. ..++|+|+|++ |..|+.+|.... .++...++.|++|
T Consensus 117 YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~q 195 (590)
T KOG1290|consen 117 YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQ 195 (590)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHH
Confidence 5577889999999982 3 479999999965 55899999999 889999997764 5999999999999
Q ss_pred HHHhhhhhcc-CceeeecccCcceeec-----------------------------------------------------
Q psy6357 347 ILSAVAYCHA-NNVVHRDIKAENLLFD----------------------------------------------------- 372 (635)
Q Consensus 347 Il~gL~~LHs-~gIiHrDLKp~NILl~----------------------------------------------------- 372 (635)
|+.||.|||. +||||.||||+||||.
T Consensus 196 vL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~k 275 (590)
T KOG1290|consen 196 VLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKK 275 (590)
T ss_pred HHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHH
Confidence 9999999995 6999999999999992
Q ss_pred -------------------------------------------------------------CC-----------------
Q psy6357 373 -------------------------------------------------------------EN----------------- 374 (635)
Q Consensus 373 -------------------------------------------------------------~~----------------- 374 (635)
..
T Consensus 276 k~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~ 355 (590)
T KOG1290|consen 276 KLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLR 355 (590)
T ss_pred HHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcc
Confidence 00
Q ss_pred -----------------------------------CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCcc
Q psy6357 375 -----------------------------------GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKS 419 (635)
Q Consensus 375 -----------------------------------~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ks 419 (635)
-.+||+|||-|++.. ..++..+.|..|+||||+.+..|. ..+
T Consensus 356 ~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~-~~A 432 (590)
T KOG1290|consen 356 DSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYS-TSA 432 (590)
T ss_pred cccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCC-Cch
Confidence 026888888887754 344566789999999999999997 999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHH------------------------------------------
Q psy6357 420 DVWSLGVVLYVMVTAQLPFDGPN------LAVLKQRIL------------------------------------------ 451 (635)
Q Consensus 420 DIwSlGvilyeLltG~~PF~~~~------~~~l~~~i~------------------------------------------ 451 (635)
||||++|++|||+||...|+..+ .++.+..|.
T Consensus 433 DiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL 512 (590)
T KOG1290|consen 433 DIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVL 512 (590)
T ss_pred hHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHH
Confidence 99999999999999999996422 111111111
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+|.++..-..++.+||.-||+++|++||||.++|+|||+..
T Consensus 513 ~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 513 IEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred HHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccC
Confidence 1122222223467899999999999999999999999999974
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.77 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=209.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||.|+||+||+|.+...+.. ....||||++.... .......+.+|+.+++.+.|+||++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----------~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~ 73 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGEN----------VKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCR 73 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCc----------cceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCce
Confidence 345677889999999999999987433211 12358999986543 3444567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.. ...+++|||+++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred EEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECC
Confidence 9999865 4578999999999999998764 5699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 382 FGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 382 FGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
||++........ .....++..|+|||++.+..++ .++|||||||++|||++ |..||.......+...+... ...
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP 231 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence 999987643222 1122346689999999887776 89999999999999998 99999887766666655544 234
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..++.++.+||.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 45678999999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.19 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=218.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+.|.+...||.|++|.||++.+.. .+..||+|++..... ....+.+|+.+++.++|+||++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~--------------~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~ 79 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA--------------TGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVD 79 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc--------------CCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeE
Confidence 44568888999999999999998732 346899999976533 4467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++......|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d 159 (286)
T cd06614 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLAD 159 (286)
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECc
Confidence 9999999999999999999999999998876 899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-C--C
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-R--I 457 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~--~ 457 (635)
||++...... .......++..|+|||++.+..++ .++||||||||+|+|++|..||...+.......+..... . .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06614 160 FGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN 238 (286)
T ss_pred cchhhhhccchhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence 9998765432 122344578899999999887775 899999999999999999999987766554444433322 2 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
+..++.++.+||.+||+.+|.+|||+.+||.|+||...+.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 2237899999999999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=331.42 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=205.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 304 (635)
+|.+.+.||.|+||.||++.+... ..+..||||++............+.+|+.+++++ +|+||++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 68 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET------------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLY 68 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC------------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheee
Confidence 477789999999999999987422 1146899999875433333456778999999999 599999999
Q ss_pred EEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 305 QVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 305 ~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++.. ...+|++|||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 69 DMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred eeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeC
Confidence 87532 245789999995 6899988887889999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 381 DFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 381 DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
|||++..+.... ......||+.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 999997654321 2234578999999998866432348999999999999999999999876543333222110
Q ss_pred -----------------------c---cCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 454 -----------------------K---FRI---PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 454 -----------------------~---~~~---p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. ..+ ...++..+.+||.+||+.||.+|||+.+++.||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 001 113578999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=322.64 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=201.2
Q ss_pred CCc-cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQ-YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y-~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++| .+++.||.|+||+||.+.+.... ...+..||||++.... .......+.+|+.+|+.++|+||+++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----------~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~ 71 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPAN----------DGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKY 71 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEcccc----------CCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 455 77899999999999988764322 2356789999997653 23344678899999999999999999
Q ss_pred EEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.. ...+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.++|+|
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred EEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEee
Confidence 998765 3468999999999999998866 4699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-------------
Q psy6357 382 FGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA------------- 444 (635)
Q Consensus 382 FGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~------------- 444 (635)
||++........ .....++..|+|||++....++ .++|||||||++|+|++|..||......
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 999987653321 1223456679999999877775 8999999999999999999998643211
Q ss_pred --HHHHHHHh-CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 445 --VLKQRILF-GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 445 --~l~~~i~~-~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+...+.. ...+.+..++.++.+|+.+||..+|++|||+++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 122345568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.15 Aligned_cols=250 Identities=29% Similarity=0.402 Sum_probs=206.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 305 (635)
|.++++||.|++|+||+|.+. .++..||||.+....... ......+|+..++++. |+||+++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~--------------~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~ 65 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK--------------ETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKE 65 (283)
T ss_pred CeeheeeccCCceEEEEEEEC--------------CCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHH
Confidence 567889999999999999873 234679999987654322 2234557999999999 999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++......|+||||+ +++|.+++.... .+++..++.++.||+.+|.|||+.+|+|+||+|+||+++.++.++|+|||
T Consensus 66 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 66 VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred HhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecc
Confidence 999999999999999 788988887764 78999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---------- 453 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---------- 453 (635)
++.............++..|+|||++......+.++||||||+++|+|++|.+||...........+...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 145 LAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred cceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 9987765444455678899999998865443358999999999999999999999876654433332210
Q ss_pred ---------ccCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 ---------KFRI-----------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 ---------~~~~-----------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...+ ....+.++.+||.+||+.+|.+|||+.||+.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000 11236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.41 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=207.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||+|+||.||++.+. .++..||||++............+.+|+.++++++|+||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDT--------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEc--------------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 367889999999999999999763 345689999997654444445678899999999999999999
Q ss_pred EEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++... ..+|+|++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCE
Confidence 9988543 3478899987 7888776654 469999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--- 454 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--- 454 (635)
||+|||++..... ......++..|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 160 kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 160 KILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred EEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999876533 23445788999999998764333489999999999999999999998765443333221100
Q ss_pred --------------------cCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 455 --------------------FRI--------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 455 --------------------~~~--------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
... ....+.++.+||.+||..||.+||++.++|.||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000 1135788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.95 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=209.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+++.||.|++|.||++... .++..||+|.+............+.+|+.+|+.++|+||++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 66 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK--------------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66 (283)
T ss_pred CccceeeecCCCceEEEEEcC--------------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHh
Confidence 567889999999999999863 345689999997765554556788899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+.....+++||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++
T Consensus 67 ~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred hccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 9999999999999975 787777663 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q psy6357 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG----------- 453 (635)
Q Consensus 386 ~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~----------- 453 (635)
....... ......++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 146 RSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred EecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 8765443 3334567889999999887633348999999999999999999999877654443333211
Q ss_pred --------ccCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 --------KFRI-----------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 --------~~~~-----------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...+ ...++.++.+||.+||..||.+||++.+|+.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0001 12367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=318.10 Aligned_cols=242 Identities=29% Similarity=0.457 Sum_probs=205.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.+.+.||+|+||.||++.. .+..||+|.+.... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~----------------~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~ 64 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY----------------RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQL 64 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE----------------cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeE
Confidence 45677889999999999999865 24579999986432 23568899999999999999999
Q ss_pred EEEE-ecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 304 FQVM-ETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 304 ~~~~-~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++ ......|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 65 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~ 144 (256)
T cd05082 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVS 144 (256)
T ss_pred EEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEec
Confidence 9975 45567999999999999999987654 38899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|||++....... .....+..|+|||++.+..++ .++|||||||++|+|++ |.+||...+...+...+... ....+
T Consensus 145 dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd05082 145 DFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 221 (256)
T ss_pred CCccceeccccC--CCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999987654322 233446689999999887775 89999999999999997 99999988877777766544 23445
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..++..+.+||.+||..+|.+|||+.++++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=320.85 Aligned_cols=243 Identities=27% Similarity=0.374 Sum_probs=201.4
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETT 310 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 310 (635)
.||+|+||.||++.+..... ...+|+|.+.... .......+.+|+.++.++ .||||+++++++...
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~------------~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 68 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGL------------RMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 68 (270)
T ss_pred cCCCCCCceEEEEEEcCCCC------------eeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC
Confidence 58999999999998742211 1257888886432 344556788999999999 799999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
...|+||||+.+++|.+++.... .+++..++.++.||+.||+|||+.+|+|+||||+|||++.+
T Consensus 69 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~ 148 (270)
T cd05047 69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148 (270)
T ss_pred CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC
Confidence 99999999999999999986542 47899999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~ 453 (635)
+.+||+|||++..............+..|+|||++....++ .++|||||||++|+|++ |..||...+.......+...
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 227 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence 99999999998643221111122335679999999877775 89999999999999997 99999888777777666554
Q ss_pred -ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 454 -KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 454 -~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
....+..++.++.+||.+||..+|.+|||+.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 33456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.16 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=207.9
Q ss_pred hhhccchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHH
Q psy6357 206 AAKEITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKL 285 (635)
Q Consensus 206 ~~~e~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~ 285 (635)
....+++.++..+. +.|..-..||+|+||.||+|.. .++..||||.+....... ...|
T Consensus 61 ~~~~fs~~el~~AT-----~~Fs~~~~ig~Ggfg~VYkG~l---------------~~~~~vAVK~~~~~~~~~--~~eF 118 (361)
T KOG1187|consen 61 PLRSFSYDELRKAT-----NNFSESNLIGEGGFGTVYKGVL---------------SDGTVVAVKRLSSNSGQG--EREF 118 (361)
T ss_pred CcceeeHHHHHHHH-----hCCchhcceecCCCeEEEEEEE---------------CCCCEEEEEEecCCCCcc--hhHH
Confidence 56778888888774 3334457899999999999987 344689999887654332 3459
Q ss_pred HHHHHHHhhCCCCceeeEEEEEecCC-eEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCc---e
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMETTN-NLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANN---V 359 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~g---I 359 (635)
.+|+.+|.+++|||||+|++||.+.+ +.+||+|||++|+|.++|.... .++|....+|+.+++.||+|||+.. |
T Consensus 119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i 198 (361)
T KOG1187|consen 119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPI 198 (361)
T ss_pred HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence 99999999999999999999999888 5999999999999999997765 8999999999999999999999854 9
Q ss_pred eeecccCcceeecCCCCeeeecccccccccC-CCccccc-cCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC
Q psy6357 360 VHRDIKAENLLFDENGDIKLADFGFSNYFTP-GHMLTTW-CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437 (635)
Q Consensus 360 iHrDLKp~NILl~~~~~ikL~DFGla~~~~~-~~~~~~~-~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P 437 (635)
||||||++|||||.+..+||+|||+|..... .....+. .||..|+|||.+.....+ .++|||||||+|.||++|+.+
T Consensus 199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt-~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLT-EKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred ecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcC-cccccccchHHHHHHHhCCcc
Confidence 9999999999999999999999999977654 4333333 899999999999876665 899999999999999999988
Q ss_pred CCCCC---HHHHHH----HHHhC------ccCCC-CCCC-----HHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 438 FDGPN---LAVLKQ----RILFG------KFRIP-FYMS-----AECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 438 F~~~~---~~~l~~----~i~~~------~~~~p-~~~s-----~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+... ...+.. .+... ...+. ..+. ..+..+..+|++.+|.+||++.||+.
T Consensus 278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 87532 111111 11111 11111 2223 23567888999999999999999854
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=326.46 Aligned_cols=263 Identities=24% Similarity=0.254 Sum_probs=206.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+.++||+|+||.||++......................||||++.... .......+.+|+++|++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 35788899999999999998876322100000000001122359999987543 44455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
++++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999885432 36888999999999999999999999999999999999
Q ss_pred cCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCHHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT--AQLPFDGPNLAVL 446 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt--G~~PF~~~~~~~l 446 (635)
+.++.+||+|||++........ .....++..|+|||++....++ .++|||||||++|+|++ +..||...+....
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999976543221 1223446789999999887775 89999999999999988 7789987766555
Q ss_pred HHHHHh--------CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 447 KQRILF--------GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 447 ~~~i~~--------~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...+.. .....+..++..+.+||.+||..||.+|||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 444321 112234557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=334.45 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=203.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||.|+||.||++... .++..||||++..... ...+.+.+|+.+|+.++|+||+++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~--------------~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~ 67 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS--------------DCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKV 67 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC--------------CCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhh
Confidence 368899999999999999999873 3457899999866543 344678899999999999999999
Q ss_pred EEEEecC--------------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 304 FQVMETT--------------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 304 ~~~~~~~--------------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
++++... ...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Ni 145 (342)
T cd07854 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145 (342)
T ss_pred HhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 9876543 35899999996 588777754 5799999999999999999999999999999999999
Q ss_pred eecC-CCCeeeecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH
Q psy6357 370 LFDE-NGDIKLADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444 (635)
Q Consensus 370 Ll~~-~~~ikL~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~ 444 (635)
|++. ++.+||+|||++....... ......++..|+|||++......+.++|||||||++|+|++|..||...+..
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9974 5678999999997653221 1223457889999998765443458999999999999999999999876644
Q ss_pred HHHHHHHhCc-------------------------c-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 445 VLKQRILFGK-------------------------F-----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 445 ~l~~~i~~~~-------------------------~-----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.....+.... . .+...++.++.+||.+||+.||.+|||+.+||.||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 4333322110 0 011246789999999999999999999999999999975
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 306 ~ 306 (342)
T cd07854 306 Y 306 (342)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.28 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=211.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
.+|.+.++||+|+||.||++........ .......||+|++.... .......+..|+.+++.+ +|+||+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~-------~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKS-------RPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCc-------cCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 4566789999999999999875321110 01234579999987543 344567788999999999 69999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++.....+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 99999999999999999999999998653 24888999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
|||++.++.+||+|||+++....... .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999986643211 1122344679999999887775 89999999999999999 9999998887
Q ss_pred HHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 444 AVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 444 ~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+...+.... ...+..++.++.+||.+||..+|++|||+.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 77777766543 35567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=326.42 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=213.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
...|.+.+.||+|+||.||++.+....... ...+..||+|++.... .......+.+|+.+++.+ +|+||++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~-------~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDK-------PKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCC-------CCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchh
Confidence 455667899999999999999764322110 1233579999987543 344567889999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++.....+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998753 2477888999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++....... ......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999998664322 12223456789999999887776 89999999999999998 899999888
Q ss_pred HHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+...+.... ...+..++.++.+||.+||..+|.+|||+.+|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888877776543 34566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=361.65 Aligned_cols=149 Identities=28% Similarity=0.505 Sum_probs=135.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
++.|.++++||+|+||.||++.+. ..+..||||++..... .......+..|+.++..++|+||++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~--------------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~ 68 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK--------------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC--------------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCe
Confidence 467889999999999999999873 3457899999976543 4455677889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.....+||||||+.+++|.+++...+.+++..++.|+.||+.||.|||..+||||||||+||||+.++.+||+||
T Consensus 69 ~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence 99999999999999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q psy6357 383 GFSN 386 (635)
Q Consensus 383 Gla~ 386 (635)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=323.66 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=214.8
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC--HHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD--ERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
|.+.+.||.|+||.||++...... .++..||||++.+.... ......+.+|+.++.++ +|+||+++
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~-----------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~ 70 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGH-----------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTL 70 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccc-----------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhh
Confidence 677899999999999998753222 24568999999754321 23446678999999999 59999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.....+|+||||+.+++|.+++.....+++..+..++.||+.+|.|||+.+++|+||||.|||++.++.++|+|||
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 71 HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred heeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECc
Confidence 99999999999999999999999999887789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc--cccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCccC
Q psy6357 384 FSNYFTPGHM--LTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQRILFGKFR 456 (635)
Q Consensus 384 la~~~~~~~~--~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~i~~~~~~ 456 (635)
++..+..... .....++..|+|||++.+.. ..+.++||||||+++|+|++|..||.... ...+.+.+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 9876543321 22356889999999987654 22489999999999999999999996432 34444555555666
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCcccccC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLT---LTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~Hpw~~~~ 495 (635)
.|..++.++.+||.+||+.||++||| +.++|+||||+..
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 77778999999999999999999998 5678999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.62 Aligned_cols=249 Identities=28% Similarity=0.483 Sum_probs=209.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.+.+.||.|+||.||++.+. .++..||+|.+..... +......+.+|+.++++++|+||+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~ 67 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL--------------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc--------------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeee
Confidence 46888899999999999999873 3456899999875433 34446788899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l 147 (267)
T cd08224 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred eeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEE
Confidence 99999999999999999999999888542 45899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCcc-
Q psy6357 380 ADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--LAVLKQRILFGKF- 455 (635)
Q Consensus 380 ~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~--~~~l~~~i~~~~~- 455 (635)
+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++|..||.... ...+...+..+.+
T Consensus 148 ~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08224 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226 (267)
T ss_pred eccceeeeccCCCcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC
Confidence 9999987654322 23345688899999999887776 89999999999999999999996543 3344444443322
Q ss_pred CCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 456 RIPF-YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 456 ~~p~-~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.|. .++.++.++|.+||..+|++|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3444 67889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.92 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=213.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
..+|.++++||+|+||.||++.+....+.. ......||+|++.... .......+.+|+.+++++ +|+||++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~-------~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDK-------PNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCcc-------CCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 346788999999999999999764322110 0123469999887542 444567889999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++.....+|+||||+.+++|.+++.... .++...+..++.||+.||.|||+.||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 377888999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..++ .++|||||||+||+|++ |..||...+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999976543221 1222335679999999888776 89999999999999998 899999988
Q ss_pred HHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+...+.... ...+..++.++.+||.+||..+|.+|||+.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888777776543 34566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.58 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=203.7
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
.||.|+||.||++... ++..||+|++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 2 ~ig~g~~g~vy~~~~~---------------~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 65 (250)
T cd05085 2 LLGKGNFGEVFKGTLK---------------DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65 (250)
T ss_pred ccCCCCCceEEEEEec---------------CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC
Confidence 6899999999999752 34579999987553 3344457889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
..++||||+++++|.+++... ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 66 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 66 PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred ccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence 999999999999999988654 4589999999999999999999999999999999999999999999999999876443
Q ss_pred CCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHHHH
Q psy6357 391 GHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAECE 466 (635)
Q Consensus 391 ~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~l~ 466 (635)
.... ....++..|+|||++....++ .++||||||+++|+|++ |..||...........+... ....+..++..+.
T Consensus 146 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (250)
T cd05085 146 GIYSSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVY 224 (250)
T ss_pred cccccCCCCCCcccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 2211 122345679999999877765 89999999999999998 99999888777666666544 2345667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHcC
Q psy6357 467 NLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 467 ~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+||.+||..+|++||++.++++.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHH
Confidence 99999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.62 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=214.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++..||.|+||.||++..+.... ......||+|.+.... .......+.+|+.+|++++|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~ 73 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEE---------EGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRL 73 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCc---------CCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeee
Confidence 3567789999999999999998743321 1234579999986543 33356778999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc---------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG---------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
++++......|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~ 153 (275)
T cd05046 74 LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ 153 (275)
T ss_pred EEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC
Confidence 999999999999999999999999997665 69999999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~ 451 (635)
+.++|+|||++....... ......++..|+|||.+.+..+. .++||||||+++|+|++ |..||.......+...+.
T Consensus 154 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred CcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 999999999987543221 22334556779999998877765 89999999999999998 889998777777666666
Q ss_pred hCcc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 452 FGKF--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 452 ~~~~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.... ..+..++..+.+||.+||+.+|.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 5543 3455688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.37 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=204.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+.++||.|+||.||++.+. ....||||++...... ...+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~---------------~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN---------------GTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPL 66 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc---------------CCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeE
Confidence 356778899999999999999762 2246999988654332 2567889999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.. ...|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|
T Consensus 67 ~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~d 145 (260)
T cd05069 67 YAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIAD 145 (260)
T ss_pred EEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECC
Confidence 998854 56899999999999999987543 488999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |.+||.+.........+... ....
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05069 146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224 (260)
T ss_pred CccceEccCCcccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999976543221 1223456789999999877765 89999999999999999 99999888777666666544 2344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++..+.+||.+||..||.+||++++|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.92 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=206.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+++.||.|+||+||+|.+...... ...+||+|.+.... .......+..|+.++.++.|+||++++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~----------~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~ 75 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS----------IKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLL 75 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc----------eeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 4566788999999999999987432210 11258888875432 334456778899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++. ....++|+||+.+++|.+++... ..+++..+..|+.||+.||.|||+.+++|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 76 GICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCc
Confidence 9875 45678999999999999999764 568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 384 FSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 384 la~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
++....... ......++..|+|||++.+..++ .++|||||||++|||++ |..||.+.....+.+.+..+. ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 998654322 12334567789999999887776 89999999999999998 999998877666655554433 3345
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..++.++.+++.+||..||.+|||+.++++.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.54 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=210.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
..+||.|+||.||++... .++..||||++... .......+.+|+.+++.++|+||+++++++..
T Consensus 25 ~~~lg~g~~g~v~~~~~~--------------~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK--------------SSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88 (292)
T ss_pred HHHcCCCCCeEEEEEEEc--------------CCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe
Confidence 468999999999998773 34568999998543 23345678899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+..|+||||+++++|.+++. ...+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 89 GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred CCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 999999999999999988764 4578999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cCCCCCCCHHH
Q psy6357 390 PGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FRIPFYMSAEC 465 (635)
Q Consensus 390 ~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~~p~~~s~~l 465 (635)
... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...........+.... +.....++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246 (292)
T ss_pred cccccccccccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence 321 22345688999999999877765 89999999999999999999998776555444443221 22233578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 466 ENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 466 ~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+||.+||..+|.+||++.+||.||||....+
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.90 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=207.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||.|++|.||++.+..... ....||||.+...... ...+.+.+|+.+|++++|+||+++++++..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~-----------~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGG-----------KVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT- 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCC-----------CceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-
Confidence 368999999999998743211 1236999999876544 566788999999999999999999999988
Q ss_pred CeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
...++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+|||++.++.+||+|||++..+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 88999999999999999997754 6899999999999999999999999999999999999999999999999999876
Q ss_pred cCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--ccCCCCCC
Q psy6357 389 TPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG--KFRIPFYM 461 (635)
Q Consensus 389 ~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~--~~~~p~~~ 461 (635)
.... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||...+..++...+... ....+..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccC
Confidence 4321 11234567789999999887776 89999999999999998 99999887777766666532 23345567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..+.+||.+||..+|++|||+.+|++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.35 Aligned_cols=246 Identities=25% Similarity=0.446 Sum_probs=209.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.++||.|+||.||++.+. .+..+|||++....... ..+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~---------------~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL---------------EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLY 65 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe---------------CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEE
Confidence 35667899999999999999773 23579999987655443 4577899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+|+||||+.+++|.+++... ..+++..++.++.||+.+|.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred EEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999988754 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCC
Q psy6357 384 FSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPF 459 (635)
Q Consensus 384 la~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~ 459 (635)
++........ .....++..|+|||++.+..+. .++||||||+++|+|++ |..||.......+.+.+..+ ....|.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05112 146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224 (256)
T ss_pred ceeecccCcccccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC
Confidence 9876543221 1123345689999999877775 89999999999999998 99999988877777776654 233455
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+..+.+|+.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.09 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=210.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.+.||.|+||.||+|.+..... ....||||++.... .......+..|+.+++.++||||++++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----------~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~ 71 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK-----------REIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLE 71 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC-----------CceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEE
Confidence 346678999999999999998754432 12469999986543 455567899999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++......++||||+.+++|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred EEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCc
Confidence 9999999999999999999999988754 568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcc---cc-cc--CCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-cc
Q psy6357 384 FSNYFTPGHML---TT-WC--GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KF 455 (635)
Q Consensus 384 la~~~~~~~~~---~~-~~--gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~ 455 (635)
++......... .. .. .+..|+|||++.+..++ .++|||||||++|||++ |..||...+.......+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~ 230 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL 230 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 98765432211 11 11 13479999999888776 89999999999999886 99999888777777766543 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+..++..+.++|.+||..+|.+||++.+|+.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 445568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.97 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=209.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+.++||.|+||.||++.+. +...||||.+...... ...+.+|+.++++++|+||+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~---------------~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN---------------GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc---------------CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeee
Confidence 456777899999999999998763 2347999998765433 3567899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECc
Confidence 999999899999999999999999987653 689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++........ ......+..|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+.......+... ....
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR 225 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999876643211 1122345689999999877765 89999999999999998 99999888777777776554 3345
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++.++.++|.+||..+|.+||+++++++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.20 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=209.7
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|.+.+.||.|+||.||+|....... ....||||.+.... .......+.+|+.+|++++||||++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----------~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK-----------REIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLE 71 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC-----------CceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456778999999999999998643321 22479999987543 344557888999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++...+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred EEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCC
Confidence 9999999999999999999999998765 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc--c--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 384 FSNYFTPGHM--L--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 384 la~~~~~~~~--~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
++........ . ....++..|+|||++.+..++ .++|||||||++|+|++ |..||...........+... ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC
Confidence 9987643221 1 112235679999999887775 89999999999999886 99999887776666666544 2334
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++..+.+||.+||+.+|.+||++.+|++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 4567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=363.02 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=218.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.-...+.||+|.||.||.|.+.-.+... ....||||.+.+.. +......|++|+.+|++++|||||++++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~---------~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSV---------SPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCc---------cceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence 3344678999999999999996554321 13469999987654 6677789999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++.+....+|++|||++|+|..+|.+. ..|+..+.+.|+.||++|+.||+++++|||||...|+||+....+|
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence 999999999999999999999999876 2489999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCcc-ccc--cCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHhC
Q psy6357 379 LADFGFSNYFTPGHML-TTW--CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQ-RILFG 453 (635)
Q Consensus 379 L~DFGla~~~~~~~~~-~~~--~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~-~i~~~ 453 (635)
|+|||+|+.+...... ... .-...|||||.+....++ .++|||||||+|||+++ |..||...+..++.. ....+
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999955433221 111 123579999999998887 99999999999999999 999999988877777 55566
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.++.|.+|+..+.+||..||+.+|++||+|..|++
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 78889999999999999999999999999999997
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=333.37 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=205.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|.++..||.|+||.||+|.+. .++..||||++.+..........+.+|+.+++.+.|+||++++
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDK--------------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeC--------------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 57888999999999999999862 3457899999976544444445688999999999999999999
Q ss_pred EEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 305 QVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 305 ~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
+++... ..+|+||||+. .+|..++ ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred heecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 998654 34699999995 4565544 23689999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG----- 453 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~----- 453 (635)
|+|||++..... ......++..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 158 L~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 158 ILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred EeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999876532 2234567889999999876433348999999999999999999999887654433332210
Q ss_pred ------------------ccCCC--------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 454 ------------------KFRIP--------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 454 ------------------~~~~p--------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
...++ ..++.++.+||.+||+.||.+||++.+||.||||....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 135778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=346.38 Aligned_cols=247 Identities=25% Similarity=0.472 Sum_probs=212.1
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEE---EEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVA---IKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VA---IKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
-..||+|+|-+||+|.+.... ..|| ||+-+. ..++..+++|..|+.+|+.|+|+|||++|++
T Consensus 45 ~evLGrGafKtVYka~De~~g--------------iEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S 109 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEG--------------IEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIRFYDS 109 (632)
T ss_pred hhhcccccceeeeeccccccc--------------hhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence 467999999999999985443 2333 332222 2256777999999999999999999999999
Q ss_pred EecCCe--EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeecCC-CCeeeec
Q psy6357 307 METTNN--LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFDEN-GDIKLAD 381 (635)
Q Consensus 307 ~~~~~~--~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~~~-~~ikL~D 381 (635)
|.+... +.+|+|++..|+|..|+++.+++....++.|++||++||.|||++. |||||||.+||+|+.+ |.|||+|
T Consensus 110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 110 WVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 987655 8899999999999999999999999999999999999999999985 9999999999999864 8999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCccCCC--
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG-PNLAVLKQRILFGKFRIP-- 458 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~-~~~~~l~~~i~~~~~~~p-- 458 (635)
+|||......... ..+|||.|||||++. ..|+ ..+||||||++|+||+|+.+||.. .+...++.++..+..+--
T Consensus 190 LGLAtl~r~s~ak-svIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 190 LGLATLLRKSHAK-SVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred hhHHHHhhccccc-eeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence 9999987665444 489999999999997 6676 999999999999999999999965 678889999988754322
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.--.+++++||.+||.. ...|+|+.|+|.||||...
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 22468999999999999 9999999999999999864
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=315.25 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=206.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
++.++|.+.+.||+|+|+.||++.. +.++..+|+|.+.... .+..+..++|++..++++||||+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~--------------~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl 81 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKG--------------LSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVL 81 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecc--------------cCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchH
Confidence 5678999999999999999997763 4566789999997664 56678899999999999999999
Q ss_pred eEEEEEecC-----CeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCccee
Q psy6357 302 KLFQVMETT-----NNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLL 370 (635)
Q Consensus 302 ~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NIL 370 (635)
+++++...+ ...||+++|...|+|.+.+... ..++|.+++.|+.+|++||++||+.. ++||||||.|||
T Consensus 82 ~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NIL 161 (302)
T KOG2345|consen 82 RLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANIL 161 (302)
T ss_pred HHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeE
Confidence 999876433 3599999999999999988654 25999999999999999999999998 999999999999
Q ss_pred ecCCCCeeeecccccccccCC----------CccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCC
Q psy6357 371 FDENGDIKLADFGFSNYFTPG----------HMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLP 437 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~----------~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~P 437 (635)
+.+.+.++|.|||.++...-. +.......|..|+|||.+.- ... ++++|||||||+||.|+.|..|
T Consensus 162 ls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti-~ertDIWSLGCtLYa~mf~~sP 240 (302)
T KOG2345|consen 162 LSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI-TERTDIWSLGCTLYAMMFGESP 240 (302)
T ss_pred ecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc-ccccchhhhhHHHHHHHHcCCc
Confidence 999999999999998764311 11223456889999999853 333 4899999999999999999999
Q ss_pred CCCCC--HHHHHHHHHhCccCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 438 FDGPN--LAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 438 F~~~~--~~~l~~~i~~~~~~~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|+..- -..+.-.+..+.+.+|. .+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 241 fe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 241 FERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred chHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 96421 11222234444555553 489999999999999999999999999875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.81 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=197.7
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
+.||+|+||.||+|.+........ ..........||+|++.... ......+.+|+.+|..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~--~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDED--DGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccc--cccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 368999999999998643221100 00112234579999876542 33445778899999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC-------eeeecc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD-------IKLADF 382 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~-------ikL~DF 382 (635)
...++||||+.+++|..++... ..+++..++.++.||+.||+|||+.+|+||||||+||||+.++. ++|+||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998887653 56999999999999999999999999999999999999987664 899999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV-TAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLl-tG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
|++...... ....++..|+|||++......+.++|||||||++|+|+ .|..||......+... +...........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~ 232 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPS 232 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCC
Confidence 998765322 23467889999999874433348999999999999998 4899988765544332 233334444446
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+.++.+||.+||+.||.+||++.+||++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.82 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=198.7
Q ss_pred eccccCCcceeeeEeeehhhhHHH----------HHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEA----------AAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~----------~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+||+|+||.||+|........... ...........||+|++.... ......+.+|+.+++.++|+||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999986543211000 001112233569999986542 23345678899999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-----
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG----- 375 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~----- 375 (635)
++++++......||||||+++++|..++.. .+.+++..+..++.||+.||+|||+.+|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999888865 45789999999999999999999999999999999999997644
Q ss_pred --CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh
Q psy6357 376 --DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV-TAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 376 --~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLl-tG~~PF~~~~~~~l~~~i~~ 452 (635)
.+||+|||++...... ....++..|+|||++.+....+.++|||||||++|||+ +|..||.......... +..
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE 235 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH
Confidence 3899999998654321 23457788999999876443358999999999999995 6999998766554433 223
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
....+|...+..+.+||.+||..+|++|||+.+||++
T Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 3445566677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.99 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=206.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHH--HHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAA--QLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~--~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.++|.+.++||+|+||.||++.+..........+. ....+...||||++.... .......+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 35688899999999999998865321110000000 111234579999987543 344556888999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-----------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-----------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-----------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
++++++......|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+.+|+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999886642 3677889999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT--AQLPFDGPNLAV 445 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt--G~~PF~~~~~~~ 445 (635)
++.++.++|+|||++..+..... .....++..|+|||++.+..++ .++|||||||++|||++ |..||...+...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999976543221 1223346789999998877775 89999999999999998 789997766555
Q ss_pred HHHHHHh--------CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 LKQRILF--------GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 l~~~i~~--------~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
....... ...+.+..++..+.+||.+||+.||.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4433211 122345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.76 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=208.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
..+|.+.+.||.|+||.||++.+..... ......||||++.... .......+.+|+.+++++ +|+||++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSK---------SDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCC---------CCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcce
Confidence 3457778999999999999987632211 1234579999987543 334456788999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++...+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+
T Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence 9999999999999999999999999987543 38999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc--
Q psy6357 381 DFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 381 DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-- 454 (635)
|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||................
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 9999976543221 1223456789999999887776 89999999999999998 999998766544443333322
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...+...+.++.+||.+||..+|++|||+.+|++
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2344567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.49 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=211.3
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM 307 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 307 (635)
.+.+.||.|+||.||.+.+..... .....||+|++.... .......+..|+.+|+.++|+||+++++++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~----------~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSG----------EKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVC 70 (258)
T ss_pred cccceeccCCCcceEEEEecCCCC----------CCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 456889999999999998843321 123689999996553 233557888999999999999999999999
Q ss_pred ecCCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
...+..|+||||+.+++|.+++..... +++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 71 TEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred cCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCc
Confidence 999999999999999999999876554 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccc--cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCC
Q psy6357 386 NYFTPGHMLT--TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYM 461 (635)
Q Consensus 386 ~~~~~~~~~~--~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~ 461 (635)
.......... ...+++.|+|||.+....++ .++|||||||++|+|++ |.+||...+...+.+.+.... ...+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T smart00219 151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC 229 (258)
T ss_pred eecccccccccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 8765432221 12367889999999766665 89999999999999998 899999888777777776553 3455668
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.++.++|.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.63 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=207.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..|.+.+.||.|+||.||++.+. .++..||||.+..... .......+.+|+.+++.+.|+||+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~--------------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~ 67 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL--------------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec--------------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhh
Confidence 45777899999999999999863 3456899998865433 34455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++...+..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|
T Consensus 68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred hheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999988763 345899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCccC
Q psy6357 380 ADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL--AVLKQRILFGKFR 456 (635)
Q Consensus 380 ~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~--~~l~~~i~~~~~~ 456 (635)
+|||++....... ......++..|+|||++.+..++ .++||||||+++|+|++|..||.+... ......+....+.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08229 148 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226 (267)
T ss_pred CcchhhhccccCCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC
Confidence 9999987664322 23345788999999999887776 899999999999999999999976543 3334444333222
Q ss_pred -CC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 -IP-FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 -~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+ ..++..+.+||.+||..||.+|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 22 357889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.51 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=210.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||.|+||.||++.+...- .-..+..||||++.... .......+.+|+.+++++.|+||+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---------~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~ 73 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLL---------PYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKL 73 (288)
T ss_pred hHhceecccccccccccEEEEEEcccC---------CCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheE
Confidence 346778899999999999998763210 00234689999987543 34445678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc----------------------cCCHHHHHHHHHHHHHhhhhhccCceee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------------QMAEKEASRLFRQILSAVAYCHANNVVH 361 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiH 361 (635)
++++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H 153 (288)
T cd05050 74 LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153 (288)
T ss_pred EEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999986432 3788899999999999999999999999
Q ss_pred ecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCC
Q psy6357 362 RDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLP 437 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~P 437 (635)
+||||+|||++.++.++|+|||++....... .......+..|+|||++.+..++ .++|||||||++|+|++ |..|
T Consensus 154 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred ccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987653221 12223346679999999887776 89999999999999997 8899
Q ss_pred CCCCCHHHHHHHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 438 FDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 438 F~~~~~~~l~~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|.+.+..++...+..+.. ..+..++.++.+||.+||+.||.+|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 233 YYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 988887777777765543 346678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=334.60 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=222.6
Q ss_pred hhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHH
Q psy6357 212 LDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDI 291 (635)
Q Consensus 212 l~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~i 291 (635)
.++|+..+.++.. -.|||-|.||.||.|.|+-.. ..||||.++.+. -.++.|+.|+.+
T Consensus 259 ~DkWEmeRtdItM-----khKLGGGQYGeVYeGvWKkys--------------lTvAVKtLKEDt---MeveEFLkEAAv 316 (1157)
T KOG4278|consen 259 ADKWEMERTDITM-----KHKLGGGQYGEVYEGVWKKYS--------------LTVAVKTLKEDT---MEVEEFLKEAAV 316 (1157)
T ss_pred cchhhccchheee-----eeccCCCcccceeeeeeeccc--------------eeeehhhhhhcc---hhHHHHHHHHHH
Confidence 4788888777766 579999999999999995433 469999987653 346789999999
Q ss_pred HhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 292 MSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
|+.+.|||+|+|+++|..+..+|||+|||..|.|++||....+ ++.-.++.++.||..||+||..+++|||||...|+
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC 396 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 396 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence 9999999999999999999999999999999999999987654 77788899999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCCcccc--ccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGHMLTT--WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~~~~~--~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
||.++..+||+||||++.+..+..... ..-..-|.|||-+.-..+. .++|||+|||+|||+.| |..||.+.+...+
T Consensus 397 LVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqV 475 (1157)
T KOG4278|consen 397 LVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 475 (1157)
T ss_pred cccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHH
Confidence 999999999999999998875533222 1235569999999988887 99999999999999998 9999999999988
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
+..+..+ .+.-|..|++.+.+||..||+|.|.+||+|.||-
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 8877655 4567889999999999999999999999999984
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.36 Aligned_cols=251 Identities=30% Similarity=0.461 Sum_probs=208.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.++++||.|.+|.||.+... .++..||+|++............+..|+.+++.++|+||++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~--------------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 66 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK--------------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66 (282)
T ss_pred CeeehcccccCcceEEEeeec--------------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhh
Confidence 456788999999999998773 346789999998765334444677889999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+......++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||++
T Consensus 67 ~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 67 IHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred hhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcc
Confidence 999999999999997 5899998876 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Q psy6357 386 NYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG----------- 453 (635)
Q Consensus 386 ~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~----------- 453 (635)
....... ......++..|+|||++......+.++|||||||++|+|++|.+||...+.......+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 146 RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 8764432 2334456788999999877633348999999999999999999999887655444333210
Q ss_pred -------ccCCC-----------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 454 -------KFRIP-----------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 454 -------~~~~p-----------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
...++ ..++..+.+||.+||..||.+||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00011 1247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.56 Aligned_cols=246 Identities=30% Similarity=0.456 Sum_probs=215.6
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
-++||.|-||.||+|.|...++. ..--||||.++.+. ..+..+.|+.|+.+|++++|||||+|+++|..
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kg----------e~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKG----------ERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred HHhhcCCcccceeeeEecccccC----------cceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 36799999999999999766432 22359999997755 44457899999999999999999999999964
Q ss_pred CCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..+|||||+++.|.|..||+..+ .|+......++.||+.||.|||+..+|||||...|||+.....+||+|||+++.+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 67899999999999999998764 5999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCccccccC--CCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHH
Q psy6357 389 TPGHMLTTWCG--SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAE 464 (635)
Q Consensus 389 ~~~~~~~~~~g--t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~ 464 (635)
..........| ..-|||||.+.-..++ .++|||.|||++||++. |..||.+....+..-.|..+ .++.|..|++.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred cccchhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChH
Confidence 87665544454 3459999999988887 89999999999999987 99999998877777777665 57889999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..|+.+||.+||.+||.+.+|..
T Consensus 621 LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999999987753
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.69 Aligned_cols=232 Identities=21% Similarity=0.369 Sum_probs=190.4
Q ss_pred cCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHH
Q psy6357 263 ELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEA 340 (635)
Q Consensus 263 ~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~ 340 (635)
++..||||++............+.+|+.+|+.++|+||+++++++......|++|||+.+++|.+++... ..+++..+
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 4578999999876556667788999999999999999999999999999999999999999999988764 45899999
Q ss_pred HHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC--------CccccccCCCCCCCccccCCC
Q psy6357 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGR 412 (635)
Q Consensus 341 ~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~~ 412 (635)
..++.||+.||+|||+.+|+|+||||+|||++.++.+||+|||.+...... .......++..|+|||++...
T Consensus 104 ~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC
Confidence 999999999999999999999999999999999999999999988654321 112334567889999998763
Q ss_pred --CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCc---------------------------------cC
Q psy6357 413 --EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL-KQRILFGK---------------------------------FR 456 (635)
Q Consensus 413 --~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l-~~~i~~~~---------------------------------~~ 456 (635)
.++ .++|||||||++|+|++|..||........ .+.+.... ..
T Consensus 184 ~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (314)
T cd08216 184 LQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP 262 (314)
T ss_pred CCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcc
Confidence 344 899999999999999999999986543322 22221000 00
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+..++.++.+||.+||.+||++|||+.+||+||||...
T Consensus 263 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 263 YTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 011245688999999999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.68 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=207.5
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|..+++||.|+||.||+|... ..+..||||++..... .......+.+|+.+++.++|+||+++++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~--------------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 88 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS--------------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC--------------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 555788999999999999762 3456899999975543 3445567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++.+....|+||||+. ++|.+++.. ...+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred EEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 9999999999999996 567676654 45689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC-C-CC
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-I-PF 459 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-~-p~ 459 (635)
+..... .....++..|+|||++. ...++ .++|||||||++|+|++|..||...+.......+.....+ . ..
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
T cd06633 168 ASKSSP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSN 243 (313)
T ss_pred CcccCC---CCCccccccccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 865432 23457888999999984 23444 8899999999999999999999877655555544433221 1 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++..+.+||.+||+.+|.+||++.+++.||||...
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.84 Aligned_cols=241 Identities=27% Similarity=0.440 Sum_probs=204.8
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||.|+||.||++.+.. +..||+|++...... .....+.+|++++++++|+||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~---------------~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 64 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG---------------NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK 64 (251)
T ss_pred CccccCCCceEEEEEEeC---------------CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Confidence 479999999999998732 467999998765433 4556788999999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
...++||||+.+++|.+++... ..+++..+..++.+++.+|.|||+.+|+|+||||+|||++.++.++|+|||++....
T Consensus 65 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 65 QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9999999999999999998653 468999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHH
Q psy6357 390 PGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAE 464 (635)
Q Consensus 390 ~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~ 464 (635)
..... .....+..|+|||++.+..++ .++|||||||++|+|++ |..||...........+... ....|..++.+
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEE 223 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 22111 112235679999999877765 89999999999999999 89999887776666666543 34456678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+||.+||..+|.+|||+.||++
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.63 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=209.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
|..+++||.|+||.||++... .++..||||++..... .......+.+|+.+|+.++|+||+++++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~--------------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 92 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDV--------------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92 (317)
T ss_pred hhhhheeccCCCeEEEEEEEc--------------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 667889999999999999763 3456899999975533 3445567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++......|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 93 CYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCC
Confidence 99999999999999974 67666643 45689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CC-CC
Q psy6357 385 SNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RI-PF 459 (635)
Q Consensus 385 a~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~-p~ 459 (635)
+..... .....++..|+|||++. ...+ +.++|||||||++|+|++|..||...+.......+..... .. +.
T Consensus 172 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 172 ASIASP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN 247 (317)
T ss_pred ccccCC---cccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCc
Confidence 876543 23456888999999974 2344 4899999999999999999999987766555555544432 22 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.++..+.+||.+||+.+|.+||++.+|++|+|+....
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 5788999999999999999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.38 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=211.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||+|+||.||+|.+...+.. ....||+|++.... .......+.+|+.+|+.++|+||+++
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~----------~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK----------VKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRL 74 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCC----------cceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 35677789999999999999987433211 12369999887654 24455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.. ...++||||+.+++|.+++... ..+++..+..++.||+.||+|||+.+|+|+||||+|||++.++.+||+||
T Consensus 75 ~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred EEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCC
Confidence 999987 7899999999999999998764 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCC
Q psy6357 383 GFSNYFTPGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRI 457 (635)
Q Consensus 383 Gla~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~ 457 (635)
|++......... ....++..|+|||.+....++ .++|||||||++|+|++ |..||......++.+.+.... ...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence 999876533221 112235679999999877775 89999999999999998 999999988888777776543 455
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|..++.++.++|.+||..||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.76 Aligned_cols=244 Identities=32% Similarity=0.493 Sum_probs=211.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
....|++...+|.|+|+.|-.+... .+....|+|++.+.. ....+|+.++... +|+||+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~--------------~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv 379 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS--------------PTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIV 379 (612)
T ss_pred cchhhccccccCCCCccceeeeecc--------------ccccchhheeccccc------cccccccchhhhhcCCCcce
Confidence 4667888888999999999877663 345679999998762 2334677666655 799999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee-cCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF-DENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl-~~~~~ikL~ 380 (635)
++++++.+..+.|+|||++.|+.|.+.+.....+. .++..|+.+|+.||.|||++|||||||||+|||+ +..++++|+
T Consensus 380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 380 KSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred eecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEE
Confidence 99999999999999999999999998888766666 8888999999999999999999999999999999 689999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCccCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFGKFRIPF 459 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~~~~~p~ 459 (635)
|||.++..... ..+.+-|..|.|||++....|+ .++||||||++||+||+|..||..... .++...|..+.+. .
T Consensus 459 yFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~ 533 (612)
T KOG0603|consen 459 YFGFWSELERS--CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--E 533 (612)
T ss_pred EechhhhCchh--hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--c
Confidence 99999877654 5566788999999999988887 999999999999999999999976544 4677777665444 7
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
.+|.++++||.+||+.||.+|+++.+|+.||||
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 799999999999999999999999999999999
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=313.55 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=208.7
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|...+.||.|+||.||++....... ....||||++.... .......+..|+.++++++|+||++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----------~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGR-----------KEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLE 72 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCC-----------CceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEE
Confidence 345667899999999999998743321 22479999986543 344456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++...+..|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred EEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCc
Confidence 9999999999999999999999998764 568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCc--cc--cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 384 FSNYFTPGHM--LT--TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 384 la~~~~~~~~--~~--~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
++........ .. ....+..|+|||++....++ .++|||||||++|+|++ |..||...+...+...+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~ 231 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA 231 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC
Confidence 9876543211 11 11234579999999877775 89999999999999997 99999887777777766543 2334
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..++.++.+||.+||..+|++||++.+|++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.55 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=205.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.++|.+++.||.|+||.||+|.+..... ...+..||||++.... .......+.+|+.+|.++ +|+||++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDK---------TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCc---------cccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhh
Confidence 4578889999999999999998632211 2345689999997543 334456788999999999 6899999
Q ss_pred EEEEEec-CCeEEEEEeccccchhhhhhhhc-------------------------------------------------
Q psy6357 303 LFQVMET-TNNLYLVTEYARGGEIFSHLLTI------------------------------------------------- 332 (635)
Q Consensus 303 l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~------------------------------------------------- 332 (635)
+++++.. ...+++|||||.+++|.+++...
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 9998754 45689999999999999888542
Q ss_pred ------------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCc-
Q psy6357 333 ------------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHM- 393 (635)
Q Consensus 333 ------------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~- 393 (635)
..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 1367788899999999999999999999999999999999999999999999976532211
Q ss_pred --cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHhC-ccCCCCCCCHHHHHH
Q psy6357 394 --LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA-VLKQRILFG-KFRIPFYMSAECENL 468 (635)
Q Consensus 394 --~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~-~l~~~i~~~-~~~~p~~~s~~l~~L 468 (635)
.....++..|+|||++.+..++ .++|||||||++|+|++ |..||...... .+...+..+ ....|..++.++.++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 1223456779999999887776 89999999999999997 99999775433 233333222 345566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHcC
Q psy6357 469 IRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 469 I~~~L~~dP~~Rps~~eiL~H 489 (635)
|..||..||++|||+.+|++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.15 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=206.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l 303 (635)
+.|.+.++||.|+||.||++.+..... ......||||++.... .......+.+|+.+|.++. |+|||++
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~---------~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSH---------SQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCC---------CCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 345567899999999999998742211 1234579999997653 3334457889999999997 9999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--------------------------------------------------
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-------------------------------------------------- 333 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------------------------------------------------- 333 (635)
++++.....+|+|||||.+|+|.+++...+
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999885431
Q ss_pred ------------------------------------------------cCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 334 ------------------------------------------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 334 ------------------------------------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
.+++..++.|+.||+.||.|||+.+|+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 25677788999999999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGP 441 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~ 441 (635)
|+|||++.++.+||+|||++..+.... ......++..|+|||++.+..+. .++|||||||++|||++ |..||...
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999998653221 12234567889999999887775 89999999999999998 89999876
Q ss_pred CHHHHHHH-HHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 NLAVLKQR-ILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 ~~~~l~~~-i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
........ +..+ ....|..++.++.+||.+||..+|.+||++.+|+..
T Consensus 346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54444333 3332 234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=373.42 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=222.1
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+++.-.+||.|.||.||-+.. ..+|.-.|+|-+............+.+|..+|..|+|||||++|+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN--------------~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyG 1301 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVN--------------LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYG 1301 (1509)
T ss_pred eeccccccCCcceeeeEEeec--------------CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCc
Confidence 344457899999999998876 467788999988776655566678889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+-.+.+.++|.||||++|+|.+++...+-..|.....+..|++.||.|||+.|||||||||.||||+.+|.||++|||.|
T Consensus 1302 VEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1302 VEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred eeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccce
Confidence 99999999999999999999999988777888889999999999999999999999999999999999999999999999
Q ss_pred ccccCC-----CccccccCCCCCCCccccCCCCc--CCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-CccC
Q psy6357 386 NYFTPG-----HMLTTWCGSPPYAAPELFGGREY--DGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILF-GKFR 456 (635)
Q Consensus 386 ~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~--~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~-~~~~ 456 (635)
..+... ..+....||+.|||||++.+..- .+-++||||||||+.||+||+.||...+. -.+..++.. -..+
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 887643 23556889999999999976542 24689999999999999999999976542 333344443 4678
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+|..+|.+.++||.+||..||++|+++.|||+|.|-....
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 8999999999999999999999999999999999976543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.26 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=200.0
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
+.||.|+||.||+|......... ......||+|++.... ....+.+..|+.+|+.+.||||+++++++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~-------~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 71 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYG-------ELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG 71 (258)
T ss_pred CCCCcccchhheeeeeccccccc-------ccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence 36999999999999874332110 1123468899886442 33446788899999999999999999999998
Q ss_pred CeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC--------eeeec
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD--------IKLAD 381 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~--------ikL~D 381 (635)
...++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+.+|+||||||+|||++.++. ++|+|
T Consensus 72 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 72 DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999999999987654 5899999999999999999999999999999999999987764 69999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
||++...... ....++..|+|||++.+....+.++|||||||++|+|++| .+||...+...... +......+|..
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~ 227 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAP 227 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCC
Confidence 9998765432 3356788999999998754335899999999999999998 57776655444332 33445567777
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+.++.+||.+||+.||++|||+++|++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.53 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=202.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
-|.++++||+|+||.||.+.+.... ...+..||||.+.... .......+.+|+.+|+.+.|+||+++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~----------~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEG----------DNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKG 73 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCC----------CCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 4678999999999999999764221 2345789999986543 3445567899999999999999999999
Q ss_pred EEecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 306 VMETT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 306 ~~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++... ...++||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+||
T Consensus 74 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 74 ICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred EEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCC
Confidence 98765 5689999999999999998664 35899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---------------H
Q psy6357 383 GFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---------------L 443 (635)
Q Consensus 383 Gla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---------------~ 443 (635)
|++..+.... ......++..|+|||++.+..++ .++|||||||++|+|+++..|+.... .
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 9998764322 12234567789999999887775 89999999999999999776643211 1
Q ss_pred HHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 444 AVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 444 ~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
......+... ..+.+..++..+.+||.+||+.+|.+|||+.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111111111 233455689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.59 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=210.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.+.+.||+|+||.||+|.+..... .....||+|++... ........+.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~----------~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~ 72 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKP----------GKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILP 72 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCC----------CceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34577788999999999999998854210 12457999998643 35556678899999999999999999
Q ss_pred EEEEEec-CCeEEEEEeccccchhhhhhhhc--------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 303 LFQVMET-TNNLYLVTEYARGGEIFSHLLTI--------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 303 l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~--------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
+++++.. ....++++||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~ 152 (280)
T cd05043 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152 (280)
T ss_pred EEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC
Confidence 9998765 56789999999999999988653 35899999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
++.+||+|||+++.+..... .....++..|+|||++.+..++ .++|||||||++|+|++ |.+||...+...+...
T Consensus 153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 99999999999986543321 1223456789999999887775 89999999999999999 9999988777776665
Q ss_pred HHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 450 ILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 450 i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+... .+..+..++.++.++|.+||..||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5543 22344557899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.10 Aligned_cols=251 Identities=27% Similarity=0.491 Sum_probs=208.3
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccc---ccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKK---RLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+|.+.++||.|+||.||++.+... +..+++|++... .........+.+|+.+++.++||||++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 66 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA--------------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC--------------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHH
Confidence 578889999999999999876322 234566665432 222333456778999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
+++++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.++
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred HHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEe
Confidence 99999999999999999999999888754 346999999999999999999999999999999999999975 5799
Q ss_pred eecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 379 LADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 379 L~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
|+|||++...... .......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...........+.... ..
T Consensus 146 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd08222 146 IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224 (260)
T ss_pred ecccCceeecCCCcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC
Confidence 9999998765432 233345678899999999877765 88999999999999999999998777666666655443 33
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++..++.++.+||.+||..+|.+||++.+|++||||
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 456788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=324.38 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=207.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||.|+||.||++... .++..||||++.+..........+.+|+.+++.++||||++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 73 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ--------------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIIS 73 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC--------------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeee
Confidence 4567999999999999999999863 34568999998765444444567889999999999999999
Q ss_pred EEEEEec-CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMET-TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++|.. ....|+||||+ +++|..++.. ..+++..+..++.||+.||.|||+.+|+|+||+|.|||++.++.++|+|
T Consensus 74 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 74 LSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCc
Confidence 9999865 56789999999 5678776654 5688999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF--------- 452 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~--------- 452 (635)
||++..... ......++..|+|||++.+....+.++|||||||++|+|++|..||...........+..
T Consensus 152 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 152 FGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999976532 223456788999999986633334899999999999999999999987654222111100
Q ss_pred ------C-----------ccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 453 ------G-----------KFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 453 ------~-----------~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
. ....| ..++.++.+||.+||+.+|++|||+++++.||||.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0 00111 236789999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=311.18 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=200.9
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-c
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME-T 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~ 309 (635)
+.||+|+||.||+|.+.... .....||||.+.... .......+.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-----------~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 68 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD-----------GQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68 (262)
T ss_pred CcccccCCceEEEEEEecCC-----------CceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence 36899999999999874322 123579999985432 3445678889999999999999999999765 4
Q ss_pred CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
+...++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++...
T Consensus 69 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 69 EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccc
Confidence 55689999999999999998764 34678888999999999999999999999999999999999999999999999765
Q ss_pred cCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCC
Q psy6357 389 TPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYM 461 (635)
Q Consensus 389 ~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~ 461 (635)
.... ......++..|+|||++.+..++ .++|||||||++|||++ |.+||...+...+...+.... ...+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 3221 11233456789999999887775 89999999999999999 577888777666666655443 3445667
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+..+.+||.+||..+|++||++.+|+..
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=313.10 Aligned_cols=252 Identities=29% Similarity=0.404 Sum_probs=209.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||.|+||.||+|.+.... .....||||.+.... .....+.+.+|+.+++.+.|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-----------~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~ 72 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE-----------NEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKL 72 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC-----------CCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhce
Confidence 345777889999999999999874331 112469999886543 34455788899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.+ ...|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+|||++.++.++|+||
T Consensus 73 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred eEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccC
Confidence 999875 55789999999999999997644 5899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcc--ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 383 GFSNYFTPGHML--TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~~~--~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|++......... ....++..|+|||.+....++ .++|||||||++|+|++ |..||...+.......+... ....|
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 152 GLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230 (270)
T ss_pred ceeeecccccceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 999766443221 122334679999999877775 89999999999999996 99999888776666666544 34566
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..++.++.+||.+||..+|.+|||+.+++..
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=313.29 Aligned_cols=243 Identities=19% Similarity=0.288 Sum_probs=194.0
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||+|+||.||+|..... .....||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~lg~G~fg~v~~~~~~~~------------~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~ 67 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG------------MSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES 67 (269)
T ss_pred CcCCccCCceEEEEEEecC------------CCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 3699999999999865322 123478999876443 344456788999999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhcc-----cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG-----QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~-----~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
..+|+||||+.+++|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 147 (269)
T cd05042 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA 147 (269)
T ss_pred CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccc
Confidence 99999999999999999987643 2467888999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cccccCCCCCCCccccCC-------CCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH-hC
Q psy6357 386 NYFTPGHM---LTTWCGSPPYAAPELFGG-------REYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRIL-FG 453 (635)
Q Consensus 386 ~~~~~~~~---~~~~~gt~~Y~APEvl~~-------~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~-~~ 453 (635)
........ .....++..|+|||++.. ..+ +.++|||||||++|+|++ |..||...........+. ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 148 LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred cccccchheeccCCCCCcccccCHHHHhhcccccccccc-chhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 75432211 123345677999999743 233 489999999999999999 889998776555444433 22
Q ss_pred ccC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 454 KFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 454 ~~~-----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
... ++..++..+.+++..|| .||++|||+++|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 222 23357889999999999 59999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.05 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=208.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..|..+++||.|+||.||+|... .++..||||.+..... .......+.+|+.+++.++|+||+++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~--------------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 80 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV--------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc--------------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccE
Confidence 34667889999999999999873 3456899999875432 34455678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++......|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred EEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCc
Confidence 999999999999999996 577776643 456899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-C-C
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-R-I 457 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~-~ 457 (635)
|++...... ....++..|+|||++.+ ..+ +.++|||||||++|+|++|..||...+.......+..... . .
T Consensus 160 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06634 160 GSASIMAPA---NXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235 (308)
T ss_pred ccceeecCc---ccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC
Confidence 998765432 34568889999999752 334 3799999999999999999999977665444444443322 2 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+..++..+.+||.+||..+|.+||++.+++.|||+...
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 33578899999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=319.15 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=205.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
...|.++++||.|+||.||++.+. .++..||||++...... .....+..|+.++.++ .|+||++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~--------------~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK--------------KTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC--------------CCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHh
Confidence 456777899999999999999873 23568999999765433 2345566787777666 4999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.....+|+||||+. +.|.+++.. ...+++..+..++.||+.||.|||+ .+|+|+||+|+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 79 CYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred hheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEEC
Confidence 9999999999999999985 466665554 3568999999999999999999997 699999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCC----cCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCc-
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGRE----YDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFGK- 454 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~----~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~~- 454 (635)
|||++..+..........++..|+|||++.+.. ++ .++||||||+++|+|++|..||..... .+....+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06618 158 DFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP 236 (296)
T ss_pred ccccchhccCCCcccCCCCCccccCHhhcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC
Confidence 999998765444444456788999999987553 44 899999999999999999999976432 23333333332
Q ss_pred cCCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 FRIPF--YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ~~~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++. .++.++.+||.+||..||.+||++++|+.|+||...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 22222 378999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=311.89 Aligned_cols=241 Identities=27% Similarity=0.420 Sum_probs=203.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.+.+.||.|+||.||++.. .+..||+|++.... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~----------------~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~ 64 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY----------------TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRL 64 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc----------------CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeE
Confidence 35678889999999999998754 34579999986532 23567899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++... ..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|
T Consensus 65 ~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~D 143 (254)
T cd05083 65 LGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSD 143 (254)
T ss_pred EEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECC
Confidence 9998654 4799999999999999987653 489999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPF 459 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~ 459 (635)
||++...... ......+..|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+.... ...+.
T Consensus 144 fg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (254)
T cd05083 144 FGLARVGSMG--VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE 220 (254)
T ss_pred Cccceecccc--CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCC
Confidence 9998764322 2223345679999999877775 89999999999999998 999999888777776665542 33455
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.++..+.+||.+||..+|.+||++++|+.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.67 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=206.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+.++||+|+||.||++.+. .+..||||++... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~---------------~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~ 65 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN---------------KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVK 65 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec---------------CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcce
Confidence 3567888999999999999999752 2346999988653 223467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.. ...++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.+||+
T Consensus 66 ~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05073 66 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 144 (260)
T ss_pred EEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEEC
Confidence 9999887 7789999999999999998763 357888999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 381 DFGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 381 DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|||++..+..... .....++..|+|||++....++ .++|||||||++|+|++ |..||...+...+...+... ...
T Consensus 145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05073 145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223 (260)
T ss_pred CCcceeeccCCCcccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 9999976543221 1223345679999999877765 89999999999999998 99999988777766666544 233
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..++.++.++|.+||..+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 45568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=357.49 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=204.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++|.++++||+|+||.||+|.+. ..+..||||++..... ......++.+|+.+++.++||||+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~--------------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl 67 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP--------------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC--------------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeE
Confidence 57899999999999999999873 3456899999976533 23445678999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-----------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-----------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-----------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++++.+.+..|+||||++|++|.+++... ..++...++.++.||+.||+|||+.||+||||||+|||++
T Consensus 68 ~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd 147 (932)
T PRK13184 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG 147 (932)
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc
Confidence 99999999999999999999999988642 2356677899999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCC-------------------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh
Q psy6357 373 ENGDIKLADFGFSNYFTPG-------------------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~-------------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt 433 (635)
.++.++|+|||++...... ......+||+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLT 226 (932)
T PRK13184 148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLT 226 (932)
T ss_pred CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHH
Confidence 9999999999999765210 011235799999999999888876 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCc-cC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 434 AQLPFDGPNLAVLKQRILFGK-FR--IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 434 G~~PF~~~~~~~l~~~i~~~~-~~--~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..||.......+........ .. ....++..+.+++.+||..||++|++..+.|.+
T Consensus 227 G~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 227 LSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999998765443322211111 11 113578899999999999999999887666544
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.16 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=207.7
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+.+.||+|+||.||+|.+.... ..+..||||++..........+.+.+|+++|+.++||||++++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 69 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED-----------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGV 69 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC-----------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 456788999999999999874332 235689999998766666667788999999999999999999998
Q ss_pred EecCC------eEEEEEeccccchhhhhhhhc------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 307 METTN------NLYLVTEYARGGEIFSHLLTI------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 307 ~~~~~------~~~LV~E~~~ggsL~~~l~~~------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+.... ..++++||+.+++|..++... ..+++..++.++.||+.||+|||+.+|+|+||||+|||++.+
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~ 149 (273)
T cd05074 70 SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN 149 (273)
T ss_pred EccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC
Confidence 86432 247899999999998876432 247899999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i 450 (635)
+.+||+|||++........ .....+++.|++||.+....++ .++|||||||++|+|++ |.+||...+...+...+
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986543221 1223445789999999877776 89999999999999999 99999888777766666
Q ss_pred HhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 451 LFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 451 ~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
... ....+..++..+.+|+.+||..+|.+|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 544 334455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.43 Aligned_cols=244 Identities=18% Similarity=0.249 Sum_probs=193.7
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
+.||+|+||.||+|.+.... ....+|+|.+..... ......+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~------------~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 67 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY------------TPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV 67 (269)
T ss_pred CcccccCCceEEEEEEcCCC------------CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 36899999999999763221 235799998876542 33345788899999999999999999999999
Q ss_pred CeEEEEEeccccchhhhhhhhcc-----cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG-----QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~-----~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
..+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~ 147 (269)
T cd05087 68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147 (269)
T ss_pred CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999999999986532 3567788899999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cccccCCCCCCCccccCCCC------cCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-Cc
Q psy6357 386 NYFTPGHM---LTTWCGSPPYAAPELFGGRE------YDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILF-GK 454 (635)
Q Consensus 386 ~~~~~~~~---~~~~~gt~~Y~APEvl~~~~------~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~-~~ 454 (635)
........ .....++..|+|||++.... ..+.++|||||||++|+|++ |..||.............. ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 75433221 22345678899999986432 12479999999999999996 9999987665554333222 22
Q ss_pred cCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 455 FRI-----PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 455 ~~~-----p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..+ ....+..+.+||..|| .+|++|||+++|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 222 2246788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.72 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=212.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
-|..|+.||-|+||.|-++.... +...+|+|.+.+... ....+..++.|-.||...+.+.||+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvD--------------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVD--------------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred ceEEEeeecccccceeEEEeecc--------------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 35568999999999999886522 223589999876543 445567788899999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
..|.+.+.+|+||+|++||++-.+|.+.+-|.|..+..++..|.+|+++.|..|+|||||||+|||||.+|+|||+||||
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccC---------CC----------------------------------ccccccCCCCCCCccccCCCCcCCCccch
Q psy6357 385 SNYFTP---------GH----------------------------------MLTTWCGSPPYAAPELFGGREYDGTKSDV 421 (635)
Q Consensus 385 a~~~~~---------~~----------------------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDI 421 (635)
|.-+.. +. .....+||+.|+|||++....|+ ..+|.
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdw 854 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDW 854 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchh
Confidence 864410 00 01236799999999999998887 89999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--ccCCC--CCCCHHHHHHHHHhcccCCCCCCC---HHHHHcCccccc
Q psy6357 422 WSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--KFRIP--FYMSAECENLIRSMLVLDPAKRLT---LTQISNHKWMSV 494 (635)
Q Consensus 422 wSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps---~~eiL~Hpw~~~ 494 (635)
||.|||||||+.|++||...+..+...+|... .+.+| ..+|.++.+||.++.. +++.|.. ++||..||||+.
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 99999999999999999877665555444432 23333 4689999999998765 7888874 678999999974
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.63 Aligned_cols=250 Identities=26% Similarity=0.483 Sum_probs=210.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc--------cCHHHHHHHHHHHHHHhh-CC
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR--------LDERNLRKLFREVDIMSH-LD 296 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~--------~~~~~~~~~~~Ei~iL~~-L~ 296 (635)
.|.+++.||.|+||.||++.+... .+..||||.+.... ........+.+|+.++.+ ++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~-------------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~ 67 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN-------------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC-------------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCC
Confidence 367789999999999999987431 24579999886432 233455677889998875 79
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceee
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLF 371 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl 371 (635)
|+||+++++++...+..|+||||+++++|.+++.. ...+++..++.++.||+.+|.|||+ .+|+|+||+|.|||+
T Consensus 68 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~ 147 (269)
T cd08528 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML 147 (269)
T ss_pred CCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE
Confidence 99999999999999999999999999999888743 3468999999999999999999996 789999999999999
Q ss_pred cCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~ 451 (635)
+.++.++|+|||++.............++..|+|||++.+..+. .++||||||+++|+|++|..||...........+.
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 226 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226 (269)
T ss_pred CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh
Confidence 99999999999999876654445566789999999999887765 89999999999999999999998877766666665
Q ss_pred hCccC-CCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 452 FGKFR-IPF-YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 452 ~~~~~-~p~-~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..... .+. .++.++.+||.+||..||.+||++.|+.++
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 227 EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 55433 222 578999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=309.39 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=195.6
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||.|+||.||+|.+........ ........|++|++...... ...+.+|+.+|+.++|+||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~----~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDI----VGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccc----cCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 469999999999999854331100 00011235888887544321 4678899999999999999999999988
Q ss_pred CeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-------Ceeeecc
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-------DIKLADF 382 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-------~ikL~DF 382 (635)
...++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .+||+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 77899999999999999998766 799999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCC--CcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGR--EYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|++..... .....++..|+|||++.+. .+ +.++|||||||++|+|++ |..||...+......... .....+.
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~ 227 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRNGQASL-TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM 227 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcCCCCCc-chhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC
Confidence 99987543 2234567789999999776 44 489999999999999999 688887765433333222 2233344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.....+.+||.+||..+|.+|||+.+|++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 44589999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.11 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=199.9
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+++.||+|+||.||++.+.... ...+..||||.+... .......+.+|+++|+.++|+||++++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~----------~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~ 71 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQ----------DNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYK 71 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCc----------CCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 46778999999999999998763211 134678999998654 344557788999999999999999999
Q ss_pred EEEec--CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 305 QVMET--TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 305 ~~~~~--~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++.. ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~d 151 (284)
T cd05081 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151 (284)
T ss_pred EEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECC
Confidence 98743 35689999999999999998764 4689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcc----ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-------------
Q psy6357 382 FGFSNYFTPGHML----TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA------------- 444 (635)
Q Consensus 382 FGla~~~~~~~~~----~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~------------- 444 (635)
||++......... ....++..|+|||++.+..++ .++|||||||++|||++|..++......
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05081 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230 (284)
T ss_pred CcccccccCCCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence 9999876433211 112234469999999887775 8999999999999999987776433211
Q ss_pred ---HHHHHHHh-CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 445 ---VLKQRILF-GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 445 ---~l~~~i~~-~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+...+.. ..++.+..++.++.+||.+||..+|++|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11111111 123345568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.78 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=203.9
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
.||.|+||.||++.+...... ...+..||||.+.... .......+.+|+.+|+.++||||+++++++....
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~--------~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGP--------GSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE 72 (269)
T ss_pred ccccccceeEEeeeecccccC--------cccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC
Confidence 589999999999877432210 0123579999886543 2344567889999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhc-------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-----Ceee
Q psy6357 312 NLYLVTEYARGGEIFSHLLTI-------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-----DIKL 379 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~-------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-----~ikL 379 (635)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .++|
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 999999999999999998643 2378899999999999999999999999999999999999877 8999
Q ss_pred ecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-c
Q psy6357 380 ADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-K 454 (635)
Q Consensus 380 ~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~ 454 (635)
+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc
Confidence 99999976543221 1223456789999999887775 99999999999999998 99999887766666665543 3
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+..+..++..+.+||.+||..+|.+||++++|++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4566678999999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=309.28 Aligned_cols=229 Identities=23% Similarity=0.356 Sum_probs=192.5
Q ss_pred cCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCeEEE
Q psy6357 236 GEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYL 315 (635)
Q Consensus 236 G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~L 315 (635)
|.|+.||++.+. .++..||+|.+.... ...+|...+....||||+++++++......|+
T Consensus 4 g~~~~v~~~~~~--------------~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 62 (237)
T cd05576 4 GVIDKVLLVMDT--------------RTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFL 62 (237)
T ss_pred cccceEEEEEEc--------------cCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEE
Confidence 889999999873 355789999997653 22345555556679999999999999999999
Q ss_pred EEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccc
Q psy6357 316 VTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT 395 (635)
Q Consensus 316 V~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~ 395 (635)
||||+.+++|.+++.+...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.++|+|||++...... ..
T Consensus 63 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~ 140 (237)
T cd05576 63 VLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CD 140 (237)
T ss_pred EEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cc
Confidence 9999999999999988778999999999999999999999999999999999999999999999999988665432 23
Q ss_pred cccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhccc
Q psy6357 396 TWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL 475 (635)
Q Consensus 396 ~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~ 475 (635)
...++..|+|||++.+..++ .++|||||||++|+|++|..||....... .....+.+|..++..+.+||.+||+.
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 141 GEAVENMYCAPEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred cCCcCccccCCcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccC
Confidence 44567789999999877775 89999999999999999998876432111 01123456777899999999999999
Q ss_pred CCCCCCCH-----HHHHcCccc
Q psy6357 476 DPAKRLTL-----TQISNHKWM 492 (635)
Q Consensus 476 dP~~Rps~-----~eiL~Hpw~ 492 (635)
||++|+++ +++++||||
T Consensus 216 dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 216 NPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CHHHhcCCCccchHHHHcCCCC
Confidence 99999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=324.26 Aligned_cols=257 Identities=29% Similarity=0.438 Sum_probs=213.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-----HHHHHHHHHHHHHHhhCCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-----ERNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-----~~~~~~~~~Ei~iL~~L~H 297 (635)
+.++|.++..||.|+|+.||++++ +...++|||||-...... +...+...+|..|.+.|+|
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFD--------------l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDH 526 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFD--------------LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDH 526 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcc--------------cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCc
Confidence 457899999999999999998876 456679999997654432 2345667899999999999
Q ss_pred CceeeEEEEEe-cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC--ceeeecccCcceeecC-
Q psy6357 298 PHIIKLFQVME-TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN--NVVHRDIKAENLLFDE- 373 (635)
Q Consensus 298 pnIv~l~~~~~-~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~--gIiHrDLKp~NILl~~- 373 (635)
|.||++|++|. +.+.+|-|+|||+|.+|.-||+..+-+++.++..|+.||+.||.||.+. .|||-||||.||||..
T Consensus 527 pRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 527 PRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred ceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence 99999999996 5567999999999999999999999999999999999999999999986 5999999999999953
Q ss_pred --CCCeeeecccccccccCCC--------ccccccCCCCCCCccccC-C--CCcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 374 --NGDIKLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFG-G--REYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 374 --~~~ikL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~-~--~~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
.|.|||+||||+.....+. ......||.||++||.+. + .+..+.++||||+|||+|.++.|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 5789999999998876432 344578999999999874 2 23335899999999999999999999965
Q ss_pred CC-HHHHHHH--HH-hCccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 441 PN-LAVLKQR--IL-FGKFRIP--FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 441 ~~-~~~l~~~--i~-~~~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. ..++++. |+ .....|| ..++.++++||++||.+--++|.+..++..||||.
T Consensus 687 nqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 687 NQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred chhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 32 3333322 22 1233444 46899999999999999999999999999999996
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.81 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=193.6
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN 311 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 311 (635)
+||+|+||.||++...... ....+++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~------------~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 68 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT------------GVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI 68 (268)
T ss_pred cCCCCcCceEEEEEEEcCC------------CcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC
Confidence 6999999999998753222 12357777776543 2344578899999999999999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 312 NLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..|+||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.+|+|+||||+|||++.++.++|+|||++..
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 999999999999999998754 2467778889999999999999999999999999999999999999999999864
Q ss_pred ccCC---CccccccCCCCCCCccccCCC-------CcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-c
Q psy6357 388 FTPG---HMLTTWCGSPPYAAPELFGGR-------EYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-F 455 (635)
Q Consensus 388 ~~~~---~~~~~~~gt~~Y~APEvl~~~-------~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~ 455 (635)
.... ......+++..|+|||++... .+ +.++|||||||++|+|++ +..||...+.......+.... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ-TKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc
Confidence 3221 122345678899999998532 22 378999999999999997 678998777665555544332 1
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 456 -----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 456 -----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.++..++..+.+||..|| .+|.+||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 233457899999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.69 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=206.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||.|+||.||++.+...... ....||+|++.... .......+.+|+.+++.++|+||+++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~----------~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~ 74 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET----------VKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRL 74 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc----------ceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 34566788999999999999987433211 11368999886543 33334568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++... ..++|+||+++|+|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 75 LGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred EEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccc
Confidence 9998654 5679999999999999987654 5899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 383 GFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 383 Gla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
|++........ .....++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.....+...+... .+..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 99987643221 2223456789999999887775 89999999999999997 99999887666555554433 2344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+..++..+.+||.+||..+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.95 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=219.1
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
.++||+|+||.||.|.|+.-..+ .-.||||++....... ....|++|+.+|.+|+|+|+++||++..+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk-----------~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGK-----------HVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCc-----------EEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 57899999999999999764432 2479999998776654 67899999999999999999999999977
Q ss_pred CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..+.+|||++++|+|.+.|.+. ..|.......++.||+.||.||.++++|||||-..||||.....||||||||.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 7889999999999999999873 3588889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCcccccc----CCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCC
Q psy6357 388 FTPGHMLTTWC----GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYM 461 (635)
Q Consensus 388 ~~~~~~~~~~~----gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~ 461 (635)
+......+.+. -...|+|||.+....++ .++|||+|||+||||++ |+.||.+.....++++|..+ .++-|.+|
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~c 340 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYC 340 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCC
Confidence 87655444332 24569999999999997 99999999999999999 99999999999999988754 46778899
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
++++.+++..||..+|++||||..|.+.-++
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999999999999755444
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.87 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=204.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|+++++||.|+||.||++.+.... ...+..||||++...... .....+.+|+++++.+.|+||++++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~----------~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~ 72 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG----------DNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYK 72 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC----------CCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEE
Confidence 45677899999999999999874321 124568999999765433 4557889999999999999999999
Q ss_pred EEEec--CCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 305 QVMET--TNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 305 ~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++.. ....++||||+++++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 73 GVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred eeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 99877 567999999999999999997654 599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcc----ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH------------
Q psy6357 382 FGFSNYFTPGHML----TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV------------ 445 (635)
Q Consensus 382 FGla~~~~~~~~~----~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~------------ 445 (635)
||++......... ....++..|+|||.+....+. .++|||||||++|+|++|..||.......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 9999876532211 122345679999999877775 89999999999999999999986532211
Q ss_pred ---HHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 ---LKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 ---l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+...+... ....+..++.++.+||.+||..+|.+|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12222211 23334567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.13 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=207.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|..+.+||+|.||.||++.. ...+.+||+|++-.+...+..-...++|+++|..|+|+||+.|
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~--------------~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nl 81 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARS--------------KNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 81 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhh--------------cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHH
Confidence 45577788999999999997755 3455678888765433222233456799999999999999999
Q ss_pred EEEEec--------CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 304 FQVMET--------TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 304 ~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+++|.. ...+||||.+|+ -+|.-+|... .+|+..++.+++.+++.||.|+|...|+|||+|+.|+||+.+
T Consensus 82 iEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 82 IEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD 160 (376)
T ss_pred HHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC
Confidence 988742 235999999996 5677777655 579999999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCC-----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 375 GDIKLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
|.+||+|||+++.+... ...+..+.|++|++||.+.+..-++...|||..|||+.||+++.+.|.+.+.......
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 99999999999766432 2345567799999999999887778999999999999999999999998776555544
Q ss_pred HHh--C-----------------cc---CCCC-------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 450 ILF--G-----------------KF---RIPF-------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 450 i~~--~-----------------~~---~~p~-------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
|.. + .+ ++|. .-.+++.+||.+||..||.+|++++++|+|.||..
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 431 0 00 0111 12458899999999999999999999999999975
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 321 d 321 (376)
T KOG0669|consen 321 D 321 (376)
T ss_pred C
Confidence 4
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=330.17 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=216.3
Q ss_pred hccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC
Q psy6357 217 ASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 217 ~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~ 296 (635)
+..++++-.+|.++...|+|-|++|..|.+.. .+..||||||.... .-.+.=+.|++||++|+
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~--------------r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~ 486 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQA--------------RGQEVAIKIIRNNE---VMHKTGLKELEILKKLN 486 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccC--------------CCCeeEEEEeecch---HHhhhhhHHHHHHHHhh
Confidence 44477888999999999999999999887742 34589999997642 23345578999999994
Q ss_pred ------CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 297 ------HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 297 ------HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
.-|+++|+-.|...+++|||+|-+ ...|.++|++.+. |....+..++.||+.||..|-.+||+|.||||+
T Consensus 487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD 565 (752)
T KOG0670|consen 487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD 565 (752)
T ss_pred ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence 348999999999999999999998 5889999998875 889999999999999999999999999999999
Q ss_pred ceeecCC-CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q psy6357 368 NLLFDEN-GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446 (635)
Q Consensus 368 NILl~~~-~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l 446 (635)
||||++. ..+||||||.|...... .++.+..+..|+|||+|.|.+|+ ...|+||+||+||||.||+..|++.+...+
T Consensus 566 NiLVNE~k~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 566 NILVNESKNILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred ceEeccCcceeeeccCccccccccc-cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHH
Confidence 9999875 56899999999877654 44556677889999999999998 999999999999999999999999886666
Q ss_pred HHHHHhCccCCCCC-----------------------------------------------------C-------CHHHH
Q psy6357 447 KQRILFGKFRIPFY-----------------------------------------------------M-------SAECE 466 (635)
Q Consensus 447 ~~~i~~~~~~~p~~-----------------------------------------------------~-------s~~l~ 466 (635)
+...+..+-++|.. + -..|.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 55443222222210 1 14589
Q ss_pred HHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 467 NLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 467 ~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+||.+||..||++|.|..|+|.||||..
T Consensus 724 dLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999999999963
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=340.55 Aligned_cols=247 Identities=30% Similarity=0.437 Sum_probs=221.0
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
-+.||.|.||.|+.|..+...++. ..||||.++... .+.....|+.|+.||-+++||||++|.++...
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre-----------~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKRE-----------ITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred EEEEecccccceecccccCCCCcc-----------eeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 567899999999999998776543 579999997554 66777899999999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
...++||+|||++|+|..+|.++ ++|+..++.-+++.|+.||+||-+.++|||||...||||+.+-.+|++||||++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999765 67999999999999999999999999999999999999999999999999999987
Q ss_pred cCCC--ccccccC--CCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCC
Q psy6357 389 TPGH--MLTTWCG--SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMS 462 (635)
Q Consensus 389 ~~~~--~~~~~~g--t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s 462 (635)
.++. ..++..| ...|.|||.|....++ .++||||+|++|||.++ |..||...+.++.++.|..+ .++.|..++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCc
Confidence 5543 2333333 4679999999999997 89999999999999988 99999999999999888876 566677899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..|.+||..||++|-.+||.|.||+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999999875
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.06 Aligned_cols=258 Identities=24% Similarity=0.444 Sum_probs=213.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|..+..+|.|.- .|-.+.+. -.++.||||.+..........++..+|..++..++|+||+.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~--------------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~ 79 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ--------------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIIS 79 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh--------------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceee
Confidence 3468888999999998 66655553 34568999999877666666788999999999999999999
Q ss_pred EEEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++.+|.-. ..+|+|||||. .+|...+. -.+.-..+..|+.|++.|+.|||+.||+||||||+||++..++.
T Consensus 80 l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 80 LLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred eeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh
Confidence 99999543 35899999994 67777766 45778889999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||+|+.....-.++.++.|..|+|||++.+..|. ..+||||+|||+.||++|...|.+.+.-+.+.++...
T Consensus 157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt 235 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT 235 (369)
T ss_pred eeeccchhhcccCcccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence 999999999988777678889999999999999998876 9999999999999999999999987644333333210
Q ss_pred ------------------------ccC----CCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ------------------------KFR----IPF-----------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ------------------------~~~----~p~-----------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+. +|. .-+..+.+|+.+||..||++|.+++++|.||||+.
T Consensus 236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 011 111 12356899999999999999999999999999987
Q ss_pred CCCCC
Q psy6357 495 HCPGD 499 (635)
Q Consensus 495 ~~~~~ 499 (635)
+...+
T Consensus 316 w~~~~ 320 (369)
T KOG0665|consen 316 WYDPD 320 (369)
T ss_pred ecccc
Confidence 64433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.77 Aligned_cols=254 Identities=17% Similarity=0.164 Sum_probs=191.3
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH--H-H------HHHHHHHHHH
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE--R-N------LRKLFREVDI 291 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~--~-~------~~~~~~Ei~i 291 (635)
++..++|.+.+.||+|+||.||+|.+..... ....+|+|+........ + . ......++..
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-----------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~ 76 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHC-----------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcc-----------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHH
Confidence 3556789999999999999999998633211 13457777654332111 0 0 0112234455
Q ss_pred HhhCCCCceeeEEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 292 MSHLDHPHIIKLFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
+..+.|++|+++++++.... ..+++||++. .++.+.+.....+++..+..|+.||+.||.|||+.+|+||||||+
T Consensus 77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~ 155 (294)
T PHA02882 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE 155 (294)
T ss_pred hccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 66778999999998765443 3478888873 456666665556789999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCC--------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCC
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~ 439 (635)
|||++.++.++|+|||+|+.+... .......||+.|+|||++.+..++ .++|||||||+||+|++|.+||.
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999765321 112335699999999999988876 99999999999999999999998
Q ss_pred CCCH-HH--------HHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 440 GPNL-AV--------LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 440 ~~~~-~~--------l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.... .. ....+...+..+ ..++.++.++|..||..+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 235 GFGHNGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ccccchHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 7632 21 223333333333 346899999999999999999999999975
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.57 Aligned_cols=257 Identities=28% Similarity=0.531 Sum_probs=229.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhC-CCCce
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHL-DHPHI 300 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnI 300 (635)
-+..|.+++.||.|+|..|.++.. .++.+.+|+|++++...+ .+.+.-++.|-.++.+. +||.+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~--------------~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRL--------------KKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred ccccceeeeeecCcchhhhhheeh--------------cccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 355677899999999999997765 345568999999987764 44566667788888776 69999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
|-|+.+|..+..+++|.||+.||+|.-++++..+|+++.+..+...|+.||.|||+.|||+||||.+||||+..|+|||+
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC--------CCHHHHHHHHH
Q psy6357 381 DFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG--------PNLAVLKQRIL 451 (635)
Q Consensus 381 DFGla~~-~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~--------~~~~~l~~~i~ 451 (635)
|+|++.. +.++...+++||||.|.|||++.+..|- ..+|.|+|||+|+||+.|+.||+- .+..-+++.|+
T Consensus 394 dygmcke~l~~gd~tstfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil 472 (593)
T KOG0695|consen 394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL 472 (593)
T ss_pred ccchhhcCCCCCcccccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence 9999976 4567888999999999999999999985 999999999999999999999963 23455778888
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCC------CHHHHHcCccccc
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRL------TLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rp------s~~eiL~Hpw~~~ 494 (635)
...+++|..+|..+..+++..|++||.+|. .+.+|..|+||..
T Consensus 473 ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 473 EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 888999999999999999999999999996 4789999999973
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=344.38 Aligned_cols=251 Identities=31% Similarity=0.480 Sum_probs=203.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|..+..||+|+||.||++..+++ |..||||.|.... +.....++++|+.+|.+|+|||||++
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlD--------------Gr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRY 542 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLD--------------GREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRY 542 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeeccc--------------chhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566789999999999999998655 4689999998876 67777899999999999999999999
Q ss_pred EEEE------------------------------------------------------------e---------------
Q psy6357 304 FQVM------------------------------------------------------------E--------------- 308 (635)
Q Consensus 304 ~~~~------------------------------------------------------------~--------------- 308 (635)
|..| .
T Consensus 543 ysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d 622 (1351)
T KOG1035|consen 543 YSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDD 622 (1351)
T ss_pred ehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccc
Confidence 8311 0
Q ss_pred ---c---------------------------------C--------CeEEEEEeccccchhhhhhhhcccC-CHHHHHHH
Q psy6357 309 ---T---------------------------------T--------NNLYLVTEYARGGEIFSHLLTIGQM-AEKEASRL 343 (635)
Q Consensus 309 ---~---------------------------------~--------~~~~LV~E~~~ggsL~~~l~~~~~l-~e~~~~~i 343 (635)
+ + ..+||-||||+..+|.+++..+... ....+|++
T Consensus 623 ~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrL 702 (1351)
T KOG1035|consen 623 SDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRL 702 (1351)
T ss_pred ccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHH
Confidence 0 0 1268999999877777766655444 47889999
Q ss_pred HHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccccc-------------------CCCccccccCCCCCC
Q psy6357 344 FRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT-------------------PGHMLTTWCGSPPYA 404 (635)
Q Consensus 344 ~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~-------------------~~~~~~~~~gt~~Y~ 404 (635)
+++|++||.|+|+.|||||||||.||+|+.++.|||+|||+|.... .....+..+||..|+
T Consensus 703 FreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 703 FREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 9999999999999999999999999999999999999999998721 112456788999999
Q ss_pred CccccCCCC---cCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCccCCCC----CCCHHHHHHHHHhcccC
Q psy6357 405 APELFGGRE---YDGTKSDVWSLGVVLYVMVTAQLPFDGP-NLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLD 476 (635)
Q Consensus 405 APEvl~~~~---~~~~ksDIwSlGvilyeLltG~~PF~~~-~~~~l~~~i~~~~~~~p~----~~s~~l~~LI~~~L~~d 476 (635)
|||++.+.. |+ .|+||||||+||+||+ .||... .-..+...+..+.++.|. .--+.-..+|++||+.|
T Consensus 783 APEll~~~~~~~Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 783 APELLSDTSSNKYN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cHHHhccccccccc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 999997765 55 9999999999999999 457543 344556666666666652 12345678999999999
Q ss_pred CCCCCCHHHHHcCcccc
Q psy6357 477 PAKRLTLTQISNHKWMS 493 (635)
Q Consensus 477 P~~Rps~~eiL~Hpw~~ 493 (635)
|.+||||.|+|++.||.
T Consensus 859 P~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 859 PSKRPTATELLNSELLP 875 (1351)
T ss_pred CccCCCHHHHhhccCCC
Confidence 99999999999999984
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.43 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=208.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
-.+.+|||+|.||.|-++... .+.+||||+++... .......|.+||++|.+|+|||||.|+++
T Consensus 540 L~~~ekiGeGqFGEVhLCeve---------------g~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGV 603 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE---------------GPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGV 603 (807)
T ss_pred eehhhhhcCcccceeEEEEec---------------CceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence 344789999999999998763 34689999997654 34456889999999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
|..++.+|+|||||+.|+|.+++.+.. .+......+|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+
T Consensus 604 C~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 604 CVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred eecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccc
Confidence 999999999999999999999998873 245666778999999999999999999999999999999999999999999
Q ss_pred cccccCCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhC------
Q psy6357 385 SNYFTPGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT--AQLPFDGPNLAVLKQRILFG------ 453 (635)
Q Consensus 385 a~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt--G~~PF~~~~~~~l~~~i~~~------ 453 (635)
++.+..+... ...+-...|||+|.+.-..++ .++|+|+||++|||+++ ...||...+.+...+....-
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc
Confidence 9976554332 233456789999999888887 99999999999999875 78999887776665544321
Q ss_pred --ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 454 --KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 454 --~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
-+..|..++..+.+||.+||..|-++||++++|-.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 23456679999999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=290.78 Aligned_cols=240 Identities=42% Similarity=0.732 Sum_probs=209.3
Q ss_pred CCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCeEEEE
Q psy6357 237 EDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLV 316 (635)
Q Consensus 237 ~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV 316 (635)
+||.||++.+. .++..||+|++........ ...+.+|++++++++|+||+++++++......++|
T Consensus 1 ~~g~v~~~~~~--------------~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 65 (244)
T smart00220 1 SFGKVYLARDK--------------KTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLV 65 (244)
T ss_pred CceEEEEEEEC--------------CCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEE
Confidence 57899999873 2457899999976643322 57888999999999999999999999999999999
Q ss_pred EeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCcccc
Q psy6357 317 TEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTT 396 (635)
Q Consensus 317 ~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~ 396 (635)
|||+.+++|.+++.....+++..++.++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++...........
T Consensus 66 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 145 (244)
T smart00220 66 MEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTT 145 (244)
T ss_pred EeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccccccc
Confidence 99999999999988776699999999999999999999999999999999999999999999999999988766545566
Q ss_pred ccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCccCCCCC---CCHHHHHHHHHh
Q psy6357 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG-PNLAVLKQRILFGKFRIPFY---MSAECENLIRSM 472 (635)
Q Consensus 397 ~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~-~~~~~l~~~i~~~~~~~p~~---~s~~l~~LI~~~ 472 (635)
..++..|++||.+....++ .++||||||+++|+|++|..||.. .+...+.+.+.......... ++.++.+++.+|
T Consensus 146 ~~~~~~~~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred ccCCcCCCCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 7788999999999877776 799999999999999999999987 56666666665554444333 889999999999
Q ss_pred cccCCCCCCCHHHHHcCccc
Q psy6357 473 LVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 473 L~~dP~~Rps~~eiL~Hpw~ 492 (635)
|..+|.+||++.++++||||
T Consensus 225 l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 225 LVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCchhccCHHHHhhCCCC
Confidence 99999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=289.17 Aligned_cols=249 Identities=26% Similarity=0.465 Sum_probs=206.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv 301 (635)
....|++++++|.|.++.||.|.. +.+.++++||+++.- ..+.+.+|+.||..|. ||||+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~--------------~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi 96 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGIN--------------ITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNII 96 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccc--------------cCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCee
Confidence 577899999999999999999876 345678999999643 3378899999999997 99999
Q ss_pred eEEEEEecCC--eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-CCee
Q psy6357 302 KLFQVMETTN--NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-GDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-~~ik 378 (635)
+|+++..+.. ...||+||+.+.+...+. ..|+..++..++.+|++||+|+|+.||+|||+||.|++|+.. -.++
T Consensus 97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred ehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceee
Confidence 9999986643 467999999876554433 458889999999999999999999999999999999999864 5799
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC-CCCCHHHHHHHHH------
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF-DGPNLAVLKQRIL------ 451 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF-~~~~~~~l~~~i~------ 451 (635)
|+|+|+|.++.++....-.+.+..|--||++..-..++..-|+|||||+|..|+..+-|| .+.+..+..-+|.
T Consensus 174 lIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred eeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 999999999999888888888999999999988776679999999999999999988887 4443222222221
Q ss_pred -------hCccCCC------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 452 -------FGKFRIP------------------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 452 -------~~~~~~p------------------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.-.+.++ ..+++++.+||.++|.+|-.+|+|+.|++.||||.
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0011111 12579999999999999999999999999999996
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=327.19 Aligned_cols=239 Identities=30% Similarity=0.441 Sum_probs=195.2
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM 307 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 307 (635)
..-+.||+|+||.||++.. .++|+.||||.++... .....+.+.+|+++|++|+|+|||+++++-
T Consensus 16 ~~~e~LG~Ga~g~V~rgrn--------------ketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~ie 80 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRN--------------KETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIE 80 (732)
T ss_pred eehhhhcCCccceeeeecc--------------cccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccC
Confidence 3356899999999999976 3567899999998755 445567889999999999999999999986
Q ss_pred ecCC------eEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC--CC-
Q psy6357 308 ETTN------NLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--NG- 375 (635)
Q Consensus 308 ~~~~------~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--~~- 375 (635)
+... .-.+|||||.||+|...|.+- ..|++.+.+.++.+++.||.|||++||+||||||.||++-. +|
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Confidence 5543 568999999999999999754 45999999999999999999999999999999999999843 33
Q ss_pred -CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Q psy6357 376 -DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQRI 450 (635)
Q Consensus 376 -~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~i 450 (635)
..||+|||.|+.+.++....+.+||+.|.+||++....+++..+|.|||||++|+++||..||-... ..++...+
T Consensus 161 ~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~ 240 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI 240 (732)
T ss_pred eEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence 4799999999999999999999999999999999864555699999999999999999999995422 11222222
Q ss_pred Hh---------------------CccCCCCCCCHH----HHHHHHHhcccCCCCCC
Q psy6357 451 LF---------------------GKFRIPFYMSAE----CENLIRSMLVLDPAKRL 481 (635)
Q Consensus 451 ~~---------------------~~~~~p~~~s~~----l~~LI~~~L~~dP~~Rp 481 (635)
.. ..+++|..++.. +...+..||.++|.+|.
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 21 122334344443 55678889999999998
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=294.46 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=207.0
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEEE
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQV 306 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 306 (635)
+.+..||.|+||+|++...+ ..+...|||.+..... +.+..+++.|.++..+- +.||||++|+.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk--------------~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHK--------------PSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred HHHHHhcCCcchhhhhhhcC--------------ccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34788999999999987663 4567899999987764 45567888888876554 69999999999
Q ss_pred EecCCeEEEEEeccccchhhhhh-----hhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeee
Q psy6357 307 METTNNLYLVTEYARGGEIFSHL-----LTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l-----~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+..++..||.||+|+ .+|..+. .+...++|..+-.|....+.||.||-. ..|||||+||+||||+..|.+|||
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence 999999999999994 4553322 233569999999999999999999985 589999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCccCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR--EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFGKFRI 457 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~--~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~~~~~ 457 (635)
|||++..+..+...+...|-..|||||-+... .|+ .++||||||++|||+.||..|+..-+. -+....+..+.++.
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 99999887766666677888999999998643 355 999999999999999999999976442 23333344444432
Q ss_pred ---CC---CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 458 ---PF---YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 458 ---p~---~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
+. .++..+..||.-||.+|-..||.+.+++.+||+.....
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 22 37899999999999999999999999999999986543
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=323.86 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=213.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
..+.++..||.|.+|.||++.. .++++.+||||+......+ +.+..|.+||+.+ .|||++.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~--------------~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~f 81 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRH--------------VKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATF 81 (953)
T ss_pred CccEEEEEEeeccceeEEEEee--------------eecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceE
Confidence 3455689999999999998876 3566789999987654333 4566789999988 59999999
Q ss_pred EEEEe-----cCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 304 FQVME-----TTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 304 ~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
|++|. .++.+|||||||.+|+..++++.. .++.|..+..|++.++.||.+||...++|||||-.||||+.++.
T Consensus 82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc
Confidence 99985 356899999999999999988764 46999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCC-CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 377 IKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 377 ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
|||+|||++..++.. ....+.+|||.|||||++.- ..|+ ..+|+||||++..||..|.+|+........+-.|
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 999999999877643 34677899999999999853 3444 8899999999999999999999888776665555
Q ss_pred HhCc---cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 451 LFGK---FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 451 ~~~~---~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
...- +.-|..++.++.+||..||.+|-.+||+..++|+|||+.
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 4432 223456899999999999999999999999999999997
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=298.19 Aligned_cols=249 Identities=24% Similarity=0.431 Sum_probs=207.7
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
-+.||+|+||.||.+.+ -.+++.||+|.+..-..+-...+++++|+++|.-++|.||+.++++...
T Consensus 58 DRPIGYGAFGVVWsVTD--------------PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTD--------------PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred CCcccccceeEEEeccC--------------CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 46899999999998776 3466789999986554445566889999999999999999999888754
Q ss_pred C-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 310 T-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 310 ~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
. ..+|+|+|+| ..+|...|..-..|+.+.++-+++||+.||+|||+.+|+||||||.|+|++.+..+||||||+
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGL 202 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGL 202 (449)
T ss_pred CCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccc
Confidence 3 3478899999 578888888888899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC--CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Q psy6357 385 SNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL----------- 451 (635)
Q Consensus 385 a~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~----------- 451 (635)
|+..... ..++..+.|.+|+|||++++...++.++||||+|||+.||+..+..|...+..+..+.|.
T Consensus 203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred ccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 9986543 346667789999999999998777799999999999999999999998766544444332
Q ss_pred ------------hCccCCCC-----------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 452 ------------FGKFRIPF-----------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 452 ------------~~~~~~p~-----------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
....+.|. .-..+..+++.+||..||.+|.+..+++.|+|+.
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 22222221 1235788999999999999999999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=321.84 Aligned_cols=258 Identities=19% Similarity=0.228 Sum_probs=177.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...+.|.+.++||+|+||.||+|.+..... ..+..||||.+...... +....| .+....+.+++
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~----------~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~ 192 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQS----------KKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCA 192 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCcc----------ccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHH
Confidence 456788899999999999999998843311 12568999988643211 111111 12222222222
Q ss_pred eEEEE------EecCCeEEEEEeccccchhhhhhhhccc--------------------CCHHHHHHHHHHHHHhhhhhc
Q psy6357 302 KLFQV------METTNNLYLVTEYARGGEIFSHLLTIGQ--------------------MAEKEASRLFRQILSAVAYCH 355 (635)
Q Consensus 302 ~l~~~------~~~~~~~~LV~E~~~ggsL~~~l~~~~~--------------------l~e~~~~~i~~qIl~gL~~LH 355 (635)
.++.. ......++|||||+.+++|.+++..... ..+..+..|+.||+.||.|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH 272 (566)
T PLN03225 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH 272 (566)
T ss_pred HHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH
Confidence 22211 2456689999999999999988865321 123456789999999999999
Q ss_pred cCceeeecccCcceeecC-CCCeeeecccccccccCC--CccccccCCCCCCCccccCCCCc------------------
Q psy6357 356 ANNVVHRDIKAENLLFDE-NGDIKLADFGFSNYFTPG--HMLTTWCGSPPYAAPELFGGREY------------------ 414 (635)
Q Consensus 356 s~gIiHrDLKp~NILl~~-~~~ikL~DFGla~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~------------------ 414 (635)
+.+|+||||||+||||+. ++.+||+|||+|..+... ......++++.|+|||++.....
T Consensus 273 ~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~ 352 (566)
T PLN03225 273 STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 352 (566)
T ss_pred HCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence 999999999999999986 579999999999865432 23456788999999997643221
Q ss_pred ---CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---------------------CCCCCCCHHHHHHHH
Q psy6357 415 ---DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF---------------------RIPFYMSAECENLIR 470 (635)
Q Consensus 415 ---~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~---------------------~~p~~~s~~l~~LI~ 470 (635)
.+.++||||||||||||+++..+++... ..+...+..... .+.......+.+||.
T Consensus 353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred cccCCCCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 1246799999999999999776654321 111111111110 011112334568999
Q ss_pred HhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 471 SMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 471 ~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+||++||.+|||+.|+|+||||....
T Consensus 432 ~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHccCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999999997643
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=314.06 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=213.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
+++||.|+||+||+|.|--.... -..+||||++.... .......++.|+-+|.+|+|||+++|++++..
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~----------vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGEN----------VKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hceeccccceeEEeeeEecCCce----------ecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 57899999999999999544221 23589999997654 33344678999999999999999999999977
Q ss_pred CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
.. +.||++||+.|.|.+++... ..+-....+.|..||++||.|||.+.++||||-..||||..-.++||.|||+|+..
T Consensus 770 s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 770 ST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred ch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 65 88999999999999999765 46889999999999999999999999999999999999999999999999999988
Q ss_pred cCCCccccc---cCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCH
Q psy6357 389 TPGHMLTTW---CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSA 463 (635)
Q Consensus 389 ~~~~~~~~~---~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~ 463 (635)
......... ...+.|||-|.+....|+ .++|||||||++||||| |..|+++....++...+..+ ++..|..++.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTI 927 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccH
Confidence 765432222 235669999999988887 99999999999999999 99999999999888877765 4677889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 464 ECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 464 ~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
++..+|.+||-.|+..||+|+++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999998875
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=322.00 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=219.0
Q ss_pred hhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHh
Q psy6357 214 EWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS 293 (635)
Q Consensus 214 e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~ 293 (635)
.|++......+ .+.||+|.||.||+|......... ......||||.+...... .+.+.+..|+++|+
T Consensus 290 ~~e~~~~~l~~-----~~~lg~g~fG~v~~~~~~~~~~~~-------~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~ 356 (609)
T KOG0200|consen 290 KWEIPRENLKL-----GKYLGEGAFGQVVKALLFGLSKAL-------LSIYVTVAVKMLKENASS-SEKKDLMSELNVLK 356 (609)
T ss_pred ceeechhhccc-----cceeecccccceEeEEEeeccccc-------ccceEEEEEEecccccCc-HHHHHHHHHHHHHH
Confidence 45555433322 458999999999999876554321 112468999999766644 67789999999999
Q ss_pred hC-CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhcc
Q psy6357 294 HL-DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHA 356 (635)
Q Consensus 294 ~L-~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs 356 (635)
.+ .|+||+.|++++.....+++|+||+..|+|.++|...+ .++..+.+.++.||+.|++||++
T Consensus 357 ~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~ 436 (609)
T KOG0200|consen 357 ELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS 436 (609)
T ss_pred HhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh
Confidence 99 59999999999999999999999999999999998766 38899999999999999999999
Q ss_pred CceeeecccCcceeecCCCCeeeecccccccccCCCccc--cccC--CCCCCCccccCCCCcCCCccchhhHHHHHHHHH
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLT--TWCG--SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~--~~~g--t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLl 432 (635)
..+|||||-..||||+.+..+||+|||+|+......... ...+ ...|||||.+....|+ .++||||||++||||+
T Consensus 437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIF 515 (609)
T ss_pred CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHh
Confidence 999999999999999999999999999999765443322 2222 2349999999997776 9999999999999999
Q ss_pred h-CCCCCCCCC-HHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 433 T-AQLPFDGPN-LAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 433 t-G~~PF~~~~-~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+ |..||.+.. ..++.+.+..+ ....|.+++.++.+||+.||..+|++||++.++.+
T Consensus 516 sLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 516 TLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred hCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9 999999865 66667766665 45789999999999999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.16 Aligned_cols=271 Identities=19% Similarity=0.216 Sum_probs=191.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHH--HHHHhhcCceEEEEEecccccCH--H----------HHHHHHHH
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAA--AAQLIEELSKVAIKIIDKKRLDE--R----------NLRKLFRE 288 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~--~~~~~~~~~~VAIKii~~~~~~~--~----------~~~~~~~E 288 (635)
....|.+.++||+|+||+||+|.+.......... .......+..||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3567888999999999999999763322111000 00112345689999986542110 0 11223347
Q ss_pred HHHHhhCCCCce-----eeEEEEEec--------CCeEEEEEeccccchhhhhhhhc-----------------------
Q psy6357 289 VDIMSHLDHPHI-----IKLFQVMET--------TNNLYLVTEYARGGEIFSHLLTI----------------------- 332 (635)
Q Consensus 289 i~iL~~L~HpnI-----v~l~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~----------------------- 332 (635)
+.++.++.|.++ +.++++|.. ....||||||+.+++|.++|...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667777643 35689999999999998887532
Q ss_pred -ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccc--cCCCCCCCcccc
Q psy6357 333 -GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTW--CGSPPYAAPELF 409 (635)
Q Consensus 333 -~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~--~gt~~Y~APEvl 409 (635)
..+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++............ .+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12456788999999999999999999999999999999999999999999999765443322222 347899999998
Q ss_pred CCCCc--------------------C-CCccchhhHHHHHHHHHhCCC-CCCCCCH-----------HHHHHHHHhCccC
Q psy6357 410 GGREY--------------------D-GTKSDVWSLGVVLYVMVTAQL-PFDGPNL-----------AVLKQRILFGKFR 456 (635)
Q Consensus 410 ~~~~~--------------------~-~~ksDIwSlGvilyeLltG~~-PF~~~~~-----------~~l~~~i~~~~~~ 456 (635)
..... . ..+.||||+|||||+|+++.+ ||..... ......+....+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 64321 1 124799999999999999876 7754211 1111112222333
Q ss_pred CC--CCCCHHHHHHHHHhcccCC---CCCCCHHHHHcCcccc
Q psy6357 457 IP--FYMSAECENLIRSMLVLDP---AKRLTLTQISNHKWMS 493 (635)
Q Consensus 457 ~p--~~~s~~l~~LI~~~L~~dP---~~Rps~~eiL~Hpw~~ 493 (635)
++ ...+..+++||.+||..+| .+|+|+.|+|+||||.
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 33 3578999999999999876 6899999999999995
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=316.99 Aligned_cols=239 Identities=26% Similarity=0.431 Sum_probs=193.4
Q ss_pred eeccccCCcc-eeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEe
Q psy6357 231 RKAGEGEDLS-QWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~-Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 308 (635)
+.+|+|+.|+ ||+|.| +++.||||.+-.. ....+.+||..|+.- +|||||++|+.-.
T Consensus 515 eilG~Gs~Gt~Vf~G~y----------------e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~ 573 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY----------------EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQ 573 (903)
T ss_pred HHcccCCCCcEEEEEee----------------CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeecc
Confidence 3468999886 579988 5678999987543 345778999999998 5999999999999
Q ss_pred cCCeEEEEEeccccchhhhhhhhccc----CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---C--CCeee
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQ----MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---N--GDIKL 379 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~----l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~--~~ikL 379 (635)
+....||..|+| ..+|.+++..... ......+.++.|+++||++||+.+||||||||+||||+. + ..++|
T Consensus 574 d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 574 DRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred CCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEe
Confidence 999999999999 5899999877411 122456889999999999999999999999999999976 2 47999
Q ss_pred ecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc
Q psy6357 380 ADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 380 ~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~ 454 (635)
+|||++..+..+. ...+..||-+|+|||++...... .++||||||||+|+.++ |..||...-. -...|+.+.
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~ 729 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGN 729 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCc
Confidence 9999999876542 35567899999999999887765 79999999999999998 5999965422 223455454
Q ss_pred cCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 FRIPF---YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~p~---~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+.+-. ....++.+||.+||..+|..||+|.+||.||+|-.
T Consensus 730 ~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 730 YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 43221 11228999999999999999999999999999963
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=289.16 Aligned_cols=238 Identities=26% Similarity=0.471 Sum_probs=192.1
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhh--CCCCceeeEEE
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSH--LDHPHIIKLFQ 305 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~ 305 (635)
.+++.||+|.||.||+|.| -|+.||||+|... +-..+++|.+|.+. |+|+||+.+++
T Consensus 214 ~L~e~IGkGRyGEVwrG~w----------------rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW----------------RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred EEEEEecCccccceeeccc----------------cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhh
Confidence 3478999999999999999 4678999999543 22678999999987 59999999998
Q ss_pred EEecC----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC--------ceeeecccCcceeecC
Q psy6357 306 VMETT----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN--------NVVHRDIKAENLLFDE 373 (635)
Q Consensus 306 ~~~~~----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~--------gIiHrDLKp~NILl~~ 373 (635)
.-..+ ..+|||++|.+.|+|+|||.. ..++....++++.-++.||+|||.. .|.|||||..||||.+
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 86443 368999999999999999988 7799999999999999999999952 3999999999999999
Q ss_pred CCCeeeecccccccccCC-----CccccccCCCCCCCccccCCCC----cC-CCccchhhHHHHHHHHHh----------
Q psy6357 374 NGDIKLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGRE----YD-GTKSDVWSLGVVLYVMVT---------- 433 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~----~~-~~ksDIwSlGvilyeLlt---------- 433 (635)
++...|+|||||...... ......+||..|||||++.... +. -..+||||||+|+||++.
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 999999999999776543 2345679999999999985321 11 157899999999999975
Q ss_pred CCCCCCC-----CCHHHHHHHHHhCccC--CCCCC--C---HHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 434 AQLPFDG-----PNLAVLKQRILFGKFR--IPFYM--S---AECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 434 G~~PF~~-----~~~~~l~~~i~~~~~~--~p~~~--s---~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
-++||.+ .+.+++...+...+++ +|..+ . ..+..||+.||..+|..|.|+--|.
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 2678854 4456666666655443 33222 1 3467889999999999999987664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=328.09 Aligned_cols=235 Identities=20% Similarity=0.286 Sum_probs=184.2
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
+.....||+|+||.||+|.+. .++..||||.+..... ....|+++|++++|||||+++++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~ 751 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSI--------------KNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGL 751 (968)
T ss_pred CCcccEEccCCCeeEEEEEEC--------------CCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEE
Confidence 444678999999999999873 3456899999865432 12356889999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc---cCceeeecccCcceeecCCCCeeeeccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH---ANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH---s~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+.+....|+||||+++++|.+++.. +++..+..|+.||+.||+||| +.+|+||||||+|||++.++..++. |+
T Consensus 752 ~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 752 CRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred EEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 9999999999999999999999853 899999999999999999999 6699999999999999998887775 66
Q ss_pred ccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh------
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-----LAVLKQRILF------ 452 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-----~~~l~~~i~~------ 452 (635)
.+..... .....+|+.|+|||++.+..++ .++|||||||++|||++|+.||+... ..........
T Consensus 828 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 828 LPGLLCT---DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccccc---CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 5543321 1234678999999999888876 89999999999999999999985421 1111111000
Q ss_pred ---Ccc----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 ---GKF----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ---~~~----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
... ..+.....++.+|+.+||+.||++|||+.||++.
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000 1111122357789999999999999999999875
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=284.97 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=192.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC--CCCcee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL--DHPHII 301 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv 301 (635)
..+-+.++.+|+|.||.||+|.+ .++.||||++. ......+..|-+|.... +|+||+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL----------------~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl 267 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL----------------DNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENIL 267 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc----------------cCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHH
Confidence 45556688999999999999977 34689999985 34557788888887764 799999
Q ss_pred eEEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC---------ceeeecccCcc
Q psy6357 302 KLFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN---------NVVHRDIKAEN 368 (635)
Q Consensus 302 ~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~---------gIiHrDLKp~N 368 (635)
+++++-+... .++||++|.+.|+|.+||+. ..+++....+|+.-|+.||+|||+. .|+|||||..|
T Consensus 268 ~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkN 346 (534)
T KOG3653|consen 268 QFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKN 346 (534)
T ss_pred HhhchhccCCccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccc
Confidence 9999876555 79999999999999999976 5699999999999999999999963 49999999999
Q ss_pred eeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcC-----CCccchhhHHHHHHHHHhCCCC---
Q psy6357 369 LLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYD-----GTKSDVWSLGVVLYVMVTAQLP--- 437 (635)
Q Consensus 369 ILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~-----~~ksDIwSlGvilyeLltG~~P--- 437 (635)
|||..|+...|+|||||..+.++. .....+||..|||||++.+..-. -.+.||||+|.|||||++...-
T Consensus 347 VLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 347 VLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred eEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 999999999999999998886543 23347899999999999764322 1468999999999999985333
Q ss_pred ---------CC-----CCCHHHHHHHHHhCc--cCCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6357 438 ---------FD-----GPNLAVLKQRILFGK--FRIPFY-----MSAECENLIRSMLVLDPAKRLTLTQI 486 (635)
Q Consensus 438 ---------F~-----~~~~~~l~~~i~~~~--~~~p~~-----~s~~l~~LI~~~L~~dP~~Rps~~ei 486 (635)
|. ..+.+++...+...+ ..+|.. ....+.+.|..||..||+.|.|+.=+
T Consensus 427 ~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 427 GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 32 133455555554433 334432 34568999999999999999998544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-33 Score=300.28 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=220.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|+.+.++|.|+||.||++.++ ..++..|||+++... ...+.-+.+|+-+++.++|+|||.+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~--------------~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay 77 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDK--------------RSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAY 77 (829)
T ss_pred ccchhheeeecCCcccchhhhccc--------------ccCchhhheeeeccC--CccccccccceeeeecCCCcChHHH
Confidence 356888999999999999988874 455679999998764 3345678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.+...+.+||.||||.+|+|.+.-.-.+.+++.++..+.+..+.||+|||+.|-+|||||-.|||+++.|.+||+|||
T Consensus 78 ~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 78 FGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred HhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccC
Confidence 99999999999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
.+-.+... .....++||+.|||||+-. ...|. ..+|||++|+...||-.-++|............+....+..|.
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc
Confidence 98766532 3456789999999999862 44554 8999999999999999988886666555555555555555543
Q ss_pred -----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 -----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 -----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+++.+.+|++.+|.++|++||+++.+|.|||+.+.
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 488999999999999999999999999999999743
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=291.53 Aligned_cols=203 Identities=34% Similarity=0.579 Sum_probs=180.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH------HHHHHHHHHHHHHhhCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE------RNLRKLFREVDIMSHLD 296 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~------~~~~~~~~Ei~iL~~L~ 296 (635)
++..|..+++||+|+||.||+++++.. ...|+||.+.++..-. ..+-.+--||+||..|+
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n--------------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~ 624 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKEN--------------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLN 624 (772)
T ss_pred ccccceeeeeccccccceEEEeeeccc--------------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhh
Confidence 456789999999999999999998533 4579999998876421 12223446999999997
Q ss_pred ---CCceeeEEEEEecCCeEEEEEecc-ccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 297 ---HPHIIKLFQVMETTNNLYLVTEYA-RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 297 ---HpnIv~l~~~~~~~~~~~LV~E~~-~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
|+||++++++|++++.+||+||-. ++.+|+++|..+..++|.+++.|++|++.|+++||+.||||||||-+||.++
T Consensus 625 ~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd 704 (772)
T KOG1152|consen 625 KHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD 704 (772)
T ss_pred hcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEe
Confidence 999999999999999999999987 4679999999999999999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
.+|.+||+|||.|.....+ ....++||..|.|||++.+..|-+..-|||+||++||-++....||.+
T Consensus 705 ~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999999877654 457889999999999999999999999999999999999999999864
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=274.92 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv 301 (635)
+.+.|.++.+||+|+|++||++.+... -....+||+|.+.....- .++..|+++|..+. +.||+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~-----------~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~ 98 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQ-----------DTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNII 98 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhh-----------ccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhh
Confidence 456788899999999999998876331 114578999999766432 56889999999995 99999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~ 380 (635)
++.+++..++..++||||++..+..+++.. ++..++..+++.++.||.++|..|||||||||.|+|.+. .+.-.|+
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEE
Confidence 999999999999999999998877776654 778999999999999999999999999999999999985 4678999
Q ss_pred ccccccccc-----------------C--C--------------------------CccccccCCCCCCCccccCCCCcC
Q psy6357 381 DFGFSNYFT-----------------P--G--------------------------HMLTTWCGSPPYAAPELFGGREYD 415 (635)
Q Consensus 381 DFGla~~~~-----------------~--~--------------------------~~~~~~~gt~~Y~APEvl~~~~~~ 415 (635)
|||+|.... . + .......||++|+|||++...+-.
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999986211 0 0 001124689999999999887777
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCCH--HHH------------HHH-HHhCc---------------------c----
Q psy6357 416 GTKSDVWSLGVVLYVMVTAQLPFDGPNL--AVL------------KQR-ILFGK---------------------F---- 455 (635)
Q Consensus 416 ~~ksDIwSlGvilyeLltG~~PF~~~~~--~~l------------~~~-i~~~~---------------------~---- 455 (635)
+.++||||.|||+..++++..||-.... ..+ .+. ...+. .
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 7899999999999999999999853210 000 000 00000 0
Q ss_pred ----CC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 456 ----RI--------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 456 ----~~--------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+. -...+..+.+|+.+||..||.+|+|++++|.||||.
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 00 012456899999999999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=240.80 Aligned_cols=211 Identities=45% Similarity=0.754 Sum_probs=184.6
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCe
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN 312 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 312 (635)
||.|.+|.||++... ..+..++||++....... ....+.+|+.+++.+.|++|+++++++.....
T Consensus 1 l~~g~~~~v~~~~~~--------------~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 65 (215)
T cd00180 1 LGEGGFGTVYLARDK--------------KTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH 65 (215)
T ss_pred CCcCCceEEEEEEec--------------CCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Confidence 689999999999873 235789999997664322 34678899999999999999999999999999
Q ss_pred EEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeeeecccccccccC
Q psy6357 313 LYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKLADFGFSNYFTP 390 (635)
Q Consensus 313 ~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL~DFGla~~~~~ 390 (635)
.++|||++.+++|.+++... ..++...++.++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 66 ~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 66 LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 99999999999999998775 57999999999999999999999999999999999999999 89999999999987654
Q ss_pred CC-ccccccCCCCCCCccccCCC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHH
Q psy6357 391 GH-MLTTWCGSPPYAAPELFGGR-EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENL 468 (635)
Q Consensus 391 ~~-~~~~~~gt~~Y~APEvl~~~-~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~L 468 (635)
.. ......+...|++||.+... .+ +.+.|+|+||+++|+| ..+.++
T Consensus 146 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~~D~~~lg~~~~~l-------------------------------~~~~~~ 193 (215)
T cd00180 146 DKSLLKTIVGTPAYMAPEVLLGKGYY-SEKSDIWSLGVILYEL-------------------------------PELKDL 193 (215)
T ss_pred CcchhhcccCCCCccChhHhcccCCC-CchhhhHHHHHHHHHH-------------------------------HHHHHH
Confidence 32 23345678889999999776 44 4899999999999999 678999
Q ss_pred HHHhcccCCCCCCCHHHHHcCc
Q psy6357 469 IRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 469 I~~~L~~dP~~Rps~~eiL~Hp 490 (635)
|.+||..+|.+||++.++++|+
T Consensus 194 l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 194 IRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHhhCCcccCcCHHHHhhCC
Confidence 9999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=245.39 Aligned_cols=195 Identities=25% Similarity=0.488 Sum_probs=165.3
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVM 307 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 307 (635)
.+..||.|++|.|-+... +.+|+-.|+|.+.... .....+++++|+.+.... .+|.+|.+|+.+
T Consensus 50 ~i~elGrGayG~vekmrh--------------~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRH--------------IQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred hhhhhcCCccchhhheee--------------ccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 367899999999875554 5678899999997654 455667888999987665 799999999999
Q ss_pred ecCCeEEEEEeccccchhhhh----hhhcccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeeeecc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSH----LLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~----l~~~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
.....+||.||.|+ .+|..+ +.+.+.++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|++|||||
T Consensus 115 ~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 99999999999994 555443 34446799999999999999999999975 8999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCC----CCcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGG----REYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~----~~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
|++..+.++-..+-..|-..|||||.+.. ..|+ .++||||||++++||.+++.||+.
T Consensus 194 GIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccc
Confidence 99988876655555678889999998853 3554 899999999999999999999965
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=240.65 Aligned_cols=212 Identities=38% Similarity=0.661 Sum_probs=182.2
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|.+.+.||.|+++.||++... .++..||||.+...... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~--------------~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~ 65 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK--------------GTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGV 65 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc--------------CCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheee
Confidence 456788999999999999873 23568999999866433 245788899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhccc-CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~-l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
+......++|+||+.+++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++
T Consensus 66 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~ 145 (225)
T smart00221 66 FEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLA 145 (225)
T ss_pred eecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence 9998999999999999999999987766 899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC--ccccccCCCCCCCcccc-CCCCcCCCccchhhHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhCc
Q psy6357 386 NYFTPGH--MLTTWCGSPPYAAPELF-GGREYDGTKSDVWSLGVVLYVMVTAQLPFDG--PNLAVLKQRILFGK 454 (635)
Q Consensus 386 ~~~~~~~--~~~~~~gt~~Y~APEvl-~~~~~~~~ksDIwSlGvilyeLltG~~PF~~--~~~~~l~~~i~~~~ 454 (635)
....... ......++..|++||++ ....+. .++|||+||+++|+|++|+.||.. .+...+.+.+..+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 146 RFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred eEecCcccccccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 8775442 34556788899999998 555565 799999999999999999999977 44446777776664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=251.82 Aligned_cols=252 Identities=20% Similarity=0.319 Sum_probs=210.3
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+....-.+-+|.||.||.|+|...+.. .+.+.|-+|.++. ..++-.+..++.|.-+|..+.|||+..+.+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~---------n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTY---------NDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCc---------chHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 344455678999999999988654432 2233466666643 336667788999999999999999999999
Q ss_pred EE-ecCCeEEEEEeccccchhhhhhhhc--------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 306 VM-ETTNNLYLVTEYARGGEIFSHLLTI--------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 306 ~~-~~~~~~~LV~E~~~ggsL~~~l~~~--------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++ ++....++++.++.-|+|..+|... ..++..+...++.||+.|++|||+.+|||.||...|.+|++.-+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 87 4556678889999889999999732 23777888899999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy6357 377 IKLADFGFSNYFTPGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~ 452 (635)
+||+|=.+++.+.+.+.. ...-....||+||.+....|+ .++|+|||||+||||++ |+.|+...+..++...++.
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999887665421 122235579999999999997 99999999999999999 9999999999999888887
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 453 G-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 453 ~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+ .+..|..+++++..+|.-||..+|++||+++|+..
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 7 46778999999999999999999999999999863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=297.60 Aligned_cols=197 Identities=15% Similarity=0.174 Sum_probs=148.8
Q ss_pred hCCC-CceeeEEEEE-------ecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 294 HLDH-PHIIKLFQVM-------ETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 294 ~L~H-pnIv~l~~~~-------~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
.+.| .||+.++++| .....++++|||+ +++|.++|... ..+++.+++.|+.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5888888877 2335678889988 67999999653 45999999999999999999999999999999
Q ss_pred cCcceeecC-------------------CCCeeeecccccccccCC-----------------CccccccCCCCCCCccc
Q psy6357 365 KAENLLFDE-------------------NGDIKLADFGFSNYFTPG-----------------HMLTTWCGSPPYAAPEL 408 (635)
Q Consensus 365 Kp~NILl~~-------------------~~~ikL~DFGla~~~~~~-----------------~~~~~~~gt~~Y~APEv 408 (635)
||+||||+. ++.+||+|||+++..... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 445667777776542110 00112468999999999
Q ss_pred cCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 409 FGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 409 l~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
+.+..|. .++||||||||||||++|.+||..... ....+.....+ ........+.+++.+||..+|.+||++.|||
T Consensus 187 ~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 9988885 999999999999999999988764321 11222111111 1111345678999999999999999999999
Q ss_pred cCccccc
Q psy6357 488 NHKWMSV 494 (635)
Q Consensus 488 ~Hpw~~~ 494 (635)
+||||..
T Consensus 264 ~h~~~~~ 270 (793)
T PLN00181 264 QSEFINE 270 (793)
T ss_pred hchhhhh
Confidence 9999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=224.66 Aligned_cols=158 Identities=25% Similarity=0.309 Sum_probs=129.2
Q ss_pred chhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCC
Q psy6357 323 GEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSP 401 (635)
Q Consensus 323 gsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~ 401 (635)
|+|.+++... ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++....... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 6788888764 45999999999999999999999998 999999999999999 99998764422 36899
Q ss_pred CCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCccC-------CCCCCCH--HHHHHHHH
Q psy6357 402 PYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILFGKFR-------IPFYMSA--ECENLIRS 471 (635)
Q Consensus 402 ~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~~~~~-------~p~~~s~--~l~~LI~~ 471 (635)
.|||||++.+..++ .++|||||||++|||++|..||..... ......+...... .+..++. ++.+||.+
T Consensus 69 ~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 99999999988886 899999999999999999999976432 2223333222111 1122333 69999999
Q ss_pred hcccCCCCCCCHHHHHcCcccc
Q psy6357 472 MLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 472 ~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
||..+|.+||++.++++|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-25 Score=225.97 Aligned_cols=251 Identities=35% Similarity=0.593 Sum_probs=209.9
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH-HHHHHHHHHHHHhhCCCC-ceeeEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER-NLRKLFREVDIMSHLDHP-HIIKLF 304 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~-~~~~~~~Ei~iL~~L~Hp-nIv~l~ 304 (635)
|.++..||.|+|+.||++.+. ..+|+|.+........ ....+.+|+.++..+.|+ +|+.++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-----------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~ 64 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-----------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-----------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEE
Confidence 567889999999999999874 4799999987665443 567889999999999988 799999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcc---cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeee
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIG---QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLA 380 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~ 380 (635)
+++......+++++++.+++|.+++.... .+.+..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++
T Consensus 65 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~ 144 (384)
T COG0515 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLI 144 (384)
T ss_pred EEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEe
Confidence 99988888999999999999997776664 799999999999999999999999999999999999999988 79999
Q ss_pred cccccccccCCC-------ccccccCCCCCCCccccCCC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHH
Q psy6357 381 DFGFSNYFTPGH-------MLTTWCGSPPYAAPELFGGR--EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLK 447 (635)
Q Consensus 381 DFGla~~~~~~~-------~~~~~~gt~~Y~APEvl~~~--~~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~ 447 (635)
|||++....... .....++|..|+|||.+.+. .......|+||+|++++++++|..||..... ....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224 (384)
T ss_pred ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence 999998654432 34678899999999999874 3445899999999999999999999877663 4555
Q ss_pred HHHHhCccC-CCCCC--------CHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 448 QRILFGKFR-IPFYM--------SAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 448 ~~i~~~~~~-~p~~~--------s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+...... ..... ...+.+++..|+..+|..|.+..+...++|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 555544433 22211 157899999999999999999999999977654
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=232.37 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=192.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
...|.+.+.||+|.||.+-++..+ ...+.+++|.+.+... ....|.+|...--.|. |.||+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr--------------~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~ 85 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR--------------QSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIID 85 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc--------------CCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhH
Confidence 346777889999999999988774 4456899999977643 3467888887766664 899998
Q ss_pred EEEE-EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC--CCCeee
Q psy6357 303 LFQV-METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--NGDIKL 379 (635)
Q Consensus 303 l~~~-~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--~~~ikL 379 (635)
-|++ |+..+.++++|||++-|+|.+.+.. ..+-|...+.++.|+++||.|||++++||||||.+||||-. ...|||
T Consensus 86 tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 86 TYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred HHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEe
Confidence 8875 6777888899999999999988766 45889999999999999999999999999999999999943 348999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCC----cCCCccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGRE----YDGTKSDVWSLGVVLYVMVTAQLPFDGPN-----LAVLKQRI 450 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~----~~~~ksDIwSlGvilyeLltG~~PF~~~~-----~~~l~~~i 450 (635)
||||+.+.... .....--+..|.+||+..... .....+|||.||+|+|.+|+|++||+... .....+..
T Consensus 165 cDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 165 CDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred eecccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 99999875432 222223355799999764321 12467899999999999999999997432 22222222
Q ss_pred HhCccCCCC---CCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcccc
Q psy6357 451 LFGKFRIPF---YMSAECENLIRSMLVLDPAKR---LTLTQISNHKWMS 493 (635)
Q Consensus 451 ~~~~~~~p~---~~s~~l~~LI~~~L~~dP~~R---ps~~eiL~Hpw~~ 493 (635)
.......|. .+++.+..+.++-|..++++| .++......-|..
T Consensus 243 ~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 243 KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 223334443 478999999999999999999 5666666777764
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-27 Score=268.06 Aligned_cols=253 Identities=31% Similarity=0.491 Sum_probs=197.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH-HHHHHHHHHHHHhhCCCCceeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER-NLRKLFREVDIMSHLDHPHIIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~-~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 308 (635)
.+.+|.|++|.|+........+.. ....+++| .. ....+. ....+..|+-+-..|.|+||+..+..+.
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~---------~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSF---------PEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred cceeeecccCceEEEEecCCCccc---------hhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 567899999977765543332210 01122232 11 222222 2223677888888899999988877777
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
+....+-+||||+. +|+.++.....+...++-.+++||+.||+|||+.||.|||||++|+|++.+|.+||+|||.+..+
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 66666666999998 99999998889999999999999999999999999999999999999999999999999999776
Q ss_pred cCC-----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH--HHH-------HhCc
Q psy6357 389 TPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK--QRI-------LFGK 454 (635)
Q Consensus 389 ~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~--~~i-------~~~~ 454 (635)
... ......+|+..|+|||++.+..|+...+||||.|+|++.|++|+.||......+.. +.. ..+.
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 432 34667899999999999999999989999999999999999999999765433221 111 1111
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+-..++...+.+|.+||+.||.+|.|+++|++.+||+.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 1222347888999999999999999999999999999974
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=229.93 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=195.2
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC----Ccee
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH----PHII 301 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv 301 (635)
+|.+.++||+|+||.||.+...... ...+|+|+......... ..+..|+.+|..+.. .++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-------------~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~ 83 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-------------NKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFP 83 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-------------CeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCC
Confidence 8999999999999999999874332 24689998866432211 257789999998863 6899
Q ss_pred eEEEEE-ecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC----
Q psy6357 302 KLFQVM-ETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---- 374 (635)
Q Consensus 302 ~l~~~~-~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---- 374 (635)
.+++.+ ......|+||+++ |.+|.++.... +.|+...+..|+.|++.+|.+||+.|++||||||+|+++...
T Consensus 84 ~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 84 KLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred EEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcc
Confidence 999999 5788899999999 89999877544 579999999999999999999999999999999999999865
Q ss_pred -CCeeeecccccc--cccCCC--------c-cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy6357 375 -GDIKLADFGFSN--YFTPGH--------M-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442 (635)
Q Consensus 375 -~~ikL~DFGla~--~~~~~~--------~-~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~ 442 (635)
..+.|.|||+|+ .+.... . ...+.||..|+++.+..+.... .+.|+||++.++.+|+.|.+||....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCcccc
Confidence 469999999998 321111 1 2345699999999999998886 99999999999999999999997755
Q ss_pred HHHHHHHHHhC----ccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 443 LAVLKQRILFG----KFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 443 ~~~l~~~i~~~----~~~-~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.......+... ... +....+.++..++..+-..+...+|....+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 242 MTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 32222222211 111 233456788888888888999999999888765
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-26 Score=250.16 Aligned_cols=244 Identities=28% Similarity=0.458 Sum_probs=211.6
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecCC
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMETTN 311 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 311 (635)
+|.|+||.|+++.-.. -.+.+.-+|+|++.+.............|..++..++ ||.+|.+...|+.+.
T Consensus 2 lg~g~~gkvfLvrk~~-----------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~ 70 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAG-----------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG 70 (612)
T ss_pred CCcCCCcchHHHHHhc-----------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc
Confidence 7999999999654311 1235567888888776553333335567888999887 999999999999999
Q ss_pred eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC
Q psy6357 312 NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 312 ~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
.++++++|..+++|...+.+...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..
T Consensus 71 kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 71 KLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred chhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999877554
Q ss_pred CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHH
Q psy6357 392 HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRS 471 (635)
Q Consensus 392 ~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~ 471 (635)
... |||..|||||++.+ .. .++|.||||+++++|++|..||.. ++...|...++.+|..++..+.+++..
T Consensus 151 ~~~---cgt~eymApEI~~g--h~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIING--HL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ 220 (612)
T ss_pred hhc---ccchhhhhhHhhhc--cC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence 333 99999999999983 22 789999999999999999999987 777888888999999999999999999
Q ss_pred hcccCCCCCCC-----HHHHHcCcccccCCC
Q psy6357 472 MLVLDPAKRLT-----LTQISNHKWMSVHCP 497 (635)
Q Consensus 472 ~L~~dP~~Rps-----~~eiL~Hpw~~~~~~ 497 (635)
|+..+|..|.- +.||++|+||+....
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 99999999985 489999999986543
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=213.51 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=197.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
--.|.+-+|||+|+||.+++|.. +-+++.||||.-...... -++..|....+.|. .++|.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~N--------------l~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~ 88 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKN--------------LYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQ 88 (449)
T ss_pred cccceeccccccCcceeeecccc--------------cccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCc
Confidence 34577789999999999999877 345679999987655422 45677888888885 789999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-----CC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-----GD 376 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-----~~ 376 (635)
+|.+.....+-.||||++ |.+|++++.-.+ +|+...+.-++.||+.-++|+|++.+|+|||||+|+||... ..
T Consensus 89 vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 89 VYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred eeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCce
Confidence 999888888899999999 889998886654 59999999999999999999999999999999999999754 36
Q ss_pred eeeecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHH
Q psy6357 377 IKLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAV 445 (635)
Q Consensus 377 ikL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~ 445 (635)
|.|+|||+|..+.+.. ......||..||+-....+...+ .+.|+-|||.++++.|.|.+||.+.. ..+
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKE 246 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence 9999999998875432 23457799999999999998886 99999999999999999999998854 445
Q ss_pred HHHHHHhCccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6357 446 LKQRILFGKFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQI 486 (635)
Q Consensus 446 l~~~i~~~~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~ei 486 (635)
-+++|-..+-..| ..++.++..-|.-.-..+-.+-|+.+-+
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 5566654443333 2467788888887777787887876544
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=210.89 Aligned_cols=245 Identities=23% Similarity=0.255 Sum_probs=201.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC-Cce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH-PHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H-pnI 300 (635)
+....|.++++||.|+||.+|.|.. +.+|+.||||+-....-. ..+..|..+...|++ ..|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~--------------i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~Gi 73 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGIS--------------ITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGI 73 (341)
T ss_pred eeccceEEEEeecCCchhheeeeee--------------ccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCC
Confidence 4567899999999999999999987 567899999987654332 357789999999974 678
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC---CC
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---GD 376 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---~~ 376 (635)
..+..++....+-.+||+++ |.+|.+++.-. ..|+...++-++-||+.-|+|+|.+++|||||||+|+|+.-+ ..
T Consensus 74 P~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 74 PHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred chhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccce
Confidence 88888888888899999999 88999887644 569999999999999999999999999999999999999643 57
Q ss_pred eeeecccccccccCC--------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH---HH
Q psy6357 377 IKLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL---AV 445 (635)
Q Consensus 377 ikL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~---~~ 445 (635)
+.|+|||+|..+.+. .......||..|.+-....+...+ .+.|+-|+|.+|..+..|.+||++... ..
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 999999999876432 123456799999999888887765 899999999999999999999998543 44
Q ss_pred HHHHHHhCccCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy6357 446 LKQRILFGKFRIPF-----YMSAECENLIRSMLVLDPAKRLTLTQI 486 (635)
Q Consensus 446 l~~~i~~~~~~~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~ei 486 (635)
-+++|...+...|. .++.++.-.|..|-..--++-|+..-|
T Consensus 232 KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 232 KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 45566666655553 478899999999998888888876443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=225.45 Aligned_cols=166 Identities=15% Similarity=0.137 Sum_probs=129.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---CHHHHHHHHHHHHHHhhCCCC
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
.....|.+.+.||+|+||+||+|.+... ++..||||++..... .......+.+|+.+|++|.|+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-------------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~ 81 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD-------------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGI 81 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC-------------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCC
Confidence 4567788899999999999999987321 345689998753311 233456788999999999999
Q ss_pred ceee-EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc-cCcceeecCCCC
Q psy6357 299 HIIK-LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI-KAENLLFDENGD 376 (635)
Q Consensus 299 nIv~-l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL-Kp~NILl~~~~~ 376 (635)
||+. ++++ +..|||||||+|++|.. +.. .. ...++.|++.+|.|||+.||+|||| ||+|||++.++.
T Consensus 82 ~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 82 GVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred CCCcEEEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC
Confidence 9985 5442 45799999999998863 211 11 2568899999999999999999999 999999999999
Q ss_pred eeeecccccccccCCC---------ccccccCCCCCCCccccCC
Q psy6357 377 IKLADFGFSNYFTPGH---------MLTTWCGSPPYAAPELFGG 411 (635)
Q Consensus 377 ikL~DFGla~~~~~~~---------~~~~~~gt~~Y~APEvl~~ 411 (635)
+||+|||+|+.+.... ......+++.|+|||.+..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999998764321 1245678888999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-22 Score=193.77 Aligned_cols=142 Identities=18% Similarity=0.189 Sum_probs=110.8
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHH------------------------HHHH
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERN------------------------LRKL 285 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~------------------------~~~~ 285 (635)
.+.||.|+||.||+|... +++.||||+++........ ....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---------------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 66 (190)
T cd05147 2 NGCISTGKEANVYHATTA---------------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWA 66 (190)
T ss_pred CCccccccceEEEEEECC---------------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHH
Confidence 468999999999999762 4578999999765321110 1223
Q ss_pred HHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhh-ccCceeeecc
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYC-HANNVVHRDI 364 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~L-Hs~gIiHrDL 364 (635)
..|+.+|.+|.+++|.....+.. . ..+|||||+.+++|...+.....+++..+..++.||+.+|.+| |+.||+||||
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl 144 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADL 144 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 45999999998877644333322 2 2389999999877766555557899999999999999999999 7999999999
Q ss_pred cCcceeecCCCCeeeeccccccccc
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
||+|||++ ++.++|+|||+|....
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccCC
Confidence 99999998 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-22 Score=197.60 Aligned_cols=175 Identities=15% Similarity=0.166 Sum_probs=135.7
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHH------HHHHHHHHh
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRK------LFREVDIMS 293 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~------~~~Ei~iL~ 293 (635)
+++..+|.+++.||.|+||.||+... ++..+|||++....... ..... +.+|+..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~----------------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~ 90 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT----------------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD 90 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec----------------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH
Confidence 46778999999999999999998543 23469999997654432 22233 578999999
Q ss_pred hCCCCceeeEEEEEecC--------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 294 HLDHPHIIKLFQVMETT--------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 294 ~L~HpnIv~l~~~~~~~--------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
+|.|++|..+.+++... ...+|||||++|.+|.++. .+++ ..+.+|+.+|..||..||+|+|||
T Consensus 91 rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dik 162 (232)
T PRK10359 91 RVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPH 162 (232)
T ss_pred HHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 99999999998886533 3588999999999997763 2333 346699999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHH
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLl 432 (635)
|+|||++.++ ++|+|||.+........... ++....|. .++|+||||+++..+.
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhhHHH-----------HHHHhHhc-ccccccceeEeehHHH
Confidence 9999999988 99999998876543222211 33445565 7899999999887654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=220.95 Aligned_cols=216 Identities=28% Similarity=0.501 Sum_probs=169.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..+..|+.+..|+||-||.+.++.. .+.+|+| +++..+ +.+- ||.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~t--------------rqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv--- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKET--------------RQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV--- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeecccc--------------ccchhhc-ccccch-------hhhc--cccccCCccee---
Confidence 4566689999999999998877433 3578885 444321 1111 33333455544
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
|+-...++..+.++.+. +.+++|||+.||+|||+||+|+||+.-|++|+.|||+
T Consensus 136 ------------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 ------------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred ------------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhh
Confidence 33344555556666544 7899999999999999999999999999999999999
Q ss_pred cccccC--------C--------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 385 SNYFTP--------G--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 385 a~~~~~--------~--------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
+..... + -.-...|||+.|.||||+....|- ..+|+|+||+|+||.+-|+.||.+.+.++++.
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 865321 1 112346899999999999988885 99999999999999999999999999999999
Q ss_pred HHHhCccCCCC---CCCHHHHHHHHHhcccCCCCCC---CHHHHHcCccccc
Q psy6357 449 RILFGKFRIPF---YMSAECENLIRSMLVLDPAKRL---TLTQISNHKWMSV 494 (635)
Q Consensus 449 ~i~~~~~~~p~---~~s~~l~~LI~~~L~~dP~~Rp---s~~eiL~Hpw~~~ 494 (635)
.+.......|+ .++.+++++|.++|..+|..|. .+-+|.+|+||..
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 98887776665 4789999999999999999995 5788899999974
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=223.69 Aligned_cols=236 Identities=24% Similarity=0.306 Sum_probs=184.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc--cCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR--LDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+...+.||.+.|-.|.++.+ .+| .|+||++-+.. ++-....+.+.|++ ...+++||++.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~---------------~eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD---------------REG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPF 86 (1431)
T ss_pred ceeeecccCchhhhhhhhccC---------------CCc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccch
Confidence 445578899999999998866 233 49999997654 34445556666777 666799999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
..+.+.+...|||-+|+ .-+|+|.|..+.-+..-+.+.|+.||+.||.-+|..||+|+|||.+||||+.-.-+.|+||.
T Consensus 87 qk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccc
Confidence 98888888899999999 57899999887778999999999999999999999999999999999999999899999998
Q ss_pred ccccc--cCCC------ccccccCCCCCCCccccCCC----------CcCCCccchhhHHHHHHHHHh-CCCCCCCC---
Q psy6357 384 FSNYF--TPGH------MLTTWCGSPPYAAPELFGGR----------EYDGTKSDVWSLGVVLYVMVT-AQLPFDGP--- 441 (635)
Q Consensus 384 la~~~--~~~~------~~~~~~gt~~Y~APEvl~~~----------~~~~~ksDIwSlGvilyeLlt-G~~PF~~~--- 441 (635)
..+.. .+++ ...+......|.|||-+... ..-+.+.||||+||+++||++ |.++|.-.
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~ 245 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL 245 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH
Confidence 76432 1111 12222334569999977431 112478999999999999998 89999531
Q ss_pred --------CHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 --------NLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 --------~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+.+.+.++| -+..++.||..|++.||.+|.+|++.|+.
T Consensus 246 aYr~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 122222222 24578999999999999999999999985
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=193.45 Aligned_cols=240 Identities=20% Similarity=0.356 Sum_probs=196.0
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
...++-||.+.-.|..|+|.|. +..+++|+++........-..|..|.-.|+-+.||||+.+++
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq----------------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlg 254 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ----------------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLG 254 (448)
T ss_pred hhhhhhhhccCCCccccccccc----------------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhh
Confidence 3445678999999999999983 346888888877666666677888999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeecCCCCeeee-
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFDENGDIKLA- 380 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~~~~~ikL~- 380 (635)
.|....++.+|..||+-|+|+..|..... +...++.+++.+|+.|++|||+.. |.---|....++|+++.+.+|.
T Consensus 255 acnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 255 ACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred hccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec
Confidence 99999999999999999999999976543 677889999999999999999874 4445688889999998776653
Q ss_pred -cccccccccCCCccccccCCCCCCCccccCCCCcC--CCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--c
Q psy6357 381 -DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYD--GTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--F 455 (635)
Q Consensus 381 -DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~--~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--~ 455 (635)
|--++. ......-.|.||+||.+...+-+ -.++|+|||+++||||.|...||......+.-.+|.... .
T Consensus 335 ad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv 408 (448)
T KOG0195|consen 335 ADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV 408 (448)
T ss_pred ccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence 322221 11223446889999999876544 257999999999999999999999888777776766554 4
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
.+|..++..+..||.-|+..||.+||.++.|+
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 67889999999999999999999999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=185.72 Aligned_cols=143 Identities=16% Similarity=0.167 Sum_probs=112.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH------------------------HHHHHH
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE------------------------RNLRKL 285 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~------------------------~~~~~~ 285 (635)
.+.||+|+||.||+|.+. ++..||||++....... .....+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~---------------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 66 (190)
T cd05145 2 NGCISTGKEANVYHARTG---------------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWA 66 (190)
T ss_pred CceeecCCCcEEEEEEcC---------------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHH
Confidence 578999999999999762 46789999998653210 001234
Q ss_pred HHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-Cceeeecc
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDI 364 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDL 364 (635)
.+|+..+.++.|++|.....+... ..||||||+.|+++...+.....+++..+..++.|++.+|.+||+ .||+||||
T Consensus 67 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDl 144 (190)
T cd05145 67 EKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDL 144 (190)
T ss_pred HHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 579999999999987544443332 248999999887665443445678899999999999999999999 99999999
Q ss_pred cCcceeecCCCCeeeecccccccccC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
||+|||++ ++.++|+|||+|.....
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999998 88999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=183.00 Aligned_cols=188 Identities=16% Similarity=0.070 Sum_probs=139.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH--HHHHHHHHHHHHHhhCC-CCceeeE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE--RNLRKLFREVDIMSHLD-HPHIIKL 303 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~--~~~~~~~~Ei~iL~~L~-HpnIv~l 303 (635)
..+...|+.|+||+||.+.. .+.+++.+.+....... -....+.+|+++|++|. |++|+++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~----------------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~l 67 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG----------------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRL 67 (218)
T ss_pred cccceeecCCCcceEEEeec----------------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEE
Confidence 45678899999999995533 44678877776544321 12235779999999995 5889999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc-cCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI-KAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL-Kp~NILl~~~~~ikL~DF 382 (635)
+++ ...|++|||+.|.+|...+.. ....++.|++.+|.+||+.||+|||| ||+|||++.++.++|+||
T Consensus 68 l~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 68 LHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred EEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence 886 346999999999888654321 12457889999999999999999999 799999999999999999
Q ss_pred cccccccCCCcc--------------ccccCCCCCCCccccCCC-CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy6357 383 GFSNYFTPGHML--------------TTWCGSPPYAAPELFGGR-EYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441 (635)
Q Consensus 383 Gla~~~~~~~~~--------------~~~~gt~~Y~APEvl~~~-~~~~~ksDIwSlGvilyeLltG~~PF~~~ 441 (635)
|+|......... .....++.|++|+...-. ..+-.+.+.++.|+-+|.++|+..++.+.
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999865432210 112257788888754321 11115678889999999999998887543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=195.98 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=176.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHH---------------------HHHHhhcCceEEEEEeccccc---C
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAA---------------------AAQLIEELSKVAIKIIDKKRL---D 278 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~---------------------~~~~~~~~~~VAIKii~~~~~---~ 278 (635)
.++.|.+-..||+|+...||.+....+...-+.. ....-...-+.|||.+-.-.. +
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 3444555678999999999998776432211110 000001122567887643222 2
Q ss_pred HHHHHHHHHHHH------HH--------hh--------CCCCceeeEEEEEec---------------------------
Q psy6357 279 ERNLRKLFREVD------IM--------SH--------LDHPHIIKLFQVMET--------------------------- 309 (635)
Q Consensus 279 ~~~~~~~~~Ei~------iL--------~~--------L~HpnIv~l~~~~~~--------------------------- 309 (635)
...++..-+|+. .+ +. -.|||||+++.+|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 223333334331 11 11 269999999877632
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec--CCC--Ceeeeccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD--ENG--DIKLADFGFS 385 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~--~~~--~ikL~DFGla 385 (635)
...+|+||.-. ..+|..++.. ...+.....-|+.|+++|+.|||.+||.|||||.+||||. +++ .+.|+|||.+
T Consensus 315 ~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 23589999887 4688888765 4567778888999999999999999999999999999984 333 5899999987
Q ss_pred ccccC-------CCccccccCCCCCCCccccCCCC-----cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH--HH
Q psy6357 386 NYFTP-------GHMLTTWCGSPPYAAPELFGGRE-----YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR--IL 451 (635)
Q Consensus 386 ~~~~~-------~~~~~~~~gt~~Y~APEvl~~~~-----~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~--i~ 451 (635)
---.. ....-...|.-..||||+....+ .+-.++|.|+.|.+.||++....||.......+... -.
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 43221 01122345677899999986432 112689999999999999999999987443222111 11
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQ 485 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~e 485 (635)
.....+|..+++.+.+|+..+|+.||.+|++..-
T Consensus 473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 2345677889999999999999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-20 Score=190.75 Aligned_cols=229 Identities=24% Similarity=0.288 Sum_probs=147.8
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCC----------C
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDH----------P 298 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~H----------p 298 (635)
.+.||.|+++.||.+.+ .++++.+|||++..... ....++.+.+|.-....+.+ -
T Consensus 17 ~~~i~~g~~~~v~~v~d--------------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~ 82 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTD--------------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHL 82 (288)
T ss_dssp EEEEEEETTEEEEEEEE--------------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH
T ss_pred ccccccCCceEEEEEEE--------------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhc
Confidence 56799999999999988 35678999999876553 23456777777655555432 1
Q ss_pred ceeeEEEEEe---------c---CC-----eEEEEEeccccchhhhhhhh---ccc----CCHHHHHHHHHHHHHhhhhh
Q psy6357 299 HIIKLFQVME---------T---TN-----NLYLVTEYARGGEIFSHLLT---IGQ----MAEKEASRLFRQILSAVAYC 354 (635)
Q Consensus 299 nIv~l~~~~~---------~---~~-----~~~LV~E~~~ggsL~~~l~~---~~~----l~e~~~~~i~~qIl~gL~~L 354 (635)
.++..++... . .. ..+++|+-+ .++|.+++.. ... +.......+..|++..+++|
T Consensus 83 r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 83 RFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp -B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence 2333333321 1 11 246788877 4677666532 222 23334456679999999999
Q ss_pred ccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCC--------CcCCCccchhhHHH
Q psy6357 355 HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR--------EYDGTKSDVWSLGV 426 (635)
Q Consensus 355 Hs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~--------~~~~~ksDIwSlGv 426 (635)
|..||+|+||+|+|+|++.+|.++|+||+....... .......+..|.+||+.... .+ +.+.|.|+||+
T Consensus 162 h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~ 238 (288)
T PF14531_consen 162 HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGI 238 (288)
T ss_dssp HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHH
T ss_pred hhcceEecccceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHH
Confidence 999999999999999999999999999988765433 22224456789999976332 33 48899999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCC
Q psy6357 427 VLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKR 480 (635)
Q Consensus 427 ilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~R 480 (635)
++|.|+|+.+||........... .+..-..+++.++.||..||+.+|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999986543322211 122112688999999999999999987
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-20 Score=211.34 Aligned_cols=257 Identities=31% Similarity=0.487 Sum_probs=209.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l 303 (635)
..|.+++.||+|+|+.|-...... .....+|+|.+............+..|..+-+.+. |.|++.+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~-------------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~ 86 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSR-------------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHM 86 (601)
T ss_pred ccccccccccccccchhhhhhhcC-------------CCcceeeccCCCCCCCccchhhhcCcccccccccccccccccc
Confidence 345667789999999987554322 23346788877666544455566667888888887 9999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhh-hhcc-cCCHHHHHHHHHHHHHhhhhhc-cCceeeecccCcceeecCCC-Ceee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHL-LTIG-QMAEKEASRLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENG-DIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l-~~~~-~l~e~~~~~i~~qIl~gL~~LH-s~gIiHrDLKp~NILl~~~~-~ikL 379 (635)
++...+....+++++|..|+++++.+ .... .++...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++
T Consensus 87 ~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 87 IEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred CCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccC
Confidence 99999999999999999999999988 5444 6888899999999999999999 99999999999999999999 9999
Q ss_pred ecccccccccC-C---CccccccC-CCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh
Q psy6357 380 ADFGFSNYFTP-G---HMLTTWCG-SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK--QRILF 452 (635)
Q Consensus 380 ~DFGla~~~~~-~---~~~~~~~g-t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~--~~i~~ 452 (635)
+|||+|..+.. . ......+| ++.|+|||...+..+.+...|+||+|+++..|++|..||......... ..+..
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~ 246 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN 246 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence 99999987654 2 33455678 999999999999888889999999999999999999999765433221 11111
Q ss_pred C---ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 453 G---KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 453 ~---~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. .......++..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 12223357889999999999999999999999999999976
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=195.29 Aligned_cols=204 Identities=22% Similarity=0.380 Sum_probs=154.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEEE-------EEe-----cCCeEEEEEeccccchhhhhhhhcc---cCCHHHHHHHHHH
Q psy6357 282 LRKLFREVDIMSHLDHPHIIKLFQ-------VME-----TTNNLYLVTEYARGGEIFSHLLTIG---QMAEKEASRLFRQ 346 (635)
Q Consensus 282 ~~~~~~Ei~iL~~L~HpnIv~l~~-------~~~-----~~~~~~LV~E~~~ggsL~~~l~~~~---~l~e~~~~~i~~q 346 (635)
.....+++..+....|-+..-+.+ .+. ...++||.|++|...+|.++|.... ..+....+.++.|
T Consensus 288 ~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q 367 (516)
T KOG1033|consen 288 CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQ 367 (516)
T ss_pred hhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHh
Confidence 355667777777666555444433 111 1335899999999999999997543 3677889999999
Q ss_pred HHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCC-------ccccccCCCCCCCccccCCCCcCCCcc
Q psy6357 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH-------MLTTWCGSPPYAAPELFGGREYDGTKS 419 (635)
Q Consensus 347 Il~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~-------~~~~~~gt~~Y~APEvl~~~~~~~~ks 419 (635)
++.|++| ++.+|+|+||.||++..+..+||.|||+........ ..+..+||.+||+||.+.+..|. .++
T Consensus 368 ~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kv 443 (516)
T KOG1033|consen 368 IAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKV 443 (516)
T ss_pred hccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhc
Confidence 9999999 999999999999999999999999999987765444 56678899999999999999997 999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCccCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 420 DVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKFRIPF-YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 420 DIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~~~~p~-~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
||||||+||+||+. =...|.. ......+..+.++... .--++-.+|+.+||...|.+||++.+..-|.|+
T Consensus 444 dIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 444 DIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred chhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 99999999999997 2222221 1122223333332111 112345689999999999999988888888875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=172.64 Aligned_cols=134 Identities=19% Similarity=0.268 Sum_probs=104.7
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-----CCCceeeEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-----DHPHIIKLF 304 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~ 304 (635)
...||+|+|+.||. .. .+..+ +||++..... ...+.+.+|+.+|+.| .||||++++
T Consensus 7 ~~~LG~G~~~~Vy~--hp--------------~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~y 67 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP--------------EDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYY 67 (210)
T ss_pred cceecCCCceEEEE--CC--------------CCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceee
Confidence 46799999999994 21 12234 6998866432 2336789999999999 579999999
Q ss_pred EEEecCC---eEE-EEEec--cccchhhhhhhhcccCCHHHHHHHHHHHHHhh-hhhccCceeeecccCcceeecCC---
Q psy6357 305 QVMETTN---NLY-LVTEY--ARGGEIFSHLLTIGQMAEKEASRLFRQILSAV-AYCHANNVVHRDIKAENLLFDEN--- 374 (635)
Q Consensus 305 ~~~~~~~---~~~-LV~E~--~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL-~~LHs~gIiHrDLKp~NILl~~~--- 374 (635)
++++++. .++ +|||| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++|+||||||+|||++..
T Consensus 68 g~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 68 GTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISES 144 (210)
T ss_pred EEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCC
Confidence 9998873 434 88999 557999999966 456666 36688888887 99999999999999999999743
Q ss_pred -CCeeeeccccc
Q psy6357 375 -GDIKLADFGFS 385 (635)
Q Consensus 375 -~~ikL~DFGla 385 (635)
..++|+||+.+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 37999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=168.91 Aligned_cols=137 Identities=24% Similarity=0.339 Sum_probs=114.1
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH------HHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE------RNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++.||+|++|.||+|.+ .+..|+||+........ .....+.+|+.++..+.|++|+..
T Consensus 1 ~~~l~~G~~~~vy~~~~----------------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 64 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF----------------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP 64 (211)
T ss_pred CcccccCceEEEEEEee----------------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC
Confidence 36799999999999976 34579999876433211 123467789999999999998877
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
..++......++||||++|++|.+++..... ....++.+|+.+|.+||+.+++|+||+|.|||++ ++.++|+|||
T Consensus 65 ~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 65 AVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred eEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 7777777788999999999999988865322 7889999999999999999999999999999999 7899999999
Q ss_pred cccc
Q psy6357 384 FSNY 387 (635)
Q Consensus 384 la~~ 387 (635)
++..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 9865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=175.22 Aligned_cols=145 Identities=18% Similarity=0.140 Sum_probs=113.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----------------------HHHHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----------------------RNLRK 284 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----------------------~~~~~ 284 (635)
|.+.+.||.|+||.||+|.+. ..++..||||++....... .....
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~-------------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDF-------------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred HHhCCeeccCcceeEEEEEec-------------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 667899999999999999731 1356789999997543210 01124
Q ss_pred HHHHHHHHhhCCCC--ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc-eee
Q psy6357 285 LFREVDIMSHLDHP--HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN-VVH 361 (635)
Q Consensus 285 ~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g-IiH 361 (635)
+.+|+.++.++.+. .+.+++++ ...+|||||+.+.+|...+.....+....+..++.||+.+|.+||..| |+|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH 172 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVH 172 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence 56899999999753 34455543 235899999999888776655556777778899999999999999999 999
Q ss_pred ecccCcceeecCCCCeeeeccccccccc
Q psy6357 362 RDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
+||||+|||++ ++.++|+|||+|....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 8899999999987543
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=201.20 Aligned_cols=192 Identities=23% Similarity=0.253 Sum_probs=156.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC---CCce
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPHI 300 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~---HpnI 300 (635)
...|.|-+.||.|+||+||.|... ++..||||+-......+-. -=.+++.+|+ -+.|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~---------------~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~ 756 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS---------------NGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSI 756 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC---------------CCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcch
Confidence 456777788999999999999763 3578999998766543321 1223444454 2334
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-------
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE------- 373 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~------- 373 (635)
..+...+.-.+..+||+||.+.|+|.+++...+.+++..+..|..||+..|++||..+|||+||||+|+||..
T Consensus 757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 757 MHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 4455555556677899999999999999998888999999999999999999999999999999999999953
Q ss_pred CCCeeeecccccccc---cCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCC
Q psy6357 374 NGDIKLADFGFSNYF---TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436 (635)
Q Consensus 374 ~~~ikL~DFGla~~~---~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~ 436 (635)
.--++|+|||.+..+ .++......++|-.+-.+|+..+.+|+ +.+|.|.|+.+++.||.|+.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 335999999998654 344567778889999999999999997 99999999999999999964
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=162.74 Aligned_cols=132 Identities=20% Similarity=0.264 Sum_probs=106.1
Q ss_pred ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC------HHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 233 AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD------ERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 233 LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
||+|+||.||++.+ .+..|+||+....... .....++.+|++++..+.|++|....-+
T Consensus 2 ig~G~~~~vy~~~~----------------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 65 (199)
T TIGR03724 2 IAKGAEAIIYLGDF----------------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVY 65 (199)
T ss_pred CCCCceEEEEEeec----------------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Confidence 79999999999975 3457999986543321 1123567789999999998876554444
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+......++||||++|++|.+++..... .++.+|+.+|.+||+.|++|+||+|.|||++ ++.++|+|||++.
T Consensus 66 ~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 66 DVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred EEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 5556677999999999999887754321 8899999999999999999999999999999 8899999999986
Q ss_pred cc
Q psy6357 387 YF 388 (635)
Q Consensus 387 ~~ 388 (635)
..
T Consensus 138 ~~ 139 (199)
T TIGR03724 138 YS 139 (199)
T ss_pred CC
Confidence 53
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=181.02 Aligned_cols=138 Identities=20% Similarity=0.254 Sum_probs=110.5
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC------HHHHHHHHHHHHHHhhCCCCc
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD------ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~------~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.|...+.||+|+||+||++.+.. ..+++|+....... ......+.+|+.+|..++|++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~----------------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 397 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLG----------------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG 397 (535)
T ss_pred ccCccceeccCCcEEEEEEeecC----------------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC
Confidence 34557889999999999987632 23444443221111 122356789999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+..+.++......++||||+++++|.+++. ....++.+|+.+|.+||+.+|+||||||+|||+ .++.++|
T Consensus 398 i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 398 VPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred CCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEE
Confidence 9888777777778899999999999988775 357899999999999999999999999999999 6789999
Q ss_pred ecccccccc
Q psy6357 380 ADFGFSNYF 388 (635)
Q Consensus 380 ~DFGla~~~ 388 (635)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.3e-17 Score=161.63 Aligned_cols=139 Identities=17% Similarity=0.216 Sum_probs=108.3
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH--------------------HHHHHHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE--------------------RNLRKLF 286 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~--------------------~~~~~~~ 286 (635)
|.+.+.||.|+||.||++.. .+++.||||++....... .....+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~---------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD---------------PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQ 81 (198)
T ss_pred hhcCCccccCcceEEEEEEc---------------CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHH
Confidence 66678999999999999875 246789999986543110 0112366
Q ss_pred HHHHHHhhCCCC--ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 287 REVDIMSHLDHP--HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 287 ~Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
+|+.++..+.|. .++.+++. ...++||||++|++|...... .....++.+|+.++.+||+.||+|+||
T Consensus 82 ~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl 151 (198)
T cd05144 82 KEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDL 151 (198)
T ss_pred HHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 899999999877 44555542 345899999999988765431 346788999999999999999999999
Q ss_pred cCcceeecCCCCeeeecccccccccC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
||+||||+.++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-17 Score=177.43 Aligned_cols=197 Identities=24% Similarity=0.323 Sum_probs=157.3
Q ss_pred HhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCce-eeecccCcce
Q psy6357 292 MSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNV-VHRDIKAENL 369 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gI-iHrDLKp~NI 369 (635)
|+.+.|.|+.++++.+.+...+++|.+||..|+|.+.+.. .-.++.-....++++|+.||.|||.-.| +|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 3468888899999999999999998765 9999999999
Q ss_pred eecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCc------CCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 370 LFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREY------DGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~------~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
+++....+||+|||+....... .......-...|.|||++..... -+.+.||||||+|++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998776420 11111123446999999976422 13679999999999999999999976
Q ss_pred CC----HHHHHHHHHhCcc--CCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 441 PN----LAVLKQRILFGKF--RIPF-----YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 441 ~~----~~~l~~~i~~~~~--~~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.. ..++...+..+.. ..|. ...+++..++..||..+|.+||++++|-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555554211 1221 24557999999999999999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.3e-16 Score=151.51 Aligned_cols=139 Identities=21% Similarity=0.272 Sum_probs=99.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHH----------------------HHH
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRK----------------------LFR 287 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~----------------------~~~ 287 (635)
.+.||+|+||.||++... ++..||||++............ ...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~---------------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 66 (187)
T cd05119 2 GGPIGTGKEADVYLALDG---------------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEK 66 (187)
T ss_pred CcccccccceeEEEEECC---------------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHH
Confidence 467999999999998762 3568999998764332211111 135
Q ss_pred HHHHHhhCCCC--ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-Cceeeecc
Q psy6357 288 EVDIMSHLDHP--HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDI 364 (635)
Q Consensus 288 Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDL 364 (635)
|...+.++.+. .+.+++.+ ...++||||+.++.+........... ..+..++.+++.++.+||. .+|+|+||
T Consensus 67 e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl 141 (187)
T cd05119 67 EFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDL 141 (187)
T ss_pred HHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCC
Confidence 66666666443 34555543 23589999999854432111111111 6788999999999999999 99999999
Q ss_pred cCcceeecCCCCeeeeccccccccc
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
||+|||++ ++.++|+|||++....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ChhhEEEE-CCcEEEEECccccccc
Confidence 99999999 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=153.52 Aligned_cols=137 Identities=18% Similarity=0.255 Sum_probs=103.5
Q ss_pred eecc-ccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-----------CHHHHHHHHHHHHHHhhCCCC
Q psy6357 231 RKAG-EGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-----------DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 231 ~kLG-~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-----------~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
..|| .|+.|+||.+.. .+..++||.+..... +.....++.+|+.++.+|.|+
T Consensus 37 ~~lg~~~g~gtv~~v~~----------------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~ 100 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT----------------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEA 100 (239)
T ss_pred ceeecCCCCccEEEEEe----------------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhC
Confidence 3566 788888887755 245799998854221 112335678999999999987
Q ss_pred ce--eeEEEEEecC-Ce---EEEEEecccc-chhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 299 HI--IKLFQVMETT-NN---LYLVTEYARG-GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 299 nI--v~l~~~~~~~-~~---~~LV~E~~~g-gsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
+| +.++++.... .. .+||||+++| .+|.+++.. ..+++. .+.+|+.+|.+||+.||+|+||||.|||+
T Consensus 101 gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 101 GLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred CCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 75 6777765332 22 3599999997 588777654 455554 35789999999999999999999999999
Q ss_pred cCCCCeeeecccccccc
Q psy6357 372 DENGDIKLADFGFSNYF 388 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~ 388 (635)
+.++.++|+|||.+...
T Consensus 176 ~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 176 DPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCCCCEEEEECCCcccC
Confidence 99999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=137.40 Aligned_cols=133 Identities=20% Similarity=0.230 Sum_probs=112.3
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC--CceeeEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH--PHIIKLFQV 306 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~ 306 (635)
+++.||.|.++.||++... +..++||++..... ...+.+|+.++..+.| .++++++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~----------------~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~ 61 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK----------------DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLAS 61 (155)
T ss_pred cceecccccccceEEEEec----------------CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence 4678999999999998762 24799999865532 3567899999999976 589999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC---ceeeecccCcceeecCCCCeeeeccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN---NVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~---gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+...+..+++|||+.+..+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||
T Consensus 62 ~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~ 134 (155)
T cd05120 62 GESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134 (155)
T ss_pred cCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence 8888889999999988877654 5566778899999999999985 79999999999999998999999999
Q ss_pred ccccc
Q psy6357 384 FSNYF 388 (635)
Q Consensus 384 la~~~ 388 (635)
++...
T Consensus 135 ~~~~~ 139 (155)
T cd05120 135 YAGYG 139 (155)
T ss_pred cccCC
Confidence 98643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-15 Score=162.62 Aligned_cols=251 Identities=24% Similarity=0.240 Sum_probs=191.7
Q ss_pred Cccceeeccc--cCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 226 PQYNLRKAGE--GEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 226 ~y~il~kLG~--G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
.+.+...+|. |.+|.||.+.... .++...+|+|.-+........-..=.+|+...++++ |++.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~------------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTN------------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred hcccccccccCCCCCceeecccCCc------------ccCCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence 4455678999 9999999776522 246678999985443322222233456777777774 999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhccc-CCHHHHHHHHHHHHH----hhhhhccCceeeecccCcceeecCC-CC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ-MAEKEASRLFRQILS----AVAYCHANNVVHRDIKAENLLFDEN-GD 376 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-l~e~~~~~i~~qIl~----gL~~LHs~gIiHrDLKp~NILl~~~-~~ 376 (635)
.+..++..+..|+-+|+| +.+|..+...... +++..++.++.++.. ||.++|+.+++|-|+||.||++..+ ..
T Consensus 183 ~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce
Confidence 999999999999999999 5778777766554 899999999999999 9999999999999999999999999 89
Q ss_pred eeeecccccccccCCCcc------ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---CHHHHH
Q psy6357 377 IKLADFGFSNYFTPGHML------TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---NLAVLK 447 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~------~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---~~~~l~ 447 (635)
.+++|||+...+...... ....+...|++||++.+.. +...|||+||.++.+..++..++... ....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 999999999887665422 1224667899999997754 47899999999999998877665332 111111
Q ss_pred HHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 448 QRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 448 ~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+.. ...++-...+.++...+..|++.+|-.|+++..+++|+++.
T Consensus 340 ~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 340 QGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred ccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 111 01112223566777799999999999999999999999986
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-14 Score=167.08 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=196.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+.+++.+-.|.++.++.+.-. ..+...++|+..+... .....+.+..+-.++-...+|-++..
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa--------------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~ 869 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPA--------------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRS 869 (1205)
T ss_pred ccceecccccCCCCcccccCCcc--------------ccccccchhhhccchhhccccccccCCccCccccCCCCceecc
Confidence 33445566667777777744321 1122233343322111 11112333444445444556777776
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
...+......+|||+|+.+++|...|...+..+++.+..++..+..++++||+..+.|+|++|.|+|+..+++.++.|||
T Consensus 870 ~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 870 FPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred cCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccc
Confidence 66667778899999999999999999988889999999999999999999999999999999999999999999999998
Q ss_pred cccccc------C------------------------C--CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHH
Q psy6357 384 FSNYFT------P------------------------G--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431 (635)
Q Consensus 384 la~~~~------~------------------------~--~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeL 431 (635)
...... . + .......+|+.|.+||.+.+.... ..+|+|++|+++++.
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEV 1028 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-Ccchhhhhhhhhhhh
Confidence 432210 0 0 112345689999999999988775 899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCccCCC---CCCCHHHHHHHHHhcccCCCCCCCHH---HHHcCcccccC
Q psy6357 432 VTAQLPFDGPNLAVLKQRILFGKFRIP---FYMSAECENLIRSMLVLDPAKRLTLT---QISNHKWMSVH 495 (635)
Q Consensus 432 ltG~~PF~~~~~~~l~~~i~~~~~~~p---~~~s~~l~~LI~~~L~~dP~~Rps~~---eiL~Hpw~~~~ 495 (635)
++|.+||.....+.+++.|.....+.| ...+.++++++..+|..+|.+|..+. ++-.|+||+..
T Consensus 1029 l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999999999999999999988876655 45889999999999999999999987 89999999754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-13 Score=150.56 Aligned_cols=143 Identities=15% Similarity=0.169 Sum_probs=97.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH--HH--------------------------
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE--RN-------------------------- 281 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~--~~-------------------------- 281 (635)
-+.||.|++|.||+|.. .+|+.||||+........ .+
T Consensus 122 ~~plasaSigQVh~A~l---------------~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~ 186 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL---------------VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEV 186 (437)
T ss_pred CcceeeeehhheEEEEe---------------cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHH
Confidence 36799999999999986 356799999986532110 00
Q ss_pred ----HH------HHHHHHHHHhhC----C-CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHH
Q psy6357 282 ----LR------KLFREVDIMSHL----D-HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFR 345 (635)
Q Consensus 282 ----~~------~~~~Ei~iL~~L----~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~ 345 (635)
.. .+.+|+..+.++ . +++|.-..-+.+.....+|||||++|.+|.+++... ..+ ....++.
T Consensus 187 ~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~ 263 (437)
T TIGR01982 187 VKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAE 263 (437)
T ss_pred HHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHH
Confidence 00 233455555554 2 343322222223345579999999999998876432 112 2344555
Q ss_pred HHHH-hhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 346 QILS-AVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 346 qIl~-gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
.++. .+..+|..|++|+|+||.||+++.++.++|+|||++..+..
T Consensus 264 ~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 264 NLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6655 46788999999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-13 Score=154.32 Aligned_cols=145 Identities=16% Similarity=0.216 Sum_probs=96.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--------------------------
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-------------------------- 277 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-------------------------- 277 (635)
+..|.. +.||.|++|.||.|... .+|+.||||++.....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~--------------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~ 183 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLK--------------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRR 183 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEEC--------------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCccccc
Confidence 334444 78999999999999873 2367999999975421
Q ss_pred -C-----HHHHHHHHH------HHHHHhhC----CCCceeeEEEEE-ecCCeEEEEEeccccchhhhh--hhhcc----c
Q psy6357 278 -D-----ERNLRKLFR------EVDIMSHL----DHPHIIKLFQVM-ETTNNLYLVTEYARGGEIFSH--LLTIG----Q 334 (635)
Q Consensus 278 -~-----~~~~~~~~~------Ei~iL~~L----~HpnIv~l~~~~-~~~~~~~LV~E~~~ggsL~~~--l~~~~----~ 334 (635)
+ .+..+.+.+ |+..+.++ .+...+.+-.++ +.....+|||||++|+.|.++ +...+ .
T Consensus 184 l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~ 263 (537)
T PRK04750 184 LKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL 263 (537)
T ss_pred CCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH
Confidence 0 011122333 33333333 233333333333 224567899999999999764 33322 3
Q ss_pred CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC----CeeeecccccccccC
Q psy6357 335 MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG----DIKLADFGFSNYFTP 390 (635)
Q Consensus 335 l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~----~ikL~DFGla~~~~~ 390 (635)
+.+..+..++.||+ ..|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 264 la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 264 LAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 55556666666665 48999999999999999988 999999999987754
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-13 Score=148.99 Aligned_cols=253 Identities=20% Similarity=0.126 Sum_probs=189.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
....+..|.+||.|.|+.|+...+. ..++..|++|-+.........-..-+.|+-+...| .|.+++
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r-------------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR-------------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec-------------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 4567778999999999999976642 13456799998876655433333445677777766 499999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-CCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-GDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-~~ikL~ 380 (635)
.++..|......||-.|||+++++...+.....+.+...+++..|++.++.++|+..++|.|+||+||++..+ +..++.
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcc
Confidence 9999999999999999999999887766555568899999999999999999999999999999999999886 788999
Q ss_pred cccccccccCCCccccccCCCCCC-CccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYA-APELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~-APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|||....+.- ........-+++ ..|++........+.|++|||..+++.+++...-... .....|..+..+...
T Consensus 410 ~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~~p~~~ 484 (524)
T KOG0601|consen 410 DFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGDTPNLP 484 (524)
T ss_pred ccccccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccc---ccceeeecccccCCC
Confidence 9999864221 111222333445 2555444333348999999999999999986432221 122334445555555
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
....++..+.+.|+..++..|+.+.++..|.-|.
T Consensus 485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 5568899999999999999999999998887553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=125.73 Aligned_cols=148 Identities=16% Similarity=0.165 Sum_probs=103.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-----------C---------HHHHHHHH---
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-----------D---------ERNLRKLF--- 286 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-----------~---------~~~~~~~~--- 286 (635)
...||.|.-+.||.|....... ....+..+|||+.+.... + ......+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~--------~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa 73 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET--------EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWA 73 (197)
T ss_pred CCccccCcceEEEEEecCcccc--------cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHH
Confidence 3578999999999987521100 001346899999854211 0 00112223
Q ss_pred -HHHHHHhhCCC--CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhh-ccCceeee
Q psy6357 287 -REVDIMSHLDH--PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYC-HANNVVHR 362 (635)
Q Consensus 287 -~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~L-Hs~gIiHr 362 (635)
+|+..|++|.. -++.+++++ ...+|||||+.+..+.....+...+++..+..++.+++.+|..| |..||||+
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG 149 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHA 149 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 79999999853 566777765 45689999997654432222333466677788899999999998 89999999
Q ss_pred cccCcceeecCCCCeeeecccccccccC
Q psy6357 363 DIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 363 DLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
||++.|||+. ++.++|+|||.+.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 57899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=137.97 Aligned_cols=163 Identities=21% Similarity=0.334 Sum_probs=128.1
Q ss_pred hcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHH
Q psy6357 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEAS 341 (635)
Q Consensus 262 ~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~ 341 (635)
.++.+|.|.+++...- .....+.+-++-|+.|+||||+++++.++.++.+|||+|-+ ..|..++.+ +....+.
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~---l~~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE---LGKEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH---hHHHHHH
Confidence 3567899998876643 44456778889999999999999999999999999999998 355566665 3477788
Q ss_pred HHHHHHHHhhhhhc-cCceeeecccCcceeecCCCCeeeecccccccccCCCc-cccccCCCCCCCccccCCCCcCCCcc
Q psy6357 342 RLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKS 419 (635)
Q Consensus 342 ~i~~qIl~gL~~LH-s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~ks 419 (635)
..+.||+.||.||| .++++|++|.-+.|+|+..|..||++|-++........ .....--..|..|+.+....+ ..
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~---s~ 184 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW---SI 184 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc---ch
Confidence 88999999999997 67899999999999999999999999998865432221 111111123667776654443 47
Q ss_pred chhhHHHHHHHHHhC
Q psy6357 420 DVWSLGVVLYVMVTA 434 (635)
Q Consensus 420 DIwSlGvilyeLltG 434 (635)
|.|-|||++++++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=3e-12 Score=122.03 Aligned_cols=128 Identities=18% Similarity=0.252 Sum_probs=96.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~ 308 (635)
++.|+.|.++.||.+.. .+..|+||+...... ....+..|+.+++.+.+.++ .+++.+..
T Consensus 3 ~~~l~~G~~~~vy~~~~----------------~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~ 63 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV----------------ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP 63 (170)
T ss_pred eeecCCcccCceEEEEE----------------CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC
Confidence 67899999999998875 245799999765421 11245689999998865544 45555543
Q ss_pred cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCce-----eeecccCcceeecCCCCeeeeccc
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNV-----VHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gI-----iHrDLKp~NILl~~~~~ikL~DFG 383 (635)
...++||||++|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+||+
T Consensus 64 --~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~ 132 (170)
T cd05151 64 --ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE 132 (170)
T ss_pred --CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence 335799999999887643 11123467899999999999885 9999999999998 6789999999
Q ss_pred cccc
Q psy6357 384 FSNY 387 (635)
Q Consensus 384 la~~ 387 (635)
.+..
T Consensus 133 ~a~~ 136 (170)
T cd05151 133 YAGM 136 (170)
T ss_pred cccC
Confidence 8864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-12 Score=133.88 Aligned_cols=197 Identities=18% Similarity=0.280 Sum_probs=140.8
Q ss_pred HhhCCCCceeeEEEEEecC-----CeEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccCc--ee
Q psy6357 292 MSHLDHPHIIKLFQVMETT-----NNLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHANN--VV 360 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~g--Ii 360 (635)
|-++.|.|||+++.|+.+. ....++.|||..|+|..+|++.. .+......+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455799999999998654 35789999999999999997653 4889999999999999999999985 99
Q ss_pred eecccCcceeecCCCCeeeecccccccccCC------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC
Q psy6357 361 HRDIKAENLLFDENGDIKLADFGFSNYFTPG------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA 434 (635)
Q Consensus 361 HrDLKp~NILl~~~~~ikL~DFGla~~~~~~------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG 434 (635)
|+.+..+-|++..+|-|||.---... .... .......+-++|.|||.=.....+ .++|||+||+...+|..+
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMCALEMAIL 278 (458)
T ss_pred cCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccc-cchhhhhhhHHHHHHHHh
Confidence 99999999999999998875321111 1110 111223456789999976544443 789999999999999887
Q ss_pred CCCC-CCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 435 QLPF-DGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 435 ~~PF-~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..-- ...+..+....|...-+-+ -...-.++|.+||+-.|..||++.++|.||.+.
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred eeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 6542 2222111111111111111 111235789999999999999999999999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-10 Score=110.97 Aligned_cols=133 Identities=20% Similarity=0.265 Sum_probs=97.8
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-----CHH-HHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-----DER-NLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-----~~~-~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.+++|+-+.+|.+.+ -+..+.+|.=....+ +.. ...+..+|+.+|.++.--.|...+=
T Consensus 3 ~i~~GAEa~i~~~~~----------------~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v 66 (204)
T COG3642 3 LIKQGAEAIIYLTDF----------------LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIV 66 (204)
T ss_pred hhhCCcceeEEeeec----------------cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeE
Confidence 578899999998865 123466665433322 211 2356678999999987555544444
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++.+.....|+|||++|..|.+++... ...++..+=.-+.-||..||+|+||.++||++.... +.++||||+
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 445666778999999988888888764 256777777778889999999999999999997654 999999999
Q ss_pred ccc
Q psy6357 386 NYF 388 (635)
Q Consensus 386 ~~~ 388 (635)
...
T Consensus 139 ~~s 141 (204)
T COG3642 139 EFS 141 (204)
T ss_pred ccc
Confidence 743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-10 Score=112.90 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=105.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC--CceeeEEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH--PHIIKLFQVM 307 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~ 307 (635)
++.|+.|.++.||++... ++..++||+....... .....+.+|+.+++.+.+ ..+.+++.+.
T Consensus 3 ~~~l~~G~~n~~~~v~~~---------------~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~ 66 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG---------------GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALC 66 (223)
T ss_pred ceecCCCccceEEEEEec---------------CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEEC
Confidence 467899999999988652 2357999997654321 123567899999999975 3467778777
Q ss_pred ecC---CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc----------------------------
Q psy6357 308 ETT---NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA---------------------------- 356 (635)
Q Consensus 308 ~~~---~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs---------------------------- 356 (635)
... +..++||||++|.+|.+.+.. ..+++.....++.+++.+|..||+
T Consensus 67 ~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (223)
T cd05154 67 EDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQ 145 (223)
T ss_pred CCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHH
Confidence 654 367899999999888775532 356666777777777777777763
Q ss_pred ----------------------------CceeeecccCcceeecC--CCCeeeecccccccc
Q psy6357 357 ----------------------------NNVVHRDIKAENLLFDE--NGDIKLADFGFSNYF 388 (635)
Q Consensus 357 ----------------------------~gIiHrDLKp~NILl~~--~~~ikL~DFGla~~~ 388 (635)
..++|+|+++.|||++. ++.+.|+||+.+...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 146 YDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 567899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=103.87 Aligned_cols=100 Identities=22% Similarity=0.340 Sum_probs=68.6
Q ss_pred HHHHHHHHHHhhCCCC--ceeeEEEEEecCCeEEEEEeccc--cchhhhhhhhcccCCHHHHHHHHHHHHHhhhh-hccC
Q psy6357 283 RKLFREVDIMSHLDHP--HIIKLFQVMETTNNLYLVTEYAR--GGEIFSHLLTIGQMAEKEASRLFRQILSAVAY-CHAN 357 (635)
Q Consensus 283 ~~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~E~~~--ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~-LHs~ 357 (635)
....+|+..|.++..- ++.+++++. ..+|||||+. |..+.. |... .++......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhc
Confidence 4567899999999765 567777553 2379999998 555543 3321 22245567788888885555 5799
Q ss_pred ceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 358 NVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 358 gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
||+|+||.+.|||++.+ .+.|+|||.+....
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999999887 99999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.3e-09 Score=102.87 Aligned_cols=143 Identities=20% Similarity=0.279 Sum_probs=104.5
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-----C-HHHHHHHHHHHHHHhhCCCCceee
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-----D-ERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-----~-~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.+..+-+|+-+.|+.+.+ .|+...||.=....+ + .-...+..+|+.+|.++.--.|.-
T Consensus 11 ~l~likQGAEArv~~~~~----------------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~ 74 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF----------------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPA 74 (229)
T ss_pred cceeeeccceeeEeeecc----------------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 467788999999998877 455666665332222 2 223467789999999986555544
Q ss_pred EEEEEecCCeEEEEEecccc-chhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---C
Q psy6357 303 LFQVMETTNNLYLVTEYARG-GEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---D 376 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~g-gsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---~ 376 (635)
..-+|.+...-+|+|||++| .++.+++..... ........++.+|-+.|.-||..+|||+||..+||+|..++ .
T Consensus 75 P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 75 PRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred ceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCc
Confidence 44445566666899999987 467777765432 33333378899999999999999999999999999997665 3
Q ss_pred eeeeccccccc
Q psy6357 377 IKLADFGFSNY 387 (635)
Q Consensus 377 ikL~DFGla~~ 387 (635)
+.|+|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 58999999864
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.2e-09 Score=112.00 Aligned_cols=200 Identities=15% Similarity=0.189 Sum_probs=147.2
Q ss_pred cCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----cCCeEEEEEecccc-chhhhhhhhc-----
Q psy6357 263 ELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVME----TTNNLYLVTEYARG-GEIFSHLLTI----- 332 (635)
Q Consensus 263 ~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~----~~~~~~LV~E~~~g-gsL~~~l~~~----- 332 (635)
+|..|++|.+...... .......-+++++++.|.|||+|.++|. .+..++||++|.++ .+|.++....
T Consensus 300 DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~ 377 (655)
T KOG3741|consen 300 DGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTK 377 (655)
T ss_pred CCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccc
Confidence 4557999998433221 1123335578899999999999999986 34579999999975 4666554221
Q ss_pred ----------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCC
Q psy6357 333 ----------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPP 402 (635)
Q Consensus 333 ----------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~ 402 (635)
...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+|+|.-.|+...+..+..
T Consensus 378 ~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------- 448 (655)
T KOG3741|consen 378 RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------- 448 (655)
T ss_pred ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------
Confidence 2378899999999999999999999999999999999999998999988777665543320
Q ss_pred CCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCC
Q psy6357 403 YAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPNLAVL-KQRILFGKFRIPFYMSAECENLIRSMLVLDPAKR 480 (635)
Q Consensus 403 Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P-F~~~~~~~l-~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~R 480 (635)
|-+.. -.+-|.=.||.+++.|.+|..- +........ ...|. ..+|.++.++|.-+...++.+
T Consensus 449 ----~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~rn~v~yl~s~~~~~- 512 (655)
T KOG3741|consen 449 ----EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDLRNVVEYLESLNFRE- 512 (655)
T ss_pred ----cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHHHHHHHHHHhcCccc-
Confidence 11211 1467899999999999998644 222222222 23332 348999999999999999987
Q ss_pred CCHHHHHcC
Q psy6357 481 LTLTQISNH 489 (635)
Q Consensus 481 ps~~eiL~H 489 (635)
-++.+++.|
T Consensus 513 ksI~~llp~ 521 (655)
T KOG3741|consen 513 KSIQDLLPM 521 (655)
T ss_pred ccHHHHHHH
Confidence 788888876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.6e-09 Score=109.57 Aligned_cols=104 Identities=15% Similarity=0.144 Sum_probs=81.8
Q ss_pred HHHHHHHHHhhCCCCce--eeEEEEEec-----CCeEEEEEeccccc-hhhhhhhh--cccCCHHHHHHHHHHHHHhhhh
Q psy6357 284 KLFREVDIMSHLDHPHI--IKLFQVMET-----TNNLYLVTEYARGG-EIFSHLLT--IGQMAEKEASRLFRQILSAVAY 353 (635)
Q Consensus 284 ~~~~Ei~iL~~L~HpnI--v~l~~~~~~-----~~~~~LV~E~~~gg-sL~~~l~~--~~~l~e~~~~~i~~qIl~gL~~ 353 (635)
.+.+|+..+.+|..-+| +.++.+++. ....+||||++++. +|.+++.. ...........++.+|+..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 37789999888854333 445555543 23578999999875 78888754 2456677888999999999999
Q ss_pred hccCceeeecccCcceeecC-------CCCeeeeccccccc
Q psy6357 354 CHANNVVHRDIKAENLLFDE-------NGDIKLADFGFSNY 387 (635)
Q Consensus 354 LHs~gIiHrDLKp~NILl~~-------~~~ikL~DFGla~~ 387 (635)
||..||+|+||++.||||+. +..+.|+||+.+..
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999975 46899999998853
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-09 Score=122.21 Aligned_cols=151 Identities=25% Similarity=0.298 Sum_probs=113.7
Q ss_pred HHHHHhhhhhcc-CceeeecccCcceeecCCCCeeeecccccccccCCCc----------cccccCCCCCCCccccCCCC
Q psy6357 345 RQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHM----------LTTWCGSPPYAAPELFGGRE 413 (635)
Q Consensus 345 ~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~----------~~~~~gt~~Y~APEvl~~~~ 413 (635)
.+++.||.|+|. .++||+.|.|++|.++.++.+||+.|+++........ .....-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344589999995 6899999999999999999999999999876544211 11122345699999998865
Q ss_pred cCCCccchhhHHHHHHHHH-hCCCCCCCCCHHHHHHHHH----hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 414 YDGTKSDVWSLGVVLYVMV-TAQLPFDGPNLAVLKQRIL----FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 414 ~~~~ksDIwSlGvilyeLl-tG~~PF~~~~~~~l~~~i~----~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
. +.++|+|||||++|.+. .|+..|........+.... ...+.....++.++++-|.++|..++..||++.+++.
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 5 48999999999999999 4666665443222221111 1123344568899999999999999999999999999
Q ss_pred CcccccCC
Q psy6357 489 HKWMSVHC 496 (635)
Q Consensus 489 Hpw~~~~~ 496 (635)
-|||...+
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99997543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.6e-08 Score=104.71 Aligned_cols=235 Identities=19% Similarity=0.230 Sum_probs=154.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEEE--
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQV-- 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~-- 306 (635)
-+.||+|+-+.+|-.- +-...+-||+...-... -.+.+..|... .||-+-.-+.+
T Consensus 16 gr~LgqGgea~ly~l~-----------------e~~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPq 73 (637)
T COG4248 16 GRPLGQGGEADLYTLG-----------------EVRDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQ 73 (637)
T ss_pred CccccCCccceeeecc-----------------hhhchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccH
Confidence 3679999999999221 11234567776543211 11223334333 56643321111
Q ss_pred ----EecC-CeEEEEEeccccchhhhhhh-------hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 307 ----METT-NNLYLVTEYARGGEIFSHLL-------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 307 ----~~~~-~~~~LV~E~~~ggsL~~~l~-------~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
.-+. ..+.++|..+.+..-...+. ....+.+..++++.+.|+.+.+.||..|.+-+|+.++|+|+.++
T Consensus 74 a~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~ 153 (637)
T COG4248 74 ATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD 153 (637)
T ss_pred HHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC
Confidence 1122 23778899887753222221 12337889999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCH-----
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTA-QLPFDGPNL----- 443 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG-~~PF~~~~~----- 443 (635)
+.+.|.|=..-.....+......+|...|.+||... +..- +...|.|.||+++++||.| +.||.+...
T Consensus 154 ~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 154 SKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred ceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 999999865544444555666778999999999764 2233 3678999999999999985 999976321
Q ss_pred HHHHHHHHhCcc-----------CCCC-----CCCHHHHHHHHHhccc--CCCCCCCHHHHH
Q psy6357 444 AVLKQRILFGKF-----------RIPF-----YMSAECENLIRSMLVL--DPAKRLTLTQIS 487 (635)
Q Consensus 444 ~~l~~~i~~~~~-----------~~p~-----~~s~~l~~LI~~~L~~--dP~~Rps~~eiL 487 (635)
.-....|..+.+ +.|. .+++++..|..+|+.. .+.-|||++..+
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 111112222211 1121 2678899999999975 356899987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.2e-08 Score=99.69 Aligned_cols=135 Identities=23% Similarity=0.282 Sum_probs=101.8
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc------------------C--HHHHHHHHHHH
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL------------------D--ERNLRKLFREV 289 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~------------------~--~~~~~~~~~Ei 289 (635)
-.+||.|.-+.||.|.+ .++.++|||.-+.... + .-....+.+|.
T Consensus 96 G~~IGvGKEsdVY~~~~---------------~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 96 GTKIGVGKESDVYVAID---------------PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred ccccccCccceEEEEEC---------------CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 46899999999999987 3567899997532111 1 12345667899
Q ss_pred HHHhhCCCC--ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 290 DIMSHLDHP--HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 290 ~iL~~L~Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++|.+|... .|.+.+++ +...+||||++|-.|...- +.......++..|+.-+..+-..||||+||.+-
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSef 231 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEF 231 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchh
Confidence 999999654 67777654 5568999999987765432 245556667777777777777999999999999
Q ss_pred ceeecCCCCeeeecccccccc
Q psy6357 368 NLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~ 388 (635)
|||++++|.+.++||--+...
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred eEEEecCCCEEEEeCcccccC
Confidence 999999999999999766544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.7e-08 Score=97.39 Aligned_cols=106 Identities=21% Similarity=0.273 Sum_probs=86.4
Q ss_pred HHHHHHHHHHhhCCCCc--eeeEEEEEecC----CeEEEEEeccccc-hhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc
Q psy6357 283 RKLFREVDIMSHLDHPH--IIKLFQVMETT----NNLYLVTEYARGG-EIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355 (635)
Q Consensus 283 ~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~----~~~~LV~E~~~gg-sL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH 355 (635)
.+..+|...+..|..-. ++..+.+.+.. ...+||+|++++. +|.+++.....++......++.+|+..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46778888888875333 45566665542 2468999999874 78888887556788888999999999999999
Q ss_pred cCceeeecccCcceeecCCC---Ceeeecccccccc
Q psy6357 356 ANNVVHRDIKAENLLFDENG---DIKLADFGFSNYF 388 (635)
Q Consensus 356 s~gIiHrDLKp~NILl~~~~---~ikL~DFGla~~~ 388 (635)
..||+|+||++.||||+.++ .+.|+||+.+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.48 E-value=2e-08 Score=111.31 Aligned_cols=241 Identities=17% Similarity=0.152 Sum_probs=167.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-ee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-II 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv 301 (635)
..+-|.....+++|+++.+++....-. . ....+.+... ....-++++|.+++||| .+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptae--------------k-lL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAE--------------K-LLQHPFVSQT-------LSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChh--------------h-heeceeeccc-------hhhHHHHHHHHHccCCCCcc
Confidence 344555677899999999997654211 1 1224444322 23445788999999999 77
Q ss_pred eEEEEEecCCeEEEEEeccccc-hhhhhh-hhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGG-EIFSHL-LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~gg-sL~~~l-~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
..++.++.+...+++|+++.++ +....+ ...-.|.+-+...+.+.-+++|++||+.--+|+| |||... +..++
T Consensus 298 ~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~ 372 (829)
T KOG0576|consen 298 RYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKL 372 (829)
T ss_pred cccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-ccccc
Confidence 7777778888999999999877 222211 1112355555666777788999999998889998 777755 68899
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
.||+....+.......+..+|+.++|||+.....+. ...|+|++++-..+|--|.+|-..... ....+-.+ ...|.
T Consensus 373 ~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~-p~s~~ 448 (829)
T KOG0576|consen 373 LDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNG-PNSPM 448 (829)
T ss_pred ccccCCcccCcccccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCC-CCccc
Confidence 999999888776667788999999999999998887 899999999877777777766433100 00000000 00000
Q ss_pred C-----CCHHH-HHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 460 Y-----MSAEC-ENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 460 ~-----~s~~l-~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. .+... .++...|+...|..++....++.|.+|..
T Consensus 449 L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 449 LTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 0 11111 24778899999999999999999999863
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.7e-07 Score=99.00 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=91.5
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---------------------------CH----
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---------------------------DE---- 279 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---------------------------~~---- 279 (635)
..|+.++-|.||.|.+ .+|+.||||+...... +.
T Consensus 131 ~PiAsASIaQVH~A~L---------------~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv 195 (517)
T COG0661 131 EPIASASIAQVHRAVL---------------KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVV 195 (517)
T ss_pred CchhhhhHhhheeEEe---------------cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHH
Confidence 5799999999999987 4578999999754211 00
Q ss_pred -HHHHH------HHHHHHHHhhC-----CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHH
Q psy6357 280 -RNLRK------LFREVDIMSHL-----DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQ 346 (635)
Q Consensus 280 -~~~~~------~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~q 346 (635)
+..+. +.+|+.-+.++ +.++|.-..=+++-...-.|+|||++|-.+.+.... ...++...+...+.+
T Consensus 196 ~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~ 275 (517)
T COG0661 196 DEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVR 275 (517)
T ss_pred HHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHH
Confidence 01111 22344444443 234443333334455667899999999988877422 233443332222222
Q ss_pred HHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 347 ILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 347 Il~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
+. +..+-..|++|.|.+|.||++..+|.+.+.|||+...+.+
T Consensus 276 ~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 276 AF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 11 2223348999999999999999999999999999987754
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-06 Score=102.09 Aligned_cols=208 Identities=17% Similarity=0.221 Sum_probs=153.2
Q ss_pred HHHHHHHHHHHHHhhCCCCceeeEEEEEecCCe----EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc
Q psy6357 280 RNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN----LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355 (635)
Q Consensus 280 ~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH 355 (635)
..+.....|+..+.++.|+|++.++.|...... +.+..++|...++...+.....++...++.+..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 344556677888889999999999988754433 2345678888899999999999999999999999999999999
Q ss_pred cCceeeecccCc---ceeecCCCCeeee--cccccccccCCCccccccCCCCCCCccccCCCCcC-CCccchhhHHHHHH
Q psy6357 356 ANNVVHRDIKAE---NLLFDENGDIKLA--DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYD-GTKSDVWSLGVVLY 429 (635)
Q Consensus 356 s~gIiHrDLKp~---NILl~~~~~ikL~--DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~-~~ksDIwSlGvily 429 (635)
+....|.-|... +-.++..+.+.+. ||+.+..+..........-+..+.++|......+. ....|+|.+|..+.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 986666655555 4444556666666 99988877665555555666778899988766654 13369999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 430 VMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 430 eLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+..|..+-... .....++ +......+.+++.+|+.-++++|+++.+++.|+|.....
T Consensus 384 ~~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 384 QLSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 998876442111 0111111 111122678999999999999999999999999997544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.2e-06 Score=85.59 Aligned_cols=140 Identities=17% Similarity=0.140 Sum_probs=88.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHH------HHHHHHHhh
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKL------FREVDIMSH 294 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~------~~Ei~iL~~ 294 (635)
+....|.+++.+-......|.+-.. ++..+.+|........ +..+..+ .+++..+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei----------------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~ 91 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI----------------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDK 91 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE----------------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHH
Confidence 4556677777777766666665544 4457899987643321 1111111 223333333
Q ss_pred C---CCCceeeEEEEE-----ecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 295 L---DHPHIIKLFQVM-----ETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 295 L---~HpnIv~l~~~~-----~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+ .-..+..++-+. .-....+|||||++|..|.++.. +.+ .+...|+++|.-||..|++|+|++|
T Consensus 92 i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hp 163 (229)
T PF06176_consen 92 IRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHP 163 (229)
T ss_pred HHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCc
Confidence 3 222333333332 22345679999999988876532 232 2446677889999999999999999
Q ss_pred cceeecCCCCeeeecccccc
Q psy6357 367 ENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~ 386 (635)
.|++++.+ .++++||+..+
T Consensus 164 gNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcEEEECC-cEEEEECcccc
Confidence 99999855 59999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.2e-06 Score=86.53 Aligned_cols=140 Identities=15% Similarity=0.161 Sum_probs=96.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHH--------------------H-HH-HHH
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERN--------------------L-RK-LFR 287 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~--------------------~-~~-~~~ 287 (635)
+..|..|.-+.||+|.. .++..||||++......-.. + .. ...
T Consensus 53 ~g~istGKEA~Vy~a~~---------------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 53 VGCISTGKEANVYLAET---------------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred EeeecCCcceEEEeecc---------------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 45778888899998764 24578999998653322111 1 11 124
Q ss_pred HHHHHhhCC--CCceeeEEEEEecCCeEEEEEeccccchhh-hhhhhcccCCHHHHHHHHHHHHHhhhhhcc-Cceeeec
Q psy6357 288 EVDIMSHLD--HPHIIKLFQVMETTNNLYLVTEYARGGEIF-SHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRD 363 (635)
Q Consensus 288 Ei~iL~~L~--HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~-~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrD 363 (635)
|..-|+++. +-.+.+.+.+.. -.|||||+....+- -.|.. -.+...++..+..++++.+.-|-. .++||+|
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgD 192 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGD 192 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCccccc
Confidence 667777763 445566666543 37999999433111 11111 234444788889999999988877 9999999
Q ss_pred ccCcceeecCCCCeeeecccccccccC
Q psy6357 364 IKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 364 LKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
|..-|||+. ++.+.|+||+-|....+
T Consensus 193 LSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 193 LSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred chhhheEEE-CCeEEEEECccccccCC
Confidence 999999999 88999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.1e-06 Score=85.32 Aligned_cols=137 Identities=15% Similarity=0.114 Sum_probs=97.2
Q ss_pred cccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-C---HHHHHHHHHHHHHHhhCCCC--ceeeEEEEE
Q psy6357 234 GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-D---ERNLRKLFREVDIMSHLDHP--HIIKLFQVM 307 (635)
Q Consensus 234 G~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~---~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~ 307 (635)
|.|+.+.|+...+ ++..+=||.-..... + .--...+.+|+..|.+|..- .+.++. ++
T Consensus 27 ~rgG~SgV~r~~~----------------~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~ 89 (216)
T PRK09902 27 RRNGMSGVQCVER----------------NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FG 89 (216)
T ss_pred CCCCcceEEEEEe----------------CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence 5688888886654 223466665531110 0 11236788999999988532 245555 33
Q ss_pred e-c----CCeEEEEEecccc-chhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC--e
Q psy6357 308 E-T----TNNLYLVTEYARG-GEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD--I 377 (635)
Q Consensus 308 ~-~----~~~~~LV~E~~~g-gsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~--i 377 (635)
. . .-..+||+|-+.+ -+|.+++... .+.++.....++.+|+..|.-||..|+.|+|+.+.|||++.++. +
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeE
Confidence 2 1 1246899998754 4777777553 35678888899999999999999999999999999999987677 9
Q ss_pred eeeccccccc
Q psy6357 378 KLADFGFSNY 387 (635)
Q Consensus 378 kL~DFGla~~ 387 (635)
+++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.8e-06 Score=83.16 Aligned_cols=134 Identities=19% Similarity=0.234 Sum_probs=83.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc--eeeEEEEEe
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH--IIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~ 308 (635)
..||.|..+.||+.. +..+++|+..... . ...+.+|.++++.+..-. +.+.+++.+
T Consensus 7 ~~i~~G~t~~~y~~~------------------~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~ 64 (226)
T TIGR02172 7 TQTGEGGNGESYTHK------------------TGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVE 64 (226)
T ss_pred eeecCCCCcceeEec------------------CCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEe
Confidence 568999999999631 2357889876432 2 234688999999986433 577888888
Q ss_pred cCCeEEEEEeccccch-hhhhh--------------hh----ccc-----CCHHHH-HHHHHHH----------HHh-hh
Q psy6357 309 TTNNLYLVTEYARGGE-IFSHL--------------LT----IGQ-----MAEKEA-SRLFRQI----------LSA-VA 352 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggs-L~~~l--------------~~----~~~-----l~e~~~-~~i~~qI----------l~g-L~ 352 (635)
..+..++|||+++|.+ +...+ .. ... ...... ..+..+| ... ..
T Consensus 65 ~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~ 144 (226)
T TIGR02172 65 DGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARA 144 (226)
T ss_pred cCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHH
Confidence 8888899999998863 11111 00 000 110000 0110000 000 11
Q ss_pred hhc----cCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 353 YCH----ANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 353 ~LH----s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
+|. ...++|+|++|.||+++.++ +.|+||+.+..
T Consensus 145 ~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 145 FIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred HHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 111 12478999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-05 Score=79.68 Aligned_cols=138 Identities=18% Similarity=0.298 Sum_probs=81.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC--ceeeEEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP--HIIKLFQVM 307 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~ 307 (635)
++.|+.|..+.||.... .+..++||+.... .....+.+|+.+++.|... .+.+++.+.
T Consensus 2 i~~l~~G~~n~~~~v~~----------------~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~ 61 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT----------------DDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFD 61 (239)
T ss_dssp EEEEEESSSSEEEEEEE----------------TTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEE
T ss_pred CccCCCCCeeeEEEEEE----------------CCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeec
Confidence 67899999999998765 2247999997543 3446777899999888533 356666644
Q ss_pred ---ecCCeEEEEEeccccchhhh----------------hhhhc-------ccCCHHH------HHHH------------
Q psy6357 308 ---ETTNNLYLVTEYARGGEIFS----------------HLLTI-------GQMAEKE------ASRL------------ 343 (635)
Q Consensus 308 ---~~~~~~~LV~E~~~ggsL~~----------------~l~~~-------~~l~e~~------~~~i------------ 343 (635)
......+++|++++|..+.. .+... ..+.... ...+
T Consensus 62 ~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (239)
T PF01636_consen 62 TSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASEL 141 (239)
T ss_dssp EETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhh
Confidence 23345799999999887766 11100 0000000 0000
Q ss_pred ---HHHHHH-hhhhhc-------cCceeeecccCcceeec-CCCCeeeeccccccc
Q psy6357 344 ---FRQILS-AVAYCH-------ANNVVHRDIKAENLLFD-ENGDIKLADFGFSNY 387 (635)
Q Consensus 344 ---~~qIl~-gL~~LH-------s~gIiHrDLKp~NILl~-~~~~ikL~DFGla~~ 387 (635)
+..+.. .+..++ ...++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 142 FDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 011111 222222 35699999999999999 667778999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.6e-06 Score=82.45 Aligned_cols=136 Identities=13% Similarity=0.104 Sum_probs=82.8
Q ss_pred eeccccCC-cceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe
Q psy6357 231 RKAGEGED-LSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVME 308 (635)
Q Consensus 231 ~kLG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 308 (635)
..|-.|.. ..||+... .+..+.||+..... ...+.+|+.+++.+. +--+.+++++..
T Consensus 4 ~~~~~g~~~~~v~~~~~----------------~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~ 62 (244)
T cd05150 4 ERVTEGQSGATVYRLDG----------------KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS 62 (244)
T ss_pred eecCCCCCcCeEEEEcC----------------CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe
Confidence 44555555 67786643 12468889875432 235678999988884 444667888877
Q ss_pred cCCeEEEEEeccccchhhhhhh----------------hcccCCH-------H--HHHHH--------------------
Q psy6357 309 TTNNLYLVTEYARGGEIFSHLL----------------TIGQMAE-------K--EASRL-------------------- 343 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~l~----------------~~~~l~e-------~--~~~~i-------------------- 343 (635)
..+..++|||+++|.+|..... +...++. . .....
T Consensus 63 ~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (244)
T cd05150 63 DDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERR 142 (244)
T ss_pred cCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhc
Confidence 7677899999999876653310 0001110 0 00000
Q ss_pred ---HHHHHHhhhh----hccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 344 ---FRQILSAVAY----CHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 344 ---~~qIl~gL~~----LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
+.++...|.. .....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 143 ~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 143 GWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0111111111 1123589999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.2e-05 Score=77.25 Aligned_cols=129 Identities=15% Similarity=0.217 Sum_probs=91.5
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVM 307 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~ 307 (635)
+.+.|++|++|.||++.|. +..+|+|+-..+. ....+..|+++|..+.-.++ .++|.+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~----------------~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg 85 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR----------------GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYG 85 (201)
T ss_pred hhhhhhcccccEEEEeecc----------------CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEec
Confidence 3678999999999999983 3479999876543 23678899999999987776 4566654
Q ss_pred ecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeeccc-CcceeecCCCCeeeecccccc
Q psy6357 308 ETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIK-AENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK-p~NILl~~~~~ikL~DFGla~ 386 (635)
++ ++.|||+.|-.|.+..... . .+-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|+
T Consensus 86 ~~----~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 86 ED----FIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hh----hhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 43 4569999987776644321 1 2334455555455667899999886 444555555699999999987
Q ss_pred cc
Q psy6357 387 YF 388 (635)
Q Consensus 387 ~~ 388 (635)
..
T Consensus 155 ~k 156 (201)
T COG2112 155 FK 156 (201)
T ss_pred hc
Confidence 43
|
|
| >KOG2945|consensus | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.6e-05 Score=79.38 Aligned_cols=127 Identities=32% Similarity=0.391 Sum_probs=83.1
Q ss_pred CCCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCcccccccC-CCCCCCCCCCCCCCCCCCCCCccccccccccCC-CCC
Q psy6357 109 RGEDGDRYRGGLGGSRPPRGRGGRGGRGGYCGGKARIRTASL-DRRPNVSGGNPANDISGDWGDQNAKLSDSVTNN-ESN 186 (635)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~Wgs~~~~~sd~~~~~-~s~ 186 (635)
..+++.|..+|++.+|.++|||++|.++++.+|++++..++. ++....+..++.+...++||+++..+.+..... ...
T Consensus 147 ~~~R~~r~~~G~~~~r~G~Grg~~g~~~~~~~~krEf~r~sgsDr~~v~s~d~~~gag~~nwgs~~ke~~d~~~~e~~~~ 226 (365)
T KOG2945|consen 147 NRDRGLRTNGGSPRGRQGGGRGNWGDDGDDITGKREFDRQSGSDRTGVESEDKRDGAGKHNWGSTKKELADKDQEEPEAK 226 (365)
T ss_pred ccccccccCCCCCcCCCCccCCCCCccccccccceeeeeeccccccccccccccCCccccccCCchHhhhcccccccccc
Confidence 346778888888889999999998889999999999655554 445688899999999999999887776622111 111
Q ss_pred CCCCCCCC-------CCCCCCChhhhhhhccchhhhhhccCCcccCCccceeecccc
Q psy6357 187 PEKAESVP-------GADQPTTEADEAAKEITLDEWKASRGTKLLKPQYNLRKAGEG 236 (635)
Q Consensus 187 p~~~~s~p-------~~~~P~~~~~~~~~e~tl~e~~~~~~~~~~~~y~il~kLG~G 236 (635)
++...+.. .+..........++++++++|+........ .+++..+++.+
T Consensus 227 ~~~~ee~e~~~ee~~k~~~~~a~~e~~~~~~tlde~k~l~~k~~~-~~e~nik~~~~ 282 (365)
T KOG2945|consen 227 EMPVEEVEKLAEEEKKALQAEAVEEEKVKEMTLDEMKALSNKDIP-PFENNIKAGEG 282 (365)
T ss_pred CCcccccccccccccccchhhhhhhhhhhhhhhhHHHHHhhcccC-chhhhhhcccc
Confidence 11111111 111222344567889999999876544433 33444444444
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.91 E-value=3.4e-05 Score=86.58 Aligned_cols=140 Identities=14% Similarity=0.155 Sum_probs=86.4
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-----------------------------HHH
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-----------------------------ERN 281 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-----------------------------~~~ 281 (635)
+.||.-+.+.|+++.. ++|+.||||+-+..... ++.
T Consensus 167 ~piaaASlaQVhrA~L---------------~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~ 231 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL---------------KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI 231 (538)
T ss_pred chhhhcchhheEEEEe---------------cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence 6799999999999986 45789999996432110 111
Q ss_pred HHHHHHHHHHHh------h----CCCCc------eeeEEEEEecCCeEEEEEeccccchhhhhh--hhcccCCHHHHHHH
Q psy6357 282 LRKLFREVDIMS------H----LDHPH------IIKLFQVMETTNNLYLVTEYARGGEIFSHL--LTIGQMAEKEASRL 343 (635)
Q Consensus 282 ~~~~~~Ei~iL~------~----L~Hpn------Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l--~~~~~l~e~~~~~i 343 (635)
.+.+..|+..++ + +.|-+ |.++|- .....-.|+||||+|..+.+.- .+ ..++...+..-
T Consensus 232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~ 308 (538)
T KOG1235|consen 232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNK 308 (538)
T ss_pred HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHH
Confidence 122223333322 1 23333 333332 2345678999999998776543 33 23554433333
Q ss_pred HHHHHHhhhhhccCceeeecccCcceeecC----CCCeeeecccccccccC
Q psy6357 344 FRQILSAVAYCHANNVVHRDIKAENLLFDE----NGDIKLADFGFSNYFTP 390 (635)
Q Consensus 344 ~~qIl~gL~~LHs~gIiHrDLKp~NILl~~----~~~ikL~DFGla~~~~~ 390 (635)
+.++..- -|=..|++|+|-+|.||++.. ++.+.|.|||+...+.+
T Consensus 309 l~~~~~~--qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 309 LVEAYLE--QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHH--HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3332221 122467999999999999984 67899999999887654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=4.7e-05 Score=77.13 Aligned_cols=31 Identities=26% Similarity=0.328 Sum_probs=26.1
Q ss_pred CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..++|+|+++.|||++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4599999999999998765567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.3e-06 Score=104.73 Aligned_cols=226 Identities=15% Similarity=0.067 Sum_probs=160.7
Q ss_pred EEEEEeccc---ccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cCCeEEEEEeccccchhhhhhhhc----ccCCH
Q psy6357 267 VAIKIIDKK---RLDERNLRKLFREVDIMSHLDHPHIIKLFQVME--TTNNLYLVTEYARGGEIFSHLLTI----GQMAE 337 (635)
Q Consensus 267 VAIKii~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e 337 (635)
+-+||.+.. .+.+...+.+..|..-++.+.|++++..+.-.. .....|.+++|+.+|.+++.|.+. ..+.+
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 455555332 223334455556666667778998877655543 234578999999999999988664 33556
Q ss_pred HHHHHHHHHHHHhhhhhccC-----ceeeecccCcceeecCCCCeeeeccccccccc-CCCccccccCCCCCCCccccCC
Q psy6357 338 KEASRLFRQILSAVAYCHAN-----NVVHRDIKAENLLFDENGDIKLADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGG 411 (635)
Q Consensus 338 ~~~~~i~~qIl~gL~~LHs~-----gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~ 411 (635)
..+.....+.+.+..-+|+. -.+|++||+-|.+|..+..+|+.++|+.+... ........++++.|+++++...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH
Confidence 66666666667777777753 27999999999999999999999999998433 3344566778889999999988
Q ss_pred CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 412 REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 412 ~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
..++ .++|+|..++.+|++..|..+|-......+...+... .+.++...|.++-.+...+|-+.-..||.-..++.-+
T Consensus 1415 ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d 1493 (2724)
T KOG1826|consen 1415 IKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRD 1493 (2724)
T ss_pred Hhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccc
Confidence 8876 6799999999999999998887433222222222222 2345555566666667777777778999999998877
Q ss_pred ccc
Q psy6357 491 WMS 493 (635)
Q Consensus 491 w~~ 493 (635)
.|.
T Consensus 1494 ~~a 1496 (2724)
T KOG1826|consen 1494 HFA 1496 (2724)
T ss_pred ccc
Confidence 765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=87.33 Aligned_cols=84 Identities=13% Similarity=0.248 Sum_probs=56.7
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCce--eeEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHI--IKLFQ 305 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~ 305 (635)
.+.+|+.|.+..+|...+.... ....+++|+........ ....+.+|+.+|+.|. |.+| .+++.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~------------~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~ 108 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGG------------SVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYC 108 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCC------------cceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3788999999999976542111 01357777764432111 1246779999999995 6665 77888
Q ss_pred EEecC---CeEEEEEeccccchh
Q psy6357 306 VMETT---NNLYLVTEYARGGEI 325 (635)
Q Consensus 306 ~~~~~---~~~~LV~E~~~ggsL 325 (635)
++.+. +..|+||||++|..+
T Consensus 109 ~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 109 LCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred EecCCCcCCCceEEEEecCCccc
Confidence 87654 467899999987643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00013 Score=72.28 Aligned_cols=129 Identities=22% Similarity=0.336 Sum_probs=91.5
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc--------------cCHHHHHHHHHHHHHHhhCC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR--------------LDERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~--------------~~~~~~~~~~~Ei~iL~~L~ 296 (635)
..||.|+.-.||.- .+.....||++.... ..........+|+.....+.
T Consensus 7 ~~i~~G~~R~cy~H-----------------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~ 69 (199)
T PF10707_consen 7 DLIAQGGERDCYQH-----------------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLS 69 (199)
T ss_pred cccccCCCceEEEC-----------------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHh
Confidence 46899999999932 123457899987665 11122355666777666665
Q ss_pred ------CCceeeEEEEEecCCeEEEEEecccc------chhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 297 ------HPHIIKLFQVMETTNNLYLVTEYARG------GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 297 ------HpnIv~l~~~~~~~~~~~LV~E~~~g------gsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
+.+|.+++++.+++.-..+|+|.+.. .+|.+++.. +.+++ . +...|-+-..||-..+|+.+||
T Consensus 70 ~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl 144 (199)
T PF10707_consen 70 LRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDL 144 (199)
T ss_pred hccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCC
Confidence 78899999999999999999998743 367777743 44655 3 3334445556788999999999
Q ss_pred cCcceeecCCC----Ceeeec
Q psy6357 365 KAENLLFDENG----DIKLAD 381 (635)
Q Consensus 365 Kp~NILl~~~~----~ikL~D 381 (635)
+|.||++.... .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 99999996532 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.73 E-value=8.8e-05 Score=72.95 Aligned_cols=98 Identities=18% Similarity=0.231 Sum_probs=80.6
Q ss_pred HHHHHHhhCCC-CceeeEEEEEecCCeEEEEEeccccchhhh---hhhhcccCCHHHHHHHHHHHHHhhhhhcc---Cce
Q psy6357 287 REVDIMSHLDH-PHIIKLFQVMETTNNLYLVTEYARGGEIFS---HLLTIGQMAEKEASRLFRQILSAVAYCHA---NNV 359 (635)
Q Consensus 287 ~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~---~l~~~~~l~e~~~~~i~~qIl~gL~~LHs---~gI 359 (635)
.|.-+|+.+.+ +++++++|+|-. ++|.||...+++.. .+......++..+.+|+.+++..+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888888875 699999999943 67889997666542 22333457899999999999999999987 458
Q ss_pred eeecccCcceeecCCCCeeeecccccccc
Q psy6357 360 VHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 360 iHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
.-.|++++|+-|+.++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0004 Score=68.77 Aligned_cols=127 Identities=19% Similarity=0.162 Sum_probs=87.9
Q ss_pred CCccceeeccccCC-cceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc----------cCH---------HHHHH
Q psy6357 225 KPQYNLRKAGEGED-LSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR----------LDE---------RNLRK 284 (635)
Q Consensus 225 ~~y~il~kLG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~----------~~~---------~~~~~ 284 (635)
..+..++.||.|.- |.||++.. .+..+|||++..-. ... ....-
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I----------------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI----------------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE----------------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 45556899999999 99999977 45689999942200 000 22345
Q ss_pred HHHHHHHHhhC---CCCce--eeEEEEEecC------------------CeEEEEEeccccchhhhhhhhcccCCHHHHH
Q psy6357 285 LFREVDIMSHL---DHPHI--IKLFQVMETT------------------NNLYLVTEYARGGEIFSHLLTIGQMAEKEAS 341 (635)
Q Consensus 285 ~~~Ei~iL~~L---~HpnI--v~l~~~~~~~------------------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~ 341 (635)
+..|.....+| .+.++ |+.+++..-. ....||.||++... .+ ..
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~ 167 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QI 167 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----ch
Confidence 66787776666 45566 8999987321 11357888775432 12 23
Q ss_pred HHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 342 RLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 342 ~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
.-+.+|++-|..||..||+-+|+++.|.. .-+|+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 34567777788899999999999999986 4589999865
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00097 Score=70.32 Aligned_cols=76 Identities=14% Similarity=0.064 Sum_probs=54.1
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC---CceeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH---PHIIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~ 306 (635)
++.||.|..+.||.... .+.++.+|+.+... . ...+..|+..|+.|.. -.|.+++++
T Consensus 19 ~~~i~~G~~~~vy~~~~----------------~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~ 78 (297)
T PRK10593 19 VECISEQPYAALWALYD----------------SQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGV 78 (297)
T ss_pred eeecCCccceeEEEEEc----------------CCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEE
Confidence 67899999999996543 11247778753311 1 1467889999998853 367888887
Q ss_pred Eec---CCeEEEEEeccccchh
Q psy6357 307 MET---TNNLYLVTEYARGGEI 325 (635)
Q Consensus 307 ~~~---~~~~~LV~E~~~ggsL 325 (635)
+.. .+..+||||++++.++
T Consensus 79 ~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 79 MTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred eccCCcCCCeEEEEeccCCEec
Confidence 754 3668999999998654
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.49 E-value=6.2e-05 Score=78.63 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=92.9
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc------------------CH--HHHHHHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL------------------DE--RNLRKLF 286 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~------------------~~--~~~~~~~ 286 (635)
+.+-++||-|.-+.||.+.+. +|...++|+-..... +. -..-...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~---------------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE---------------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred hhhccccccccccceEEEecC---------------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 345678999999999988773 344555554322111 11 1123456
Q ss_pred HHHHHHhhCCC--CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 287 REVDIMSHLDH--PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 287 ~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
+|...|+.|.. --|.+.+++ +..|+|||++.|..|...-. ...+..+...|+.-+--|-..|+||+|+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDF 228 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDF 228 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceeccc
Confidence 79999998853 234555544 46789999999887755321 1223445555666666788899999999
Q ss_pred cCcceeecCCCCeeeecccccccc
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~ 388 (635)
.--||+|++++.++++||--....
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred chheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999765444
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0011 Score=68.04 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=75.5
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEEecC
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVMETT 310 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~ 310 (635)
.+..|-...+|+... ++..+++|+.......- . -...+|..+|+.+....+ .+++..+.
T Consensus 3 ~~~~G~tn~~y~~~~----------------~~~~~vlR~~~~~~~~~-~-~~r~~E~~~l~~l~~~g~~P~~i~~~~-- 62 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH----------------PGISFVWRPQSPVCKAL-G-VDRQREYQILQALSALGLAPKPILVNE-- 62 (256)
T ss_pred cCCCcCcCCeEEEEe----------------CCccEEEeeCCcccccc-c-CcHHHHHHHHHHHHhcCCCCceEEEeC--
Confidence 355677778886642 23468888764331110 0 124678899998864333 44554432
Q ss_pred CeEEEEEeccccchhhhh-------h-------hhcc-------cCCH-HHHHHHHHHH---------HHhhhhhc----
Q psy6357 311 NNLYLVTEYARGGEIFSH-------L-------LTIG-------QMAE-KEASRLFRQI---------LSAVAYCH---- 355 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~-------l-------~~~~-------~l~e-~~~~~i~~qI---------l~gL~~LH---- 355 (635)
-++||||++|..+... + .+.. .+.. ..+..+..++ ...+..+-
T Consensus 63 --~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 140 (256)
T TIGR02721 63 --HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPE 140 (256)
T ss_pred --CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccC
Confidence 2689999988665321 1 1110 1111 1111221111 11111111
Q ss_pred ----cCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 356 ----ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 356 ----s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
...++|+|+.|.|||++.++ +.|+||..|....
T Consensus 141 ~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 141 PAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred CCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence 12589999999999999877 7899999886543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0061 Score=66.81 Aligned_cols=78 Identities=14% Similarity=-0.008 Sum_probs=53.4
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcC-ceEEEEEeccccc-----CHHHHHHHHHHHHHHhhCC---CCc
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEEL-SKVAIKIIDKKRL-----DERNLRKLFREVDIMSHLD---HPH 299 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~-~~VAIKii~~~~~-----~~~~~~~~~~Ei~iL~~L~---Hpn 299 (635)
.++.||-|.+..||.+... ++ ..|.||.-..... ..-..++...|...|+.+. ..+
T Consensus 30 ~~~elggGn~N~VyrV~~~---------------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~ 94 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDT---------------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDL 94 (401)
T ss_pred eeeEcCCCceEEEEEEEeC---------------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCC
Confidence 4678999999999988762 22 3699998531100 0123456778888888863 346
Q ss_pred eeeEEEEEecCCeEEEEEeccccc
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGG 323 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~gg 323 (635)
+++++.+. .+..++|||++++.
T Consensus 95 VPkV~~~D--~~~~~lVME~L~~~ 116 (401)
T PRK09550 95 VPKVYHYD--EELAVTVMEDLSDH 116 (401)
T ss_pred CCeEEEEC--CCCCEEEEecCCCc
Confidence 77788773 35578999999764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0026 Score=64.09 Aligned_cols=76 Identities=16% Similarity=0.169 Sum_probs=46.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-eeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-IIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~ 308 (635)
++.|..|-...||+...... .+..|++|+....... .-...+|+.+++.+...+ +++++..+.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~-------------~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~ 66 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED-------------NQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ 66 (235)
T ss_pred EEEcCCcccceEEEEEcCCC-------------CCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC
Confidence 56788888889997643100 1347899987543211 112347888888885333 455555443
Q ss_pred cCCeEEEEEeccccchh
Q psy6357 309 TTNNLYLVTEYARGGEI 325 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL 325 (635)
. .+||||++|.++
T Consensus 67 ~----~~l~e~i~G~~l 79 (235)
T cd05157 67 N----GLIYEFIPGRTL 79 (235)
T ss_pred C----cEEEEeeCCCcC
Confidence 2 489999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0027 Score=67.05 Aligned_cols=137 Identities=16% Similarity=0.233 Sum_probs=79.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc--eeeEEEE-
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH--IIKLFQV- 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~- 306 (635)
++.++.|....||+... ++..+++|+..... .. ..+..|++++..|.... |++++..
T Consensus 27 i~~~~~G~~n~~y~v~t----------------~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT----------------DVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred ccccCCccccceEEEEe----------------CCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 66778888889996542 12257789875432 12 34456777777774222 4444432
Q ss_pred -----EecCCeEEEEEeccccchhhhh----hhhc-----------ccC--------CHHHHH---------------HH
Q psy6357 307 -----METTNNLYLVTEYARGGEIFSH----LLTI-----------GQM--------AEKEAS---------------RL 343 (635)
Q Consensus 307 -----~~~~~~~~LV~E~~~ggsL~~~----l~~~-----------~~l--------~e~~~~---------------~i 343 (635)
....+..++||+|++|..+... +... ..+ ...... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 1234567899999988543210 0000 001 000000 00
Q ss_pred HHHHHHhhhhhc-------cCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 344 FRQILSAVAYCH-------ANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 344 ~~qIl~gL~~LH-------s~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
...+...+++|. ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 111223444443 2689999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.005 Score=64.30 Aligned_cols=137 Identities=16% Similarity=0.195 Sum_probs=81.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC--ceeeEEEE-
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP--HIIKLFQV- 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~- 306 (635)
++.|..|....+|+... .+..+++|+.... . ...+..|+.++..|.+. .+++++..
T Consensus 19 i~~i~~G~~n~~y~v~~----------------~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~ 77 (296)
T cd05153 19 FEGISAGIENTNYFVTT----------------DSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADR 77 (296)
T ss_pred eecccCccccceEEEEe----------------CCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCC
Confidence 66788888889997643 1236889988641 2 24566788888887432 24455432
Q ss_pred -----EecCCeEEEEEeccccchhhh----hhhhc-----------ccCCH--------HHHH------------HHHHH
Q psy6357 307 -----METTNNLYLVTEYARGGEIFS----HLLTI-----------GQMAE--------KEAS------------RLFRQ 346 (635)
Q Consensus 307 -----~~~~~~~~LV~E~~~ggsL~~----~l~~~-----------~~l~e--------~~~~------------~i~~q 346 (635)
....+..++||++++|..+.. .+... ..+.. .... .....
T Consensus 78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 157 (296)
T cd05153 78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL 157 (296)
T ss_pred CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence 233456789999998865432 01000 00000 0000 01111
Q ss_pred HHHhhhhhcc-------CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 347 ILSAVAYCHA-------NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 347 Il~gL~~LHs-------~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
+..++.++.. .+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 2223333332 4799999999999999887778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0058 Score=64.66 Aligned_cols=31 Identities=29% Similarity=0.490 Sum_probs=26.5
Q ss_pred CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
.++||+|+++.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4799999999999998665568999998753
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0021 Score=70.98 Aligned_cols=161 Identities=20% Similarity=0.242 Sum_probs=103.7
Q ss_pred HHHHHHHHHHhhCCCCceeeEEEEEec-CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceee
Q psy6357 283 RKLFREVDIMSHLDHPHIIKLFQVMET-TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVH 361 (635)
Q Consensus 283 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiH 361 (635)
.+++--..+++.+.|+|..+.+++... .....+|||++ +.+|++.+.... +...... .+++.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 345566788999999999999988753 34578999999 688888776543 2111111 222222
Q ss_pred ecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy6357 362 RDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~ 441 (635)
.|| ++++| -++.. | |-.+ +.++||||+|.|+.++..|...|...
T Consensus 91 -----~~~-------~~~td-~~~t~---------------~--~~~~------~pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFLTK---------------Y--PSPI------GPKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred -----ehh-------hhccc-ccccc---------------C--CCCC------CcchhhhhHHHHHHHHHHhhHHHHHH
Confidence 122 23333 00000 0 1111 25899999999999999998877665
Q ss_pred CHHHHHHHHHhCcc------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 442 NLAVLKQRILFGKF------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 442 ~~~~l~~~i~~~~~------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+....+..-.. .+-..++..+.+++.+|+...|..||...++++|+-|...
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 54443333322110 1112356778899999999999999999999999998754
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0028 Score=67.64 Aligned_cols=143 Identities=21% Similarity=0.245 Sum_probs=95.6
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc----------------------CHHHHHHH--
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL----------------------DERNLRKL-- 285 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~----------------------~~~~~~~~-- 285 (635)
-+.|.-|.-+.||.+.- .+|..+||||++...+ ++..+-++
T Consensus 149 nGCiSTGKEANVYHat~---------------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WA 213 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE---------------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWA 213 (520)
T ss_pred ccccccCccceeEeeec---------------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHH
Confidence 35778888999998764 4677899999854221 11111222
Q ss_pred HHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc-cCceeeecc
Q psy6357 286 FREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH-ANNVVHRDI 364 (635)
Q Consensus 286 ~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH-s~gIiHrDL 364 (635)
..|+.-|++|....|.-.--+.. ....|||+|+.......-..+.-.++...+..+..+++.-|.-|- .+++||.||
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL 291 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL 291 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence 25677777775544432111111 234699999954333222334456888889999899988888774 689999999
Q ss_pred cCcceeecCCCCeeeecccccccccC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
.--|+|+. +|.+.|+|.+-+.....
T Consensus 292 SEfN~Lyh-dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 292 SEFNLLYH-DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hhhhheEE-CCEEEEEEccccccCCC
Confidence 99999994 57999999988765543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0054 Score=64.39 Aligned_cols=82 Identities=16% Similarity=0.202 Sum_probs=47.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~ 308 (635)
++.|..|-.-.||+........ ....+..|++|+...... ......+|+.++..+....+ .+++.++.
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~--------~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~ 71 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDA--------LSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP 71 (302)
T ss_pred EEEecCcccceeEEEEcCCccc--------ccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC
Confidence 4556666666888665311000 011246799999765421 12345688888888853333 45666654
Q ss_pred cCCeEEEEEeccccchhh
Q psy6357 309 TTNNLYLVTEYARGGEIF 326 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~ 326 (635)
. .+|+||++|..+.
T Consensus 72 ~----~~v~e~i~G~~l~ 85 (302)
T cd05156 72 N----GRIEEFIPSRTLT 85 (302)
T ss_pred C----CchhheeCCCcCC
Confidence 2 3689999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.013 Score=61.07 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=26.1
Q ss_pred ceeeecccCcceeecCCCC-eeeecccccccc
Q psy6357 358 NVVHRDIKAENLLFDENGD-IKLADFGFSNYF 388 (635)
Q Consensus 358 gIiHrDLKp~NILl~~~~~-ikL~DFGla~~~ 388 (635)
.++|+|+++.|||++.++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999997555 469999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.018 Score=62.12 Aligned_cols=142 Identities=13% Similarity=0.170 Sum_probs=81.8
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVM 307 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~ 307 (635)
.+..|-.|-.-.+|+........ ..+..|++|+..... +..+. -.+|+.+++.+..-++ .++++.+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~----------~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~ 106 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEG----------NLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRF 106 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCC----------CCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEE
Confidence 36778678888999865421110 123579999886542 22222 2578899988865444 4566666
Q ss_pred ecCCeEEEEEeccccchhhhh--------------hhhcc---------cCCHHHHHHHHHHH-----------------
Q psy6357 308 ETTNNLYLVTEYARGGEIFSH--------------LLTIG---------QMAEKEASRLFRQI----------------- 347 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~~~--------------l~~~~---------~l~e~~~~~i~~qI----------------- 347 (635)
... .|++|+++.+|... |.+.. ......+..++.++
T Consensus 107 ~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l 182 (344)
T PLN02236 107 PNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL 182 (344)
T ss_pred CCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence 432 58999977655311 00000 01112222222211
Q ss_pred HHhhhh--------hccCceeeecccCcceeecC-CCCeeeeccccccc
Q psy6357 348 LSAVAY--------CHANNVVHRDIKAENLLFDE-NGDIKLADFGFSNY 387 (635)
Q Consensus 348 l~gL~~--------LHs~gIiHrDLKp~NILl~~-~~~ikL~DFGla~~ 387 (635)
...+.. .+...++|+||++.|||++. ++.+.|+||..|..
T Consensus 183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111111 22346899999999999986 46899999998854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.041 Score=58.46 Aligned_cols=127 Identities=16% Similarity=0.209 Sum_probs=74.0
Q ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHhhCCC--CceeeEEEEEecCC--eEEEEEeccccchhhh------------
Q psy6357 264 LSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH--PHIIKLFQVMETTN--NLYLVTEYARGGEIFS------------ 327 (635)
Q Consensus 264 ~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~--~~~LV~E~~~ggsL~~------------ 327 (635)
++++++. ...............+|..+|+.+.- --+...+++|..+. ..|.||+|++|..+.+
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 4567777 33212223344667788999888753 23445566665554 6799999998732211
Q ss_pred ------hhhhccc--------------CCHHHHHHHHHHH--------------HHhhhhhcc--------Cceeeeccc
Q psy6357 328 ------HLLTIGQ--------------MAEKEASRLFRQI--------------LSAVAYCHA--------NNVVHRDIK 365 (635)
Q Consensus 328 ------~l~~~~~--------------l~e~~~~~i~~qI--------------l~gL~~LHs--------~gIiHrDLK 365 (635)
.|..... +...++..+..+. ..-..||+. ..++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 1111000 0111111111111 112333332 248999999
Q ss_pred CcceeecCCCCeeeecccccccccCC
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPG 391 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~ 391 (635)
+.||+|+..+.+=|+||+++....+.
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCCcH
Confidence 99999999988999999999876553
|
|
| >PF04774 HABP4_PAI-RBP1: Hyaluronan / mRNA binding family; InterPro: IPR006861 This entry includes the HABP4 protein family of hyaluronan-binding proteins, and the PAI-1 mRNA-binding protein, PAI-RBP1 | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.0084 Score=53.21 Aligned_cols=95 Identities=32% Similarity=0.510 Sum_probs=57.7
Q ss_pred CCcccccccCCCCCCCCCCCCCCCCCCCCCCccccccccccC---CCCCCCCCCCCC------CCCCCC--Chhhhhhhc
Q psy6357 141 GKARIRTASLDRRPNVSGGNPANDISGDWGDQNAKLSDSVTN---NESNPEKAESVP------GADQPT--TEADEAAKE 209 (635)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~Wgs~~~~~sd~~~~---~~s~p~~~~s~p------~~~~P~--~~~~~~~~e 209 (635)
|++.+.++|.+.++ ....++.+.+.++||+....+++.... ...........+ ....+. .+..+..++
T Consensus 1 g~R~fDR~Sgs~r~-~~~~Kk~G~G~~NWG~~~dei~e~~~~~~~~~~~~~~~E~~~~~e~~~~e~~~e~~~~~eee~k~ 79 (106)
T PF04774_consen 1 GKREFDRHSGSGRT-KSEDKKGGGGAHNWGSPKDEISELNEEQAEEEEVEEEEEHQPEAEEENEENEAEEEEPEEEEEKE 79 (106)
T ss_pred CCCcccCCCCCCCC-CCccCCCCccccCCCCccchhhhhccccccccccccccccccccccccccccccccccccccccc
Confidence 56777777777766 667788999999999998876555221 111111111111 001111 133556789
Q ss_pred cchhhhhhccCCcccCCccceeecccc
Q psy6357 210 ITLDEWKASRGTKLLKPQYNLRKAGEG 236 (635)
Q Consensus 210 ~tl~e~~~~~~~~~~~~y~il~kLG~G 236 (635)
+||++|+........+.-+.|++-|+|
T Consensus 80 mTLdE~k~~q~k~~~~~~~niRk~~eg 106 (106)
T PF04774_consen 80 MTLDEYKALQEKRRAKPEFNIRKAGEG 106 (106)
T ss_pred cCHHHHHHHHHhhhcccccccccCCCC
Confidence 999999776655455555667777765
|
HABP4 has been observed to bind hyaluronan (a glucosaminoglycan), but it is not known whether this is its primary role in vivo. It has also been observed to bind RNA, but with a lower affinity than that for hyaluronan []. PAI-1 mRNA-binding protein specifically binds the mRNA of type-1 plasminogen activator inhibitor (PAI-1), and is thought to be involved in regulation of mRNA stability []. However, in both cases, the sequence motifs predicted to be important for ligand binding are not conserved throughout the family, so it is not known whether members of this family share a common function. Hyaluronan/mRNA-binding protein may be involved in nuclear functions such as the remodeling of chromatin and the regulation of transcription [, ]. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.025 Score=56.22 Aligned_cols=31 Identities=32% Similarity=0.756 Sum_probs=21.9
Q ss_pred CceeeecccCcceee-cCCCCeeeeccccccc
Q psy6357 357 NNVVHRDIKAENLLF-DENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ~gIiHrDLKp~NILl-~~~~~ikL~DFGla~~ 387 (635)
.-++|.||.+.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.053 Score=58.02 Aligned_cols=140 Identities=12% Similarity=0.227 Sum_probs=77.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~ 308 (635)
++.|-.|=.-.+|+....... .+...|++|+...... . .-.-.+|+.+++.+..-+| .++++++.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~-----------~~~~~~v~Ri~g~~t~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~ 84 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEEN-----------GNEVSVTVRLFGPNTD--Y-VIDRERELQAIKYLSAAGFGAKLLGVFG 84 (330)
T ss_pred EEEeCCcccceEEEEEecCCC-----------CCCceEEEEEecCCcC--e-EechHHHHHHHHHHHhcCCCCceeEEeC
Confidence 566666777778866542110 0123789998754321 1 1123478889888865555 45666653
Q ss_pred cCCeEEEEEeccccchhhh-------hh-------hhcc--c------C-CHHHHHHHHHHH------------------
Q psy6357 309 TTNNLYLVTEYARGGEIFS-------HL-------LTIG--Q------M-AEKEASRLFRQI------------------ 347 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~-------~l-------~~~~--~------l-~e~~~~~i~~qI------------------ 347 (635)
. + +|.+|+++..|.. .+ .+.. . + ....+..++.++
T Consensus 85 ~-G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~ 160 (330)
T PLN02421 85 N-G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETIS 160 (330)
T ss_pred C-c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccC
Confidence 2 2 5889987665421 01 1100 0 1 112222222221
Q ss_pred ----HHhhh----hhccC----ceeeecccCcceeecC-CCCeeeeccccccc
Q psy6357 348 ----LSAVA----YCHAN----NVVHRDIKAENLLFDE-NGDIKLADFGFSNY 387 (635)
Q Consensus 348 ----l~gL~----~LHs~----gIiHrDLKp~NILl~~-~~~ikL~DFGla~~ 387 (635)
..-+. .+... -++|.||.+.|||+++ ++.++|+||..|..
T Consensus 161 ~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 161 FEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 11122 3799999999999975 47899999998854
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.093 Score=56.69 Aligned_cols=76 Identities=13% Similarity=0.015 Sum_probs=46.5
Q ss_pred eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccc-----ccCHHHHHHHHHHHHHHhhCC--CC-ceeeE
Q psy6357 232 KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKK-----RLDERNLRKLFREVDIMSHLD--HP-HIIKL 303 (635)
Q Consensus 232 kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~-----~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l 303 (635)
.+|-|....||++.... .+..|+||--... ...+-...+...|...|+.+. -| .++++
T Consensus 2 EigdGnlN~VfrV~~~~--------------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v 67 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE--------------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI 67 (370)
T ss_pred cCCCCceEEEEEEEcCC--------------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE
Confidence 57889999999887520 1135888864311 011223456667888887763 34 45566
Q ss_pred EEEEecCCeEEEEEeccccc
Q psy6357 304 FQVMETTNNLYLVTEYARGG 323 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~gg 323 (635)
|.+ +.....+|||+++..
T Consensus 68 y~~--D~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 68 FHF--DTEMAVTVMEDLSHH 85 (370)
T ss_pred EEE--ccccceehHhhCccc
Confidence 544 455567999998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.1 Score=57.24 Aligned_cols=76 Identities=9% Similarity=0.092 Sum_probs=50.9
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--C---HHHHHHHHHHHHHHhhCC---CCce
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--D---ERNLRKLFREVDIMSHLD---HPHI 300 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~---~~~~~~~~~Ei~iL~~L~---HpnI 300 (635)
.++.||-|....||+... .+..|+||.-..... . .....+...|+..|+.+. ...|
T Consensus 36 ~~~eiggGn~N~VyrV~~----------------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~V 99 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS----------------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHV 99 (418)
T ss_pred eEEEcCCCceeeEEEEEc----------------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCC
Confidence 477899999999998654 122488887642111 1 123455566777777664 3578
Q ss_pred eeEEEEEecCCeEEEEEecccc
Q psy6357 301 IKLFQVMETTNNLYLVTEYARG 322 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~g 322 (635)
.++|.+++ +..++|||++++
T Consensus 100 PkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 100 PEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred CeEEEECC--CCCEEEEeecCC
Confidence 88888877 446788999976
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.12 Score=54.28 Aligned_cols=73 Identities=12% Similarity=0.122 Sum_probs=45.2
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC---CCceeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPHIIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~ 306 (635)
+..++-|....+|.... ++..+.||+-..... ..+..|+.-|+.|. --.|++++.+
T Consensus 22 ~~~v~GG~i~~a~~~~~----------------~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~ 80 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT----------------DGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAW 80 (288)
T ss_dssp EEEE--SSSSEEEEEET----------------TS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEE
T ss_pred eEecCCCChhheEEEEC----------------CCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 56788899999886542 445799998763221 35667888887773 4467889998
Q ss_pred EecCCeEEEEEeccccc
Q psy6357 307 METTNNLYLVTEYARGG 323 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~gg 323 (635)
....+..||||||++.+
T Consensus 81 G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 81 GEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE-SSCCEEEEE-----
T ss_pred EeecCCceEEEEeecCC
Confidence 88777779999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.047 Score=58.47 Aligned_cols=104 Identities=23% Similarity=0.375 Sum_probs=67.8
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
....|++|++. |+.|.- + .-...+++..|+.+.+..++-|..+ .+-||||...||||+ +|+|.|+||-+++.-
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34567888886 444432 2 2245677888888888877777654 689999999999999 999999999999854
Q ss_pred cCCCccccccCCCCCCCccccCCCCcCCCccchhhHH
Q psy6357 389 TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLG 425 (635)
Q Consensus 389 ~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlG 425 (635)
....... ....--|-.+.|.. +..-+||-+-
T Consensus 372 ~~q~~is----y~rldhp~lF~G~d--d~QFeIYrlM 402 (488)
T COG5072 372 YSQGIIS----YNRLDHPDLFNGVD--DYQFEIYRLM 402 (488)
T ss_pred cCCceee----ccccCchhhhcCcc--ceeeeHHHHH
Confidence 3322111 11222344444433 3566776543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.36 Score=51.00 Aligned_cols=30 Identities=20% Similarity=0.417 Sum_probs=27.7
Q ss_pred ceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 358 NVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 358 gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG3973|consensus | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.12 Score=54.02 Aligned_cols=17 Identities=76% Similarity=1.466 Sum_probs=12.5
Q ss_pred CCCCCCCCCCCCCCCCC
Q psy6357 125 PPRGRGGRGGRGGYCGG 141 (635)
Q Consensus 125 ~~r~~~~~~~~~~~~~~ 141 (635)
++|||||+||+|+|-.|
T Consensus 447 ggrgrgggggrg~y~~g 463 (465)
T KOG3973|consen 447 GGRGRGGGGGRGGYRGG 463 (465)
T ss_pred CCCCCCCCCCCcccCCC
Confidence 67788887777776555
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.17 Score=55.35 Aligned_cols=78 Identities=14% Similarity=0.096 Sum_probs=50.1
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecc----cccCHHHHHHHHHHHHHHhhCC--CC-cee
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDK----KRLDERNLRKLFREVDIMSHLD--HP-HII 301 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~----~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv 301 (635)
.++.||-|.-..||++.+.. .+..|+||--.. .....-..++..-|..+|+.+. -| +++
T Consensus 33 ~~~eigdGnlN~VfrV~~~~--------------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP 98 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQ--------------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVP 98 (409)
T ss_pred eeeEcCCCceEEEEEEeeCC--------------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCC
Confidence 47889999999999987621 123577775421 1111234567778888888763 34 566
Q ss_pred eEEEEEecCCeEEEEEecccc
Q psy6357 302 KLFQVMETTNNLYLVTEYARG 322 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~g 322 (635)
++|.+ +.....+|||+++.
T Consensus 99 ~vy~~--D~e~~~~vMEdL~~ 117 (409)
T PRK12396 99 KVYLF--DSVMNCCVMEDLSD 117 (409)
T ss_pred eEEEE--CcHHhhHHHHhCcc
Confidence 66654 45556789998854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.77 E-value=1 Score=48.02 Aligned_cols=29 Identities=17% Similarity=0.258 Sum_probs=24.6
Q ss_pred CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 4 578999998753
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=92.91 E-value=0.17 Score=55.06 Aligned_cols=60 Identities=23% Similarity=0.292 Sum_probs=43.6
Q ss_pred EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhh-ccCceeeecccCcceeecC
Q psy6357 313 LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYC-HANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 313 ~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~L-Hs~gIiHrDLKp~NILl~~ 373 (635)
..||-+|..|.++..++... ..++.....++.-.+.||--+ --.+++|.|++|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 46777788888888877653 455666666666666665444 3578999999999999954
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.29 E-value=0.17 Score=52.96 Aligned_cols=29 Identities=21% Similarity=0.558 Sum_probs=25.8
Q ss_pred CceeeecccCcceeecCCCCeeeecccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
.+++|+|+++.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.32 Score=53.24 Aligned_cols=83 Identities=13% Similarity=0.138 Sum_probs=47.0
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVM 307 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~ 307 (635)
.++.|..|=...+|++........ .-....|.+++.... .... -.-.+|+.+++.|...++ .++++.+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~--------~~~~k~Vl~R~~g~~--~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f 122 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKD--------RYPIKSVCIKKSSTY--NSLV-IDNDLQYNIAKLLGDNNFGPKIIGRF 122 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCC--------ccccceEEEEeccCC--CceE-eccHHHHHHHHHHHhCCCCCeEEEec
Confidence 367777788888997754211000 000012555543211 1111 122478999999975555 5677776
Q ss_pred ecCCeEEEEEeccccchhh
Q psy6357 308 ETTNNLYLVTEYARGGEIF 326 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~ 326 (635)
.. ++|.||++|-+|.
T Consensus 123 ~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 123 GD----FTIQEWVEGNTMG 137 (383)
T ss_pred CC----EEEEEEeccccCC
Confidence 53 6999999887653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.50 E-value=0.4 Score=48.33 Aligned_cols=84 Identities=18% Similarity=0.263 Sum_probs=57.0
Q ss_pred HHHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc--Cceee
Q psy6357 284 KLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA--NNVVH 361 (635)
Q Consensus 284 ~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs--~gIiH 361 (635)
-+..+..++.++. .|++|..- ..-.+.++.|+|..... .-..++..=+.+|.-.|+ .+.+|
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHhHHHHHHhhccCCCeec
Confidence 4567788887763 47777622 33346699999943211 011222222566777884 47999
Q ss_pred ecccCcceeecCCCCeeeecccc
Q psy6357 362 RDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGl 384 (635)
+|..|+||+.+..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999654
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 635 | ||||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-84 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-84 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-84 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-83 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-83 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-83 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-83 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-82 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-80 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-79 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-57 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-57 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-57 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-57 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-56 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-56 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-55 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-55 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-51 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-44 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-44 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-44 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-44 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-44 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-43 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-42 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-42 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-42 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-41 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-41 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-41 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-40 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-40 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-40 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-40 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-40 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-39 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-39 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-39 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-39 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-39 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-39 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-38 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-38 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-38 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-38 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-38 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-38 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-38 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-37 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-37 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-37 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-37 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-37 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-37 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-37 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-37 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-36 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-36 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-36 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-36 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-36 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-36 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-36 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-36 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-36 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-36 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-36 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-36 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-35 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-35 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-35 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-35 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-35 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-35 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-35 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-35 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-35 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-35 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-35 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-35 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-35 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-35 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-35 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-35 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-35 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-35 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-35 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-35 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-35 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-35 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-35 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-35 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-35 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-35 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-35 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-35 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-35 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-35 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-35 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-35 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-35 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-35 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-35 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-35 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-35 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-35 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-35 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-35 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-35 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-35 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-34 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-34 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-34 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-34 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-34 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-34 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-33 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-33 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-33 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-33 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-33 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-33 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-33 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-33 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-33 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-33 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-33 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-33 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-33 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-33 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-33 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-33 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-33 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-33 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-33 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-33 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-33 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-32 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-32 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-32 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-32 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-32 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-32 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-32 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-32 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-32 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-32 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-32 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-31 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-31 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-31 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-31 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-31 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-31 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-31 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-31 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-31 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-31 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-31 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-31 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-30 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-30 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-30 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-30 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-30 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-30 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-30 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-30 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-30 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-30 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-30 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-30 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-30 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-30 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-30 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-30 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-30 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-30 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-30 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-30 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-30 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-30 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-30 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-29 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-29 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-29 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-29 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-29 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-29 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-29 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-29 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-29 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-29 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-29 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-29 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-29 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-29 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-29 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-29 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-28 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-28 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-27 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-27 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-27 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-27 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-27 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-27 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-27 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-27 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-27 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-27 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-27 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-27 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-27 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-27 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-27 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-27 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-27 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-27 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-27 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-27 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-27 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-27 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-27 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-27 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-27 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-27 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-27 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-27 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-27 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-27 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-27 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-27 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-27 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-27 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-26 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-26 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-26 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-26 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-26 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-26 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-26 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-26 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-26 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-25 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-23 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-23 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-23 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-22 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-19 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-16 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 |
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.04 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.54 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.88 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.34 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.7 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.76 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=492.03 Aligned_cols=258 Identities=41% Similarity=0.745 Sum_probs=221.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+++|.++++||+|+||+||++.+. .+++.||||++.+.... ......+.+|+.+|++|+|||||+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 77 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHT--------------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECT--------------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred eeCeEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCe
Confidence 468999999999999999999873 45679999999876553 334567899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++++.+.+||||||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 78 ~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 78 LYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp EEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeec
Confidence 999999999999999999 6899999999899999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
|+|+.........+.+||+.|||||++.+..|++.++|||||||+||+|++|.+||.+.+...+.+.+..+.+.+|..+|
T Consensus 157 Gla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s 236 (275)
T 3hyh_A 157 GLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 236 (275)
T ss_dssp SCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred CCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 99998777667778899999999999999988778999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+++++||.+||++||++|||++|||+||||+...
T Consensus 237 ~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 237 PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 9999999999999999999999999999997543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=493.62 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=234.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..|.+++.||+|+||+||++.+. .+++.||||++.+... .....+.+.+|+++|++|+|||||++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~--------------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l 97 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLAREL--------------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccEEEEEEecccCeEEEEEEEC--------------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 45888999999999999999873 4567899999986543 22345678999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|++.+.+|||||||+||+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 98 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 384 FSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 384 la~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
+|+.+... ....+.+||+.|||||++.+..|+ .++||||||||||+|++|.+||.+.+...+..+|....+.+|..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~ 256 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK 256 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99877532 345678999999999999988886 99999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHH------HHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQ------ISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~e------iL~Hpw~~~ 494 (635)
+|+++++||.+||++||++|||++| |++||||+.
T Consensus 257 ~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp CCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999999987 689999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=500.16 Aligned_cols=256 Identities=26% Similarity=0.515 Sum_probs=228.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.++++||+|+||+||++.+. .+++.||||++.+........+.+.+|+.+|++|+|||||++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~ 88 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST--------------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET--------------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceEEeEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcE
Confidence 468999999999999999999873 456789999999888787788899999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++|++.+.+|||||||+||+|.++|...+ .+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|
T Consensus 89 ~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~D 168 (350)
T 4b9d_A 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168 (350)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECS
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999999997543 579999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-CCCC
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-RIPF 459 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-~~p~ 459 (635)
||+|+.+... ....+.+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+...+..+|..+.+ +++.
T Consensus 169 FGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~ 247 (350)
T 4b9d_A 169 FGIARVLNSTVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL 247 (350)
T ss_dssp TTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred cccceeecCCcccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc
Confidence 9999876543 234567899999999999998886 999999999999999999999999999999999988765 4567
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+|.++++||.+||++||++|||++|||+||||..
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 89999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=496.15 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=229.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||+|+||+||+|.++ .+++.||||++.+..... .+.+.+|+.+|++|+|||||++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~--------------~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l 136 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR--------------SSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEM 136 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCE
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC--------------CCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcE
Confidence 356899999999999999999873 456789999997654332 3567899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|++.+.+|||||||+||+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 137 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 137 YNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCc
Confidence 9999999999999999999999998865 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---CCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF---RIPF 459 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~---~~p~ 459 (635)
+|..+... ....+.+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+...+...|..... ..+.
T Consensus 216 la~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 294 (346)
T 4fih_A 216 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 294 (346)
T ss_dssp TCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGG
T ss_pred CceecCCCCCcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccc
Confidence 99877543 456778999999999999988886 999999999999999999999999998888888876532 3334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+|+++++||.+||++||++|||+.|||+||||....+
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 68999999999999999999999999999999986544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=489.42 Aligned_cols=259 Identities=30% Similarity=0.507 Sum_probs=228.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||+|+||+||++.....+ ..++.||||++.+..........+.+|+.+|++|+|||||++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l 91 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGS-----------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSST-----------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCC-----------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeE
Confidence 457999999999999999999864332 245789999998765443333467899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|++.+.+|||||||+||+|.++|.+.+.+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 92 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 384 FSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 384 la~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
+|+.... .....+.+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+..++...|....+.+|..+|
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 250 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCC
Confidence 9986543 3455678999999999999998887 8999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+++++||.+||++||++||| ++||++||||+.
T Consensus 251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999999999999998 589999999963
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=496.08 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=229.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||.||+|.++ .+++.||||++....... .+.+.+|+.+|++|+|||||++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~--------------~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l 213 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR--------------SSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEM 213 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCE
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC--------------CCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCce
Confidence 356899999999999999999873 456789999998654332 3568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|++.+.+|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFG 292 (423)
T 4fie_A 214 YNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG 292 (423)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCT
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCc
Confidence 9999999999999999999999998864 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cCCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FRIPF 459 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~~p~ 459 (635)
+|..+... ....+.+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+...+...|.... +..+.
T Consensus 293 la~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 371 (423)
T 4fie_A 293 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLH 371 (423)
T ss_dssp TCEECCSSCCCBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred cceECCCCCccccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccc
Confidence 99876543 456778999999999999998886 99999999999999999999999999888888887653 33445
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
.+|+++++||.+||.+||++|||+.|||+||||....+
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 78999999999999999999999999999999986544
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=469.00 Aligned_cols=254 Identities=22% Similarity=0.425 Sum_probs=221.2
Q ss_pred cCCcc-ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQY-NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~-il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..+|+ +.++||+|+||+||+|.+. .++..||||++..........+.+.+|+.+|++|+|||||+
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~ 89 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDT--------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCceEEeeeEEecCcCcEEEEEEEC--------------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 34553 4567999999999999873 45678999999887777777889999999999999999999
Q ss_pred EEEEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeecC-CC
Q psy6357 303 LFQVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFDE-NG 375 (635)
Q Consensus 303 l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~~-~~ 375 (635)
++++|++ ...+|||||||++|+|.++|.+.+.+++..+..|+.||+.||+|||+++ ||||||||+||||+. ++
T Consensus 90 ~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g 169 (290)
T 3fpq_A 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS
T ss_pred EEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC
Confidence 9999865 4568999999999999999999899999999999999999999999998 999999999999984 79
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCc
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-NLAVLKQRILFGK 454 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-~~~~l~~~i~~~~ 454 (635)
.+||+|||+|+... .....+.+||+.|||||++.+ .|+ .++||||||||||||++|.+||.+. +...+...+..+.
T Consensus 170 ~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~ 246 (290)
T 3fpq_A 170 SVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246 (290)
T ss_dssp CEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC
Confidence 99999999998643 345567899999999999876 465 9999999999999999999999764 4555666666553
Q ss_pred c--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 F--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. .++..+++++++||.+||..||++|||+.|||+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 3 345568899999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-57 Score=476.82 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=219.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||+||+|.++ .++..||||+++..... .+|+.+|+.|+|||||++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~--------------~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l 115 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDK--------------QTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPL 115 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCE
T ss_pred hhheEeCcEeccCCCeEEEEEEEC--------------CCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcE
Confidence 345777899999999999999873 45678999999876432 479999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ceeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ikL~DF 382 (635)
+++|.+.+.+|||||||+||+|.++|.+.+.|++..++.|+.||+.||+|||+++||||||||+||||+.++ .+||+||
T Consensus 116 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCC
T ss_pred EEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeC
Confidence 999999999999999999999999999989999999999999999999999999999999999999999987 6999999
Q ss_pred cccccccCCC------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-
Q psy6357 383 GFSNYFTPGH------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF- 455 (635)
Q Consensus 383 Gla~~~~~~~------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~- 455 (635)
|+|+.+.... .....+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+...+...|.....
T Consensus 196 Gla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 274 (336)
T 4g3f_A 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP 274 (336)
T ss_dssp TTCEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG
T ss_pred CCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC
Confidence 9998765432 12346899999999999998886 899999999999999999999998887777788877654
Q ss_pred --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHH-------------HcCccccc
Q psy6357 456 --RIPFYMSAECENLIRSMLVLDPAKRLTLTQI-------------SNHKWMSV 494 (635)
Q Consensus 456 --~~p~~~s~~l~~LI~~~L~~dP~~Rps~~ei-------------L~Hpw~~~ 494 (635)
.+|..+++++.+||.+||.+||.+|||+.|| |+|||+..
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 4567899999999999999999999999998 56899864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=475.70 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=226.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||+||+|.+. .+++.||||++.+........+.+.+|+.+|++|+|||||++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~--------------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 118 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRR--------------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 118 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCeEEEEEEecccCeEEEEEEEC--------------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceE
Confidence 357999999999999999999873 456799999998777667777889999999999999999999
Q ss_pred EEEEec------CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMET------TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~------~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++.. ...+|||||||. |+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+
T Consensus 119 ~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 119 KDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp EEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred eeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCE
Confidence 999753 367999999995 6799999998999999999999999999999999999999999999999999999
Q ss_pred eeecccccccccC-----CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 378 KLADFGFSNYFTP-----GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 378 kL~DFGla~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
||+|||+|+.+.. .....+.+||+.|||||++.+..+++.++||||||||||||++|.+||.+.+..+....|..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999987643 23456789999999999999877767999999999999999999999999998888777753
Q ss_pred CccCC-------------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 453 GKFRI-------------------------------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 453 ~~~~~-------------------------------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..... ...++.++++||.+||.+||.+|||+.|+|+||||+...
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 21111 123689999999999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=448.05 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=221.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||+||+|.+..... ..++..||||+++.. +....+.+.+|+.+|++|+|||||++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~---------~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCP---------EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC-------------CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCccc---------CCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccE
Confidence 3456668999999999999998743211 124678999999754 45566789999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
+++|.+.+.+|||||||++|+|.++|... ..|++..++.|+.||+.||.|||+++||||||||+|||
T Consensus 81 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 160 (299)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence 99999999999999999999999999764 35999999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
|+.++.+||+|||+|+....... ....+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++
T Consensus 161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 239 (299)
T 4asz_A 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239 (299)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999986543322 2345689999999999988886 99999999999999998 9999999999988
Q ss_pred HHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 447 KQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 447 ~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
...+..+. .+.|..+++++.+||.+||+.||++|||+.+| |+|+.
T Consensus 240 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 240 IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 88888765 56788899999999999999999999999999 45664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=443.94 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=210.6
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
..|++.. +.+.+.++||+|+||+||+|.+. ..||||+++....+....+.+.+|+.+|
T Consensus 29 ~~Wei~~-----~~l~l~~~iG~G~fG~Vy~~~~~-----------------~~vAvK~~~~~~~~~~~~~~f~~E~~il 86 (307)
T 3omv_A 29 YYWEIEA-----SEVMLSTRIGSGSFGTVYKGKWH-----------------GDVAVKILKVVDPTPEQFQAFRNEVAVL 86 (307)
T ss_dssp CCCBCCT-----TSCCEEEECCCCSSSEEEEEESS-----------------SEEEEEECCCSSCCHHHHHHHHHHHHHH
T ss_pred cCcEEcH-----HHeEEeeEEeeCCCcEEEEEEEC-----------------CcEEEEEEEecCCCHHHHHHHHHHHHHH
Confidence 4466553 44556899999999999999762 2599999987766777788999999999
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
++|+|||||++++++.. +.+|||||||++|+|.++|... ..+++..+..|+.||+.||+|||+.+||||||||+||||
T Consensus 87 ~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl 165 (307)
T 3omv_A 87 RKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL 165 (307)
T ss_dssp TTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE
T ss_pred HhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE
Confidence 99999999999998864 5689999999999999999654 579999999999999999999999999999999999999
Q ss_pred cCCCCeeeecccccccccC---CCccccccCCCCCCCccccCCC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 372 DENGDIKLADFGFSNYFTP---GHMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~---~~~~~~~~gt~~Y~APEvl~~~---~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
+.++.+||+|||+|+.... .......+||+.|||||++.+. .|+ .++||||||||||||++|+.||.+.+...
T Consensus 166 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 166 HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 9999999999999987643 2334567899999999999643 454 89999999999999999999998866544
Q ss_pred HHHHHHhCcc------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 446 LKQRILFGKF------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 446 l~~~i~~~~~------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
....+..... .++..++.++.+||.+||+.||++|||+.||+++-
T Consensus 245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4443333322 23456899999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=448.74 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=213.9
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.+.+.++||+|+||+||+|.+..... ..++..||||+++.. +....+.+.+|+.+|++|+|||||++++
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~---------~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLP---------EQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC------------CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCccc---------CCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34456899999999999998743211 124678999999754 4556678999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc---------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI---------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~---------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
+|.+...+|||||||++|+|.++|.+. .++++.+++.|+.||+.||.|||+.+||||||||+|||
T Consensus 111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 999999999999999999999998754 35899999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
|+.++.+||+|||+|+...... .....+||+.|||||++.+..|+ .++||||||||||||+| |+.||.+.+..++
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999998764332 23456799999999999998886 99999999999999999 9999999998888
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+..+ .++.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 270 ~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8888776 467788899999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=446.10 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=219.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..+.++++||+|+||+||+|.+..... ..+++.||||++.... .....+.+.+|+.+|++|+|||||+|+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~---------~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAP---------GEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC----------------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCcc---------CCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 345568999999999999998743211 2356789999997543 333456789999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~N 368 (635)
++|.+...+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+.+||||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 9999999999999999999999999643 358999999999999999999999999999999999
Q ss_pred eeecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH
Q psy6357 369 LLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA 444 (635)
Q Consensus 369 ILl~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~ 444 (635)
|||+.++.+||+|||+|+..... ......+||+.|||||++.+..|+ .++||||||||||||+| |..||.+.+..
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876432 234557899999999999988886 99999999999999998 89999999998
Q ss_pred HHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 445 VLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 445 ~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
++...+..+. .+.|..++.++.+||.+||+.||.+|||+.||+++
T Consensus 255 ~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888887764 46788899999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=443.61 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=199.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+++.||+|+||+||+|.++ .++..||||++.... .+...+.+.+|+.+|++|+|||||+++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~--------------~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~ 69 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK--------------VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYF 69 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET--------------TTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC--------------CCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35788999999999999999873 356789999997654 445567889999999999999999999
Q ss_pred EEEecCC------------eEEEEEeccccchhhhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 305 QVMETTN------------NLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 305 ~~~~~~~------------~~~LV~E~~~ggsL~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
++|.+.+ .+|||||||++|+|.+++..... ..+..++.|+.||+.||+|||++|||||||||+||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NI 149 (299)
T 4g31_A 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149 (299)
T ss_dssp EEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred EEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHe
Confidence 9986543 47999999999999999987654 45677899999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCC-------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCC
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGH-------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~-------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~ 436 (635)
||+.++.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+ .++||||||||||||++
T Consensus 150 Ll~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp EECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---
T ss_pred EECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---
Confidence 99999999999999998765432 22456899999999999998886 99999999999999996
Q ss_pred CCCCCCH-HHHHHHHHhCccC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 437 PFDGPNL-AVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 437 PF~~~~~-~~l~~~i~~~~~~-~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
||..... ......+....++ .+...++.+.+||.+||+.||++|||+.|||+||||+.
T Consensus 226 Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 226 PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 7865322 2223333333221 11235677899999999999999999999999999963
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=451.04 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=208.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
+.+.|.++++||+|+||+||+|.++... ..+..||||++..... ..++.+|+++|+.+ .|||||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----------~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv 83 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQV-----------GPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVM 83 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTT-----------SCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBC
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccC-----------CCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCc
Confidence 4567999999999999999999875432 2346899999866532 24678999999998 699999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-CCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-GDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-~~ikL~ 380 (635)
+++++|.+.+++|||||||++++|.+++. .+++.+++.++.||+.||+|||++||+||||||+||||+.+ +.+||+
T Consensus 84 ~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 84 GVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp CCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999999999999884 59999999999999999999999999999999999999877 799999
Q ss_pred cccccccccCC-----------------------------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHH
Q psy6357 381 DFGFSNYFTPG-----------------------------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVM 431 (635)
Q Consensus 381 DFGla~~~~~~-----------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeL 431 (635)
|||+|+..... ....+.+||++|||||++.+..+++.++||||+|||+|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 99999754322 1234568999999999998877556999999999999999
Q ss_pred HhCCCCCCCC-CHHHHHHHHHh--------------------------------------Ccc----------------C
Q psy6357 432 VTAQLPFDGP-NLAVLKQRILF--------------------------------------GKF----------------R 456 (635)
Q Consensus 432 ltG~~PF~~~-~~~~l~~~i~~--------------------------------------~~~----------------~ 456 (635)
++|+.||... +.......|.. ... .
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 9999999543 33333332211 000 0
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
....+|+++++||.+||++||++|+|++|+|+||||+
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 1124789999999999999999999999999999996
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=436.90 Aligned_cols=263 Identities=54% Similarity=0.915 Sum_probs=246.1
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.....+|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|+.++||||
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 76 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHI--------------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCE
Confidence 345778999999999999999999872 456789999998877777778889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.....+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~ 156 (328)
T 3fe3_A 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIA 156 (328)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred eeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999988999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
|||++............+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+...+...+..+.+.+|..
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 157 DFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236 (328)
T ss_dssp STTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred eccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 99999887776677788999999999999988887789999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
++.++.+||.+||..||.+|||++|||+||||.....
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 9999999999999999999999999999999986543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=475.15 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=233.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||.||++.++ .++..||||++.... ....+.+.+|+.+|+.|+|||||+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~--------------~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~ 218 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTER--------------ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVN 218 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCC
T ss_pred CccccEEEEEEeeccCeEEEEEEEC--------------CCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCe
Confidence 4568999999999999999999873 456789999997653 344567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC--CCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN--GDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~--~~ikL 379 (635)
|+++|++...+|||||||+||+|.++|.. .+.|++.++..|+.||+.||.|||+++|+||||||+||||+.+ +.+||
T Consensus 219 l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEE
Confidence 99999999999999999999999999864 4679999999999999999999999999999999999999854 89999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP- 458 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p- 458 (635)
+|||+|+.+.........+||+.|||||++.+..|+ .++||||||||||+|++|.+||.+.+..++...|....+.++
T Consensus 299 ~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 299 IDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 377 (573)
T ss_dssp CCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS
T ss_pred eeccceeEccCCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc
Confidence 999999998877778888999999999999999886 999999999999999999999999999999999988876655
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+|.++++||.+||.+||.+|||+.|||+||||+..
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 3589999999999999999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=474.91 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=227.6
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc----CHHHHHHHHHHHHHHhhCC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL----DERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~----~~~~~~~~~~Ei~iL~~L~ 296 (635)
.+..+.|.+++.||+|+||.||++... .++..||||++.+..+ ..........++.+++.++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~--------------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~ 250 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKA--------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC
T ss_pred CCchHHeEEEEEEecccCeEEEEEEEC--------------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC
Confidence 456788999999999999999999873 4667999999976543 1222233344577788889
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
|||||+|+++|++.+.+|||||||.||+|.++|.+.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+|+
T Consensus 251 HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC
T ss_pred CCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---NLAVLKQRILFG 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---~~~~l~~~i~~~ 453 (635)
+||+|||+|..+... ...+.+||+.|||||++.....++.++||||||||||||++|.+||.+. +...+...+...
T Consensus 331 vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~ 409 (689)
T 3v5w_A 331 VRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409 (689)
T ss_dssp EEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC
T ss_pred EEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Confidence 999999999876543 3467899999999999975433349999999999999999999999753 455677788888
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
.+.+|..+|+++++||.+||++||.+|++ ++||++||||..
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 88999999999999999999999999998 799999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=444.33 Aligned_cols=263 Identities=21% Similarity=0.342 Sum_probs=222.7
Q ss_pred chhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHH
Q psy6357 211 TLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVD 290 (635)
Q Consensus 211 tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~ 290 (635)
...+|++. ..+|.+.++||+|+||+||+|.+...... ..++.||||++.... .....+.+.+|+.
T Consensus 55 ~~~~wEi~-----~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~---------~~~k~VAvK~l~~~~-~~~~~~~~~~E~~ 119 (353)
T 4ase_A 55 DASKWEFP-----RDRLKLGKPLGRGAFGQVIEADAFGIDKT---------ATCRTVAVKMLKEGA-THSEHRALMSELK 119 (353)
T ss_dssp CHHHHBCC-----GGGEEEEEEEEECSSEEEEEEEEETSSST---------TCEEEEEEEEECTTC-CHHHHHHHHHHHH
T ss_pred CCcccEec-----HHHeEEeeEEecCCCeEEEEEEEcCCCcc---------cCCeEEEEEEEcccc-ChHHHHHHHHHHH
Confidence 34568766 45677799999999999999987543321 234679999997654 4455678999999
Q ss_pred HHhhCCC-CceeeEEEEEec-CCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhh
Q psy6357 291 IMSHLDH-PHIIKLFQVMET-TNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVA 352 (635)
Q Consensus 291 iL~~L~H-pnIv~l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~ 352 (635)
+|.++.| ||||+++++|.. ...+|||||||++|+|.++|... ..+++..+..|+.||+.||+
T Consensus 120 il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 199 (353)
T 4ase_A 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 199 (353)
T ss_dssp HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH
Confidence 9999975 899999999865 46799999999999999999753 23899999999999999999
Q ss_pred hhccCceeeecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHH
Q psy6357 353 YCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429 (635)
Q Consensus 353 ~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvily 429 (635)
|||+++||||||||+||||+.++.+||+|||+|+.+.... .....+||+.|||||++.+..|+ .++|||||||+||
T Consensus 200 yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~ 278 (353)
T 4ase_A 200 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 278 (353)
T ss_dssp HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHH
T ss_pred hHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHH
Confidence 9999999999999999999999999999999998765432 23456789999999999988886 9999999999999
Q ss_pred HHHh-CCCCCCCCCH-HHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 430 VMVT-AQLPFDGPNL-AVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 430 eLlt-G~~PF~~~~~-~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
||++ |..||.+.+. ..+...+..+ .++.|..+++++.+||.+||+.||++|||+.||++|
T Consensus 279 El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 279 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9998 9999988664 4445555544 467788899999999999999999999999999988
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=427.32 Aligned_cols=295 Identities=37% Similarity=0.667 Sum_probs=251.4
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~Hpn 299 (635)
...+++|.+++.||+|+||.||++.+. .++..||||++....... .....+.+|+.+|+.++|||
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 70 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHY--------------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTT
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCC
Confidence 356788999999999999999999872 456789999997543221 12356889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.....+||||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 71 Iv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 149 (336)
T 3h4j_B 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKI 149 (336)
T ss_dssp BCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEE
T ss_pred CCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEE
Confidence 999999999999999999999 7899999988889999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||++............+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.......+...+....+.+|.
T Consensus 150 ~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 229 (336)
T 3h4j_B 150 ADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD 229 (336)
T ss_dssp CCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCT
T ss_pred EEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcc
Confidence 99999998877777778899999999999998888668999999999999999999999988777776677777778888
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCCCCCcccCCCC-CCCCCCChHHHHHHhcCccchhhhhh
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVP-SEPKLPNSFVIDQMLQLPALTRNRIL 533 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~i~ 533 (635)
.++.++.+||.+||..||.+|||+.||++||||+...+... .|.. ......+..+...+.+..+.+.+.|.
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 301 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL---RPMEEVQGSYADSRIVSKLGEAMGFSEDYIV 301 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCGGG---SCCCCCCCCCCCHHHHHHHHHTTCCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcccc---CCchhcccccCCHHHHHHHHHHcCCCHHHHH
Confidence 99999999999999999999999999999999986544221 1211 12234456666666666666666554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=418.43 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=233.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..+.|.+++.||+|+||.||++... .++..||||++.+... .......+.+|+.+|+.++||||+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 68 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREK--------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBC
T ss_pred ChHHeEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCc
Confidence 3567888999999999999999873 3567899999976432 222346788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.+.+.+||||||+++++|..++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 69 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred cccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 382 FGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 382 FGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
||++.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|..
T Consensus 149 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~ 227 (337)
T 1o6l_A 149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227 (337)
T ss_dssp CTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred ccchhhcccCCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 99998643 33456678899999999999988876 99999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
++.++.+||.+||..||.+|| ++.||++||||..
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999999 9999999999963
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=419.32 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=232.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCCC
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~H 297 (635)
...+.|.+++.||+|+||.||++.+. .++..||||++.+..... ...+.+.+|+.+|++++|
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~--------------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h 74 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREK--------------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEEC--------------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC
Confidence 45567899999999999999999873 356789999998764321 124678899999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC--
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-- 375 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-- 375 (635)
|||++++++|.+...+|||||||.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++
T Consensus 75 pnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred cCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCC
Confidence 999999999999999999999999999999999888999999999999999999999999999999999999998877
Q ss_pred --CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 376 --DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 376 --~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
.+||+|||++............+||+.|+|||++.+..++ .++||||||||+|+|++|..||.+.+...+...+...
T Consensus 155 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp SCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 7999999999887766666778899999999999988876 9999999999999999999999999999999999888
Q ss_pred ccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 KFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.+.++ ..++.++++||.+||..||.+|||+.|+|+||||.
T Consensus 234 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 234 SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 77665 46899999999999999999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=424.00 Aligned_cols=258 Identities=27% Similarity=0.489 Sum_probs=227.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
...+.|.+++.||+|+||.||++.+. .++..||||++.+... .......+.+|+.+|..+ +|||
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~ 85 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK--------------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTT
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc--------------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCc
Confidence 45678999999999999999999873 3567899999976532 233456788999999988 7999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+|||||||.+++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 86 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 86 LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred eeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999999899999999999999999999999999999999999999999999999
Q ss_pred eccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||+|.... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...|......+|
T Consensus 166 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 244 (353)
T 3txo_A 166 ADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244 (353)
T ss_dssp CCCTTCBCSCC---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccccceeecccCCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999998643 33445677899999999999887776 899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTL------TQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~------~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||.+||.+||++ .+|++||||..
T Consensus 245 ~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 9999999999999999999999999 99999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=418.27 Aligned_cols=259 Identities=32% Similarity=0.559 Sum_probs=236.1
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
......|.++++||+|+||.||++.+. .++..||||++............+.+|+.+|+.|+||||
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 90 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHK--------------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEEC--------------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCC
Confidence 344567899999999999999999873 356789999998877777777889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---Ce
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---DI 377 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---~i 377 (635)
|++++++.+....|||||||.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++ .+
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCE
Confidence 999999999999999999999999999998888899999999999999999999999999999999999998654 59
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
||+|||++............+||+.|+|||++.+..++ .++||||||||+|+|++|.+||.+.+...+...+..+.+.+
T Consensus 171 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249 (362)
T ss_dssp EECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEeecCcceEecCCcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999999887766666678899999999999988876 89999999999999999999999999989999998887766
Q ss_pred CC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 458 PF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 458 p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
|. .++.++.+||.+||..||.+|||+.++|+||||..
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 64 47999999999999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=409.36 Aligned_cols=255 Identities=27% Similarity=0.532 Sum_probs=231.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....|.+++.||+|+||.||++... .++..||||++.+.... ....+.+.+|+.+|+.++||||+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv 69 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSR--------------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBC
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCc
Confidence 4567888999999999999999872 35678999999764321 12346678999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.+...+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECC
T ss_pred eEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEee
Confidence 99999999999999999999999999999888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+|..+
T Consensus 150 fg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~ 226 (318)
T 1fot_A 150 FGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 226 (318)
T ss_dssp CSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred cCcceecCC--ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 999987543 34567899999999999988876 999999999999999999999999999999999999989999999
Q ss_pred CHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 462 SAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+.++.+||.+||..||.+|| ++++|++||||..
T Consensus 227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999999999999 9999999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=422.64 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=229.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
+....|.++++||+|+||.||++.+. .++..||||++.+.... ......+.+|+.+|.++ +|||
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~--------------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~ 114 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLK--------------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTT
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCC
Confidence 44667888999999999999999873 34578999999876543 34456678999999887 8999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
||+++++|.+...+|||||||.+++|..++.+.+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 115 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL 194 (396)
T 4dc2_A 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 194 (396)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred cCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred eccccccc-ccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---------CHHHHHHH
Q psy6357 380 ADFGFSNY-FTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP---------NLAVLKQR 449 (635)
Q Consensus 380 ~DFGla~~-~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~---------~~~~l~~~ 449 (635)
+|||+|.. ........+.+||+.|+|||++.+..++ .++||||||||||+|++|.+||... ....+.+.
T Consensus 195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred eecceeeecccCCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 99999986 3344566778999999999999998886 9999999999999999999999642 34557788
Q ss_pred HHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCccccc
Q psy6357 450 ILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTL------TQISNHKWMSV 494 (635)
Q Consensus 450 i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~------~eiL~Hpw~~~ 494 (635)
+....+.+|..++.++.+||.+||+.||.+||++ .||++||||..
T Consensus 274 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred HhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 8888899999999999999999999999999984 89999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=410.79 Aligned_cols=258 Identities=29% Similarity=0.525 Sum_probs=230.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
.....|.+++.||+|+||.||++.+. .++..||||++.+... .......+.+|+.+|.++ +|||
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~ 71 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLK--------------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTT
T ss_pred CchhheEEEEEEEecCCeEEEEEEEC--------------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCc
Confidence 44567888999999999999999873 3457899999987654 455667788999999988 8999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+||||||+++++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 72 iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL 151 (345)
T 3a8x_A 72 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 151 (345)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred cCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred eccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC---------CCHHHHHHH
Q psy6357 380 ADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG---------PNLAVLKQR 449 (635)
Q Consensus 380 ~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~---------~~~~~l~~~ 449 (635)
+|||++.... ........+||+.|+|||++.+..++ .++||||||||+|+|++|..||.. .....+.+.
T Consensus 152 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 152 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred EeccccccccCCCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 9999998643 34456678999999999999988875 999999999999999999999975 344566778
Q ss_pred HHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCH------HHHHcCccccc
Q psy6357 450 ILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTL------TQISNHKWMSV 494 (635)
Q Consensus 450 i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~------~eiL~Hpw~~~ 494 (635)
+......+|..++.++.+||.+||..||.+||++ .+|++||||..
T Consensus 231 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 231 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 8888888999999999999999999999999995 89999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=429.30 Aligned_cols=265 Identities=40% Similarity=0.715 Sum_probs=241.7
Q ss_pred cCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCC
Q psy6357 219 RGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 219 ~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~H 297 (635)
.+......|.+++.||+|+||.||+|.+. .++..||||++....... .....+.+|+.+|+.++|
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~--------------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H 75 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHE--------------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEET--------------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC
Confidence 35567889999999999999999999873 356789999997653221 234678899999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
|||+++++++.....+|||||||++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 76 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCE
T ss_pred CCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCe
Confidence 99999999999999999999999999999999988899999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
||+|||++..........+.+||+.|+|||++.+..+.+.++||||||||+|+|++|..||...+...+...+..+.+..
T Consensus 156 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 235 (476)
T 2y94_A 156 KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235 (476)
T ss_dssp EECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC
T ss_pred EEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 99999999987776667788999999999999988876689999999999999999999999999889999999988889
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
|..++.++.+||.+||..||.+|||+.||++||||....+
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 9999999999999999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=397.47 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=217.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++++||+|+||+||++.+. .++..||||++............+.+|+.+|++++||||++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 67 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR--------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC--------------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEE
Confidence 57899999999999999999873 3567899999987766666667888999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+|||||||.++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999999999999997654444444467899999999999999999999999999999999999999999999999999
Q ss_pred cccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCc--------
Q psy6357 385 SNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPNLAVLKQRILFGK-------- 454 (635)
Q Consensus 385 a~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P-F~~~~~~~l~~~i~~~~-------- 454 (635)
+..... .......++|+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+....
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 987643 23445668899999999998877445999999999999999987766 66666666555554210
Q ss_pred ---------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 455 ---------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 455 ---------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
......++.++.+||.+||+.||++|||++|||+||||+..++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 0111247899999999999999999999999999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=425.18 Aligned_cols=258 Identities=31% Similarity=0.539 Sum_probs=232.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...+.|.++++||+|+||+||++... .++..||+|++............+.+|+.+|+.|+|||||
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~--------------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv 73 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKV--------------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEET--------------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred cccCCeEEEEEeccCCCeEEEEEEEC--------------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCC
Confidence 34567889999999999999999873 3567899999988777667778899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec---CCCCee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD---ENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~---~~~~ik 378 (635)
++++++.+.+.+|||||||.+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||||+ .++.+|
T Consensus 74 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp CEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEE
T ss_pred eEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEE
Confidence 99999999999999999999999999999989999999999999999999999999999999999999998 467899
Q ss_pred eecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 379 LADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 379 L~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
|+|||++...... ......+||+.|+|||++.+..++ .++||||||||+|+|++|.+||.+.+...+...+..+.+.+
T Consensus 154 L~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 154 LADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF 232 (444)
T ss_dssp ECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred EccCceeEEecCCCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC
Confidence 9999999876543 334567899999999999988876 89999999999999999999999999999999999887766
Q ss_pred CC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 458 PF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 458 p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+. .+++++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 54 57999999999999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=413.84 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=232.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
.....|.+++.||+|+||.||++.+. .++..||||++.+... .......+..|+.+|..+ .||+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~ 82 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERK--------------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEET--------------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTT
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCE
Confidence 45678999999999999999999873 3456899999976532 122346778999999988 7999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+|||||||++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 83 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 83 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred eccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||++.... ........+||+.|+|||++.+..++ .++|||||||++|||++|..||.+.+...+.+.|....+.+|
T Consensus 163 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 241 (353)
T 2i0e_A 163 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241 (353)
T ss_dssp CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EeCCcccccccCCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999998643 33455678899999999999988886 999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||..||.+||+ +.+|++||||..
T Consensus 242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999999999999999994 699999999973
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=412.22 Aligned_cols=266 Identities=32% Similarity=0.577 Sum_probs=238.4
Q ss_pred hhhhhhcc-CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHH
Q psy6357 212 LDEWKASR-GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREV 289 (635)
Q Consensus 212 l~e~~~~~-~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei 289 (635)
+..|.... ......+|.+++.||+|+||.||++.+. .++..||||++.+... .......+.+|+
T Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~ 92 (350)
T 1rdq_E 27 LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--------------ESGNHYAMKILDKQKVVKLKQIEHTLNEK 92 (350)
T ss_dssp HHHHHSCCCCCCCGGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHH
T ss_pred HhhhccccccCCCHHHCEEEEEeecCcCcEEEEEEEC--------------CCCCEEEEEEEEhHHhccHHHHHHHHHHH
Confidence 34454432 3456789999999999999999999873 3567899999976532 122346788999
Q ss_pred HHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 290 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
.+|+.++||||+++++++.+...+||||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 93 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp HHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 99999999999999999999999999999999999999999888999999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
||+.++.+||+|||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...
T Consensus 173 ll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 249 (350)
T 1rdq_E 173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249 (350)
T ss_dssp EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999999999876532 3467899999999999988876 999999999999999999999999999999999
Q ss_pred HHhCccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 450 ILFGKFRIPFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 450 i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+..+...+|..++.++.+||.+||+.||.+||+ +++|++||||..
T Consensus 250 i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 250 IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999999999999999999999999998 999999999963
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=408.92 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=192.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.+.++||+|+||+||+|.+ .++.||||++.... ........|+.++.+|+|||||+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~----------------~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~ 63 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW----------------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 63 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE----------------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE----------------CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEE
Confidence 3456678999999999999987 34689999996542 1112234566677789999999999
Q ss_pred EEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC--------ceeeecccCcceeec
Q psy6357 305 QVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN--------NVVHRDIKAENLLFD 372 (635)
Q Consensus 305 ~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~--------gIiHrDLKp~NILl~ 372 (635)
+++...+ .+|||||||++|+|.++|.. ..+++..+..|+.|++.||+|||+. +||||||||+||||+
T Consensus 64 g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~ 142 (303)
T 3hmm_A 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC
Confidence 9997653 68999999999999999975 5699999999999999999999987 899999999999999
Q ss_pred CCCCeeeecccccccccCCC-----ccccccCCCCCCCccccCCCC------cCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy6357 373 ENGDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGRE------YDGTKSDVWSLGVVLYVMVTAQLPFDGP 441 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~------~~~~ksDIwSlGvilyeLltG~~PF~~~ 441 (635)
.++.+||+|||+|+...... .....+||+.|||||++.+.. ++ .++||||||||||||++|.+||...
T Consensus 143 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~-~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccC-hhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 99999999999998765432 223468999999999997652 33 7899999999999999997765321
Q ss_pred ---------------CHHHHHHHHHhCcc--CCCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 ---------------NLAVLKQRILFGKF--RIPFY-----MSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 ---------------~~~~l~~~i~~~~~--~~p~~-----~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
....+...+....+ .+|.. ++..+.+||.+||+.||++|||+.||++.
T Consensus 222 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 23344444444433 23322 33578999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.22 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=225.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...++|.++++||+|+||+||++.+. .++..||||++....... .+.+.+|+.+|+.++||||+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv 80 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDV--------------ATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIV 80 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBT--------------TTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBC
T ss_pred ChhhceeeeeeeccCCCeEEEEEEEC--------------CCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCC
Confidence 35678999999999999999999762 456789999997654333 35678999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++...+.+|+|||||.+++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred eEeEEEEECCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999999999998876 4699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCC
Q psy6357 382 FGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRI 457 (635)
Q Consensus 382 FGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~ 457 (635)
||++...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+... ....
T Consensus 160 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T 3fxz_A 160 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238 (297)
T ss_dssp CTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSC
T ss_pred CCCceecCCcccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 9999876543 334567899999999999988886 9999999999999999999999988776655555433 3344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
|..++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 667899999999999999999999999999999998653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=392.41 Aligned_cols=260 Identities=32% Similarity=0.558 Sum_probs=236.7
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
+.+.++|.++++||+|+||.||++.+. .++..||||++............+.+|+.++++++||||
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 67 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHK--------------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEc--------------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCc
Confidence 355688999999999999999999873 346789999998877777778889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC---e
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD---I 377 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~---i 377 (635)
+++++++......|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++. +
T Consensus 68 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~ 147 (284)
T 3kk8_A 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 147 (284)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCE
T ss_pred CeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcE
Confidence 9999999999999999999999999999998889999999999999999999999999999999999999987655 9
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
||+|||++.............||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+......+
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (284)
T 3kk8_A 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226 (284)
T ss_dssp EECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC
Confidence 99999999887766666677899999999999988876 89999999999999999999999999888888888776665
Q ss_pred CC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 PF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
|. .++.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 53 579999999999999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=414.42 Aligned_cols=258 Identities=28% Similarity=0.508 Sum_probs=231.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
.....|.+++.||+|+||.||++.++ .++..||||++.+... .......+..|..+|..+ +|||
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~ 79 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK--------------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTT
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCC
Confidence 45678889999999999999999873 3457899999976532 122345678899999876 8999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+|||||||++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 80 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 80 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred CCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|
T Consensus 160 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 238 (345)
T 1xjd_A 160 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 238 (345)
T ss_dssp CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred eEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99999986532 3345677899999999999988876 999999999999999999999999999999999999988899
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHH-HHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLT-QISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~-eiL~Hpw~~~ 494 (635)
..++.++.+||.+||..||.+||++. +|++||||..
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999999999999998 9999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=415.85 Aligned_cols=260 Identities=24% Similarity=0.471 Sum_probs=232.3
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
+.+.++.|.+++.||+|+||.||++.+. .++..||||++.+... .......+.+|+.+|+.++||
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~--------------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp 75 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKN--------------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCT
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCC
Confidence 4566788999999999999999999873 3457899999976432 223346788999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
|||+++++|.+...+|+|||||.+++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus 76 ~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp TBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEE
Confidence 99999999999999999999999999999999888999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHh
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDG---PNLAVLKQRILF 452 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~---~~~~~l~~~i~~ 452 (635)
|+|||++............+||+.|+|||++.. ..++ .++||||||||||+|++|..||.. .....+...+..
T Consensus 156 L~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~ 234 (384)
T 4fr4_A 156 ITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234 (384)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred EeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence 999999998777667778899999999999974 3354 899999999999999999999974 345666777777
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHcCccccc
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRLT-LTQISNHKWMSV 494 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps-~~eiL~Hpw~~~ 494 (635)
....+|..++.++.+||.+||..||.+||+ +++|++||||..
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 788889999999999999999999999998 999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=401.64 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=214.2
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
+.+.++|.++++||+|+||+||++.+ .++..||||++............+.+|+.+|++++||||
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 81 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKD---------------SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEE---------------TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTB
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEE---------------CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCE
Confidence 35678999999999999999999986 235689999997665555455778899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++.+...+|||||||.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp CCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEE
Confidence 9999999999999999999975 777777654 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---
Q psy6357 380 ADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF--- 455 (635)
Q Consensus 380 ~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~--- 455 (635)
+|||++...... ......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 161 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp CCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred ccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence 999999876432 3445568899999999998754445999999999999999999999988765555544432100
Q ss_pred ---------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 456 ---------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 456 ---------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+...++.++.+||.+||++||.+|||+.|||+||||+.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0112467899999999999999999999999999999743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=404.40 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=229.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCCCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~Hp 298 (635)
..+.|.+++.||+|+||.||++.+. .++..||||++....... ...+.+.+|+.+|+.++||
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 74 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREK--------------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEET--------------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCT
T ss_pred cccceEeceEEeeCCCeEEEEEEEC--------------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCC
Confidence 4456888999999999999999873 356789999997654321 1246788999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG--- 375 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~--- 375 (635)
||+++++++.....+|+|||||++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++
T Consensus 75 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred CCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence 99999999999999999999999999999998888899999999999999999999999999999999999999887
Q ss_pred -CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 376 -DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 376 -~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
.+||+|||++............+||+.|+|||++.+..++ .++||||||||+|+|++|..||.+.+.......+....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC
Confidence 8999999999887665566677899999999999888876 89999999999999999999999988888888887766
Q ss_pred cCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 FRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+.++ ..++..+.+||.+||..||.+|||+.|||+||||..
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 6554 358999999999999999999999999999999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=404.89 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=223.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHHHHHHHHHHhhCCCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
+....|.+++.||+|+||.||++...... .++..||||++.+... .......+.+|+.+|+.++|||
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 82 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGA-----------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSST-----------TTTCEEEEEEECCC--------------HHHHHHHCCCTT
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccC-----------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCC
Confidence 44677888999999999999999874322 3567899999987643 2234466789999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++...+.+|||||||++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl 162 (327)
T 3a62_A 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKL 162 (327)
T ss_dssp BCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEE
T ss_pred ccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+......+|
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99999976432 3344567899999999999888775 899999999999999999999999999899999998888999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||..||.+|| ++.||++||||..
T Consensus 242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999999999 8999999999973
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=406.12 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=230.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||+||++.+. .++..||+|++.... .....+.+|+.+|+.++||||++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~ 65 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVET--------------SSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILH 65 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCC
T ss_pred hhhceEeeeEEecCCCeEEEEEEEC--------------CCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCe
Confidence 4578999999999999999999873 345789999997542 33466889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC--CCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--NGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--~~~ikL 379 (635)
+++++.+...+|+|||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 66 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEE
Confidence 9999999999999999999999999997654 6999999999999999999999999999999999999987 789999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...+...+....+.++.
T Consensus 146 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 146 IEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred EECCCCeECCCCCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh
Confidence 999999988776666778899999999999888775 8999999999999999999999999999888988888776653
Q ss_pred ----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 ----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 689999999999999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=408.95 Aligned_cols=260 Identities=35% Similarity=0.587 Sum_probs=215.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||+|+||+||++.+. .++..||||++....... ..+.+|+.+++.++||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDK--------------LTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEET--------------TTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEEC--------------CCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCC
Confidence 34578999999999999999999873 356789999997654332 4577999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC--eee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD--IKL 379 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~--ikL 379 (635)
++++++.....+|||||||.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++. +||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 999999999999999999999999999988889999999999999999999999999999999999999987765 999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCcc
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQRILFGKF 455 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~i~~~~~ 455 (635)
+|||++............+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.. .....+.+....+
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 999999865554555667899999999999888887556999999999999999999998743 3455566666666
Q ss_pred CCCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCCC
Q psy6357 456 RIPF--YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPG 498 (635)
Q Consensus 456 ~~p~--~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~~ 498 (635)
.+|. .++.++.+||.+||..||.+|||+.|||+||||....+.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 6655 589999999999999999999999999999999765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=426.66 Aligned_cols=256 Identities=25% Similarity=0.457 Sum_probs=213.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||+||++.+. .++..||||++............+.+|+.+|+.++|||||+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 125 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA--------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET--------------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC--------------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4688999999999999999999873 34578999999877667777788999999999999999999
Q ss_pred EEEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++... ..+|||||||.++ |.+.+.. .+++..++.++.||+.||+|||+.||+||||||+||||+.++.
T Consensus 126 l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 126 LLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp CSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred EEEEEccCCccccCCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC
Confidence 99999654 4689999999755 5555543 5999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
+||+|||+|............+||+.|+|||++.+..|+ .++||||||||||+|++|.+||.+.+..+....|....
T Consensus 203 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 203 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp EEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999987766667778999999999999998886 89999999999999999999999988766666554310
Q ss_pred -------------------------cCC----CCC-----------CCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 -------------------------FRI----PFY-----------MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 -------------------------~~~----p~~-----------~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+ |.. .+.++.+||.+||.+||.+|||++|||+||||..
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000 000 1567999999999999999999999999999986
Q ss_pred CC
Q psy6357 495 HC 496 (635)
Q Consensus 495 ~~ 496 (635)
..
T Consensus 362 ~~ 363 (464)
T 3ttj_A 362 WY 363 (464)
T ss_dssp GC
T ss_pred cc
Confidence 43
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=394.37 Aligned_cols=257 Identities=30% Similarity=0.561 Sum_probs=219.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----------------------
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE---------------------- 279 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~---------------------- 279 (635)
+..++|.++++||+|+||.||++.+. .++..||||++.......
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 75 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNE--------------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEET--------------TTTEEEEEEEEECC--------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEEEEC--------------CCCcEEEEEEeehhhhhhhccccccccccccccccccccc
Confidence 55678999999999999999999873 345789999997654321
Q ss_pred --HHHHHHHHHHHHHhhCCCCceeeEEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc
Q psy6357 280 --RNLRKLFREVDIMSHLDHPHIIKLFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355 (635)
Q Consensus 280 --~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH 355 (635)
...+.+.+|+.+|++++||||+++++++.+ ...+||||||+++++|.+++. ...+++..++.++.||+.||.|||
T Consensus 76 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp -----CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 124568899999999999999999999986 678999999999999988654 467999999999999999999999
Q ss_pred cCceeeecccCcceeecCCCCeeeecccccccccCC-CccccccCCCCCCCccccCCCCc--CCCccchhhHHHHHHHHH
Q psy6357 356 ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREY--DGTKSDVWSLGVVLYVMV 432 (635)
Q Consensus 356 s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~--~~~ksDIwSlGvilyeLl 432 (635)
+.||+||||||+||||+.++.+||+|||++...... .......||+.|+|||++.+... .+.++|||||||++|+|+
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999999999999999999999876543 23455689999999999976542 347899999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhCccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 433 TAQLPFDGPNLAVLKQRILFGKFRIP--FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 433 tG~~PF~~~~~~~l~~~i~~~~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+|..||.......+...+......+| ..++.++.+||.+||..||.+|||+.|||+||||.
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 99999999888888888877666555 36899999999999999999999999999999995
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=410.51 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=209.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI 300 (635)
...++|.++++||+|+||.||++.+. .++..||||++............+.+|+.+|+++. ||||
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~ni 71 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDR--------------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI 71 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEET--------------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTB
T ss_pred cccCceEEEEEeeeCCCeEEEEEEEC--------------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCC
Confidence 45678999999999999999999873 45678999999876666777788999999999997 9999
Q ss_pred eeEEEEEecCC--eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 301 IKLFQVMETTN--NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 301 v~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
+++++++...+ .+|||||||. ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+||||+.++.+|
T Consensus 72 v~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 72 VNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp CCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred CeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEE
Confidence 99999997543 7999999997 688887765 5799999999999999999999999999999999999999999999
Q ss_pred eecccccccccC----------------------CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCC
Q psy6357 379 LADFGFSNYFTP----------------------GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436 (635)
Q Consensus 379 L~DFGla~~~~~----------------------~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~ 436 (635)
|+|||+|+.+.. .......+||++|+|||++.+...++.++||||||||||+|++|.+
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 999999976532 1234557899999999999874444599999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCc-----------------------------------------------cCCCCCCCHHHHHHH
Q psy6357 437 PFDGPNLAVLKQRILFGK-----------------------------------------------FRIPFYMSAECENLI 469 (635)
Q Consensus 437 PF~~~~~~~l~~~i~~~~-----------------------------------------------~~~p~~~s~~l~~LI 469 (635)
||.+.+.......|.... ...+..++.++.+||
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 999988776666554210 001125789999999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 470 RSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 470 ~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+||++||.+|||++|+|+||||...
T Consensus 310 ~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHhhccCcccCCCHHHHhCCHHHHHh
Confidence 99999999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=411.22 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=224.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHH-HhhCCCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDI-MSHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~i-L~~L~Hpn 299 (635)
.....|.+++.||+|+||.||++.++ .++..||||++.+.... ......+..|..+ ++.++|||
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~--------------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~ 100 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHK--------------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEET--------------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTT
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEc--------------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCC
Confidence 44567888999999999999999873 34578999999876543 3344567788877 57789999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
||+++++|.+.+.+|||||||.+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred eccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||++.... ........+||+.|+|||++.+..++ .++||||||||+|||++|..||.+.+...+...|......+|
T Consensus 181 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 259 (373)
T 2r5t_A 181 TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259 (373)
T ss_dssp CCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC
T ss_pred eeCccccccccCCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 9999998643 33456678999999999999988876 999999999999999999999999999999999999888899
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH----HHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTL----TQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~----~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||+.||.+||++ .+|++||||..
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999999999999986 69999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=422.48 Aligned_cols=258 Identities=31% Similarity=0.521 Sum_probs=223.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
+....|.++++||+|+||.||++.+. .++..||||++..... .......+.+|+.+|+.++||||
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 210 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEK--------------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTS
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEc--------------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeE
Confidence 44567899999999999999999872 4567899999976533 33445677899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++...+.+|||||||++++|.+++.....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||
T Consensus 211 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp CCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEE
T ss_pred eeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999999988899999999999999999999998 99999999999999999999999
Q ss_pred eccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 380 ADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 380 ~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
+|||+|.... ........+||+.|+|||++.+..++ .++||||||||||+|++|..||.+.+...+...+......+|
T Consensus 291 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 291 TDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP 369 (446)
T ss_dssp CCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccCCCceeccCCCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999998643 33445678899999999999888886 999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
..++.++.+||.+||..||.+|| |+.|||+||||..
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999999999999999 9999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=389.32 Aligned_cols=263 Identities=41% Similarity=0.699 Sum_probs=226.6
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~Hp 298 (635)
+.+..++|.++++||+|+||.||++.+. .++..||||++...... ......+.+|+.+|+.++||
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 71 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQ--------------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCT
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEEC--------------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCC
Confidence 4567789999999999999999999873 34678999999754321 12345788999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
||+++++++.....+|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+|
T Consensus 72 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEE
T ss_pred CEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEE
Confidence 99999999999999999999999999999998888999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
|+|||++.............+|+.|+|||++.+..+.+.++||||||+++|+|++|..||.......+...+......+|
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc
Confidence 99999998876655556678999999999998877655899999999999999999999999988888888888888888
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..++.++.+||.+||+.||.+|||+.+|++||||....
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 88999999999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=399.06 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=218.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||+||++.+. .+++.||||++...... ...+.+.+|+.+++.++||||++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 69 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR--------------VTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVK 69 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCC
T ss_pred HhhhceeeeEEecCCCEEEEEEEEC--------------CCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCe
Confidence 4678999999999999999999873 35678999999765432 23356889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.+....|||||||++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+||
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 149 (323)
T 3tki_A 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDF 149 (323)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEe
Confidence 99999999999999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCccCCC
Q psy6357 383 GFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQRILFGKFRIP 458 (635)
Q Consensus 383 Gla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~i~~~~~~~p 458 (635)
|++..+... ......+||+.|+|||++.+..+.+.++|||||||+||+|++|..||...... .....+.......+
T Consensus 150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (323)
T 3tki_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229 (323)
T ss_dssp TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTST
T ss_pred eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCC
Confidence 999765422 23456789999999999988877558899999999999999999999876543 22223332222222
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 --FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 --~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 4589999999999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=389.07 Aligned_cols=259 Identities=31% Similarity=0.569 Sum_probs=229.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~HpnI 300 (635)
....+|.+++.||+|+||+||++.+. .++..||||++....... .....+.+|+.+++.++||||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 71 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREK--------------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTB
T ss_pred eecccEEEeeEEecCCCeEEEEEEEc--------------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCC
Confidence 45678889999999999999999873 345689999996543322 224568899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.+....++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEEC
T ss_pred cchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEE
Confidence 99999999999999999999999999999988899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
|||++...... ......||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+......+|..
T Consensus 152 Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T 3fdn_A 152 DFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229 (279)
T ss_dssp SCCEESCC---------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eccccccCCcc-cccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc
Confidence 99998665432 33456889999999999888775 89999999999999999999999999999999998888889999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
++.++.+||.+||..||.+|||+.|||+||||....
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=391.72 Aligned_cols=254 Identities=30% Similarity=0.433 Sum_probs=212.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
.+|.++++||+|+||+||++.+ ..+..||||++............+.+|+.+|++++||||++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~---------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN---------------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE---------------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred ccchhhhhcccCCCEEEEEEEc---------------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeee
Confidence 5789999999999999999976 2356899999976654443446778999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++...+.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||
T Consensus 67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp EEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred eEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECc
Confidence 999999999999999975 888888764 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--------
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-------- 454 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-------- 454 (635)
++...... ......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 146 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 146 LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 99865432 334456789999999999875544599999999999999999999999887766655553210
Q ss_pred ------------c---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 ------------F---------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ------------~---------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+ .+...++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 011347899999999999999999999999999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=408.01 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=218.7
Q ss_pred ccCCccceeecccc--CCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 223 LLKPQYNLRKAGEG--EDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 223 ~~~~y~il~kLG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
..++|.++++||+| +||+||++.+. .++..||||++............+.+|+.+|+.++||||
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYK--------------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEET--------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEc--------------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC
Confidence 46789999999999 99999999873 356789999998877777777889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
|++++++.+.+.+|||||||++++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999999775 6799999999999999999999999999999999999999999999
Q ss_pred eecccccccccCC--------CccccccCCCCCCCccccCC--CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 379 LADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGG--REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 379 L~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~--~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
|+|||++...... ......+||+.|+|||++.+ ..++ .++||||||||+|+|++|..||.+.+......
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999998654221 12234578999999999987 4554 89999999999999999999998765444333
Q ss_pred HHHhCcc----------------------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCC
Q psy6357 449 RILFGKF----------------------------------------------RIPFYMSAECENLIRSMLVLDPAKRLT 482 (635)
Q Consensus 449 ~i~~~~~----------------------------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps 482 (635)
.+..+.. +++..++.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 3322111 133457899999999999999999999
Q ss_pred HHHHHcCcccccC
Q psy6357 483 LTQISNHKWMSVH 495 (635)
Q Consensus 483 ~~eiL~Hpw~~~~ 495 (635)
+.|||+||||...
T Consensus 328 a~ell~hp~f~~~ 340 (389)
T 3gni_B 328 ASTLLNHSFFKQI 340 (389)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcCHHHHHH
Confidence 9999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=405.87 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=220.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---HHHHHHHHHHHHHHhhCCCCc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
+...|.+++.||+|+||+||++.+. .++..||||++...... ....+.+.+|+.+|+.++|||
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 87 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR--------------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTT
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCC
Confidence 3457888999999999999999873 35678999999653211 112467889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|+++++++.....+|||||||++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+||||+.++
T Consensus 88 Iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~ 167 (351)
T 3c0i_A 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE 167 (351)
T ss_dssp BCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS
T ss_pred CCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC
Confidence 9999999999999999999999999988886542 489999999999999999999999999999999999998765
Q ss_pred C---eeeecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6357 376 D---IKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 376 ~---ikL~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~ 451 (635)
. +||+|||++....... .....+||+.|+|||++.+..++ .++||||||||||+|++|..||.+.. ..+...+.
T Consensus 168 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~ 245 (351)
T 3c0i_A 168 NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGII 245 (351)
T ss_dssp TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHH
T ss_pred CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHH
Confidence 4 9999999998765443 34567899999999999988876 99999999999999999999998754 55666676
Q ss_pred hCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 FGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...+.++ ..++.++.+||.+||..||.+|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 6665554 368999999999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=391.15 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=216.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.++++||+|+||+||++.+. .++..||||++............+.+|+.+|++++||||+++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 67 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR--------------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEeeEEeecCCeEEEEEEeC--------------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccch
Confidence 468999999999999999999872 346789999998776666667788899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.....+++||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 68 LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred hheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999999999999988888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Q psy6357 384 FSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--------- 453 (635)
Q Consensus 384 la~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--------- 453 (635)
++..... .......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 148 FARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp TCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 9987653 233456688999999999987444459999999999999999999999988766554443321
Q ss_pred ----------ccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 ----------KFRIP------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ----------~~~~p------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
....+ ..++.++.+||.+||..||.+|||++|||+||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00111 2478899999999999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=420.09 Aligned_cols=267 Identities=34% Similarity=0.622 Sum_probs=233.4
Q ss_pred hhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-----------HHH
Q psy6357 214 EWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-----------RNL 282 (635)
Q Consensus 214 e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-----------~~~ 282 (635)
.|.......+..+|.++++||+|+||+||++.+. .++..||||++.+..... ...
T Consensus 25 ~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~ 90 (504)
T 3q5i_A 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEK--------------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90 (504)
T ss_dssp GGCCEECSCGGGTEEEEEEEEC--CEEEEEEEET--------------TTCCEEEEEEEEC----------------CTH
T ss_pred heeeccCCCcccceEEEeEecccCCeEEEEEEEC--------------CCCcEEEEEEEEhhhcccccccccchhhHHHH
Confidence 3333444556788999999999999999999873 355789999998754332 234
Q ss_pred HHHHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeee
Q psy6357 283 RKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHR 362 (635)
Q Consensus 283 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHr 362 (635)
+.+.+|+.+|++|+|||||++++++.+...+|||||||.+++|.+++.....+++..++.|+.||+.||.|||+.||+||
T Consensus 91 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 170 (504)
T 3q5i_A 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHR 170 (504)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 67889999999999999999999999999999999999999999999988899999999999999999999999999999
Q ss_pred cccCcceeecCCC---CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCC
Q psy6357 363 DIKAENLLFDENG---DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439 (635)
Q Consensus 363 DLKp~NILl~~~~---~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~ 439 (635)
||||+||||+.++ .+||+|||++............+||+.|+|||++.+ .++ .++||||||||+|+|++|.+||.
T Consensus 171 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp CCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999998776 699999999998877666777889999999999875 454 89999999999999999999999
Q ss_pred CCCHHHHHHHHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 440 GPNLAVLKQRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 440 ~~~~~~l~~~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
+.+...+...+..+.+.++ ..++.++++||.+||.+||.+|||+.|+|+||||....
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 249 GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 9999999999988877665 46899999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=384.32 Aligned_cols=255 Identities=35% Similarity=0.638 Sum_probs=230.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+.++||+|+||.||++.+. .++..||+|++....... .+.+.+|+.+|++++||||++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~ 70 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQK--------------GTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIR 70 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeC--------------CCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEee
Confidence 3467888999999999999999873 345689999997654332 467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~~ikL 379 (635)
+++++.+...+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999999999999999999988889999999999999999999999999999999999999 77889999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||++.............+|+.|+|||++.+. + +.++|||||||++|+|++|..||...+.......+......+|.
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T 3f3z_A 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228 (277)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred EecccceeccCccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999999887776667778899999999999765 4 48999999999999999999999999988888888888777765
Q ss_pred ----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 ----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 689999999999999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=420.24 Aligned_cols=257 Identities=33% Similarity=0.588 Sum_probs=225.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.+...|.++++||+|+||+||++.+. .++..||||++.+..........+.+|+.+|+.++|||||
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 99 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDK--------------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEET--------------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBC
T ss_pred chhcCeEEeeEEecCCCEEEEEEEEC--------------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCC
Confidence 45567999999999999999999873 3557899999987654444456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC---CCee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---GDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---~~ik 378 (635)
+++++|.+...+|||||||.+++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.. +.+|
T Consensus 100 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred eEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEE
Confidence 9999999999999999999999999999988899999999999999999999999999999999999999764 4599
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
|+|||++............+||+.|+|||++.+ .++ .++||||||||+|+|++|.+||.+.+...+...+..+.+.++
T Consensus 180 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 180 IVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257 (494)
T ss_dssp ECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 999999988877666777889999999999874 454 899999999999999999999999999999999988876654
Q ss_pred C----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 459 F----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 459 ~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. .++.++++||.+||+.||.+|||+.|+|+||||..
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 3 58999999999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=398.62 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=210.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||+|+||+||++.+. .++..||||++............+.+|+.+|++++||||+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 96 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDT--------------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBC
T ss_pred cchhhEEEEEEEEecCCeEEEEEEEC--------------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcc
Confidence 44668999999999999999999873 3557899999987665555567788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec-----CCCC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD-----ENGD 376 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~-----~~~~ 376 (635)
++++++.+...+||||||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+ ..+.
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 97 ELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp CEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCE
T ss_pred eEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccce
Confidence 99999999999999999997 59999999888999999999999999999999999999999999999995 4456
Q ss_pred eeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc
Q psy6357 377 IKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF 455 (635)
Q Consensus 377 ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~ 455 (635)
+||+|||++...... ......++|+.|+|||++.+....+.++||||||||+|+|++|..||.+.+.......+.....
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp EEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 999999999876432 3345567899999999998765445999999999999999999999998887666665543100
Q ss_pred ------------------CC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 456 ------------------RI------------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 456 ------------------~~------------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+ +..++.++.+||.+||..||.+|||+.|||+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 11268999999999999999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=392.95 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=213.9
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---HHHHHHHHHHHHHHhhC-
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---ERNLRKLFREVDIMSHL- 295 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---~~~~~~~~~Ei~iL~~L- 295 (635)
++....+|.++++||+|+||+||++.+. .++..||||++...... ......+.+|+.+++.+
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 69 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDP--------------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECT--------------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHH
T ss_pred CcccccceEEEEEEecCCCeEEEEEEEC--------------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHh
Confidence 4456789999999999999999999862 35678999999754321 11123456777777766
Q ss_pred --CCCceeeEEEEEecCC-----eEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 296 --DHPHIIKLFQVMETTN-----NLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 296 --~HpnIv~l~~~~~~~~-----~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
.||||+++++++.... .+++||||+. ++|.+++..... +++..++.|+.||+.||.|||+.+|+||||||
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 148 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP 148 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCT
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 5999999999997654 5899999996 699999887654 99999999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l 446 (635)
+||||+.++.+||+|||++............+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+....
T Consensus 149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 149 ENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp TTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred HHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999999887766666778999999999999888876 899999999999999999999999887777
Q ss_pred HHHHHhCccC---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 447 KQRILFGKFR---------------------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~~~~---------------------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+...... +...++.++.+||.+||++||.+|||+.|+|+||||...
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 6666432100 112478999999999999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=405.18 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=228.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.++++||+|+||.||++.+. .++..||+|++.... ......+.+|+.+|+.|+||||++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~--------------~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~ 112 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEK--------------ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLIN 112 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCC
T ss_pred cccceEEEEEEecCCCEEEEEEEEC--------------CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCe
Confidence 3567999999999999999999873 356789999997653 334467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC--CCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--NGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--~~~ikL 379 (635)
+++++.+...+|||||||.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+. .+.+||
T Consensus 113 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEE
Confidence 9999999999999999999999999987654 6999999999999999999999999999999999999974 478999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP- 458 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p- 458 (635)
+|||++............+||+.|+|||++.+..++ .++||||||||+|+|++|..||.+.+.......+....+.++
T Consensus 193 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 271 (387)
T 1kob_A 193 IDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271 (387)
T ss_dssp CCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred EecccceecCCCcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999999987766666677899999999999988876 899999999999999999999999988888888877665544
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 3589999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=413.92 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=200.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||+||++.+. .++..||||++..........+.+.+|+.+|++|+|||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 116 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDK--------------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVK 116 (458)
T ss_dssp SCTTEEECCC-------CEEEEEEC--------------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEEC--------------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3468999999999999999999874 34568999999876667777788999999999999999999
Q ss_pred EEEEEe-----cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 303 LFQVME-----TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 303 l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
+++++. ....+||||||+ +++|.+++.....+++..++.|+.||+.||.|||+.|||||||||+||||+.++.+
T Consensus 117 l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp EEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCE
T ss_pred eEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCE
Confidence 999994 335799999998 57899999888889999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC----------------------------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHH
Q psy6357 378 KLADFGFSNYFTPG----------------------------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429 (635)
Q Consensus 378 kL~DFGla~~~~~~----------------------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvily 429 (635)
||+|||+|+..... ......+||++|+|||++.....++.++||||||||||
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999876421 13455688999999998754443359999999999999
Q ss_pred HHHh-----------CCCCCCCCCH--------------------HHHHHHHHh--C--------------------c--
Q psy6357 430 VMVT-----------AQLPFDGPNL--------------------AVLKQRILF--G--------------------K-- 454 (635)
Q Consensus 430 eLlt-----------G~~PF~~~~~--------------------~~l~~~i~~--~--------------------~-- 454 (635)
||++ |.++|.+.+. ......|.. + .
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 9998 7777866541 111111110 0 0
Q ss_pred -------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 -------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 -------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
......++.++.+||.+||.+||.+|||++|||+||||...
T Consensus 356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 00112468999999999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=408.53 Aligned_cols=252 Identities=35% Similarity=0.596 Sum_probs=209.0
Q ss_pred cccCCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHh-hCCCCc
Q psy6357 222 KLLKPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMS-HLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~-~L~Hpn 299 (635)
.....|+++ +.||.|+||+||++.+. .++..||||++... ..+.+|+.++. .++|||
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~--------------~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~ 116 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNK--------------RTQEKFALKMLQDC-------PKARREVELHWRASQCPH 116 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTT
T ss_pred cccccceeccceeeeccCeEEEEEEEC--------------CCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCC
Confidence 355678877 68999999999999873 35678999999643 35678888875 458999
Q ss_pred eeeEEEEEec----CCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 300 IIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 300 Iv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
|++++++|.. ...+|||||||++++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||||+.
T Consensus 117 iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 196 (400)
T 1nxk_A 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196 (400)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred cceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEec
Confidence 9999999875 667999999999999999998754 5999999999999999999999999999999999999997
Q ss_pred ---CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH----HH
Q psy6357 374 ---NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA----VL 446 (635)
Q Consensus 374 ---~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~----~l 446 (635)
++.+||+|||++............+||+.|+|||++.+..++ .++||||||||||+|++|..||...... .+
T Consensus 197 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 275 (400)
T 1nxk_A 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275 (400)
T ss_dssp SSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH
T ss_pred CCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHH
Confidence 789999999999877665566778999999999999888886 9999999999999999999999775432 24
Q ss_pred HHHHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 447 KQRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+..+.+.+| ..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 276 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 276 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 556666666655 3589999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=393.79 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=230.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCCC
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~H 297 (635)
...+.|.+++.||+|+||.||++.+. .++..||||++....... ...+.+.+|+.+|+++.|
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 74 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREK--------------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC
T ss_pred hhhccEEEeeEeeecCCEEEEEEEEC--------------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC
Confidence 34567888999999999999999873 356789999997654321 124678899999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC--
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-- 375 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-- 375 (635)
|||+++++++.....+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++
T Consensus 75 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSS
T ss_pred CCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCC
Confidence 999999999999999999999999999999999888899999999999999999999999999999999999999887
Q ss_pred --CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 376 --DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 376 --~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
.+||+|||++.............||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+...
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp SCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred cCCEEEccCccceecCccccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 7999999999887666556677899999999999888876 8999999999999999999999999888888888776
Q ss_pred ccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 KFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.+.++ ..++..+.+||.+||..||.+|||+.|+|+||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 66554 46899999999999999999999999999999996
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=419.60 Aligned_cols=259 Identities=33% Similarity=0.639 Sum_probs=228.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||+||++.+. .++..||||++.+..........+.+|+.+|++++|||||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 85 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDR--------------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEET--------------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhcceEEeEEEeecCCEEEEEEEEC--------------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCe
Confidence 4567899999999999999999873 35678999999765433334567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec---CCCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD---ENGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~---~~~~ikL 379 (635)
+++++.+...+|+|||||.+++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+ .++.+||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEE
Confidence 9999999999999999999999999998888999999999999999999999999999999999999995 4567999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP- 458 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p- 458 (635)
+|||++............+||+.|+|||++.+. ++ .++||||||||+|+|++|.+||.+.+...+...+..+.+.++
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp CSCSCTTTBCCC----CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred EECCcCeECCCCCccCCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 999999887766666778899999999999864 54 899999999999999999999999999999888888766544
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
..+|.++++||.+||..||.+|||+.|+|+||||.....
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 358999999999999999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=393.76 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=204.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||.||+|.+. .++..||||++..... ......+.+|+.+|++++||||+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~ 68 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK--------------TTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRL 68 (317)
T ss_dssp ---------------CEEEEEECS--------------SSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC--------------CCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceE
Confidence 457888999999999999999773 3467899999976542 2223567899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~ 147 (317)
T 2pmi_A 69 YDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL 147 (317)
T ss_dssp EEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred EEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCE
Confidence 999999999999999997 5898888654 359999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 378 KLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 378 kL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
||+|||++...... ......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 148 KLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp EECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999876432 334566899999999999875434599999999999999999999999988776666554210
Q ss_pred --------------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 --------------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 --------------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
...+..++.++.+||.+||+.||.+|||+.|||+||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001224788999999999999999999999999999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=384.14 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=234.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
....+|.+.+.||+|+||.||++.+. ..+..||+|++..... .....+.+.+|+.+++.+.|+||
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 77 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDA--------------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred CcccceEEEEEEeecCCEEEEEEEEC--------------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCE
Confidence 34568899999999999999999873 3457899999976643 45566788899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.+.+.+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEE
Confidence 99999999999999999999999999999888889999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 381 DFGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 381 DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|||++..... ........||+.|+|||++.+..++ .++||||||+++|+|++|..||...........+......+|.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T 2rku_A 158 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 236 (294)
T ss_dssp CCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred eccCceecccCccccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc
Confidence 9999987643 2334556799999999999887775 8999999999999999999999999888888888888888899
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.++..+.+||.+||..||.+|||+.+||+||||....
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=385.11 Aligned_cols=259 Identities=30% Similarity=0.576 Sum_probs=231.4
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~~~~~~~Ei~iL~~L~Hpn 299 (635)
....++|.+++.||+|+||.||++.+. .++..||||++....... .....+.+|+.+++.++|||
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 75 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREK--------------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTT
T ss_pred chhhhhceeeheecCCCCeEEEEEEEc--------------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCC
Confidence 345678889999999999999999873 345689999996543211 12356889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.+...+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||
T Consensus 76 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 155 (284)
T 2vgo_A 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKI 155 (284)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEE
T ss_pred EeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999999999998889999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||++...... ......|++.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+......+|.
T Consensus 156 ~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2vgo_A 156 ADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233 (284)
T ss_dssp CCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred ecccccccCccc-ccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC
Confidence 999998765432 33456789999999999988876 8999999999999999999999999888888888888888888
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.++.+||.+||..||.+|||+.+|++||||...
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=403.22 Aligned_cols=252 Identities=32% Similarity=0.571 Sum_probs=222.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH------HHHHHHHHHHHHHhhCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE------RNLRKLFREVDIMSHLD 296 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~------~~~~~~~~Ei~iL~~L~ 296 (635)
..++|.++++||+|+||+||++.+. .++..||||++....... .....+.+|+.+|++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 87 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK--------------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET--------------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC
T ss_pred cccceEEEeEEEecCCEEEEEEEEC--------------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC
Confidence 4568999999999999999999873 355789999998764321 13345678999999999
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccc-hhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGG-EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~gg-sL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
||||+++++++.+...+++||||+.++ +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++
T Consensus 88 h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred CCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC
Confidence 999999999999999999999999766 9999999888999999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF 455 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~ 455 (635)
.+||+|||++............+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .......
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~ 241 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI 241 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCC
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhcc
Confidence 9999999999988776666778899999999999988886689999999999999999999997632 2233445
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..|..++.++.+||.+||..||.+|||+.+||+||||..
T Consensus 242 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 567779999999999999999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=413.14 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=223.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.....|.++++||+|+||.||++.+. .++..||||++.+.... ......+.+|+.+|+.++||||
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~--------------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I 131 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHK--------------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB
T ss_pred cCccccEEEEEEEcCCCEEEEEEEEC--------------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence 45678999999999999999999873 34678999999753211 1112347789999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
|+++++|.+...+|||||||++|+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 132 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999999999998865 579999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCC----cCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGRE----YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~----~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|||+|....... ...+.+||+.|+|||++.+.. ++ .++||||||||||+|++|.+||.+.+...+...|....
T Consensus 211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 999998765443 234678999999999997654 44 89999999999999999999999999988888887643
Q ss_pred --cCCCC--CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCccccc
Q psy6357 455 --FRIPF--YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSV 494 (635)
Q Consensus 455 --~~~p~--~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~ 494 (635)
+.+|. .++.++++||.+||..+|.+ |++++||++||||+.
T Consensus 290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 34443 68999999999999999988 999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=400.20 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=212.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|++++||||+++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 89 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG--------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET--------------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred cceEEEeEEeeecCCeEEEEEEEC--------------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCc
Confidence 468999999999999999999872 456789999997766666677889999999999999999999
Q ss_pred EEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++... ..+||||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred eeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCE
Confidence 9999765 3469999999 8899888865 679999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--- 454 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--- 454 (635)
||+|||++..... .....++|++|+|||++.+....+.++||||||||+|+|++|..||.+.+.......|....
T Consensus 168 kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 168 KILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp EECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999987543 34567899999999999873333499999999999999999999999888766555543210
Q ss_pred ----------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 ----------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ----------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+...+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 01223578999999999999999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=393.18 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=234.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
....+|.+++.||+|+||.||++.+. .++..||+|++..... .....+.+.+|+.+|+.++|+||
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 103 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDA--------------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCC
Confidence 34567889999999999999999873 3457899999976643 45566788999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++.+.+.+|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEEC
T ss_pred CeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEe
Confidence 99999999999999999999999999999888889999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 381 DFGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 381 DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|||++..... ........||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+....+.+|.
T Consensus 184 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 262 (335)
T 2owb_A 184 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262 (335)
T ss_dssp CCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT
T ss_pred eccCceecccCcccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc
Confidence 9999987643 2334556799999999999888775 8999999999999999999999999888888888888888899
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.++.++.+||.+||..||.+|||+.|||+||||....
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999999999999998543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=419.30 Aligned_cols=260 Identities=33% Similarity=0.610 Sum_probs=233.1
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.....+|.++++||+|+||.||++.+. .++..||||++.+.... ......+.+|+.+|++++|||
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 87 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDK--------------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTT
T ss_pred CcccCceEEeeEEecCCCEEEEEEEEC--------------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCC
Confidence 455678999999999999999999873 35678999999765432 334567889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCCC
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGD 376 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~~ 376 (635)
||++++++.+...+|+|||||.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||| +.++.
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC
T ss_pred CCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc
Confidence 999999999999999999999999999999988899999999999999999999999999999999999999 56789
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
+||+|||++..+.........+||+.|+|||++.+ .++ .++||||||||+|+|++|.+||.+.+...+...+..+.+.
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245 (484)
T ss_dssp EEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEEEeeeeeEEcccccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999999988877666677889999999999977 454 8999999999999999999999999999999998888665
Q ss_pred CC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 457 IP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 457 ~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
++ ..++.++++||.+||.+||.+|||+.|+|+||||....
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 54 35899999999999999999999999999999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=432.75 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=233.7
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC-CCC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL-DHP 298 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L-~Hp 298 (635)
......|.+++.||+|+||.||++.+. .++..||||++.+... .......+..|+.+|..+ .|+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~--------------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~ 402 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERK--------------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEES--------------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCT
T ss_pred cccccceEEEEEEccCCCEEEEEEEEC--------------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCC
Confidence 345678999999999999999999873 3456899999976432 223346778899999988 699
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
+|+++++++++.+.+||||||+++++|.+++...+.+++..++.|+.||+.||.|||+.|||||||||+||||+.++.+|
T Consensus 403 ~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp TBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred eEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence 99999999999999999999999999999999989999999999999999999999999999999999999999999999
Q ss_pred eeccccccccc-CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC
Q psy6357 379 LADFGFSNYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI 457 (635)
Q Consensus 379 L~DFGla~~~~-~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~ 457 (635)
|+|||+|.... ........+||+.|+|||++.+..|+ .++||||||||||||++|.+||.+.+..++.+.|....+.+
T Consensus 483 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 561 (674)
T 3pfq_A 483 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 561 (674)
T ss_dssp ECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC
T ss_pred EeecceeeccccCCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999998643 34456678999999999999988886 99999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCH-----HHHHcCccccc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTL-----TQISNHKWMSV 494 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~-----~eiL~Hpw~~~ 494 (635)
|..++.++.+||.+||++||.+||++ +||++||||..
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999999999999999997 99999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=384.85 Aligned_cols=255 Identities=31% Similarity=0.570 Sum_probs=216.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+.+.|.+.++||+|+||.||++.+. .++..||||++..... ....+.+.+|+.+|++++||||++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~ 84 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEER--------------SSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIK 84 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhheeecceeccCCCeEEEEEEEc--------------cCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHh
Confidence 3457888999999999999999873 3467899999976542 223467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENG 375 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~ 375 (635)
+++++.+...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||| +.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~ 164 (285)
T 3is5_A 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164 (285)
T ss_dssp EEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC
T ss_pred HHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC
Confidence 999999999999999999999999988654 569999999999999999999999999999999999999 4567
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF 455 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~ 455 (635)
.+||+|||++.............||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+.+...+...+.....
T Consensus 165 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 242 (285)
T 3is5_A 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242 (285)
T ss_dssp CEEECCCCCCCC----------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc
Confidence 899999999987766666667789999999999864 454 899999999999999999999999988888877776654
Q ss_pred CCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIP---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++ ..+++++.+||.+||..||.+|||+.|||+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 443 247899999999999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=394.97 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=215.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||.||++.+. .++..||||++............+.+|+.+|+.++||||++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 80 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHR--------------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 80 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEET--------------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceeEEEEEecCCCcEEEEEEEC--------------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCccc
Confidence 3578999999999999999999873 45678999999766544444456789999999999999999
Q ss_pred EEEEEec--------CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 303 LFQVMET--------TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 303 l~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
+++++.. .+.+||||||+.+ +|.+.+... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~ 159 (351)
T 3mi9_A 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 159 (351)
T ss_dssp EEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred HhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC
Confidence 9999976 4568999999975 666666543 57999999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccC-----CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTP-----GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~-----~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
++.+||+|||++..+.. .......+||+.|+|||++.+....+.++||||||||+|+|++|.+||.+.+......
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 239 (351)
T 3mi9_A 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239 (351)
T ss_dssp TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999986542 2234556789999999999875544599999999999999999999999988777666
Q ss_pred HHHhCccCCCCC--------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 449 RILFGKFRIPFY--------------------------------MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 449 ~i~~~~~~~p~~--------------------------------~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+......++.. .++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 665322111110 26789999999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=400.14 Aligned_cols=248 Identities=27% Similarity=0.485 Sum_probs=217.0
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
.+.||+|+||.||++.+. .++..||||++.... ....+.+.+|+.+|++|+||||+++++++..
T Consensus 94 ~~~lG~G~~g~Vy~a~~~--------------~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 157 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET--------------ATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES 157 (373)
T ss_dssp EEECC-----CEEEEEET--------------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceEEecCcCEEEEEEEEc--------------CCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 567999999999999872 356789999997653 3445778899999999999999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee--cCCCCeeeecccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF--DENGDIKLADFGFSN 386 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl--~~~~~ikL~DFGla~ 386 (635)
...+|||||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||| +.++.+||+|||++.
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 99999999999999999988654 469999999999999999999999999999999999999 567789999999999
Q ss_pred cccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC----CCCC
Q psy6357 387 YFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP----FYMS 462 (635)
Q Consensus 387 ~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p----~~~s 462 (635)
...........+||+.|+|||++.+..++ .++||||||||||+|++|..||.+.+.......+....+.++ ..++
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSC
T ss_pred ecCCccccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCC
Confidence 87766666677899999999999887775 899999999999999999999999998888888887766554 3589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++.+||.+||..||.+|||+.|||+||||..
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999999973
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=397.87 Aligned_cols=256 Identities=33% Similarity=0.577 Sum_probs=207.1
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
......|.++++||+|+||.||++.+. .++..||||++.... ..+.+.+|+.+|++++||||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~ni 110 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQK--------------GTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNI 110 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEC--------------CHHHHHCCCTTB
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEEC--------------CCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCC
Confidence 345677899999999999999999873 345689999997643 23567789999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---CCCe
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---NGDI 377 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~~~i 377 (635)
+++++++.....+||||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+
T Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred cceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCE
Confidence 9999999999999999999999999999998888999999999999999999999999999999999999975 8899
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCccC
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQRILFGKFR 456 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~i~~~~~~ 456 (635)
||+|||++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||...... .+...+....+.
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~ 269 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269 (349)
T ss_dssp EECCCC----------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC
T ss_pred EEccCccccccCcccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc
Confidence 99999999877665556677899999999999988876 8999999999999999999999776544 366666665544
Q ss_pred CC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 IP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
++ ..++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 33 3589999999999999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=403.56 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=210.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+..+|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|++++|+||++
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 89 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDK--------------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIR 89 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEET--------------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEEC--------------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcce
Confidence 3568999999999999999999873 34578999999876666677788999999999999999999
Q ss_pred EEEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 303 LFQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 303 l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
+++++... ..+||||||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 90 l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 90 LYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp EEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred EEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCE
Confidence 99999766 57999999996 6999999888889999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCC-----------------------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-
Q psy6357 378 KLADFGFSNYFTPGH-----------------------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT- 433 (635)
Q Consensus 378 kL~DFGla~~~~~~~-----------------------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt- 433 (635)
||+|||+|+...... .....+||++|+|||++.....++.++||||||||||||++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 999999998764321 24678899999999997544434599999999999999998
Q ss_pred ----------CCCCCCCCCH-----------------HHHHHHH------------------------HhCccCCC----
Q psy6357 434 ----------AQLPFDGPNL-----------------AVLKQRI------------------------LFGKFRIP---- 458 (635)
Q Consensus 434 ----------G~~PF~~~~~-----------------~~l~~~i------------------------~~~~~~~p---- 458 (635)
|.++|.+.+. ......| .......+
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK 328 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence 4455544321 1111111 11111111
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..+++++.+||.+||.+||.+|||++|||+||||....
T Consensus 329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 24799999999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=383.94 Aligned_cols=258 Identities=31% Similarity=0.543 Sum_probs=202.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...+|.+++.||+|+||.||++.+. .++..||||++...... ......+.+|+.++++++||||+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 74 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI--------------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBC
T ss_pred ccccceeeeeecCCCceEEEEEEEc--------------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeE
Confidence 3467899999999999999999862 35678999999654321 12246788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.+....|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~ 154 (278)
T 3cok_A 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIA 154 (278)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEEC
T ss_pred eEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEE
Confidence 9999999999999999999999999998765 569999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 381 DFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 381 DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+....+.+|.
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (278)
T 3cok_A 155 DFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233 (278)
T ss_dssp CCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCT
T ss_pred eecceeeccCCCCcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCcc
Confidence 99999876432 233456789999999999887775 8999999999999999999999987776666777666777888
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.++.+||.+||..||.+|||+.+||+||||...
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 899999999999999999999999999999999743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=396.30 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=222.0
Q ss_pred hhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHH
Q psy6357 212 LDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDI 291 (635)
Q Consensus 212 l~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~i 291 (635)
...+....+....++|.++++||+|+||+||++.+. .++..||||++... ......+..|+.+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~---~~~~~~~~~e~~~ 84 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI--------------DNKKYYAVKVVRNI---KKYTRSAKIEADI 84 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECSC---HHHHHHHHHHHHH
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC--------------CCCeEEEEEEeccc---hhhhhhhHHHHHH
Confidence 344555667788899999999999999999999873 35678999999643 3444667789999
Q ss_pred HhhCC-----CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 292 MSHLD-----HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 292 L~~L~-----HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
|+.+. ||||+++++++...+.+||||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||
T Consensus 85 l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 163 (360)
T 3llt_A 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163 (360)
T ss_dssp HHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 99986 999999999999999999999999 899999997754 4999999999999999999999999999999
Q ss_pred cCcceeecC-------------------------CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCcc
Q psy6357 365 KAENLLFDE-------------------------NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKS 419 (635)
Q Consensus 365 Kp~NILl~~-------------------------~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ks 419 (635)
||+||||+. ++.+||+|||++..... .....+||+.|+|||++.+..++ .++
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~ 240 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWD-VSS 240 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCC-TTH
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCC-Ccc
Confidence 999999975 78999999999986543 33467899999999999988886 999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC----------------------------------------
Q psy6357 420 DVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF---------------------------------------- 459 (635)
Q Consensus 420 DIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~---------------------------------------- 459 (635)
||||||||||+|++|..||...+.......+......+|.
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 320 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence 9999999999999999999988776665555432222210
Q ss_pred ------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 460 ------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 460 ------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..++.+.+||.+||+.||.+|||+.|||+||||+
T Consensus 321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1247788999999999999999999999999994
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=412.83 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=223.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.....|.++++||+|+||+||++.+. .++..||||++.+.... ......+.+|+.+|..++||||
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~--------------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLK--------------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEc--------------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 44678999999999999999999873 34568999999753221 1122347789999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++++|.+...+|||||||.+|+|.+++.+ ...+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEE
Confidence 9999999999999999999999999999987 467999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCc--cccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 380 ADFGFSNYFTPGHM--LTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 380 ~DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
+|||+|........ ....+||+.|+|||++. ...++ .++|||||||+||||++|..||.+.+..++...|..
T Consensus 217 ~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred cchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 99999977654332 34468999999999986 44554 899999999999999999999999998888888875
Q ss_pred C--ccCCCC---CCCHHHHHHHHHhcccCCCC--CCCHHHHHcCcccccC
Q psy6357 453 G--KFRIPF---YMSAECENLIRSMLVLDPAK--RLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 ~--~~~~p~---~~s~~l~~LI~~~L~~dP~~--Rps~~eiL~Hpw~~~~ 495 (635)
. .+.+|. .++.++++||.+||..+|++ |++++||++||||..-
T Consensus 296 ~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 296 HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 3 345554 38999999999999998888 9999999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=387.32 Aligned_cols=257 Identities=31% Similarity=0.528 Sum_probs=213.5
Q ss_pred ccCCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCce
Q psy6357 223 LLKPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHI 300 (635)
Q Consensus 223 ~~~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 300 (635)
....|.++ +.||+|+||+||++.+. .++..||||++...... ....+.+|+.+|.++ .||||
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i 73 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINL--------------ITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNV 73 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECS--------------SSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTB
T ss_pred cceeEEecCceecCCceEEEEEEEEc--------------CCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCe
Confidence 44677776 67999999999999863 35678999999765322 336788999999985 79999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC---e
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD---I 377 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~---i 377 (635)
+++++++.+.+.+||||||+++++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+||||+.++. +
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCce
Confidence 9999999999999999999999999999998889999999999999999999999999999999999999998776 9
Q ss_pred eeecccccccccCC--------CccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC--
Q psy6357 378 KLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-- 442 (635)
Q Consensus 378 kL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-- 442 (635)
||+|||++...... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++|..||....
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999998765321 12334569999999999865 3344 89999999999999999999998754
Q ss_pred -------------HHHHHHHHHhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 443 -------------LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 443 -------------~~~l~~~i~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
...+...+....+.+|. .++.++.+||.+||..||.+|||+.|||+||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 24456677777776663 5899999999999999999999999999999997543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=390.68 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=218.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...++|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|++++||||+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 87 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNK--------------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEET--------------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhheeeeEEeecCCEEEEEEEEC--------------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEe
Confidence 34678999999999999999999873 3467899999987766666677788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.....+|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~D 167 (331)
T 4aaa_A 88 NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCD 167 (331)
T ss_dssp CEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEe
Confidence 99999999999999999999999988887778899999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Q psy6357 382 FGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG------- 453 (635)
Q Consensus 382 FGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~------- 453 (635)
||++..... .......++|+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 168 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 168 FGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp CTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 999976543 234456689999999999987644458999999999999999999999988766555444311
Q ss_pred ------------ccCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ------------KFRIP------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ------------~~~~p------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...++ ..++.++.+||.+||..||.+|||+.|||+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 247899999999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=397.87 Aligned_cols=252 Identities=33% Similarity=0.550 Sum_probs=220.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
+...|.+++.||+|+||.||++.+. .++..||||++.+... ...+|+.+|.++ +||||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv 79 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHK--------------ATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNII 79 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcC
Confidence 4567888999999999999999873 3457899999977643 234688888887 799999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC----CCe
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN----GDI 377 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~----~~i 377 (635)
++++++.+...+|||||||++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+... +.+
T Consensus 80 ~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred eEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeE
Confidence 9999999999999999999999999999988899999999999999999999999999999999999998543 359
Q ss_pred eeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhC
Q psy6357 378 KLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG---PNLAVLKQRILFG 453 (635)
Q Consensus 378 kL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~---~~~~~l~~~i~~~ 453 (635)
||+|||++...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.. .+...+...+..+
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 160 RICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp EECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred EEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence 99999999876543 345567899999999999877776 899999999999999999999976 4567788888887
Q ss_pred ccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 KFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+.++ ..++.++.+||.+||..||.+|||+.+||+||||..+
T Consensus 239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 77655 3589999999999999999999999999999999653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=389.78 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=210.9
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~Hp 298 (635)
+....++|.++++||+|+||+||+|.+. .++..||||++...............|+..+..+ .|+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~ 117 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSK--------------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEET--------------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEEC--------------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCC
Confidence 3445578999999999999999999873 3567899999977665665556666777766665 899
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
||++++++|.+...+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+||||+.++.+
T Consensus 118 ~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp TBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCE
T ss_pred cEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999 678888876654 59999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc--
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-- 455 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-- 455 (635)
||+|||++.............||+.|+|||++.+ .++ .++|||||||++|+|++|..||.... ....+.....
T Consensus 197 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~ 271 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPP 271 (311)
T ss_dssp EECCCTTCEECC------CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCH
T ss_pred EEccceeeeecccCCCCcccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCc
Confidence 9999999987766555666789999999999987 454 89999999999999999976665432 2223332222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++..++.++.+||.+||..||.+|||+.|||+||||+.
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 234568999999999999999999999999999999963
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=421.38 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=231.2
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~Hp 298 (635)
..+....|.+++.||+|+||.||++.+. .++..||||++.+.... ......+.+|+.+|+.++||
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~--------------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 244 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVR--------------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCT
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEEC--------------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3456778999999999999999999873 35678999999765321 12235678999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
|||++++++.+...+|||||||+|++|.+++...+. +++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 245 ~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~ 324 (576)
T 2acx_A 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH 324 (576)
T ss_dssp TBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred CEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC
Confidence 999999999999999999999999999999977654 999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN----LAVLKQRILF 452 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~----~~~l~~~i~~ 452 (635)
+||+|||++............+||+.|+|||++.+..++ .++||||||||||+|++|..||.... ...+...+..
T Consensus 325 vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~ 403 (576)
T 2acx_A 325 IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403 (576)
T ss_dssp EEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred eEEEecccceecccCccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence 999999999887766666678999999999999988876 99999999999999999999998753 4566777777
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
....+|..++.++.+||.+||..||.+|| ++.||++||||..
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 77788888999999999999999999999 8999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=405.65 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=222.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
...+.|.+++.||+|+||.||++.++ .+++.||||++.+... .......+.+|+.+|..++||||
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~--------------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMK--------------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 44678999999999999999999873 3567899999976432 12233457889999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
++++++|.+...+|||||||++++|.+++.+.+ .+++..++.++.||+.||.|||+.||+||||||+||||+.++++||
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEE
Confidence 999999999999999999999999999998764 7999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCc--cccccCCCCCCCccccC-------CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 380 ADFGFSNYFTPGHM--LTTWCGSPPYAAPELFG-------GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 380 ~DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~-------~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
+|||++........ ....+||+.|+|||++. ...++ .++||||||||+|||++|..||...+...+...|
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 282 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999987654332 33568999999999997 34454 8999999999999999999999999988888888
Q ss_pred HhCc--cCCC---CCCCHHHHHHHHHhcccCCCCC---CCHHHHHcCcccccC
Q psy6357 451 LFGK--FRIP---FYMSAECENLIRSMLVLDPAKR---LTLTQISNHKWMSVH 495 (635)
Q Consensus 451 ~~~~--~~~p---~~~s~~l~~LI~~~L~~dP~~R---ps~~eiL~Hpw~~~~ 495 (635)
.... +.+| ..++.++++||.+||. +|.+| ++++||++||||..-
T Consensus 283 ~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 283 VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred HhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 7532 3344 4699999999999999 99998 599999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=380.19 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=222.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCCCCc
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.++|.++++||+|+||.||++.+. .++..||||++....... ...+.+.+|+.+|++++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 69 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK--------------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTT
T ss_pred hhhhhhHHhhcccCceEEEEEEEc--------------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCC
Confidence 356888999999999999999873 346789999997654321 12467889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC----
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---- 375 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---- 375 (635)
|+++++++......|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSC
T ss_pred eeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCC
Confidence 9999999999999999999999999999998888899999999999999999999999999999999999998877
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF 455 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~ 455 (635)
.+||+|||++.............+|+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.....
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228 (283)
T ss_dssp CEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred ceEEEecccceeccCCCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence 8999999999877655555667899999999999888776 899999999999999999999999888888887776655
Q ss_pred CCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++ ..++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 544 468999999999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=391.85 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=215.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC--Cc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH--PH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H--pn 299 (635)
+..+.|.++++||+|+||.||++.+ .++..||||++............+.+|+.+|+++.| +|
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 70 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN---------------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC---------------TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTT
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe---------------CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCc
Confidence 3456799999999999999999876 235689999998877777777889999999999986 99
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++.....+|||||+ .+++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+ ++.+||
T Consensus 71 iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp BCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred eEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 99999999999999999995 5889999999988999999999999999999999999999999999999997 678999
Q ss_pred ecccccccccCCC---ccccccCCCCCCCccccCC-----------CCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-H
Q psy6357 380 ADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGG-----------REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-A 444 (635)
Q Consensus 380 ~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~-----------~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~ 444 (635)
+|||++....... .....+||+.|+|||++.+ ..+ +.++||||||||||+|++|..||..... .
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 9999998765432 2345689999999999854 444 4899999999999999999999987433 2
Q ss_pred HHHHHHHh--CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 445 VLKQRILF--GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 445 ~l~~~i~~--~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.....+.. ....+|...+.++.+||.+||..||.+|||+.|||+||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 33333332 2345677788999999999999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=391.90 Aligned_cols=259 Identities=30% Similarity=0.483 Sum_probs=221.9
Q ss_pred cccCCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCc
Q psy6357 222 KLLKPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPH 299 (635)
Q Consensus 222 ~~~~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn 299 (635)
.+...|.++ ++||+|+||.||++.+. .++..||||++............+.+|+.+|+.+. |||
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 90 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISK--------------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEEC--------------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence 345567776 78999999999999873 35678999999876554444567889999999995 699
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---C
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---N 374 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~ 374 (635)
|+++++++.....+|+|||||.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+. +
T Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB
T ss_pred EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC
Confidence 999999999999999999999999999998654 67999999999999999999999999999999999999987 7
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
+.+||+|||++............+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+....
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp CCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 89999999999887666556677899999999999988876 89999999999999999999999998888877777655
Q ss_pred cCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 FRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++ ..++..+.+||.+||..||.+|||+++||+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 4443 3589999999999999999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=391.67 Aligned_cols=245 Identities=35% Similarity=0.611 Sum_probs=197.2
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMET 309 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 309 (635)
++||+|+||+||++.+. .++..||||++.... ...+.+|+.+|+.+. ||||+++++++.+
T Consensus 17 ~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK--------------KSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp CCSEEETTEEEEEEEET--------------TTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CccccCCCeEEEEEEEC--------------CCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 67999999999999873 356789999996542 256778999999997 9999999999999
Q ss_pred CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---Ceeeecccccc
Q psy6357 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG---DIKLADFGFSN 386 (635)
Q Consensus 310 ~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~---~ikL~DFGla~ 386 (635)
....|||||||++++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+||||+.++ .+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999999999999988999999999999999999999999999999999999998765 89999999998
Q ss_pred cccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCccCCC
Q psy6357 387 YFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-------LAVLKQRILFGKFRIP 458 (635)
Q Consensus 387 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-------~~~l~~~i~~~~~~~p 458 (635)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+ ...+...+..+.+.++
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ECCC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 65433 344567889999999999988876 89999999999999999999997643 3566777777766665
Q ss_pred C----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 F----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. .++.++.+||.+||..||.+|||+.||++||||...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 3 489999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=399.55 Aligned_cols=255 Identities=24% Similarity=0.439 Sum_probs=207.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|+.++||||++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 88 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA--------------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC--------------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccc
Confidence 4678999999999999999999873 34568999999876666677788999999999999999999
Q ss_pred EEEEEecCC------eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTN------NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++.... .+|||||||. ++|.+++. ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 89 LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp EEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred eEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC
Confidence 999997654 7899999997 56777775 46999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF- 455 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~- 455 (635)
+||+|||++............+||+.|+|||++.+..++ .++||||||||+|+|++|..||.+.+.......+.....
T Consensus 166 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 166 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp EEECCCCC----------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEEEeecccccccccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999877655556677899999999999988876 899999999999999999999999887666665543210
Q ss_pred ---------------------C--------------CCC------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 ---------------------R--------------IPF------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ---------------------~--------------~p~------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. +|. ..+.++.+||.+||..||.+|||++|||+||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 010 01578999999999999999999999999999985
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 325 ~ 325 (371)
T 2xrw_A 325 W 325 (371)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=386.20 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=217.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.++++||+|+||+||++.+ .+..||||++............+.+|+.+|++++||||+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 97 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW----------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE----------------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CChhHceeeeEeecCCCeEEEEEEE----------------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEe
Confidence 3466788899999999999999976 346799999988777777788899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeecCCCC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFDENGD 376 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~~~~~ 376 (635)
++++++.....+|+||||+++++|.+++..... +++..++.++.||+.||.|||+.| |+||||||+||||+.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp CEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred eEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence 999999999999999999999999999987653 999999999999999999999999 999999999999999999
Q ss_pred eeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--C
Q psy6357 377 IKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF--G 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~--~ 453 (635)
+||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.. .
T Consensus 178 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256 (309)
T ss_dssp EEECCCC-----------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC
T ss_pred EEECCCCCCccccccccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 999999999765433 224456899999999999988875 899999999999999999999999888777776643 3
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--Cccccc
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN--HKWMSV 494 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~--Hpw~~~ 494 (635)
...+|..++.++.+||.+||..||.+|||+.+|++ ++|+..
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 45677889999999999999999999999999997 566653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=391.27 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=207.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++++||+|+||+||++.+. .++..||||++..... ......+.+|+.+|+.++||||++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~ 66 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK--------------LTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLH 66 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC--------------CCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeee
Confidence 57899999999999999999873 3457899999975432 12222455799999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++.....+||||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 145 (324)
T 3mtl_A 67 DIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG 145 (324)
T ss_dssp EEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSS
T ss_pred eEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCc
Confidence 99999999999999997 58888887654 59999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-------
Q psy6357 384 FSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF------- 455 (635)
Q Consensus 384 la~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~------- 455 (635)
++..... .......++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 146 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 146 LARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225 (324)
T ss_dssp EEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence 9976543 23345567899999999998754445999999999999999999999999887776665543100
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 456 -----------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 456 -----------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+..++.++.+||.+||++||.+|||+.|||+||||...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0112468899999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.45 Aligned_cols=256 Identities=31% Similarity=0.530 Sum_probs=224.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...++|.+++.||+|+||.||++.+. .++..||||++..... .....+.+|+.+|++++||||+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~ 69 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQR--------------LTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIV 69 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBC
T ss_pred chhccceeeeeccCCCCceEEEEEEC--------------CCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCee
Confidence 34567889999999999999999873 3567899999976532 2235688999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCCCee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~~ik 378 (635)
++++++.+...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+|
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEE
T ss_pred ehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEE
Confidence 9999999999999999999999999999888899999999999999999999999999999999999999 7788999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP 458 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p 458 (635)
|+|||++..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+....+.++
T Consensus 150 l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 150 ITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE 227 (304)
T ss_dssp BCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC
T ss_pred EccCCcceecCC-CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999999976543 234456799999999999988876 899999999999999999999999988888888887765443
Q ss_pred ----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 ----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 4589999999999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=395.83 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=200.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||+|+||.||+|.+. .++..||||++............+.+|+.+|+.++||||+++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 93 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT--------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET--------------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCceEEeeEEeecCCeEEEEEEEC--------------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 478999999999999999999862 356789999998766666677889999999999999999999
Q ss_pred EEEEecC------CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 304 FQVMETT------NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 304 ~~~~~~~------~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++... ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp SEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred EEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCE
Confidence 9998654 5689999999 7899888765 679999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--- 454 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--- 454 (635)
||+|||++..... .....+||++|+|||++.+...++.++||||||||+|+|++|..||.+.+.......+....
T Consensus 172 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 172 KILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp EECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred EEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999987543 24567899999999999874434599999999999999999999999988766555543210
Q ss_pred --------------------cCC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 --------------------FRI--------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 --------------------~~~--------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
... ...+++++.+||.+||..||.+|||+.|+|+||||....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 124688999999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=384.04 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=219.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV 306 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 306 (635)
|...++||+|+||.||+|.+. .++..||||++...... ..+.+.+|+.+|+.++||||++++++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~--------------~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 110 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREK--------------HSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKS 110 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhccEEeccCCCeEEEEEEEC--------------CCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 556789999999999999872 35678999999765432 23568899999999999999999999
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccc
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
+......||||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++.
T Consensus 111 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 111 YLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 9999999999999999999998765 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---CCCCCCC
Q psy6357 387 YFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF---RIPFYMS 462 (635)
Q Consensus 387 ~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~---~~p~~~s 462 (635)
..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..... ..+..++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred ecccCccccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCC
Confidence 76543 234567899999999999888876 899999999999999999999998887777776665432 2234588
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.++.+||.+||..||.+|||+.+||+||||...
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 999999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=391.64 Aligned_cols=256 Identities=32% Similarity=0.565 Sum_probs=226.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--C----HHHHHHHHHHHHHHhhC-
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--D----ERNLRKLFREVDIMSHL- 295 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~----~~~~~~~~~Ei~iL~~L- 295 (635)
...+|.+++.||.|+||.||++.+. .++..||||++..... . ....+.+.+|+.+|+++
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~--------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 157 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHR--------------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhcccceEEecCCCEEEEEEEEC--------------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 3467888999999999999999872 3567899999976542 2 22346678999999999
Q ss_pred CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 296 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
+||||+++++++......||||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 79999999999999999999999999999999998888899999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCC------CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG------REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~------~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
.+||+|||++..+.........+||+.|+|||++.+ ..+ +.++||||||||+|+|++|..||...+.......
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999999988776666677889999999999853 234 4899999999999999999999999888888888
Q ss_pred HHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 450 ILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 450 i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+....+.++ ..++.++.+||.+||..||.+|||+.+||+||||+
T Consensus 317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 877766554 35889999999999999999999999999999996
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=390.71 Aligned_cols=257 Identities=32% Similarity=0.511 Sum_probs=217.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.++|.++++||+|+||.||++.+. .++..||||++..... .......+.+|+.+|++++||||
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 90 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN--------------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB
T ss_pred hhheeecceeeecCCeEEEEEEEC--------------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc
Confidence 467888999999999999999873 3557899999976432 33456788999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc----------------------------------------ccCCHHHH
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI----------------------------------------GQMAEKEA 340 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------------------------------~~l~e~~~ 340 (635)
+++++++.+...+|||||||++++|.+++... ..+++..+
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (345)
T 3hko_A 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred ceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence 99999999999999999999999999988521 12468889
Q ss_pred HHHHHHHHHhhhhhccCceeeecccCcceeecCCC--CeeeecccccccccCC-----CccccccCCCCCCCccccCC--
Q psy6357 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG--DIKLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGG-- 411 (635)
Q Consensus 341 ~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~--~ikL~DFGla~~~~~~-----~~~~~~~gt~~Y~APEvl~~-- 411 (635)
+.|+.||+.||.|||+.+|+||||||+||||+.++ .+||+|||++..+... .......||+.|+|||++.+
T Consensus 171 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 99999999999999999999999999999998776 8999999999865321 12456679999999999975
Q ss_pred CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy6357 412 REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQIS 487 (635)
Q Consensus 412 ~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL 487 (635)
..+ +.++|||||||++|+|++|..||.+.+.......+......++. .++.++.+||.+||..||.+|||+.++|
T Consensus 251 ~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 251 ESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp SCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCC-CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 445 48999999999999999999999999888888888777655443 3799999999999999999999999999
Q ss_pred cCcccccC
Q psy6357 488 NHKWMSVH 495 (635)
Q Consensus 488 ~Hpw~~~~ 495 (635)
+||||...
T Consensus 330 ~hp~~~~~ 337 (345)
T 3hko_A 330 QHPWISQF 337 (345)
T ss_dssp HSHHHHTT
T ss_pred cChhhccC
Confidence 99999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=374.74 Aligned_cols=254 Identities=22% Similarity=0.423 Sum_probs=218.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||+||+|.+. .++..||+|++............+.+|+.+|++++||||+++
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~--------------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDT--------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEec--------------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 344666788999999999999873 355789999998877777778899999999999999999999
Q ss_pred EEEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeec-CCCC
Q psy6357 304 FQVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFD-ENGD 376 (635)
Q Consensus 304 ~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~-~~~~ 376 (635)
++++.. ...+|+||||+++++|.+++.....+++..++.|+.||+.||.|||+.+ |+|+||||+||||+ .++.
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~ 170 (290)
T 1t4h_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC
T ss_pred eeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC
Confidence 999865 4568999999999999999998889999999999999999999999999 99999999999998 7899
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCc-
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVLKQRILFGK- 454 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l~~~i~~~~- 454 (635)
+||+|||++..... .......||+.|+|||++.+. ++ .++|||||||++|+|++|..||.... ...+...+....
T Consensus 171 ~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 171 VKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp EEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred EEEeeCCCcccccc-cccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC
Confidence 99999999976543 334556799999999998754 54 89999999999999999999998744 444445444432
Q ss_pred -cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 -FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 -~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..++..+++++.+||.+||..||.+|||+.+||+||||+.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 2344567899999999999999999999999999999963
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.77 Aligned_cols=260 Identities=31% Similarity=0.542 Sum_probs=222.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC--HHHHHHHHHHHHHHhhCCCCce
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD--ERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~--~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
..++|.+++.||+|+||.||++.+. .++..||||++...... ......+.+|+.+|++++|+||
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~--------------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 68 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDS--------------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBT--------------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTB
T ss_pred cccceeEeeEEecCCCeEEEEEEEC--------------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCe
Confidence 4578999999999999999999862 35678999999765321 2345678899999999999999
Q ss_pred eeEEEEE--ecCCeEEEEEeccccchhhhhhhh--cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 301 IKLFQVM--ETTNNLYLVTEYARGGEIFSHLLT--IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 301 v~l~~~~--~~~~~~~LV~E~~~ggsL~~~l~~--~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++++ .....+||||||+.++ |.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 69 IQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp CCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc
Confidence 9999998 4556899999999876 6666654 356999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccC---CCccccccCCCCCCCccccCCCCc-CCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 377 IKLADFGFSNYFTP---GHMLTTWCGSPPYAAPELFGGREY-DGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 377 ikL~DFGla~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~-~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
+||+|||++..... ........||+.|+|||++.+... .+.++|||||||++|+|++|..||...+...+...+..
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 227 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence 99999999987643 223345678999999999976432 34789999999999999999999999998888899988
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCCC
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
..+.+|..++.++.+||.+||..||.+|||+.||++||||....+
T Consensus 228 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 888889999999999999999999999999999999999986544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=388.03 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=219.8
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
..+.++|.+++.||+|+||.||++.+. .++..||||++..... .......+.+|+.++++++|||
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 73 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDL--------------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEEC--------------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCC
Confidence 356678999999999999999999873 3557899999987644 4455678899999999999999
Q ss_pred eeeEEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 300 IIKLFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 300 Iv~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|+++++++.... ..||||||+++++|.+++...+.+++..++.++.||+.||.|||+.+|+||||||+||||+.++
T Consensus 74 iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 153 (311)
T 3ork_A 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 153 (311)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS
T ss_pred cceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC
Confidence 999999987654 3599999999999999999888999999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~ 451 (635)
.+||+|||++..+... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.
T Consensus 154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp CEEECCCSCC------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 9999999999876432 123346789999999999988876 89999999999999999999999988777766666
Q ss_pred hCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 452 FGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 452 ~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
......+ ..++.++.+||.+||..||.+||++.++|.|+|+....
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 5543322 35899999999999999999999999999999998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=377.02 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=228.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---C----HHHHHHHHHHHHHHhh
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---D----ERNLRKLFREVDIMSH 294 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---~----~~~~~~~~~Ei~iL~~ 294 (635)
....+|.+++.||+|+||.||++.+. .++..||||++..... . ....+.+.+|+.+|++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 79 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHK--------------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhccceeeeecCCCceEEEEEEEc--------------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999873 3457899999976531 1 2335678899999999
Q ss_pred CC-CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 295 LD-HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 295 L~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
+. ||||+++++++......|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.
T Consensus 80 l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159 (298)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred hcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC
Confidence 95 99999999999999999999999999999999998888999999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCCccccccCCCCCCCccccC------CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG------GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK 447 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~------~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~ 447 (635)
++.+||+|||++.............+|+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp TCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 9999999999998877666666778999999999985 3344 48999999999999999999999998888888
Q ss_pred HHHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 448 QRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 448 ~~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+....+.++ ..++.++.+||.+||..||.+|||+.+||+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 88877766544 2578999999999999999999999999999999743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=375.93 Aligned_cols=258 Identities=29% Similarity=0.486 Sum_probs=226.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .++..||||++..........+.+.+|+.+|++++||||++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 69 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK--------------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhheeeehhccCCCCcEEEEEEEC--------------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCe
Confidence 3567889999999999999999873 35678999999887777777788999999999999999999
Q ss_pred EEEEEe--cCCeEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccCc-----eeeecccCcceee
Q psy6357 303 LFQVME--TTNNLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHANN-----VVHRDIKAENLLF 371 (635)
Q Consensus 303 l~~~~~--~~~~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~g-----IiHrDLKp~NILl 371 (635)
+++++. ....+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||||+|||+
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~ 149 (279)
T 2w5a_A 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149 (279)
T ss_dssp EEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE
T ss_pred EEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE
Confidence 999874 4678999999999999999997643 3999999999999999999999999 9999999999999
Q ss_pred cCCCCeeeecccccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
+.++.+||+|||++....... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence 999999999999998765432 23456789999999999888776 8999999999999999999999998888888888
Q ss_pred HhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 451 LFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 451 ~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+.. .+|..++.++.+||.+||..||.+|||+.|||+|+|+...
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 77655 5677899999999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=396.03 Aligned_cols=254 Identities=25% Similarity=0.423 Sum_probs=216.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC--CCcee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD--HPHII 301 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv 301 (635)
...|.++++||+|+||.||++.+. .+..||||++............+.+|+.+|++|. |+||+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~---------------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv 119 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE---------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT---------------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC---------------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEE
Confidence 456889999999999999999762 3568999999887767777888999999999996 59999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++++.....+||||| +.+++|.+++.....+++..++.|+.||+.||.|||+.+|+||||||+||||+ ++.+||+|
T Consensus 120 ~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp CEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECC
T ss_pred EEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEe
Confidence 99999999999999999 55889999999888999999999999999999999999999999999999995 58999999
Q ss_pred ccccccccCCC---ccccccCCCCCCCccccCC-----------CCcCCCccchhhHHHHHHHHHhCCCCCCCCC-HHHH
Q psy6357 382 FGFSNYFTPGH---MLTTWCGSPPYAAPELFGG-----------REYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-LAVL 446 (635)
Q Consensus 382 FGla~~~~~~~---~~~~~~gt~~Y~APEvl~~-----------~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-~~~l 446 (635)
||++..+.... .....+||+.|+|||++.+ ..+ +.++||||||||||+|++|..||.... ....
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCC-CChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 99998765432 2346789999999999865 234 489999999999999999999998753 3334
Q ss_pred HHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 447 KQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+... ...+|...+.++.+||.+||..||.+|||+.|||+||||...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 4444443 345667789999999999999999999999999999999854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=395.68 Aligned_cols=251 Identities=26% Similarity=0.320 Sum_probs=211.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||+||++.+. .++..||||++..... ...+|+.+|+.++|||||+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~--------------~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~ 64 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDI--------------ESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIK 64 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEET--------------TTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCC
T ss_pred ccceEEEEEEEEeccCEEEEEEEEC--------------CCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccc
Confidence 4568999999999999999999872 4567999999865432 2347999999999999999
Q ss_pred EEEEEec--------------------------------------CCeEEEEEeccccchhhhhhh----hcccCCHHHH
Q psy6357 303 LFQVMET--------------------------------------TNNLYLVTEYARGGEIFSHLL----TIGQMAEKEA 340 (635)
Q Consensus 303 l~~~~~~--------------------------------------~~~~~LV~E~~~ggsL~~~l~----~~~~l~e~~~ 340 (635)
++++|.. ...++|||||++ ++|.+.+. ....+++..+
T Consensus 65 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~ 143 (383)
T 3eb0_A 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLI 143 (383)
T ss_dssp EEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHH
T ss_pred hhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHH
Confidence 9999843 334899999997 46665554 3467999999
Q ss_pred HHHHHHHHHhhhhhccCceeeecccCcceeec-CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCcc
Q psy6357 341 SRLFRQILSAVAYCHANNVVHRDIKAENLLFD-ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKS 419 (635)
Q Consensus 341 ~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~-~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ks 419 (635)
+.++.||+.||.|||+.||+||||||+||||+ .++.+||+|||+|............++|+.|+|||++.+....+.++
T Consensus 144 ~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 144 SIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999999999999999999999999999998 68899999999999877666667788999999999998766445999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------cc------------CCCCCCCHHHHHHHH
Q psy6357 420 DVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-----------------KF------------RIPFYMSAECENLIR 470 (635)
Q Consensus 420 DIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-----------------~~------------~~p~~~s~~l~~LI~ 470 (635)
||||||||+|+|++|.+||.+.+..+....+... .. .+|..++.++.+||.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 9999999999999999999998876665555421 01 134558899999999
Q ss_pred HhcccCCCCCCCHHHHHcCccccc
Q psy6357 471 SMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 471 ~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+||.+||.+|||+.|+|+||||..
T Consensus 304 ~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHccCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=413.50 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=229.1
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
......|.+++.||+|+||.||++.+. .+++.||||++.+.... ......+.+|+.+|++++|||
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~--------------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 246 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMK--------------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTT
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEEC--------------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCC
Confidence 355678999999999999999999872 35678999999765432 123467889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|++++++|.+...+|||||||+|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++
T Consensus 247 Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g 326 (543)
T 3c4z_A 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG 326 (543)
T ss_dssp BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred EeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC
Confidence 999999999999999999999999999998764 3699999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCc-cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPGHM-LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP----NLAVLKQRI 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~-~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~----~~~~l~~~i 450 (635)
.+||+|||++..+..... ....+||+.|+|||++.+..++ .++||||||||||||++|.+||... ....+.+.+
T Consensus 327 ~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i 405 (543)
T 3c4z_A 327 NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405 (543)
T ss_dssp CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence 999999999987755433 3456899999999999988886 9999999999999999999999875 456778888
Q ss_pred HhCccCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 451 LFGKFRIPFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 451 ~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
......+|..++.++.+||.+||..||.+||+ +++|++||||..
T Consensus 406 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred hhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 88888889999999999999999999999996 589999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=376.92 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=201.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.++++||+|+||+||++.+. .++..||||++............+.++..+++.+.||||+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv 69 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHV--------------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEec--------------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEE
Confidence 45678899999999999999999873 3567899999977654444445555666668889999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ 376 (635)
++++++.+....|+||||++ ++|.+++.. ...+++..++.|+.||+.||.|||+. ||+||||||+||||+.++.
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~ 148 (290)
T 3fme_A 70 TFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ 148 (290)
T ss_dssp CEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC
T ss_pred EEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999997 477666643 45799999999999999999999998 9999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCcccc----CCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-CH-HHHHHHH
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELF----GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-NL-AVLKQRI 450 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl----~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-~~-~~l~~~i 450 (635)
+||+|||++.............||+.|+|||++ .+..+ +.++|||||||++|+|++|..||... .. ..+...+
T Consensus 149 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 149 VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp EEBCCC---------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred EEEeecCCcccccccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 999999999877665555566899999999996 34445 48999999999999999999999863 22 3333334
Q ss_pred HhCccCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 451 LFGKFRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 451 ~~~~~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.......+ ..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 33333333 3689999999999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=372.89 Aligned_cols=257 Identities=32% Similarity=0.524 Sum_probs=219.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||+|+||.||++.+. .++..||||++...... ...+.+.+|+.+++.++||||+++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~ 70 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR--------------VTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKF 70 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ecceEEEEEeecCCCcEEEEEEEC--------------CCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceee
Confidence 467888999999999999999873 34678999999765432 344678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.+....|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCC
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCccCC--
Q psy6357 384 FSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQRILFGKFRI-- 457 (635)
Q Consensus 384 la~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~i~~~~~~~-- 457 (635)
++...... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... .....+.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc
Confidence 99765422 23455678999999999988776557899999999999999999999876543 2233333322222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...++..+.+||.+||..||.+|||+.||++||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 23589999999999999999999999999999999743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=401.38 Aligned_cols=255 Identities=31% Similarity=0.574 Sum_probs=207.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC------HHHHHHHHHHHHHHhhCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD------ERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~------~~~~~~~~~Ei~iL~~L~ 296 (635)
..+.|.++++||+|+||+||+|.+. .++..||||++.+.... ......+.+|+.+|++++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 198 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFER--------------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC
T ss_pred hhccEEEEeEEeeCCCeEEEEEEEC--------------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC
Confidence 4578999999999999999999873 45678999999765421 122335789999999999
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG- 375 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~- 375 (635)
||||+++++++.. ..+|||||||++++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+||||+.++
T Consensus 199 hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 199 HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSS
T ss_pred CCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCC
Confidence 9999999999854 55899999999999999999888999999999999999999999999999999999999997544
Q ss_pred --CeeeecccccccccCCCccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHH
Q psy6357 376 --DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQR 449 (635)
Q Consensus 376 --~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~ 449 (635)
.+||+|||++............+||+.|+|||++.+ ..++ .++|||||||+||+|++|..||..... ..+...
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp SCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH
T ss_pred cceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH
Confidence 599999999998776666677899999999999864 4444 899999999999999999999976543 344455
Q ss_pred HHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 450 ILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 450 i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+....+.++ ..++.++.+||.+||..||.+|||+.|+|+||||+
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 555554443 35899999999999999999999999999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=389.99 Aligned_cols=262 Identities=22% Similarity=0.415 Sum_probs=223.0
Q ss_pred hccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC
Q psy6357 217 ASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 217 ~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~ 296 (635)
...+.+..++|.++++||+|+||+||++.+. .++..||+|++.... .......+.+|+.+|++++
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~ 89 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHK--------------PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 89 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCC
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEEC--------------CCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCC
Confidence 3446778889999999999999999999873 356789999997653 4556678899999999999
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCC
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENG 375 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~ 375 (635)
||||+++++++.....+||||||+++++|.+++.....+++..+..++.||+.||.|||+. ||+|+||||+||||+.++
T Consensus 90 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~ 169 (360)
T 3eqc_A 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169 (360)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC
T ss_pred CCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC
Confidence 9999999999999999999999999999999999888999999999999999999999996 999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI----- 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i----- 450 (635)
.+||+|||++...... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+
T Consensus 170 ~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 247 (360)
T 3eqc_A 170 EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247 (360)
T ss_dssp CEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----
T ss_pred CEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence 9999999999755322 23456899999999999988876 9999999999999999999999876654432221
Q ss_pred -------------------------------------HhCc-cCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 451 -------------------------------------LFGK-FRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 451 -------------------------------------~~~~-~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
.... ...+ ..++.++.+||.+||..||.+|||+.|||+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 1111 1111 247899999999999999999999999999999
Q ss_pred cccC
Q psy6357 492 MSVH 495 (635)
Q Consensus 492 ~~~~ 495 (635)
|+..
T Consensus 328 ~~~~ 331 (360)
T 3eqc_A 328 IKRS 331 (360)
T ss_dssp HHHH
T ss_pred hhcc
Confidence 9743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=372.82 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=214.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+++.||+|+||+||++.+. .++..||||++............+.+|+.++..+ +||||+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv 74 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKR--------------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBC
T ss_pred ccchhhhhhhhcCCCceEEEEEEEc--------------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCee
Confidence 4567888999999999999999873 3567899999987665555667888999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC---
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN--- 374 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~--- 374 (635)
++++++.+.+.+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----
T ss_pred eeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCC
Confidence 9999999999999999999999999999765 569999999999999999999999999999999999999844
Q ss_pred ----------------CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 375 ----------------GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 375 ----------------~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
..+||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++|.+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 47999999999876543 23468999999999987644447999999999999999998877
Q ss_pred CCCCHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 439 DGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 439 ~~~~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.... ....+.... ..+|..++.++.+||.+||..||.+|||+.+||+||||..
T Consensus 232 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 232 RNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp SSSH---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred cchh---HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 5443 233333333 3567789999999999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.24 Aligned_cols=257 Identities=33% Similarity=0.640 Sum_probs=228.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||.||++.+. .++..||||++............+.+|+.+|++++||||++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~--------------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR--------------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCC
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc--------------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccE
Confidence 4568899999999999999999873 34578999999776554445578889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC---CCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---GDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---~~ikL 379 (635)
+++++.....+|+||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.+ +.+||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEE
Confidence 999999999999999999999999999888899999999999999999999999999999999999999754 47999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP- 458 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p- 458 (635)
+|||++.............+|+.|+|||++.+. ++ .++||||||+++|+|++|..||...+...+...+..+.+.++
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (287)
T ss_dssp CSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred eccCcceeecCCCccccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 999999877665555666789999999999765 54 899999999999999999999999988888888877765443
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++.++.+||.+||..||.+|||+.+||+||||...
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 3589999999999999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=386.07 Aligned_cols=259 Identities=27% Similarity=0.356 Sum_probs=211.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH---HHHHHHHHHHHHHhhCCCCc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE---RNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~---~~~~~~~~Ei~iL~~L~Hpn 299 (635)
..++|.+++.||+|+||.||++.+. .++..||||++....... .....+.+|+.+|+.++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 73 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK--------------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 73 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS--------------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC--------------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCC
Confidence 4578999999999999999999873 346789999997643321 12346789999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
|+++++++.+...+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus 74 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 74 IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp BCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred CCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999975 787777654 4699999999999999999999999999999999999999999999
Q ss_pred eecccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc--
Q psy6357 379 LADFGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF-- 455 (635)
Q Consensus 379 L~DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~-- 455 (635)
|+|||++..... .......++|+.|+|||++.+....+.++||||||||+|+|++|.+||.+.+.......+.....
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 153 LADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp ECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999999987643 33455678999999999997765445899999999999999999999999887776666543210
Q ss_pred ---------C-----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 456 ---------R-----------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 456 ---------~-----------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. +...++.++.+||.+||..||.+|||+.|||+||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0 0134678999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.11 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=206.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||.||++.+. .++..||||++.... .....+.+.+|+.+|++|+|||||+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~ 68 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNK--------------VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVR 68 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEET--------------TTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEc--------------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEee
Confidence 4567889999999999999999873 356789999997654 3334578899999999999999999
Q ss_pred EEEEEecCC---------------------------------------------------------eEEEEEeccccchh
Q psy6357 303 LFQVMETTN---------------------------------------------------------NLYLVTEYARGGEI 325 (635)
Q Consensus 303 l~~~~~~~~---------------------------------------------------------~~~LV~E~~~ggsL 325 (635)
++++|.+.. .+|+|||||++++|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 148 (332)
T 3qd2_B 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148 (332)
T ss_dssp EEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCH
T ss_pred EEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCH
Confidence 999985433 38999999999999
Q ss_pred hhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCC----------
Q psy6357 326 FSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---------- 392 (635)
Q Consensus 326 ~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---------- 392 (635)
.+++..... ..+..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp HHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------
T ss_pred HHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccc
Confidence 999987543 5667799999999999999999999999999999999999999999999998765431
Q ss_pred ---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC-CCCCCHHHHHH
Q psy6357 393 ---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI-PFYMSAECENL 468 (635)
Q Consensus 393 ---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~-p~~~s~~l~~L 468 (635)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..|+.. .......+....++. +..+++++.+|
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMM 305 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHH
T ss_pred ccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHH
Confidence 23446799999999999988876 999999999999999998776532 122223333322211 12357889999
Q ss_pred HHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 469 IRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 469 I~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
|.+||+.||.+|||+.|||+||||+
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHHccCCCCcCCCHHHHhhchhhh
Confidence 9999999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=381.00 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=210.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI 300 (635)
....+|.++++||+|+||+||++.+. .++..||||++.... ...+.+|+.+|+++. ||||
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i 93 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINI--------------TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNI 93 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTB
T ss_pred cCCCceEEEEEecccCCeEEEEEEEC--------------CCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCE
Confidence 34678999999999999999999872 356789999997542 256889999999997 9999
Q ss_pred eeEEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Ce
Q psy6357 301 IKLFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DI 377 (635)
Q Consensus 301 v~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~i 377 (635)
+++++++.. ....++||||+.+++|.+++. .+++..++.++.||+.||.|||+.||+||||||+||||+.++ .+
T Consensus 94 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp CCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred EEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEE
Confidence 999999987 678999999999999988875 489999999999999999999999999999999999999777 89
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHH-------
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-NLAVLKQR------- 449 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-~~~~l~~~------- 449 (635)
||+|||++............++|+.|+|||++.+....+.++|||||||++|+|++|..||... ........
T Consensus 171 kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250 (330)
T ss_dssp EECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred EEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence 9999999988776666677789999999999987444459999999999999999999999543 22221111
Q ss_pred ------HHhCccCC------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 450 ------ILFGKFRI------------------------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 450 ------i~~~~~~~------------------------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+......+ +..++.++.+||.+||.+||.+|||++|||+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 11111111 1227999999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.56 Aligned_cols=253 Identities=27% Similarity=0.372 Sum_probs=218.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.+.|.++++||+|+||+||+|.+. .++..||||++..... .......+.+|+.+|++++||||++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 118 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDV--------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhheeeeeEEccCCCEEEEEEEEc--------------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 356888999999999999999862 3567899999976543 3445678899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhh-hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~-~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++......||||||+. |+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 119 ~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp EEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred EEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999997 57777775 346799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC--
Q psy6357 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-- 456 (635)
Q Consensus 382 FGla~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-- 456 (635)
||++..... ....+||+.|+|||++. ...++ .++||||||||+|+|++|..||...+.......+.....+
T Consensus 198 fG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 198 FGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273 (348)
T ss_dssp CTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ccCceecCC---CCcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 999987643 24568999999999985 44554 8999999999999999999999988876666666555432
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+..++..+.+||.+||..||.+|||+.+||+||||...
T Consensus 274 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 234689999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.94 Aligned_cols=260 Identities=27% Similarity=0.371 Sum_probs=220.7
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
++.+.++|.++++||+|+||.||++.+. ..+..||||++..... .....+.+.+|+.++++++||
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp 71 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDT--------------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEET--------------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBT
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEEC--------------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCC
Confidence 5677889999999999999999999873 3457899999866543 456677899999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
||+++++++...+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus 72 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999999999888999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC
Q psy6357 379 LADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR 456 (635)
Q Consensus 379 L~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~ 456 (635)
|+|||++....... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 230 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP 230 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC
Confidence 99999998765432 23446799999999999988875 8999999999999999999999998876665555544322
Q ss_pred -----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 457 -----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 457 -----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+..++..+.+||.+||..||.+||+..+.+.+.|...
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 34568999999999999999999997677777777653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=394.06 Aligned_cols=251 Identities=26% Similarity=0.334 Sum_probs=207.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+++.||+|+||.||++.+. .++..||||++.... ....+|+.+|+.|+|+|||++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~--------------~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l 112 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC--------------DSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRL 112 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC--------------CCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccce
Confidence 446888999999999999999873 356789999996543 123479999999999999999
Q ss_pred EEEEec------CCeEEEEEeccccchhhhhhh----hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 304 FQVMET------TNNLYLVTEYARGGEIFSHLL----TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 304 ~~~~~~------~~~~~LV~E~~~ggsL~~~l~----~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
+++|.. ...++|||||+.+ +|.+++. ....+++..++.|+.||+.||.|||+.||+||||||+||||+.
T Consensus 113 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~ 191 (420)
T 1j1b_A 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191 (420)
T ss_dssp EEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET
T ss_pred eeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC
Confidence 999843 2247799999975 5555543 2457999999999999999999999999999999999999996
Q ss_pred C-CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 374 N-GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 374 ~-~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
+ +.+||+|||+++.+.........++|+.|+|||++.+...++.++||||||||||||++|.+||.+.+..+....+..
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 192 DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5 578999999998876655566778999999999998764345999999999999999999999998876555544432
Q ss_pred -----------------CccC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 453 -----------------GKFR------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 -----------------~~~~------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+. ++..++.++.+||.+||.+||.+|||+.|+|+||||...
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1112 223568999999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=387.41 Aligned_cols=258 Identities=25% Similarity=0.448 Sum_probs=225.3
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHH---------------HHHH
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDER---------------NLRK 284 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~---------------~~~~ 284 (635)
+....++|.+++.||+|+||.||++.+ ++..||||++........ ....
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK----------------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE----------------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHH
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc----------------CCceEEEEEeecccccchhhhccccchhhhHHhHHHH
Confidence 456678999999999999999999987 246899999975432211 1267
Q ss_pred HHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhh------hhh--cccCCHHHHHHHHHHHHHhhhhhcc
Q psy6357 285 LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSH------LLT--IGQMAEKEASRLFRQILSAVAYCHA 356 (635)
Q Consensus 285 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~------l~~--~~~l~e~~~~~i~~qIl~gL~~LHs 356 (635)
+.+|+.+|++++||||+++++++.+.+.+|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+
T Consensus 90 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp HHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999999999999998 665 5679999999999999999999999
Q ss_pred -CceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCC-CcCCCccchhhHHHHHHHHHhC
Q psy6357 357 -NNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR-EYDGTKSDVWSLGVVLYVMVTA 434 (635)
Q Consensus 357 -~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~-~~~~~ksDIwSlGvilyeLltG 434 (635)
.||+|+||||+||||+.++.+||+|||++...... ......+|+.|+|||++.+. .++..++|||||||++|+|++|
T Consensus 170 ~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred cCCEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999876543 44567899999999999887 5553399999999999999999
Q ss_pred CCCCCCCCH-HHHHHHHHhCccCCC-------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 435 QLPFDGPNL-AVLKQRILFGKFRIP-------------------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 435 ~~PF~~~~~-~~l~~~i~~~~~~~p-------------------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..||..... ..+...+......+| ..++.++.+||.+||..||.+|||+.|||+||||..
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 999988776 777777777766666 568999999999999999999999999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.08 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=223.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHHHHHHHHHHhhC-CCC
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIMSHL-DHP 298 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~~~~Ei~iL~~L-~Hp 298 (635)
+....|.++++||+|+||.||++.+.... .++..||||++..... .......+.+|+.+|+++ .|+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ 119 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGH-----------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSST-----------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCT
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccC-----------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCC
Confidence 34567888999999999999999874321 2567999999975432 112234567899999999 699
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
||+++++++.....+|||||||++++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+|
T Consensus 120 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred ceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEE
Confidence 99999999999999999999999999999999888999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCC--CccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Q psy6357 379 LADFGFSNYFTPG--HMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGP----NLAVLKQRIL 451 (635)
Q Consensus 379 L~DFGla~~~~~~--~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~----~~~~l~~~i~ 451 (635)
|+|||++..+... ......+||+.|+|||++.+.. ..+.++||||||||||+|++|..||... ....+...+.
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 9999999865432 2334568999999999998632 2348999999999999999999999743 3456666777
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
.....+|..++..+.+||.+||..||.+|| |++||++||||..
T Consensus 280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 777788888999999999999999999999 9999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=385.32 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=215.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||.||++.+. .++..||||++.... .......+.+|+.+|++++||||+++
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 90 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN--------------LNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGI 90 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC--------------CCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccc
Confidence 368999999999999999999873 345689999997543 45556788999999999999999999
Q ss_pred EEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 304 FQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 304 ~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++... ..+|+||||+. ++|.+++.. ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+|
T Consensus 91 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 91 NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp CEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred eeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEE
Confidence 9999654 46899999996 588888765 5799999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 379 LADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 379 L~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|+|||++....... .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh
Confidence 99999998664321 23456899999999987655533589999999999999999999999887665555543210
Q ss_pred -------------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 -------------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 -------------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
..+...++.++.+||.+||.+||.+|||+.|||+||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 001134789999999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=380.91 Aligned_cols=255 Identities=32% Similarity=0.580 Sum_probs=212.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC------HHHHHHHHHHHHHHhhCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD------ERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~------~~~~~~~~~Ei~iL~~L~ 296 (635)
..++|.++++||+|+||.||++.+. .++..||||++...... ......+.+|+.+|++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 73 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFER--------------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECC---------------CHHHHHHHHHHCC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEc--------------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC
Confidence 3467888999999999999999873 34578999999765321 223345789999999999
Q ss_pred CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 297 HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 297 HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
||||+++++++.... +|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 74 h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 74 HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp CTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSS
T ss_pred CCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCC
Confidence 999999999997655 8999999999999999988889999999999999999999999999999999999999987664
Q ss_pred ---eeeecccccccccCCCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHH
Q psy6357 377 ---IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQR 449 (635)
Q Consensus 377 ---ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~ 449 (635)
+||+|||++.............||+.|+|||++. ...++ .++|||||||++|+|++|..||...... .+...
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 9999999998776555555678999999999973 34454 8999999999999999999999765432 34444
Q ss_pred HHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 450 ILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 450 i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+..+.+.+. ..++.++.+||.+||..||.+|||+.++|+||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 555544332 35899999999999999999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=390.94 Aligned_cols=255 Identities=27% Similarity=0.329 Sum_probs=209.8
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
+.....+|.+++.||+|+||+||++.+. ....||||++..... ...+|+.+|+.++|||
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~---------------~~~~~aikk~~~~~~------~~~~E~~il~~l~h~n 93 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLV---------------ESDEVAIKKVLQDKR------FKNRELQIMRIVKHPN 93 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEET---------------TTEEEEEEEEECCTT------SCCHHHHHHHTCCCTT
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEEC---------------CCCeEEEEEEecCcc------hHHHHHHHHHhCCCCC
Confidence 4456678999999999999999999863 223588888865431 2237999999999999
Q ss_pred eeeEEEEEecCC------eEEEEEeccccchhhhhh---hhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 300 IIKLFQVMETTN------NLYLVTEYARGGEIFSHL---LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 300 Iv~l~~~~~~~~------~~~LV~E~~~ggsL~~~l---~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
|++++++|.... .+|||||||.++.+.... .....+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 94 iv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil 173 (394)
T 4e7w_A 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173 (394)
T ss_dssp BCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence 999999995433 388999999765433222 23467999999999999999999999999999999999999
Q ss_pred ec-CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 371 FD-ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 371 l~-~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
|+ .++.+||+|||+|............++|+.|+|||++.+...++.++||||||||||+|++|.+||.+.+.......
T Consensus 174 l~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253 (394)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99 78999999999998876666666788999999999998765445999999999999999999999999886655554
Q ss_pred HHhC-----------------ccC------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 450 ILFG-----------------KFR------------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 450 i~~~-----------------~~~------------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+... ... ++..++.++.+||.+||++||.+|||+.|+|+||||...
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 4321 011 223478999999999999999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=382.99 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=211.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||+|+||+||++.+. .++..||||++...... .....+.+|+.+|++++||||+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv 70 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHK--------------KTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIV 70 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEEC--------------CCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcc
Confidence 45678999999999999999999873 34678999999764422 2246678999999999999999
Q ss_pred eEEEEEecCC--eEEEEEeccccchhhhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee----c
Q psy6357 302 KLFQVMETTN--NLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----D 372 (635)
Q Consensus 302 ~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl----~ 372 (635)
++++++.... .+||||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||| +
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 150 (319)
T 4euu_A 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150 (319)
T ss_dssp CEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT
T ss_pred eEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC
Confidence 9999997655 78999999999999999987544 9999999999999999999999999999999999999 7
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccC--------CCCcCCCccchhhHHHHHHHHHhCCCCCCCCC--
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG--------GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-- 442 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~--------~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~-- 442 (635)
.++.+||+|||++............+||+.|+|||++. +..++ .++||||||||+|+|++|..||....
T Consensus 151 ~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 151 GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 77889999999998877666666778999999999986 45554 89999999999999999999996432
Q ss_pred --HHHHHHHHHhCcc-------------------CCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 443 --LAVLKQRILFGKF-------------------RIP------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 443 --~~~l~~~i~~~~~-------------------~~p------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
...+...+..+.. .+| ..++..+.+||.+||+.||++|||++|+|+||=
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2334444443221 111 224568899999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=395.96 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=212.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC------
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL------ 295 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L------ 295 (635)
....+|.++++||+|+||+||+|.+. .++..||||++... ......+.+|+.+|+.+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~--------------~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~ 156 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDH--------------KVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKD 156 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEET--------------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTT
T ss_pred cccCcEEEEEEcccCccEEEEEEEEC--------------CCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhcccc
Confidence 45668999999999999999999873 34578999999753 33445677888888777
Q ss_pred CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 296 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
.|+||+++++++.....+||||||+. ++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+||||+.
T Consensus 157 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~ 235 (429)
T 3kvw_A 157 NTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235 (429)
T ss_dssp SCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESS
T ss_pred CCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcc
Confidence 57799999999999999999999995 68988887654 4999999999999999999999999999999999999999
Q ss_pred CCC--eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy6357 374 NGD--IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 374 ~~~--ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~ 451 (635)
++. +||+|||++..... .....+||+.|+|||++.+..++ .++||||||||||+|++|.+||.+.+.......+.
T Consensus 236 ~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 236 QGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 887 99999999976543 34567899999999999988876 99999999999999999999999988766555443
Q ss_pred hCcc-----------------------------------------------------------CCCCCCCHHHHHHHHHh
Q psy6357 452 FGKF-----------------------------------------------------------RIPFYMSAECENLIRSM 472 (635)
Q Consensus 452 ~~~~-----------------------------------------------------------~~p~~~s~~l~~LI~~~ 472 (635)
...- .++...++++.+||.+|
T Consensus 313 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~ 392 (429)
T 3kvw_A 313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392 (429)
T ss_dssp HHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHH
T ss_pred HHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHH
Confidence 2100 01112478899999999
Q ss_pred cccCCCCCCCHHHHHcCcccccCCC
Q psy6357 473 LVLDPAKRLTLTQISNHKWMSVHCP 497 (635)
Q Consensus 473 L~~dP~~Rps~~eiL~Hpw~~~~~~ 497 (635)
|++||.+|||+.|||+||||....+
T Consensus 393 L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 393 LEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TCSSTTTSCCHHHHHTSTTTC----
T ss_pred CCCChhhCCCHHHHhCChhhccCCC
Confidence 9999999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=384.60 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=213.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+.++|.++++||+|+||+||++.+. .++..||||++............+.+|+.+|+.++||||++
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 105 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDK--------------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 105 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccEEEEeEEecCCCeEEEEEEEC--------------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchh
Confidence 3478999999999999999999873 35678999999877667777788999999999999999999
Q ss_pred EEEEEecCCeE------EEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTNNL------YLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~~~------~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++...... |+||||+. ++|.+++. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 106 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 106 LLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp CSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred hhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC
Confidence 99999877654 99999996 67877764 35999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
+||+|||++..... .....++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 183 LKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260 (371)
T ss_dssp EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999986543 34456889999999999874334599999999999999999999999888666655553210
Q ss_pred -----------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 -----------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 -----------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+..++.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 01123478999999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=382.24 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=205.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc---------CHHHHHHHHHHHHHH
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL---------DERNLRKLFREVDIM 292 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~---------~~~~~~~~~~Ei~iL 292 (635)
...++|.+++.||+|+||.||++.+. .+..||||++..... +....+.+.+|+.+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS---------------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT---------------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HhccceEEeEEeccCCCEEEEEEECC---------------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 34678999999999999999999762 357899999965332 234457889999999
Q ss_pred hhCCCCceeeEEEEEe-----cCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 293 SHLDHPHIIKLFQVME-----TTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
++++||||+++++++. ....+||||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 162 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP 162 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCCh
Confidence 9999999999999984 3347899999997 5777777654 4699999999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l 446 (635)
+||||+.++.+||+|||++............++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp GGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999998766555566778999999999998744345999999999999999999999998876666
Q ss_pred HHHHHhCc------------------------c--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 447 KQRILFGK------------------------F--------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 447 ~~~i~~~~------------------------~--------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...+.... . ..+..+++.+.+||.+||..||.+|||+.|||+||||..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 55553210 0 112346889999999999999999999999999999986
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 323 ~ 323 (362)
T 3pg1_A 323 L 323 (362)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=371.19 Aligned_cols=255 Identities=27% Similarity=0.474 Sum_probs=223.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.++++||+|+||.||+|.+. .++..||||++...... .....+.+|+.+|+.+.||||+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~ 85 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDN--------------RTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKY 85 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHHHHHhhhhcccCCeEEEEEEEC--------------CCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEE
Confidence 345888999999999999999762 35678999999765432 335678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.....+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 86 YGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999999999998865 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc-cCCCCCC
Q psy6357 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-FRIPFYM 461 (635)
Q Consensus 384 la~~~~~~~-~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-~~~p~~~ 461 (635)
++....... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+.... ..++..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY 243 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSC
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcccc
Confidence 998765432 33456789999999999888876 89999999999999999999999888777666665543 3456678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+..+.+||.+||..||.+|||+.+||+||||...
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=377.04 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=216.5
Q ss_pred hccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC
Q psy6357 217 ASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 217 ~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~ 296 (635)
...++....+|.++++||+|+||.||++.+.. .++..||||++... ......+.+|+.+|+.+.
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------------~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~ 69 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHK-------------AGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLN 69 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETT-------------TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHH
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecC-------------CCCcEEEEEEEecC---CchhHHHHHHHHHHHHhh
Confidence 34466778899999999999999999997621 24568999999643 344567889999999886
Q ss_pred CC------ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcc
Q psy6357 297 HP------HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368 (635)
Q Consensus 297 Hp------nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~N 368 (635)
|+ +|+++++++...+.+||||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 70 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 148 (339)
T 1z57_A 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPEN 148 (339)
T ss_dssp HHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 55 5999999999999999999999 899999998765 68999999999999999999999999999999999
Q ss_pred eeecC-------------------CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHH
Q psy6357 369 LLFDE-------------------NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429 (635)
Q Consensus 369 ILl~~-------------------~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvily 429 (635)
|||+. ++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|
T Consensus 149 il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ 225 (339)
T 1z57_A 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILI 225 (339)
T ss_dssp EEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHH
T ss_pred EEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHH
Confidence 99987 66899999999986543 33456899999999999988876 9999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCccCC--------------------------------------------CCCCCHHH
Q psy6357 430 VMVTAQLPFDGPNLAVLKQRILFGKFRI--------------------------------------------PFYMSAEC 465 (635)
Q Consensus 430 eLltG~~PF~~~~~~~l~~~i~~~~~~~--------------------------------------------p~~~s~~l 465 (635)
+|++|..||...+.......+......+ +...+.++
T Consensus 226 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 9999999999887665544432211111 11235789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 466 ENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 466 ~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+||.+||..||.+|||+.|||+||||..
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred HHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 99999999999999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.23 Aligned_cols=256 Identities=26% Similarity=0.340 Sum_probs=220.9
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.+...+|.+++.||+|+||+||+|.+..... .+..||||++.... .......+.+|+.+|++++||||
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~-----------~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i 112 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ-----------RDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNI 112 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTS-----------CCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCC-----------CCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCC
Confidence 4567789999999999999999998854332 33469999997543 45566789999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++.+...+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl 192 (325)
T 3kul_A 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192 (325)
T ss_dssp CCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEE
Confidence 99999999999999999999999999999654 57999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-
Q psy6357 380 ADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG- 453 (635)
Q Consensus 380 ~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~- 453 (635)
+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......+...+...
T Consensus 193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 271 (325)
T 3kul_A 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271 (325)
T ss_dssp CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred CCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 9999998765332 12233457789999999888776 89999999999999999 99999999888888877765
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+.+..++.++.+||.+||..||.+|||+.+|++.
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 456677899999999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=375.32 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=216.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC---CCCc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L---~Hpn 299 (635)
..++|.+++.||+|+||.||++.+.. .++..||||++............+.+|+.+++.+ .|||
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~ 75 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK-------------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT-------------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTT
T ss_pred chhceeeeeeecccccEEEEEEEecC-------------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCC
Confidence 34789999999999999999998721 2356899999976543322223456777777766 8999
Q ss_pred eeeEEEEEe-----cCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 300 IIKLFQVME-----TTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 300 Iv~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
|+++++++. ....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||||+
T Consensus 76 i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~ 154 (326)
T 1blx_A 76 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 154 (326)
T ss_dssp BCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred eEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc
Confidence 999999987 5678999999997 69999887654 499999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
.++.+||+|||++.............+|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999876654455667899999999999888876 899999999999999999999999887766665542
Q ss_pred Cc---------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 453 GK---------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 ~~---------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.. ..++..++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 10 01224578999999999999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=371.43 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=209.3
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
..+..+|.++++||+|+||.||++.+. .++..||||++... +....+.+.+|+.+|++++||||
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i 70 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDN--------------DCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNI 70 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEET--------------TTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTB
T ss_pred CccCCceeEEEEeccCCCeEEEEEEEC--------------CCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCe
Confidence 455688999999999999999999873 34578999999754 45566788999999999999999
Q ss_pred eeEEEEEe--------------cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 301 IKLFQVME--------------TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 301 v~l~~~~~--------------~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++++. ....+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||||
T Consensus 71 v~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 148 (320)
T 2i6l_A 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKP 148 (320)
T ss_dssp CCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSG
T ss_pred eEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence 99999873 4467899999997 689888864 6799999999999999999999999999999999
Q ss_pred cceeec-CCCCeeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q psy6357 367 ENLLFD-ENGDIKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441 (635)
Q Consensus 367 ~NILl~-~~~~ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~ 441 (635)
+||||+ .++.+||+|||++...... .......+|..|+|||++.+....+.++|||||||++|+|++|..||.+.
T Consensus 149 ~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp GGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999997 5679999999999876432 22345567999999999876333358999999999999999999999988
Q ss_pred CHHHHHHHHHhCcc------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 442 NLAVLKQRILFGKF------------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 442 ~~~~l~~~i~~~~~------------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
+.......+..... .++..++.++.+||.+||..||.+|||+.|||+|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 87665555543210 112358999999999999999999999999999999
Q ss_pred cccC
Q psy6357 492 MSVH 495 (635)
Q Consensus 492 ~~~~ 495 (635)
|+..
T Consensus 309 ~~~~ 312 (320)
T 2i6l_A 309 MSIY 312 (320)
T ss_dssp HHTT
T ss_pred cccc
Confidence 9854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=370.36 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=215.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.....|.++++||+|+||.||++.+. .++..||||++..... ...+.+|+.+|+.++||||+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~ 87 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK--------------ETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVV 87 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET--------------TTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBC
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC--------------CCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCc
Confidence 34567889999999999999999872 3467899999976542 25678999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.....+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp CEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred cEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEe
Confidence 999999999999999999999999999863 4679999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---cC
Q psy6357 381 DFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK---FR 456 (635)
Q Consensus 381 DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~---~~ 456 (635)
|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...........+.... +.
T Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T 3com_A 168 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR 246 (314)
T ss_dssp CCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ecccchhhhhhccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccC
Confidence 99999776543 234456789999999999888776 89999999999999999999999877665555444332 33
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+..++.++.+||.+||..||.+|||+.+||+||||...
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 455689999999999999999999999999999999743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=377.76 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=204.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.+++.||+|+||.||++.+..... ....||||++..........+.+.+|+.+|++++||||+
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 88 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG-----------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC------------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCC-----------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCcee
Confidence 446789999999999999999998743321 123799999987765666678899999999999999999
Q ss_pred eEEEEEecCCeE------EEEEeccccchhhhhhhhcc------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 302 KLFQVMETTNNL------YLVTEYARGGEIFSHLLTIG------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 302 ~l~~~~~~~~~~------~LV~E~~~ggsL~~~l~~~~------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
++++++...... ++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NI 168 (323)
T 3qup_A 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC 168 (323)
T ss_dssp CCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred hhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceE
Confidence 999999877655 99999999999999986543 599999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAV 445 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~ 445 (635)
||+.++.+||+|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+...
T Consensus 169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999987654322 2234567789999999888776 99999999999999999 999999988877
Q ss_pred HHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHcCcccccCC
Q psy6357 446 LKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLT-------LTQISNHKWMSVHC 496 (635)
Q Consensus 446 l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps-------~~eiL~Hpw~~~~~ 496 (635)
+...+... ....+..++.++.+||.+||..||.+||| +++++.|+|+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 77777655 35667789999999999999999999999 78888999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=385.15 Aligned_cols=259 Identities=26% Similarity=0.338 Sum_probs=222.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 300 (635)
+....|.+.+.||+|+||.||++.+...... ....+..||||++.... .......+.+|+.+|+.+ +||||
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~-------~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnI 149 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKD-------KPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNI 149 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTT-------CTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCc-------CcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCE
Confidence 3456788899999999999999987432210 01245679999997653 456677899999999999 89999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
+++++++...+.+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||
T Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 229 (370)
T 2psq_A 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229 (370)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999999999999999999999999999997653 4899999999999999999999999999999
Q ss_pred cCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~ 440 (635)
||+||||+.++.+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||+||||++ |..||.+
T Consensus 230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999998665432 22345567899999999888876 99999999999999999 9999999
Q ss_pred CCHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 441 PNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 441 ~~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.....+...+..+. ...|..++.++.+||.+||..||.+|||+.||+++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 309 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888777776653 45677899999999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=379.19 Aligned_cols=256 Identities=24% Similarity=0.277 Sum_probs=201.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||+||++.+. .++..||||++...... .....+|+..|..++||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~ 83 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEK--------------STGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQ 83 (360)
T ss_dssp HHTTEEEC----------CEEEEET--------------TTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCC
T ss_pred hccceEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCccc
Confidence 3568889999999999999999873 35678999998654322 134567888889999999999
Q ss_pred EEEEEecCCe-------EEEEEeccccchhh---hhhhhcccCCHHHHHHHHHHHHHhhhhhc--cCceeeecccCccee
Q psy6357 303 LFQVMETTNN-------LYLVTEYARGGEIF---SHLLTIGQMAEKEASRLFRQILSAVAYCH--ANNVVHRDIKAENLL 370 (635)
Q Consensus 303 l~~~~~~~~~-------~~LV~E~~~ggsL~---~~l~~~~~l~e~~~~~i~~qIl~gL~~LH--s~gIiHrDLKp~NIL 370 (635)
++++|..... +++||||+.++.+. .++.....+++..++.++.||+.||.||| +.||+||||||+|||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL 163 (360)
T ss_dssp EEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEE
T ss_pred HHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEE
Confidence 9999965433 88999999865322 23335567999999999999999999999 999999999999999
Q ss_pred ecC-CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy6357 371 FDE-NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQR 449 (635)
Q Consensus 371 l~~-~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~ 449 (635)
|+. ++.+||+|||++.............||+.|+|||++.+....+.++||||||||+|+|++|..||.+.+.......
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 997 8999999999999877666666778999999999997766445999999999999999999999999887666665
Q ss_pred HHhCc--------------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 450 ILFGK--------------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 450 i~~~~--------------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+.... ...+..++.++.+||.+||+.||.+|||+.|||+||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 54210 01112257899999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=373.27 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=211.6
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn 299 (635)
.....+|.+++.||+|+||.||+|.+. .++..||||++...... ...+.+|+.+|+++ .|||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~ 82 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHV--------------KTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRN 82 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTT
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEEC--------------CCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCC
Confidence 345678999999999999999999873 35678999999765432 25678999999999 7999
Q ss_pred eeeEEEEEec------CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 300 IIKLFQVMET------TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 300 Iv~l~~~~~~------~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
|+++++++.. ...+||||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||||
T Consensus 83 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 162 (326)
T ss_dssp BCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred eeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE
Confidence 9999999976 56899999999999999999764 469999999999999999999999999999999999999
Q ss_pred cCCCCeeeecccccccccCC-CccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
+.++.+||+|||++...... .......||+.|+|||++. +..++ .++|||||||++|+|++|..||.......
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 99999999999999876432 2334567899999999987 34454 89999999999999999999998887766
Q ss_pred HHHHHHhCccC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 446 LKQRILFGKFR--IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 446 l~~~i~~~~~~--~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
....+...... .+..++..+.+||.+||..||.+|||+.+||+||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 242 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 66555544322 23468999999999999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=376.33 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=212.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .++..||||++............+.+|+.+|+.++||||++
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 87 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDK--------------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCceEEEeeeEecCCCeEEEEEEEC--------------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccc
Confidence 3478999999999999999999873 35678999999877666667788999999999999999999
Q ss_pred EEEEEecCCe------EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTNN------LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~~------~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
+++++..... +|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 88 LLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp CSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC
T ss_pred HhheEecccccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc
Confidence 9999977654 599999996 688887753 5999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||++..... .....++|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 165 ~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 165 LKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp EEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCB
T ss_pred EEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999986543 2345678999999999987433458999999999999999999999988766555444321
Q ss_pred ----------------------------ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 ----------------------------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ----------------------------~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
....+..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011223578999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=396.78 Aligned_cols=247 Identities=15% Similarity=0.182 Sum_probs=202.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHH---HHhhCCCCc
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVD---IMSHLDHPH 299 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~---iL~~L~Hpn 299 (635)
...|.++++||+|+||+||+|.+. .++..||||++..... .....+.+.+|+. +|++++|||
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpn 137 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ--------------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC---------------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHH
T ss_pred CceEEEcceeecCCCEEEEEEEEC--------------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHH
Confidence 467888999999999999999873 3567899999976532 3445678889994 555568999
Q ss_pred eeeEE-------EEEecCC-----------------eEEEEEeccccchhhhhhhhcccCCH-------HHHHHHHHHHH
Q psy6357 300 IIKLF-------QVMETTN-----------------NLYLVTEYARGGEIFSHLLTIGQMAE-------KEASRLFRQIL 348 (635)
Q Consensus 300 Iv~l~-------~~~~~~~-----------------~~~LV~E~~~ggsL~~~l~~~~~l~e-------~~~~~i~~qIl 348 (635)
||+++ ++++..+ ..||||||+ +|+|.+++...+.+++ ..++.|+.||+
T Consensus 138 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~ 216 (377)
T 3byv_A 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216 (377)
T ss_dssp HHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHH
Confidence 99998 7776553 389999999 6899999987766665 88889999999
Q ss_pred HhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCC-----------CcCCC
Q psy6357 349 SAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGR-----------EYDGT 417 (635)
Q Consensus 349 ~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~-----------~~~~~ 417 (635)
.||+|||+.||+||||||+||||+.++.+||+|||+|.... ......+| +.|+|||++.+. .++ .
T Consensus 217 ~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~ 292 (377)
T 3byv_A 217 RLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-F 292 (377)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-H
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCC-h
Confidence 99999999999999999999999999999999999998643 24456678 999999999877 665 9
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 418 KSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 418 ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
++|||||||+||+|++|..||...+.......+. ..+..++.++.+||.+||..||.+|||+.|||+||||.
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 9999999999999999999998765443333332 23356899999999999999999999999999999996
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=371.50 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=214.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.....|.++++||+|+||.||++.+. .++..||||++.... ......+.+|+.+|+.++||||+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~--------------~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~ 79 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNK--------------ETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIV 79 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEET--------------TTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBC
T ss_pred CCccceeecceeccCCCeEEEEEEEc--------------CCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEe
Confidence 45678999999999999999999873 346789999997553 22346788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.....+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp CEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999998876 3569999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CCccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 381 DFGFSNYFTP-GHMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 381 DFGla~~~~~-~~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|||++..... ........||+.|+|||++. ...++ .++|||||||++|+|++|..||...+.......+....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (302)
T 2j7t_A 160 DFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238 (302)
T ss_dssp CCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ECCCCccccccccccccccCChhhcCCeeeccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence 9999754321 11233457899999999983 45554 89999999999999999999999988777766666554
Q ss_pred c---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 F---RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~---~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. ..+..++.++.+||.+||..||.+|||+.+|++||||..
T Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 3 234568999999999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=388.51 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=191.3
Q ss_pred CCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.+. ++||+|+||+||++.+... .++..||||++...... ..+.+|+.+|++|+|||||++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~------------~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~ 83 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG------------KDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISL 83 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS------------SCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCC
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC------------CCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeE
Confidence 445553 4799999999999986321 24568999999766544 357799999999999999999
Q ss_pred EEEEe--cCCeEEEEEeccccchhhhhhhhcc---------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee-
Q psy6357 304 FQVME--TTNNLYLVTEYARGGEIFSHLLTIG---------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF- 371 (635)
Q Consensus 304 ~~~~~--~~~~~~LV~E~~~ggsL~~~l~~~~---------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl- 371 (635)
++++. ....+||||||+. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~ 162 (405)
T 3rgf_A 84 QKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 162 (405)
T ss_dssp CEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred eeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEe
Confidence 99994 4778999999996 57777775322 49999999999999999999999999999999999999
Q ss_pred ---cCCCCeeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH
Q psy6357 372 ---DENGDIKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444 (635)
Q Consensus 372 ---~~~~~ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~ 444 (635)
+.++.+||+|||+|..+... ......+||+.|+|||++.+...++.++||||||||||+|++|.+||.+....
T Consensus 163 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 242 (405)
T 3rgf_A 163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242 (405)
T ss_dssp CSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred cCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccc
Confidence 67789999999999876432 23456789999999999988654459999999999999999999999765431
Q ss_pred ---------HHHHHHHhC-ccC-------------------------------------CCCCCCHHHHHHHHHhcccCC
Q psy6357 445 ---------VLKQRILFG-KFR-------------------------------------IPFYMSAECENLIRSMLVLDP 477 (635)
Q Consensus 445 ---------~l~~~i~~~-~~~-------------------------------------~p~~~s~~l~~LI~~~L~~dP 477 (635)
.....+... ..+ .....+.++.+||.+||.+||
T Consensus 243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP 322 (405)
T 3rgf_A 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322 (405)
T ss_dssp ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence 222222110 000 001126789999999999999
Q ss_pred CCCCCHHHHHcCcccccC
Q psy6357 478 AKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 478 ~~Rps~~eiL~Hpw~~~~ 495 (635)
.+|||+.|||+||||...
T Consensus 323 ~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 323 IKRITSEQAMQDPYFLED 340 (405)
T ss_dssp GGSCCHHHHHTSGGGTSS
T ss_pred ccCCCHHHHhcChhhccC
Confidence 999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.72 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=218.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||.||++.+. ++..||||++....... +.+.+|+.+|++++||||++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~---------------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~ 69 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL---------------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQ 69 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET---------------TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCC
T ss_pred ChhhceeeheecCCCccEEEEEEec---------------CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEee
Confidence 3567888999999999999999873 34579999998765544 46789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.+...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 70 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecc
Confidence 999999999999999999999999999654 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...+... ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccccccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence 99998664322 22344567789999999877776 89999999999999999 99999999988888887765 4455
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..++.++.+||.+||..||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 66789999999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=385.00 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=224.7
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.+..++|.++++||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.+|++++||||
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPN---------DPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC--------------CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCC---------CCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCC
Confidence 3456778889999999999999998643211 2356789999996543 44555678899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc-------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
|++++++......|||||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.
T Consensus 137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 999999999999999999999999999997653 4899999999999999999999999999999999999995
Q ss_pred CC---CeeeecccccccccC---CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 374 NG---DIKLADFGFSNYFTP---GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 374 ~~---~ikL~DFGla~~~~~---~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
++ .+||+|||++..... ........+|+.|+|||++.+..++ .++|||||||+||+|++ |..||...+...+
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 55 599999999975422 1233456789999999999888776 89999999999999998 9999999998888
Q ss_pred HHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 447 KQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 447 ~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...+..+. ...+..++..+.+||.+||+.||.+|||+.+|++|.|+..
T Consensus 296 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 88887664 4567789999999999999999999999999999988754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=386.82 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=208.8
Q ss_pred ccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-
Q psy6357 218 SRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD- 296 (635)
Q Consensus 218 ~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~- 296 (635)
..++...++|.++++||+|+||+||++.+. .++..||||++... ......+.+|+.+|+.+.
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~ 92 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDI--------------QGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRN 92 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHH
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEec--------------CCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhh
Confidence 345677789999999999999999999773 34578999999743 345567889999999985
Q ss_pred -------CCceeeEEEEEe----cCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccC-ceeee
Q psy6357 297 -------HPHIIKLFQVME----TTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHAN-NVVHR 362 (635)
Q Consensus 297 -------HpnIv~l~~~~~----~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHr 362 (635)
|+||+++++++. ....+||||||+ +++|.+++... ..+++..++.|+.||+.||.|||++ ||+||
T Consensus 93 ~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp SCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred cCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 788999999997 566899999999 56666666544 4699999999999999999999998 99999
Q ss_pred cccCcceeecCCC-------------------------------------------------CeeeecccccccccCCCc
Q psy6357 363 DIKAENLLFDENG-------------------------------------------------DIKLADFGFSNYFTPGHM 393 (635)
Q Consensus 363 DLKp~NILl~~~~-------------------------------------------------~ikL~DFGla~~~~~~~~ 393 (635)
||||+||||+.++ .+||+|||++..... .
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~ 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--C
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--c
Confidence 9999999998775 799999999987643 2
Q ss_pred cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh--C------------
Q psy6357 394 LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL------AVLKQRILF--G------------ 453 (635)
Q Consensus 394 ~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~------~~l~~~i~~--~------------ 453 (635)
....+||+.|+|||++.+..++ .++||||||||||+|++|..||...+. ......+.. +
T Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 328 (397)
T 1wak_A 250 FTEDIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328 (397)
T ss_dssp SCSCCSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred CccCCCCCcccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence 4556899999999999988876 899999999999999999999976541 111111111 0
Q ss_pred ----------------------------ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 ----------------------------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ----------------------------~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.+..+..++.++.+||.+||+.||.+|||+.|||+||||+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0111223456789999999999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.67 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=196.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.+++.||+|+||.||++.+. .++..||||++..... ......+.+|+.+|++++||||+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 76 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCA--------------PKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIV 76 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC------------------CEEEEECCC-----------------CCCCCCCTTBC
T ss_pred cchhhhhhhheeccccceEEEEEEEC--------------CCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEe
Confidence 44678899999999999999999873 2456899999875432 23456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh--------cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT--------IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~--------~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
++++++...+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 156 (303)
T 2vwi_A 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156 (303)
T ss_dssp CEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred eEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC
Confidence 999999999999999999999999998864 355999999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCC------CccccccCCCCCCCccccCC-CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH
Q psy6357 374 NGDIKLADFGFSNYFTPG------HMLTTWCGSPPYAAPELFGG-REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL 446 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~------~~~~~~~gt~~Y~APEvl~~-~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l 446 (635)
++.+||+|||++...... .......||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||........
T Consensus 157 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp TCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCC-CTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCC-CchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 999999999998765432 12345679999999999865 334 4899999999999999999999988766554
Q ss_pred HHHHHhCcc----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 447 KQRILFGKF----------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~~~----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
......... .....++.++.+||.+||..||.+|||+.+|++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 444433321 1224578999999999999999999999999999999743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=362.24 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=218.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.++++||+|+||.||++.+. ++..||||++....... ..+.+|+.+|++++||||+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~---------------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~ 66 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK---------------GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLV 66 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET---------------TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBC
T ss_pred echhheeeeeeeccCCCceEEEEEec---------------CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEe
Confidence 34577889999999999999999762 34579999998765544 4678999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.....+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~ 146 (268)
T 3sxs_A 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVS 146 (268)
T ss_dssp CEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEEC
T ss_pred eEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEc
Confidence 99999999999999999999999999997764 49999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 381 DFGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 381 DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
|||++........ .....+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...........+.... ..
T Consensus 147 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (268)
T 3sxs_A 147 DFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225 (268)
T ss_dssp CTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cCccceecchhhhhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence 9999987654322 2234456779999999887776 89999999999999999 999999988888777776654 34
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.|..++.++.+||.+||+.||.+|||+.+|++|
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566789999999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=374.04 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=212.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.....|.+++.||+|+||.||++.+. .++..||||++.... .......+.+|+.+|++++||||+
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 72 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHK--------------PTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENII 72 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEEC--------------CCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcC
Confidence 45678999999999999999999873 345789999996543 445567788999999999999999
Q ss_pred eEEEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 302 KLFQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 302 ~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++++++... ...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 73 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~ 150 (353)
T 2b9h_A 73 TIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD 150 (353)
T ss_dssp CEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred CeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc
Confidence 999998654 67999999996 688888765 57999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCC-----------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 377 IKLADFGFSNYFTPGH-----------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 377 ikL~DFGla~~~~~~~-----------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
+||+|||++....... .....+||+.|+|||++......+.++|||||||++|+|++|..||.+.+...
T Consensus 151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 230 (353)
T 2b9h_A 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230 (353)
T ss_dssp EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999998764321 12345789999999988653333589999999999999999999999887655
Q ss_pred HHHHHHhC------------------------cc--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 446 LKQRILFG------------------------KF--------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 446 l~~~i~~~------------------------~~--------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
....+... .. ..+..++.++.+||.+||..||.+|||+.|||+||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 44433210 00 01135789999999999999999999999999999998
Q ss_pred cC
Q psy6357 494 VH 495 (635)
Q Consensus 494 ~~ 495 (635)
..
T Consensus 311 ~~ 312 (353)
T 2b9h_A 311 TY 312 (353)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=371.25 Aligned_cols=256 Identities=27% Similarity=0.361 Sum_probs=221.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+.+.||+|+||.||++.+...+. ...+..||||++.... .....+.+.+|+.+|++++||||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKG---------RAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGG---------CSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCc---------ccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceee
Confidence 35778889999999999999998743321 1245689999997543 5566788999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhccc------------------------CCHHHHHHHHHHHHHhhhhhccCc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ------------------------MAEKEASRLFRQILSAVAYCHANN 358 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~------------------------l~e~~~~~i~~qIl~gL~~LHs~g 358 (635)
+++++.+...+|+||||+++++|.+++..... +++..++.++.||+.||.|||+.|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999976543 899999999999999999999999
Q ss_pred eeeecccCcceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-C
Q psy6357 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-A 434 (635)
Q Consensus 359 IiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G 434 (635)
|+|+||||+||||+.++.+||+|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTS
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987644322 2344567889999999887776 99999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 435 QLPFDGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 435 ~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..||.+.....+...+.... ...+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 250 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999988877777776553 45667899999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=364.79 Aligned_cols=249 Identities=21% Similarity=0.383 Sum_probs=215.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.++++||+|+||+||++.+. .+..||||++....... ..+.+|+.+|++++|+||+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~---------------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~ 82 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR---------------GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLV 82 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET---------------TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc---------------CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEe
Confidence 34667888999999999999999762 34579999998765544 4678999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.+...+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~ 162 (283)
T 3gen_A 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 162 (283)
T ss_dssp CEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEc
Confidence 999999999999999999999999999977 4679999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+.... ..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3gen_A 163 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY 241 (283)
T ss_dssp STTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccccccccccccccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC
Confidence 999998664321 22334567789999999877775 89999999999999998 999999998888888777663 45
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.|..++..+.+||.+||..||.+|||+.+|++|
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 566789999999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=380.07 Aligned_cols=265 Identities=21% Similarity=0.341 Sum_probs=219.8
Q ss_pred ccchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHH
Q psy6357 209 EITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFRE 288 (635)
Q Consensus 209 e~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~E 288 (635)
.+....|.+. ..+|.++++||+|+||.||++.+..... ..++..||||++.... .......+.+|
T Consensus 11 ~~~~~~~~~~-----~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E 75 (359)
T 3vhe_A 11 PYDASKWEFP-----RDRLKLGKPLGRGAFGQVIEADAFGIDK---------TATCRTVAVKMLKEGA-THSEHRALMSE 75 (359)
T ss_dssp CCCHHHHBCC-----GGGEEEEEEEEECSSEEEEEEEEESSSS---------TTCEEEEEEEEECTTC-CHHHHHHHHHH
T ss_pred CCCccccccc-----ccceeeceeecCCCCceEEEEEeccccc---------cccceEEEEEEecCcC-CHHHHHHHHHH
Confidence 3445566554 5678889999999999999998643211 2355789999997653 44556788999
Q ss_pred HHHHhhC-CCCceeeEEEEEecCC-eEEEEEeccccchhhhhhhhccc--------------------------------
Q psy6357 289 VDIMSHL-DHPHIIKLFQVMETTN-NLYLVTEYARGGEIFSHLLTIGQ-------------------------------- 334 (635)
Q Consensus 289 i~iL~~L-~HpnIv~l~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~-------------------------------- 334 (635)
+.+|.++ .|||||++++++...+ .+++|||||.+++|.+++.....
T Consensus 76 ~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (359)
T 3vhe_A 76 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDS 155 (359)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------
T ss_pred HHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccc
Confidence 9999999 7899999999997754 49999999999999999976543
Q ss_pred ----------------------------------CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 335 ----------------------------------MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 335 ----------------------------------l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp ----------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred cCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEE
Confidence 8999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-c
Q psy6357 381 DFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAV-LKQRILFG-K 454 (635)
Q Consensus 381 DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~-l~~~i~~~-~ 454 (635)
|||++....... ......+|+.|+|||++.+..++ .++||||||||+|+|++ |..||.+..... +...+... .
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 314 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC
Confidence 999998664322 23456688899999999888776 99999999999999998 999998866433 33333333 4
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...|..++.++.+||.+||..||.+|||+.||++|
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 56677899999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=358.54 Aligned_cols=248 Identities=19% Similarity=0.340 Sum_probs=218.7
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.+..++|.++++||+|+||+||++.+ .+..||||++..........+.+.+|+.+|++++||||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 69 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW----------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE----------------TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE----------------CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCch
Confidence 34567899999999999999999987 24579999998877777777889999999999999999
Q ss_pred eeEEEEEecC--CeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeecCC
Q psy6357 301 IKLFQVMETT--NNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFDEN 374 (635)
Q Consensus 301 v~l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~~~ 374 (635)
+++++++.+. ..+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.+
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED 149 (271)
T ss_dssp ECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT
T ss_pred hheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC
Confidence 9999999877 78999999999999999998765 4899999999999999999999999 9999999999999999
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCC--CccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDG--TKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~--~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
+.++|+|||++..... ....+|+.|+|||++.+..+.. .++|||||||++|+|++|..||...+.......+..
T Consensus 150 ~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 225 (271)
T 3kmu_A 150 MTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225 (271)
T ss_dssp SCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH
T ss_pred cceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh
Confidence 9999999988765332 3457899999999998776552 279999999999999999999999888777666665
Q ss_pred C--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 453 G--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 453 ~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
. ...+|..++.++.+||.+||..||.+|||+.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4 34566789999999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=375.11 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=214.5
Q ss_pred hhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC
Q psy6357 216 KASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL 295 (635)
Q Consensus 216 ~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L 295 (635)
....++.+.++|.++++||+|+||+||++.+... .+..||||++... ......+.+|+.+|+.+
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------------~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l 73 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR-------------GKSQVALKIIRNV---GKYREAARLEINVLKKI 73 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTT-------------TTEEEEEEEECSC---HHHHHHHHHHHHHHHHH
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCC-------------CceEEEEEEEccc---ccchhHHHHHHHHHHHH
Confidence 3445667788999999999999999999987322 2258999999643 34456788899999998
Q ss_pred CCCc------eeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 296 DHPH------IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 296 ~Hpn------Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
.|++ |+.+++++.....+||||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~ 152 (355)
T 2eu9_A 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPE 152 (355)
T ss_dssp HHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred hhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 7655 999999999999999999999 666777776543 6999999999999999999999999999999999
Q ss_pred ceee-------------------cCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHH
Q psy6357 368 NLLF-------------------DENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVL 428 (635)
Q Consensus 368 NILl-------------------~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvil 428 (635)
|||| +.++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||+|
T Consensus 153 NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il 229 (355)
T 2eu9_A 153 NILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCIL 229 (355)
T ss_dssp GEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHH
T ss_pred HEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHH
Confidence 9999 5678999999999986543 33456899999999999988876 899999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCccCCC--------------------------------------------CCCCHH
Q psy6357 429 YVMVTAQLPFDGPNLAVLKQRILFGKFRIP--------------------------------------------FYMSAE 464 (635)
Q Consensus 429 yeLltG~~PF~~~~~~~l~~~i~~~~~~~p--------------------------------------------~~~s~~ 464 (635)
|+|++|..||...+.......+......+| ...+.+
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 999999999998776554443332111111 112458
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
+.+||.+||..||.+|||+.|||+||||...
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 8999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.39 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=224.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 300 (635)
+..++|.+.++||+|+||+||++.+....... ...+..||||++.... .......+.+|+.+|+++ +||||
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~-------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDK-------PNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTC-------TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccc-------cccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchh
Confidence 34568888999999999999999874322110 1234579999997653 556668899999999999 89999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
|++++++...+.+||||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 217 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 999999999999999999999999999997654 4999999999999999999999999999999
Q ss_pred cCcceeecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~ 440 (635)
||+||||+.++.+||+|||++...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543 223345567889999999888876 99999999999999999 9999999
Q ss_pred CCHHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 441 PNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 441 ~~~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+...+...+... ....|..++.++.+||.+||..||.+|||+.||+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9988888877765 455677899999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=374.95 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=221.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.+++.||+|+||.||++.+..... ..++..||||++.... .......+.+|+.+|++++||||+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv 113 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLP---------YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIV 113 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSST---------TSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCC---------CCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEE
Confidence 456788999999999999999998743211 1244689999997653 455567889999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc------------------------ccCCHHHHHHHHHHHHHhhhhhccC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI------------------------GQMAEKEASRLFRQILSAVAYCHAN 357 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~------------------------~~l~e~~~~~i~~qIl~gL~~LHs~ 357 (635)
++++++.....+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+.
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999764 5699999999999999999999999
Q ss_pred ceeeecccCcceeecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-
Q psy6357 358 NVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT- 433 (635)
Q Consensus 358 gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt- 433 (635)
||+||||||+||||+.++.+||+|||++...... .......+|+.|+|||++.+..++ .++|||||||++|+|++
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhc
Confidence 9999999999999999999999999999765432 223345678899999999887776 99999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 434 AQLPFDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 434 G~~PF~~~~~~~l~~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..||.+.+...+...+..+.. .+|..++.++.+||.+||..||.+|||+.+|+++
T Consensus 273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999999988888887776653 5677899999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=381.40 Aligned_cols=259 Identities=25% Similarity=0.299 Sum_probs=214.6
Q ss_pred hhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC
Q psy6357 216 KASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL 295 (635)
Q Consensus 216 ~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L 295 (635)
.+..++....+|.++++||+|+||+||+|.+. .++..||||++... ......+..|+.+++.+
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l 107 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDR--------------VEQEWVAIKIIKNK---KAFLNQAQIEVRLLELM 107 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEET--------------TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHH
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEc--------------CCCcEEEEEEEecc---HHHHHHHHHHHHHHHHH
Confidence 34456677889999999999999999999873 34568999999743 34456777899998888
Q ss_pred C-CC-----ceeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhc--cCceeeeccc
Q psy6357 296 D-HP-----HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCH--ANNVVHRDIK 365 (635)
Q Consensus 296 ~-Hp-----nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LH--s~gIiHrDLK 365 (635)
. |+ +|+++++++.....+||||||+. ++|.+++... ..+++..++.++.||+.||.||| ..||+|||||
T Consensus 108 ~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk 186 (382)
T 2vx3_A 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK 186 (382)
T ss_dssp HHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS
T ss_pred HhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC
Confidence 5 44 49999999999999999999996 5999988765 45999999999999999999999 4799999999
Q ss_pred Ccceeec--CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH
Q psy6357 366 AENLLFD--ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443 (635)
Q Consensus 366 p~NILl~--~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~ 443 (635)
|+||||+ .++.+||+|||++..... .....+||+.|+|||++.+..++ .++||||||||||+|++|..||.+.+.
T Consensus 187 p~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 187 PENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccEEEecCCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999995 477899999999987643 34567899999999999998876 999999999999999999999999887
Q ss_pred HHHHHHHHhCccCC------------------CC-------------------C--------------------------
Q psy6357 444 AVLKQRILFGKFRI------------------PF-------------------Y-------------------------- 460 (635)
Q Consensus 444 ~~l~~~i~~~~~~~------------------p~-------------------~-------------------------- 460 (635)
......+....... |. .
T Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 343 (382)
T 2vx3_A 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343 (382)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCH
T ss_pred HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccc
Confidence 76666554311000 00 0
Q ss_pred -CCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 461 -MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 461 -~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+.++.+||.+||++||++|||+.|||+||||...
T Consensus 344 ~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01478999999999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.88 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=216.0
Q ss_pred cccCCcccee-eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLR-KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~-kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
+..++|.+.+ .||+|+||+||++.+.... .+..||||++..........+.+.+|+.+|+.++||||
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 80 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKK------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSS------------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCC------------ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE
Confidence 3456788888 8999999999999764332 34689999998765555566789999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++ ....+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEc
Confidence 9999999 567789999999999999999988889999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-
Q psy6357 381 DFGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 381 DFGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~- 454 (635)
|||++........ .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...+....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 238 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999987654322 2223457889999999887776 89999999999999999 999999988888777776653
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..+|..++.++.+||.+||..||.+|||+.+|++
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4567789999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.82 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=210.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.+.++||+|+||+||++.+. .++..||||++... +......+.+|+.+|++++||||+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------------~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv 70 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHR--------------ETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVL 70 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEET--------------TTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred eChhHeeccceecCCCCEEEEEEEEC--------------CCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcc
Confidence 34567888999999999999999873 35678999998543 556678899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.+....++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~ 150 (310)
T 3s95_A 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVA 150 (310)
T ss_dssp CEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEEC
T ss_pred cEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEe
Confidence 999999999999999999999999999987 4679999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc---------------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 381 DFGFSNYFTPGHM---------------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 381 DFGla~~~~~~~~---------------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
|||++........ ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred ecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 9999987643221 1256799999999999988876 89999999999999999999986532111
Q ss_pred -----HHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 -----LKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 -----l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...... ....|..++.++.+||.+||..||.+|||+.+|++
T Consensus 230 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 230 MDFGLNVRGFL--DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTSSBCHHHHH--HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhhhhccc--cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 011111 12346678899999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=376.45 Aligned_cols=254 Identities=32% Similarity=0.543 Sum_probs=218.6
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLD 296 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~ 296 (635)
.....+|.+++.||+|+||.||++.+. .++..||||++....... .....+.+|+.+|+++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRV--------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEET--------------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEEC--------------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc
Confidence 456778999999999999999999873 345789999997654321 12245668999999996
Q ss_pred --CCceeeEEEEEecCCeEEEEEecccc-chhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec-
Q psy6357 297 --HPHIIKLFQVMETTNNLYLVTEYARG-GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD- 372 (635)
Q Consensus 297 --HpnIv~l~~~~~~~~~~~LV~E~~~g-gsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~- 372 (635)
|+||+++++++...+.+++|||++.+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+
T Consensus 105 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184 (320)
T ss_dssp SSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred cCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC
Confidence 59999999999999999999999976 89999999888999999999999999999999999999999999999999
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
.++.+||+|||++...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+..
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~ 257 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR 257 (320)
T ss_dssp TTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH
T ss_pred CCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc
Confidence 7889999999999876543 34456799999999999877765588999999999999999999997532 3344
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
....++..++.++.+||.+||..||.+|||+.+|++||||...
T Consensus 258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 5566777899999999999999999999999999999999743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=372.96 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=210.6
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhC-
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHL- 295 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L- 295 (635)
+...++|.++++||+|+||.||++.+. .++..||||++....... .....+.+|+.++.++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 92 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL--------------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT--------------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHH
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc--------------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhc
Confidence 355678999999999999999999762 356789999997654322 2234456799999998
Q ss_pred ---CCCceeeEEEEEecCCeEEEEEec-cccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 296 ---DHPHIIKLFQVMETTNNLYLVTEY-ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 296 ---~HpnIv~l~~~~~~~~~~~LV~E~-~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
+|+||+++++++...+..++|||+ +.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||+
T Consensus 93 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI 172 (312)
T ss_dssp SSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE
T ss_pred ccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE
Confidence 899999999999999999999999 7899999999988889999999999999999999999999999999999999
Q ss_pred c-CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 372 D-ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 372 ~-~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
+ .++.+||+|||++...... ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||... ..+
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~ 245 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEI 245 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH
T ss_pred eCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHH
Confidence 9 7899999999999876543 3455679999999999987776546899999999999999999999753 234
Q ss_pred HhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 451 LFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 451 ~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
......++..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 246 LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred hhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 445667788899999999999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=365.08 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=196.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||.||++.+. .++..||||++............+..+..+++.++||||++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 88 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFR--------------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ 88 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEET--------------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhccccccceeeecCCeeEEEEEEe--------------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceee
Confidence 3567888999999999999999873 35678999999876544444445555666788889999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.....+||||||+ ++.+..++.. ...+++..++.++.||+.||.|||+. ||+|+||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~ 167 (318)
T 2dyl_A 89 CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLC 167 (318)
T ss_dssp EEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999 5555554443 46799999999999999999999995 99999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCc
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDG-PNLAVLKQRILFGK 454 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~-~~~~~l~~~i~~~~ 454 (635)
|||++.............+|+.|+|||++. ...++ .++|||||||++|+|++|..||.. .........+....
T Consensus 168 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (318)
T 2dyl_A 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246 (318)
T ss_dssp CCTTC--------------CCTTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC
T ss_pred ECCCchhccCCccccccCCCccccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC
Confidence 999998776555556678999999999995 33444 899999999999999999999987 34445555555443
Q ss_pred c-CCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 F-RIP--FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 ~-~~p--~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
. .+| ..++.++.+||.+||..||.+|||+.+||+||||..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 3 233 358999999999999999999999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.07 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=210.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.....||+|+||.||+|.+. .++..||||++.... ......+.+|+.+++.++||||+++
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~ 84 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDL--------------SNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQY 84 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEET--------------TTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCCCCcEEEeecCcEEEEEEEEC--------------CCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 334455678999999999999873 356789999997653 3344678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc---cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-CCCeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG---QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-NGDIKL 379 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-~~~ikL 379 (635)
++++...+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||||+. ++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl 164 (295)
T 2clq_A 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI 164 (295)
T ss_dssp EEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEE
T ss_pred eeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEE
Confidence 999999999999999999999999987652 4679999999999999999999999999999999999987 899999
Q ss_pred ecccccccccCC-CccccccCCCCCCCccccCCCC--cCCCccchhhHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHhC
Q psy6357 380 ADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGRE--YDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV--LKQ-RILFG 453 (635)
Q Consensus 380 ~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~--~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~--l~~-~i~~~ 453 (635)
+|||++...... .......||+.|+|||++.+.. + +.++|||||||++|+|++|..||....... ... .....
T Consensus 165 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (295)
T 2clq_A 165 SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243 (295)
T ss_dssp CCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGC-SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC
T ss_pred eecccccccCCCCCcccccCCCccccChhhhcCCCCCC-CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc
Confidence 999999876432 2234567899999999987543 4 489999999999999999999997643221 111 12233
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+|..++.++.+||.+||..||.+|||+.+||+||||...
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 446677899999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=367.72 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=214.2
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC--CC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD--HP 298 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~--Hp 298 (635)
.+..+.|.+++.||+|+||.||++.+. ++..||||++............+.+|+.+|.++. |+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 88 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE---------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT---------------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC---------------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence 345677999999999999999999762 3568999999877767777888999999999997 59
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
||+++++++.....+||||| +.+++|.+++.....+++..++.++.||+.||.|||+.+|+|+||||+|||++ ++.+|
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~k 166 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 166 (313)
T ss_dssp TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEE
T ss_pred ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEE
Confidence 99999999999999999999 55889999999888999999999999999999999999999999999999996 48999
Q ss_pred eecccccccccCCC---ccccccCCCCCCCccccCC-----------CCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-
Q psy6357 379 LADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGG-----------REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL- 443 (635)
Q Consensus 379 L~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~-----------~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~- 443 (635)
|+|||++....... ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.....
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 99999998764332 2345678999999999875 244 4899999999999999999999977542
Q ss_pred HHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 444 AVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 444 ~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
......+... ...+|..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 2333333332 335666789999999999999999999999999999999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=363.39 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=207.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.+.+.||+|+||.||+|.+.... ..+..||||++.... .....+.+.+|+.+|++++||||+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----------~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv 79 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPE-----------NPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIV 79 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC-------------CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCC-----------CCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccc
Confidence 34678889999999999999999874332 134579999987543 455667889999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++. .+..|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 80 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp CEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred eEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence 9999984 567899999999999999997654 69999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 381 DFGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 381 DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.....+...+.... ..
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237 (281)
T ss_dssp C-------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccCcccccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC
Confidence 9999987654322 2334567789999999877776 89999999999999997 999999888777777776553 46
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
++..++.++.+||.+||..||.+|||+.+|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 677899999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=362.33 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=204.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+++.||+|+||.||++.+. .++..||||++.. .......+.+|+.+|++++||||+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~ 67 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA--------------LDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRY 67 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccchhhheeccCCcEEEEEEEEc--------------CCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHH
Confidence 456888999999999999999862 3567899999964 34456788999999999999999999
Q ss_pred EEEEec-------------CCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 304 FQVMET-------------TNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 304 ~~~~~~-------------~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
++++.+ ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Ni 147 (303)
T 1zy4_A 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNI 147 (303)
T ss_dssp EEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhE
Confidence 998854 46789999999999999999754 3588999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCC---------------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC
Q psy6357 370 LFDENGDIKLADFGFSNYFTPG---------------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA 434 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~---------------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG 434 (635)
||+.++.+||+|||++...... .......||+.|+|||++.+....+.++|||||||++|+|++
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 9999999999999999865421 223456789999999999876434589999999999999998
Q ss_pred CCCCCC-CCHHHHHHHHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 435 QLPFDG-PNLAVLKQRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 435 ~~PF~~-~~~~~l~~~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
||.. .+...+...+......+| ..++..+.+||.+||..||.+|||+.+||+||||...
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5543 233445555555444444 3467889999999999999999999999999999643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=383.93 Aligned_cols=252 Identities=16% Similarity=0.160 Sum_probs=191.8
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhC--CCCcee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHL--DHPHII 301 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L--~HpnIv 301 (635)
..|.++++||+|+||.||++.+. .++..||||++..... .......+.+|+.+++.| +||||+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv 127 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV--------------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC------
T ss_pred eeeeeeeeccCCCCEEEEEEEEC--------------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhh
Confidence 44888999999999999999873 3457899999988765 334556777885544444 699988
Q ss_pred eEE-------EEEecC-----------------CeEEEEEeccccchhhhhhhhcc-cCCHHHH------HHHHHHHHHh
Q psy6357 302 KLF-------QVMETT-----------------NNLYLVTEYARGGEIFSHLLTIG-QMAEKEA------SRLFRQILSA 350 (635)
Q Consensus 302 ~l~-------~~~~~~-----------------~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~------~~i~~qIl~g 350 (635)
+++ +++... ..+|||||||+ ++|.+++.... .+.+... +.++.||+.|
T Consensus 128 ~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp ----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHH
Confidence 755 555432 34899999998 89999998753 3444445 6777999999
Q ss_pred hhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCC--CCcCCCccchhhHHHHH
Q psy6357 351 VAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG--REYDGTKSDVWSLGVVL 428 (635)
Q Consensus 351 L~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~--~~~~~~ksDIwSlGvil 428 (635)
|+|||++||+||||||+||||+.++.+||+|||+|..... ......+|+.|+|||++.+ ..++ .++|||||||+|
T Consensus 207 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il 283 (371)
T 3q60_A 207 AANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSI 283 (371)
T ss_dssp HHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHH
T ss_pred HHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHH
Confidence 9999999999999999999999999999999999986643 2225567799999999987 5565 999999999999
Q ss_pred HHHHhCCCCCCCCCHHHH--HHH-----HHhCccCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 429 YVMVTAQLPFDGPNLAVL--KQR-----ILFGKFRIP--FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 429 yeLltG~~PF~~~~~~~l--~~~-----i~~~~~~~p--~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
|+|++|..||........ ... .....+.++ ..++.++.+||.+||..||++|||+.++|+||||..
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred HHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 999999999987643211 000 001122223 468999999999999999999999999999999963
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=381.00 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=216.5
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||.||+|.+. .++..||||++... ........+.+|+.+|++++|||||++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~ 177 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR--------------ADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRL 177 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe--------------cCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 457778999999999999999873 24578999999754 345556678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.....+|||||||++++|.+++...+ .+++..++.++.||+.||+|||+.+|+||||||+||||+.++.+||+||
T Consensus 178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999999999999997654 5999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcc---ccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 383 GFSNYFTPGHML---TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 383 Gla~~~~~~~~~---~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
|++......... ....+++.|+|||++.+..++ .++|||||||+||||++ |..||...+...+...+..+ ..+.
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999865432211 112346679999999887776 89999999999999998 99999998887777766654 4566
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|..++.++.+||.+||..||.+|||+.+|++
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7789999999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.28 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=204.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC--HHHHHHHHHHHHHHhhCCCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD--ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~--~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
+...+|.+.++||+|+||.||++.+ .+..||||++...... ....+.+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 67 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW----------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE----------------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTT
T ss_pred cchhheeeeeeeccCCCeEEEEEEE----------------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCC
Confidence 4467888999999999999999986 2457999998765432 233567889999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc---eeeecccCcceeecC---
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN---VVHRDIKAENLLFDE--- 373 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g---IiHrDLKp~NILl~~--- 373 (635)
|+++++++......|+||||+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp BCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred EeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 9999999999999999999999999988875 467999999999999999999999999 999999999999986
Q ss_pred -----CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy6357 374 -----NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ 448 (635)
Q Consensus 374 -----~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~ 448 (635)
++.+||+|||++....... .....||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+......
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp SSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred cccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6789999999998665432 2356789999999999887776 89999999999999999999999988777776
Q ss_pred HHHhCc--cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 449 RILFGK--FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 449 ~i~~~~--~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+.... ..++..++.++.+||.+||..||.+|||+.||++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 666554 34567799999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=364.47 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=209.3
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
++..++|.++++||+|+||+||++.+.... ..++..||||++... .......+.+|+.+|++++||||
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i 73 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ----------DNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNI 73 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTC----------SSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTB
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEeccc----------CCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCE
Confidence 456678999999999999999999863221 235678999999754 45566788999999999999999
Q ss_pred eeEEEEEec--CCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 301 IKLFQVMET--TNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 301 v~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
+++++++.. ...+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+
T Consensus 74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153 (295)
T ss_dssp CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeE
Confidence 999999854 356899999999999999997754 49999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH---------
Q psy6357 378 KLADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA--------- 444 (635)
Q Consensus 378 kL~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~--------- 444 (635)
||+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence 999999998765432 22334567779999999888876 9999999999999999999998653211
Q ss_pred -------HHHHHHH-hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 445 -------VLKQRIL-FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 445 -------~l~~~i~-~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+...+. ....+.|..++.++.+||.+||..||.+|||+.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1222222 22455677899999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=369.48 Aligned_cols=246 Identities=21% Similarity=0.223 Sum_probs=208.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 300 (635)
+...+|.++++||+|+||.||++.+. .++..||||++...... ..+.+|+.+|++| .|+||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i 67 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNL--------------YTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGI 67 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEET--------------TTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTS
T ss_pred EEcCCeEEEEEeeccCCceEEEEEEC--------------CCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCC
Confidence 44578999999999999999999862 35678999999765432 3577999999999 89999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC---
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD--- 376 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~--- 376 (635)
+++++++......||||||+ +++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~ 146 (330)
T 2izr_A 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQ 146 (330)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCT
T ss_pred CEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCC
Confidence 99999999999999999999 99999998864 67999999999999999999999999999999999999998887
Q ss_pred --eeeecccccccccCCCc--------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---H
Q psy6357 377 --IKLADFGFSNYFTPGHM--------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---L 443 (635)
Q Consensus 377 --ikL~DFGla~~~~~~~~--------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~ 443 (635)
+||+|||++..+..... ....+||+.|+|||++.+..++ .++|||||||+||+|++|..||.+.+ .
T Consensus 147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 99999999987643321 2467899999999999998876 99999999999999999999998743 4
Q ss_pred HHHHHHHHhCccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 444 AVLKQRILFGKFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 444 ~~l~~~i~~~~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
......+.......+ ..++ ++.+||..||..||.+||++++|++
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 226 KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 444555544333333 2245 9999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.66 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=212.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.++++||+|+||+||++.+....... ......||+|++.... ....+.+.+|+.+|++++||||+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~-------~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv 75 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYG-------QLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLV 75 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGG-------CEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccc-------cccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEe
Confidence 45678888999999999999999886443210 0123579999996543 23346788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhccc-CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC----
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD---- 376 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~---- 376 (635)
++++++......|+||||+.+++|.+++..... +++..++.++.||+.||.|||+.+|+||||||+||||+.++.
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred EEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence 999999999999999999999999999987655 999999999999999999999999999999999999998887
Q ss_pred ----eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q psy6357 377 ----IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGPNLAVLKQRIL 451 (635)
Q Consensus 377 ----ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~~PF~~~~~~~l~~~i~ 451 (635)
+||+|||++..... .....+|+.|+|||++.+....+.++|||||||++|+|++| .+||......... .+.
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHh
Confidence 99999999976543 23456889999999998734335999999999999999995 5556555544433 344
Q ss_pred hCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 452 FGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 452 ~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.....+|..++.++.+||.+||+.||.+|||+.+|++|
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45666777789999999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=372.10 Aligned_cols=251 Identities=34% Similarity=0.597 Sum_probs=182.0
Q ss_pred cccCCccceee-ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHH-HHHhhCCCCc
Q psy6357 222 KLLKPQYNLRK-AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV-DIMSHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~k-LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei-~iL~~L~Hpn 299 (635)
....+|.++++ ||+|+||+||++.+. .++..||||++.... ...+|+ ..++.+.|+|
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~ 83 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHR--------------RTGQKCALKLLYDSP-------KARQEVDHHWQASGGPH 83 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTT
T ss_pred cccceeEecceeeeeCCCeEEEEEEEC--------------CCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCC
Confidence 34567888765 899999999999873 356789999996532 222333 3456679999
Q ss_pred eeeEEEEEec----CCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 300 IIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 300 Iv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
|+++++++.. ...+|||||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.
T Consensus 84 i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~ 163 (336)
T 3fhr_A 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS 163 (336)
T ss_dssp BCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred hHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEe
Confidence 9999999976 556899999999999999998764 6999999999999999999999999999999999999976
Q ss_pred ---CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH----
Q psy6357 374 ---NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL---- 446 (635)
Q Consensus 374 ---~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l---- 446 (635)
++.+||+|||++..... ......++|+.|+|||++.+..++ .++|||||||++|+|++|..||........
T Consensus 164 ~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (336)
T 3fhr_A 164 KEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241 (336)
T ss_dssp SSTTCCEEECCCTTCEEC-----------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred cCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH
Confidence 45599999999986653 234456789999999999888876 899999999999999999999977654433
Q ss_pred HHHHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 447 KQRILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+....+.++ ..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 223333333333 3589999999999999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=374.80 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=206.6
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-----
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD----- 296 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~----- 296 (635)
....+|.++++||+|+||+||++.+. .++..||||++... ......+.+|+.+|+++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~ 78 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDM--------------VNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNT 78 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCS
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEec--------------CCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhccccc
Confidence 34578999999999999999999873 34578999999753 334467789999999886
Q ss_pred ------CCceeeEEEEEecCC----eEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccC-ceeeec
Q psy6357 297 ------HPHIIKLFQVMETTN----NLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHAN-NVVHRD 363 (635)
Q Consensus 297 ------HpnIv~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrD 363 (635)
|+||+++++++.... .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. ||+|||
T Consensus 79 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp HHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred chhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 899999999997654 789999999 89999998764 4599999999999999999999998 999999
Q ss_pred ccCcceeec------CCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC
Q psy6357 364 IKAENLLFD------ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437 (635)
Q Consensus 364 LKp~NILl~------~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P 437 (635)
|||+||||+ ..+.+||+|||++..... .....+||+.|+|||++.+..++ .++||||||||||+|++|..|
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCC
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCC
Confidence 999999995 344799999999987643 33456899999999999988876 999999999999999999999
Q ss_pred CCCCCH------HHHHHHHH------------------------------------------hCccCCCCCCCHHHHHHH
Q psy6357 438 FDGPNL------AVLKQRIL------------------------------------------FGKFRIPFYMSAECENLI 469 (635)
Q Consensus 438 F~~~~~------~~l~~~i~------------------------------------------~~~~~~p~~~s~~l~~LI 469 (635)
|...+. ......+. ...+.++..++.++.+||
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 986541 11111111 112233444578899999
Q ss_pred HHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 470 RSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 470 ~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+||+.||.+|||+.|||+||||....
T Consensus 315 ~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHhccCccccCCHHHHhhChhhhccc
Confidence 999999999999999999999998543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=363.44 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=210.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.+.+.||+|+||.||+|.+.... ..+..||||++............+.+|+.+|++++||||+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 99 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQED-----------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTT-----------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccC-----------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCee
Confidence 34567888999999999999999875332 1345899999987776777778899999999999999999
Q ss_pred eEEEEEecCC-----eEEEEEeccccchhhhhhh------hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 302 KLFQVMETTN-----NLYLVTEYARGGEIFSHLL------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 302 ~l~~~~~~~~-----~~~LV~E~~~ggsL~~~l~------~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
++++++.... ..|+||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus 100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl 179 (313)
T 3brb_A 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179 (313)
T ss_dssp CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 9999997654 3599999999999999884 2356999999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
|+.++.+||+|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.......+
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999999998764332 22334567889999999888776 89999999999999999 9999998887777
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+... ....+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7777665 345667899999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=358.90 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=217.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||.||++.+. ..+..||||++.... ...+.+.+|+.+|++++||||++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK--------------KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG--------------GGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccceeEEeecCCCCceeEEEeEec--------------CCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEee
Confidence 4667888999999999999999873 345689999997543 23467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.+...+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999999764 349999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|||++....... ......+|+.|+|||++.+..++ .++||||||+++|+|++ |..||...+...+...+... ...
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 3kfa_A 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232 (288)
T ss_dssp CCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred cCccceeccCCccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence 999998765432 23344567889999999887775 89999999999999999 99999998877777766655 455
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.|..++.++.+||.+||..||.+|||+.+|++.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 677899999999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=365.11 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=224.0
Q ss_pred cchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHH
Q psy6357 210 ITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289 (635)
Q Consensus 210 ~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei 289 (635)
+..++|.+ ..++|.+.+.||+|+||.||+|.+..... ...+..||||++.... .......+.+|+
T Consensus 15 ~~~~~~~~-----~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~~~E~ 79 (322)
T 1p4o_A 15 YVPDEWEV-----AREKITMSRELGQGSFGMVYEGVAKGVVK---------DEPETRVAIKTVNEAA-SMRERIEFLNEA 79 (322)
T ss_dssp CCCCTTBC-----CGGGEEEEEEEEECSSSEEEEEEEEEEET---------TEEEEEEEEEECCTTS-CHHHHHHHHHHH
T ss_pred cChhhhcc-----hhhheeeeeEeccCCceEEEeeeecCccC---------CCCceEEEEEeccccc-CHHHHHHHHHHH
Confidence 34455544 35678889999999999999998753111 0234689999997543 445556788999
Q ss_pred HHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc----------ccCCHHHHHHHHHHHHHhhhhhccCce
Q psy6357 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI----------GQMAEKEASRLFRQILSAVAYCHANNV 359 (635)
Q Consensus 290 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------~~l~e~~~~~i~~qIl~gL~~LHs~gI 359 (635)
.+|++++|+||+++++++.+....|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||
T Consensus 80 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 159 (322)
T 1p4o_A 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 159 (322)
T ss_dssp HHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999999999999999998764 346999999999999999999999999
Q ss_pred eeecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CC
Q psy6357 360 VHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQ 435 (635)
Q Consensus 360 iHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~ 435 (635)
+||||||+||||+.++.+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |.
T Consensus 160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~ 238 (322)
T 1p4o_A 160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAE 238 (322)
T ss_dssp BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSC
T ss_pred ccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCC
Confidence 999999999999999999999999998654322 22334568899999999887776 89999999999999999 89
Q ss_pred CCCCCCCHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 436 LPFDGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 436 ~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.||...+...+...+.... ...+..++.++.+||.+||..||.+|||+.+|++|
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999988888887776654 35667899999999999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=367.71 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=188.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHH-HHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVD-IMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv 301 (635)
....|.+++.||+|+||.||++.+. .++..||||++.... .......+..|+. +++.++||||+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHK--------------PSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEET--------------TTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBC
T ss_pred CHHHhhehheeccCCCEEEEEEEEc--------------CCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEe
Confidence 3567888999999999999999873 345789999997654 3344455666666 77788999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhh-----cccCCHHHHHHHHHHHHHhhhhhccC-ceeeecccCcceeecCCC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLT-----IGQMAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAENLLFDENG 375 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-----~~~l~e~~~~~i~~qIl~gL~~LHs~-gIiHrDLKp~NILl~~~~ 375 (635)
++++++...+..||||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+. ||+|+||||+||||+.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 85 QFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp CEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT
T ss_pred eeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC
Confidence 999999999999999999975 77776653 46799999999999999999999998 999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCcccc----CCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELF----GGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA-VLKQRI 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl----~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~-~l~~~i 450 (635)
.+||+|||++.............||+.|+|||++ .+..++ .++|||||||++|+|++|..||...... .....+
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp EEEECCCSSSCC------------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence 9999999999877655445556899999999998 344554 8999999999999999999999864321 222222
Q ss_pred HhCc-cCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 451 LFGK-FRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 451 ~~~~-~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+. ..++ ..++.++.+||.+||..||.+|||+.+|++||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 2221 1122 358999999999999999999999999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.53 Aligned_cols=250 Identities=23% Similarity=0.410 Sum_probs=202.2
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
++...+|.+.++||+|+||+||++.+. ..||||++..........+.+.+|+.+|++++|+||
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH-----------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS-----------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc-----------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE
Confidence 456778999999999999999998751 359999998877777778889999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++ ....+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 83 v~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEE
Confidence 9999965 556789999999999999998644 56999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC---CCccccccCCCCCCCccccC---CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q psy6357 380 ADFGFSNYFTP---GHMLTTWCGSPPYAAPELFG---GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRILF 452 (635)
Q Consensus 380 ~DFGla~~~~~---~~~~~~~~gt~~Y~APEvl~---~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~~ 452 (635)
+|||++..... ........||+.|+|||++. +..++ .++|||||||++|+|++|..||..... ..+...+..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 99999976542 22344567999999999986 44554 799999999999999999999987554 444444444
Q ss_pred CccC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 GKFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~~~~-----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.... ++..++.++.+||.+||..||.+|||+.+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 3332 234688999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=358.64 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=218.2
Q ss_pred ccCCcccee-eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLR-KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~-kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
..++|+++. .||+|+||.||+|.+... ..+..||||++.... .....+.+.+|+.+|++++||||+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~------------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~ 73 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMR------------KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 73 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---------------CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHhhhhhccccccCceeEEEeEeccC------------CCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEe
Confidence 346677787 899999999999987432 245689999997653 455667899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++ ..+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 74 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 152 (287)
T 1u59_A 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKIS 152 (287)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEEC
T ss_pred EEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEEC
Confidence 999999 456799999999999999998654 469999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-
Q psy6357 381 DFGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK- 454 (635)
Q Consensus 381 DFGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~- 454 (635)
|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......+...+....
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~ 231 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc
Confidence 9999987653322 2234567889999999877776 89999999999999998 999999888877777776653
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
..+|..++.++.+||.+||..||.+|||+.+|++|.+
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 5667789999999999999999999999999998865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=367.47 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=214.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
..+.|.+++.||+|+||.||++.+...+.. ..||||++.... .......+.+|+.+|+++ +||||+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------------~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLR------------MDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEE------------EEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBC
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcc------------cceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchh
Confidence 356788899999999999999987543211 145999987532 344456788999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
++++++.+.+.+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 169 (327)
T 1fvr_A 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169 (327)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence 99999999999999999999999999997654 69999999999999999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHH
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLA 444 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~ 444 (635)
|+||||+.++.+||+|||++.............+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..
T Consensus 170 p~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 170 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 99999999999999999999754433333445678899999999887775 89999999999999998 99999999988
Q ss_pred HHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 445 VLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 445 ~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+...+... ....+..++.++.+||.+||..||.+|||+.+|++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888877765 345667789999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=374.30 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=209.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+....|.+.+.||+|+||.||+|.+.... ..+..||||++.... .......+.+|+.+|++++||||+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----------~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 109 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPS-----------KKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNII 109 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTT-----------SCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCC-----------CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 44567888999999999999999875332 245679999997653 455667899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.....+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 189 (373)
T 2qol_A 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189 (373)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEEC
Confidence 99999999999999999999999999997654 69999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-c
Q psy6357 381 DFGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-K 454 (635)
Q Consensus 381 DFGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~ 454 (635)
|||++........ .....+++.|+|||++.+..++ .++|||||||+||||++ |..||...+...+...+... .
T Consensus 190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CC----------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred cCccccccccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999987653321 1223457789999999888776 89999999999999998 99999998888887777655 3
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+.+..++.++.+||.+||..||.+||++.+|++.
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 44566789999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=363.10 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=215.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+.+.||+|+||.||++.+..... ...+..||||++.... .....+.+.+|+.+|+++ +||||+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~ 90 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIK---------SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIV 90 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSS---------TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccc---------cchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCee
Confidence 35678889999999999999998632111 1345789999997653 344567889999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc------------------cCCHHHHHHHHHHHHHhhhhhccCceeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG------------------QMAEKEASRLFRQILSAVAYCHANNVVHRD 363 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrD 363 (635)
++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+|
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 170 (313)
T 1t46_A 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (313)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 99999999999999999999999999997654 489999999999999999999999999999
Q ss_pred ccCcceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCC
Q psy6357 364 IKAENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFD 439 (635)
Q Consensus 364 LKp~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~ 439 (635)
|||+||||+.++.+||+|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654322 2345578889999999887776 99999999999999999 999998
Q ss_pred CCCHHHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 440 GPNLAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 440 ~~~~~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..........+... ....+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 87654443333332 233456789999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.90 Aligned_cols=258 Identities=26% Similarity=0.349 Sum_probs=220.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
...+|.+++.||+|+||.||++.+...... ...++..||||++.... .......+.+|+.+|+.+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKD-------KPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTT-------CC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CHhHeEEeeEEeecCceeEEEeEecccccc-------ccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 356788899999999999999987422110 01245689999997553 455667899999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
++++++...+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+|||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999997654 38999999999999999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGP 441 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~ 441 (635)
|+||||+.++.+||+|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999999999987654322 2334567889999999887775 89999999999999999 99999999
Q ss_pred CHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 NLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 ~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
....+...+.... ...+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888877776653 45677899999999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.21 Aligned_cols=250 Identities=21% Similarity=0.210 Sum_probs=211.4
Q ss_pred CCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCC
Q psy6357 220 GTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHP 298 (635)
Q Consensus 220 ~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~Hp 298 (635)
+++..++|.+++.||+|+||.||++.+. .++..||||++...... ..+.+|+.+++.+ .|+
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~ 66 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNL--------------LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCT 66 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEET--------------TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEEC--------------CCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCC
Confidence 4567788999999999999999999862 35678999999755432 3577899999999 799
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC-
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD- 376 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~- 376 (635)
||+++++++......|+||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 67 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 145 (298)
T 1csn_A 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSK 145 (298)
T ss_dssp TCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSST
T ss_pred CCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCC
Confidence 9999999999999999999999 999999998754 5999999999999999999999999999999999999987776
Q ss_pred ----eeeecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC---
Q psy6357 377 ----IKLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP--- 441 (635)
Q Consensus 377 ----ikL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~--- 441 (635)
+||+|||++....... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 146 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 146 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 9999999998765432 23556799999999999988875 9999999999999999999999874
Q ss_pred CHHHHHHHHHhCccC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 NLAVLKQRILFGKFR-----IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 ~~~~l~~~i~~~~~~-----~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
........+...... +...++.++.+||.+||..||.+|||+.+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 225 TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 334444444333222 234689999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=382.11 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=212.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.++++||+|+||.||+|.+ .+..||||++.... ..+.+.+|+.+|++++|||||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~----------------~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv 249 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY----------------RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLV 249 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE----------------TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe----------------cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEE
Confidence 3467788899999999999999977 24589999997654 235788999999999999999
Q ss_pred eEEEEEecCC-eEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 302 KLFQVMETTN-NLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++++.... .+|||||||++++|.+++...+. +++..++.++.||+.||.|||+++|+||||||+||||+.++.+|
T Consensus 250 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp CEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEE
Confidence 9999986654 79999999999999999987654 79999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|+|||++...... .....+++.|+|||++.+..++ .++|||||||+||||++ |..||...+..++...+..+ ...
T Consensus 330 l~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 406 (450)
T 1k9a_A 330 VSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 406 (450)
T ss_dssp ECCCTTCEECC--------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred EeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999999865432 2334678899999999888876 99999999999999998 99999988877777777655 456
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.|..++.++.+||.+||..||.+|||+.+|++
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77889999999999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=370.72 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=214.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
....|.+++.||+|+||.||++.+..... ...+..||||++.... .......+.+|+.+|+++ .||||+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISK---------TGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSS---------SSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CHHHceeeeeecCCCCceeEEeeeecccc---------CCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 35678889999999999999998732211 1244689999997543 334457889999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-----------------------cCCHHHHHHHHHHHHHhhhhhccCc
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-----------------------QMAEKEASRLFRQILSAVAYCHANN 358 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-----------------------~l~e~~~~~i~~qIl~gL~~LHs~g 358 (635)
++++++...+.+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999997653 2799999999999999999999999
Q ss_pred eeeecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-C
Q psy6357 359 VVHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-A 434 (635)
Q Consensus 359 IiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G 434 (635)
|+||||||+||||+.++.+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||+||+|++ |
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTS
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999998764332 23345678899999999887776 99999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 435 QLPFDGPNLAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 435 ~~PF~~~~~~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
..||.+.........+... ....|..++.++.+||.+||..||.+|||+.+|++|..-
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 9999887655444444433 344567789999999999999999999999999987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.44 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=216.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.+++.||+|+||.||++.+. ++..||||++....... +.+.+|+.++++++||||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~---------------~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~ 68 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL---------------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQL 68 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------------TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCE
T ss_pred hhheeeeeEecCCCceeEEEEEec---------------CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeE
Confidence 567888999999999999999873 34579999998765443 568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.+...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+||
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred EEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccc
Confidence 99999999999999999999999999765 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 383 GFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 383 Gla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
|++....... ......+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+...+...+.... ...|
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 227 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 227 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccccccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC
Confidence 9998664321 22334567789999999877775 89999999999999999 999999988888888777653 3456
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..++..+.+||.+||..||.+|||+.+|+++
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=365.99 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=219.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.+++.||+|+||.||++.+.... ...++..||||++.... .......+.+|+.+|++++||||+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---------~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMP---------NDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC-----------------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCC---------CCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCC
Confidence 55678999999999999999999863221 12356789999996443 455567888999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-------cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE- 373 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~- 373 (635)
++++++......||||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 176 (327)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence 99999999999999999999999999998753 4899999999999999999999999999999999999984
Q ss_pred --CCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy6357 374 --NGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLK 447 (635)
Q Consensus 374 --~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~ 447 (635)
+..+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......+.
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 4469999999997553322 23345678999999999887776 89999999999999998 99999998888877
Q ss_pred HHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 448 QRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 448 ~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+... ....+..++..+.+||.+||..||.+|||+.+|++|.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 777665 34566779999999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=353.06 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=208.0
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH--HHH---HHHHHHHHHHhhC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE--RNL---RKLFREVDIMSHL 295 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~--~~~---~~~~~Ei~iL~~L 295 (635)
....++|.+++.||+|+||+||++.+. .++..||||++....... ... ..+.+|+.+|+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 80 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLV--------------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEET--------------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC
T ss_pred hhhhccceehhccccCCceeEEEEEEc--------------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC
Confidence 355678899999999999999999873 356789999997654322 111 6788999999999
Q ss_pred CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeec
Q psy6357 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFD 372 (635)
Q Consensus 296 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~ 372 (635)
+||||+++++++.+.. ++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||||+
T Consensus 81 ~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp CCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES
T ss_pred CCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe
Confidence 9999999999997665 6999999999998888654 46999999999999999999999999 99999999999998
Q ss_pred CCCC-----eeeecccccccccCCCccccccCCCCCCCccccC--CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 373 ENGD-----IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG--GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 373 ~~~~-----ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~--~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
.++. +||+|||++..... ......||+.|+|||++. ...+ +.++|||||||++|+|++|..||.......
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred ccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 8776 99999999975443 345578999999999984 3344 489999999999999999999998765433
Q ss_pred H--HHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 L--KQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 l--~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
. ...+... ...++..++.++.+||.+||..||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 3333333 33566789999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.61 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=206.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
..+++|.+++.||+|+||.||++.+. .++..||||++..... .......+.+|+.++++++||||
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i 96 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDT--------------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTB
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEc--------------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCe
Confidence 34678999999999999999999873 3456899999976544 34556788999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++++...+.+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEe
Confidence 99999999999999999999999999999988889999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF--- 455 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~--- 455 (635)
|||++....... ......+|+.|+|||++.+..++ .++||||||+++|+|++|..||...+...+...+.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (309)
T 2h34_A 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPS 255 (309)
T ss_dssp SCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGG
T ss_pred cCccCccccccccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCcc
Confidence 999997765432 23456789999999999888776 899999999999999999999998776655554443322
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCC-CHHHHHc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRL-TLTQISN 488 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rp-s~~eiL~ 488 (635)
..+..++.++.+||.+||..||.+|| |++++++
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 23456899999999999999999999 7888875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=368.65 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=210.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||+|+||+||+|.+...... -..+||+|.+.... .......+.+|+.+|++++||||+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----------~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 80 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK----------VKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVC 80 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC--------------CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBC
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCce----------EEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEe
Confidence 3456788899999999999999987433221 12357888886433 333456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.... .++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+.+|+||||||+||||+.++.+||+
T Consensus 81 ~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp CEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEc
Confidence 9999998754 78999999999999999774 569999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc---cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-cc
Q psy6357 381 DFGFSNYFTPGHM---LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KF 455 (635)
Q Consensus 381 DFGla~~~~~~~~---~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~ 455 (635)
|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.....+...+... ..
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC
Confidence 9999987644322 2334567899999999888876 99999999999999999 99999998877777766655 34
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5677799999999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=363.80 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=214.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+....|.+.+.||+|+||+||+|.+..... ..+..||||++.... .......+.+|+.+|++++||||+
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv 109 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSG----------KKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNII 109 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC-------------CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCC----------CccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 456678889999999999999998754321 123469999997543 455567889999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.....+||||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 189 (333)
T 1mqb_A 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189 (333)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEEC
Confidence 9999999999999999999999999999765 569999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-c
Q psy6357 381 DFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-K 454 (635)
Q Consensus 381 DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~ 454 (635)
|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...+..+ .
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence 999998765322 12223457789999999888776 89999999999999999 99999998888887777665 4
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+.+..++.++.+||.+||..||.+||++.+|+++
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45667799999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.33 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=214.3
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.+...+|.++++||+|+||+||+|.+...... ...+||+|++..... ......+.+|+.++++++||||
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----------~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i 77 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGES----------IKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHI 77 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCS----------CCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTB
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCce----------EEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCc
Confidence 34567889999999999999999987533221 123588888854431 2223456789999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++. ....++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||
T Consensus 78 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp CCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEE
T ss_pred CeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEE
Confidence 99999986 56789999999999999999775 57999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-c
Q psy6357 380 ADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-K 454 (635)
Q Consensus 380 ~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~ 454 (635)
+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.....+...+... .
T Consensus 157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 235 (325)
T 3kex_A 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235 (325)
T ss_dssp CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred CCCCcccccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence 9999998765432 23456678899999999887776 99999999999999999 99999998877777777665 4
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...|..++.++.+||.+||..||.+|||+.+|++|
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55667789999999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.99 Aligned_cols=246 Identities=25% Similarity=0.430 Sum_probs=213.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .+..||||++...... .+.+.+|+.+|++++||||++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~ 72 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN---------------GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVR 72 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET---------------TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc---------------CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcce
Confidence 3578889999999999999999762 3357999999765443 356889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++.. +..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 73 ~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEEC
Confidence 9999864 56899999999999999997654 69999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|||++....... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+...+...+... ...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC
Confidence 999998765432 22334567889999999877775 89999999999999999 99999998888877777655 345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..++.++.+||.+||..||.+|||+.+|++
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 56778999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.17 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=208.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...++|.+.+.||+|+||+||+|.+ .++..||||++..... ...+.+.+|+.+|+.++||||+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------------~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv 98 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL---------------RDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLV 98 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC---------------TTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBC
T ss_pred HHHhccCccceeecCCCeeEEEEEE---------------CCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEe
Confidence 3567899999999999999999976 2356899999876532 3456788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
++++++...+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCE
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999986643 58999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------
Q psy6357 378 KLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK------- 447 (635)
Q Consensus 378 kL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~------- 447 (635)
||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||.........
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 99999999765322 223445689999999999887776 9999999999999999999999764322111
Q ss_pred HHHHhCcc----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 448 QRILFGKF----------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 448 ~~i~~~~~----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
.......+ .++..++..+.+||.+||..||++|||+.||++|..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111 112234678999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=381.49 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=213.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||.||+|.+. .+..||||++...... .+.+.+|+.+|++|+|||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~---------------~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l 248 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN---------------KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL 248 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET---------------TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC---------------CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeE
Confidence 556778999999999999999872 3457999999865433 4678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++. ...+|||||||.+++|.+++.... .+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 249 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 249 HAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp EEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECS
T ss_pred EEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEee
Confidence 99986 667899999999999999997643 689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++....... ......+|+.|+|||++....++ .++|||||||+||||++ |..||.+.+..++...+..+ ..+.
T Consensus 328 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 406 (454)
T 1qcf_A 328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406 (454)
T ss_dssp TTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred CCCceEcCCCceeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998764321 12234467789999999877776 99999999999999999 99999999888887777655 3456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|..++.++.+||.+||..||.+|||+.+|+.
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7789999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.51 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=200.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||+||+|.+. +..||||++.... .......+|+.+|++++|||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~ 82 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL----------------NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQ 82 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET----------------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred chhhchhhheecccCceEEEEEEEC----------------CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchh
Confidence 3568889999999999999999762 4689999996542 23345667999999999999999
Q ss_pred EEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC----------ceeeecccCcc
Q psy6357 303 LFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN----------NVVHRDIKAEN 368 (635)
Q Consensus 303 l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~----------gIiHrDLKp~N 368 (635)
+++++.... .+|||||||++++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~N 161 (322)
T 3soc_A 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGG
T ss_pred hcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHh
Confidence 999997643 47999999999999999866 5699999999999999999999999 99999999999
Q ss_pred eeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCC-----CcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 369 LLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGR-----EYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 369 ILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~-----~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
|||+.++.+||+|||++....... .....+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||.+
T Consensus 162 ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA-FLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp EEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHH-HHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred EEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCC-CccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999997765432 23446799999999999863 33 3688999999999999999999975
Q ss_pred CC----------------HHHHHHHHHhCccC--CCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 441 PN----------------LAVLKQRILFGKFR--IPF-----YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 441 ~~----------------~~~l~~~i~~~~~~--~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.. ...+...+...... ++. ..+.++.+||.+||+.||++|||+.||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32 22333333322221 111 134569999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.04 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=213.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.+++.||+|+||.||++.+. .++..||||++.... ..+.+|+.+|++++||||+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~ 67 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHR--------------IDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIV 67 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEET--------------TTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBC
T ss_pred hhccccceeeeeccCCceEEEEEEEc--------------CCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEE
Confidence 34567889999999999999999873 346789999997653 3567899999999999999
Q ss_pred eEEEEEec----------------CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeec
Q psy6357 302 KLFQVMET----------------TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRD 363 (635)
Q Consensus 302 ~l~~~~~~----------------~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrD 363 (635)
++++++.. ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+|
T Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 147 (284)
T 2a19_B 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRD 147 (284)
T ss_dssp CEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99998854 45689999999999999999754 5699999999999999999999999999999
Q ss_pred ccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH
Q psy6357 364 IKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443 (635)
Q Consensus 364 LKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~ 443 (635)
|||+||||+.++.+||+|||++.............+|+.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 148 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~-- 224 (284)
T 2a19_B 148 LKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET-- 224 (284)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--
T ss_pred CCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--
Confidence 9999999999999999999999887665556667899999999999888776 8999999999999999999887432
Q ss_pred HHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 444 AVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 444 ~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
......+... .++..++.++.+||.+||..||.+|||+.||++|.|....
T Consensus 225 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 2233333332 3456789999999999999999999999999999887644
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.88 Aligned_cols=254 Identities=27% Similarity=0.330 Sum_probs=214.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.+.+.||+|+||+||++.+..... .+..||||++.... .....+.+.+|+.+|+.++||||+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----------~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKG-----------EKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTC-----------CEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCC-----------CcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcc
Confidence 345678889999999999999998754321 23469999997653 445567899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.+ ...|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred eEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeC
Confidence 99999875 45689999999999999997654 59999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 381 DFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 381 DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...........+... ...
T Consensus 156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (281)
T 3cc6_A 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234 (281)
T ss_dssp CCCGGGCC---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred ccCCCcccccccccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC
Confidence 999998765432 22344567889999999877776 89999999999999998 99999887766666666554 345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 677799999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.84 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=215.5
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
..++|.+++.||+|+||+||++.+..... ..++..||||++.... .......+.+|+.+|.++ +||||+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDK---------TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSS---------TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCc---------cccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCee
Confidence 35778889999999999999998643211 1355789999997653 445567889999999999 699999
Q ss_pred eEEEEEecCC-eEEEEEeccccchhhhhhhhccc----------------CCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 302 KLFQVMETTN-NLYLVTEYARGGEIFSHLLTIGQ----------------MAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 302 ~l~~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~----------------l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
++++++...+ .+|+||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~di 174 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 9999987654 59999999999999999987544 899999999999999999999999999999
Q ss_pred cCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDG 440 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~ 440 (635)
||+||||+.++.+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999998764332 23345678899999999887776 99999999999999998 9999987
Q ss_pred CCHH-HHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 441 PNLA-VLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 441 ~~~~-~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.... .+...+... ....+..++.++.+||.+||..||.+|||+.+|++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6543 333344333 355677899999999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=353.63 Aligned_cols=244 Identities=27% Similarity=0.436 Sum_probs=205.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..++|.+++.||+|+||+||++.+ .+..||||++.... ..+.+.+|+.+|++++||||+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv 77 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY----------------RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLV 77 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE----------------TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBC
T ss_pred CChhhceEEeEEecCCCceEEEEEE----------------cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEe
Confidence 4567899999999999999999976 24689999997543 346788999999999999999
Q ss_pred eEEEEEec-CCeEEEEEeccccchhhhhhhhccc--CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 302 KLFQVMET-TNNLYLVTEYARGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~--l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++++.. ...+|+||||+++++|.+++..... +++..++.++.||+.||.|||+.||+|+||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 157 (278)
T 1byg_A 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 157 (278)
T ss_dssp CEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred eEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEE
Confidence 99999754 4578999999999999999977654 89999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|+|||++...... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.......+...+... ...
T Consensus 158 l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (278)
T 1byg_A 158 VSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 234 (278)
T ss_dssp ECCCCC--------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred Eeecccccccccc--ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999999765432 2344678899999999877775 89999999999999998 99999988877777766654 345
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..++..+.+||.+||..||.+|||+.+|++
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 67789999999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=360.49 Aligned_cols=255 Identities=27% Similarity=0.333 Sum_probs=211.7
Q ss_pred CcccCCc-cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQ-YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y-~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.++.++| .++++||+|+||+||++.+.... ..++..||||++.... .......+.+|+.+|++++|||
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~----------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 94 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN----------DGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC------------CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTT
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCC----------CCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcc
Confidence 3455666 78899999999999998774332 2367899999997653 4556678999999999999999
Q ss_pred eeeEEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 300 IIKLFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 300 Iv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
|+++++++.+ ...++|||||+++++|.+++... .+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+
T Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred hhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCE
Confidence 9999999987 46799999999999999988764 59999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH---------
Q psy6357 378 KLADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA--------- 444 (635)
Q Consensus 378 kL~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~--------- 444 (635)
||+|||++....... ......+|..|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 999999998775432 23345678889999999888876 8999999999999999999999753221
Q ss_pred ------HHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 445 ------VLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 445 ------~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+...+... ....+..++.++.+||.+||..||.+|||+.+|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112222222 34566779999999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=383.95 Aligned_cols=247 Identities=24% Similarity=0.418 Sum_probs=215.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||.||+|.+. ..+..||||++...... .+.+.+|+.+|++|+|||||++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~--------------~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWK--------------KYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEG--------------GGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEc--------------CCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeE
Confidence 456777999999999999999883 23568999999765433 3678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.....+|||||||.+++|.+++... ..+++..++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~D 361 (495)
T 1opk_A 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVAD 361 (495)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECC
T ss_pred EEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEee
Confidence 99999999999999999999999999764 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++........ .....+++.|+|||++....++ .++|||||||+||||++ |..||.+.+...+...+... ....
T Consensus 362 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 440 (495)
T 1opk_A 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 440 (495)
T ss_dssp TTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred cccceeccCCceeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999987654321 2234456789999999887776 89999999999999999 99999998887777766654 3456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|..++.++.+||.+||..||.+|||+.+|++
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 7789999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=358.34 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=208.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+....|.++++||+|+||.||++.+.... ..++..||||++.... .......+.+|+.+|+.++||||+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEG----------DNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTS----------SSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEcccc----------CccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCee
Confidence 44566888999999999999999863222 2366799999997553 223346788999999999999999
Q ss_pred eEEEEEecC--CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 302 KLFQVMETT--NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~--~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++++... ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+|
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEE
Confidence 999999876 6799999999999999999544 5699999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC------------
Q psy6357 379 LADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN------------ 442 (635)
Q Consensus 379 L~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~------------ 442 (635)
|+|||++....... ......+|..|+|||++.+..++ .++|||||||++|+|++|..||....
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 99999998765432 23445678889999999888876 89999999999999999998864321
Q ss_pred ---HHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 443 ---LAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 443 ---~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...+...+... ....|..++.++.+||.+||..||.+|||+.+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 12222223222 34567789999999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=366.00 Aligned_cols=255 Identities=18% Similarity=0.172 Sum_probs=201.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-H--------HHHHHHHHHHHH
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-R--------NLRKLFREVDIM 292 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~--------~~~~~~~Ei~iL 292 (635)
...++|.++++||+|+||.||+|.+.... ..+..||||++....... . ....+.+|+.++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----------~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKP-----------EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSC-----------GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCC-----------CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhh
Confidence 34568999999999999999999885421 134689999997653211 0 112356788999
Q ss_pred hhCCCCceeeEEEEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcc
Q psy6357 293 SHLDHPHIIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~N 368 (635)
+.+.||||+++++++.. ...+||||||+ +++|.+++...+.+++..++.|+.||+.||.|||+.+|+||||||+|
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 181 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN 181 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHH
Confidence 99999999999999987 77899999999 99999999888899999999999999999999999999999999999
Q ss_pred eeecCCC--CeeeecccccccccCC--------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 369 LLFDENG--DIKLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 369 ILl~~~~--~ikL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
|||+.++ .+||+|||++..+... .......||+.|+|||++.+..++ .++|||||||+||+|++|..||
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCc
Confidence 9999887 9999999999765322 122456899999999999988776 9999999999999999999999
Q ss_pred CC--CCHHHHHHHHHhCccCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 439 DG--PNLAVLKQRILFGKFRIP---------FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 439 ~~--~~~~~l~~~i~~~~~~~p---------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.. .+...+..........+| ..++.++.+||.+||..||.+|||+.+|++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 261 EQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp GGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 65 222222222211111222 1689999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=362.92 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=214.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv 301 (635)
....|.+.+.||+|+||.||++.+...... .....||||++.... .......+.+|+.+|+++ +||||+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv 113 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKE---------DAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIV 113 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSS---------CCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcc---------cchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCee
Confidence 356788899999999999999987432211 123579999997654 445567889999999999 899999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc--------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI--------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
++++++...+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193 (333)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence 9999999999999999999999999998754 34799999999999999999999999999999999
Q ss_pred ceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCH
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNL 443 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~ 443 (635)
||||+.++.+||+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+...
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999999999999999998664332 12345567889999999887776 99999999999999998 9999988765
Q ss_pred HHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 444 AVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 444 ~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
......+... ....|..++.++.+||.+||..||.+|||+.+|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 4444444333 234566789999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.13 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=203.9
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc-cCHHHHHHHHHHHHHHhhCCCCc
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR-LDERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~-~~~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.....+|.++++||+|+||.||++.+. .++..||||++.... ........+.+|+.+|+.++|||
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 93 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACL--------------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEET--------------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred cccccceEEEEeecCCCCceEEEEEEc--------------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCC
Confidence 345678999999999999999999873 356789999997643 34566778899999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|+++++++......++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||||+.++
T Consensus 94 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp BCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC
Confidence 99999999999999999999999999998865 34599999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Q psy6357 376 DIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN--LAVLKQRILF 452 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~--~~~l~~~i~~ 452 (635)
.+||+|||++...... .......+++.|+|||++.+..++ .++|||||||++|+|++|..||.+.. ...+...+..
T Consensus 174 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 252 (310)
T 2wqm_A 174 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252 (310)
T ss_dssp CEEECCC------------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT
T ss_pred CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc
Confidence 9999999999876432 223456789999999999888776 89999999999999999999997643 3445555554
Q ss_pred CccC-C-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 GKFR-I-PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~~~~-~-p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+. . +..++.++.+||.+||..||.+|||+.+|+++
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4432 2 24689999999999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.71 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=208.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
+..++|.++++||+|+||+||++.+..... ....||||++..... .....+.+.+|+.+|++++||||
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 83 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSG-----------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTS-----------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCC-----------ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 345688899999999999999998743321 123699999976543 33556788999999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++++.... .++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEE
Confidence 99999998765 89999999999999998765 56999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc
Q psy6357 380 ADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 380 ~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~ 454 (635)
+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+...+...+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred ccccccccccccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 9999998765432 12344577889999999887776 89999999999999999 999999998888888777654
Q ss_pred c--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 F--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
. ..+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3 4456789999999999999999999999999973
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=354.17 Aligned_cols=245 Identities=24% Similarity=0.429 Sum_probs=197.6
Q ss_pred CcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhh--CCCC
Q psy6357 221 TKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSH--LDHP 298 (635)
Q Consensus 221 ~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~--L~Hp 298 (635)
....++|.++++||+|+||+||+|.+ ++..||||++.... ...+.+|.+++.. ++||
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ 62 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW----------------QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHE 62 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE----------------TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCT
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE----------------CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCc
Confidence 35567899999999999999999976 34689999996542 2445667777766 7999
Q ss_pred ceeeEEEEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc--------cCceeeecccC
Q psy6357 299 HIIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH--------ANNVVHRDIKA 366 (635)
Q Consensus 299 nIv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH--------s~gIiHrDLKp 366 (635)
||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+|+||||||
T Consensus 63 niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 141 (301)
T 3q4u_A 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141 (301)
T ss_dssp TBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG
T ss_pred CeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh
Confidence 99999998643 3568999999999999999854 57999999999999999999999 99999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCc-----cccccCCCCCCCccccCCC------CcCCCccchhhHHHHHHHHHhC-
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHM-----LTTWCGSPPYAAPELFGGR------EYDGTKSDVWSLGVVLYVMVTA- 434 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~-----~~~~~gt~~Y~APEvl~~~------~~~~~ksDIwSlGvilyeLltG- 434 (635)
+||||+.++.+||+|||++........ ....+||+.|+|||++.+. .++ .++|||||||++|+|++|
T Consensus 142 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHH-HHHHHHHHHHHHHHHHTTB
T ss_pred HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCC-chhhHHHHHHHHHHHHhhh
Confidence 999999999999999999976544322 2345799999999999876 333 689999999999999999
Q ss_pred ---------CCCCCCCC-----HHHHHHHHHhCc--cCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 435 ---------QLPFDGPN-----LAVLKQRILFGK--FRIPF-----YMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 435 ---------~~PF~~~~-----~~~l~~~i~~~~--~~~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
..||.... ...+...+.... ..+|. .++.++.+||.+||+.||.+|||+.+|++
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88885532 223333222221 12221 25578999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=367.63 Aligned_cols=256 Identities=14% Similarity=0.155 Sum_probs=201.0
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH-HH--------HHHHHHHHHHH
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE-RN--------LRKLFREVDIM 292 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~-~~--------~~~~~~Ei~iL 292 (635)
...+.|.++++||+|+||.||+|.+..... ...+..||||++....... .. ...+..|+..+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSES---------VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSC---------CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccc---------cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 345689999999999999999998754321 1234689999987653210 00 11234566677
Q ss_pred hhCCCCceeeEEEEEecC----CeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 293 SHLDHPHIIKLFQVMETT----NNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~----~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
..+.|+||+++++++... ...||||||| +++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~ 181 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKAS 181 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHH
Confidence 888999999999998764 5689999999 99999999776 57999999999999999999999999999999999
Q ss_pred ceeec--CCCCeeeecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCC
Q psy6357 368 NLLFD--ENGDIKLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437 (635)
Q Consensus 368 NILl~--~~~~ikL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~P 437 (635)
||||+ .++.+||+|||++..+.... .....+||+.|+|||++.+..++ .++|||||||+||+|++|..|
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 99999 88999999999997654321 12345699999999999988876 999999999999999999999
Q ss_pred CCCCCHH-HHHHHHHh----Ccc------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 438 FDGPNLA-VLKQRILF----GKF------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 438 F~~~~~~-~l~~~i~~----~~~------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|.+.... ........ ... -.+..++.++.+||..||..||.+||++.+|++
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 9853221 11111110 000 012467999999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.47 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=208.9
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||+|+||+||+|.+. .++..||||++...... .....+.+|+.+|++++||||+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~--------------~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv 70 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHK--------------KTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIV 70 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEEC--------------CCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCC
Confidence 45678999999999999999999873 34678999999764322 2246678999999999999999
Q ss_pred eEEEEEecCC--eEEEEEeccccchhhhhhhhccc---CCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee----c
Q psy6357 302 KLFQVMETTN--NLYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF----D 372 (635)
Q Consensus 302 ~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~~~~~---l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl----~ 372 (635)
++++++.... ..|||||||++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||| +
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 150 (396)
T 4eut_A 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150 (396)
T ss_dssp CEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT
T ss_pred eEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC
Confidence 9999997655 78999999999999999977544 9999999999999999999999999999999999999 7
Q ss_pred CCCCeeeecccccccccCCCccccccCCCCCCCccccCC--------CCcCCCccchhhHHHHHHHHHhCCCCCCCC---
Q psy6357 373 ENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG--------REYDGTKSDVWSLGVVLYVMVTAQLPFDGP--- 441 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~--------~~~~~~ksDIwSlGvilyeLltG~~PF~~~--- 441 (635)
.++.+||+|||++............+||+.|+|||++.+ ..++ .++|||||||++|+|++|..||...
T Consensus 151 ~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 151 GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 777899999999988776666667789999999999864 3444 7999999999999999999999642
Q ss_pred -CHHHHHHHHHhCccC-------------------CC------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 442 -NLAVLKQRILFGKFR-------------------IP------FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 442 -~~~~l~~~i~~~~~~-------------------~p------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
....+...+..+... +| ..++..+.+||.+||.+||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 233444445443221 11 1245678999999999999999999998654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=360.26 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=212.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.++++||+|+||.||++.+.... ...+..||||++... .....+.+.+|+.+|++++|+||++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~ 88 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLG----------DNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVK 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTS----------SSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCC----------CCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeE
Confidence 4578889999999999999999863222 235678999999765 4455677899999999999999999
Q ss_pred EEEEEe--cCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 303 LFQVME--TTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 303 l~~~~~--~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
+++++. ....+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+.||+|+||||+||||+.++.+||
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp EEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEE
Confidence 999886 556799999999999999999774 56999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH-----------
Q psy6357 380 ADFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA----------- 444 (635)
Q Consensus 380 ~DFGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~----------- 444 (635)
+|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 9999998765432 22345678889999999888776 8999999999999999999998654321
Q ss_pred ----HHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 445 ----VLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 445 ----~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+...+... ....+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222222 345667799999999999999999999999999765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=377.10 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=208.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||.||+|.+. .+..||||++....... +.+.+|+.+|++|+||||+++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~---------------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~ 244 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN---------------GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQL 244 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------------TTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC---------------CCceEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEeeE
Confidence 456778999999999999999873 23479999998655442 568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.. ..+|||||||.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 245 ~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp EEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECC
Confidence 999876 6789999999999999999753 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++....... ......+++.|+|||++....++ .++|||||||+||||++ |..||.+....++...+..+ ..+.
T Consensus 324 fG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CccceecCCCceecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998765332 12334567889999999887776 89999999999999999 99999998888887777655 3456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
|..++..+.+||.+||..||.+|||+++|++
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7789999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.27 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=211.7
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+.++||+|+||+||+|.+.... ..+..||||++.... .....+.+.+|+.+|++++||||+++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~-----------~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA-----------QNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS-----------SCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred EEccCceeccCCCceEEEEEEecCC-----------Cceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3445689999999999999874332 123479999997543 4556678899999999999999999999
Q ss_pred EEecCCeE-EEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VMETTNNL-YLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~~~~~~-~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++.+.+.. ++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCC
Confidence 99876655 999999999999999976 3569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 384 FSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 384 la~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
++...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ +.+||...+...+...+.... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP 248 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence 99765432 223345678899999999988876 89999999999999999 566677777666666665543 45
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.+..++.++.+||.+||..||.+|||+.+|++.
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 677799999999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=392.02 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=211.8
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||+|+||.||+|.+.... .+..||||++.....+....+.+.+|+.+|++|+|||||++++++..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~------------~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKK------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp EEEEECSSEEEEEEEEECSS------------CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred CEeccCCCEEEEEEEEcCCC------------cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 47999999999999875432 34689999998766555556789999999999999999999999964
Q ss_pred CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
+.++||||||.+++|.+++.....+++..++.|+.||+.||.|||+.+|+||||||+||||+.++.+||+|||++..+..
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 56899999999999999999888899999999999999999999999999999999999999999999999999987654
Q ss_pred CC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCCCCCCHH
Q psy6357 391 GH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIPFYMSAE 464 (635)
Q Consensus 391 ~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p~~~s~~ 464 (635)
.. ......+|+.|+|||++.+..++ .++||||||||||||++ |..||.+.+...+...+..+. ...|..++.+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 600 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32 22334567889999999888876 99999999999999998 999999999888888877663 5677889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+||.+||..||++|||+.+|++
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=360.20 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=209.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+...+|.++++||+|+||+||++.+...... -..+||+|.+.... .......+.+|+.+|++++||||+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----------~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv 80 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK----------VKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVC 80 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCS----------CCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBC
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCce----------EEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCee
Confidence 4457899999999999999999987543321 12356888775433 223346788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++.... .++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+
T Consensus 81 ~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp CCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEc
Confidence 9999998754 78999999999999999764 569999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-c
Q psy6357 381 DFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-F 455 (635)
Q Consensus 381 DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~ 455 (635)
|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.....+...+.... .
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998764332 22334567789999999888876 89999999999999999 999999988877777776553 5
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+..++.++.+||.+||..||.+|||+.||++.
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6677799999999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.79 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=209.9
Q ss_pred hccchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHH
Q psy6357 208 KEITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFR 287 (635)
Q Consensus 208 ~e~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~ 287 (635)
..+++.++... .++|.+++.||+|+||.||++.+ .++..||||++...... .....+.+
T Consensus 18 ~~~~~~~~~~~-----~~~y~~~~~lg~G~~g~V~~~~~---------------~~~~~vavK~~~~~~~~-~~~~~~~~ 76 (326)
T 3uim_A 18 KRFSLRELQVA-----SDNFSNKNILGRGGFGKVYKGRL---------------ADGTLVAVKRLKEERTQ-GGELQFQT 76 (326)
T ss_dssp EECCTHHHHTT-----TTSSCSTTEEECCSSSEEEEECC---------------SSSCCEEEEECCC------CCCHHHH
T ss_pred ceecHHHHHHH-----hhccccceeEecCCCcEEEEEEe---------------cCCCEEEEEEeccccCc-hHHHHHHH
Confidence 45666666544 56788899999999999999865 24568999999765422 11236789
Q ss_pred HHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc----cCCHHHHHHHHHHHHHhhhhhccC---cee
Q psy6357 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG----QMAEKEASRLFRQILSAVAYCHAN---NVV 360 (635)
Q Consensus 288 Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----~l~e~~~~~i~~qIl~gL~~LHs~---gIi 360 (635)
|+.+|+.++||||+++++++......++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+. ||+
T Consensus 77 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv 156 (326)
T 3uim_A 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156 (326)
T ss_dssp HHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEE
T ss_pred HHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Confidence 9999999999999999999999999999999999999999997653 399999999999999999999999 999
Q ss_pred eecccCcceeecCCCCeeeecccccccccCC--CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 361 HRDIKAENLLFDENGDIKLADFGFSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 361 HrDLKp~NILl~~~~~ikL~DFGla~~~~~~--~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
||||||+||||+.++.+||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSB
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcc
Confidence 9999999999999999999999999876432 234455699999999999887775 9999999999999999999999
Q ss_pred CCC-----CHHHHHHHHH---hC-cc----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 439 DGP-----NLAVLKQRIL---FG-KF----------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 439 ~~~-----~~~~l~~~i~---~~-~~----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
... ........+. .. .. .++...+..+.+||.+||+.||.+|||+.+|++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 521 1111111111 00 00 111123478999999999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.51 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=211.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
....|.+.++||+|+||+||+|.+..... ....||||++.... .......+.+|+.+|++++||||++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----------~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~ 90 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDG-----------KKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 90 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC----------------CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCC-----------ceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 34568889999999999999998743221 23468999987643 4556678999999999999999999
Q ss_pred EEEEE-ecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 303 LFQVM-ETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 303 l~~~~-~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++ ......|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 91 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp CCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred eeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEEC
Confidence 99985 5566889999999999999999764 458999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc
Q psy6357 381 DFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 381 DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~ 454 (635)
|||++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ +.+||...+...+...+....
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence 999998664322 23345677889999999888776 89999999999999999 778888877666666666554
Q ss_pred -cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 -FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 -~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...|..++..+.+||.+||..||.+|||+.+|++.
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34567789999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=355.62 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=203.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.++++||+|+||.||++... .++..||||++... .......+.+|+.+++.++||||++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~ 90 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGL--------------HDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILR 90 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEET--------------TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCeEEEEEEEecCCCCeEEEEEEec--------------CCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3567999999999999999999872 35678999998654 4456678899999999999999999
Q ss_pred EEEEEe----cCCeEEEEEeccccchhhhhhhh----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC
Q psy6357 303 LFQVME----TTNNLYLVTEYARGGEIFSHLLT----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 303 l~~~~~----~~~~~~LV~E~~~ggsL~~~l~~----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~ 374 (635)
+++++. .....|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+|+|+||||+||||+.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~ 170 (317)
T 2buj_A 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE 170 (317)
T ss_dssp CCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred EEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC
Confidence 999986 34578999999999999998876 3569999999999999999999999999999999999999999
Q ss_pred CCeeeecccccccccCCC----------ccccccCCCCCCCccccCCCCc--CCCccchhhHHHHHHHHHhCCCCCCCCC
Q psy6357 375 GDIKLADFGFSNYFTPGH----------MLTTWCGSPPYAAPELFGGREY--DGTKSDVWSLGVVLYVMVTAQLPFDGPN 442 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~----------~~~~~~gt~~Y~APEvl~~~~~--~~~ksDIwSlGvilyeLltG~~PF~~~~ 442 (635)
+.+||+|||++....... ......||+.|+|||++.+... .+.++|||||||++|+|++|..||....
T Consensus 171 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 999999999987653211 1123457999999999976542 2489999999999999999999995411
Q ss_pred --HHHHHHHHHh-CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 443 --LAVLKQRILF-GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 443 --~~~l~~~i~~-~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
...+...+.. ...+.+..++.++.+||.+||..||.+|||+.+|+++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 251 QKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0111122221 12333456899999999999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.67 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=204.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .++..||||++...... ..+.+|+.+++.+.|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~ 68 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI--------------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIP 68 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET--------------TTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEc--------------CCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCC
Confidence 4578999999999999999999863 35678999998765433 35789999999999887665
Q ss_pred EEEEE-ecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec---CCCCe
Q psy6357 303 LFQVM-ETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD---ENGDI 377 (635)
Q Consensus 303 l~~~~-~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~---~~~~i 377 (635)
.+.++ ......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||||+ .++.+
T Consensus 69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCE
T ss_pred ccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeE
Confidence 55544 6677889999999 8999999874 45799999999999999999999999999999999999994 78899
Q ss_pred eeecccccccccCCCc--------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHH
Q psy6357 378 KLADFGFSNYFTPGHM--------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAVL 446 (635)
Q Consensus 378 kL~DFGla~~~~~~~~--------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~l 446 (635)
||+|||++........ .....||+.|+|||++.+..++ .++|||||||++|+|++|..||.... ....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 9999999987654322 3456899999999999988876 99999999999999999999998643 2223
Q ss_pred HHHHHhCccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 447 KQRILFGKFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 447 ~~~i~~~~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...+.......+ ..++.++.+||.+||+.||.+|||+.+|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 333333333333 5689999999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.00 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=187.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
..+|.++++||+|+||.||++.+. .++..||||++... .......+.+|+.+|+++. ||||++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDV--------------GSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEET--------------TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred CceEEEEEEEccCCceEEEEEEEC--------------CCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhh
Confidence 457888999999999999999872 35678999998554 4455677889999999996 999999
Q ss_pred EEEEE--------ecCCeEEEEEeccccchhhhhhhh---cccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcce
Q psy6357 303 LFQVM--------ETTNNLYLVTEYARGGEIFSHLLT---IGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENL 369 (635)
Q Consensus 303 l~~~~--------~~~~~~~LV~E~~~ggsL~~~l~~---~~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NI 369 (635)
+++++ .....+++||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+|+||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENL 169 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGC
T ss_pred ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccE
Confidence 99998 34456899999995 788888765 456999999999999999999999999 99999999999
Q ss_pred eecCCCCeeeecccccccccCCCc-------------cccccCCCCCCCcccc---CCCCcCCCccchhhHHHHHHHHHh
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGHM-------------LTTWCGSPPYAAPELF---GGREYDGTKSDVWSLGVVLYVMVT 433 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~~-------------~~~~~gt~~Y~APEvl---~~~~~~~~ksDIwSlGvilyeLlt 433 (635)
||+.++.+||+|||++........ ....++|+.|+|||++ .+..++ .++||||||||+|+|++
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~ 248 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCF 248 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHh
Confidence 999999999999999987654221 1245689999999998 445554 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 434 AQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 434 G~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
|..||.......+..... ....+..++..+.+||.+||+.||.+|||+.||++|-+-
T Consensus 249 g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 249 RQHPFEDGAKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp SSCCC------------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcchhHHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999998755443322211 223345577889999999999999999999999998553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=382.94 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=213.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.++||+|+||.||+|.+. ....||||++....... +.+.+|+.+|++|+|+|||++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~---------------~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~ 327 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN---------------GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQL 327 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------------TTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhheecccCCCeEEEEEEEC---------------CCceEEEEEeCCCCCCH---HHHHHHHHHHHhCCCCCEeeE
Confidence 566778999999999999999873 23479999998765442 568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
++++.. ..+|||||||.+++|.++|... ..+++..++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 328 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp EEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcc
Confidence 999876 6789999999999999999753 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCC
Q psy6357 382 FGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRI 457 (635)
Q Consensus 382 FGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~ 457 (635)
||++....... ......++..|+|||++....++ .++||||||||||||++ |..||.+....++...+..+ ....
T Consensus 407 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 485 (535)
T 2h8h_A 407 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485 (535)
T ss_dssp TTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cccceecCCCceecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998764321 12234567789999999887776 89999999999999999 99999998888888777655 3456
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..++.++.+||.+||..||++|||+.+|++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77899999999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=386.75 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=212.2
Q ss_pred CCcccee-eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLR-KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~-kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+.+.. +||+|+||.||+|.+...+ .+..||||++.... .....+.+.+|+.+|++++|||||++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~------------~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l 401 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRK------------KQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRL 401 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSS------------CEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCC------------CcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3444555 7999999999999885432 33579999997653 23345788999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.. +.+|||||||.+++|.+++... ..+++..++.|+.||+.||.|||+.+|+||||||+||||+.++.+||+||
T Consensus 402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DF 480 (613)
T 2ozo_A 402 IGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480 (613)
T ss_dssp EEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeec
Confidence 999976 5699999999999999998754 45999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 383 GFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 383 Gla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
|++..+..... .....+|+.|+|||++.+..++ .++||||||||||||++ |..||.+.+..++...+..+. ..
T Consensus 481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 559 (613)
T 2ozo_A 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559 (613)
T ss_dssp STTTTCC--------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC
T ss_pred cCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99987643321 1223456889999999887776 89999999999999998 999999988888888877653 56
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHH---cCcccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQIS---NHKWMS 493 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL---~Hpw~~ 493 (635)
+|..++.++.+||.+||..||.+|||+.+|+ ++.|+.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 7778999999999999999999999999985 455554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=370.08 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=190.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeEEE
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 305 (635)
|.+.+.||+|+||+||.+.. .++..||||++.... .+.+.+|+.+|+++ +|||||++++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~---------------~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~ 76 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGS---------------FQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYC 76 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEE---------------SSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred eeccCeEeeCCCeEEEEEEE---------------ECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEE
Confidence 34457799999999985432 246789999986542 24567899999876 8999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccC-------CHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC----
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQM-------AEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN---- 374 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l-------~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~---- 374 (635)
++.+...+|||||||. ++|.+++...... .+..++.++.||+.||.|||+.||+||||||+||||+.+
T Consensus 77 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp EEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHH
T ss_pred EEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccc
Confidence 9999999999999995 6999999775433 233467899999999999999999999999999999754
Q ss_pred ---------CCeeeecccccccccCCC-----ccccccCCCCCCCccccCC-------CCcCCCccchhhHHHHHHHHHh
Q psy6357 375 ---------GDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGG-------REYDGTKSDVWSLGVVLYVMVT 433 (635)
Q Consensus 375 ---------~~ikL~DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~-------~~~~~~ksDIwSlGvilyeLlt 433 (635)
+.+||+|||++....... .....+||+.|+|||++.+ ..+ +.++||||||||+|+|++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt 234 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILS 234 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHh
Confidence 489999999998765432 2335689999999999975 344 489999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHhCccCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 434 -AQLPFDGPNLAVLKQRILFGKFRIPF-------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 434 -G~~PF~~~~~~~l~~~i~~~~~~~p~-------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
|..||....... ..+....+.++. .++.++.+||.+||+.||.+|||+.+||+||||.
T Consensus 235 ~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 235 KGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp TSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred CCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 999997654333 233333333221 2458899999999999999999999999999995
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.54 Aligned_cols=243 Identities=28% Similarity=0.418 Sum_probs=198.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.+++.||+|+||.||++.+ .+..||||++... ...+.+.+|+.+|++++||||+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv 64 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW----------------RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE----------------TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBC
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE----------------CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcC
Confidence 3456788899999999999999976 2357999998643 2346788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcc---cCCHHHHHHHHHHHHHhhhhhcc---CceeeecccCcceeecCCC
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIG---QMAEKEASRLFRQILSAVAYCHA---NNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~---~l~e~~~~~i~~qIl~gL~~LHs---~gIiHrDLKp~NILl~~~~ 375 (635)
++++++.+ ..||||||+++++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 65 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp CEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT
T ss_pred eEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC
Confidence 99998874 4799999999999999997654 37899999999999999999999 8999999999999999888
Q ss_pred C-eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Q psy6357 376 D-IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL--AVLKQRILF 452 (635)
Q Consensus 376 ~-ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~--~~l~~~i~~ 452 (635)
. +||+|||++...... .....||+.|+|||++.+..++ .++|||||||++|+|++|..||..... ..+...+..
T Consensus 143 ~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 219 (307)
T 2eva_A 143 TVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219 (307)
T ss_dssp TEEEECCCCC--------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT
T ss_pred CEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc
Confidence 6 799999999765432 3345799999999999988876 899999999999999999999976432 223333333
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 453 G-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 453 ~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
. ...++..++..+.+||.+||..||.+|||+.+|+++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2 344556789999999999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.86 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=203.3
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.+.+.||+|+||+||+|.+..... ....||||++.... .......+.+|+.+|++++||||+++++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~-----------~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDG-----------KKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTT-----------EEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCC-----------cEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46678899999999999998754321 22469999987543 4455678999999999999999999999
Q ss_pred EEe-cCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 306 VME-TTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 306 ~~~-~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++. ..+..|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||
T Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecc
Confidence 864 4568899999999999999997653 58999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cC
Q psy6357 384 FSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FR 456 (635)
Q Consensus 384 la~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~ 456 (635)
++....... ......+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+...+...+..+. ..
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~ 316 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 316 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC
Confidence 998654322 12334567889999999888776 89999999999999999 788998877666666665543 44
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.|..++..+.+||.+||..||.+|||+.+|+++
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567799999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.48 Aligned_cols=246 Identities=22% Similarity=0.228 Sum_probs=199.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
..++|.+++.||+|+||.||++.+. .++..||||++...... ..+.+|+.+++.+.|++++.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~--------------~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~ 68 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI--------------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIP 68 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEc--------------CCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCC
Confidence 4578999999999999999999863 35578999997654322 35778999999999877666
Q ss_pred EEEEE-ecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCCCe
Q psy6357 303 LFQVM-ETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGDI 377 (635)
Q Consensus 303 l~~~~-~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~~i 377 (635)
.+.++ ......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||| +.++.+
T Consensus 69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCE
T ss_pred eeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeE
Confidence 55554 6778899999999 9999999875 4579999999999999999999999999999999999999 788999
Q ss_pred eeecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH---HHH
Q psy6357 378 KLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL---AVL 446 (635)
Q Consensus 378 kL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~---~~l 446 (635)
||+|||++....... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+... ...
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 999999998765432 23356799999999999988876 999999999999999999999976432 122
Q ss_pred HHHHHhCccCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 447 KQRILFGKFRIP-----FYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 447 ~~~i~~~~~~~p-----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...+.......| ..++.++.+||.+||+.||.+|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 333332222233 567999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=357.11 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=212.6
Q ss_pred cchhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHH
Q psy6357 210 ITLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREV 289 (635)
Q Consensus 210 ~tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei 289 (635)
..+.+|.+. .++|.+++.||+|+||.||++.+. ..||||++..........+.+.+|+
T Consensus 23 ~~~~~~~i~-----~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~avk~~~~~~~~~~~~~~~~~e~ 80 (319)
T 2y4i_B 23 IFLQEWDIP-----FEQLEIGELIGKGRFGQVYHGRWH-----------------GEVAIRLIDIERDNEDQLKAFKREV 80 (319)
T ss_dssp CCGGGSSSC-----CSCEECCCBCCCSSSSEEEEEEES-----------------SSEEEEECCCCSCCCCCCCCCCTTG
T ss_pred cccccccCC-----HHHeEEeeEeccCCceEEEEEEEc-----------------CeEEEEEeecCCCCHHHHHHHHHHH
Confidence 344555544 667888999999999999999762 2499999976554444445677899
Q ss_pred HHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcc
Q psy6357 290 DIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368 (635)
Q Consensus 290 ~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~N 368 (635)
.++++++|+||+++++++.....+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|
T Consensus 81 ~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~N 160 (319)
T 2y4i_B 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160 (319)
T ss_dssp GGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTT
T ss_pred HHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhh
Confidence 99999999999999999999999999999999999999998755 69999999999999999999999999999999999
Q ss_pred eeecCCCCeeeecccccccccC------CCccccccCCCCCCCccccCC---------CCcCCCccchhhHHHHHHHHHh
Q psy6357 369 LLFDENGDIKLADFGFSNYFTP------GHMLTTWCGSPPYAAPELFGG---------REYDGTKSDVWSLGVVLYVMVT 433 (635)
Q Consensus 369 ILl~~~~~ikL~DFGla~~~~~------~~~~~~~~gt~~Y~APEvl~~---------~~~~~~ksDIwSlGvilyeLlt 433 (635)
||++ ++.+||+|||++..... ........||+.|+|||++.. ..+ +.++|||||||++|+|++
T Consensus 161 Il~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 161 VFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF-SKHSDVFALGTIWYELHA 238 (319)
T ss_dssp EEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCC-CHHHHHHHHHHHHHHHHH
T ss_pred EEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCC-CchhhHHHHHHHHHHHHh
Confidence 9998 68999999999875431 123344568999999999875 234 489999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCccCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 434 AQLPFDGPNLAVLKQRILFGKFRI--PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 434 G~~PF~~~~~~~l~~~i~~~~~~~--p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..||.......+...+....... +..++.++.+||.+||..||.+|||+.+|++.
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999988888777776654332 23578999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=350.42 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=210.4
Q ss_pred hccchhhhhhccCCcccCCcc-ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHH
Q psy6357 208 KEITLDEWKASRGTKLLKPQY-NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRK 284 (635)
Q Consensus 208 ~e~tl~e~~~~~~~~~~~~y~-il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~ 284 (635)
..++..++...........++ ..++||+|+||.||+|.+ ++..||||++..... .......
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~ 76 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----------------NNTTVAVKKLAAMVDITTEELKQQ 76 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES----------------SSCEEEEEEECCCTTSCTTTHHHH
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE----------------CCceEEEEEEecccCcchHHHHHH
Confidence 445556655544443333333 348899999999999975 346899999975432 3345678
Q ss_pred HHHHHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc---ccCCHHHHHHHHHHHHHhhhhhccCceee
Q psy6357 285 LFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI---GQMAEKEASRLFRQILSAVAYCHANNVVH 361 (635)
Q Consensus 285 ~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~---~~l~e~~~~~i~~qIl~gL~~LHs~gIiH 361 (635)
+.+|+.+|++++||||+++++++.+....|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|
T Consensus 77 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 156 (307)
T 2nru_A 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156 (307)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 899999999999999999999999999999999999999999988643 45999999999999999999999999999
Q ss_pred ecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 362 RDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 362 rDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
+||||+||||+.++.+||+|||++....... ......||+.|+|||++.+. ++ .++|||||||++|+|++|..||
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSB
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCc
Confidence 9999999999999999999999997654322 23345789999999998764 44 8999999999999999999999
Q ss_pred CCCCHH----HHHHHHHhCcc-----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 439 DGPNLA----VLKQRILFGKF-----------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 439 ~~~~~~----~l~~~i~~~~~-----------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
...... .+...+..... ..+..++..+.+||.+||..||.+|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 765432 22222221111 1222356789999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.93 Aligned_cols=231 Identities=33% Similarity=0.597 Sum_probs=190.5
Q ss_pred cccCCccce-eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH-hhCCCCc
Q psy6357 222 KLLKPQYNL-RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM-SHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il-~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL-~~L~Hpn 299 (635)
.....|+++ +.||+|+||.||++.+. .++..||||++... ..+.+|+.++ +.+.|||
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~--------------~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~ 72 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNK--------------RTQEKFALKMLQDC-------PKARREVELHWRASQCPH 72 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEc--------------CCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCC
Confidence 345678887 67999999999999873 35678999999653 4567899888 5668999
Q ss_pred eeeEEEEEec----CCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 300 IIKLFQVMET----TNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 300 Iv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
|+++++++.. ...+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.
T Consensus 73 i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 152 (299)
T 3m2w_A 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 152 (299)
T ss_dssp BCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred chhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEec
Confidence 9999999976 778999999999999999998764 6999999999999999999999999999999999999998
Q ss_pred ---CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH--
Q psy6357 374 ---NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ-- 448 (635)
Q Consensus 374 ---~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~-- 448 (635)
++.+||+|||++.... +..++ .++|||||||++|+|++|..||..........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 210 (299)
T 3m2w_A 153 KRPNAILKLTDFGFAKETT---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210 (299)
T ss_dssp SSTTCCEEECCCTTCEECT---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCS
T ss_pred CCCCCcEEEeccccccccc---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH
Confidence 7899999999986543 13344 89999999999999999999998765433321
Q ss_pred --HHHhCccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 449 --RILFGKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 449 --~i~~~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+......++ ..++.++.+||.+||..||.+|||+.|||+||||...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1222233334 4589999999999999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=371.20 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=194.2
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
..|.+.+.||+|+||+||.... .+++.||||++..... ..+.+|+.+|+++ +|||||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~---------------~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l 83 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM---------------FDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRY 83 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE---------------SSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCE
T ss_pred EEEecCCeeecCcCEEEEEEEE---------------eCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeE
Confidence 3577889999999999763222 2467899999976543 2356899999999 79999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---C--CCe
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---N--GDI 377 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~--~~i 377 (635)
++++.+...+|||||||. ++|.+++.... .+.+..++.++.||+.||.|||+.||+||||||+||||+. + ..+
T Consensus 84 ~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 999999999999999996 69999887654 4666678899999999999999999999999999999953 2 357
Q ss_pred eeecccccccccCC----CccccccCCCCCCCccccCC---CCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy6357 378 KLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGG---REYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQR 449 (635)
Q Consensus 378 kL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~---~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~ 449 (635)
||+|||+|...... ......+||+.|+|||++.+ ..+ +.++||||||||+|+|++ |..||...........
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~ 241 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence 89999999876543 23445789999999999974 334 379999999999999999 9999976654443333
Q ss_pred HHhCccC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 450 ILFGKFR---IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 450 i~~~~~~---~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
+...... .+...+..+.+||.+||+.||.+|||+.+||+||||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 2222221 1223456789999999999999999999999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=358.43 Aligned_cols=251 Identities=17% Similarity=0.200 Sum_probs=202.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee-
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK- 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~- 302 (635)
.++|.+++.||+|+||.||++.+...... .....+..||||++... ..+.+|+.+|++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~------~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC------DSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc------cccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhh
Confidence 47899999999999999999988542110 00113568999999755 35779999999999999887
Q ss_pred --------------EEEEEec-CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 303 --------------LFQVMET-TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 303 --------------l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
+++++.. ...+||||||+ +++|.+++... ..+++..++.|+.||+.||.|||+.||+|||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 186 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT 186 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 6777765 77899999999 99999999876 679999999999999999999999999999999
Q ss_pred CcceeecCCC--CeeeecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCC
Q psy6357 366 AENLLFDENG--DIKLADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435 (635)
Q Consensus 366 p~NILl~~~~--~ikL~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~ 435 (635)
|+||||+.++ .+||+|||++..+.... ......||+.|+|||++.+..++ .++|||||||+||+|++|.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCC
Confidence 9999999998 99999999997654321 22445899999999999988775 8999999999999999999
Q ss_pred CCCCCCC--HHHHHHHH---HhCccCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 436 LPFDGPN--LAVLKQRI---LFGKFRIPF------YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 436 ~PF~~~~--~~~l~~~i---~~~~~~~p~------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.||.... ...+.... ......++. .++.++.+||.+||..||.+|||+.+|++.
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 9998753 33333222 222222221 468999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.05 Aligned_cols=246 Identities=24% Similarity=0.418 Sum_probs=197.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC--CCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL--DHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L--~Hpn 299 (635)
...++|.++++||+|+||.||++.+ .+..||||++.... ...+.+|.+++..+ +|||
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~----------------~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~ 92 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW----------------RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHEN 92 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE----------------TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTT
T ss_pred ccccceEEEeEeecCCCeEEEEEEE----------------CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCC
Confidence 4557899999999999999999977 24689999986442 13445566666554 8999
Q ss_pred eeeEEEEEecC----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC--------ceeeecccCc
Q psy6357 300 IIKLFQVMETT----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN--------NVVHRDIKAE 367 (635)
Q Consensus 300 Iv~l~~~~~~~----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~--------gIiHrDLKp~ 367 (635)
|+++++++... ..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 93 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp BCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGG
T ss_pred eeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchH
Confidence 99999999876 789999999999999999865 4799999999999999999999998 9999999999
Q ss_pred ceeecCCCCeeeecccccccccCCCc-----cccccCCCCCCCccccCCCCcCCC-----ccchhhHHHHHHHHHhC---
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHM-----LTTWCGSPPYAAPELFGGREYDGT-----KSDVWSLGVVLYVMVTA--- 434 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~-----~~~~~gt~~Y~APEvl~~~~~~~~-----ksDIwSlGvilyeLltG--- 434 (635)
||||+.++.+||+|||++..+..... ....+||+.|+|||++.+..+... ++||||||||+|+|++|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 99999999999999999976543221 235689999999999987766522 38999999999999999
Q ss_pred -------CCCCCCC-----CHHHHHHHHHhCc--cCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 435 -------QLPFDGP-----NLAVLKQRILFGK--FRIPF-----YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 435 -------~~PF~~~-----~~~~l~~~i~~~~--~~~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..||... ....+...+.... ..+|. .++.++.+||.+||..||.+|||+.+|++|
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7777543 2233333332222 22222 356789999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.80 Aligned_cols=249 Identities=17% Similarity=0.236 Sum_probs=200.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC---CCc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~---Hpn 299 (635)
..+.|.++++||+|+||+||+|.+.... ....+..||||++.... ...+.+|+.+++.+. |+|
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---------~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLN---------DAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC----------------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGG
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCc---------ccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhh
Confidence 3567888999999999999999753211 13467899999997653 245667788887776 999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhh-----cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLT-----IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE- 373 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-----~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~- 373 (635)
|+.+++++...+..|||||||++++|.+++.. ...+++..++.|+.||+.||+|||+.||+||||||+||||+.
T Consensus 129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 99999999999999999999999999999974 356999999999999999999999999999999999999998
Q ss_pred ----------CCCeeeeccccccccc---CCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q psy6357 374 ----------NGDIKLADFGFSNYFT---PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440 (635)
Q Consensus 374 ----------~~~ikL~DFGla~~~~---~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~ 440 (635)
++.+||+|||+|..+. ........+||+.|+|||++.+..++ .++||||||||||+|++|..||..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999996543 33455667899999999999998876 999999999999999999999964
Q ss_pred CCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 441 PNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 441 ~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
....... + ...+. ....++.+.+|+..||..+|.+|++..+.|.+.
T Consensus 288 ~~~~~~~--~-~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 288 NEGGECK--P-EGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp EETTEEE--E-CSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred CCCCcee--e-chhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 3221100 0 01111 113578899999999999999997655555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.85 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=209.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+....|.++++||+|+||.||++.+.... ..++..||||++... .......+.+|+.+|++++||||+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv 105 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQ----------DNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIV 105 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTS----------SSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEecccc----------CCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCee
Confidence 44567888999999999999999863221 235678999999764 345567889999999999999999
Q ss_pred eEEEEEecCC--eEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 302 KLFQVMETTN--NLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 302 ~l~~~~~~~~--~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++++.... .+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+|
T Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp CEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred eEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEE
Confidence 9999986644 789999999999999999875 4599999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCc----cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHH----------
Q psy6357 379 LADFGFSNYFTPGHM----LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA---------- 444 (635)
Q Consensus 379 L~DFGla~~~~~~~~----~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~---------- 444 (635)
|+|||++........ .....++..|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence 999999987654322 2334567789999999887776 8999999999999999999998643110
Q ss_pred ------HHHHHHHh-CccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 445 ------VLKQRILF-GKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 445 ------~l~~~i~~-~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+...+.. ...+.|..++.++.+||.+||..||.+|||+.+|++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222222 234566789999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=385.79 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=209.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
....+|.++++||.|+||+||++.+. .++..||||++... ........+.+|+.+|++++||||+
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~--------------~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV 75 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQ--------------DTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVV 75 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCT--------------TTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEEC--------------CCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 34578999999999999999998763 35678999998764 3556667899999999999999999
Q ss_pred eEEEEEec------CCeEEEEEeccccchhhhhhhhcc---cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec
Q psy6357 302 KLFQVMET------TNNLYLVTEYARGGEIFSHLLTIG---QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD 372 (635)
Q Consensus 302 ~l~~~~~~------~~~~~LV~E~~~ggsL~~~l~~~~---~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~ 372 (635)
++++++.. ....|||||||++++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||||+
T Consensus 76 ~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~ 155 (676)
T 3qa8_A 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155 (676)
T ss_dssp CEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEE
T ss_pred ceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEee
Confidence 99999765 677899999999999999998754 599999999999999999999999999999999999999
Q ss_pred CCCC---eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHH--
Q psy6357 373 ENGD---IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLK-- 447 (635)
Q Consensus 373 ~~~~---ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~-- 447 (635)
.++. +||+|||++.............||+.|+|||++.+..++ .++|||||||++|+|++|..||.........
T Consensus 156 ~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 156 PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp CCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred cCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 7765 999999999988766666778899999999999988886 8999999999999999999999764322110
Q ss_pred -------HHH-----HhCccCC------C----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 448 -------QRI-----LFGKFRI------P----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 448 -------~~i-----~~~~~~~------p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+ ..+...+ | ..++..+.+||.+||.+||.+|||+.++|+||||..
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000 0111111 1 235789999999999999999999999999999973
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=365.14 Aligned_cols=247 Identities=21% Similarity=0.234 Sum_probs=205.8
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC-Cce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH-PHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H-pnI 300 (635)
.+.++|.++++||+|+||.||++.+. .++..||||++...... ..+.+|+.+|+.|.| ++|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~--------------~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i 65 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNI--------------QTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGI 65 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEET--------------TTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTC
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEEC--------------CCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCC
Confidence 45678999999999999999999872 45678999998765433 347789999999986 566
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee---cCCCC
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGD 376 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl---~~~~~ 376 (635)
+.+..++......||||||+ +++|.+++.. ...+++..++.|+.||+.||.|||+++||||||||+|||| +.++.
T Consensus 66 ~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC
T ss_pred CeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe
Confidence 67777777888999999999 9999999975 4579999999999999999999999999999999999999 58899
Q ss_pred eeeecccccccccCCCc--------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH---HH
Q psy6357 377 IKLADFGFSNYFTPGHM--------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL---AV 445 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~--------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~---~~ 445 (635)
+||+|||++..+..... ....+||+.|+|||++.+..++ .++||||||||||+|++|..||.+... ..
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence 99999999987654322 2367899999999999998886 999999999999999999999987542 33
Q ss_pred HHHHHHhCcc-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 446 LKQRILFGKF-----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 446 l~~~i~~~~~-----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+..+..... .++..++.++.+||..||..||.+||++.+|++
T Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 224 KYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3333332221 223568999999999999999999999998875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.33 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=203.1
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhh--CCCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSH--LDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~--L~Hpn 299 (635)
.+.++|.+++.||+|+||.||++.+ .+..||||++.... ...+.+|++++.. ++|||
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~----------------~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~n 97 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW----------------RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHEN 97 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE----------------TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTT
T ss_pred cccccEEEEeeecCCCCcEEEEEEE----------------cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCc
Confidence 3456788899999999999999976 24689999996432 2567789999887 78999
Q ss_pred eeeEEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc--------cCceeeecccCc
Q psy6357 300 IIKLFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCH--------ANNVVHRDIKAE 367 (635)
Q Consensus 300 Iv~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH--------s~gIiHrDLKp~ 367 (635)
|+++++++.... .+|+||||+++++|.+++.+ ..+++..++.++.||+.||.||| +.+|+||||||+
T Consensus 98 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~ 176 (342)
T 1b6c_B 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176 (342)
T ss_dssp BCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred EEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence 999999998776 89999999999999999965 57999999999999999999999 899999999999
Q ss_pred ceeecCCCCeeeecccccccccCCC-----ccccccCCCCCCCccccCCCCcC-----CCccchhhHHHHHHHHHhC---
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREYD-----GTKSDVWSLGVVLYVMVTA--- 434 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~-----~~ksDIwSlGvilyeLltG--- 434 (635)
||||+.++.+||+|||++....... ......||+.|+|||++.+.... +.++|||||||++|+|++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 9999999999999999998765433 23456799999999999765321 1689999999999999999
Q ss_pred -------CCCCCCC-----CHHHHHHHHHhCcc--CCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 435 -------QLPFDGP-----NLAVLKQRILFGKF--RIPF-----YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 435 -------~~PF~~~-----~~~~l~~~i~~~~~--~~p~-----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..||... ....+...+..... .+|. .++..+.+||.+||..||.+|||+.+|++|
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 7898654 23444444443322 2232 234689999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.63 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=191.3
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHH--HHHHhhCCCCc
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFRE--VDIMSHLDHPH 299 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~E--i~iL~~L~Hpn 299 (635)
+..++|.++++||+|+||.||+|.+ ++..||||++..... ..+..| +..+..++|+|
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~----------------~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~ 68 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL----------------DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDN 68 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE----------------TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE----------------CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcc
Confidence 4567899999999999999999965 346899999975431 233344 44455689999
Q ss_pred eeeEEEEEe-----cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccC---------ceeeeccc
Q psy6357 300 IIKLFQVME-----TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHAN---------NVVHRDIK 365 (635)
Q Consensus 300 Iv~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~---------gIiHrDLK 365 (635)
|+++++++. ....+|||||||++++|.+++.. ..+++..++.++.||+.||.|||+. +|+|||||
T Consensus 69 i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dik 147 (336)
T 3g2f_A 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147 (336)
T ss_dssp BCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCS
T ss_pred hhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccc
Confidence 999998653 23468999999999999999865 4568999999999999999999999 99999999
Q ss_pred CcceeecCCCCeeeecccccccccCC---------CccccccCCCCCCCccccCCC-------CcCCCccchhhHHHHHH
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPG---------HMLTTWCGSPPYAAPELFGGR-------EYDGTKSDVWSLGVVLY 429 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~---------~~~~~~~gt~~Y~APEvl~~~-------~~~~~ksDIwSlGvily 429 (635)
|+||||+.++.+||+|||++..+... ......+||+.|+|||++.+. .++ .++|||||||++|
T Consensus 148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ 226 (336)
T 3g2f_A 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYW 226 (336)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccc-cccchHHHHHHHH
Confidence 99999999999999999999866432 223356799999999999873 333 7899999999999
Q ss_pred HHHhCCCCCCC-CC-----------------HHHHHHHHHhC--ccCCCCC------CCHHHHHHHHHhcccCCCCCCCH
Q psy6357 430 VMVTAQLPFDG-PN-----------------LAVLKQRILFG--KFRIPFY------MSAECENLIRSMLVLDPAKRLTL 483 (635)
Q Consensus 430 eLltG~~PF~~-~~-----------------~~~l~~~i~~~--~~~~p~~------~s~~l~~LI~~~L~~dP~~Rps~ 483 (635)
+|++|..||.. .. ...+...+... ...+|.. ++.++.+||.+||..||++|||+
T Consensus 227 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (336)
T 3g2f_A 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306 (336)
T ss_dssp HHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence 99999766532 11 11111111111 1223332 34589999999999999999999
Q ss_pred HHHHc------Cccccc
Q psy6357 484 TQISN------HKWMSV 494 (635)
Q Consensus 484 ~eiL~------Hpw~~~ 494 (635)
.||++ ++|-..
T Consensus 307 ~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 307 QXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHHHHhc
Confidence 99954 566543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=360.72 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=193.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc------CHHHHHHHHHHHHHHhhCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL------DERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~------~~~~~~~~~~Ei~iL~~L~ 296 (635)
...+|.++++||+|+||+||++.+ ++..||||++..... .....+.+.+|+.+|+.|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~----------------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 81 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA----------------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELS 81 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE----------------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHH
T ss_pred ccccchheeeecccCceEEEEEEe----------------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHH
Confidence 346678889999999999999976 246899999986542 2223467788999988885
Q ss_pred ---------CCceeeEEEEE-----------------ec-------------CCeEEEEEeccccchhhhhhhhcccCCH
Q psy6357 297 ---------HPHIIKLFQVM-----------------ET-------------TNNLYLVTEYARGGEIFSHLLTIGQMAE 337 (635)
Q Consensus 297 ---------HpnIv~l~~~~-----------------~~-------------~~~~~LV~E~~~ggsL~~~l~~~~~l~e 337 (635)
|+|||++++++ .+ ...+|||||||++|+|.+.+.+ ..+++
T Consensus 82 ~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~ 160 (336)
T 2vuw_A 82 LLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSL 160 (336)
T ss_dssp HGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCH
T ss_pred HhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCH
Confidence 77777777664 22 6789999999999988777755 67999
Q ss_pred HHHHHHHHHHHHhhhhhc-cCceeeecccCcceeecCCC--------------------CeeeecccccccccCCCcccc
Q psy6357 338 KEASRLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENG--------------------DIKLADFGFSNYFTPGHMLTT 396 (635)
Q Consensus 338 ~~~~~i~~qIl~gL~~LH-s~gIiHrDLKp~NILl~~~~--------------------~ikL~DFGla~~~~~~~~~~~ 396 (635)
..++.|+.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+..... .
T Consensus 161 ~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~ 236 (336)
T 2vuw_A 161 ATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----I 236 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----E
T ss_pred HHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----c
Confidence 999999999999999999 99999999999999999887 8999999999876542 4
Q ss_pred ccCCCCCCCccccCCCCcCCCccchhhHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC-ccC--C----CCCCCHHHHH
Q psy6357 397 WCGSPPYAAPELFGGREYDGTKSDVWSLGVV-LYVMVTAQLPFDGPNL-AVLKQRILFG-KFR--I----PFYMSAECEN 467 (635)
Q Consensus 397 ~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvi-lyeLltG~~PF~~~~~-~~l~~~i~~~-~~~--~----p~~~s~~l~~ 467 (635)
.+||+.|+|||++.+.. +.++|||||+++ .++++.|..||..... ..+...+... ... . +..+++++.+
T Consensus 237 ~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp EECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred EEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence 58999999999998776 489999998777 7788899999954221 1222333311 111 1 1247889999
Q ss_pred HHHHhcccCCCCCCCHHHHH-cCcccc
Q psy6357 468 LIRSMLVLDPAKRLTLTQIS-NHKWMS 493 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~~eiL-~Hpw~~ 493 (635)
||.+||++| |+.|+| +||||+
T Consensus 315 li~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHhccC-----CHHHHHhcCCCcC
Confidence 999999987 999999 999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=376.59 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=215.0
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...+|.+.+.||+|+||.||+|.+..... .+..||||++.... .....+.+.+|+.+|++++||||++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----------~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~ 455 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPEN-----------PAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVK 455 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSS-----------CCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCC-----------ccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34678889999999999999998853321 24579999986543 4555678899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++. .+.+||||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|
T Consensus 456 l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEe
Confidence 999985 466899999999999999997654 699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCC
Q psy6357 382 FGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRI 457 (635)
Q Consensus 382 FGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~ 457 (635)
||++........ .....+|+.|+|||++.+..++ .++|||||||++|||++ |..||.+.....+...+..+. ..+
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~ 613 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999987654322 2234567889999999887776 89999999999999997 999999988888887777653 567
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
|..++..+.+||.+||..||.+|||+.+|+++
T Consensus 614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78899999999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=359.40 Aligned_cols=245 Identities=15% Similarity=0.132 Sum_probs=191.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCC-Cce---
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDH-PHI--- 300 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnI--- 300 (635)
.|...+.||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+++.+.| .|+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~--------------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~ 144 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATD--------------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEE--------------TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred eEEEecccccCCCEEEEEEEe--------------cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence 455678899999999999987 24567999999974432 23345778899999999987 221
Q ss_pred ------ee------------EEEEEec-----CCeEEEEEeccccchhhhhhhh-------cccCCHHHHHHHHHHHHHh
Q psy6357 301 ------IK------------LFQVMET-----TNNLYLVTEYARGGEIFSHLLT-------IGQMAEKEASRLFRQILSA 350 (635)
Q Consensus 301 ------v~------------l~~~~~~-----~~~~~LV~E~~~ggsL~~~l~~-------~~~l~e~~~~~i~~qIl~g 350 (635)
+. ++.++.. ...++++|+++ +++|.+++.. ...+++..++.|+.||+.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a 223 (413)
T 3dzo_A 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223 (413)
T ss_dssp HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence 11 1111111 23467888877 6888888742 2348888999999999999
Q ss_pred hhhhccCceeeecccCcceeecCCCCeeeecccccccccCCCccccccCCCCCCCcccc----------CCCCcCCCccc
Q psy6357 351 VAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELF----------GGREYDGTKSD 420 (635)
Q Consensus 351 L~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl----------~~~~~~~~ksD 420 (635)
|.|||+.||+||||||+||||+.++.+||+|||++...... ....+| +.|+|||++ ....++ .++|
T Consensus 224 L~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~D 299 (413)
T 3dzo_A 224 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFD 299 (413)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHH
T ss_pred HHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhh
Confidence 99999999999999999999999999999999998765432 456678 999999999 444554 8999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 421 VWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 421 IwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
||||||+||+|++|..||...+.......+.. ....++.++.+||.+||..||.+|||+.++|+||||.
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 99999999999999999988765544433322 2235789999999999999999999999999999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=375.55 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=203.6
Q ss_pred cCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC
Q psy6357 219 RGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 219 ~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp 298 (635)
.++...++|.++++||+|+||.||++.+... ++..||||++.... .......+.+|+.+|++++||
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-------------~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp 139 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNV-------------NGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHP 139 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGG-------------TTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCT
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCC-------------CCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCC
Confidence 3456678999999999999999999987321 35689999986543 445567788999999999999
Q ss_pred ceeeEEEEEecCCe-----EEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 299 HIIKLFQVMETTNN-----LYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 299 nIv~l~~~~~~~~~-----~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
|||++++++...+. .||||||+++++|.+++.. .+++..++.|+.||+.||.|||+.|||||||||+||||+.
T Consensus 140 ~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217 (681)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred CcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC
Confidence 99999999987665 7999999999999987765 7999999999999999999999999999999999999987
Q ss_pred CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
+ .+||+|||++...... ...+||+.|+|||++.+.. +.++||||||||||+|++|..||.+.....+.
T Consensus 218 ~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------ 285 (681)
T 2pzi_A 218 E-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------ 285 (681)
T ss_dssp S-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------
T ss_pred C-cEEEEecccchhcccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------
Confidence 5 9999999999876543 4567999999999987654 48999999999999999999998753211000
Q ss_pred ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.......++..+.+||.+||..||.+||+..+++.|+|+.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000012467899999999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.12 Aligned_cols=226 Identities=18% Similarity=0.208 Sum_probs=188.5
Q ss_pred CC-cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCC
Q psy6357 220 GT-KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDH 297 (635)
Q Consensus 220 ~~-~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~H 297 (635)
++ ++.++|.++++||+|+||.||++.+. ..+..||||++..... .......+.+|+.++.+++|
T Consensus 25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~--------------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 90 (286)
T 3uqc_A 25 GARIANGRYRLLIFHGGVPPLQFWQALDT--------------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90 (286)
T ss_dssp TCEETTTTEEEEEEEEBSTTCEEEEEEET--------------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC
T ss_pred CCEEecCcEEEEEEEcccCCeEEEEEEec--------------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC
Confidence 44 56678999999999999999999873 3457899999987654 35666889999999999999
Q ss_pred CceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCe
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~i 377 (635)
|||+++++++...+..||||||+++++|.+++.. .....++..|+.||+.||.|||+.||+||||||+||||+.++.+
T Consensus 91 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCE
T ss_pred CCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCE
Confidence 9999999999999999999999999999999854 24666789999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCc
Q psy6357 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ---RILFGK 454 (635)
Q Consensus 378 kL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~---~i~~~~ 454 (635)
||++++ |++| + +.++|||||||+||+|++|..||.+.+...... ......
T Consensus 169 kl~~~~-------------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 221 (286)
T 3uqc_A 169 VLAYPA-------------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221 (286)
T ss_dssp EECSCC-------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC
T ss_pred EEEecc-------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC
Confidence 998554 3332 3 489999999999999999999998765432110 111111
Q ss_pred c----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 455 F----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 455 ~----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
. .++..++.++.+||.+||..||.+| |+.|+++.
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 1 1234689999999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=307.78 Aligned_cols=213 Identities=15% Similarity=0.100 Sum_probs=157.4
Q ss_pred cCceEEEEEeccccc--------CHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc
Q psy6357 263 ELSKVAIKIIDKKRL--------DERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG 333 (635)
Q Consensus 263 ~~~~VAIKii~~~~~--------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~ 333 (635)
.++.||||++.+... .+...+.+.+|+++|+++ .|+||++++++++++..+|||||||+|++|.++|...+
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence 567899999976532 234567799999999999 69999999999999999999999999999999999988
Q ss_pred cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccCC-CccccccCCCCCCCccccCCC
Q psy6357 334 QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGR 412 (635)
Q Consensus 334 ~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~ 412 (635)
.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+..... ....+.+||+.|||||++.+.
T Consensus 338 ~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 338 EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---
T ss_pred CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC
Confidence 88875 48899999999999999999999999999999999999999999876543 445678899999999999875
Q ss_pred CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 413 EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 413 ~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
. ..++|+||+|+++|+|+++..+| ...+. . .+.. ...+..++..++..+|..|+....+..|+|.
T Consensus 415 ~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~-~---~~~~-~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 415 K--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVW-Q---EPVE-RWNFVLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp ----------------CCCCTTHHHH--------HHHHH-T---SCGG-GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred C--CCcccccccccchhhhccccchh--------HHHhh-c---CCCC-CCcHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence 4 36899999999998887654332 11111 1 1110 1124567777888888888887777777776
Q ss_pred c
Q psy6357 493 S 493 (635)
Q Consensus 493 ~ 493 (635)
.
T Consensus 480 ~ 480 (569)
T 4azs_A 480 I 480 (569)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=266.17 Aligned_cols=182 Identities=19% Similarity=0.216 Sum_probs=144.3
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH------HHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE------RNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.||+|+||.||++.+ .+..+|+|++....... ...+.+.+|+.+|++++||||+++
T Consensus 341 ~~~LG~G~fg~Vy~~~~----------------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 404 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY----------------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAP 404 (540)
T ss_dssp -------CCEEEEEEEC----------------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCC
T ss_pred CCEEeeCCCEEEEEEEE----------------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCce
Confidence 46899999999999954 34579999876544321 124568899999999999999955
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
..++......|||||||++++|.+++.. +..|+.||+.||.|||+++|+||||||+||||+. .+||+|||
T Consensus 405 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 405 YIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp CEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred EEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECc
Confidence 5555566777999999999999999876 6789999999999999999999999999999998 99999999
Q ss_pred ccccccCCCc--------cccccCCCCCCCccccCC--CCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 384 FSNYFTPGHM--------LTTWCGSPPYAAPELFGG--REYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 384 la~~~~~~~~--------~~~~~gt~~Y~APEvl~~--~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
+|+....... ....+||+.|||||++.. ..|. ..+|+||..+-..+.+.++-+|
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 9988754321 246789999999999976 4555 7889999998888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.8e-23 Score=216.32 Aligned_cols=145 Identities=17% Similarity=0.203 Sum_probs=115.1
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----------------HHHHHHHHHHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----------------RNLRKLFREVD 290 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----------------~~~~~~~~Ei~ 290 (635)
|.+.+.||.|+||.||++.+ .++..||||++....... .....+.+|+.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~---------------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~ 156 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS---------------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 156 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE---------------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH
T ss_pred EEecCEeccCCCceEEEEEe---------------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH
Confidence 44559999999999999987 235689999996543211 23567889999
Q ss_pred HHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 291 IMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 291 iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
+|+++. | +++++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||+.||+||||||+|||
T Consensus 157 ~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NIL 225 (282)
T 1zar_A 157 ALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 225 (282)
T ss_dssp HHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred HHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEE
Confidence 999999 4 555555543 55699999999999988 421 235579999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCCccccccCCCCCCCccccC
Q psy6357 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFG 410 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~ 410 (635)
|+ ++.+||+|||+|.. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99 99999999999964 33678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=7e-20 Score=186.58 Aligned_cols=139 Identities=12% Similarity=0.128 Sum_probs=106.0
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCce--EEEEEecccccCH----------------------HHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSK--VAIKIIDKKRLDE----------------------RNL 282 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~--VAIKii~~~~~~~----------------------~~~ 282 (635)
|.+.+.||.|+||.||+|.+. .++.. ||||++....... ...
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~--------------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV--------------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVF 114 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE--------------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEc--------------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHH
Confidence 567889999999999999873 24567 9999986542110 112
Q ss_pred HHHHHHHHHHhhCCCCce--eeEEEEEecCCeEEEEEecccc-c----hhhhhhhhcccCCHHHHHHHHHHHHHhhhhhc
Q psy6357 283 RKLFREVDIMSHLDHPHI--IKLFQVMETTNNLYLVTEYARG-G----EIFSHLLTIGQMAEKEASRLFRQILSAVAYCH 355 (635)
Q Consensus 283 ~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~~~~~LV~E~~~g-g----sL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LH 355 (635)
..+.+|+.+|..|.|++| +.++++ ...+|||||+.+ | +|.+++.. +++..+..++.||+.+|.|||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHH
Confidence 357899999999988754 445543 356899999942 3 55544322 345678899999999999999
Q ss_pred -cCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 356 -ANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 356 -s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
+.||+||||||+||||+. .++|+|||+|...
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=6.1e-17 Score=173.94 Aligned_cols=138 Identities=14% Similarity=0.110 Sum_probs=101.6
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC---------------HH---HH--HHHH
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD---------------ER---NL--RKLF 286 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~---------------~~---~~--~~~~ 286 (635)
|.+.++||.|+||.||+|.. .+|..||||+++....+ .. .. ....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d---------------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~ 161 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD---------------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAI 161 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC---------------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEEC---------------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHH
Confidence 88899999999999999976 35678999998643111 00 01 1124
Q ss_pred HHHHHHhhCCCCce--eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecc
Q psy6357 287 REVDIMSHLDHPHI--IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDI 364 (635)
Q Consensus 287 ~Ei~iL~~L~HpnI--v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDL 364 (635)
+|...|.+|.+.+| ...+++. ..+|||||++|.+|..++. ...+..++.||+.+|.+||+.|||||||
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQS----RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEEE----TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHhcCCCCCeeeecc----CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 57777877755444 3333332 2379999999988866532 2245678999999999999999999999
Q ss_pred cCcceeecCCCC----------eeeeccccccccc
Q psy6357 365 KAENLLFDENGD----------IKLADFGFSNYFT 389 (635)
Q Consensus 365 Kp~NILl~~~~~----------ikL~DFGla~~~~ 389 (635)
||.||||+.++. +.|+||+-+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999988763 8999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=8.4e-12 Score=125.98 Aligned_cols=141 Identities=14% Similarity=0.148 Sum_probs=109.3
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
+..|.+...++.|+.+.||+... .+..++||+........ ...+.+|+.+|+.|. +..|.+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~----------------~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~ 74 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG----------------ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPK 74 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC----------------SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCC
T ss_pred hccceeEeeccCCCCCeEEEEEC----------------CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCe
Confidence 34577788888899999997753 24579999986532111 135788999999984 677889
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc--------------------------
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-------------------------- 356 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-------------------------- 356 (635)
+++++...+..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 75 v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T 3tm0_A 75 VLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence 9999988889999999999998876531 122344778889999999998
Q ss_pred ---------------------------------CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 357 ---------------------------------NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ---------------------------------~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=5.6e-11 Score=118.78 Aligned_cols=130 Identities=15% Similarity=0.132 Sum_probs=94.0
Q ss_pred eeecc-ccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc--eeeEEEE
Q psy6357 230 LRKAG-EGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH--IIKLFQV 306 (635)
Q Consensus 230 l~kLG-~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~ 306 (635)
+..++ .|..+.||+... .++..++||+..... ...+.+|+.+|+.|.+.+ |.+++.+
T Consensus 24 ~~~~~~gg~~~~v~~~~~---------------~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~ 83 (264)
T 1nd4_A 24 WAQQTIGCSDAAVFRLSA---------------QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDV 83 (264)
T ss_dssp EEECSCTTSSCEEEEEEC---------------TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEE
T ss_pred eEecccCCCCceEEEEec---------------CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEe
Confidence 34554 556689997753 234579999976542 135678999999885444 5678998
Q ss_pred EecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc----------------------------
Q psy6357 307 METTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN---------------------------- 358 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g---------------------------- 358 (635)
+...+..++||||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 84 ~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 84 VTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp EECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred ccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 88888899999999998884 21 111 1245666666667776532
Q ss_pred ------------------------------eeeecccCcceeecCCCCeeeeccccccc
Q psy6357 359 ------------------------------VVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 359 ------------------------------IiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
++|+||+|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.5e-10 Score=120.90 Aligned_cols=144 Identities=16% Similarity=0.321 Sum_probs=107.4
Q ss_pred ccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEec--ccccCHHHHHHHHHHHHHHhhCC--CCceee
Q psy6357 227 QYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIID--KKRLDERNLRKLFREVDIMSHLD--HPHIIK 302 (635)
Q Consensus 227 y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~ 302 (635)
...++.|+.|.+..||+... .+..+++|+.. ..... .....+.+|+.+|+.|. +..|++
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~----------------~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~ 102 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT----------------PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAK 102 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC----------------SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCC
T ss_pred CceEEEcCCcccceEEEEEE----------------CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCc
Confidence 33478999999999997754 23468898875 32211 12346778999999997 455788
Q ss_pred EEEEEecC---CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-----------------------
Q psy6357 303 LFQVMETT---NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA----------------------- 356 (635)
Q Consensus 303 l~~~~~~~---~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs----------------------- 356 (635)
++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 103 ~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3dxp_A 103 MYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIE 180 (359)
T ss_dssp EEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHH
T ss_pred EEEECCCCCccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHH
Confidence 99988766 4589999999988775422 2347788888999999999999996
Q ss_pred -----------------------------------CceeeecccCcceeecCCCC--eeeeccccccccc
Q psy6357 357 -----------------------------------NNVVHRDIKAENLLFDENGD--IKLADFGFSNYFT 389 (635)
Q Consensus 357 -----------------------------------~gIiHrDLKp~NILl~~~~~--ikL~DFGla~~~~ 389 (635)
..++|+|+++.|||++.++. +.|+||+.+....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 181 RWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 36999999999999997753 6899999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.2e-10 Score=118.56 Aligned_cols=181 Identities=18% Similarity=0.283 Sum_probs=121.0
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCc--eeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPH--IIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--Iv~l~~~ 306 (635)
++.++.|.+..||... ..++||+.... .....+.+|+.+|+.|. +.. +.+++..
T Consensus 25 i~~~~~G~~n~v~~v~-------------------~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~ 81 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-------------------RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFT 81 (304)
T ss_dssp CCEEEECSSEEEEEST-------------------TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEE
T ss_pred eEecCCCCcceEEEEC-------------------CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEee
Confidence 5678999999999642 25899986432 34567889999998873 333 4556555
Q ss_pred EecCC---eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc---------------------------
Q psy6357 307 METTN---NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA--------------------------- 356 (635)
Q Consensus 307 ~~~~~---~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs--------------------------- 356 (635)
..... ..|+||++++|.+|..... ..++..+...++.+++..|..||+
T Consensus 82 ~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (304)
T 3sg8_A 82 GMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKK 159 (304)
T ss_dssp CCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHH
Confidence 44333 3489999999988865332 346777777777777777777774
Q ss_pred -------------------------------CceeeecccCcceeecC--CCCeeeecccccccccCCCccccccCCCCC
Q psy6357 357 -------------------------------NNVVHRDIKAENLLFDE--NGDIKLADFGFSNYFTPGHMLTTWCGSPPY 403 (635)
Q Consensus 357 -------------------------------~gIiHrDLKp~NILl~~--~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y 403 (635)
..++|+|++|.|||++. ...+.|+||+.+.................-
T Consensus 160 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~ 239 (304)
T 3sg8_A 160 LLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEE 239 (304)
T ss_dssp HHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTS
T ss_pred HhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccc
Confidence 24799999999999998 456889999998765432111111100000
Q ss_pred CCcc----------------ccCCCCcCCCccchhhHHHHHHHHHhCCCCC
Q psy6357 404 AAPE----------------LFGGREYDGTKSDVWSLGVVLYVMVTAQLPF 438 (635)
Q Consensus 404 ~APE----------------vl~~~~~~~~ksDIwSlGvilyeLltG~~PF 438 (635)
..|+ .+.... ...++|+++.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence 2222 221111 1258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2e-06 Score=89.12 Aligned_cols=135 Identities=14% Similarity=0.170 Sum_probs=90.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC---ceeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP---HIIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~ 306 (635)
+..++.|....||.. +..++||+-. .......+.+|+.+|+.|.+. .|.+++.+
T Consensus 24 v~~l~~G~~n~v~~v-------------------g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~ 80 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-------------------NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYI 80 (306)
T ss_dssp EEEEEECSSEEEEEE-------------------TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEE
T ss_pred eeecCCCcceeEEEE-------------------CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEee
Confidence 567888888888855 1358899853 233456788999999999642 35677777
Q ss_pred Ee-cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-----------------------------
Q psy6357 307 ME-TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA----------------------------- 356 (635)
Q Consensus 307 ~~-~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs----------------------------- 356 (635)
.. ..+..|+|||+++|..|..... ..++......++.++...|..||+
T Consensus 81 ~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~ 158 (306)
T 3tdw_A 81 GKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVED 158 (306)
T ss_dssp EECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHH
T ss_pred cccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHH
Confidence 64 4556789999999987765211 123333333333333333333332
Q ss_pred -------------------------------CceeeecccCcceeecC---CCC-eeeeccccccccc
Q psy6357 357 -------------------------------NNVVHRDIKAENLLFDE---NGD-IKLADFGFSNYFT 389 (635)
Q Consensus 357 -------------------------------~gIiHrDLKp~NILl~~---~~~-ikL~DFGla~~~~ 389 (635)
..++|+|+++.|||++. ++. +.|+||+.+....
T Consensus 159 ~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 159 QVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred hcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 25799999999999987 455 4899999886543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.9e-06 Score=85.44 Aligned_cols=116 Identities=18% Similarity=0.213 Sum_probs=78.7
Q ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHH
Q psy6357 264 LSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASR 342 (635)
Q Consensus 264 ~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~ 342 (635)
+..+.||+-... ....+.+|+.+|+.|. +--|.+++.++.+.+..|+|||+++|.++.+...... .....
T Consensus 50 ~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~----~~~~~ 120 (272)
T 4gkh_A 50 APELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP----DSGEN 120 (272)
T ss_dssp CCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG----GGHHH
T ss_pred CeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH----HHHHH
Confidence 457899986532 3456788999999884 3346788999998899999999999877655432210 11112
Q ss_pred HHHHHHHhhhhhcc----------------------------------------------------------Cceeeecc
Q psy6357 343 LFRQILSAVAYCHA----------------------------------------------------------NNVVHRDI 364 (635)
Q Consensus 343 i~~qIl~gL~~LHs----------------------------------------------------------~gIiHrDL 364 (635)
+..++...|..||. ..++|+|+
T Consensus 121 ~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl 200 (272)
T 4gkh_A 121 IVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDF 200 (272)
T ss_dssp HHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCC
T ss_pred HHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCC
Confidence 22222222222221 13799999
Q ss_pred cCcceeecCCCCeeeecccccccc
Q psy6357 365 KAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 365 Kp~NILl~~~~~ikL~DFGla~~~ 388 (635)
++.|||++.++.+-|+||+.+...
T Consensus 201 ~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 201 SLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCeEEEECCeEEEEEECcccccC
Confidence 999999998777789999988643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.4e-06 Score=87.81 Aligned_cols=88 Identities=7% Similarity=0.034 Sum_probs=55.2
Q ss_pred eeec-cccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc---cCHHHHHHHHHHHHHHhhCC-C--Cceee
Q psy6357 230 LRKA-GEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR---LDERNLRKLFREVDIMSHLD-H--PHIIK 302 (635)
Q Consensus 230 l~kL-G~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~---~~~~~~~~~~~Ei~iL~~L~-H--pnIv~ 302 (635)
++.| +.|....+|.......... -.++..+++|+..... ... ...+.+|+.+|+.|. + -.|.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~--------~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~ 94 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDG--------RSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPR 94 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETT--------EEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCC
T ss_pred EEECCCCCccceEEEEEEecccCC--------CCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCc
Confidence 5677 8888899997654210000 0013468899875432 100 134678888888884 2 35778
Q ss_pred EEEEEecC---CeEEEEEeccccchhhh
Q psy6357 303 LFQVMETT---NNLYLVTEYARGGEIFS 327 (635)
Q Consensus 303 l~~~~~~~---~~~~LV~E~~~ggsL~~ 327 (635)
++.++.+. +..|+||||++|..|.+
T Consensus 95 v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 95 VRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEEEccCCCccCCceEEEEecCCCChhh
Confidence 88887655 35689999998876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.3e-05 Score=85.74 Aligned_cols=80 Identities=14% Similarity=0.023 Sum_probs=50.0
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CH---HHHHHHHHHHHHHhhCCC--C-c
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DE---RNLRKLFREVDIMSHLDH--P-H 299 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~---~~~~~~~~Ei~iL~~L~H--p-n 299 (635)
..++.||.|.++.||++.... .+..|+||....... .. ....++..|+.+|+.+.. + .
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~--------------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~ 98 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQE--------------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHL 98 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC------------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGG
T ss_pred eEEEECCCCceEEEEEEEECC--------------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCC
Confidence 347889999999999886421 235799998653211 00 012456779999887742 3 3
Q ss_pred eeeEEEEEecCCeEEEEEeccccc
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGG 323 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~gg 323 (635)
+.+++.+. ....++|||++.+.
T Consensus 99 vP~~~~~d--~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 99 VPRVFYSD--TEMAVTVMEDLSHL 120 (397)
T ss_dssp SCCEEEEE--TTTTEEEECCCTTS
T ss_pred cCeEEEEc--CCccEEEEEeCCCc
Confidence 45666543 34468999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.1e-05 Score=81.50 Aligned_cols=31 Identities=29% Similarity=0.454 Sum_probs=27.8
Q ss_pred CceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0005 Score=71.47 Aligned_cols=75 Identities=17% Similarity=0.170 Sum_probs=58.7
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC---CCceeeEEEE
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD---HPHIIKLFQV 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~ 306 (635)
++.|+.|....+|.... ++..++||+.... ....+..|+.+|+.|. ...|++++.+
T Consensus 41 ~~~l~gG~~n~~y~v~~----------------~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~ 99 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND----------------EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGI 99 (312)
T ss_dssp EEEECCSSSSEEEEEES----------------SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred eEEeCCccceeeeEEEE----------------CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence 67899999999997653 2357899987643 1356788999998884 3568889998
Q ss_pred EecCCeEEEEEeccccchh
Q psy6357 307 METTNNLYLVTEYARGGEI 325 (635)
Q Consensus 307 ~~~~~~~~LV~E~~~ggsL 325 (635)
....+..|+||||+++..+
T Consensus 100 ~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 100 GNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECSSEEEEEEECCCCCCC
T ss_pred eecCCceEEEEEeccCCCC
Confidence 8888889999999988754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00043 Score=74.60 Aligned_cols=34 Identities=21% Similarity=0.412 Sum_probs=29.5
Q ss_pred ccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 355 HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 355 Hs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
+...++|+|+++.|||++.++ ++|+||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 467899999999999998876 9999999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0009 Score=65.69 Aligned_cols=136 Identities=18% Similarity=0.138 Sum_probs=89.7
Q ss_pred cchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhc-cCceeeecccCcceeecCCCCeeeecccccccccCCCccccccC
Q psy6357 322 GGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPGHMLTTWCG 399 (635)
Q Consensus 322 ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LH-s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~g 399 (635)
..+|.+.|... .+|+|+++|.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|.+.+ ..+. ..
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 35788888765 46999999999999999988761 11112334457899999999988764 2111 11
Q ss_pred CCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCCHHHHHHHHHhccc----
Q psy6357 400 SPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVL---- 475 (635)
Q Consensus 400 t~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s~~l~~LI~~~L~~---- 475 (635)
...+.|||..... .+.+.=|||||++||..+--.+| -..+..+|+.|..||..|..-
T Consensus 100 ~~~~~~pe~~~~~--~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~~~d~ 160 (229)
T 2yle_A 100 EPPPVAGKLGYSQ--CMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANTVEAD 160 (229)
T ss_dssp -------CCSSSS--SCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTCCC--
T ss_pred ccCCCChhhcccc--chHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhccccc
Confidence 2356788887421 23778899999999998852222 112345899999999999865
Q ss_pred ---------------------CCCCCCCHHHHHc
Q psy6357 476 ---------------------DPAKRLTLTQISN 488 (635)
Q Consensus 476 ---------------------dP~~Rps~~eiL~ 488 (635)
.+..|.++.+||+
T Consensus 161 ~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 161 GSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ------------------CCSCCCCCCSHHHHHH
T ss_pred ccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457788888875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0014 Score=67.50 Aligned_cols=138 Identities=13% Similarity=0.131 Sum_probs=78.8
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCC--ceeeEEEE-
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP--HIIKLFQV- 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~- 306 (635)
+..|+ |....||.... .++..+++|+........ ..+..|+.++..|... .+++++..
T Consensus 31 ~~~l~-g~~n~~y~v~~---------------~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~ 91 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD---------------EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFN 91 (328)
T ss_dssp CEEEC-CSSSEEEEECC---------------TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBT
T ss_pred EEeec-CcccceEEEEc---------------CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecC
Confidence 45566 77888886543 234579999986433232 3556788888777421 24444432
Q ss_pred ----EecCCeEEEEEeccccchhhh-----------hh---hh----c-----ccCCHHHH-------------------
Q psy6357 307 ----METTNNLYLVTEYARGGEIFS-----------HL---LT----I-----GQMAEKEA------------------- 340 (635)
Q Consensus 307 ----~~~~~~~~LV~E~~~ggsL~~-----------~l---~~----~-----~~l~e~~~------------------- 340 (635)
....+..++||++++|..+.. .| .. . ..+.....
T Consensus 92 g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 171 (328)
T 1zyl_A 92 GQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLK 171 (328)
T ss_dssp TBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTH
T ss_pred CcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHH
Confidence 123456789999998754321 00 00 0 01111110
Q ss_pred ---HHHHHHHHHhhhhh----ccCceeeecccCcceeecCCCCeeeecccccccc
Q psy6357 341 ---SRLFRQILSAVAYC----HANNVVHRDIKAENLLFDENGDIKLADFGFSNYF 388 (635)
Q Consensus 341 ---~~i~~qIl~gL~~L----Hs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~ 388 (635)
..++..++..+.-+ ....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 172 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 172 AAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 11112222222221 235689999999999998 4 8999999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0011 Score=68.76 Aligned_cols=34 Identities=29% Similarity=0.369 Sum_probs=29.0
Q ss_pred cCceeeecccCcceeecCC----CCeeeeccccccccc
Q psy6357 356 ANNVVHRDIKAENLLFDEN----GDIKLADFGFSNYFT 389 (635)
Q Consensus 356 s~gIiHrDLKp~NILl~~~----~~ikL~DFGla~~~~ 389 (635)
...++|+|+++.|||++.+ +.+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4579999999999999874 679999999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00029 Score=72.28 Aligned_cols=134 Identities=15% Similarity=0.125 Sum_probs=75.0
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~ 308 (635)
++.|+.|....+|+. ..+++|+...... ......+|+.+++.+....| .+++.++.
T Consensus 23 i~~l~gG~tN~~~~~--------------------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~ 79 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA--------------------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDP 79 (301)
T ss_dssp CEEEESCSSEEEEEE--------------------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT
T ss_pred eeEcCCcccccccee--------------------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEEC
Confidence 688999999999976 1489998864311 11122468888777742223 46665543
Q ss_pred cCCeEEEEEecc-ccchhhhh--------h-------hhc---c-cC----C-HHHHHHHHH------------------
Q psy6357 309 TTNNLYLVTEYA-RGGEIFSH--------L-------LTI---G-QM----A-EKEASRLFR------------------ 345 (635)
Q Consensus 309 ~~~~~~LV~E~~-~ggsL~~~--------l-------~~~---~-~l----~-e~~~~~i~~------------------ 345 (635)
+.-++|+||+ +|.+|... + .+. . .+ . ...+..+..
T Consensus 80 --~~~~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 157 (301)
T 3dxq_A 80 --ATGVMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVR 157 (301)
T ss_dssp --TTCCEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHH
T ss_pred --CCCEEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHH
Confidence 3347899999 66555321 0 000 0 00 0 111111111
Q ss_pred ---HHHHhhhhh-ccCceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 346 ---QILSAVAYC-HANNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 346 ---qIl~gL~~L-Hs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
.+...+.-. ....++|+|+.+.||| ..++.+.|+||..+....
T Consensus 158 ~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 158 EAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp HHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 111111110 1235899999999999 566788999999886543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0021 Score=65.27 Aligned_cols=75 Identities=8% Similarity=0.009 Sum_probs=52.0
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC---CceeeEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH---PHIIKLFQ 305 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~ 305 (635)
-+..+|.|..+.||+... .+|+.|.||+........ ...+..|+..|+.|.. --+++++.
T Consensus 19 ~v~~~g~G~~~~vyrv~l---------------~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~ 81 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVEL---------------ADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAG 81 (288)
T ss_dssp EEEEEEEETTEEEEEEEE---------------TTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred EEEecCCCCCeEEEEEEE---------------CCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence 378899999999998865 467889999865432211 1346789999988842 23556665
Q ss_pred EEecCCeEEEEEeccccch
Q psy6357 306 VMETTNNLYLVTEYARGGE 324 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggs 324 (635)
+. .-++||||+++..
T Consensus 82 ~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 82 WD----DRTLAMEWVDERP 96 (288)
T ss_dssp EE----TTEEEEECCCCCC
T ss_pred cc----CceEEEEeecccC
Confidence 53 2378999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0024 Score=68.22 Aligned_cols=144 Identities=17% Similarity=0.198 Sum_probs=82.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 308 (635)
++.|.-|-...+|+......-.. .-.++..|.+|+..... .....+.+|+.+|+.|. +.-..++++++.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~-------~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPS-------VGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCC-------CSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEcCCcccccEEEEEeCCCccc-------cCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 57788888888997764210000 00123579999863321 11345568999998884 333467777765
Q ss_pred cCCeEEEEEeccccchhhhh-h-------------hhc-------c-cC--CHHHHHHHHHHHHHh--------------
Q psy6357 309 TTNNLYLVTEYARGGEIFSH-L-------------LTI-------G-QM--AEKEASRLFRQILSA-------------- 350 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL~~~-l-------------~~~-------~-~l--~e~~~~~i~~qIl~g-------------- 350 (635)
. .+||||++|..|... + .+. . .. -+..+.+++.++...
T Consensus 125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 4 299999998655311 0 000 0 11 134555555544221
Q ss_pred -----hhhhc--------cCceeeecccCcceeecCC----CCeeeeccccccc
Q psy6357 351 -----VAYCH--------ANNVVHRDIKAENLLFDEN----GDIKLADFGFSNY 387 (635)
Q Consensus 351 -----L~~LH--------s~gIiHrDLKp~NILl~~~----~~ikL~DFGla~~ 387 (635)
+..|. ...++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22222 2359999999999999876 7899999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0017 Score=70.43 Aligned_cols=81 Identities=16% Similarity=0.146 Sum_probs=50.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-eeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-IIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~ 308 (635)
++.|+.|-...||+......... .-..+..|++|+..... . ...+..|+.+|+.|...+ .+++++.+.
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~-------~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPP-------IRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC-------SSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEeCCCcccceEEEEeCCCccc-------cCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 67888898899998765210000 00023579999984321 1 134457999998885333 367777665
Q ss_pred cCCeEEEEEeccccchh
Q psy6357 309 TTNNLYLVTEYARGGEI 325 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL 325 (635)
. .+||||++|.+|
T Consensus 147 ~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G----GRLEEYIPSRPL 159 (429)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----CEEEEEeCCccc
Confidence 3 389999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0018 Score=66.51 Aligned_cols=138 Identities=16% Similarity=0.163 Sum_probs=75.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc--eeeEEEE-
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH--IIKLFQV- 306 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~- 306 (635)
++.|+.|....||.... ++..+++|+..... ....+..|+.++..|.... +.+++..
T Consensus 27 ~~~i~~G~~n~~~~v~~----------------~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT----------------TKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp EEEECC---EEEEEEEE----------------SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred eeccCCCcccceEEEEe----------------CCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 67788888889997653 11258899987531 1134556888877764212 3333321
Q ss_pred -----EecCCeEEEEEeccccchhhh-----------h---hhhc-cc--------CCHHHHHHHHH-------------
Q psy6357 307 -----METTNNLYLVTEYARGGEIFS-----------H---LLTI-GQ--------MAEKEASRLFR------------- 345 (635)
Q Consensus 307 -----~~~~~~~~LV~E~~~ggsL~~-----------~---l~~~-~~--------l~e~~~~~i~~------------- 345 (635)
....+..++||+|++|..+.. . +... .. .........+.
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 123456789999998764321 0 0000 00 01110011000
Q ss_pred --HHHHhhhhhc-------cCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 346 --QILSAVAYCH-------ANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 346 --qIl~gL~~LH-------s~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
.+...+++|. ..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 1222333333 24799999999999998876668999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0016 Score=68.72 Aligned_cols=83 Identities=12% Similarity=0.133 Sum_probs=44.9
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-eeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-IIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~ 308 (635)
+..|+.|..-.+|+......... ..-..+..|++|+...... .......|+.+|+.|...+ +.++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~------~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETAN------NYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHT------TCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEeCCcccceEEEEEeCCCCcc------cccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC
Confidence 67888888889997765211000 0000125789998754311 1112357888888875333 456776552
Q ss_pred cCCeEEEEEeccccchh
Q psy6357 309 TTNNLYLVTEYARGGEI 325 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL 325 (635)
-++||||++|..+
T Consensus 109 ----~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 ----GGRIEEWLYGDPL 121 (369)
T ss_dssp ----TEEEEECCCSEEC
T ss_pred ----CcEEEEEecCCcC
Confidence 2689999987644
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0055 Score=64.02 Aligned_cols=33 Identities=24% Similarity=0.311 Sum_probs=28.8
Q ss_pred CceeeecccCcceeecCCCCeeeeccccccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSNYFT 389 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~ 389 (635)
..++|+|+.+.|||++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 469999999999999988889999998876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0063 Score=66.53 Aligned_cols=76 Identities=16% Similarity=0.097 Sum_probs=47.5
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce-eeEEEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI-IKLFQVM 307 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~ 307 (635)
.++.|+.|-...+|+..... .+..|++|+....... . -...+|+.+|+.|...+| .++++++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~--------------~~~~~vLRi~g~~~~~--~-idR~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS--------------KQAKYLIRLYGPKTDE--I-INREREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEEECC--CEEEEEEEETT--------------TTEEEEEEEECC-CCS--C-SCHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEEcCCCeEeEEEEEEECC--------------CCceEEEEECCCChhh--h-cCHHHHHHHHHHHHhcCCCCCEEEEe
Confidence 46788888888999876511 1257899987542110 0 011478999998865444 5777777
Q ss_pred ecCCeEEEEEeccccchh
Q psy6357 308 ETTNNLYLVTEYARGGEI 325 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL 325 (635)
.. .+||||++|.+|
T Consensus 175 ~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 175 TN----GRIEEFMDGYAL 188 (458)
T ss_dssp TT----EEEEECCCSEEC
T ss_pred CC----eEEEEeeCCccC
Confidence 32 359999987554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.04 Score=59.51 Aligned_cols=82 Identities=11% Similarity=0.073 Sum_probs=48.5
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 308 (635)
++.|.-|-...+|+......... .-..+..|++|+..... . ..-...+|+.+++.|. +.-..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~-------~~~~~~~~vlRi~g~~t--~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMS-------LSLKHPRILFRIYGKHV--G-KFYDSKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC------------CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEcCCCcccceEEEEeCCCccc-------ccCCCCeEEEEECCCCc--c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 67888888888998765311000 00114679999875432 1 1112347888888874 333456666443
Q ss_pred cCCeEEEEEeccccchh
Q psy6357 309 TTNNLYLVTEYARGGEI 325 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL 325 (635)
-++||||++|..|
T Consensus 145 ----~~~I~efI~G~~l 157 (424)
T 3mes_A 145 ----EGRIEEFIDGEPL 157 (424)
T ss_dssp ----TEEEEECCCSEEC
T ss_pred ----CCEEEEEeCCccC
Confidence 2789999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.88 E-value=0.17 Score=53.85 Aligned_cols=31 Identities=32% Similarity=0.580 Sum_probs=25.8
Q ss_pred ceeeecccCcceee------cCCCCeeeecccccccc
Q psy6357 358 NVVHRDIKAENLLF------DENGDIKLADFGFSNYF 388 (635)
Q Consensus 358 gIiHrDLKp~NILl------~~~~~ikL~DFGla~~~ 388 (635)
.++|+|+.+.|||+ +.+..++|+||.+|..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 36899999999999 44678999999988643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.34 E-value=2.7 Score=40.80 Aligned_cols=121 Identities=12% Similarity=0.201 Sum_probs=81.5
Q ss_pred HHHHHhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCc
Q psy6357 288 EVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAE 367 (635)
Q Consensus 288 Ei~iL~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~ 367 (635)
|+.+|.. .||+++.. .+-++.+.+.|.++.-..+.-+.. -..++....++++.+|+....+++. -+|--|+|+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~ 108 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPD 108 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGG
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecc
Confidence 4444332 68888876 566677777777776543322222 3458899999999999998865543 456678999
Q ss_pred ceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchh-hHHHHHHHHHhCCCCC
Q psy6357 368 NLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVW-SLGVVLYVMVTAQLPF 438 (635)
Q Consensus 368 NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIw-SlGvilyeLltG~~PF 438 (635)
||+++.++.++|.=.|+-..+ +|.-+ ...|.| .+=|++..++.++..|
T Consensus 109 NL~f~~~~~p~i~~RGik~~l----------------~P~~~-------~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV----------------DPLPV-------SEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB----------------SCCCC-------CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred eEEEcCCCCEEEEEccCccCC----------------CCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999877764332 22211 122333 5668888888888776
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.70 E-value=0.075 Score=58.02 Aligned_cols=63 Identities=14% Similarity=0.081 Sum_probs=17.3
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEE------EEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAI------KIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAI------Kii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+.++|| ||.||+|.+... ..+||| |.+.......+....+.+|+.+++.++|+|+++
T Consensus 146 l~~~lG---fG~v~~g~~~~~--------------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~ 208 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKK--------------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEK 208 (463)
T ss_dssp STTTSS---BCCC-----------------------CCBGGGC-----------------------------------CB
T ss_pred ccccCC---chhhhccccccc--------------CCchhhhhccCccccccccccccccccccccccccccccccccCC
Confidence 356787 999999987321 246888 766554555555667889999999999999999
Q ss_pred EEEEEe
Q psy6357 303 LFQVME 308 (635)
Q Consensus 303 l~~~~~ 308 (635)
.+.+..
T Consensus 209 ~h~f~~ 214 (463)
T 3cxl_A 209 IHNFKV 214 (463)
T ss_dssp CCCEEE
T ss_pred CcceEE
Confidence 887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.76 E-value=5.7 Score=38.63 Aligned_cols=113 Identities=12% Similarity=0.162 Sum_probs=77.1
Q ss_pred CCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhh-hhccCceeeecccCcceeecCC
Q psy6357 296 DHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVA-YCHANNVVHRDIKAENLLFDEN 374 (635)
Q Consensus 296 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~-~LHs~gIiHrDLKp~NILl~~~ 374 (635)
.||++ -..+-.+++.+.|.++.-+++.-+..+ ..++....++++.+|+.... +++ .-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCC
Confidence 57888 444457778877877776444333333 45889999999999998777 554 34566789999999999
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchh-hHHHHHHHHHhCCCCC
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVW-SLGVVLYVMVTAQLPF 438 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIw-SlGvilyeLltG~~PF 438 (635)
+.++|.-.|+-.. ++|.-+ ...|.| .+=|++..++.++..|
T Consensus 121 ~~p~i~hRGi~~~----------------lpP~e~-------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 121 LEPFFLHVGVKES----------------LPPDEW-------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCEEESCCEETTT----------------BSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred CcEEEEEcCCccc----------------CCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999987776432 233322 223333 5667777777777665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 635 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-78 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-74 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-70 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-66 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-64 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-62 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-61 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-48 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-47 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-42 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 9e-78
Identities = 77/231 (33%), Positives = 132/231 (57%), Gaps = 3/231 (1%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+A+K++ K +L++ + REV+I SHL HP+I++L+ +YL+ EYA G
Sbjct: 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
++ L + + E+ + ++ +A++YCH+ V+HRDIK ENLL G++K+ADFG+
Sbjct: 93 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 152
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
S P TT CG+ Y PE+ GR +D K D+WSLGV+ Y + + PF+
Sbjct: 153 SV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
+RI +F P +++ +LI +L +P++R L ++ H W++ +
Sbjct: 211 ETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 1e-74
Identities = 78/238 (32%), Positives = 121/238 (50%), Gaps = 7/238 (2%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+KI+D KR + + +E+ I L+H +++K + N YL EY GGE+
Sbjct: 32 AVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
F + M E +A R F Q+++ V Y H + HRDIK ENLL DE ++K++DFG +
Sbjct: 91 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 150
Query: 386 NYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
F +L CG+ PY APEL RE+ DVWS G+VL M+ +LP+D P+
Sbjct: 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210
Query: 443 LAVLKQRILFGK---FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCP 497
+ + K + + L+ +LV +P+ R+T+ I +W +
Sbjct: 211 DSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 1e-72
Identities = 71/234 (30%), Positives = 123/234 (52%), Gaps = 5/234 (2%)
Query: 266 KVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+ AIKI++K+ + E + + RE D+MS LDHP +KL+ + LY YA+ GE
Sbjct: 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ ++ IG E +I+SA+ Y H ++HRD+K EN+L +E+ I++ DFG
Sbjct: 95 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 154
Query: 385 SNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
+ +P ++ G+ Y +PEL + SD+W+LG ++Y +V PF
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAG 213
Query: 442 NLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
N ++ Q+I+ ++ P + +L+ +LVLD KRL ++ + + H
Sbjct: 214 NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 1e-72
Identities = 70/239 (29%), Positives = 114/239 (47%), Gaps = 14/239 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVM--ETTNNLYLVTEYARGG 323
+ K +D + E + L EV+++ L HP+I++ + + T LY+V EY GG
Sbjct: 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90
Query: 324 EIFSHLLTIGQ----MAEKEASRLFRQILSAVAYCH-----ANNVVHRDIKAENLLFDEN 374
++ S + + + E+ R+ Q+ A+ CH + V+HRD+K N+ D
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 375 GDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
++KL DFG + + G+P Y +PE Y+ KSD+WSLG +LY +
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCA 209
Query: 434 AQLPFDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491
PF + L +I GKF RIP+ S E +I ML L R ++ +I +
Sbjct: 210 LMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 3e-72
Identities = 74/239 (30%), Positives = 121/239 (50%), Gaps = 11/239 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A K+ID K E L E+DI++ DHP+I+KL NNL+++ E+ GG +
Sbjct: 39 LAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96
Query: 326 FSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ +L + + + E + + +Q L A+ Y H N ++HRD+KA N+LF +GDIKLADFG
Sbjct: 97 DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 156
Query: 385 SNYFT-PGHMLTTWCGSPPYAAPELFGGREYD----GTKSDVWSLGVVLYVMVTAQLPFD 439
S T ++ G+P + APE+ K+DVWSLG+ L M + P
Sbjct: 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
Query: 440 GPNLAVLKQRILFGK---FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495
N + +I + P S+ ++ ++ L + R T +Q+ H +++V
Sbjct: 217 ELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 2e-71
Identities = 65/250 (26%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAI+ ++ ++ ++ + E+ +M +P+I+ + L++V EY GG +
Sbjct: 47 EVAIRQMNLQQQPKK--ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
++T M E + + + R+ L A+ + H+N V+HRDIK++N+L +G +KL DFGF
Sbjct: 105 T-DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 386 NYFT-PGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
T +T G+P + APE+ + Y K D+WSLG++ M+ + P+ N
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 445 VLKQRILFG---KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPV 501
I + + P +SA + + L +D KR + ++ H+++ + P
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS- 281
Query: 502 IVNPVPSEPK 511
+ P+ + K
Sbjct: 282 -LTPLIAAAK 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 230 bits (587), Expect = 4e-71
Identities = 89/253 (35%), Positives = 137/253 (54%), Gaps = 9/253 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK I KK L+ + + E+ ++ + HP+I+ L + E+ +LYL+ + GGE+
Sbjct: 36 LVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGDIKLADF 382
F ++ G E++ASRL Q+L AV Y H +VHRD+K ENLL+ DE+ I ++DF
Sbjct: 95 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G S PG +L+T CG+P Y APE+ + Y D WS+GV+ Y+++ PF N
Sbjct: 155 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDEN 213
Query: 443 LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPG 498
A L ++IL ++ +S ++ IR ++ DP KR T Q H W++
Sbjct: 214 DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273
Query: 499 DPVIVNPVPSEPK 511
D I V + K
Sbjct: 274 DKNIHQSVSEQIK 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 228 bits (583), Expect = 5e-71
Identities = 77/247 (31%), Positives = 124/247 (50%), Gaps = 17/247 (6%)
Query: 266 KVAIKIIDKKRLDERNLRK-------LFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVT 317
+ A+KIID + + +EVDI+ + HP+II+L ET +LV
Sbjct: 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89
Query: 318 EYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ + GE+F +L ++EKE ++ R +L + H N+VHRD+K EN+L D++ +I
Sbjct: 90 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 149
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYD-----GTKSDVWSLGVVLYVMV 432
KL DFGFS PG L CG+P Y APE+ D G + D+WS GV++Y ++
Sbjct: 150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209
Query: 433 TAQLPFDGPNLAVLKQRILFGKFRIPFY----MSAECENLIRSMLVLDPAKRLTLTQISN 488
PF ++ + I+ G ++ S ++L+ LV+ P KR T +
Sbjct: 210 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 489 HKWMSVH 495
H + +
Sbjct: 270 HPFFQQY 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 229 bits (586), Expect = 2e-70
Identities = 71/259 (27%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A K + ++ + +E+ MS L HP ++ L E N + ++ E+ GGE+
Sbjct: 53 NFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110
Query: 326 FSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF--DENGDIKLADF 382
F + +M+E EA RQ+ + + H NN VH D+K EN++F + ++KL DF
Sbjct: 111 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 170
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G + + P + G+ +AAPE+ G+ G +D+WS+GV+ Y++++ PF G N
Sbjct: 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGEN 229
Query: 443 LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS-VHCP 497
+ + + + +S + ++ IR +L+ DP R+T+ Q H W++ + P
Sbjct: 230 DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289
Query: 498 GDPVIVNPVPSEPKLPNSF 516
G + P K+ +S
Sbjct: 290 GRDSQI-PSSRYTKIRDSI 307
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 226 bits (578), Expect = 9e-70
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 17/275 (6%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VAIK + + +EV + L HP+ I+ + +LV EY G
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+ + E E + + L +AY H++N++HRD+KA N+L E G +KL DFG
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 161
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYD--GTKSDVWSLGVVLYVMVTAQLPFDGPN 442
++ P ++ G+P + APE+ + K DVWSLG+ + + P N
Sbjct: 162 ASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 443 LAVLKQRILFGKFR--IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDP 500
I + + S N + S L P R T + H+++ P P
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP--P 276
Query: 501 VIVNPVPSEPKLPNSFVIDQMLQLPALTRNRILEF 535
++ + K D + +L L ++ +
Sbjct: 277 TVIMDLIQRTK-------DAVRELDNLQYRKMKKI 304
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-68
Identities = 56/234 (23%), Positives = 113/234 (48%), Gaps = 11/234 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
K + K D+ ++ +E+ I++ H +I+ L + E+ L ++ E+ G +I
Sbjct: 32 TYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 326 FSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD--ENGDIKLADF 382
F + T ++ E+E Q+ A+ + H++N+ H DI+ EN+++ + IK+ +F
Sbjct: 89 FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G + PG +P Y APE+ T +D+WSLG ++YV+++ PF
Sbjct: 149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAET 207
Query: 443 LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
+ + I+ ++ +S E + + +LV + R+T ++ H W+
Sbjct: 208 NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 224 bits (572), Expect = 2e-68
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 10/234 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
K I+ ++ + E+ IM+ L HP +I L E + L+ E+ GGE+
Sbjct: 56 VFVAKFINTPYPLDK--YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113
Query: 326 FSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD--ENGDIKLADF 382
F + M+E E RQ + + H +++VH DIK EN++ + + +K+ DF
Sbjct: 114 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 173
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G + P ++ + +AAPE+ +D+W++GV+ YV+++ PF G +
Sbjct: 174 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGED 232
Query: 443 LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
Q + + +S E ++ I+++L +P KRLT+ H W+
Sbjct: 233 DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 4e-68
Identities = 56/245 (22%), Positives = 109/245 (44%), Gaps = 13/245 (5%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT----NNL 313
E +VA + ++L + ++ E +++ L HP+I++ + E+T +
Sbjct: 28 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87
Query: 314 YLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAEN-LL 370
LVTE G + ++L M K RQIL + + H ++HRD+K +N +
Sbjct: 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 371 FDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYV 430
G +K+ D G + G+P + APE++ + YD DV++ G+ +
Sbjct: 148 TGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLE 204
Query: 431 MVTAQLPFDG-PNLAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDPAKRLTLTQIS 487
M T++ P+ N A + +R+ G F E + +I + + +R ++ +
Sbjct: 205 MATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
Query: 488 NHKWM 492
NH +
Sbjct: 265 NHAFF 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 5e-67
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 48/272 (17%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+A K+I + ++ RE+ ++ + P+I+ + + + + E+ GG +
Sbjct: 33 VMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCH-ANNVVHRDIKAENLLFDENGDIKLADFGF 384
L G++ E+ ++ ++ + Y + ++HRD+K N+L + G+IKL DFG
Sbjct: 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN-- 442
S M ++ G+ Y +PE G Y +SD+WS+G+ L M + P P+
Sbjct: 152 SGQL-IDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 443 -LAVLKQRILFGKFRI-----------------------------------------PFY 460
L ++ + G
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269
Query: 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
S E ++ + L+ +PA+R L Q+ H ++
Sbjct: 270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 9e-66
Identities = 55/237 (23%), Positives = 103/237 (43%), Gaps = 13/237 (5%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K+++ + L+ EV ++ H +I+ T L +VT++ G
Sbjct: 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSS 89
Query: 325 IFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ HL I + + + RQ + Y HA +++HRD+K+ N+ E+ +K+ DFG
Sbjct: 90 LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 384 FSNYFTPG---HMLTTWCGSPPYAAPELFGGREYD--GTKSDVWSLGVVLYVMVTAQLPF 438
+ + H GS + APE+ ++ + +SDV++ G+VLY ++T QLP+
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209
Query: 439 DGPNLAVLKQRILFGKFRIPFY------MSAECENLIRSMLVLDPAKRLTLTQISNH 489
N ++ + P + L+ L +R QI
Sbjct: 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 9e-64
Identities = 71/232 (30%), Positives = 118/232 (50%), Gaps = 5/232 (2%)
Query: 266 KVAIKIIDKKR-LDERNLRKLFREVDIMSH-LDHPHIIKLFQVMETTNNLYLVTEYARGG 323
AIK + K L + ++ E ++S +HP + +F +T NL+ V EY GG
Sbjct: 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88
Query: 324 EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
++ H+ + + A+ +I+ + + H+ +V+RD+K +N+L D++G IK+ADFG
Sbjct: 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148
Query: 384 FSNYFTPGH-MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN 442
G T+CG+P Y APE+ G++Y+ D WS GV+LY M+ Q PF G +
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 443 LAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLT-QISNHKWMS 493
L I P ++ E ++L+ + V +P KRL + I H
Sbjct: 208 EEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 210 bits (536), Expect = 6e-63
Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 13/248 (5%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERNLRKLF----REVDIMSHLDHPHIIKLFQVMETTNNL 313
+ + A+K +DKKR+ + L + ++S D P I+ + T + L
Sbjct: 23 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82
Query: 314 YLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373
+ + GG++ HL G +E + +I+ + + H VV+RD+K N+L DE
Sbjct: 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 142
Query: 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
+G ++++D G + F+ G+ Y APE+ + +D +SLG +L+ ++
Sbjct: 143 HGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201
Query: 434 AQLPFDGPN---LAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTL-----TQ 485
PF + + L +P S E +L+ +L D +RL +
Sbjct: 202 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 261
Query: 486 ISNHKWMS 493
+ +
Sbjct: 262 VKESPFFR 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 208 bits (531), Expect = 8e-63
Identities = 65/234 (27%), Positives = 121/234 (51%), Gaps = 9/234 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
A+K++ K+ + + E ++S + HP II+++ + ++++ +Y GGE
Sbjct: 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+FS L + A ++ A+ Y H+ ++++RD+K EN+L D+NG IK+ DFGF
Sbjct: 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
+ Y + T CG+P Y APE+ + Y+ D WS G+++Y M+ PF N
Sbjct: 151 AKYV--PDVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTM 207
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMS 493
++IL + R P + + + ++L+ ++ D ++RL + NH W
Sbjct: 208 KTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-62
Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 13/239 (5%)
Query: 266 KVAIKIIDKKRLDERN----LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYAR 321
+ A K I K+R + REV I+ + HP++I L +V E ++ L+ E
Sbjct: 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 322 GGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD----I 377
GGE+F L + E+EA+ +QIL+ V Y H+ + H D+K EN++ + I
Sbjct: 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437
K+ DFG ++ G+ G+P + APE+ ++D+WS+GV+ Y++++ P
Sbjct: 157 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASP 215
Query: 438 FDGPNLAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
F G + + SA ++ IR +LV DP KR+T+ H W+
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-62
Identities = 93/278 (33%), Positives = 142/278 (51%), Gaps = 28/278 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETT----NNLYLVTEYA 320
K A+K++ K REV++ PHI+++ V E L +V E
Sbjct: 39 KFALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91
Query: 321 RGGEIFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD---ENG 375
GGE+FS + G E+EAS + + I A+ Y H+ N+ HRD+K ENLL+ N
Sbjct: 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151
Query: 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435
+KL DFGF+ T + LTT C +P Y APE+ G +YD D+WSLGV++Y+++
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGY 210
Query: 436 LPFDGPN----LAVLKQRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQIS 487
PF + +K RI G++ P +S E + LIR++L +P +R+T+T+
Sbjct: 211 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
Query: 488 NHKWM--SVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQ 523
NH W+ S P P+ + V E K V ++M
Sbjct: 271 NHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 308
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-61
Identities = 80/248 (32%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 266 KVAIKIIDKKRLDER----NLRKLFREVDIMSHLDHPH--IIKLFQVMETTNNLYLVTEY 319
VAIK ++K R+ + N ++ EV ++ + +I+L E ++ L+ E
Sbjct: 31 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90
Query: 320 ARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-GDI 377
+ +T G + E+ A F Q+L AV +CH V+HRDIK EN+L D N G++
Sbjct: 91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437
KL DFG T + G+ Y+ PE Y G + VWSLG++LY MV +P
Sbjct: 151 KLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
Query: 438 FDGPNLAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM-SVHC 496
F+ I+ G+ +S+EC++LIR L L P+ R T +I NH WM V
Sbjct: 210 FEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263
Query: 497 PGDPVIVN 504
P + ++
Sbjct: 264 PQETAEIH 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 6e-61
Identities = 78/235 (33%), Positives = 124/235 (52%), Gaps = 8/235 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
A+KI+ K+ + ++ E ++ + HP + L +T + L V EYA GGE
Sbjct: 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+F HL E+ A +I+SA+ Y H+ +VV+RDIK ENL+ D++G IK+ DFG
Sbjct: 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 385 S-NYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
+ G + T+CG+P Y APE+ +Y D W LGVV+Y M+ +LPF +
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 444 AVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMS 493
L + IL + R P +S E ++L+ +L DP +RL ++ H++
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-60
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 8/227 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+KI+ + D +L E ++M LD+P+I+++ + E + LV E A G +
Sbjct: 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPL 94
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+L + +K L Q+ + Y +N VHRD+ A N+L K++DFG S
Sbjct: 95 NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 154
Query: 386 NYFTPGHML----TTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDG 440
T + APE ++ +KSDVWS GV+++ + Q P+ G
Sbjct: 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRG 213
Query: 441 PNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ + + G+ P E +L+ D R +
Sbjct: 214 MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-59
Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 12/229 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV-METTNNLYLVTEYARGGE 324
KVA+K I + E +M+ L H ++++L V +E LY+VTEY G
Sbjct: 32 KVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87
Query: 325 IFSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ +L + G+ + + + A+ Y NN VHRD+ A N+L E+ K++DF
Sbjct: 88 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
Query: 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGP 441
G + + T + APE +++ TKSDVWS G++L+ + + ++P+
Sbjct: 148 GLTKEASSTQ--DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 442 NLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
L + R+ G K P ++++ LD A R + Q+
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-58
Identities = 69/275 (25%), Positives = 105/275 (38%), Gaps = 32/275 (11%)
Query: 266 KVAIKIIDKKRLDERN---LRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARG 322
VAIK I E R RE+ ++ L HP+II L +N+ LV ++
Sbjct: 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ L + Y H + ++HRD+K NLL DENG +KLADF
Sbjct: 85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 144
Query: 383 GFSNYFTPGHMLTTW-CGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG- 440
G + F + T + Y APEL G G D+W++G +L ++ G
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204
Query: 441 ---------------------PNLAVLKQRILFGKF------RIPFYMSAECENLIRSML 473
P++ L + F F I + +LI+ +
Sbjct: 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264
Query: 474 VLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPS 508
+ +P R+T TQ K+ S P P P+
Sbjct: 265 LFNPCARITATQALKMKYFSNRPGPTPGCQLPRPN 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-57
Identities = 48/229 (20%), Positives = 106/229 (46%), Gaps = 9/229 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK+I + + E E +M +L H +++L+ V ++++TEY G +
Sbjct: 30 DVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 326 FSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
++L + ++ + + + A+ Y + +HRD+ A N L ++ G +K++DFG
Sbjct: 87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 146
Query: 385 SNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGP 441
S Y ++ PE+ ++ +KSD+W+ GV+++ + + ++P++
Sbjct: 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 442 NLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ + I G + P S + ++ S +R T + ++
Sbjct: 206 TNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-57
Identities = 66/291 (22%), Positives = 109/291 (37%), Gaps = 54/291 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT--------NNLYLVT 317
KVA+K + + E RE+ I+ L H +++ L ++ T ++YLV
Sbjct: 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 318 EYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
++ + + E R+ + +L+ + Y H N ++HRD+KA N+L +G +
Sbjct: 97 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 156
Query: 378 KLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432
KLADFG + F+ + T + Y PEL G G D+W G ++ M
Sbjct: 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216
Query: 433 TAQLPFDGPNLAVLKQRILFGKFRIP--------------------------------FY 460
T G I I +
Sbjct: 217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV 276
Query: 461 MSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPK 511
+LI +LVLDPA+R+ NH + +P+PS+ K
Sbjct: 277 RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW---------SDPMPSDLK 318
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 191 bits (485), Expect = 1e-56
Identities = 70/257 (27%), Positives = 107/257 (41%), Gaps = 30/257 (11%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
A+K I ++ DE RE+ I+ L H +I+KL+ V+ T L LV E+
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ G + A Q+L+ +AYCH V+HRD+K +NLL + G++K+ADFG +
Sbjct: 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
Query: 386 NYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
F P T + Y AP++ G + T D+WS+G + MV F G + A
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
Query: 445 VLKQRILFGKF-----------------------------RIPFYMSAECENLIRSMLVL 475
RI + +L+ ML L
Sbjct: 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267
Query: 476 DPAKRLTLTQISNHKWM 492
DP +R+T Q H +
Sbjct: 268 DPNQRITAKQALEHAYF 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-56
Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 13/244 (5%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK++ K+ ++ + ++ RE IM LD+P+I++L V + L LV E A GG +
Sbjct: 39 VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLH 96
Query: 327 SHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
L+ ++ + L Q+ + Y N VHRD+ A N+L K++DFG S
Sbjct: 97 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 156
Query: 386 NYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDG 440
+ + APE R++ ++SDVWS GV ++ ++ Q P+
Sbjct: 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 441 PNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQIS---NHKWMSVHC 496
+ I GK P E L+ + R + + S+
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 497 PGDP 500
+
Sbjct: 276 KVEG 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 189 bits (482), Expect = 2e-56
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 14/243 (5%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNN----LYLVTEYA 320
VA+K++ + + F RE + L+HP I+ ++ E Y+V EY
Sbjct: 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93
Query: 321 RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
G + + T G M K A + A+ + H N ++HRD+K N++ +K+
Sbjct: 94 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVM 153
Query: 381 DFGFSNYF----TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
DFG + G+ Y +PE G D +SDV+SLG VLY ++T +
Sbjct: 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEP 212
Query: 437 PFDGPNLAVLKQRILFGKFRIPFY----MSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492
PF G + + + + P +SA+ + ++ L +P R +
Sbjct: 213 PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
Query: 493 SVH 495
VH
Sbjct: 273 RVH 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 5e-56
Identities = 79/234 (33%), Positives = 130/234 (55%), Gaps = 9/234 (3%)
Query: 266 KVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
A+KI+DK+++ + + E I+ ++ P ++KL + +NLY+V EY GGE
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+FSHL IG+ +E A QI+ Y H+ ++++RD+K ENLL D+ G I++ DFGF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 385 SNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLA 444
+ T CG+P APE+ + Y+ D W+LGV++Y M PF
Sbjct: 188 AKRVK--GRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 445 VLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMS 493
+ ++I+ GK R P + S++ ++L+R++L +D KR + I NHKW +
Sbjct: 245 QIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-56
Identities = 73/310 (23%), Positives = 124/310 (40%), Gaps = 50/310 (16%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET------TNNLYLVTEY 319
KVAIK + + E ++ +RE+ ++ H+ H ++I L V + YLV +
Sbjct: 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104
Query: 320 ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
G L+ ++ E L Q+L + Y HA ++HRD+K NL +E+ ++K+
Sbjct: 105 M--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162
Query: 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439
DFG + +T + + Y APE+ D+WS+G ++ M+T + F
Sbjct: 163 LDFGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 440 GPNLAVLKQRILFGKFRIPFYM-------------------------------SAECENL 468
G + + I+ P S NL
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 469 IRSMLVLDPAKRLTLTQISNHKWM-SVHCPGDPVIVNPVPSEPKLPNSF--VIDQMLQLP 525
+ MLVLD +R+T + H + S+H D P K +SF V + +
Sbjct: 281 LEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE------PQVQKYDDSFDDVDRTLDEWK 334
Query: 526 ALTRNRILEF 535
+T +L F
Sbjct: 335 RVTYKEVLSF 344
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 76/259 (29%), Positives = 114/259 (44%), Gaps = 31/259 (11%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYA-RGGE 324
VA+K I E RE+ ++ L+HP+I+KL V+ T N LYLV E+ + +
Sbjct: 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
F + + Q+L +A+CH++ V+HRD+K +NLL + G IKLADFG
Sbjct: 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148
Query: 385 SNYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL 443
+ F P T + Y APE+ G +Y T D+WSLG + MVT + F G +
Sbjct: 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 444 AVLKQRIL-----------FGKFRIPFY------------------MSAECENLIRSMLV 474
RI G +P Y + + +L+ ML
Sbjct: 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268
Query: 475 LDPAKRLTLTQISNHKWMS 493
DP KR++ H +
Sbjct: 269 YDPNKRISAKAALAHPFFQ 287
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 2e-55
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 11/232 (4%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIF 326
VAIK + K E+ R E IM DHP++I L V+ + + ++TE+ G +
Sbjct: 57 VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 115
Query: 327 SHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
S L GQ + + R I + + Y N VHRD+ A N+L + N K++DFG S
Sbjct: 116 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 386 NYFTPGHMLTT------WCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
+ T + APE R++ + SDVWS G+V++ +++ + P+
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPY 234
Query: 439 DGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ I + P + L+ D R QI N
Sbjct: 235 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 53/254 (20%), Positives = 105/254 (41%), Gaps = 32/254 (12%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+VA+K++ K++ D L E+ +M+ L H +I+ L + +YL+ EY G+
Sbjct: 69 QVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 325 IFSHL-----------------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVH 361
+ ++L + + ++ Q+ + + + VH
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187
Query: 362 RDIKAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTK 418
RD+ A N+L +K+ DFG + + + APE Y K
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IK 246
Query: 419 SDVWSLGVVLYVMVTA-QLPFDGPNLAVLKQRILFGKFR--IPFYMSAECENLIRSMLVL 475
SDVWS G++L+ + + P+ G + +++ F+ PFY + E +++S
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 476 DPAKRLTLTQISNH 489
D KR + +++
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 73/243 (30%), Positives = 117/243 (48%), Gaps = 15/243 (6%)
Query: 266 KVAIKIIDKKRL--DERNLRKLFREVDIMSHLDH-PHIIKLFQVMETTNNLYLVTEYARG 322
A+K++ K + + E ++ H+ P ++ L +T L+L+ +Y G
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
GE+F+HL + E E +I+ A+ + H +++RDIK EN+L D NG + L DF
Sbjct: 114 GELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173
Query: 383 GFSNYFTP--GHMLTTWCGSPPYAAPE-LFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439
G S F +CG+ Y AP+ + GG D WSLGV++Y ++T PF
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
Query: 440 GPN----LAVLKQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHK 490
A + +RIL + P MSA ++LI+ +L+ DP KRL +I H
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293
Query: 491 WMS 493
+
Sbjct: 294 FFQ 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-54
Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 9/229 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
KVAIK I + + E + E ++M L HP +++L+ V + LV E+ G +
Sbjct: 31 KVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87
Query: 326 FSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
+L T G A + + + +AY V+HRD+ A N L EN IK++DFG
Sbjct: 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
Query: 385 SNYFTPGHMLTTWC--GSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGP 441
+ + ++ +A+PE+F Y +KSDVWS GV+++ + + ++P++
Sbjct: 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 442 NLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ + + + I G + P S ++ P R +++
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 68/314 (21%), Positives = 118/314 (37%), Gaps = 45/314 (14%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTN-----NLYLVTEYA 320
+VAIK I + ++ RE+ I+ H +II + ++ ++YLVT
Sbjct: 35 RVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93
Query: 321 RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
G LL ++ QIL + Y H+ NV+HRD+K NLL + D+K+
Sbjct: 94 --GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151
Query: 381 DFGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQL 436
DFG + P H LT + + Y APE+ + D+WS+G +L M++ +
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211
Query: 437 PFDGPNLAVLKQRILFGKF-------------------------------RIPFYMSAEC 465
F G + IL R+ ++
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
Query: 466 ENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLP 525
+L+ ML +P KR+ + Q H ++ + + P + + + + L+
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLK-- 329
Query: 526 ALTRNRILEFDDNL 539
L F
Sbjct: 330 ELIFEETARFQPGY 343
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 11/230 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLF-REVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K + L + F REV+ M LDH ++I+L+ V+ T + +VTE A G
Sbjct: 38 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGS 96
Query: 325 IFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+ L G SR Q+ + Y + +HRD+ A NLL +K+ DFG
Sbjct: 97 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 384 FSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPF 438
M + APE R + SD W GV L+ M T Q P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPW 215
Query: 439 DGPNLAVLKQRILFGKFRIPF--YMSAECENLIRSMLVLDPAKRLTLTQI 486
G N + + +I R+P + N++ P R T +
Sbjct: 216 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-53
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 31/263 (11%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+K + DE RE+ ++ L H +I++L V+ + L LV E+
Sbjct: 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
G + + Q+L + +CH+ NV+HRD+K +NLL + NG++KLA+FG +
Sbjct: 89 KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
Query: 386 NYF-TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP-FDGPNL 443
F P + + Y P++ G + T D+WS G + + A P F G ++
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208
Query: 444 AVLKQRILFGKFRIPFY-----------------------------MSAECENLIRSMLV 474
+RI ++A +L++++L
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 475 LDPAKRLTLTQISNHKWMSVHCP 497
+P +R++ + H + S CP
Sbjct: 269 CNPVQRISAEEALQHPYFSDFCP 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-53
Identities = 64/243 (26%), Positives = 98/243 (40%), Gaps = 21/243 (8%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGE 324
AIK + K+ + + R E++++ L HP+II L E LYL EYA G
Sbjct: 39 DAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 325 IFSHLL----------------TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368
+ L T ++ ++ + + Y +HRD+ A N
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157
Query: 369 LLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVL 428
+L EN K+ADFG S T + A E Y T SDVWS GV+L
Sbjct: 158 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLL 216
Query: 429 YVMVTA-QLPFDGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ +V+ P+ G A L +++ G + P E +L+R P +R + QI
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276
Query: 487 SNH 489
Sbjct: 277 LVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-53
Identities = 51/287 (17%), Positives = 111/287 (38%), Gaps = 21/287 (7%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK + ++ + +++ E +M+ +D+PH+ +L + T+ + G +
Sbjct: 40 PVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 98
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385
+ + QI + Y +VHRD+ A N+L +K+ DFG +
Sbjct: 99 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
Query: 386 NYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGP 441
+ + A E R Y +SDVWS GV ++ ++T P+DG
Sbjct: 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 442 NLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH-------KWMS 493
+ + + G+ P + + ++ ++D R ++
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277
Query: 494 VHCPGDPVIVNPVPSEPKLPNSFVIDQMLQLPALTRNRILEFDDNLM 540
+ GD + P P++ + + ++ + +++ D+ L+
Sbjct: 278 LVIQGDERMHLPSPTDSNFYRALMDEE-------DMDDVVDADEYLI 317
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 70/303 (23%), Positives = 110/303 (36%), Gaps = 51/303 (16%)
Query: 258 AQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN----- 312
A+L + VAIK + + + + RE+ IM LDH +I++L ++
Sbjct: 39 AKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92
Query: 313 -LYLVTEYARGG---EIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368
L LV +Y + + Q+ ++AY H+ + HRDIK +N
Sbjct: 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152
Query: 369 LLFDENG-DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVV 427
LL D + +KL DFG + G ++ S Y APEL G + DVWS G V
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 428 LYVMVTAQLPFDGPNLAVLKQRIL-----------------FGKFRIPFY---------- 460
L ++ Q F G + I+ + +F+ P
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 461 --MSAECENLIRSMLVLDPAKRLTLTQISNHKWMS-VHCPGDPVIVNPVPSEPKLPNSFV 517
E L +L P RLT + H + + P +P+ P F
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV-----KLPNGRDTPALFN 327
Query: 518 IDQ 520
Sbjct: 328 FTT 330
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-52
Identities = 61/262 (23%), Positives = 110/262 (41%), Gaps = 37/262 (14%)
Query: 267 VAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPHIIKLFQVMETT-----NNLYLVTE 318
VA+K + + +E REV ++ HL +HP++++LF V + L LV E
Sbjct: 36 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE 95
Query: 319 YARGGEI-FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDI 377
+ + + + + + Q+L + + H++ VVHRD+K +N+L +G I
Sbjct: 96 HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 155
Query: 378 KLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLP 437
KLADFG + ++ LT+ + Y APE+ Y T D+WS+G + M +
Sbjct: 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPL 214
Query: 438 FDGPNLAVLKQRILFGKF---------------------------RIPFYMSAECENLIR 470
F G + +IL + + ++L+
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274
Query: 471 SMLVLDPAKRLTLTQISNHKWM 492
L +PAKR++ +H +
Sbjct: 275 KCLTFNPAKRISAYSALSHPYF 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 11/228 (4%)
Query: 265 SKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGE 324
+KVA+K + + + E ++M L H +++L+ V+ T +Y++TEY G
Sbjct: 38 TKVAVKSLKQGSMSPDAFL---AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGS 93
Query: 325 IFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382
+ L T ++ + + QI +A+ N +HRD++A N+L + K+ADF
Sbjct: 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 383 GFSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFD 439
G + + APE + KSDVWS G++L +VT ++P+
Sbjct: 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYP 212
Query: 440 GPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
G + Q + G + P E L+R P R T +
Sbjct: 213 GMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 2e-52
Identities = 64/309 (20%), Positives = 128/309 (41%), Gaps = 48/309 (15%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET-----TNNLYLVTEYA 320
+VA+K + + + ++ +RE+ ++ H+ H ++I L V N + +
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 321 RGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380
G ++ +++ ++ + L QIL + Y H+ +++HRD+K NL +E+ ++K+
Sbjct: 105 MGADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDG 440
DFG + + +T + + Y APE+ + D+WS+G ++ ++T + F G
Sbjct: 164 DFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 441 PNLAVLKQRILFGKFRIPFYM-------------------------------SAECENLI 469
+ + IL + + +L+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 470 RSMLVLDPAKRLTLTQISNHKWMS-VHCPGDPVIVNPVPSEPKLPNSFVIDQML--QLPA 526
MLVLD KR+T Q H + + H P D P SF +L + +
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDE------PVADPYDQSFESRDLLIDEWKS 335
Query: 527 LTRNRILEF 535
LT + ++ F
Sbjct: 336 LTYDEVISF 344
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 11/227 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK + + +E +M L H +++L+ V+ + +Y+VTEY G +
Sbjct: 43 RVAIKTLKPGTMSPEAFL---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSL 98
Query: 326 FSHLL--TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
L T + + + QI S +AY N VHRD++A N+L EN K+ADFG
Sbjct: 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158
Query: 384 FSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDG 440
+ + APE + KSDVWS G++L + T ++P+ G
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPG 217
Query: 441 PNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ ++ G + P +L+ +P +R T +
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (452), Expect = 7e-52
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 10/227 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+K + + ++ +E +M + HP++++L V Y++TE+ G +
Sbjct: 44 TVAVKTLKEDTMEVEEFL---KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 326 FSHLLTIGQ--MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+L + ++ + QI SA+ Y N +HRD+ A N L EN +K+ADFG
Sbjct: 101 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 384 FSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDG 440
S T + APE ++ KSDVW+ GV+L+ + T P+ G
Sbjct: 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 441 PNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+L+ + + + + P + L+R+ +P+ R + +I
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 1e-50
Identities = 62/250 (24%), Positives = 97/250 (38%), Gaps = 31/250 (12%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VA+K++ K+ RE +M+ D+P+I+KL V + L+ EY G++
Sbjct: 45 MVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103
Query: 326 FSHLLTIGQ------------------------MAEKEASRLFRQILSAVAYCHANNVVH 361
L ++ ++ E + RQ+ + +AY VH
Sbjct: 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163
Query: 362 RDIKAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTK 418
RD+ N L EN +K+ADFG S + PE Y T+
Sbjct: 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TE 222
Query: 419 SDVWSLGVVLYVMVTAQL-PFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLD 476
SDVW+ GVVL+ + + L P+ G + + G P E NL+R
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKL 282
Query: 477 PAKRLTLTQI 486
PA R + I
Sbjct: 283 PADRPSFCSI 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-50
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 8/229 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK K + K +E M DHPHI+KL V+ T N ++++ E GE+
Sbjct: 37 AVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL 94
Query: 326 FSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
S L + Q+ +A+AY + VHRDI A N+L N +KL DFG
Sbjct: 95 RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154
Query: 385 SNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGP 441
S Y + + + APE R + SDVW GV ++ ++ PF G
Sbjct: 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 442 NLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ RI G + +P +L+ DP++R T++
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 24/243 (9%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGE 324
KVA+K++ K E++L L E+++M + H +II L LY++ EYA G
Sbjct: 47 KVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 325 IFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAEN 368
+ +L Q++ K+ Q+ + Y + +HRD+ A N
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165
Query: 369 LLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLG 425
+L E+ +K+ADFG + T + APE R Y +SDVWS G
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFG 224
Query: 426 VVLYVMVTA-QLPFDGPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTL 483
V+L+ + T P+ G + L + + G + P + E ++R P++R T
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 484 TQI 486
Q+
Sbjct: 285 KQL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-49
Identities = 49/233 (21%), Positives = 97/233 (41%), Gaps = 11/233 (4%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV-METTNNLYLVTEYARGGE 324
A+K +++ D + + E IM HP+++ L + + + + +V Y + G+
Sbjct: 57 HCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 325 IFSHLLTIGQ-MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383
+ + + K+ Q+ + + + VHRD+ A N + DE +K+ADFG
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 384 FSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLP 437
+ H T + A E +++ TKSDVWS GV+L+ ++T P
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPP 234
Query: 438 FDGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ N + +L G+ P Y ++ R + +++ +
Sbjct: 235 YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 9/228 (3%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
VAIK + K E+ E IM H +II+L V+ + ++TEY G +
Sbjct: 38 PVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 96
Query: 326 FSHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384
L G+ + + + R I + + Y N VHRD+ A N+L + N K++DFG
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156
Query: 385 SNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD- 439
S + + + APE R++ + SDVWS G+V++ ++T
Sbjct: 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYW 215
Query: 440 GPNLAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQI 486
+ + + I G + P + L+ + A+R I
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-48
Identities = 49/245 (20%), Positives = 95/245 (38%), Gaps = 25/245 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVMETTNNLYLVTEYARGGE 324
VA+K++ L E+ ++S+L +H +I+ L ++TEY G+
Sbjct: 55 TVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 325 IFSHL------------------LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366
+ + L + ++ Q+ +A+ + N +HRD+ A
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173
Query: 367 ENLLFDENGDIKLADFGFSNYFTPG--HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSL 424
N+L K+ DFG + +++ P +SDVWS
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 425 GVVLYVMVTAQLP-FDGPNLAVLKQRILFGKFR--IPFYMSAECENLIRSMLVLDPAKRL 481
G+ L+ + + + G + +++ FR P + AE +++++ DP KR
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
Query: 482 TLTQI 486
T QI
Sbjct: 294 TFKQI 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 67/327 (20%), Positives = 131/327 (40%), Gaps = 65/327 (19%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQV------METTNNLYLVTEY 319
VAIK + + ++ + ++ +RE+ +M ++H +II L V +E ++YLV E
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 320 ARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379
++ + S L Q+L + + H+ ++HRD+K N++ + +K+
Sbjct: 104 MDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD 439
DFG + M+T + + Y APE+ G Y D+WS+G ++ MV ++ F
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFP 219
Query: 440 GPNLAVLKQRILFGKFRIP----------------------------------------- 458
G + +++
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 459 -FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHCPGDPVIVNPVPSEPKLPNSFV 517
+++ +L+ MLV+DPAKR+++ H +++V P+E + P +
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW---------YDPAEVEAPPPQI 330
Query: 518 IDQMLQLPALTRNRILEFDDNLMETEI 544
D+ L T E L+ E+
Sbjct: 331 YDKQLDEREHTIEEWKE----LIYKEV 353
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (415), Expect = 3e-46
Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 50/268 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKLFQVME--TTNNLYLVTEYARG 322
KV +KI+ + +K+ RE+ I+ +L P+II L +++ + LV E+
Sbjct: 62 KVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116
Query: 323 GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD-ENGDIKLAD 381
+ + + + +IL A+ YCH+ ++HRD+K N++ D E+ ++L D
Sbjct: 117 TDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 173
Query: 382 FGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP 441
+G + ++ PG S + PEL + D+WSLG +L M+ + PF
Sbjct: 174 WGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
Query: 442 N----LAVLKQRILFGKFRIPF----------------------------------YMSA 463
+ V ++L + + +S
Sbjct: 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 464 ECENLIRSMLVLDPAKRLTLTQISNHKW 491
E + + +L D RLT + H +
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-45
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 48/265 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN----LYLVTEYAR 321
+VA+KI + E+ L H +I+ N L+LV++Y
Sbjct: 28 EVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 322 GGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA--------NNVVHRDIKAENLLFDE 373
G +F +L + + +L S +A+ H + HRD+K++N+L +
Sbjct: 85 HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 374 NGDIKLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYD-----GTKSDVWS 423
NG +AD G + G+ Y APE+ ++D+++
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 424 LGVVLYVMVTAQLPFDG---------------PNLAVLKQRILFGKFRIPF---YMSAEC 465
+G+V + + P++ +++ + K R + S E
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263
Query: 466 E----NLIRSMLVLDPAKRLTLTQI 486
++R + A RLT +I
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRI 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 17/239 (7%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK + + R + E +M + H+++L V+ ++ E G++
Sbjct: 52 RVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110
Query: 326 FSHLLTIGQ----------MAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375
S+L ++ + + ++ +I +AY +AN VHRD+ A N + E+
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170
Query: 376 DIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432
+K+ DFG + + +PE + T SDVWS GVVL+ +
Sbjct: 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIA 229
Query: 433 T-AQLPFDGPNLAVLKQRILFGKFR-IPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
T A+ P+ G + + + ++ G P L+R +P R + +I +
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 3e-44
Identities = 47/241 (19%), Positives = 80/241 (33%), Gaps = 25/241 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNN-LYLVTEYARGGE 324
+VAIK+ K + L E I + I + + +V E
Sbjct: 34 EVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL 89
Query: 325 IFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF---DENGDIKLAD 381
+ + K L Q++S + Y H+ N +HRD+K +N L + + + D
Sbjct: 90 EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 149
Query: 382 FGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT 433
FG + + G+ YA+ G E + D+ SLG VL
Sbjct: 150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNL 208
Query: 434 AQLPFDGPNLAVLKQRIL---FGKFRIPF-----YMSAECENLIRSMLVLDPAKRLTLTQ 485
LP+ G A +Q+ K P +E + L + +
Sbjct: 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY 268
Query: 486 I 486
+
Sbjct: 269 L 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-42
Identities = 59/289 (20%), Positives = 108/289 (37%), Gaps = 39/289 (13%)
Query: 238 DLSQWE---GMYELKKK----------KEEAAAAQLIEELSKVAIKIIDKKRLDERNLRK 284
D S+WE +L K + +A VA+K++ K+ R
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA 62
Query: 285 LFREVDIMSHLDHPHIIKLFQ--VMETTNNLYLVTEYARGGEIFSHL------------- 329
L E+ I+ H+ H + + L ++ E+ + G + ++L
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 330 ---LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSN 386
L + + Q+ + + + +HRD+ A N+L E +K+ DFG +
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 387 YFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442
+ APE R Y +SDVWS GV+L+ + + P+ G
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 443 LAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489
+ R L + R P Y + E + +P++R T +++ H
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (382), Expect = 7e-42
Identities = 48/242 (19%), Positives = 82/242 (33%), Gaps = 25/242 (10%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEI 325
+VAIK +R D LR +R +++ I ++ + + LV +
Sbjct: 32 QVAIKFE-PRRSDAPQLRDEYRTYKLLAG--CTGIPNVYYFGQEGLHNVLVIDLLGPSLE 88
Query: 326 FSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-----NGDIKLA 380
L + + K + +Q+L+ V H ++V+RDIK +N L I +
Sbjct: 89 DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148
Query: 381 DFGFSNYF--------TPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMV 432
DFG ++ P G+ Y + GRE + D+ +LG V +
Sbjct: 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFL 207
Query: 433 TAQLPFDG---PNLAVLKQRILFGKFRIPF-----YMSAECENLIRSMLVLDPAKRLTLT 484
LP+ G +RI K P E + L
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267
Query: 485 QI 486
+
Sbjct: 268 YL 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (313), Expect = 6e-32
Identities = 54/320 (16%), Positives = 109/320 (34%), Gaps = 80/320 (25%)
Query: 266 KVAIKIIDKKRLDERNLRKLFREVDIMSHLDHP-----------HIIKLFQVMET--TNN 312
VA+KI+ ++ E+ ++ ++ HI+KL N
Sbjct: 40 HVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96
Query: 313 LYLVTEYARGGEIFSHLLTIGQ---MAEKEASRLFRQILSAVAYCHAN-NVVHRDIKAEN 368
+++V + GE L+ + + ++ +Q+L + Y H ++H DIK EN
Sbjct: 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156
Query: 369 LLFDENG------DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVW 422
+L + IK+AD G + ++ + + Y +PE+ G + +D+W
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYT--NSIQTREYRSPEVLLGAPWG-CGADIW 213
Query: 423 SLGVVLYVMVTAQLPFDGPNLAVL------------------------------------ 446
S +++ ++T F+
Sbjct: 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273
Query: 447 ------------KQRILFGKFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494
+ +L K++ + E + + ML LDP KR + NH W+
Sbjct: 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333
Query: 495 HCPGDPVIVNPVPSEPKLPN 514
+ + VP +
Sbjct: 334 TLGMEEI---RVPDRELYGS 350
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 27/182 (14%), Positives = 56/182 (30%), Gaps = 33/182 (18%)
Query: 266 KVAIKIIDKKRLDERNLRKLF----------------REVDIMSHLDHPHIIKLFQVMET 309
+ +K + +++ E + L + K++
Sbjct: 26 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85
Query: 310 TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369
++ E E++ ++ + + IL VA + +VH D+ N+
Sbjct: 86 ----AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 134
Query: 370 LFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429
L E G I + DF S G + R Y T+ D+ S +
Sbjct: 135 LVSEEG-IWIIDFPQSV--EVGEEGWREILERDVRNIITYFSRTY-RTEKDINS--AIDR 188
Query: 430 VM 431
++
Sbjct: 189 IL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 635 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-58 Score=467.32 Aligned_cols=255 Identities=32% Similarity=0.584 Sum_probs=233.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
++.|.+++.||+|+||+||+|.++ .++..||||++.+.... ......+.+|+.+|++++|||||+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 70 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK--------------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC--------------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCe
Confidence 346888999999999999999873 35678999999765432 223467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.+.+.+|||||||++|+|.+++.+...+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 71 ~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeeccc
Confidence 99999999999999999999999999999899999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
|+|...... .....+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+...+...+....+.+|..+|
T Consensus 151 G~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 228 (263)
T d2j4za1 151 GWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 228 (263)
T ss_dssp CSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSC
T ss_pred ceeeecCCC-cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCC
Confidence 999876543 34567899999999999998886 9999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
+++++||.+||+.||.+|||++|||+||||+.
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=463.89 Aligned_cols=257 Identities=32% Similarity=0.526 Sum_probs=219.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||+||+|.++ .++..||||++...... ...+.+.+|+.+|++|+|||||++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~--------------~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~ 68 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR--------------VTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKF 68 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeE
Confidence 456889999999999999999873 35678999999766432 334678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.+.+.+|||||||++|+|.++|.....+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 69 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp EEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccch
Confidence 99999999999999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCccCC--
Q psy6357 384 FSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV-LKQRILFGKFRI-- 457 (635)
Q Consensus 384 la~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~-l~~~i~~~~~~~-- 457 (635)
+|...... ......+||+.|||||++.+..+++.++||||||||||+|++|.+||....... ....+.......
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 99876432 235567899999999999988876688999999999999999999997755432 223333222222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 458 PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 458 p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
...+|+++.+||.+||+.||++|||++|||+||||+..
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 24589999999999999999999999999999999743
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=461.80 Aligned_cols=255 Identities=26% Similarity=0.458 Sum_probs=225.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.++++||+|+||+||+|.+. .+++.||||++....... .+.+.+|+.+|++++|||||++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~--------------~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~ 82 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV--------------ATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNY 82 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT--------------TTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccEEEEEEecCcCcEEEEEEEC--------------CCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeE
Confidence 357999999999999999999872 456799999998664432 3678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
+++|.+.+.+|||||||++|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccch
Confidence 9999999999999999999999987755 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---ccCCCC
Q psy6357 384 FSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG---KFRIPF 459 (635)
Q Consensus 384 la~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~---~~~~p~ 459 (635)
+|..+... ......+||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+.......+... .+..|.
T Consensus 162 ~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (293)
T ss_dssp TCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGG
T ss_pred hheeeccccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 99877543 445677899999999999998886 8999999999999999999999988876666555543 234556
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
.+|.++++||.+||..||.+|||++|||+||||+...
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 7999999999999999999999999999999997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=461.51 Aligned_cols=256 Identities=29% Similarity=0.515 Sum_probs=229.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
...|.+++.||+|+||+||+|.+. .++..||||++.+... .....+.+.+|+.+|++|+|||||+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 72 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLAREL--------------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCC
T ss_pred CCCCEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeE
Confidence 356888999999999999999873 3567899999976543 2234467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++|.+.+.+|||||||++|+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+||
T Consensus 73 l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 383 GFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 383 Gla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
|+|..+... ....+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+...+.+.|....+.+|.
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 231 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc
Confidence 999876532 234567899999999999998886 8999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHH------HHcCccccc
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQ------ISNHKWMSV 494 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~e------iL~Hpw~~~ 494 (635)
.+++++++||.+||+.||.+|||++| |++||||+.
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999999999987 588999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=455.41 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=217.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+++.||+|+||+||++.++ .+++.||||++.....++...+.+.+|+++|++++|||||+++
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 69 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK--------------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEE
T ss_pred hhCEEeEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 46888999999999999999873 4567899999998877777788899999999999999999999
Q ss_pred EEEec--CCeEEEEEeccccchhhhhhhhc----ccCCHHHHHHHHHHHHHhhhhhccCc-----eeeecccCcceeecC
Q psy6357 305 QVMET--TNNLYLVTEYARGGEIFSHLLTI----GQMAEKEASRLFRQILSAVAYCHANN-----VVHRDIKAENLLFDE 373 (635)
Q Consensus 305 ~~~~~--~~~~~LV~E~~~ggsL~~~l~~~----~~l~e~~~~~i~~qIl~gL~~LHs~g-----IiHrDLKp~NILl~~ 373 (635)
+++.+ ...+|||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 70 ~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp EEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred EEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 99854 56789999999999999988643 46999999999999999999999876 999999999999999
Q ss_pred CCCeeeecccccccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 374 NGDIKLADFGFSNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
++.+||+|||+|..+... ......+||+.|||||++.+..|+ .++||||||||||||++|..||.+.+..++...+..
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~ 228 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228 (269)
T ss_dssp TSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 999999999999877543 344568899999999999988886 999999999999999999999999999999888887
Q ss_pred Ccc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccc
Q psy6357 453 GKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWM 492 (635)
Q Consensus 453 ~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~ 492 (635)
+.+ .+|..+|+++.+||.+||+.||.+|||++|||+|||+
T Consensus 229 ~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 765 4677899999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-55 Score=461.68 Aligned_cols=256 Identities=34% Similarity=0.573 Sum_probs=212.4
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+.+.|.+++.||+|+||+||+|.++ .+++.||||++.+..... ....+.+|+.+|++|+|||||+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~--------------~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~ 71 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDK--------------RTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVA 71 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEET--------------TTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCC
T ss_pred CccceEEEEEEeeccCeEEEEEEEC--------------CCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCc
Confidence 3466899999999999999999873 356789999998765433 2356789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec---CCCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD---ENGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~---~~~~ikL 379 (635)
+++++.+.+.+|||||||+|++|.++|...+.+++..+..|+.||+.||+|||+.||+||||||+|||+. .++.+||
T Consensus 72 l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEE
Confidence 9999999999999999999999999999988999999999999999999999999999999999999995 4789999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC-
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP- 458 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p- 458 (635)
+|||+|..........+.+||+.|||||++.+..|+ .++|||||||+||+|++|.+||.+.+...+...+......++
T Consensus 152 ~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 152 SDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230 (307)
T ss_dssp CCC------------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT
T ss_pred eccceeEEccCCCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence 999999988777677788999999999999998886 999999999999999999999999999999999988766554
Q ss_pred ---CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 459 ---FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 459 ---~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+|+++.+||.+||++||.+|||++|||+||||+.
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 468999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=466.03 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=236.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
.++.|.+++.||+|+||.||++.++ .++..||||++.+... .......+.+|+.+|++++|||||
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~--------------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 68 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREK--------------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBC
T ss_pred chHhcEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3456888999999999999999873 4567999999986543 223457788999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++|.+...+|||||||++|+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|
T Consensus 69 ~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 382 FGFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 382 FGla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
||+|+.... .......+||+.|||||++.+..|+ .++||||||||||||++|.+||.+.+...+.+.+....+.+|..
T Consensus 149 FG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~ 227 (337)
T d1o6la_ 149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227 (337)
T ss_dssp CTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred cccccccccCCcccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc
Confidence 999987643 4456678999999999999999886 99999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+|+++++||.+||++||.+|++ ++||++||||..
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999999999999994 999999999963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=456.51 Aligned_cols=252 Identities=32% Similarity=0.506 Sum_probs=221.8
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|.++++||+|+||+||+|.+. .++..||||++.... ....+.+.+|+++|++|+|||||++++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~--------------~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~ 76 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNK--------------ETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLD 76 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEEC--------------CCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5788999999999999999873 456789999997653 234567889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++.+.+.+|||||||++|+|.+++.+. +.+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp EEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechh
Confidence 999999999999999999999987654 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccC-----CCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFG-----GREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF--- 455 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~-----~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~--- 455 (635)
|...... ....+.+||+.|||||++. ...|+ .++|||||||+||+|++|.+||.+.+..++...+.....
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9765432 2345678999999999984 33444 899999999999999999999999888888888777643
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..|..+|+++.+||.+||+.||.+|||++|||+||||+.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 345578999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=446.12 Aligned_cols=254 Identities=22% Similarity=0.425 Sum_probs=220.1
Q ss_pred ccCCcc-ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 223 LLKPQY-NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 223 ~~~~y~-il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
...+|+ +.++||+|+||+||+|.+. .++..||||++..........+.+.+|+++|++|+|||||
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~--------------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv 71 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDT--------------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEEC--------------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCee
Confidence 344564 4568999999999999873 3567899999988777777778899999999999999999
Q ss_pred eEEEEEec----CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCc--eeeecccCcceeec-CC
Q psy6357 302 KLFQVMET----TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANN--VVHRDIKAENLLFD-EN 374 (635)
Q Consensus 302 ~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~g--IiHrDLKp~NILl~-~~ 374 (635)
+++++|++ ...+|||||||++|+|.+++.+...+++..++.|+.||+.||+|||+++ |+||||||+||||+ .+
T Consensus 72 ~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~ 151 (270)
T d1t4ha_ 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 151 (270)
T ss_dssp CEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT
T ss_pred eEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCC
Confidence 99999865 4568999999999999999999889999999999999999999999998 99999999999997 57
Q ss_pred CCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhC
Q psy6357 375 GDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGP-NLAVLKQRILFG 453 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~-~~~~l~~~i~~~ 453 (635)
+.+||+|||+|..... ......+||+.|||||++.+. ++ .++||||||||||+|++|..||.+. +...+...+..+
T Consensus 152 ~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~~-~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228 (270)
T ss_dssp SCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred CCEEEeecCcceeccC-CccCCcccCccccCHHHhCCC-CC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence 8999999999986543 345577899999999999764 65 9999999999999999999999765 455566666654
Q ss_pred cc--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 KF--RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ~~--~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
.. .++..+++++.+||.+||+.||++|||++|||+||||+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 33 34456899999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-55 Score=451.89 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=233.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCCCC
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLDHP 298 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~Hp 298 (635)
+.++|.++++||+|+||+||+|.++ .+++.||||++.+..... ...+.+.+|+.+|++|+||
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~--------------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~Hp 73 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREK--------------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET--------------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCT
T ss_pred cccCEEEeEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCC
Confidence 3467899999999999999999873 456789999997654422 2356788999999999999
Q ss_pred ceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC---
Q psy6357 299 HIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG--- 375 (635)
Q Consensus 299 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~--- 375 (635)
|||+++++|++...+|||||||++|+|.+++...+.+++..++.++.||+.||+|||+.+|+||||||+||||+.++
T Consensus 74 nIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSS
T ss_pred CCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcc
Confidence 99999999999999999999999999999999888999999999999999999999999999999999999998776
Q ss_pred -CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 376 -DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 376 -~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
.+||+|||+|..........+.+||+.|+|||++.+..++ .++|||||||+||+|++|..||.+.+..++...+....
T Consensus 154 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp CCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 5999999999988777777788999999999999988775 99999999999999999999999999999988888877
Q ss_pred cCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 455 FRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 455 ~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..++ ..+|.++++||.+||+.||.+|||++|||+||||+..
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 6654 4689999999999999999999999999999999743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.5e-55 Score=462.36 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=232.1
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
++++|.+++.||+|+||.||+|.+. .++..||||++.... ....+.+.+|+.+|++|+|||||+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~--------------~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~ 87 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTER--------------ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVN 87 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------------TTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCC
T ss_pred CccCeEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3568999999999999999999873 356789999997653 344577889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC--CCCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE--NGDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~--~~~ikL 379 (635)
++++|.+.+.+|||||||++|+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||
T Consensus 88 ~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL 167 (350)
T d1koaa2 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKL 167 (350)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEE
T ss_pred EEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEE
Confidence 99999999999999999999999999854 467999999999999999999999999999999999999964 578999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||+|..+.......+.+||+.|||||++.+..|+ .++||||||||+|+|++|..||.+.+..++...|....+.++.
T Consensus 168 ~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 246 (350)
T d1koaa2 168 IDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246 (350)
T ss_dssp CCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC
T ss_pred eecchheecccccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 999999988777777788999999999999998886 9999999999999999999999999999999999887766553
Q ss_pred ----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 ----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+|+++++||.+||..||.+|||+.|||+||||+..
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 589999999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.6e-55 Score=463.48 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=232.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
++.|.++++||+|+||+||+|.+. .++..||||++.+.. ......+.+|+.+|++|+|||||++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~--------------~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~ 91 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK--------------ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINL 91 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcE
Confidence 467999999999999999999873 456789999997653 3344678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeec--CCCCeeee
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFD--ENGDIKLA 380 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~--~~~~ikL~ 380 (635)
+++|++...+|||||||++|+|.+++.... +|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+
T Consensus 92 ~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp EEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEe
Confidence 999999999999999999999998876654 699999999999999999999999999999999999998 57899999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCC--
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIP-- 458 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p-- 458 (635)
|||+|..+.........+||+.|||||++.+..|+ .++|||||||+||+|++|.+||.+.+...+...+....+.+|
T Consensus 172 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 172 DFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250 (352)
T ss_dssp CCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred ecccceecCCCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 99999998877777888999999999999998886 999999999999999999999999999999999988877655
Q ss_pred --CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 --FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 --~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+|+++.+||.+||++||.+|||+.|||+||||+..
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 3589999999999999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=462.79 Aligned_cols=256 Identities=23% Similarity=0.423 Sum_probs=217.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.++++||+|+||+||+|.+. .++..||||+++... .......+.+|+.+|++++|||||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~--------------~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv 67 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHK--------------PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIV 67 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEET--------------TTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEEC--------------CCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCC
Confidence 34567899999999999999999872 456789999997654 334457889999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc-CceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
+++++|.+..++|||||||++|+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+
T Consensus 68 ~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp CEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred cEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEe
Confidence 9999999999999999999999999999998999999999999999999999997 599999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------------
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQ------------ 448 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~------------ 448 (635)
|||+|...... ...+.+||+.|||||++.+..|+ .++||||||||+|||++|+.||.+.+......
T Consensus 148 DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 148 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred eCCCccccCCC-ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 99999876432 34567999999999999998886 99999999999999999999997755322111
Q ss_pred ------------------------------HHHhCc-cCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 449 ------------------------------RILFGK-FRIP-FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 449 ------------------------------~i~~~~-~~~p-~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+.... ..+| ..+|.++.+||.+||++||.+|||++|+|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 011110 1111 136899999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-55 Score=456.14 Aligned_cols=254 Identities=28% Similarity=0.540 Sum_probs=233.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
++.|.++++||+|+||+||+|.++ .++..||||++.+... .....+.+.+|+.+|+.++|||||+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~--------------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~ 68 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR--------------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCC
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC--------------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhh
Confidence 356888999999999999999873 4567899999976543 2233567889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.+.+.+|+|||||.|++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 69 ~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCCC
Q psy6357 383 GFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYMS 462 (635)
Q Consensus 383 Gla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~s 462 (635)
|+|..... ...+.+||+.|||||++.+..|+ .++|||||||+||+|++|..||.+.+...+...+......+|..++
T Consensus 149 G~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 225 (316)
T d1fota_ 149 GFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 225 (316)
T ss_dssp SSCEECSS--CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ccceEecc--ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCC
Confidence 99987653 34567899999999999998886 8999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 463 AECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 463 ~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+++.+||.+||.+||.+|+ |+++||+||||+.
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 9999999999999999996 9999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-54 Score=453.50 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=224.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-HHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-ERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
+.|.++++||+|+||+||+|.+. .++..||||++...... ....+.+.+|+.+|++|+|||||++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~ 80 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV--------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred HhcEeeEEEecCCCeEEEEEEEC--------------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeE
Confidence 34888999999999999999873 35678999999876553 4556788999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++++.+.+.+|||||||.+++|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||
T Consensus 81 ~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecc
Confidence 99999999999999999999998888888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccCCCCCCCccccCCC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCC--C
Q psy6357 384 FSNYFTPGHMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRI--P 458 (635)
Q Consensus 384 la~~~~~~~~~~~~~gt~~Y~APEvl~~~---~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~--p 458 (635)
+|..... ....+||+.|||||++.+. .|+ .++|||||||++|||++|..||.+.+.......+.....+. +
T Consensus 161 ~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 161 SASIMAP---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236 (309)
T ss_dssp TCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred cccccCC---CCccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 9987643 3456899999999998643 354 89999999999999999999999988877777777665432 3
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+|+++++||.+||+.||.+|||++|||+||||...
T Consensus 237 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 4689999999999999999999999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-54 Score=459.12 Aligned_cols=256 Identities=32% Similarity=0.566 Sum_probs=234.7
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
..+++|.++++||+|+||.||+|.++ .+++.||||++.+... .....+.+.+|+.+|+.++||||
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~--------------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI 103 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHK--------------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB
T ss_pred CCccCeEEEEEeecCcCcEEEEEEEC--------------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcE
Confidence 34678999999999999999999873 4567899999976443 22345678899999999999999
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
|++++++.+...+|+||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++||||||||+||||+.++.+||+
T Consensus 104 v~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEee
Confidence 99999999999999999999999999999998999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFY 460 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~ 460 (635)
|||+|+.+.. ...+.+||+.|||||++.+..|+ .++||||||||||+|++|.+||.+.+...+...|....+.+|..
T Consensus 184 DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 260 (350)
T d1rdqe_ 184 DFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260 (350)
T ss_dssp CCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred eceeeeeccc--ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc
Confidence 9999987754 34567899999999999998886 99999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 461 MSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
+++++.+||.+||.+||.+|+ |+++||+||||..
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999999999999999999995 9999999999963
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-53 Score=440.21 Aligned_cols=257 Identities=30% Similarity=0.520 Sum_probs=230.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC-------HHHHHHHHHHHHHHhhCC
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD-------ERNLRKLFREVDIMSHLD 296 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~-------~~~~~~~~~Ei~iL~~L~ 296 (635)
.++|.++++||+|+||+||++.+. .+++.||||++.+.... ....+.+.+|+.+|++|.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~--------------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 67 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK--------------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccCEEceEEecCcCeEEEEEEEC--------------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc
Confidence 467999999999999999999873 35678999999875432 223456889999999997
Q ss_pred -CCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 297 -HPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 297 -HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
|||||++++++.+.+.+|||||||++++|.++|...+.+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC
Confidence 9999999999999999999999999999999999989999999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCC-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGG-----REYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~-----~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
.+||+|||++..+.........+||+.|+|||++.+ ....+.++||||||||||+|++|..||.+.+...+.+.+
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 999999999998877666777899999999999853 222358999999999999999999999999999888888
Q ss_pred HhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 451 LFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 451 ~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
..+...++. .+|+++++||.+||+.||.+|||++|||+||||+.
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 887665443 68999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=450.66 Aligned_cols=255 Identities=23% Similarity=0.419 Sum_probs=231.9
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
++++|.++++||+|+||+||+|.+. .++..||||++.+... ....+.+|+.+|+.++|||||+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~--------------~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~ 65 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVET--------------SSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILH 65 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCC
T ss_pred CccceEEEEEEecCCCeEEEEEEEC--------------CCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCe
Confidence 5678999999999999999999873 3557899999977542 2346789999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC--CCeee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN--GDIKL 379 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~--~~ikL 379 (635)
++++|++.+.+|||||||+|++|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+||||+.+ ..+||
T Consensus 66 ~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEE
Confidence 9999999999999999999999999998765 79999999999999999999999999999999999999854 58999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPF 459 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~ 459 (635)
+|||++............++|+.|+|||++.+..|+ .++||||||||||+|++|..||.+.+...+...|....+.++.
T Consensus 146 ~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 146 IEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccchhhccccCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh
Confidence 999999988777777778999999999999988886 9999999999999999999999999999999999988777664
Q ss_pred ----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 460 ----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 460 ----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
.+|.++++||.+||.+||.+|||++|||+||||...
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 689999999999999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=442.65 Aligned_cols=253 Identities=27% Similarity=0.356 Sum_probs=214.0
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH---HHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE---RNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.++.||+|+||+||+|.+. .+++.||||++....... .....+.+|+.+|++++|||||++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~ 67 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK--------------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67 (299)
T ss_dssp EEEEEEEETTEEEEEEECS--------------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEeccCcCeEEEEEEEC--------------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEe
Confidence 4789999999999999873 356789999997654322 22356889999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFS 385 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla 385 (635)
++.+.+.+|||||||.++++..++.....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 68 ~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 68 AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp EECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccc
Confidence 99999999999999999988887777788999999999999999999999999999999999999999999999999999
Q ss_pred ccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc---------
Q psy6357 386 NYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF--------- 455 (635)
Q Consensus 386 ~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~--------- 455 (635)
...... ......+||+.|+|||++.....++.++||||||||+|||++|.+||.+.+..+....|.....
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 148 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 876543 3445678999999999998766556999999999999999999999999888777766643100
Q ss_pred -----------C--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 456 -----------R--------IPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 456 -----------~--------~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
. ....+++++.+||.+||++||++|||++|||+||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 012468899999999999999999999999999999743
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=448.62 Aligned_cols=255 Identities=28% Similarity=0.517 Sum_probs=230.3
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHh-hCCCCceee
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMS-HLDHPHIIK 302 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~ 302 (635)
+.|.++++||+|+||+||+|.+. .+++.||||++.+... .....+.+..|+.++. .++|||||+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~--------------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~ 67 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK--------------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred CCeEEeeEEecCCCcEEEEEEEC--------------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEE
Confidence 46888999999999999999873 3567899999976432 2233456677777765 689999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
+++++.+.+.+|||||||++|+|.+++.....+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 68 ~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceecccc
Confidence 99999999999999999999999999999899999999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccCCCCCC
Q psy6357 383 GFSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFRIPFYM 461 (635)
Q Consensus 383 Gla~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~~p~~~ 461 (635)
|+|..... .......+||+.|+|||++.+..|+ .++||||||||+|+|++|..||.+.+...+...+....+.+|..+
T Consensus 148 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~ 226 (320)
T d1xjda_ 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226 (320)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred chhhhcccccccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccC
Confidence 99987653 3445567899999999999999887 899999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHH-HHHcCccccc
Q psy6357 462 SAECENLIRSMLVLDPAKRLTLT-QISNHKWMSV 494 (635)
Q Consensus 462 s~~l~~LI~~~L~~dP~~Rps~~-eiL~Hpw~~~ 494 (635)
|+++.+||.+||++||.+|||+. +|++||||+.
T Consensus 227 s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999999999995 8999999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-53 Score=449.09 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=221.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC----HHHHHHHHHHHHHHhhCCCCc
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD----ERNLRKLFREVDIMSHLDHPH 299 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~----~~~~~~~~~Ei~iL~~L~Hpn 299 (635)
.+.|.+++.||+|+||.||+|.+. .++..||||++.+.... .........|+.+|+.++|||
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~--------------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpn 68 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA--------------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTT
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC--------------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCc
Confidence 456888999999999999999872 45678999999765432 122233345577888889999
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
||+++++|.+.+.+|||||||++++|.++|.+...+++..++.|+.||+.||.|||+.|||||||||+||||+.++.+||
T Consensus 69 Iv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEE
T ss_pred EEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEE
Confidence 99999999999999999999999999999999899999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCccC
Q psy6357 380 ADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---LAVLKQRILFGKFR 456 (635)
Q Consensus 380 ~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~~~l~~~i~~~~~~ 456 (635)
+|||+|..+... .....+||+.|||||++.....++.++||||||||||+|++|..||.+.+ ...+...+......
T Consensus 149 ~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 227 (364)
T d1omwa3 149 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227 (364)
T ss_dssp CCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC
T ss_pred eeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 999999876543 34567899999999999765444599999999999999999999998654 33445555556677
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHHcCccccc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLT-----LTQISNHKWMSV 494 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps-----~~eiL~Hpw~~~ 494 (635)
+|..+|+++.+||.+||++||.+||| ++||++||||..
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 78889999999999999999999999 799999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=443.61 Aligned_cols=251 Identities=34% Similarity=0.596 Sum_probs=216.0
Q ss_pred ccCCccceee-ccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhh-CCCCce
Q psy6357 223 LLKPQYNLRK-AGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSH-LDHPHI 300 (635)
Q Consensus 223 ~~~~y~il~k-LG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~-L~HpnI 300 (635)
....|+++.+ ||+|+||+||+|.+. .+++.||||++... ..+.+|+.++.+ ++||||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~--------------~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnI 67 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNK--------------RTQEKFALKMLQDC-------PKARREVELHWRASQCPHI 67 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEET--------------TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTB
T ss_pred cccCEEEeeEEeeeccCeEEEEEEEC--------------CCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCC
Confidence 4568988875 999999999999873 45678999999754 457789998765 589999
Q ss_pred eeEEEEEec----CCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-
Q psy6357 301 IKLFQVMET----TNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE- 373 (635)
Q Consensus 301 v~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~- 373 (635)
|+++++|++ ...+|||||||+||+|.++|.+. ..|++.+++.|+.||+.||+|||+.||+||||||+|||++.
T Consensus 68 v~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~ 147 (335)
T d2ozaa1 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 147 (335)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred CeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc
Confidence 999999875 46799999999999999999775 36999999999999999999999999999999999999985
Q ss_pred --CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHH----H
Q psy6357 374 --NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVL----K 447 (635)
Q Consensus 374 --~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l----~ 447 (635)
.+.+||+|||+|............+||+.|||||++.+..|+ .++||||||||||+|++|.+||.+.+.... .
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~ 226 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 467999999999988777777788999999999999988886 999999999999999999999987654333 3
Q ss_pred HHHHhCccCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 448 QRILFGKFRIPF----YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 448 ~~i~~~~~~~p~----~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
..+....+.+|. .+|+++.+||.+||++||++|||+.|||+||||...
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 344445555554 489999999999999999999999999999999743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=429.21 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=214.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.++++||+|+||+||+|.+ ..+++.||||++......+.....+.+|+++|++++|||||+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~--------------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~ 67 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARN--------------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE--------------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCEeccEEecCcCeEEEEEEE--------------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEec
Confidence 4788999999999999999987 34567899999977655444557889999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhh-cccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLT-IGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~-~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++|.+...+|||||||.++.+...... ...+++..++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||
T Consensus 68 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred cccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCC
Confidence 999999999999999976544433333 3569999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc-------
Q psy6357 384 FSNYFTP-GHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF------- 455 (635)
Q Consensus 384 la~~~~~-~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~------- 455 (635)
+|..... .......+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 148 ~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 9987654 34556678999999999998888777999999999999999999999998887666555432100
Q ss_pred -----------CC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 -----------RI-----------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 -----------~~-----------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.+ ...+|.++++||.+||+.||++|||++|||+||||+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00 1146789999999999999999999999999999963
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=432.45 Aligned_cols=250 Identities=33% Similarity=0.551 Sum_probs=218.6
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCH----HHHHHHHHHHHHHhhCC--C
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDE----RNLRKLFREVDIMSHLD--H 297 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~----~~~~~~~~Ei~iL~~L~--H 297 (635)
.++|.+.+.||+|+||+||+|.+. .++..||||++.+..... ....++.+|+.+|++++ |
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h 68 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV--------------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCC
Confidence 467999999999999999999873 456789999997654321 11234668999999986 8
Q ss_pred CceeeEEEEEecCCeEEEEEecccc-chhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCC-C
Q psy6357 298 PHIIKLFQVMETTNNLYLVTEYARG-GEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDEN-G 375 (635)
Q Consensus 298 pnIv~l~~~~~~~~~~~LV~E~~~g-gsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~-~ 375 (635)
||||++++++.+.+.+|+||||+.+ +++.+++.....+++.+++.++.||+.||+|||+.||+||||||+||||+.+ +
T Consensus 69 ~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred CCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC
Confidence 9999999999999999999999976 6788888888899999999999999999999999999999999999999854 7
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCcc
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKF 455 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~ 455 (635)
.+||+|||+|..... ....+.+||+.|+|||++.+..+++.++|||||||+||+|++|..||... ..+.....
T Consensus 149 ~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~ 221 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV 221 (273)
T ss_dssp EEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCC
T ss_pred eEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhccc
Confidence 999999999986543 34567789999999999988777667899999999999999999999763 34566777
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 456 RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 456 ~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.++..+|+++++||.+||+.||++|||++|||+||||+.
T Consensus 222 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 222 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 888899999999999999999999999999999999963
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-52 Score=427.65 Aligned_cols=254 Identities=29% Similarity=0.400 Sum_probs=218.4
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++++||+|+||+||+|.+. +++.||||++......+...+.+.+|+.+|++++|||||+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~---------------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~ 66 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN---------------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET---------------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred CCceeccEEecCCCcEEEEEEeC---------------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeee
Confidence 58999999999999999999872 456899999987655554557889999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++|...+.+|+||||+.++.+..+....+.+++..++.|+.||+.||+|||+.+||||||||+||||+.++.+||+|||+
T Consensus 67 ~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999999999999998888887777788899999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc---------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK--------- 454 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~--------- 454 (635)
|...... .......+++.|+|||++.+..+.+.++|||||||++|||++|++||.+.+..+....+....
T Consensus 147 a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 147 ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp HHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhcc
Confidence 9876543 334556789999999999877766799999999999999999999999888776666554210
Q ss_pred --------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 455 --------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 455 --------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
..++..+++++.+||.+||++||++|||++|||+||||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 012234789999999999999999999999999999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=427.34 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=211.0
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
++|++. .+.|.+.++||+|+||+||+|.+. ..||||+++....+....+.+.+|+.+|
T Consensus 1 ddwei~-----~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l 58 (276)
T d1uwha_ 1 DDWEIP-----DGQITVGQRIGSGSFGTVYKGKWH-----------------GDVAVKMLNVTAPTPQQLQAFKNEVGVL 58 (276)
T ss_dssp CCCBCC-----TTCCCCCSEEEECSSCEEEEEESS-----------------SEEEEEECCCSSCCTTHHHHHHHHHHHH
T ss_pred CCcccc-----cccEEEEEEEeeCCCcEEEEEEEC-----------------CEEEEEEEEcccCCHHHHHHHHHHHHHH
Confidence 356554 456777899999999999999651 3599999987776677778999999999
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
++++|||||++++++. ...+|||||||++|+|.+++... ..+++..+..|+.||+.||+|||+++||||||||+||||
T Consensus 59 ~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 59 RKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp TTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred HhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence 9999999999999875 45689999999999999999654 569999999999999999999999999999999999999
Q ss_pred cCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCHHH
Q psy6357 372 DENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGR---EYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAV 445 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~---~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~ 445 (635)
+.++.+||+|||+|...... .......||+.|||||++.+. .| +.++|||||||+||||++|..||.+.+...
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~ 216 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRD 216 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHHCCCCCCCCChHH
Confidence 99999999999999876432 234567899999999999653 34 489999999999999999999998866543
Q ss_pred -HHHHHHhCcc-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCc
Q psy6357 446 -LKQRILFGKF-----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHK 490 (635)
Q Consensus 446 -l~~~i~~~~~-----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hp 490 (635)
+...+..+.. .++..+++++.+||.+||..||.+|||+.||++|-
T Consensus 217 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 217 QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 3344433321 24556899999999999999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=427.95 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=214.6
Q ss_pred eeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Q psy6357 231 RKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMETT 310 (635)
Q Consensus 231 ~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 310 (635)
++||+|+||+||+|.+...+ .+..||||++.....+....+.+.+|+.+|++|+|||||+++++|+.
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~------------~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS------------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred CCcccCCCeEEEEEEEccCC------------cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence 47999999999999875332 33579999997765555666789999999999999999999999965
Q ss_pred CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccccccccC
Q psy6357 311 NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTP 390 (635)
Q Consensus 311 ~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~ 390 (635)
+..|||||||++|+|.+++.....+++..++.|+.||+.||+|||+.+|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 46789999999999999999888999999999999999999999999999999999999999999999999999987654
Q ss_pred CC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCCCCCHH
Q psy6357 391 GH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPFYMSAE 464 (635)
Q Consensus 391 ~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~~~s~~ 464 (635)
.. ......||+.|||||++.+..++ .++|||||||++|||++ |.+||.+.+..++...+..+ .+++|..+|.+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 238 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 238 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 32 22345689999999999888886 89999999999999998 99999999888888888765 45678889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHH---HcCcccc
Q psy6357 465 CENLIRSMLVLDPAKRLTLTQI---SNHKWMS 493 (635)
Q Consensus 465 l~~LI~~~L~~dP~~Rps~~ei---L~Hpw~~ 493 (635)
+.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999999998 4666653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-52 Score=429.33 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=216.3
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC---CCCc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL---DHPH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L---~Hpn 299 (635)
..++|.++++||+|+||+||+|.+... .++.||||++............+.+|+.+|+.| +|||
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~-------------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~Hpn 71 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKN-------------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT-------------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTT
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECC-------------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCC
Confidence 346899999999999999999987311 245799999976544433334566788887766 7999
Q ss_pred eeeEEEEEe-----cCCeEEEEEeccccchhhhhhh-hcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC
Q psy6357 300 IIKLFQVME-----TTNNLYLVTEYARGGEIFSHLL-TIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE 373 (635)
Q Consensus 300 Iv~l~~~~~-----~~~~~~LV~E~~~ggsL~~~l~-~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~ 373 (635)
||+++++|. ....+|+|||||.++.+..... ....+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 72 Iv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151 (305)
T ss_dssp BCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC
Confidence 999999985 3457899999999887754433 3356999999999999999999999999999999999999999
Q ss_pred CCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy6357 374 NGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 374 ~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~ 453 (635)
++.+||+|||++............+||+.|+|||++.+..|+ .++||||||||||||++|.+||.+.+..+....+...
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999999887666677788999999999999999886 9999999999999999999999998877776665421
Q ss_pred ---------------------------ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccc
Q psy6357 454 ---------------------------KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMS 493 (635)
Q Consensus 454 ---------------------------~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~ 493 (635)
...++..+++++++||.+||++||++|||+.|||+||||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 0012345789999999999999999999999999999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=417.50 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=209.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||+||+|.+. ++..||||++....... +.+.+|+.+|++++|||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~---------------~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~ 65 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL---------------NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQL 65 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET---------------TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC---------------CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccc
Confidence 356788999999999999999872 34579999998765443 468899999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++...+.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||+.+|+||||||+||||+.++.+||+||
T Consensus 66 ~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred cceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEeccc
Confidence 99999999999999999999999988655 56899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 383 GFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 383 Gla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|+|+...... ......||+.|+|||++.+..|+ .++|||||||+||||++ |.+||...+...+...+..+ ....|
T Consensus 146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224 (263)
T ss_dssp C------------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred chheeccCCCceeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 9998765432 23346789999999999998886 99999999999999999 68888888888888887765 34567
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+++++.+||.+||+.||++|||++||++|
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 7899999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=421.84 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=221.0
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
++|++. .+.|.++++||+|+||+||+|.++ ++..||||++....... +.+.+|+.+|
T Consensus 6 ~~wei~-----~~~~~~~~~iG~G~fg~Vy~~~~~---------------~~~~vAvK~~~~~~~~~---~~~~~E~~~l 62 (272)
T d1qpca_ 6 DEWEVP-----RETLKLVERLGAGQFGEVWMGYYN---------------GHTKVAVKSLKQGSMSP---DAFLAEANLM 62 (272)
T ss_dssp CTTBCC-----GGGEEEEEEEEEETTEEEEEEEET---------------TTEEEEEEEECTTSSCH---HHHHHHHHHH
T ss_pred CCeecC-----HHHeEEeEEEecCCCcEEEEEEEC---------------CCCEEEEEEEccCcCCH---HHHHHHHHHH
Confidence 456554 456788999999999999999872 34579999997665443 5688999999
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
++++|||||++++++.+ +.+|||||||++|+|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||
T Consensus 63 ~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp HHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 99999999999998854 56799999999999998775543 5999999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLK 447 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~ 447 (635)
|+.++.+||+|||+|+...... ......||+.|||||++.+..++ .++|||||||+||||++ |.+||...+...+.
T Consensus 142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~ 220 (272)
T d1qpca_ 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (272)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred eecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998775432 33456789999999999888876 99999999999999999 56677778888888
Q ss_pred HHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--Ccccc
Q psy6357 448 QRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN--HKWMS 493 (635)
Q Consensus 448 ~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~--Hpw~~ 493 (635)
+.+..+ ....|..+++++.+||.+||+.||++|||+++|++ |+||.
T Consensus 221 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 877765 45667789999999999999999999999999998 78885
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=431.80 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=212.6
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+..+|.++++||+|+||+||+|.+. .+++.||||++.+...+....+.+.+|+.+|++|+|||||+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~ 81 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDG--------------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEET--------------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeE
Confidence 3568999999999999999999872 45689999999877767777888999999999999999999
Q ss_pred EEEEEecCC------eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVMETTN------NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~~~~------~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++++|...+ ++||||||| +.+|..++ +...|++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 82 l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 82 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp CSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred EEEEeccCccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc
Confidence 999997654 579999999 56666554 5578999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc--
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK-- 454 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~-- 454 (635)
+||+|||+|..... .....+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 160 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 160 LKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp EEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence 99999999987653 34567899999999999876666699999999999999999999999887655544332210
Q ss_pred -----------------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 455 -----------------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 455 -----------------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
......+++++.+||.+||.+||.+|||+.|||+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0122357899999999999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=422.55 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=218.5
Q ss_pred cccee-eccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 227 QYNLR-KAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 227 y~il~-kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
+.+.. +||+|+||+||+|.+...+ ++..||||+++... .....+.+.+|+.+|++++|||||++++
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~------------~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRK------------KQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---------------CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCC------------CcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 44455 5999999999999874332 34579999997653 5566788999999999999999999999
Q ss_pred EEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 306 VMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 306 ~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
++.. +.+|||||||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 77 VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred eecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 9865 5689999999999999987654 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 385 SNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 385 a~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
|+.+.... .....+||+.|+|||++.+..++ .++|||||||+||||++ |..||.+.+..++...+..+. .++|
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 234 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 98765432 23345689999999999888876 99999999999999998 999999988888888887663 5778
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHH---HcCccccc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQI---SNHKWMSV 494 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~ei---L~Hpw~~~ 494 (635)
..+++++.+||.+||..||++|||+.+| |+|+|++.
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 8899999999999999999999999888 67888864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-51 Score=423.12 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=218.1
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
++|++. .+.|.+.++||+|+||+||+|.+. .++..||||++...... .+.+.+|+.+|
T Consensus 10 ~~wei~-----~~~~~~~~~iG~G~fg~Vy~a~~~--------------~~~~~vAvK~i~~~~~~---~~~~~~E~~il 67 (287)
T d1opja_ 10 DKWEME-----RTDITMKHKLGGGQYGEVYEGVWK--------------KYSLTVAVKTLKEDTME---VEEFLKEAAVM 67 (287)
T ss_dssp CTTBCC-----GGGEEEEEETTTTTTSSEEEEEEG--------------GGTEEEEEEECCTTCSC---HHHHHHHHHHH
T ss_pred cccEec-----HHHeEEeeEEeeCCCeEEEEEEEC--------------CCCeEEEEEEECCccch---HHHHHHHHHHH
Confidence 456554 456777899999999999999883 34568999999765543 35688999999
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCccee
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLL 370 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NIL 370 (635)
++|+|||||+++++|.+.+.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 68 ~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NIL 147 (287)
T d1opja_ 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 147 (287)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEE
Confidence 9999999999999999999999999999999999998754 56899999999999999999999999999999999999
Q ss_pred ecCCCCeeeecccccccccCCCc--cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCC-CCCCCCCHHHHH
Q psy6357 371 FDENGDIKLADFGFSNYFTPGHM--LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ-LPFDGPNLAVLK 447 (635)
Q Consensus 371 l~~~~~ikL~DFGla~~~~~~~~--~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~-~PF~~~~~~~l~ 447 (635)
|+.++.+||+|||+|+....... .....||+.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+...+.
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp ECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 99999999999999987654322 3334578999999999988886 9999999999999999955 556667777777
Q ss_pred HHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 448 QRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 448 ~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+..+ ..++|..+++++.+||.+||+.||++|||+.||++
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 666554 45677789999999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=424.71 Aligned_cols=257 Identities=26% Similarity=0.344 Sum_probs=214.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.++|.++++||+|+||+||+|.+. .+++.||||++......+.....+.+|+.+|++++|+||+++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~ 74 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR--------------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccce
Confidence 578999999999999999999873 456799999997765555555778899999999999999999
Q ss_pred EEEEec--------CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC
Q psy6357 304 FQVMET--------TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG 375 (635)
Q Consensus 304 ~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~ 375 (635)
++++.. ...+|+|||||.++.+..+......+++..++.|+.||+.||.|||+.||+||||||+||||+.++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp EEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred EeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC
Confidence 999854 456899999998888777777777899999999999999999999999999999999999999999
Q ss_pred CeeeecccccccccCC-----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 376 DIKLADFGFSNYFTPG-----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~-----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
.+||+|||++..+... ......+||+.|+|||++.+...++.++|||||||++|||++|.+||.+.+.......+
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i 234 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence 9999999999765432 23445689999999999987654459999999999999999999999988877766655
Q ss_pred HhCccCCCC--------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 451 LFGKFRIPF--------------------------------YMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 451 ~~~~~~~p~--------------------------------~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
......++. ..++++.+||.+||++||++|||++|||+||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 432111110 13678899999999999999999999999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-51 Score=422.91 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=211.5
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCcee
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHII 301 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 301 (635)
+..+.|.+.+.||+|+||+||+|.+..... ....||||++.... .....+.+.+|+.+|++|+|||||
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-----------~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv 90 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGK-----------REIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVI 90 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC--------------CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCC-----------EEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCc
Confidence 445678888999999999999998854432 22368999886543 455667899999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 302 KLFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 302 ~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++++...+.+|||||||++|+|.+++... +.+++.+++.|+.||+.||.|||+.+|+||||||+||||+.++.+||+
T Consensus 91 ~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVS 170 (299)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEEC
Confidence 9999999999999999999999999988764 469999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCc------cccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy6357 381 DFGFSNYFTPGHM------LTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG 453 (635)
Q Consensus 381 DFGla~~~~~~~~------~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~ 453 (635)
|||+|+.+..... .....||+.|||||++.+..++ .++|||||||+||||++ |..||.+.+...+...+..+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~ 249 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD 249 (299)
T ss_dssp CC-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999987654322 1224578899999999988886 89999999999999998 89999999988888888765
Q ss_pred -ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 454 -KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 454 -~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+.|..++.++.+||.+||+.||.+|||+.||+++
T Consensus 250 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 250 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 356677899999999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=413.58 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=224.0
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
++|.++++||+|+||+||+|.+. .+++.||||+++...........+.+|+.+|++++|||||+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~--------------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~ 67 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR--------------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET--------------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC--------------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeec
Confidence 58999999999999999999873 4567899999987766666778899999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGF 384 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGl 384 (635)
+++.+...+++|||++.+++|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 68 ~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred cccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecch
Confidence 99999999999999999999999888888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCc--------
Q psy6357 385 SNYFTPG-HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPF-DGPNLAVLKQRILFGK-------- 454 (635)
Q Consensus 385 a~~~~~~-~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF-~~~~~~~l~~~i~~~~-------- 454 (635)
|...... .......+++.|+|||++....+.+.++|||||||++|+|++|..|| .+.+..+....+....
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred hhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 9876543 34445567889999999988776569999999999999999999885 5555555555543210
Q ss_pred ---------------------cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 ---------------------FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 ---------------------~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
...+..++.++.+||.+||++||.+|||++|||+||||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 011234688999999999999999999999999999997544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-50 Score=416.30 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=216.4
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnI 300 (635)
.+.++|.+++.||+|+||+||+|.+. .+++.||||++.+... +......+.+|+.+|+.++||||
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpni 69 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDL--------------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred CccceeEEeEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCC
Confidence 34578999999999999999999873 4567899999987655 45566789999999999999999
Q ss_pred eeEEEEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 301 IKLFQVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 301 v~l~~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
|++++++...+ .+|||||||+|++|.+++...+.+++.+++.|+.||+.||+|||+.||+||||||+||||+.++.
T Consensus 70 v~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~ 149 (277)
T d1o6ya_ 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 149 (277)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC
T ss_pred CcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc
Confidence 99999997654 48999999999999999999899999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy6357 377 IKLADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILF 452 (635)
Q Consensus 377 ikL~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~ 452 (635)
++|+|||++...... ......+||+.|||||++.+..++ .++||||||||||+|++|.+||.+.+...+...+..
T Consensus 150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp EEECCCTTCEECC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 999999998765332 244567899999999999988886 899999999999999999999999988888777776
Q ss_pred CccCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 453 GKFRIP----FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 453 ~~~~~p----~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.....| ..+|+++.+||.+||++||.+||+..+.|.|+|++.
T Consensus 229 ~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 654333 468999999999999999999995444455777653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=411.27 Aligned_cols=246 Identities=22% Similarity=0.412 Sum_probs=220.1
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
+.|.++++||+|+||+||+|.++ ++..||||++++..... +.+++|+.++++++|||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~---------------~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~ 65 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR---------------GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 65 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET---------------TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC---------------CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEE
Confidence 46778899999999999999972 34589999998776554 4688999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++|.+.+.+++||||+++|+|..++... ..+++..++.|+.||+.||.|||+.||+||||||+||||+.++.+||+|||
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcch
Confidence 9999999999999999999999886554 569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCCC
Q psy6357 384 FSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIPF 459 (635)
Q Consensus 384 la~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p~ 459 (635)
++....... ......+|+.|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+ ....|.
T Consensus 146 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 224 (258)
T d1k2pa_ 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224 (258)
T ss_dssp SCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred hheeccCCCceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 998765432 23346789999999999988886 89999999999999998 89999999999888888775 456777
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 460 YMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 460 ~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.++.++.+||.+||+.||++|||+++||+|
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 899999999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=428.86 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=214.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.+.|.+.++||+|+||+||+|.+...... .....||||++.... .......+.+|+.+|.++ +|||||+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~ 105 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKT---------GVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVN 105 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSS---------SCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcc---------cceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeE
Confidence 34677789999999999999987543221 123479999987553 334456788999999998 8999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc-----------------------cCCHHHHHHHHHHHHHhhhhhccCce
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG-----------------------QMAEKEASRLFRQILSAVAYCHANNV 359 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-----------------------~l~e~~~~~i~~qIl~gL~~LHs~gI 359 (635)
+++++.+.+.+|||||||++|+|.++|.... .+++..++.|+.||+.||+|||+++|
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I 185 (325)
T d1rjba_ 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185 (325)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999999999999999999999999996542 48999999999999999999999999
Q ss_pred eeecccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CC
Q psy6357 360 VHRDIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQ 435 (635)
Q Consensus 360 iHrDLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~ 435 (635)
|||||||+|||++.++.+||+|||+|+...... ...+..||+.|||||++.+..++ .++|||||||+||||++ |.
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSC
T ss_pred eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCC
Confidence 999999999999999999999999998765432 23456789999999999888886 99999999999999997 89
Q ss_pred CCCCCCCHHHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 436 LPFDGPNLAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 436 ~PF~~~~~~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+||.+.+.......+... .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999987665555555544 345677899999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=424.79 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=216.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||+||+|.+. .+++.||||++.+...+....+.+.+|+.+|++|+|||||++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~--------------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~ 82 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT--------------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET--------------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 367999999999999999999873 456799999998877777777889999999999999999999
Q ss_pred EEEEecC-----CeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 304 FQVMETT-----NNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 304 ~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++... ...++||+|+.+++|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp SEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccc
Confidence 9998533 334566677779999998854 5799999999999999999999999999999999999999999999
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCccC--
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGKFR-- 456 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~~~-- 456 (635)
|+|||++.... ....+..||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 162 l~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 162 ILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp ECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999997654 34456788999999999888777679999999999999999999999998877666665432111
Q ss_pred ---------------------C--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 457 ---------------------I--------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 457 ---------------------~--------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. ...+++++++||.+||.+||.+|||+.|||+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 1 124789999999999999999999999999999998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=424.39 Aligned_cols=249 Identities=26% Similarity=0.310 Sum_probs=209.6
Q ss_pred CccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEE
Q psy6357 226 PQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQ 305 (635)
Q Consensus 226 ~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 305 (635)
.|..+++||+|+||+||+|.+. .+++.||||++..... .+.+|+.+|++|+|+|||++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~--------------~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~ 80 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC--------------DSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRY 80 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--------------TTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEEC--------------CCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEE
Confidence 5778999999999999999873 4567899999976542 2347999999999999999999
Q ss_pred EEec------CCeEEEEEeccccchhhhh---hhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-
Q psy6357 306 VMET------TNNLYLVTEYARGGEIFSH---LLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG- 375 (635)
Q Consensus 306 ~~~~------~~~~~LV~E~~~ggsL~~~---l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~- 375 (635)
+|.. ..++|||||||.++.+..+ ......+++..++.|+.||+.||+|||++||+||||||+||||+.++
T Consensus 81 ~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~ 160 (350)
T d1q5ka_ 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 160 (350)
T ss_dssp EEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC
T ss_pred EEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC
Confidence 9843 3458999999986643332 23445799999999999999999999999999999999999999775
Q ss_pred CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy6357 376 DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG-- 453 (635)
Q Consensus 376 ~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~-- 453 (635)
.+||+|||++..........+.+||+.|+|||++.+...++.++|||||||++|||++|..||...+..+....+...
T Consensus 161 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 161 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence 899999999998877777778899999999999887655569999999999999999999999988876665555320
Q ss_pred ---------------ccCC------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 ---------------KFRI------------PFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 ---------------~~~~------------p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
...+ ...+++++.+||.+||.+||++|||+.|||+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1111 1247899999999999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=409.74 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=208.7
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.+.+.||+|+||.||+|.+...+. .+..||||++.... .....+.+.+|+.+|++++|||||++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-----------~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l 73 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPEN-----------PALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKL 73 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC-------------CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCc-----------eeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4568889999999999999998854331 23568999886543 45566789999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++. .+.+|||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 74 ~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccc
Confidence 99996 46789999999999999887654 46999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 383 GFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 383 Gla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
|+|+...... ......||+.|+|||++.+..++ .++|||||||+||||++ |.+||...+..++...+..+. .++|
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 231 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9998765332 33456689999999999888886 89999999999999998 999999998888888887764 5678
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+|+++.+||.+||..||.+|||+.||++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8899999999999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=416.87 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=210.1
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
..+|.++++||+|+||+||+|.+. .+++.||||++.+.. .....+.+++|+.+|++|+||||+++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~--------------~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~ 71 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDN--------------VNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGI 71 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEET--------------TTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEEC--------------CCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcE
Confidence 367999999999999999999872 456789999997654 45556788999999999999999999
Q ss_pred EEEEecCC-----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCee
Q psy6357 304 FQVMETTN-----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIK 378 (635)
Q Consensus 304 ~~~~~~~~-----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ik 378 (635)
++++.... .+|||| |+.+++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+|
T Consensus 72 ~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~k 149 (345)
T d1pmea_ 72 NDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 149 (345)
T ss_dssp CEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EEEEeeccccccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEE
Confidence 99996543 355555 5558999998865 5799999999999999999999999999999999999999999999
Q ss_pred eecccccccccCC----CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCc
Q psy6357 379 LADFGFSNYFTPG----HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFGK 454 (635)
Q Consensus 379 L~DFGla~~~~~~----~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~~ 454 (635)
|+|||+|...... ......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~ 229 (345)
T d1pmea_ 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229 (345)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc
Confidence 9999999765432 234567899999999999766655689999999999999999999998877554444332110
Q ss_pred --------------------------c-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcccccCC
Q psy6357 455 --------------------------F-----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSVHC 496 (635)
Q Consensus 455 --------------------------~-----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~~~ 496 (635)
. .....++.++++||.+||++||.+|||++|||+||||....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0 01224688999999999999999999999999999998543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=411.02 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=216.4
Q ss_pred hhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHH
Q psy6357 212 LDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDI 291 (635)
Q Consensus 212 l~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~i 291 (635)
.++|++. ...|.+.++||+|+||+||+|.+. ++..||||++....... +.+.+|+.+
T Consensus 9 ~~~~~i~-----~~~~~i~~~iG~G~fg~Vy~~~~~---------------~~~~vAiK~l~~~~~~~---~~~~~E~~~ 65 (285)
T d1fmka3 9 KDAWEIP-----RESLRLEVKLGQGCFGEVWMGTWN---------------GTTRVAIKTLKPGTMSP---EAFLQEAQV 65 (285)
T ss_dssp TTCSBCC-----GGGEEEEEEEEECSSCEEEEEEET---------------TTEEEEEEECCTTSSCH---HHHHHHHHH
T ss_pred CcceEcC-----HHHEEEeeEEeeCCCeEEEEEEEC---------------CCCEEEEEEECcccCCH---HHHHHHHHH
Confidence 3556654 456888999999999999999872 33579999997665443 568899999
Q ss_pred HhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc--ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcce
Q psy6357 292 MSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI--GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENL 369 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~--~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NI 369 (635)
|++++|+|||++++++.+ +.+|+|||||++|+|..++... ..+++.+++.|+.||+.||+|||+.+|+||||||+||
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 999999999999999854 5679999999999998887653 4699999999999999999999999999999999999
Q ss_pred eecCCCCeeeecccccccccCCC--ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHH
Q psy6357 370 LFDENGDIKLADFGFSNYFTPGH--MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVL 446 (635)
Q Consensus 370 Ll~~~~~ikL~DFGla~~~~~~~--~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l 446 (635)
||+.++.+||+|||+|+...... ......||+.|+|||++....++ .++||||||||||||++ |.+||......++
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~ 223 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV 223 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998764432 33446789999999999888886 99999999999999999 5666777777778
Q ss_pred HHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc--CcccccC
Q psy6357 447 KQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN--HKWMSVH 495 (635)
Q Consensus 447 ~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~--Hpw~~~~ 495 (635)
...+..+ ..+.+..+++++++||.+||+.||++|||+++|++ |+||...
T Consensus 224 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 8777655 45677889999999999999999999999999988 8888643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=419.59 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=205.8
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
+.++|.++++||+|+||+||+|.+. .++..||||++.+...+.....++.+|+.+|++++|||||+
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~--------------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 80 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDA--------------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEET--------------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEEC--------------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeE
Confidence 3478999999999999999999873 35678999999888777777788999999999999999999
Q ss_pred EEEEEe------cCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCC
Q psy6357 303 LFQVME------TTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGD 376 (635)
Q Consensus 303 l~~~~~------~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ 376 (635)
++++|. ...++|+|||||.++.+ +.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 81 ~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 81 LLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp CSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred EEEEEecccccccCceeEEEEeccchHHH-Hhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc
Confidence 999995 34689999999976554 4443 46999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---
Q psy6357 377 IKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRILFG--- 453 (635)
Q Consensus 377 ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i~~~--- 453 (635)
+||+|||++............++|+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+.......+...
T Consensus 158 ~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp EEECCCCC---------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeeechhhhhccccccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 999999999888777777788899999999999998876 8999999999999999999999988766655544311
Q ss_pred -------------------ccCC--------------C------CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 454 -------------------KFRI--------------P------FYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 454 -------------------~~~~--------------p------~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.... + ...+.++.+||.+||.+||++|||++|||+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0 013678999999999999999999999999999986
Q ss_pred C
Q psy6357 495 H 495 (635)
Q Consensus 495 ~ 495 (635)
.
T Consensus 317 ~ 317 (355)
T d2b1pa1 317 W 317 (355)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=403.90 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=209.2
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
...|.+.+.||+|+||+||+|.++.... .....||||++.... .+.....+.+|+.+|++|+|||||++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~----------~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSG----------KKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC-------------CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCC----------EEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3456667889999999999998854431 122479999997544 45556678999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeecc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADF 382 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DF 382 (635)
++++.+...+++|||||.+++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+||
T Consensus 75 ~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp EEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEccc
Confidence 99999999999999999999998877655 56999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccC
Q psy6357 383 GFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFR 456 (635)
Q Consensus 383 Gla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~ 456 (635)
|+|+...... ......||+.|||||++.+..++ .++|||||||+||||++ |.+||...+...+...+..+ ..+
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 9998764432 23345689999999999988886 89999999999999999 56667777777777777665 356
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 457 IPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 457 ~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.|..++.++.+||.+||..||++|||+.||++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 67789999999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-49 Score=412.24 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=209.2
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCcee
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHII 301 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv 301 (635)
..++|.++++||+|+||+||+|.+. .+++.||||+++... .+.+.+|+.+|+++. ||||+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~--------------~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv 93 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI--------------TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNII 93 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC--------------CCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCc
Confidence 3467999999999999999999873 456789999997543 256789999999995 99999
Q ss_pred eEEEEEec--CCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCC-Cee
Q psy6357 302 KLFQVMET--TNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENG-DIK 378 (635)
Q Consensus 302 ~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~-~ik 378 (635)
+++++|.. ...+|+|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+|
T Consensus 94 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vk 170 (328)
T d3bqca1 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 170 (328)
T ss_dssp CEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeee
Confidence 99999974 45799999999999987764 4699999999999999999999999999999999999998655 699
Q ss_pred eecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH------
Q psy6357 379 LADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNL-AVLKQRIL------ 451 (635)
Q Consensus 379 L~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~-~~l~~~i~------ 451 (635)
|+|||+|............++|+.|+|||++.+...++.++|||||||++|+|++|..||..... ......+.
T Consensus 171 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 171 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp ECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred ecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99999999887777777889999999999998776556999999999999999999999976442 11111111
Q ss_pred -------hCcc------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcCccccc
Q psy6357 452 -------FGKF------------------------RIPFYMSAECENLIRSMLVLDPAKRLTLTQISNHKWMSV 494 (635)
Q Consensus 452 -------~~~~------------------------~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw~~~ 494 (635)
.... .....+++++.+||.+||++||.+|||++|||+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000 011237899999999999999999999999999999963
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=416.74 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=223.7
Q ss_pred ccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc--CHHHHHHHHHHHHHHhhCCC-Cc
Q psy6357 223 LLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL--DERNLRKLFREVDIMSHLDH-PH 299 (635)
Q Consensus 223 ~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~--~~~~~~~~~~Ei~iL~~L~H-pn 299 (635)
.++.|.++++||+|+||+||+|.....+ .+++.||||++++... +....+.+.+|+.+|++++| ||
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pn 90 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGH-----------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSST-----------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTT
T ss_pred chhceEEEEEEecCCCeEEEEEEECccC-----------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCe
Confidence 4567899999999999999999874432 2567899999976543 12233567899999999976 89
Q ss_pred eeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeee
Q psy6357 300 IIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKL 379 (635)
Q Consensus 300 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL 379 (635)
|+++++++++...+++|||||.+++|.+++...+.+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||
T Consensus 91 Iv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccccccC--CCccccccCCCCCCCccccCCCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q psy6357 380 ADFGFSNYFTP--GHMLTTWCGSPPYAAPELFGGRE-YDGTKSDVWSLGVVLYVMVTAQLPFDGPNL----AVLKQRILF 452 (635)
Q Consensus 380 ~DFGla~~~~~--~~~~~~~~gt~~Y~APEvl~~~~-~~~~ksDIwSlGvilyeLltG~~PF~~~~~----~~l~~~i~~ 452 (635)
+|||+|..+.. .....+..|++.|+|||++.+.. +.+.++|||||||+||+|++|..||.+.+. ..+......
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 99999986543 23455678999999999997654 335799999999999999999999977543 344455555
Q ss_pred CccCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHcCccccc
Q psy6357 453 GKFRIPFYMSAECENLIRSMLVLDPAKRL-----TLTQISNHKWMSV 494 (635)
Q Consensus 453 ~~~~~p~~~s~~l~~LI~~~L~~dP~~Rp-----s~~eiL~Hpw~~~ 494 (635)
....+|..+|.++.+||.+||++||.+|| |++|||+||||+.
T Consensus 251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 66778888999999999999999999999 5899999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=409.16 Aligned_cols=254 Identities=20% Similarity=0.314 Sum_probs=212.6
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.++++||+|+||+||+|.+...+. ....+||||.+.... +....+.+.+|+.+|++++|||||+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~----------~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~ 77 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGE----------KVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLL 77 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC--------------CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCC----------EEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 458889999999999999998743322 122469999886543 333456789999999999999999999
Q ss_pred EEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccc
Q psy6357 305 QVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFG 383 (635)
Q Consensus 305 ~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFG 383 (635)
++|.+. ..++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||
T Consensus 78 g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 78 GICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccc
Confidence 999764 567888999999998877664 569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCc-cCCC
Q psy6357 384 FSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGK-FRIP 458 (635)
Q Consensus 384 la~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~-~~~p 458 (635)
+|....... ......||+.|||||++.+..|+ .++|||||||+||||++ |.+||.+.+..++...+..+. ++.|
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p 235 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred cceecccccccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998765432 23345689999999999988886 99999999999999998 899999988888877777654 5677
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcCcc
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNHKW 491 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~Hpw 491 (635)
..++.++.+||.+||..||.+|||+.||++|.+
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 889999999999999999999999999998843
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=400.55 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=207.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEeccccc-CHHHHHHHHHHHHHHhhCCCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRL-DERNLRKLFREVDIMSHLDHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~ 302 (635)
.+.|.++++||+|+||+||+|.+..... ....||||++.+... .....+.+.+|+.+|++++|||||+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~-----------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~ 75 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG-----------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS-----------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC-----------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 4568889999999999999998854432 224799999977654 3445678999999999999999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc-ccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeec
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI-GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLAD 381 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~-~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~D 381 (635)
+++++.+ ..+++|||||++++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|
T Consensus 76 ~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeecc
Confidence 9999975 4678999999999999877654 5699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCC----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCcc-
Q psy6357 382 FGFSNYFTPGH----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFGKF- 455 (635)
Q Consensus 382 FGla~~~~~~~----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~~~- 455 (635)
||+++...... ......++..|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+.....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 99998765432 22345678899999999988876 89999999999999998 8999999999999888877654
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 456 -RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 456 -~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.+..+|.++.+||.+||..||++|||+.||++
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 455679999999999999999999999999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=398.41 Aligned_cols=243 Identities=28% Similarity=0.443 Sum_probs=205.9
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||.||+|.+ .++.||||+++... ..+.+.+|+++|++++|||||++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~----------------~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~ 65 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY----------------RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQL 65 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE----------------TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE----------------CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeE
Confidence 44566789999999999999987 24579999997653 23568899999999999999999
Q ss_pred EEEEec-CCeEEEEEeccccchhhhhhhhcc--cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeee
Q psy6357 304 FQVMET-TNNLYLVTEYARGGEIFSHLLTIG--QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLA 380 (635)
Q Consensus 304 ~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~--~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~ 380 (635)
++++.+ .+.+||||||+++|+|.++|.+.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~ 145 (262)
T d1byga_ 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 145 (262)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeec
Confidence 999854 567899999999999999997653 49999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-ccCCC
Q psy6357 381 DFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPNLAVLKQRILFG-KFRIP 458 (635)
Q Consensus 381 DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~~~~l~~~i~~~-~~~~p 458 (635)
|||+++.... ......+|+.|+|||++.+..++ .++|||||||++|||++ |.+||...+..++...+..+ ..++|
T Consensus 146 dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 146 DFGLTKEASS--TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 222 (262)
T ss_dssp CCCC--------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred ccccceecCC--CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999987543 23455789999999999888876 99999999999999998 89999998888888888764 56778
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 459 FYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 459 ~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
..+++++.+||.+||..||.+|||+.+|+++
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 8899999999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=403.94 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=219.4
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeE
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKL 303 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l 303 (635)
.+.|.++++||+|+||+||+|.+..... ..+++.||||++.... .....+.+.+|+.+|++++||||+++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~---------~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLP---------YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSST---------TSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCcc---------CCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccc
Confidence 4467889999999999999998743211 2355689999997543 45566789999999999999999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc------------------------cCCHHHHHHHHHHHHHhhhhhccCce
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG------------------------QMAEKEASRLFRQILSAVAYCHANNV 359 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~------------------------~l~e~~~~~i~~qIl~gL~~LHs~gI 359 (635)
++++.....+++||||+.+++|.+++.... .+++..++.|+.||+.||+|||+.+|
T Consensus 82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i 161 (301)
T d1lufa_ 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161 (301)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence 999999999999999999999999986532 38899999999999999999999999
Q ss_pred eeecccCcceeecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-C
Q psy6357 360 VHRDIKAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-Q 435 (635)
Q Consensus 360 iHrDLKp~NILl~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~ 435 (635)
|||||||+||||+.++.+||+|||+|...... ....+.++|+.|+|||++.+..|+ .++||||||||||||++| .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999765432 233456789999999999988886 999999999999999998 4
Q ss_pred CCCCCCCHHHHHHHHHhCcc-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 436 LPFDGPNLAVLKQRILFGKF-RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 436 ~PF~~~~~~~l~~~i~~~~~-~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+||.+.+..++...+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus 241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999998888888887754 467789999999999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=404.27 Aligned_cols=263 Identities=21% Similarity=0.337 Sum_probs=209.5
Q ss_pred chhhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHH
Q psy6357 211 TLDEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVD 290 (635)
Q Consensus 211 tl~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~ 290 (635)
..++|++. ..+|.++++||+|+||.||+|.+...... .+++.||||++.... .....+.+.+|+.
T Consensus 4 ~~~~wei~-----~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~---------~~~~~vAvK~l~~~~-~~~~~~~~~~e~~ 68 (299)
T d1ywna1 4 DASKWEFP-----RDRLKLGKPLGRGAFGQVIEADAFGIDKT---------ATCRTVAVKMLKEGA-THSEHRALMSELK 68 (299)
T ss_dssp CHHHHBCC-----GGGEEEEEEEEECSSCEEEEEEEESTTSS---------SCEEEEEEEEC-----CHHHHHHHHHHHH
T ss_pred CCcccccc-----HHHEEEeeEEeecCCeEEEEEEEcCCCcc---------cCCeEEEEEEEcccc-CcHHHHHHHHHHH
Confidence 34667655 35688899999999999999988544321 245689999997544 3445567888888
Q ss_pred HHhhC-CCCceeeEEEEEec-CCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhh
Q psy6357 291 IMSHL-DHPHIIKLFQVMET-TNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVA 352 (635)
Q Consensus 291 iL~~L-~HpnIv~l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~ 352 (635)
++.++ .|+|||.+++++.. ...+++|||||++|+|.++|.... .+++..++.|+.||+.||.
T Consensus 69 ~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 148 (299)
T d1ywna1 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 148 (299)
T ss_dssp HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHH
Confidence 88877 68999999998765 457899999999999999986532 4899999999999999999
Q ss_pred hhccCceeeecccCcceeecCCCCeeeecccccccccCC---CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHH
Q psy6357 353 YCHANNVVHRDIKAENLLFDENGDIKLADFGFSNYFTPG---HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLY 429 (635)
Q Consensus 353 ~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~~~~~---~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvily 429 (635)
|||+++||||||||+||||+.++.+||+|||+|+..... ......+||+.|||||++.+..++ .++|||||||++|
T Consensus 149 ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ 227 (299)
T d1ywna1 149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 227 (299)
T ss_dssp HHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHH
T ss_pred HHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHH
Confidence 999999999999999999999999999999999865432 233456799999999999988876 9999999999999
Q ss_pred HHHhC-CCCCCCCCHHH-HHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 430 VMVTA-QLPFDGPNLAV-LKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 430 eLltG-~~PF~~~~~~~-l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
||++| .+||.+..... +...+..+ .+.+|..+++++.+||.+||+.||.+|||+.||++|
T Consensus 228 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 228 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99985 67887765443 33444433 456777899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=405.44 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=215.0
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.+.|.+.++||+|+||+||+|.++..+. ...||||.+.... .....+.+.+|+++|.++ +|||||+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~------------~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~ 75 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGL------------RMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 75 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTE------------EEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCC
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCe------------EEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEee
Confidence 4566778999999999999999854321 1257888875443 334556789999999999 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhc----------------ccCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTI----------------GQMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
+++++.+.+.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+.+|+||||||
T Consensus 76 ~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp 155 (309)
T d1fvra_ 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 155 (309)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccccccc
Confidence 999999999999999999999999998654 4699999999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCHHH
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPFDGPNLAV 445 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~~PF~~~~~~~ 445 (635)
+|||++.++.+||+|||+|+............||..|+|||++.+..++ .++||||||||+|||++| .+||.+.+..+
T Consensus 156 ~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 156 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999999876654455566799999999999988886 899999999999999995 57899999999
Q ss_pred HHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 446 LKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 446 l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+...+..+ .+..|..+++++.+||.+||+.||++|||+.||++|
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 235 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88888765 456777899999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=401.14 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=216.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~ 302 (635)
.++|.+.++||+|+||.||+|.+....+. ....+..||||++.... .......+.+|+.++.++ +|||||+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~-------~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKD-------KPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC-----------CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcc-------cccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 45778899999999999999987543321 11344689999997654 455667888999999888 7999999
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhhhhcc----------------cCCHHHHHHHHHHHHHhhhhhccCceeeecccC
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHLLTIG----------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIKA 366 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp 366 (635)
++++|.++..+|+|||||++|+|.++|.... .+++..++.++.||+.||+|||+.+||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999999999999996543 489999999999999999999999999999999
Q ss_pred cceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q psy6357 367 ENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGPN 442 (635)
Q Consensus 367 ~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~~ 442 (635)
+|||++.++.+||+|||++....... ......+|+.|+|||++.+..|+ .++||||||||+|||++ |.+||.+.+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999998765432 33456789999999999888886 99999999999999998 799999999
Q ss_pred HHHHHHHHHhC-ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 443 LAVLKQRILFG-KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 443 ~~~l~~~i~~~-~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
...+...+..+ .+..|..+++++.+||.+||+.||.+|||+.||++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888887665 45677789999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=400.63 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=223.7
Q ss_pred hhhhhccCCcccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHH
Q psy6357 213 DEWKASRGTKLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIM 292 (635)
Q Consensus 213 ~e~~~~~~~~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL 292 (635)
++|++. .+.|.++++||+|+||+||+|.+...... ..++.||||+++... .......+.+|+.+|
T Consensus 13 ~~~ei~-----~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~---------~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il 77 (308)
T d1p4oa_ 13 DEWEVA-----REKITMSRELGQGSFGMVYEGVAKGVVKD---------EPETRVAIKTVNEAA-SMRERIEFLNEASVM 77 (308)
T ss_dssp CTTBCC-----GGGEEEEEEEEECSSSEEEEEEEEEEETT---------EEEEEEEEEECCTTS-CHHHHHHHHHHHHHG
T ss_pred cceeec-----HHHeEEeeEEeeCCCeEEEEEEECCcccC---------CCCcEEEEEEECccc-ChHHHHHHHHHHHHH
Confidence 456554 45677789999999999999988543211 234689999997553 555667889999999
Q ss_pred hhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhc----------ccCCHHHHHHHHHHHHHhhhhhccCceeee
Q psy6357 293 SHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTI----------GQMAEKEASRLFRQILSAVAYCHANNVVHR 362 (635)
Q Consensus 293 ~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~----------~~l~e~~~~~i~~qIl~gL~~LHs~gIiHr 362 (635)
++++|||||++++++.....+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||
T Consensus 78 ~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHr 157 (308)
T d1p4oa_ 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157 (308)
T ss_dssp GGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred HHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence 9999999999999999999999999999999999988643 237889999999999999999999999999
Q ss_pred cccCcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhC-CCCC
Q psy6357 363 DIKAENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTA-QLPF 438 (635)
Q Consensus 363 DLKp~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG-~~PF 438 (635)
||||+||||+.++.+||+|||+|+...... ......+|+.|+|||.+.+..++ .++|||||||+||||++| .+||
T Consensus 158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTT
T ss_pred eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764332 23345689999999999988886 899999999999999997 6899
Q ss_pred CCCCHHHHHHHHHhCc-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 439 DGPNLAVLKQRILFGK-FRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 439 ~~~~~~~l~~~i~~~~-~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
.+.+...+...+..+. ...|..++..+.+||.+||+.||.+|||+.+|++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999988888887754 4567789999999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=394.07 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=214.7
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhC-CCCceeeE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHL-DHPHIIKL 303 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 303 (635)
.+|.+.++||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.+++++ +|||||++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~---------~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIK---------SDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSS---------TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHeEEeeEEeecCCeEEEEEEEecccc---------CCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 467778999999999999998743221 1355789999997654 445567889999999999 69999999
Q ss_pred EEEEecCCeEEEEEeccccchhhhhhhhcc------------------cCCHHHHHHHHHHHHHhhhhhccCceeeeccc
Q psy6357 304 FQVMETTNNLYLVTEYARGGEIFSHLLTIG------------------QMAEKEASRLFRQILSAVAYCHANNVVHRDIK 365 (635)
Q Consensus 304 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~------------------~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLK 365 (635)
++++.+...+|||||||++|+|.+++.... .+++..+..|+.||+.||+|||+++|||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999987543 58999999999999999999999999999999
Q ss_pred CcceeecCCCCeeeecccccccccCCC---ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q psy6357 366 AENLLFDENGDIKLADFGFSNYFTPGH---MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVT-AQLPFDGP 441 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~~~~~~---~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLlt-G~~PF~~~ 441 (635)
|+|||++.++.+||+|||+++...... .....+||+.|+|||++.+..++ .++|||||||++|||++ |.+||...
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998765432 23446789999999999887776 99999999999999998 77778776
Q ss_pred CHHHHHHHHHhC--ccCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 442 NLAVLKQRILFG--KFRIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 442 ~~~~l~~~i~~~--~~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
+.......+... ....|..++.++.+||.+||+.||.+|||+.||++
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 665544444333 33456678999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=385.25 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=204.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLFQVMET 309 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 309 (635)
-++||+|+||+||+|.+..... ....||||++++. .+....+.+.+|+++|++|+|||||++++++..
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~-----------~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 99 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG-----------KKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99 (311)
T ss_dssp EEEEEEETTEEEEEEEECC---------------CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC-----------EEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe
Confidence 3579999999999998854321 1236999999753 356677889999999999999999999999865
Q ss_pred -CCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecCCCCeeeeccccccc
Q psy6357 310 -TNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 310 -~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~~~~ikL~DFGla~~ 387 (635)
+..+++|||||++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred cCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhh
Confidence 568999999999999999887544 588899999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-----ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-ccCCCCC
Q psy6357 388 FTPGH-----MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFD-GPNLAVLKQRILFG-KFRIPFY 460 (635)
Q Consensus 388 ~~~~~-----~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~-~~~~~~l~~~i~~~-~~~~p~~ 460 (635)
..... ......||+.|+|||++....++ .++||||||++||||++|..||. ..+..++...+..+ .+..|..
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~ 258 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTT
T ss_pred ccccccccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 65332 22345689999999999888876 99999999999999999666664 44455556666555 3456778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 461 MSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 461 ~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
+++++.+||.+||..||++|||+.||++|
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-44 Score=374.50 Aligned_cols=252 Identities=20% Similarity=0.191 Sum_probs=199.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCc-eee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPH-IIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~ 302 (635)
.++|.++++||+|+||+||+|.+. .+++.||||++...... ..+.+|+++++.+.|++ |+.
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~--------------~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~ 67 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI--------------AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPT 67 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET--------------TTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEEC--------------CCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccE
Confidence 357999999999999999999872 35678999998765433 35778999999998766 555
Q ss_pred EEEEEecCCeEEEEEeccccchhhhhh-hhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC---CCCee
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSHL-LTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE---NGDIK 378 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~l-~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~---~~~ik 378 (635)
+..++.+....++|||||. ++|.+.+ .....+++..+..++.||+.||+|||++||+||||||+|||++. +..+|
T Consensus 68 ~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 68 IRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceee
Confidence 6666778889999999995 5555544 44567999999999999999999999999999999999999764 55799
Q ss_pred eecccccccccCCC--------ccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy6357 379 LADFGFSNYFTPGH--------MLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPNLAVLKQRI 450 (635)
Q Consensus 379 L~DFGla~~~~~~~--------~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~~~~l~~~i 450 (635)
|+|||+|..+.... .....+||+.|||||++.+..++ .++|||||||++|||++|..||...........+
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~ 225 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence 99999998765432 23456899999999999998886 9999999999999999999999875543322222
Q ss_pred ---HhCc-----cCCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HHcCcccccC
Q psy6357 451 ---LFGK-----FRIPFYMSAECENLIRSMLVLDPAKRLTLTQ---ISNHKWMSVH 495 (635)
Q Consensus 451 ---~~~~-----~~~p~~~s~~l~~LI~~~L~~dP~~Rps~~e---iL~Hpw~~~~ 495 (635)
.... ..++..+|+++.+||..||..||.+||++.+ +|+|+|....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 226 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 1111 1233568999999999999999999999874 5778876543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=376.35 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=191.5
Q ss_pred CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCceeeEE
Q psy6357 225 KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHIIKLF 304 (635)
Q Consensus 225 ~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~ 304 (635)
..|.+.++||+|+||+||+|.+ ++..||||++.... ........|+..+.+++|||||+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~----------------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~ 63 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW----------------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 63 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE----------------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE----------------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceE
Confidence 3455678999999999999986 34689999996542 1112223455566778999999999
Q ss_pred EEEecCC----eEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhcc--------CceeeecccCcceeec
Q psy6357 305 QVMETTN----NLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHA--------NNVVHRDIKAENLLFD 372 (635)
Q Consensus 305 ~~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs--------~gIiHrDLKp~NILl~ 372 (635)
+++.+.. .+|||||||++|+|.++|.+ ..+++..++.++.|++.||.|||+ .|||||||||+||||+
T Consensus 64 ~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~ 142 (303)
T d1vjya_ 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp EEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred EEEEeCCCcceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence 9997643 68999999999999999976 469999999999999999999996 5999999999999999
Q ss_pred CCCCeeeecccccccccCCC-----ccccccCCCCCCCccccCCCCc-----CCCccchhhHHHHHHHHHhCCCCCCC--
Q psy6357 373 ENGDIKLADFGFSNYFTPGH-----MLTTWCGSPPYAAPELFGGREY-----DGTKSDVWSLGVVLYVMVTAQLPFDG-- 440 (635)
Q Consensus 373 ~~~~ikL~DFGla~~~~~~~-----~~~~~~gt~~Y~APEvl~~~~~-----~~~ksDIwSlGvilyeLltG~~PF~~-- 440 (635)
.++.+||+|||++....... .....+||+.|+|||++.+... .+.++|||||||+||||++|..||..
T Consensus 143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99999999999998765432 2345789999999999876431 13789999999999999999887632
Q ss_pred -------------CCHHHHHHHHHhCccC--CCCC-----CCHHHHHHHHHhcccCCCCCCCHHHHHcC
Q psy6357 441 -------------PNLAVLKQRILFGKFR--IPFY-----MSAECENLIRSMLVLDPAKRLTLTQISNH 489 (635)
Q Consensus 441 -------------~~~~~l~~~i~~~~~~--~p~~-----~s~~l~~LI~~~L~~dP~~Rps~~eiL~H 489 (635)
.....+...+...... +|.. ....+.+||.+||+.||++|||+.||+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1233444444433332 2221 23568999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-43 Score=367.21 Aligned_cols=247 Identities=21% Similarity=0.214 Sum_probs=205.2
Q ss_pred cccCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC-Cce
Q psy6357 222 KLLKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH-PHI 300 (635)
Q Consensus 222 ~~~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H-pnI 300 (635)
+..++|.++++||+|+||+||+|.+. .+++.||||++...... ..+.+|+++++.|.| +||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~--------------~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i 63 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNL--------------LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGI 63 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEET--------------TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTC
T ss_pred CCCCceEEEEEEecCCCeEEEEEEEC--------------CCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCC
Confidence 34578999999999999999999873 34678999998665422 346788999999975 899
Q ss_pred eeEEEEEecCCeEEEEEeccccchhhhhhhhcc-cCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceeecC-----C
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGEIFSHLLTIG-QMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLFDE-----N 374 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~-~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl~~-----~ 374 (635)
+.+++++......|+||||| +++|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||||+. +
T Consensus 64 ~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~ 142 (293)
T d1csna_ 64 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNA 142 (293)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTT
T ss_pred CEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccC
Confidence 99999999999999999999 789988887654 6999999999999999999999999999999999999974 5
Q ss_pred CCeeeecccccccccCC--------CccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCCCCCCCCC---H
Q psy6357 375 GDIKLADFGFSNYFTPG--------HMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQLPFDGPN---L 443 (635)
Q Consensus 375 ~~ikL~DFGla~~~~~~--------~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~~PF~~~~---~ 443 (635)
+.+||+|||+|+.+... ......+||+.|||||++.+..++ .++|||||||++|||++|..||.+.. .
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred CceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 78999999999876432 224456899999999999998886 99999999999999999999997643 2
Q ss_pred HHHHHHHHhCcc-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHc
Q psy6357 444 AVLKQRILFGKF-----RIPFYMSAECENLIRSMLVLDPAKRLTLTQISN 488 (635)
Q Consensus 444 ~~l~~~i~~~~~-----~~p~~~s~~l~~LI~~~L~~dP~~Rps~~eiL~ 488 (635)
......+..... .++..+++++.+||..|+..+|++||+++.|.+
T Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 233333332211 233568899999999999999999999887754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-42 Score=367.28 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=195.5
Q ss_pred CCccc-CCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC--
Q psy6357 220 GTKLL-KPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-- 296 (635)
Q Consensus 220 ~~~~~-~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-- 296 (635)
|+.+. .+|.++++||+|+||+||+|.+. .+++.||||++++.. ...+.+.+|+.+|+.+.
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~--------------~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~ 69 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDM--------------VNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDA 69 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEET--------------TTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHT
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEEC--------------CCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcch
Confidence 45443 57999999999999999999873 456789999997643 33456778999988875
Q ss_pred ---------CCceeeEEEEEec--CCeEEEEEeccccchhhhh---hhhcccCCHHHHHHHHHHHHHhhhhhcc-Cceee
Q psy6357 297 ---------HPHIIKLFQVMET--TNNLYLVTEYARGGEIFSH---LLTIGQMAEKEASRLFRQILSAVAYCHA-NNVVH 361 (635)
Q Consensus 297 ---------HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~---l~~~~~l~e~~~~~i~~qIl~gL~~LHs-~gIiH 361 (635)
|+|||++++++.. ....++||+++..+..... ......+++..++.++.||+.||.|||+ .||+|
T Consensus 70 ~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvH 149 (362)
T d1q8ya_ 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIH 149 (362)
T ss_dssp CCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEEC
T ss_pred hhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 5789999998864 3456666666654433222 2233569999999999999999999997 89999
Q ss_pred ecccCcceeecCCC------CeeeecccccccccCCCccccccCCCCCCCccccCCCCcCCCccchhhHHHHHHHHHhCC
Q psy6357 362 RDIKAENLLFDENG------DIKLADFGFSNYFTPGHMLTTWCGSPPYAAPELFGGREYDGTKSDVWSLGVVLYVMVTAQ 435 (635)
Q Consensus 362 rDLKp~NILl~~~~------~ikL~DFGla~~~~~~~~~~~~~gt~~Y~APEvl~~~~~~~~ksDIwSlGvilyeLltG~ 435 (635)
|||||+||||+.++ .++|+|||.|..... .....+||+.|+|||++....++ .++|||||||++++|++|+
T Consensus 150 rDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 150 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGD 226 (362)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSS
T ss_pred ccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCC
Confidence 99999999998665 399999999976543 34567899999999999988886 8999999999999999999
Q ss_pred CCCCCCCHH-------HHHHHHHh-----------------------------------------CccCCCCCCCHHHHH
Q psy6357 436 LPFDGPNLA-------VLKQRILF-----------------------------------------GKFRIPFYMSAECEN 467 (635)
Q Consensus 436 ~PF~~~~~~-------~l~~~i~~-----------------------------------------~~~~~p~~~s~~l~~ 467 (635)
.||...... .+...+.. ..+.++...++++.+
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 999754311 11111000 001111124678999
Q ss_pred HHHHhcccCCCCCCCHHHHHcCcccccC
Q psy6357 468 LIRSMLVLDPAKRLTLTQISNHKWMSVH 495 (635)
Q Consensus 468 LI~~~L~~dP~~Rps~~eiL~Hpw~~~~ 495 (635)
||.+||.+||.+|||++|||+||||+..
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.8e-24 Score=203.01 Aligned_cols=135 Identities=19% Similarity=0.231 Sum_probs=106.2
Q ss_pred cceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccC----------------HHHHHHHHHHHHH
Q psy6357 228 YNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLD----------------ERNLRKLFREVDI 291 (635)
Q Consensus 228 ~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~----------------~~~~~~~~~Ei~i 291 (635)
.+-++||+|+||+||+|.+ .++..||||+++..... ......+..|+.+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~---------------~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 67 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS---------------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE---------------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred hhCCEeeeCcceEEEEEEC---------------CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHH
Confidence 3567999999999999976 24568999997532111 1122345578999
Q ss_pred HhhCCCCceeeEEEEEecCCeEEEEEeccccchhhhhhhhcccCCHHHHHHHHHHHHHhhhhhccCceeeecccCcceee
Q psy6357 292 MSHLDHPHIIKLFQVMETTNNLYLVTEYARGGEIFSHLLTIGQMAEKEASRLFRQILSAVAYCHANNVVHRDIKAENLLF 371 (635)
Q Consensus 292 L~~L~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~l~e~~~~~i~~qIl~gL~~LHs~gIiHrDLKp~NILl 371 (635)
|.++.|.+++..+++.. .+|||||+.+..+.. +++..+..++.||+.+|.|||++||+||||||+|||+
T Consensus 68 l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv 136 (191)
T d1zara2 68 LQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136 (191)
T ss_dssp HHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred HHHccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee
Confidence 99999999999887643 279999998765533 4556678899999999999999999999999999999
Q ss_pred cCCCCeeeeccccccccc
Q psy6357 372 DENGDIKLADFGFSNYFT 389 (635)
Q Consensus 372 ~~~~~ikL~DFGla~~~~ 389 (635)
+++ .++|+|||+|....
T Consensus 137 ~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp ETT-EEEECCCTTCEETT
T ss_pred eCC-CEEEEECCCcccCC
Confidence 865 58999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=5.9e-07 Score=87.66 Aligned_cols=87 Identities=14% Similarity=0.094 Sum_probs=58.8
Q ss_pred cCCccceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceee
Q psy6357 224 LKPQYNLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIK 302 (635)
Q Consensus 224 ~~~y~il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~ 302 (635)
+..|+.++..+-++.+.||.... ++..+.||+....... ....+.+|+.+|..|. +--+.+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~----------------~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~ 74 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG----------------ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPK 74 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC----------------SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe----------------CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCc
Confidence 34566666655555578886543 3456888887644221 1234678888888774 444678
Q ss_pred EEEEEecCCeEEEEEeccccchhhhh
Q psy6357 303 LFQVMETTNNLYLVTEYARGGEIFSH 328 (635)
Q Consensus 303 l~~~~~~~~~~~LV~E~~~ggsL~~~ 328 (635)
++.++...+..|+||++++|.++.+.
T Consensus 75 vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 75 VLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred EEEEEecCCceEEEEEeccccccccc
Confidence 88888888999999999998776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=1.6e-05 Score=76.67 Aligned_cols=76 Identities=13% Similarity=0.102 Sum_probs=51.8
Q ss_pred eeccccCC-cceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCC--CceeeEEEEE
Q psy6357 231 RKAGEGED-LSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDH--PHIIKLFQVM 307 (635)
Q Consensus 231 ~kLG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~ 307 (635)
..+..|.. ..||.... ..+..+.+|+...... ..+..|+.+|+.|.. -.+.+++.+.
T Consensus 16 ~~~~~G~s~~~v~r~~~---------------~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~ 75 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA---------------QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVV 75 (255)
T ss_dssp EECSCTTSSCEEEEEEC---------------TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEE
T ss_pred EEcCCcccCCeEEEEEe---------------CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeec
Confidence 34555553 56786643 2445688998755432 246678888877743 3367788888
Q ss_pred ecCCeEEEEEeccccchhh
Q psy6357 308 ETTNNLYLVTEYARGGEIF 326 (635)
Q Consensus 308 ~~~~~~~LV~E~~~ggsL~ 326 (635)
.+.+..++||++++|.++.
T Consensus 76 ~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 76 TEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSSCEEEEEECCSSEETT
T ss_pred ccccceEEEEEeeeccccc
Confidence 8888999999999887654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.68 E-value=4.5e-05 Score=79.32 Aligned_cols=80 Identities=14% Similarity=0.019 Sum_probs=48.9
Q ss_pred ceeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccc-c----CHHHHHHHHHHHHHHhhCC-C--Cce
Q psy6357 229 NLRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKR-L----DERNLRKLFREVDIMSHLD-H--PHI 300 (635)
Q Consensus 229 il~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~-~----~~~~~~~~~~Ei~iL~~L~-H--pnI 300 (635)
.++.||.|..-.||+.... ..+..|+||.-.... . ......+...|+.+|+.+. + ..+
T Consensus 30 ~~~eig~G~~N~vfrV~~~--------------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~v 95 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQ--------------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLV 95 (392)
T ss_dssp EEEECCSSSSEEEEEEEC------------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGS
T ss_pred eEEEeCCCceEeEEEEEeC--------------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCc
Confidence 3678999999999987652 123578888653210 0 0112245567888887663 2 346
Q ss_pred eeEEEEEecCCeEEEEEeccccch
Q psy6357 301 IKLFQVMETTNNLYLVTEYARGGE 324 (635)
Q Consensus 301 v~l~~~~~~~~~~~LV~E~~~ggs 324 (635)
++++.+. ....++|||++.+..
T Consensus 96 P~v~~~d--~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 96 PRVFYSD--TEMAVTVMEDLSHLK 117 (392)
T ss_dssp CCEEEEE--TTTTEEEECCCTTSE
T ss_pred ceEEEEc--CCCCEEEEeccCCcc
Confidence 6676553 345578999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.00071 Score=67.90 Aligned_cols=121 Identities=13% Similarity=0.196 Sum_probs=68.9
Q ss_pred hcCceEEEEEecccccCHHHHHHHHHHHHHHhhCCCCce--eeEE-----EEEecCCeEEEEEeccccchhhh----hhh
Q psy6357 262 EELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLDHPHI--IKLF-----QVMETTNNLYLVTEYARGGEIFS----HLL 330 (635)
Q Consensus 262 ~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~-----~~~~~~~~~~LV~E~~~ggsL~~----~l~ 330 (635)
++|..|++|+......+. +.+..|+.+|..|....| +..+ ..++.....+.|++++.|..+.. .+.
T Consensus 44 ~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~ 120 (325)
T d1zyla1 44 EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQME 120 (325)
T ss_dssp TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHH
T ss_pred CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHH
Confidence 467789999987654443 456678888888742222 2111 11244567889999997653311 000
Q ss_pred h--------------c-----ccCCH----------------------HHHHHHHHHHHHhhhhhc----cCceeeeccc
Q psy6357 331 T--------------I-----GQMAE----------------------KEASRLFRQILSAVAYCH----ANNVVHRDIK 365 (635)
Q Consensus 331 ~--------------~-----~~l~e----------------------~~~~~i~~qIl~gL~~LH----s~gIiHrDLK 365 (635)
. . ..+.. .....++.+++..+.-+- ..++||+|++
T Consensus 121 ~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh 200 (325)
T d1zyla1 121 AVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCH 200 (325)
T ss_dssp HHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCS
T ss_pred HHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCC
Confidence 0 0 00111 112223333333332221 2479999999
Q ss_pred CcceeecCCCCeeeeccccccc
Q psy6357 366 AENLLFDENGDIKLADFGFSNY 387 (635)
Q Consensus 366 p~NILl~~~~~ikL~DFGla~~ 387 (635)
+.|||++. + ..|+||+-+..
T Consensus 201 ~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 201 AGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp GGGEEESS-S-EEECCCTTCCE
T ss_pred cccEEEeC-C-ceEEechhccc
Confidence 99999974 3 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.62 E-value=0.0025 Score=65.56 Aligned_cols=81 Identities=16% Similarity=0.140 Sum_probs=52.4
Q ss_pred eeeccccCCcceeeeEeeehhhhHHHHHHHHhhcCceEEEEEecccccCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEe
Q psy6357 230 LRKAGEGEDLSQWEGMYELKKKKEEAAAAQLIEELSKVAIKIIDKKRLDERNLRKLFREVDIMSHLD-HPHIIKLFQVME 308 (635)
Q Consensus 230 l~kLG~G~fg~Vy~~~~~~~~~~~~~~~~~~~~~~~~VAIKii~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 308 (635)
+++|+-|-.=.+|++........ .......|.+++.-... .. ....+|..+++.+. +.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~-------~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPP-------IRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC-------SSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEcCCccccceEEEEeCCCCcc-------ccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 67898888889998765322110 01234568888876322 22 23457999998885 433457888875
Q ss_pred cCCeEEEEEeccccchh
Q psy6357 309 TTNNLYLVTEYARGGEI 325 (635)
Q Consensus 309 ~~~~~~LV~E~~~ggsL 325 (635)
. .+||||++|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 4 689999987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.0018 Score=64.06 Aligned_cols=30 Identities=30% Similarity=0.448 Sum_probs=27.3
Q ss_pred CceeeecccCcceeecCCCCeeeecccccc
Q psy6357 357 NNVVHRDIKAENLLFDENGDIKLADFGFSN 386 (635)
Q Consensus 357 ~gIiHrDLKp~NILl~~~~~ikL~DFGla~ 386 (635)
.|+||+|+.++|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 589999999999999988777899999885
|